{"title": "PDF", "author": "PDF", "url": "www.medicinabalear.org/pdfs/Vol37n3.pdf", "hostname": "PDF", "description": "PDF", "sitename": "PDF", "date": "PDF", "id": "PDF", "license": "PDF", "body": "PDF", "comments": "PDF", "commentsbody": "PDF", "raw_text": "PDF", "text": "www.medicinabalear.orgVOLUME 37  NUMBER 3 MAY - JUNE 2022\nMEDICINA BALEARACADEMIC  JOURNAL  \nOF HEALTH  SCIENCES\nPUBLICATION OF THE ROYAL ACADEMY OF MEDICINE OF THE BALEARIC ISLANDSA systematic review of the literature describing the outcomes of near-peer mentoringand near-peer teaching and learning programs for medical students in Iran \nEgg White Hydrolysate as a new bioactive food ingredient in the prevention ofgastrointestinal effects induced by aluminum exposure in rats \nInvestigation of the dynamic system of providing medical services in the hospital for Covid-19 disease patients \nClinical epidemiological characterization of positive cases for COVID-19 in Villa Clara. March-November 2020 \nStudy the late gadolinium enhancement (LGE) in patients with heart valvular disorders \nThe relationship between saliva and the prevalence of tooth decay: A mini review\nRelationship of maxillary anterior teeth and some facial landmarks\nStudy the antimicrobial effects of Zataria multiflora -based mouthwash on the microbial \ncommunity of dental plaques isolated from children: A candidate of novel plant-based mouthwash \nEffectiveness of an Interventional program on nurses\u2019 practices about \nthe preventive measures of transmission of COVID-19 in Baghdad Teaching Hospital\nAllocation and development of hospital formulary for obstetrics and gynecology departmentin a tertiary care teaching hospital of southwest India\nEvaluation of the menstrual cycle of female infected with SARS-CoV-2 in womenaged 36 to 45 years in iranian society\nThe effect of intraoperative subcutaneous heparin on prophylaxy of deep vein thrombosis (DVT)in surgical treatment of acetabular fractures\nQuantitative digito-palmar dermatoglyphics analysis in essential hypertension in a Nigerian population\nRelationship of muscle stretching exercise with reducing fatigue in renal failure patients chronic\nHelicobacter Pylori  infection among asymptomatic schoolchildren: Link with parental educational level\nA review on endometrial cancer; artificial intelligence, imaging modalities\nOrbital rhabdomyosarcoma in the pediatric population: A prospective, observational study from Mid-West Nepal\nMedical and psychiatric comorbidity in the patients with intellectual disabilityin a rehabilitation setting, Kingdom of Saudi Arabia\nToxicity profiles of the hydroalocholic seed extract of Psoralea Corylifolia L Fabaceae  in Wistar rats\nEvaluation of sexual dimorphism by radiographic analysis of mental orificeand mandibular height in a sample of Kurdish population of Iraq\nThe management of human papilloma virus infection: results of the paloma clinical trial and derived research projects\nCardiometabolic risk level estimated in workers with overweight/obesity.Lifestyle and sociodemographic variables  \nDigitization with 3D haptic technology in dental training\nOn the psychological levels of general population of Saudi Arabiaamidst the second wave of COVID 19: a cross sectional study  \nThe Russian flu pandemic in the Balearic Islands (1889-1892)\nDistribution of the antibiotic resistance genes amongst methicillin-resistant\nStaphylococcus aureus  bacteria isolated from human clinical infections  \nGeneralized anxiety disorder among saudi university medical students\nVaccination against human papilloma virus in men: situation and proposals\nDesmopressin as treatment of anemizing hematuria secondary to platelet dysfunction in the setting of uremia   \nMeningococcal pneumonia: a new caseAcademic Journal of Health Sciences Medicina Balear  is the organ of the Royal Academy of \nMedicine of the Balearic Island ,It was created in 1986 with the aim of following up the scientific \nconcerns and promoting the research spirit of health professionals in the Balearic Islands and with \nthe additional objective of projecting health issues of interest to society.\nCurrently Academic Journal of Health Sciences Medicina Balear  publishes in English, Spanish \nor Catalan original papers, review articles, letters to the editor and other writings of interest related \nto health sciences. The journal submits the originals to the anonymous review of at least two external \nexperts (peer review).\nThe scientific material published in AJHS Medicina Balear  is protected by copyright. AJHS \nMedicina Balear  is not responsible for the information and opinions of the authors.\nThis work-unless otherwise indicated in the text, photographs, or other illustrations-is licensed under \nthe Creative Commons NonCommercial-NoDerivativeWorks 3.0 Spain license.\nCreative Commons; http://creativecommons.org/licenses/by-nc-nd/3.0/es/. In addition, the general \npublic is authorized to reproduce, distribute and communicate the work provided that the authorship \nand the publishing entity are acknowledged and that no commercial use or derivative work is made.\nMedicina Balear is included in the Digital Library of the Balearic Islands, of the University of the \nBalearic Islands, and is included in the following databases: Emerging Sources Citation Index (ESCI), \nSherpa Romeo, Dulcinea, Latindex (cat\u00e0leg), Dialnet, \u00cdndice M\u00e9dico Espa\u00f1ol, DOAJ, Imbiomed, \nREDIB, Google Scholar and Journal Citation Indicator (JCI).\nEDIT\nRoyal Academy of Medicine of the Balearic Islands\nCampaner, 4, 07003 Palma de Mallorca Tel. 971 72 12 30 Email: info@ramib.org  \nP\u00e0gina web: http://www.ramib.org\n \nDip\u00f2sit Legal: PM 486 - 95 \neISSN: 2255 - 0569\nDesign and layout\nIntelagencia Publicitat - www.intelagencia.es - intelagencia@intelagencia.es\nwww.ramib.org \nwww.medicinabalear.org\n2020 With the collaborationA. Arturo L\u00f3pez Gonz\u00e1lez, RAMIB , \nReial Acad\u00e8mia de Medicina de les Illes Balears (RAMIB)\nJoan March Noguera, RAMIB\nMarta Couce Matovelle, Case Western Reserve University\nJos\u00e9 A. Guijarro Pastor, AEMET \u00b7 Jaume Rossell\u00f3 Mir, UIB\nJ. L. Olea Vallejo, RAMIB\nAntoni Aguil\u00f3 Pons, Universitat de les Illes Balears  \u00b7 Antonia Barcel\u00f3 \nBennassar, Hospital Son Espases  \u00b7 Bartolom\u00e9 Burguera Gonz\u00e1lez, Cleveland \nClinic (Ohio)  \u00b7 Amador Calafat Far, Socidrogalcohol  \u00b7 Valent\u00edn Esteban \nBuedo, Conselleria de Sanitat, Generalitat Valenciana  \u00b7 Carmen Gonz\u00e1lez \nBosch, Universitat de Val\u00e8ncia  \u00b7 Miguel A. Limon Pons, Institut Menorqu\u00ed \nd\u2019Estudis  \u00b7 Jordi Mart\u00ednez Serra, Hospital Son Espases \u00b7  Virgili P\u00e1ez Cervi, \nBibliosalut  \u00b7 Lucio Pallar\u00e9s Ferreres, Hospital Son Espases \u00b7 Ignacio Ricci \nCabello, University of Oxford  \u00b7 Guillermo S\u00e1ez Tormo, Universitat de Val\u00e8ncia  \n\u00b7 Ma Te\u00f3fila Vicente Herrero, IUNICS\nM\u00aa Jos\u00e9 Anad\u00f3n Baselga ( Universidad Complutense de Madrid ), Miquel Cap\u00f3 \nMart\u00ed ( Universidad Complutense de Madrid ), Antonio Coca Payeras ( Universitat \nde Barcelona ), James Drane ( Edinboro University ), Leopoldo Forner Navarro \n(Universitat de Val\u00e8ncia ), Alexandre Garc\u00eda-Mas, ( Universitat de les Illes Balears ), \nAntoni Gelabert Mas ( Universitat Aut\u00f2noma de Barcelona ), Joan Grimalt \nObrador (Consell Superior d\u2019Investigacions Cient\u00edfiques, CSIC) , Federico \nHawkins Carranza ( Universitat Complutense de Madrid ), Joan Carles March \nCerd\u00e0 (Escuela Andaluza de Salud P\u00fablica, EASP ), Gabriel Mart\u00ed Amengual \n(Universitat de Barcelona ), Jasone Monasterio Aspiri ( Universitat Aut\u00f2noma \nde Barcelona ) Rosa Pulgar Encinas ( Universidad de Granada ), Ciril Rozman \n(Universitat de Barcelona ), Joan Benejam Gual (Hospital de Manacor), Joan \nLlobera C\u00e0naves ( Atenci\u00f3 Prim\u00e0ria - Mallorca ), Jos\u00e9 Reyes Moreno ( Hospital \nde Inca ), Jos\u00e9 Mar\u00eda Vicens Colom ( Cercle d\u2019Economia de Mallorca ), Carmen \nTom\u00e1s-Valiente Lanuza ( UIB), Antonio Pareja Bezares ( Conselleria de Salut ), \nFarhad Safarpoor Dehkordi ( Tehran University ), Anton Erkoreka Barrena ( Director \ndel Museo Vasco de Historia de la Medicina y de la Ciencia ), Jos\u00e9 Ignacio \nRam\u00edrez Manent ( Atenci\u00f3n Primaria de Mallorca-Facultad de Medicina UIB ), \nColwyn M. Jones ( European Association of Dental Public Health ), P\u00e5l Barkvoll \n(Universitetet i Oslo ), Teresa Szupiany-Janeczek ( Jagiellonian University Medical \nCollege Krakow ), Yarmukhamedov Bekhzod ( Tashkent University ), Dr. Pablo \nArsenio L\u00f3pez ( Director de LA PRENSA M\u00c9DICA ARGENTINA ), Manuel Luis \nMart\u00ed ( Academia Nacional de Medicina de Buenos Aires ), Jes\u00fas Yasoda Endo \nMil\u00e1n ( Universidad de Ciencias M\u00e9dicas de Villa Clara. Cuba ), Manel Gen\u00e9 \nBadia ( Universidad de Barcelona ), Pedro Juan T\u00e1rraga L\u00f3pez ( Universidad de \nCastilla la Mancha ), Natalia Tretiak ( Poltava Ukrainian Medical & Stomatological \nAcademy ), Petro Tretiak Kravchuk ( Poltava Ukrainian Medical & Stomatological \nAcademy ), Hans A Egu\u00eda ( Dansk Selskab for Almen Medicin-DSAM ).Bimonthly journal of the Royal Academic of Medicine \nof the Balearic Island\nEditor \nAssistant manager  \nScientific editor \nEditorials consultings\nEditor-in -chief\nVowels \nEDITORIAL COUNCIL\n  \n \nSCIENTIFIC COUNCILPREMIOS DE INVESTIGACI\u00d3N\nLa Fundaci\u00f3 Patronat Cient\u00edfic  convoca los Premios de Investigaci\u00f3n Mateu Orfila , Dami\u00e0 Carb\u00f3  y \nMetge Matas  con la finalidad de premiar la trayectoria de la investigaci\u00f3n en Ciencias de la Salud  en \nnuestra comunidad.\nPREMIO FUNDACI\u00d3 MUTUAL M\u00c8DICA  \nAL MEJOR PROYECTO DE TESIS DOCTORAL  \nEl premio tiene como finalidad facilitar a los m\u00e9dicos colegiados  en las Illes Balears la obtenci\u00f3n del \nt\u00edtulo de Doctor . Con el patrocinio de la Fundaci\u00f3 Mutual M\u00e9dica .\nBECAS FUNDACI\u00d3N BANCO SABADELL \nDE ROTACI\u00d3N EXTERNA PARA M\u00c9DICOS RESIDENTES  \nFacilitar a los m\u00e9dicos que realicen la residencia en hospitales de Balears la formaci\u00f3n , al menos durante \nun mes, en centros hospitalarios nacionales y extranjeros , en los dos \u00faltimos a\u00f1os de la residencia o al \nterminar la misma. Con la colaboraci\u00f3n de la Fundaci\u00f3 Banc Sabadell .\nBECAS DE INNOVACI\u00d3N  \nTienen como objetivo facilitar a los m\u00e9dicos colegiados en las Illes Balears, excepto MIR, la formaci\u00f3n, durante \nal menos un mes, en centros sanitarios nacionales y extranjeros en t\u00e9cnicas diagn\u00f3sticas o terap\u00e9uticas. \nCERTAMEN DE CASOS CL\u00cdNICOS PARA M\u00c9DICOS RESIDENTES\nPremios a los mejores casos cl\u00ednicos presentados por m\u00e9dicos residentes colegiados en Illes Balears de \ncualquier especialidad m\u00e9dica o quir\u00fargica .\nPREMIO CAMILO JOS\u00c9 CELA DE HUMANIDADES M\u00c9DICAS \nPremio literario de \u00e1mbito nacional destinado a honrar la especial relaci\u00f3n que tuvo el Nobel con los m\u00e9dicos  \na lo largo de su vida.https://www.comib.com/premios-y-becas-de-la-fundacio-patronat-cientific-del-comib-convocatoria-2022/PREMIOS Y BECAS 2022\nwww.comib.com2022/37 (3): 76 -83VOLUME 37  NUM. 3\nMAY - JUNE 2022 CONTENTS\nEDITORIAL \nThe psychology of eating 9-10\nAndreu Genestra\nORIGINALS ARTICLES\nA systematic review of the literature describing the outcomes of near-peer mentoring 11-17and near-peer teaching and learning programs for medical students in Iran \nFaham Khamesipour, Zohreh Khoshgoftar, Nasrin Khajeali, Mohsin Yakub\nEgg White Hydrolysate as a new bioactive food ingredient in the prevention of  18-28gastrointestinal effects induced by aluminum exposure in rats \nCaroline Silveira Martinez, Jos\u00e9 Antonio Uranga Ocio, Franck Maciel Pe\u00e7anha, Dalton Valentim Vassallo, Marta Miguel, Giulia Alessandra Wiggers\nInvestigation of the dynamic system of providing medical services in the hospital  29-34for Covid-19 disease patients \nMohammad Hassan Hajian, Mina Alvandi, Ghazal Rezaei, Seyed Behnam Razavian\nClinical epidemiological characterization of positive cases for COVID-19 in Villa Clara.  35-40March-November 2020 \nOmar Mili\u00e1n Ram\u00edrez, Yakel\u00edn Luna Carvajal, Angela Moms Carballo, Yamilet Medina Padr\u00f3n, Gretza S\u00e1nchez Padr\u00f3n, Jes\u00fas Yasoda Endo Milan\u00a1\nStudy the late gadolinium enhancement (LGE) in patients with heart valvular disorders  41-45\nHamidreza Pouraliakbar, Ahmad Amin, Marzie Bazzi\nThe relationship between saliva and the prevalence of tooth decay: A mini review  46-50\nZahra Husseinzadeh\nRelationship of maxillary anterior teeth and some facial landmarks  51-57\nParviz Amini, Bahareh Saeed, Rezvan Darabi, Reza Amini, Parinaz Pourmoshrefi\nStudy the antimicrobial effects of Zataria multiflora -based mouthwash on the microbial  58-63community of dental plaques isolated from children: A candidate of novel plant-based mouthwash \nKianosh Mirzaei, Amirhossein Fathi, Seyedeh Mohadeseh Asadinejad, Nastaran Chokhachi Zadeh Moghadam\nEffectiveness of an Interventional program on nurses\u2019 practices about the preventive measures   64-69\nof transmission of COVID-19 in Baghdad Teaching Hospital  \nBasaad Salem Mahmood, Sabah Abbas Ahmed\nAllocation and development of hospital formulary for obstetrics and gynecology department  70-75in a tertiary care teaching hospital of southwest India\nSadaf Hojjati, Nisar Ahmed, Pouyan Haghpanah, Yasaman Jafarniay Jahromi\nEvaluation of the menstrual cycle of female infected with SARS-CoV-2 in women  76-79aged 36 to 45 years in iranian society\nFaegeh Miryousefiata, Ruhollah Khalil Arjmandi\nThe effect of intraoperative subcutaneous heparin on prophylaxy of deep vein thrombosis (DVT)  80-84in surgical treatment of acetabular fractures\nHassan Taleb, Mitra Ghodratizadeh, Soma Hassanzadeh\nQuantitative digito-palmar dermatoglyphics analysis in essential hypertension in a Nigerian population     85-90\nBusuyi Kolade Akinola, Toluwase Solomon Olawuyi\nRelationship of muscle stretching exercise with reducing fatigue in renal failure patients chronic  91-94\nLuvitha Herli, Elis Anggeria, Patimah Sari Siregar\nHelicobacter Pylori  infection among asymptomatic schoolchildren: Link with parental educational level   95-101\nPedro Antonio L\u00f3pez Guti\u00e9rrez, Alexandra Marcela Palma Gonz\u00e1les, Sarah Angelly Membre\u00f1o Soto, \nGabriel Isa\u00edas Rodriguez Lagos, Wadia Marie Sim\u00f3n Andonie, Blanca Nelys Licona Hern\u00e1ndez \nA review on endometrial cancer; artificial intelligence, imaging modalities 102-107\nLeila Yaminifar, Barbara Altisench Jan\u00e9, Pedro Juan T\u00e1rraga L\u00f3pez, Pooya Jafari Doudaran, Jesus Yasoda Endo Mil\u00e1n, Nafiseh Hivechi\nOrbital rhabdomyosarcoma in the pediatric population: A prospective, observational study from Mid-West Nepal  108-112\nPradeep Bastola, Sheeksha Bastola, Mandira Khadka, Sunil Koirala\nMedical and psychiatric comorbidity in the patients with intellectual disability  113-119in a rehabilitation setting, Kingdom of Saudi Arabia\nAalia Akhtar Hayat, Tabassum Alvi, Saira Farhan, Waqas Sami, Arej Habib Meny\nToxicity profiles of the hydroalocholic seed extract of Psoralea Corylifolia L Fabaceae  in Wistar rats 120-126\nSubasini Uthirapathy, Javed Ahamad\nEvaluation of sexual dimorphism by radiographic analysis of mental orifice  127-130and mandibular height in a sample of Kurdish population of Iraq\nNithin Kumar  \nThe management of human papilloma virus infection: results of the paloma  131-133clinical trial and derived research projects\nJavier Cort\u00e9s, Dami\u00e1n Dexeus, Andr\u00e9s Carlos L\u00f3pez, Luis Serrano, Fernando Losa, Josep Combalia, Carine Emsellem, Yann Gaslain, Santiago Palacios\nCardiometabolic risk level estimated in workers with overweight/obesity.  134-141Lifestyle and sociodemographic variables  \nM\u00aa Te\u00f3fila Vicente-Herrero, M\u00aa Victoria Ram\u00edrez-I\u00f1iguez de la Torre, \u00c1ngel Arturo L\u00f3pez Gonz\u00e1lez\nDigitization with 3D haptic technology in dental training 142-146\nDiego Gonz\u00e1lez-Carrasco, Pere Riutord-Sbert), Daniela Paz Vallejos Rojas, Daniel Alexander Norton, Teresa Szupiany-Janeczek, \nJorge Dom\u00ednguez P\u00e9rez, Thais Cristina Pereira, P\u00e5l Barkvoll, Pilar Tom\u00e1s Gil\nOn the psychological levels of general population of Saudi Arabia  147-151amidst the second wave of COVID 19: a cross sectional study  \nTintu Thomas Uthup, Shaima S. Ali Miraj, Mohammed AL-Mohaithef\nThe Russian flu pandemic in the Balearic Islands (1889-1892) 152-156\nJosu Hernando-P\u00e9rez, Joan March, Anton Erkoreka, Joana Maria Pujadas-Mora\nDistribution of the antibiotic resistance genes amongst methicillin-resistant  157-161Staphylococcus aureus  bacteria isolated from human clinical infections  \nAtiyeh Ziyaei Chamgordami, Hassan Momtaz, Noosha Zia-Jahromi\nGeneralized anxiety disorder among saudi university medical students 162-165\nElsadig Y. Mohamed\nSPECIAL ARTICLES\nVaccination against human papilloma virus in men: situation and proposals 166-170\nJavier Cort\u00e9s, \u00c1ngel Gil, Federico Martin\u00f3n, Francisco Xavier Bosch, Jos\u00e9 Manuel Ram\u00f3n y Cajal\nCASE REPORT\nDesmopressin as treatment of anemizing hematuria secondary to platelet dysfunction  171-172in the setting of uremia   \nLaura Aizpiri Anto\u00f1ana, Daniel Mu\u00f1oz V\u00e9lez, Enrique Carmelo Pieras Ayala\nMeningococcal pneumonia: a new case 173-174\nCarolina Quintero, Francisco L\u00f3pez, Jaime Llabr\u00e9s, Francisco Aliagawww.bancamarch.es\u00bfQu\u00e9 profesional puede\ntener 45 a\u00f1os de edad y\n90 de experiencia?\nLa respuesta es Banca March\nLa experiencia de un profesional no est\u00e1 \n\u00fanicamente en su edad, sino tambi\u00e9n en la edad de \nla firma para la que trabaja.\nY 90 a\u00f1os de experiencia es lo que ofrecen los \nprofesionales de Banca March.\n90 a\u00f1os gestionando patrimonios y demostrando \nentre otras cosas, que la prudencia no est\u00e1 re\u00f1ida \ncon la rentabilidad.2022/37 (3): 76 -83\nwww.bancamarch.es\u00bfQu\u00e9 profesional puede\ntener 45 a\u00f1os de edad y\n90 de experiencia?\nLa respuesta es Banca March\nLa experiencia de un profesional no est\u00e1 \n\u00fanicamente en su edad, sino tambi\u00e9n en la edad de \nla firma para la que trabaja.\nY 90 a\u00f1os de experiencia es lo que ofrecen los \nprofesionales de Banca March.\n90 a\u00f1os gestionando patrimonios y demostrando \nentre otras cosas, que la prudencia no est\u00e1 re\u00f1ida \ncon la rentabilidad.VOLUMEN 37  NUM. 3\nMAY - JUNE 2022 SUMARIO\nEDITORIAL \nLa psicolog\u00eda del comer  9-10\nAndreu Genestra\nART\u00cdCULOS ORIGINALES\nUna revisi\u00f3n sistem\u00e1tica de la literatura que describe los resultados de los programas 11-17de tutor\u00eda y ense\u00f1anza y aprendizaje entre pares para estudiantes de medicina en Ir\u00e1n \nFaham Khamesipour, Zohreh Khoshgoftar, Nasrin Khajeali, Mohsin Yakub\nHidrolizado de clara de huevo como nuevo ingrediente alimentario bioactivo en la prevenci\u00f3n  18-28de los efectos gastrointestinales inducidos por la exposici\u00f3n al aluminio en ratas \nCaroline Silveira Martinez, Jos\u00e9 Antonio Uranga Ocio, Franck Maciel Pe\u00e7anha, Dalton Valentim Vassallo, Marta Miguel, Giulia Alessandra Wiggers\nInvestigaci\u00f3n del sistema din\u00e1mico de prestaci\u00f3n de servicios m\u00e9dicos en el hospital  29-34para pacientes con la enfermedad de Covid-19 \nMohammad Hassan Hajian, Mina Alvandi, Ghazal Rezaei, Seyed Behnam Razavian\nCaracterizaci\u00f3n cl\u00ednico epidemiol\u00f3gica de los casos positivos a la COVID-19 en Villa Clara.  35-40Marzo-noviembre 2020 \nOmar Mili\u00e1n Ram\u00edrez, Yakel\u00edn Luna Carvajal, Angela Moms Carballo, Yamilet Medina Padr\u00f3n, Gretza S\u00e1nchez Padr\u00f3n, Jes\u00fas Yasoda Endo Milan\nEstudiar el realce tard\u00edo del gadolinio (LGE) en pacientes con trastornos valvulares del coraz\u00f3n  41-45\nHamidreza Pouraliakbar, Ahmad Amin, Marzie Bazzi\nLa relaci\u00f3n entre la saliva y la prevalencia de la caries dental: Una mini revisi\u00f3n  46-50\nZahra Husseinzadeh\nRelaci\u00f3n de los dientes maxilares anteriores y algunos puntos de referencia faciales  51-57\nParviz Amini, Bahareh Saeed, Rezvan Darabi, Reza Amini, Parinaz Pourmoshrefi\nEstudio de los efectos antimicrobianos del enjuague bucal a base de Zataria multiflora  sobre la comunidad   58-63\nmicrobiana de placas dentales aisladas de ni\u00f1os: Un candidato a enjuague bucal novedoso a base de plantas \nKianosh Mirzaei, Amirhossein Fathi, Seyedeh Mohadeseh Asadinejad, Nastaran Chokhachi Zadeh Moghadam\nEficacia de un programa de intervenci\u00f3n sobre pr\u00e1cticas de enfermer\u00eda   64-69\nsobre las medidas preventivas de transmisi\u00f3n de COVID-19 en el Hospital Docente de Bagdad  \nBasaad Salem Mahmood, Sabah Abbas Ahmed\nAsignaci\u00f3n y desarrollo del formulario hospitalario para el departamento de obstetricia  70-75y ginecolog\u00eda en un hospital universitario de atenci\u00f3n terciaria del suroeste de la India\nSadaf Hojjati, Nisar Ahmed, Pouyan Haghpanah, Yasaman Jafarniay Jahromi\nEvaluaci\u00f3n del ciclo menstrual de mujeres infectadas con SARS-CoV-2  76-79en mujeres de 36 a 45 a\u00f1os en la sociedad iran\u00ed\nFaegeh Miryousefiata, Ruhollah Khalil Arjmandi\nEl efecto de la heparina subcut\u00e1nea intraoperatoria en la profilaxis de la thrombosis venosa profunda (TVP)  80-84en el tratamiento quir\u00fargico de las fracturas acetabulares\nHassan Taleb, Mitra Ghodratizadeh, Soma Hassanzadeh\nAn\u00e1lisis cuantitativo de los dermatoglifos digito-palmares en la hipertensi\u00f3n esencial en una poblaci\u00f3n nigeriana     85-90\nBusuyi Kolade Akinola, Toluwase Solomon Olawuyi\nRelaci\u00f3n del ejercicio de estiramiento muscular con la reducci\u00f3n de la fatiga en pacientes con insuficiencia renal cr\u00f3nica  91-94\nLuvitha Herli, Elis Anggeria, Patimah Sari Siregar\nInfecci\u00f3n por Helicobacter Pylori  en escolares asintom\u00e1ticos: Relaci\u00f3n con el nivel educativo de los padres   95-101\nPedro Antonio L\u00f3pez Guti\u00e9rrez, Alexandra Marcela Palma Gonz\u00e1les, Sarah Angelly Membre\u00f1o Soto, \nGabriel Isa\u00edas Rodriguez Lagos, Wadia Marie Sim\u00f3n Andonie, Blanca Nelys Licona Hern\u00e1ndez \nUna revisi\u00f3n sobre el c\u00e1ncer de endometrio; inteligencia artificial, modalidades de imagen 102-107\nLeila Yaminifar, Barbara Altisench Jan\u00e9, Pedro Juan T\u00e1rraga L\u00f3pez, Pooya Jafari Doudaran, Jesus Yasoda Endo Mil\u00e1n, Nafiseh Hivechi\nRabdomiosarcoma orbital en la poblaci\u00f3n pedi\u00e1trica: Un estudio prospectivo y observacional del Medio Oeste de Nepal  108-112\nPradeep Bastola, Sheeksha Bastola, Mandira Khadka, Sunil Koirala\nMedical and psychiatric comorbidity in the patients with intellectual disability  113-119in a rehabilitation setting, Kingdom of Saudi Arabia\nAalia Akhtar Hayat, Tabassum Alvi, Saira Farhan, Waqas Sami, Arej Habib Meny\nPerfiles de toxicidad del extracto hidroalcoh\u00f3lico de semillas de Psoralea corylifolia L Fabaceae  en ratas Wistar  120-126\nSubasini Uthirapathy, Javed Ahamad\nEvaluaci\u00f3n del dimorfismo sexual mediante el an\u00e1lisis radiogr\u00e1fico del orificio mental  127-130y la altura mandibular en una muestra de poblaci\u00f3n kurda de Iraq\nNithin Kumar  \nEl manejo de la infecci\u00f3n por el virus del papiloma humano:  131-133resultados del ensayo cl\u00ednico paloma y proyectos de investigaci\u00f3n derivados\nJavier Cort\u00e9s, Dami\u00e1n Dexeus, Andr\u00e9s Carlos L\u00f3pez, Luis Serrano, Fernando Losa, Josep Combalia, Carine Emsellem, Yann Gaslain, Santiago Palacios\nEstimaci\u00f3n del nivel de riesgo cardiometab\u00f3lico en trabajadores con sobrepeso/obesidad.  134-141durante la pandemia Covid-19. Estilo de vida y variables sociodemogr\u00e1ficas  \nM\u00aa Te\u00f3fila Vicente-Herrero, M\u00aa Victoria Ram\u00edrez-I\u00f1iguez de la Torre, \u00c1ngel Arturo L\u00f3pez Gonz\u00e1lez\nDigitalizaci\u00f3n con tecnolog\u00eda h\u00e1ptica 3D en la formaci\u00f3n dental 142-146\nDiego Gonz\u00e1lez-Carrasco, Pere Riutord-Sbert), Daniela Paz Vallejos Rojas, Daniel Alexander Norton, Teresa Szupiany-Janeczek, \nJorge Dom\u00ednguez P\u00e9rez, Thais Cristina Pereira, P\u00e5l Barkvoll, Pilar Tom\u00e1s Gil\nSobre los niveles psicol\u00f3gicos de la poblaci\u00f3n general de Arabia Saud\u00ed  147-151en medio de la segunda ola de COVID 19: un estudio transversal  \nTintu Thomas Uthup, Shaima S. Ali Miraj, Mohammed AL-Mohaithef\nLa pandemia de gripe rusa en las Islas Baleares (1889-1892) 152-156\nJosu Hernando-P\u00e9rez, Joan March, Anton Erkoreka, Joana Maria Pujadas-Mora\nDistribuci\u00f3n de los genes de resistencia a los antibi\u00f3ticos en las bacterias Staphylococcus aureus   157-161resistentes a la meticilina aisladas de infecciones cl\u00ednicas humanas  \nAtiyeh Ziyaei Chamgordami, Hassan Momtaz, Noosha Zia-Jahromi\nTrastorno de ansiedad generalizada en estudiantes de universitarios saud\u00edes  162-165\nElsadig Y. Mohamed\nART\u00cdCULOS ESPECIALES\nVacunaci\u00f3n contra el virus del papiloma humano en hombres: situaci\u00f3n y propuestas  166-170\nJavier Cort\u00e9s, \u00c1ngel Gil, Federico Martin\u00f3n, Francisco Xavier Bosch, Jos\u00e9 Manuel Ram\u00f3n y Cajal\nESTUDIO DE CASOS\nDesmopresina como tratamiento de la hematuria anemizante secundaria  171-172a la disfunci\u00f3n plaquetaria en el contexto de la uremia \nLaura Aizpiri Anto\u00f1ana, Daniel Mu\u00f1oz V\u00e9lez, Enrique Carmelo Pieras Ayala\nNeumonia meningoc\u00f3cica: un nuevo caso 173-174\nCarolina Quintero, Francisco L\u00f3pez, Jaime Llabr\u00e9s, Francisco Aliaga.com\nHaz algo grande por tu salud\nEn Asisa somos expertos en salud y sabemos \nque el sue\u00f1o es vital para el buen \nfuncionamiento de tu coraz\u00f3n, tu cerebro y \ntodo tu organismo.\nLos especialistas determinan que una \npersona adulta necesita entre 7 y 9 horas \ndiarias de sue\u00f1o para estar bien. \nSin embargo, se estima que el 80% de los \nespa\u00f1oles duermen menos de este tiempo, exponi\u00e9ndose a sufrir hipertensi\u00f3n, \ntaquicardia, depresi\u00f3n, p\u00e9rdida de \nmemoria, sobrepeso y diabetes, entre otros \nproblemas. Y como sabes, en Asisa solo nos \npreocupa tu salud. Por eso invertimos \ntodos nuestros recursos en cuidarte , \nincluido este anuncio en el que te \naconsejamos que duermas una hora m\u00e1s \ntodos los d\u00edas.\nAsisa Palma de Mallorca.\nC/ Pere Dezcallar i Net, 10\nasisa.e s 901 10 10 10Empresa Colaboradora:Nada m\u00e1s que tu salud\nNada menos que tu saludC\nM\nY\nCM\nMY\nCY\nCMY\nK170203 AF PG. PALMA DE MALLORCA generico A4.pdf   1   3/2/17   14:249\n2022/37 (3): 9-10.com\nHaz algo grande por tu salud\nEn Asisa somos expertos en salud y sabemos \nque el sue\u00f1o es vital para el buen \nfuncionamiento de tu coraz\u00f3n, tu cerebro y \ntodo tu organismo.\nLos especialistas determinan que una \npersona adulta necesita entre 7 y 9 horas \ndiarias de sue\u00f1o para estar bien. \nSin embargo, se estima que el 80% de los \nespa\u00f1oles duermen menos de este tiempo, exponi\u00e9ndose a sufrir hipertensi\u00f3n, \ntaquicardia, depresi\u00f3n, p\u00e9rdida de \nmemoria, sobrepeso y diabetes, entre otros \nproblemas. Y como sabes, en Asisa solo nos \npreocupa tu salud. Por eso invertimos \ntodos nuestros recursos en cuidarte , \nincluido este anuncio en el que te \naconsejamos que duermas una hora m\u00e1s \ntodos los d\u00edas.\nAsisa Palma de Mallorca.\nC/ Pere Dezcallar i Net, 10\nasisa.e s 901 10 10 10Empresa Colaboradora:Nada m\u00e1s que tu salud\nNada menos que tu saludC\nM\nY\nCM\nMY\nCY\nCMY\nK170203 AF PG. PALMA DE MALLORCA generico A4.pdf   1   3/2/17   14:24\neISSN 2255-0569\nEDITORIAL\nLa psicolog\u00eda del comer\nThe psychology of eating\nAndreu Genestra\nCocinero con una estrella Michel\u00edn \nDe acuerdo que no va a tener ning\u00fan riesgo a nivel \nbacterias ni a efectos t\u00e9cnicos sanitarios pero\u2026 d\u00f3nde \nest\u00e1 el valor an\u00edmico? Acaso no importa el efecto \npsicol\u00f3gico de un paciente?\n \nPor qu\u00e9 a los ni\u00f1os peque\u00f1os se les da el pescado \npasado de cocci\u00f3n? Por qu\u00e9 las comidas no se las \nsazonamos con especias? Por qu\u00e9 las verduras, el \narroz, la pasta no se la servimos al dente?\n \nSon preguntas que desde el prisma culinario no entiendo \ny me cuestiono siempre.\nEl cerebro es nuestra fuente procesadora de est\u00edmulos, \ndonde a la hora de la alimentaci\u00f3n no solo se procesa \nla ingesta de calor\u00edas en nuestro organismo sino que \ntambi\u00e9n trabaja el sentido de la vista, el olor, el gusto, la \ntextura y los sonidos que se puedan producir.\nOlvidamos una parte muy importante de la experiencia \nde la alimentaci\u00f3n: la felicidad, el sentirnos confortables, \nsensaci\u00f3n de evadirse por un momento y centrarse en \nuno mismo, la acci\u00f3n que nos permita seguir viviendo y \nque solemos realizar unas cuantas veces durante el d\u00eda. \nDir\u00eda que es la meditaci\u00f3n m\u00e1s b\u00e1sica que conecta con \nuno mismo.\n \nDebemos remontar a nuestro primer placer innato; aquel \nque se nos ofrece al darnos el pecho de una madre, \nporque no solo es la leche materna que alimenta al \nreci\u00e9n nacido , es el olor corporal, la textura que el bebe \nrecibe al tocar con las manos el seno o el sonido que \naporta el chupar.\n \nSi nos damos cuenta la alimentaci\u00f3n no solo contribuye \nal est\u00f3mago sino al alma. Cuando cocinamos influimos a \nnuestro subconsciente con sabores como el picante o el \n\u00e1cido, toques amargos o salados o dulces , que hacen \nestremecernos.. Las texturas ya sean blandas o gelatinosas, \ncrujientes como el ma\u00edz salado o semi espesas, quedan en \nnuestro recuerdo siempre, todo es importante.\n \nLa gastronom\u00eda afecta al car\u00e1cter, a la autoestima y no \ndeja de ser un lenguaje no escrito el cu\u00e1l identificamos Me operaron de una luxaci\u00f3n externa y el \u00fanico recuerdo que tengo al salir de la \nanestesia es de hambre, mucha hambre. Crema p\u00e1lida de verduras y carne seca era \nlo que me esperaba para la primera comida despu\u00e9s de 24 horas\u2026\npara expresar un territorio, una cultura o una religi\u00f3n. \nPor qu\u00e9 la evoluci\u00f3n no nos lleva a mejorar todos esos \nestigmas sino que lo empeora? La evoluci\u00f3n nos ha \nllevado a comer de la peor manera que jam\u00e1s se ha \nproducido un alimento, por ejemplo el pan. No solo lo \nproducimos mal sino que hemos creado una legi\u00f3n de \nsoldados gastron\u00f3micos en contra del gluten\u2026 Se han \npreguntado si un pan de harinas ecol\u00f3gicas sin apenas \nrefinar tiene mucho gluten?\n \nBajo mi humilde mirada como cocinero me da pena \ncuando sin prescripci\u00f3n m\u00e9dica nos autocensuramos \nprivilegios alimenticios como pueda ser comer carne, \npescado, l\u00e1cteos\u2026 El ser humano deber\u00eda seguir la dieta \nmediterr\u00e1nea como m\u00e9todo preventivo de enfermedades, \nsin tener que tomar aditivos qu\u00edmicos o homeop\u00e1ticos \nen substituci\u00f3n de lo que encontramos en nuestros \nmercados. Dieta mediterr\u00e1nea significa temporalidad, \nbuenos productos de procedencia cercana y sobretodo \nen su justa medida.\n \nLa globalizaci\u00f3n nos lleva a consumir productos de todo \nel mundo, al menos lo creemos. El Aguacate, vegetal \nque denominamos como sano, su cultivo produce la \ndesertificaci\u00f3n de la zona por el alto consumo de agua, \nmucho m\u00e1s cal\u00f3rico que un filete y que normalmente \nnunca lo consumimos maduro al venir de la otra \nparte del mundo. Si la compar\u00e1semos con una col, \nconsiderada uno de los mejores vegetales, que su \ncultivo no es agresivo y sus propiedades alimenticias \nson incre\u00edbles? Seguramente me dir\u00e1n que no es \ntan apetecible, pero \u00bfy si se les ense\u00f1a a que sea \napetecible y f\u00e1cil?\n \nDebemos dedicarle tiempo, no hay otra. Debemos \nhacer una inversi\u00f3n a nuestra salud y bienestar. Nuestro \nrecetario local cuida de nuestro entorno, nuestra \ncultura y nuestros sabores\u2026 esa herencia transmitida \nfamiliarmente que no podemos olvidar.\n \nRecuerden ,no hay que vivir para comer sino comer para \nvivir\u2026 aunque si la comida se convierte en un acto de \ncuidar la mente, el alma y el est\u00f3mago nos aporta algo \nm\u00e1s que simple calor\u00edas\u202610\n2022/37 (3): 9-10 La psicolog\u00eda del comer Andreu Genestra  \nThey operated on me for an external dislocation and the only memory I have when I \ncome out of anesthesia is of hunger, very hungry. Pale cream of vegetables and dried \nmeat was what I expected for the first meal after 24 hours\u2026\nI agree that it will not have any risk at the bacterial level \nor for technical sanitary purposes, but\u2026 where is the \nemotional value? Doesn\u2019t the psychological effect on a \npatient matter?\nWhy are young children given overcooked fish? Why \ndon\u2019t we season foods with spices? Why are vegetables, \nrice and pasta not served al dente ?\nThese are questions that from a culinary point of view I do \nnot understand and I always question myself.\nThe brain is our processing source of stimuli, where \nat the time of feeding not only is the intake of calories \nprocessed in our body but also the sense of sight, \nsmell, taste, texture and sounds that are heard work \nthey can produce.\nWe forget a very important part of the eating experience: \nhappiness, feeling comfortable, the feeling of escaping \nfor a moment and focusing on oneself, the action that \nallows us to continue living and that us usually do a few \ntimes during the day. I would say that it is the most basic \nmeditation that connects with oneself.\nWe must go back to our first innate pleasure; the one \nthat is offered to us by giving us a mother\u2019s breast, \nbecause it is not only the breast milk that feeds the \nnewborn, it is the body odor, the texture that the baby \nreceives when touching the breast with his hands or the \nsound that the suck.\nIf we realize food not only contributes to the stomach \nbut also to the soul. When we cook we influence our \nsubconscious with flavors such as spicy or acid, bitter \nor salty or sweet touches, which make us shudder. \nThe textures, whether soft or gelatinous, crunchy like \nsalted corn or semi thick, always remain in our memory, \neverything is important.\nGastronomy affects character, self-esteem and is still an \nunwritten language that we identify to express a territory, a culture or a religion. Why does evolution not lead us \nto improve all these stigmas but rather worsens them? \nEvolution has led us to eat in the worst way that food \nhas ever been produced, for example BREAD. Not only \ndo we produce it poorly, but we have created a legion \nof gastronomic soldiers against gluten. Have you ever \nwondered if a bread made from organic flour with hardly \nany refinement has a lot of gluten? \nUnder my humble gaze as a cook, it pains me to observe \nhow when, without a medical prescription, we self-censor \nfood privileges such as eating meat, fish, dairy products... \nHuman beings should follow the Mediterranean diet as a \npreventive method for diseases, without having to take \nchemical additives or homeopathic in substitution of \nwhat we find in our markets. Mediterranean diet means \ntemporality, good products from nearby sources and \nabove all in the right measure.\nGlobalization leads us to consume products from \nall over the world, at least we think so. Avocado is a \nvegetable that we consider healthy, but its cultivation \nproduces desertification in the area due to the high water \nconsumption it requires, it is much more caloric than a \nsteak and, moreover, we normally never consume it ripe \nas it comes from the other part of the world. What if we \ncompared it to a cabbage, which should be considered \none of the best vegetables, with a non-aggressive \ncultivation and incredible nutritional properties? Surely \nthey will tell me that it is not so appetizing, but what if it is \ntaught to be appetizing and easy?\nWe must dedicate time to it, there is no other. We must \nmake an investment in our health and well-being. Our \nlocal cookbook takes care of our environment, our \nculture and our flavors, that family-transmitted heritage \nthat we cannot forget.\n Remember, you don\u2019t have to live to eat but eat to live... \nalthough if food becomes an act of caring for the mind, \nsoul and stomach, it gives us something more than \nsimple calories...11\n2022/37 (3): 11-17Received:  7 - II - 2022\nAccepted:  27 - II - 2022\ndoi: 10.3306/AJHS.2022.37.03.11Corresponding author\nFaham Khamesipour  \nE-mail: faham.khamesipour@yahoo.com  \nAbstract  \nIntroduction and objective:  The complex or peculiar nature of medical studies does not always allow all students to succeed \nin Iran\u2019s academic experiences. The first year of medical studies, for example, is described as stressful and difficult for students. \nApproaches such as near-peer mentoring and near-peer teaching can be instrumental in supporting students. \nMethods:  This systematic review aims to analyze the literature describing the outcomes of near-peer mentoring and near-peer \nteaching and learning programs for medical students in Iran. Scientific databases were explored using keywords such as near-peer \nmentoring, near-peer teaching, medical students, peer coaching, peer advice, peer guidance, big brothers big sisters mentoring \nprogram, peer support and peer counseling, Iran. Out of 17845 studies initially identified, about 14 met the inclusion criteria \n(programs involving medical students, regardless of the year of study, mentors close to their peers, i.e., in the second year, but not \nlimited to, program located in Iran). The drafting was done according to PRISMA standards.  \nResults:  The results show that there are several outcomes for near-peer mentoring and near-peer teaching. The primary identified \noutcomes are positive relationships, improving academic support, improving psychosocial support, and developing specific \nprofessional skills. \nConclusion: We conclude that near-peer mentoring and near-peer teaching can help students\u2019 support and capacity building \namong medical students in Iran.\nKeywords:  Near-peer mentoring, near-peer teaching, medical students. \nResumen\nIntroducci\u00f3n y objetivos:  La naturaleza compleja o peculiar de los estudios de medicina no siempre permite a todos los estu -\ndiantes tener \u00e9xito en las experiencias acad\u00e9micas de Ir\u00e1n. El primer a\u00f1o de los estudios de medicina, por ejemplo, se describe \ncomo estresante y dif\u00edcil para los estudiantes. Enfoques como la tutor\u00eda y la ense\u00f1anza entre pares pueden ser fundamentales \npara apoyar a los estudiantes. Esta revisi\u00f3n sistem\u00e1tica tiene como objetivo analizar la literatura que describe los resultados de los \nprogramas de tutor\u00eda y ense\u00f1anza cercana a los pares para estudiantes de medicina en Ir\u00e1n. \nMetodolog\u00eda: Se exploraron las bases de datos cient\u00edficas con palabras clave como near-peer mentoring, near-peer teaching, \nmedical students, peer coaching, peer advice, peer guidance, big brothers big sisters mentoring program, peer support and peer \ncounseling, Iran. De los 17845 estudios identificados inicialmente, unos 14 cumplieron los criterios de inclusi\u00f3n (programas con \nestudiantes de medicina, independientemente del a\u00f1o de estudio, mentores cercanos a sus pares, es decir, en el segundo a\u00f1o, \npero sin limitarse a ellos, programa ubicado en Ir\u00e1n). La redacci\u00f3n se realiz\u00f3 seg\u00fan las normas PRISMA.  \nResultados:  Los resultados muestran que hay varios trabajos para la tutor\u00eda cercana a los pares y la ense\u00f1anza cercana a los \npares. Los principales resultados identificados son las relaciones positivas, la mejora del apoyo acad\u00e9mico, la mejora del apoyo \npsicosocial y el desarrollo de habilidades profesionales espec\u00edficas. \nConclusi\u00f3n:  Llegamos a la conclusi\u00f3n de que la tutor\u00eda entre pares y la ense\u00f1anza entre pares pueden contribuir al apoyo y al \ndesarrollo de capacidades de los estudiantes de medicina en Ir\u00e1n.\nPalabras clave: Tutor\u00eda entre pares, ense\u00f1anza entre pares, estudiantes de medicina. ORIGINAL\nA systematic review of the literature describing the outcomes \nof near-peer mentoring and near-peer teaching and learning \nprograms for medical students in Iran \nUna revisi\u00f3n sistem\u00e1tica de la literatura que describe los resultados de los programas \nde tutor\u00eda y ense\u00f1anza y aprendizaje entre pares para estudiantes de medicina en Ir\u00e1n \nFaham Khamesipour1      , Zohreh Khoshgoftar1      , Nasrin Khajeali2      , Mohsin Yakub3      \n1. Virtual School of Medical Education and Management, Shahid Beheshti University of Medical Sciences, Tehran, Iran\n2. Department of Medical Education, Fasa University of Medical Sciences, Fasa, Iran\n3. Department of Medical Education, School of Medicine, California University of Science & Medicine, Colton, California, USAeISSN 2255-0569\nID ID ID ID12\n2022/37 (3): 11-17Faham Khamesipour et al.  \nIntroduction \nPeer mentoring is designed to help to matriculate \nmedical students reach their potential through supported \nmatches with other medical students in the second \nyear or above. Many universities worldwide are opting \nfor near-peer mentoring and near-peer teaching and \nlearning programs to help medical students and ensure \ntheir success. In their admissions process, several \nmedical schools highlight peer mentoring in the support \nsystem that the school offers to their students. Such a \nprogram focuses on young minds development, and \nthe peer acts as a role model and provides guidance \nto the junior students through a relationship based on \ntrust and caring. This type of mentoring or support meets \nseveral requirements: the great diversity of students, the \nimpossibility for faculty mentors to provide personalized \nsupport to each student, etc. New student support \nenables new students to deal with students\u2019 diversity and \nthe problems resulting1.\nPeer mentoring can be defined as a formal relationship \nin which a more qualified student provides guidance and \nsupport to another student2. It is an academic relationship \nin which a senior learner (a year or more above) provides \nguidance and support to a new (junior) learner to enable \nhim to navigate their education3. Peer education is close \nto a subset of peer education, in which the \u201cteacher\u201d has \nexperiences approximately \u201c2 to 5\u201d years more than a \n\u201cstudent\u201d4.\nThe benefits of near-peer mentoring and near-peer \nteaching have been reported in several studies. \nAnalyzing the literature on near-peer mentoring \nprograms\u2019 outcomes, Akinla et al. (2018)3 have identified \nthree primary outcomes: professional and personal \ndevelopment, stress reduction, and ease of transitioning. \nPrevious scientific evidence reports that mentoring helps \nto reduce stress and makes it easier for first-year medical \nstudents to adjust5.\nPrevious data attributed beneficial effects to near-peer \nmentoring and near-peer teaching that deserve to \nbe studied and valued in Iran. This systematic review \nproposes to analyze literature describing the outcomes of \nnear-peer mentoring and near-peer teaching and learning \nprograms for medical students in Iran. This will also \ninvolve; describing the effects of near-peer mentoring \nschemes and near-peer teaching and learning programs \nfor medical sciences students in Iran\u2019s transition phase. \nComparison with other countries, identifying similar \nmentoring programs in medical sciences schools in \nalready published literature, and determining how the \nevaluation was carried out in such programs. All this will \nmake it possible to decide the factors involved in effective \npeer mentoring programs and the outcomes\u2019 scope in \nsupporting success.Methodology\nThe method used to carry out this systematic review \nwas instigated by that used by Akinla et al.3, with several \nmodifications. The PRISMA guidelines are observed \nstrictly throughout the search. The data collection and \nprocessing considered four main stages.\nEligibility criteria: The most relevant articles from Iran \nwithout regard to the publication year were selected based \non the keywords searched, the rigor of the methodology \nused and the conclusions drawn. The articles were in \nEnglish or Arabic and the impact factor of the publication \njournal was also considered. The programs presented in \neach article concern the first-year medical school student \nand lasted an average of one year. Evaluations of the \nprograms were done throughout the program or at the \nend depending on the study.\nInformation sources:  The targeted databases were \nPubMed, Google Scholar, Embase, SID, Magiran, \nand Scopus. They were screened from January to \nFebruary 2021.\nSearch and study selection:  Equations were designed \nfrom the keywords to research the databases. PRISMA \nFlowchart showing search process and study selection \nare presented in figure 1 .\nData collection process and data items:  Data were \nextracted from the reports using pre-designed forms. \nThe data collected was considered true. No confirmation \nwas made with the investigators.\nDefinition of a hierarchy of evidence:  To optimize \nthe bibliographic search quality and identify the most \nrelevant articles, the hierarchy of evidence successively \nconsidered randomized controlled trials, systematic \nreviews, quantitative studies, qualitative studies/policy \ndocuments, and finally, experts\u2019 opinions. \nKeywords:  Equations were designed from the following \nkeywords to carry out the research (\u2018\u2019near-peer mentoring \n\u201cOR\u201d near-peer teaching\u201d) AND \u201c \u2018medical student\u2019 \u201cAND \nIran; \u201cnear-peer mentoring\u201d AND Iran; \u201cpeer coaching\u201d \nOR \u201cpeer advice\u201d OR \u201cpeer guidance\u201d OR \u201cbig brothers \nbig sisters mentoring program\u201d OR \u201cpeer support and \npeer counseling\u201d AND \u2018\u2019medical student\u2019 \u2018AND Iran etc.\nInclusion criteria:  \nInclusion criteria are:\n1. programs involving medical students, regardless of the \nyear of study, \n2. Mentors should be close to their peers, i.e., in the \nsecond year, but not limited to\n3. Program located in Iran. No restrictions were made \nregarding the year in which the study was carried out.13\n2022/37 (3): 11-17A systematic review of the literature describing the outcomes of near-peer mentoring and near-peer teaching and learning programs for medical students in Iran\nExclusion criteria:  \nExclusion criteria are\n1. lack of sufficient detail about the program and its \noutcomes\n2. Duplicate contents in the articles\n3. A mentor is close to their peers (faculty mentor\u2026)\n4. Mentorship programs inadequately described, i.e., \nlacking details on structure, objectives, and/or evaluation\n5. Programs aimed at recruiting students to particular \nspecialties or field of interests\n6. Mentorship program not related to medical student\nAnalysis and processing of articles: At the end of the \nprocess, 14 articles were retained ( figure 1 ). Their \nanalysis took into account the recommendations of \nLincoln and Guba6. The recurring codes in the articles \nwere used to write the results.Results\nStudy selection and characteristics:  14 articles \nwere selected, evaluated for eligibility, and included in the \njournal from a total of 17875 articles.\nDescription of each program:  The inclusion criteria \nidentified six main programs whose characteristics are \nsummarized in table I .\nThe dual mentoring program from Tehran University \nof Medical Sciences (TUMS), School of Medicine:  \nIn 2011, Tehran University of Medical Sciences (TUMS), \nSchool of Medicine launched the dual mentoring \nprogram7. One of the particularities of this program \nwas the students\u2019 involvement from the beginning. Four \nvolunteer fifth-year medical students received approval \nfrom the school administration to organize the program. \nFigure 1: PRISMA Flowchart showing search process and study selection. 14\n2022/37 (3): 11-17Faham Khamesipour et al.  \nTable I: Anthropometric, clinical and analytical characteristics of participants in the study. \nN Program Academic Launch Aim Actors Characteristics Main References\n Name  institutions year  involved of mentees outcomes\n      and mentor \ndual mentoring \nprogram\nmentoring \nprogram\nnear-peer \neducation\nPeer Assisted \nLearning \nApproach on \nclinical\nSelf-efficacy \nof Nursing \nStudents\nPeer mentoring \nfor medical \nstudents during \nthe COVID-19 \npandemic via \na social media \nplatform1\n2\n3\n4\n5Tehran University of \nMedical Sciences \n(TUMS), School of \nMedicine\nShiraz Medical \nSchool\nNursing students of \nIlam University of\nMedical Sciences\nIslamic Azad \nUniversity of Tehran \nMedical Sciences \nBranch\n3.1.5. Peer mentoring \nfor medical students \nduring the COVID-19 \npandemic via a \nsocial media platformassist the first-year \nmedical students\nassist the first-year \nmedical students\ndetermine the effect \nof two\neducational methods \n(Near-Peer and \nInstructor) on hand\nhygiene skills \nlearning in nursing \nstudents\nEvaluate the effect of \nusing Peer Assisted\nLearning approach \non\nClinical self-efficacy \nof nursing students \nin selected fields of \nIslamic Azad\nUniversity of Medical \nSciences in Tehran\nShiraz University of \nMedical SciencesMentor, mentee, \na faculty member\nMentor, mentee, \na full academic \nprofessor with \nexperiences in \nmedical science\nnear-pear and \nstudents\nPeer-assisted \nlearner\nNursing students\nPeer mentors\nmenteeindividual \nmentee, two \nstudents (one in \nthe clinical phase \nand another in \nthe preclinical \nphase)\nThree mentees \nassigned to one \nmentor\nthe first-year \nnursing students \nas a mentee\nthe last year \nnursing\nstudents as \nnear-peer\nPeer-assisted \nlearner\nAssisted nursing \nstudents\n371 \nundergraduate \nstudents (as \nmentee) were \nassisted by \nten final year \nstudents (as peer \nmentors)helpful in guiding \nstudents on their \nfirst-year courses, \nclinical mentors \nwere effective \nin shaping \nthe mentees\u2019 \nprofessional \nidentity and \npromoting their\ninterests in basic \nscience subjects\nadjusting faster \nto the new \nconditions\nsignificant \nincrease of grade \npoint average\nDeveloping \nspecific \nprofessional \n(hand hygiene by \nNurses students)\nIncreasing clinical \nself-efficacy of \nnursing students\nimpact in helping \nstudents adapt \nmore quickly \nto the current \nemergency \ncondition; \nParticipation \nin this initiative \nwould have been \nbeneficial for \ntheir professional \ndevelopment[7]\n[8]\n[9]\n[10]\n[11]2011\nJuly \n2015\n2020\n2016\n2020The actors involved:  The actors involved in the program \nare 12 medical students (as mentors): 6 from the clinical \nphase and six from the preclinical phase, with a faculty \nfrom the school involved in the mentors\u2019 supervision.\nCharacteristics and preparation of the actors : \nAn initial preparation phase trained the mentors in \ncommunication techniques and the fundamentals of \nmentoring. Mentoring pairs were then formed (a clinical \nmentor linked to a preclinical mentor) and named dual \nmentoring. Thirty-six mentees were randomly selected \nfrom among 150 first-year medical students. \nPractical implementation:  Mentors and mentees \nwere expected to communicate through the following \nmeans: telephone calls (once a week at the beginning \nto form the mentor-mentee relationship, which was \ngradually reduced to once every three weeks at the end of the program); e-mail or virtual modalities (including \ne-mail templates, addressing common first-year student \nproblems and learning concepts and skills); and face-to-\nface meetings (individually or in groups). Meetings with \nrole models (those who have been successful in junior \nclinical medical schools) were also part of the program. \nDue to the likely limitations of the student mentors\u2019 \nconsulting abilities in psychology, education, or finance, \na referral system was developed to direct recipients to \nuniversity support or leadership centers, as appropriate. \nAlso, regular weekly inter mentor sessions were \norganized so that mentors could exchange ideas and \nshare their experiences. To identify the program\u2019s reach, \nimpact, and outcome, researchers conducted a study \ninvolving all mentors (n=12) and a group of mentees \n(n=21). Through group discussions, the perceptions of \nthe stakeholders were collected.15\n2022/37 (3): 11-17A systematic review of the literature describing the outcomes of near-peer mentoring and near-peer teaching and learning programs for medical students in Iran\nMentoring program from Shiraz Medical School\nActors involved and their characteristics:  Fifteen \nhigh-caliber medical students (third or fifth semester) with \ngood communication skills were invited to participate in \nthe program as mentors.\nPractical implementation: A preparation phase took \nplace to train the new mentors. Workshops were held \nto build their unique teaching and learning methods, \ncommunication, and consultation techniques. Three \nmentees were placed under the responsibility of a \nmentor. Good communication between the mentor and \nmentees was a criterion for selection. An experienced full \nprofessor acted as a supervisor.\nEvaluation:  The program\u2019s effectiveness was evaluated \nat the end of the first year of the study through a \nquestionnaire (containing five questions) addressed to \nthe mentees8.\nNear peer teaching on hand hygiene skills \nlearning in nursing students of Ilam University \nof Medical Sciences:  In this case, researchers \nused a near-peer teaching method to evaluate \nits impact on learning hand hygiene skills in Ilam \nUniversity of Medical Sciences nursing students9. \nActors and preparation: A mentor group comprises \nfive top-scoring final year students with good speaking \nskills and sufficient teaching proficiency. They are \nselected and trained.\nPractical implementation:  Eight first-year students \nwere assigned to a near-peer mentoring. Exercises \nwere performed in 3 sessions of 30 to 45 minutes each \nover two weeks. The control group was trained by the \ninstructor according to the usual methods of the faculty. \nAll students were evaluated after four weeks of training.\nPeer-assisted learning approach on clinical \nself-efficacy of nursing students at Islamic \nAzad University of Tehran Medical Sciences \nBranch:  Experimenting with this type of learning \nled to dividing the subjects (into two case groups \nand a simple random sampling control group); \nthe control group received conventional methods \n(by the clinical instructor) and the case groups \nby peer learning, and received clinical training for \nthree weeks. The data collection tool included \npsychometric questionnaires to assess self-\nefficacy in clinical practice with a 4-point Likert \nscale in 4 domains10.\nPeer mentoring for medical students during \nthe COVID-19 pandemic via a social media \nplatform:  To help medical students manage the \nstress and anxiety associated with universities\u2019 temporary closure during the COVID-19 pandemic, \na virtual social platform was created with Shiraz \nUniversity\u2019s medical school students. Through \nthis platform, high-level medical students were \nable to mentor and assist undergraduate medical \nstudents. The study involved 371 undergraduate \nstudents and ten final-year students as experts \n(with experienced professors). Discussions \nfocused on managing stress and anxiety and how \nto organize one\u2019s work time during the pandemic.\nThe evaluation involved the use of a questionnaire to \nmeasure the effects of this activity. 71% of early-career \nmedical students felt that the social media platform had \na significant impact in helping them adapt more quickly \nto the current emergency conditions. Participation in this \ninitiative would have been beneficial for their professional \ndevelopment11. \nThe effect of peer mentoring program \nperformance on clinical function in second-\nsemester nursing students: For this program \n44-second semester nursing students were \nselected by census and meeting pre-determined \ninclusion criteria, were randomly assigned into two \ngroups: a control group (21) and an intervention \ngroup (23). The control group received clinical \ninstruction using the traditional method and the \nsecond group received instruction based on the \npeer mentoring program. In the intervention group, \na 7th-semester mentor was assigned to 5-4 \nsecond-semester students. The mentors were to \nguide and support the younger students12.\nOutcomes\nPositive Relationship:  Mentors involved in the dual-\nmentoring of Tehran University of Medical Sciences \n(TUMS), School of Medicine, felt that mentoring was a \nreliable, persistent, and systematic relationship7.\nAcademic support:  Improved academic support is \na reported outcome in all identified programs. In dual-\nmentoring, the mentees felt that the mentors provided \nthem with a great deal of academic support, especially \nwhen preparing for exams7. A significant increase in \naverage scores was observed in the mentees\u2019 scores in \nthe mentoring program of Shiraz Medical School8. \nPsychosocial Support:  Psychosocial benefits include \nincreased motivation and hope for mentees and reduced \nstress in the face of difficulties7. The evaluation of Shiraz \nMedical School\u2019s mentoring program showed that 53% of \nmentees impacted their ability to adapt to new situations8.\nDeveloping specific Professional skills:  The \nexample of Near peer teaching on hand hygiene skills \nlearning in nursing students of Ilam University of Medical 16\n2022/37 (3): 11-17Faham Khamesipour et al.  \nSciences is illustrative since the study did not focus on a \nset of academic activities over a year but the development \nof a specific competency. The results showed that the \nscores for hand hygiene competency in the Peer group \npost-test were significantly higher than those before the \nintervention (P<0.001). Also, scores for hand hygiene \ncompetence between post-test \u201cNear-Peer\u201d group were \nsignificantly higher than the instructor group (P<0.001)9. \nIn the same sense, the peer-assisted learning approach \nexperimented at Islamic Azad University of Tehran Medical \nSciences Branch has resulted in increased clinical self-\nefficacy of nursing students10.\nIncreasing the mentors\u2019 abilities and social skills:  \nIn Peer mentoring for medical students during the \nCOVID-19 pandemic via a social media platform at Shiraz \nUniversity of Medical Sciences, the activity would have \ncontributed to strengthening the mentors\u2019 professional \nskills as future physicians11.\nDiscussion\nThis systematic review aimed to analyze the literature \ndescribing the outcomes of near-peer mentoring and \nnear-peer teaching and learning programs for medical \nstudents in Iran. The inclusion criteria identified six main \nprograms, with each of the specific characteristics. \nIn the analysis, we found that the various studies\u2019 \noutcomes are similar, with benefits for both the mentor \nand the mentees. The primary outcomes are positive \nrelationships, academic support, psychosocial support, \ndeveloping specific professional skills, and increasing the \nmentors\u2019 abilities and social skills. Several studies have \nalso highlighted such outcomes for medical student\u2019s \nmentoring programs. According to13, \u201cClinical mentoring \nprograms help to develop students\u2019 clinical skills and can \nincrease interest in under-subscribed specialties.\u201d Also, \npositive mentoring can have a significant influence on \nspecialty choice. \nThere are many similarities between the programs \nidentified in Iran and some mentoring programs in other \ncountries. Many dissimilarities also exist. Examining \nthese two aspects allows you to draw your conclusions \nabout the prospects for improving programs in Iran. The \nBigSib student peer mentoring program, for example, \nhas been implemented at Universiti Sains Malaysia \nmedical school to enhance and strengthen the training \nof medical students in soft skills and professional \ndevelopment. A study reported a percentage of 45.9% of \nstudents perceiving the program as a success. It would \nhelp develop the interpersonal skills and professionalism \nof students. It is a kind of platform that puts second-\nyear medical students and first-year medical students \nin interaction. The BigSibs are a group of second-\nyear medical students selected based on academic \nperformance and attitude. The roles of BigSib are to act as Siblings, Eyes, and Ears for the School, Counselor, \nRole-model and Trainer (SECRET). As siblings, they are \nexpected to share experiences, support, and help the \njuniors14. Medical Education Unit of University College of \nMedical Sciences, Delhi, initiated in 2009 a mentorship \nprogram in which volunteer teachers mentored first-\nyear medical students. The mentor was responsible \nfor interacting with the new students and providing \nthem with an immediate support network15. In 2010, \nthe program\u2019s evaluation results led to introducing a \nnew mentoring style based on \u201cnear-peers.\u201d An older or \nmore competent peer act as a mentor to a younger one. \nResults from a study designed to gather the perceptions \nof mentors and mentees of the program showed that \nmentees liked the impacts of the experience to the point \nthat they, in turn, wanted to be mentors5.\nMedical students generally need the more experienced \nseniors to guide them16. Participants in this study \nmentioned that the formal mentor-mentee relationship is \nmore effective because of the reciprocal commitment and \nreliable, accurate, and specific advice from the mentors. \nBased on the results, dual mentoring was successful \nbecause the preclinical mentors were successful in their \nmission to guide students on their first-year courses and \nexams. The clinical mentors were effective in establishing \nthe professional identity of the mentees. The system of \ninvolving multiple mentors in medical students has been \nshown to resolve differences between faculty mentors \nand mentees17-19. \nHowever, although few studies have demonstrated the \neffects of mentoring on mentors, those who participated \nin this program felt that the relationship established with \ntheir mentees was very beneficial to them. It increased \ntheir personal and social skills but also gave them a sense \nof satisfaction, which is consistent with the results of other \npeer mentoring programs20,21. From a resource-saving \nperspective, student-led mentoring programs are proving \nto be an effective alternative to school-based programs. \nHowever, independence from school administrations may \nresult in the loss of some important support systems. \nFornari et al. (2014) reported that most schools house their \nmentoring programs in the office of student affairs and the \noffice of academic affairs without any accountability given \nto undergraduate medical students22. \nLimitations \nAs a limitation of this program, the views of mentors and \nmentees were identified using a qualitative methodology. \nAnalysis of the short- and long-term outcomes of the \nmentoring program in terms of academic improvement \ncould certainly quantitatively improve understanding of the \nprogram. Another limitation is that the mentoring program \nwas established only for first-year medical students, so \ndifferent results could be obtained from other students. 17\n2022/37 (3): 11-17A systematic review of the literature describing the outcomes of near-peer mentoring and near-peer teaching and learning programs for medical students in Iran\nConclusions\nWe conclude that near-peer mentoring and near-peer \nteaching can help students\u2019 support and capacity \nbuilding among medical students in Iran.\nList of Abbreviations \nPRISMA: Preferred Reporting Items for Systematic \nReviews and Meta-Analyses; TUMS: Tehran University \nof Medical Sciences; SECRET: School, Counselor, Role-\nmodel and Trainer.\nCompeting interests \nThe authors declare that they have no competing \ninterests.Funding  \nNo Funding was received for this study. \nAuthors\u2019 contributions \nAll authors were involved in data curation, formal analysis, \ninvestigation, methodology and reviewing and editing \nthe manuscript. All authors have read and approved the \nmanuscript. \nAcknowledgements \nWe would like to express our appreciation to Vice-\nPresident, Research of Shahid Beheshti University of \nMedical Sciences.\nReferences\n1. Quesnel M, King J, Guilcher S, Evans C. The Knowledge, Attitudes, \nand Practices of Canadian Master of Physical Therapy Students \nRegarding Peer Mentorship. Physiother Can 2012; 64: 65\u201376. https://\ndoi.org/10.3138/ptc.2011-02.\n2. Kram K. 1988. Mentoring at Work: Developmental Relationships in \nOrganizational Life, New Ed \u00e9dition. ed. University Press of America, \nLanham Md.\n3. Akinla O, Hagan P , Atiomo W. A systematic review of the literature \ndescribing the outcomes of near-peer mentoring programs for first \nyear medical students. BMC Med Educ 2018; 18: 1\u201310. https://doi.\norg/10.1186/s12909-018-1195-1\n4. Singh S. Near-peer role modeling: the fledgling scholars education \nparadigm. Anat Sci Educ 2010; 3: 50\u201351. https://doi.org/10.1002/\nase.126\n5. Singh S, Singh N, Dhaliwal U. Near-peer mentoring to complement \nfaculty mentoring of first-year medical students in India. J Educ Eval Health \nProf 2014; 11. https://doi.org/10.3352/jeehp.2014.11.12\n6. Lincoln YS, Guba EG. 1985. Naturalistic Inquiry. SAGE.\n7. Abdolalizadeh P , Pourhassan S, Gandomkar R, Heidari F, Alam A, \nSohrabpour AA. Dual peer mentoring program: exploring the perceptions \nof mentors and mentees. Med J Islam Repub Iran 2017; 31: 2\u20136. https://\ndoi.org/10.18869/mjiri.31.2\n8. Ghahramani S, Seddigh F, Jahromi A, Khandel A, Nematollahi P , \nHashempoor Z, Rastegar Kazerooni A. Mentoring medical students \nby their Peers, Three Years\u2019 experience at Shiraz Medical School. J \nAdv Med Educ Prof 2019; 7: 156\u2013157. https://doi.org/10.30476/\nJAMP .2019.45018\n9. Shohani M, Moradi S, Khorshidi A, Jalilian M. Comparison of the effect \nof \u201cnear-peer\u201d teaching and trainer on hand hygiene in first year nursing \nstudents of Ilam University of Medical Sciences. 2020; Issue S 10, 5.\n10. Samaneh P , Mahboubeh S, Soheila M, Shiva S, Simin EPZ, Hooman \nB. Effect of using peer assisted learning approach on clinical self-efficacy \nof nursing students at Islamic Azad University of Tehran medical Sciences \nBranch. JNE 2018; 6: 8-15.\n11. Rastegar Kazerooni A, Amini M, Tabari P , Moosavi M. Peer mentoring \nfor medical students during the COVID-19 pandemic via a social \nmedia platform. Med Educ 2020; 54: 762-3. https://doi.org/10.1111/\nmedu.1420612. Bagherieh F, Maslakpak MH, Khalkhali H. THE EFFECT OF PEER \nMENTORING PROGRAM PERFORMANCE ON CLINICAL FUNCTION IN \nSECOND SEMESTER NURSING STUDENTS. J Urmia Nurs Midwifery \nFac 2013; 10: 749.\n13. Nimmons D, Giny S, Rosenthal J. Medical student mentoring \nprograms: current insights. Adv Med Educ Pract 2019; 10: 113\u2013123. \nhttps://doi.org/10.2147/AMEP .S154974\n14. Yusoff MSB, Rahim F, Noor A, Azwany Y, Hussin M. Evaluation of \nmedical students\u2019 perception towards the BigSib programme in the \nSchool of Medical Sciences, Universiti Sains Malaysia. Educ Med J 2009; \n2: https://doi.org/10.5959/eimj.2.1.2010.or1\n15. Bhatia A, Singh N, Dhaliwal U. Mentoring for first year medical \nstudents: humanising medical education. Indian J Med Ethics 2013; 10: \n100\u2013103. https://doi.org/10.20529/IJME.2013.030\n16. Murr AH, Miller C, Papadakis M. Mentorship through advisory colleges. \nAcad Med J Assoc Am Med Coll 2002; 77: 1172\u20131173. https://doi.\norg/10.1097/00001888-200211000-00042\n17. Jackson VA, Palepu A, Szalacha L, Caswell C, Carr PL, Inui T. \n\u201cHaving the right chemistry\u201d: a qualitative study of mentoring in academic \nmedicine. Acad Med J Assoc Am Med Coll 2003; 78: 328-34. https://\ndoi.org/10.1097/00001888-200303000-00020\n18. Koopman RJ, Thiedke CC. Views of family medicine department \nChairs about mentoring junior faculty. Med Teach 2005; 27: 734-7. \nhttps://doi.org/10.1080/01421590500271209\n19. Straus SE, Chatur F, Taylor M. Issues in the mentor-mentee relationship \nin academic medicine: a qualitative study. Acad Med J Assoc Am Med Coll \n2009; 84: 135\u2013139. https://doi.org/10.1097/ACM.0b013e31819301ab\n20. Stenfors-Hayes T, Hult H, Dahlgren LO. What does it mean to be a \nmentor in medical education? Med Teach 2011; 33: e423-428. https://\ndoi.org/10.3109/0142159X.2011.586746\n21. Stenfors-Hayes T, Kal\u00e9n S, Hult H, Dahlgren LO, Hindbeck H, Ponzer \nS. Being a mentor for undergraduate medical students enhances personal \nand professional development. Med Teach 2010; 32: 148\u2013153. https://\ndoi.org/10.3109/01421590903196995\n22. Fornari A, Murray TS, Menzin AW, Woo VA, Clifton M, Lombardi M, \nShelov S. Mentoring program design and implementation in new medical \nschools. Med Educ Online 2014; 19. https://doi.org/10.3402/meo.\nv19.2457018\n2022/37 (3): 18-28Received:  9 - II - 2022\nAccepted:  28 - II - 2022\ndoi: 10.3306/AJHS.2022.37.03.18Corresponding authors\nCaroline S. Martinez  \nE-mail: c.martinez@qmul.ac.uk / caroline.s.martinez@gmail.com   \nGiulia A. Wiggers  \nE-mail: giuliapecanha@unipampa.edu.br \nAbstract  \nObjective:  We investigated the effects of an egg-white hydrolysate (EWH) on the gastrointestinal tract and organs related to \naluminum (Al) metabolism after Al exposure at both low and high-human dietary levels. \nMethods:  Male Wistar rats were orally treated to both low and high dietary doses of Al. Group 1) Aluminum-low dietary level (AlCl3 \nat 8.3 mg/kg b.w. for 60 days), co-treated or not with EWH (1 g/kg/day); Group 2) Aluminum-high dietary level (AlCl3 at 100 mg/\nkg b.w. for 42 days), co-treated or not with EWH. \nResults:  Both Al treatments increased oxidative damage in the liver and kidney. The highest Al dose impaired colon morphology, \ninducing inflammation and mucosal ulcerations. EWH prevented the raised oxidative stress level and colon damage and seems to \nreduce the presence of Al at the tissue level. \nConclusions:  Our results appoint the EWH as a promisor food ingredient to prevent adverse effects produced by Al exposure in \nhuman health.\nKeywords:  Environmental contaminant, human health, bioactive ingredient, egg-derived peptides. \nResumen\nObjetivos:  Se investigaron los efectos de un hidrolizado de clara de huevo (EWH) en el tracto gastrointestinal y en los \u00f3rganos \nrelacionados con el metabolismo del aluminio (Al) tras la exposici\u00f3n a niveles diet\u00e9ticos bajos y altos de Al. \nMetodolog\u00eda: Las ratas Wistar macho fueron tratadas por v\u00eda oral con dosis diet\u00e9ticas bajas y altas de Al. Grupo 1) Nivel diet\u00e9tico \nbajo de aluminio (AlCl3 a 8,3 mg/kg de peso durante 60 d\u00edas), tratado o no con EWH (1 g/kg/d\u00eda); Grupo 2) Nivel diet\u00e9tico alto de \naluminio (AlCl3 a 100 mg/kg de peso durante 42 d\u00edas), tratado o no con EWH. \nResultado:  Ambos tratamientos con Al aumentaron el da\u00f1o oxidativo en el h\u00edgado y el ri\u00f1\u00f3n. La dosis m\u00e1s alta de Al deterior\u00f3 la \nmorfolog\u00eda del colon, induciendo inflamaci\u00f3n y ulceraciones en la mucosa. El EWH evit\u00f3 el aumento del nivel de estr\u00e9s oxidativo y \nel da\u00f1o en el colon y parece reducir la presencia de Al a nivel tisular. \nConclusi\u00f3n:  Nuestros resultados designan al EWH como un ingrediente alimentario prometedor para prevenir los efectos adversos \nproducidos por la exposici\u00f3n al Al en la salud humana.\nPalabras clave: Contaminante ambiental, salud humana, ingrediente bioactivo, p\u00e9ptidos derivados del huevo.ORIGINAL\nEgg White Hydrolysate as a new bioactive food ingredient \nin the prevention of gastrointestinal effects induced by \naluminum exposure in rats \nHidrolizado de clara de huevo como nuevo ingrediente alimentario bioactivo en la \nprevenci\u00f3n de los efectos gastrointestinales inducidos por la exposici\u00f3n al aluminio en ratas  \nCaroline Silveira Martinez1      , Jos\u00e9 Antonio Uranga Ocio2      , Franck Maciel Pe\u00e7anha1     , \nDalton Valentim Vassallo3      , Marta Miguel4      , Giulia Alessandra Wiggers1\n1. Graduate Program in Biochemistry and Multicentric Graduate Program in Physiological Sciences, Universidade Federal do \nPampa, Uruguaiana, Rio Grande do Sul, Brazil   2. Department of Ciencias B\u00e1sicas de la Salud, Universidad Rey Juan Carlos, \nAlcorc\u00f3n, Spain   3. Departments of Physiological Sciences, Universidade Federal do Esp\u00edrito Santo and School of Medicine of \nSanta Casa de Miseric\u00f3rdia - EMESCAM, Vit\u00f3ria, Esp\u00edrito Santo, Brazil,    4. Bioactivity and Food Analysis Laboratory, Instituto de \nInvestigaci\u00f3n en Ciencias de la Alimentaci\u00f3n, Campus Universitario de Cantoblanco, Madrid, SpaineISSN 2255-0569\nID ID\nID ID IDID19\n2022/37 (3): 18-28Egg White Hydrolysate as a new bioactive food ingredient in the prevention of gastrointestinal effects induced by aluminum exposure in rats\nIntroduction\nHuman is continuously exposed to aluminum (Al), \na hazardous environmental contaminant without \nphysiological function, and diet is an important route \nby which humans are exposed to this non-essential \nmetal1,2. After reaching the gastrointestinal tract, the \nabsorption and, consequently, distribution and excretion \nof Al from the human body are under continuous \ninvestigation. However, it seems that the bioavailability \nof Al is dependent on the surrounding gastrointestinal \nmedium3,4. Once in the body, Al is deposited in bone and \nbrain5, kidney6, liver7, heart, and in reproductive organs of \nrats8 producing deleterious effects.\nAl is a toxin; therefore, the increased presence in the \nbody of this metal may have consequences for human \nhealth and is linked to the development of hematological \ndisorders9,10, osteopenia11, neurological disorders12, \nmacrophagic myofascitis13, cardiovascular dysfunction14, \nreproductive disorders15 and breast cancer16. However, \nwe still do not understand the real consequences of Al in \nthe body and the predominant toxic mechanism. \nRecently, the oxidative and inflammatory actions of \nAl have been suggested17,18. Moreover, pro-oxidant capacity of Al has been recognized and seems to be that \na Fenton promotion cycle catalyzed by the formation of \nthe radical Al-superoxide is underlying19. \nNevertheless, the systemic and long-term effects of \nAl exposure in human health are not well understood. \nRecently, by creating an animal model of dietary \nexposure to Al, we have demonstrated that Al even at \na considered low-level of exposure could represent a \nrisk for human health and, more than once, the adverse \neffects were similar to the observed after a high-dietary \nlevel of Al exposure17.  \nConsidering the burgeoning human exposure to Al, the \ndevelopment of therapies to prevent or minimize these \nconsequences is of great importance. In previous works, \nthe dietary administration of this egg white hydrolysate \n(EWH) prevented in part the development of memory loss, \nbehavioral impairment and cardiovascular dysfunction \nobserved after Al exposure in rats20,21. Moreover, the \nbeneficial effects of EWH against cardiometabolic \ndysfunction observed in various obesity experimental \nmodels22,23 as well as in the prevention of systemic \ntoxicity induced by heavy metals in rats24,25 have been \n20\n2022/37 (3): 18-28Caroline Silveira Mart\u00ednez et al.  \nalso demonstrated. These effects seem to be associated \nwith the potent anti-inflammatory and antioxidant \nproperties of EWH26,27,28, which could minimize the \nimpact of the growing environmental presence of Al in the \nhuman health. In this regard, the effect of these bioactive \npeptides produced after an enzymatic treatment of egg \nwhite with pepsin for 8h29, could counteract the toxic \nconsequences of Al exposure.\nIn this context, the gastrointestinal tract plays an \nimportant role in the absorption and metabolism of \nAl into the body. Therefore, the consequences of Al \nexposure in the gastrointestinal epithelium and, whether \nEWH could achieve a protective role on gastrointestinal \ntract are unknown. In the current study, our purpose \nwas to investigate the effects of Al exposure on the \ngastrointestinal tract and on other related digestive \norgans implicated in the Al metabolism, and to elucidate \nthe protective role of EWH on these effects.  \nMaterials and Methods \n1. Preparation of Egg White Hydrolysate\nEWH was obtained after enzymatic treatment of \npasteurized egg white with pepsin for 8h, frozen, and \nlyophilized until used, as described22. The peptide profile \nand the degree of hydrolysis of EWH were checked \nby RP-HPLC and some bioactive peptide sequences \npreviously identified were analyzed by HPLC-MS/MS \n(FRADHPFL, RADHPFL, YAEERYPIL, YRGGLEPINF, \nESIINF, RDILNQ, IVF, YQIGL, SALAM, FSL)29. \n2. Animals treatment \nMale Wistar rats (90 days-old, 350 \u00b1 10.5 g) were obtained \nfrom the Charles River Animal Laboratory (Barcelona, \nSpain), housed under constant room temperature, \nhumidity, and 12:12h light-dark, with water and food ad \nlibitum. The experiments presented in this study were \ndeveloped in accordance with the Brazilian Societies of \nExperimental Biology and the European legislation on \nthe use of experimental animals (EU Directive 2010/63/\nEU; R.D. 53/2013). This work has Brazilian and Spanish \nethical approvals (CEUA, Universidade Federal do \nPampa, Brazil - 017/2018; Universidad Rey Juan Carlos, \nSpain - 39/2014).\nRats were randomized into two groups:  \nGroup 1.  Aluminum low dietary level - rats were divided \ninto 4 subgroups (n=8/each) (1a-d) and received once \na day for 60 days: a) Control - ultrapure water (Milli-Q, \nMerck Millipore Corporation. \u00a9 2012 EMD Millipore, \nBillerica, MA); b) Aluminum \u2013 Al at 8.3 mg/kg b.w., \ndose similar to human dietary Al intake17; c) Hydrolysate \n- ultrapure water plus EWH at 1 g/kg by gavage27; d) \nHydrolysate-Aluminum - Al at 8.3 mg/kg b.w. plus EWH. \nIn Group 1 rats received water and Al in their drinking water for 60 days, to simulate human exposure by diet17. \nGroup 2.  Aluminum high dietary level - rats were divided \ninto 4 subgroups (n=8/each) (2a-d) and received daily \nfor 42 days: a) Control \u2013 ultrapure water; b) Aluminum \n\u2013 Al at 100 mg/kg b.w., dose considered as a super-\ndietary Al intake30; c) Hydrolysate - ultrapure water plus \nEWH at 1 g/kg by gavage; d) Hydrolysate-Aluminum - Al \nat 100 mg/kg b.w. plus EWH. In Group 2 rats received \nAl by gavage and ultrapure water as drinking water for 42 \ndays30. The stock solutions of Al (AlCl3.6 H2O at 0.034 \nM, Group 1; 8.3 mg/kg/b.w. and, 0.331 M, Group 2; \n100 mg/kg/b.w.) was prepared in ultrapure water. \nThe body weights and the consumption of food and liquid \nintakes were measured once a week. After the exposure \nperiod, rats were euthanized, and the kidney, liver, and \ncolon were removed and, being one side processed for \nimaging analysis and the other prepared for biochemical \ndeterminations [homogenized in 50 mM Tris HCl, pH \n7.4, (1/10, w/v) centrifuged and, supernatants were \nfrozen at -80\u00b0C].\n3. Reactive species levels\nReactive oxygen species levels in the liver and kidney \nwere measured by the spectrofluorometric method \nof31 with modifications17. The fluorescence intensity \nwas recorded for 60 min at 15 min intervals (520 nm \nemission, 480 nm excitation - SpectraMax M5 Molecular \nDevices, CA, USA), and the reactive species levels were \nexpressed as units of fluorescence. \n4. Lipid peroxidation levels\nLipid peroxidation levels in liver and kidney were \ndetermined as malondialdehyde (MDA) levels according \nto the colorimetric method of32, with modifications17. \nThe lipid peroxidation levels were measured at 532 nm \n(SpectraMax M5 Molecular Devices, CA, USA) and \nexpressed as nanomoles of MDA per mg of protein.\n5. Ferric Reducing/Antioxidant Power Assay\nThe total antioxidant capacity in the liver and kidney \nwas measured by Ferric Reducing/Antioxidant Power \n(FRAP) assay, according to33, with modifications17. \nThe FRAP levels in tissues were measured at 593 \nnm (SpectraMax M5 Molecular Devices, CA, USA), \nnormalized using a dose-response curve of Trolox (50-\n1000 \u03bcM \u2013vitamin E analog) and expressed respected \nto Trolox equivalents.\n6. Histological analysis \nThe liver, kidney, and colon were histopathological \nanalyzed. For that, tissues were fixed for 2 days in \n10% formaldehyde, washed, embedded in paraffin, \nsectioned at 5 \u00b5m, and stained with hematoxylin/\neosin. 10 randomly regions of each tissue were \nblinded evaluated under the 10X objective using a \nZeiss Axioskop 2 microscope (Zeiss, Jena, Germany), \nand the images were analyzed using AxioVision 4.6. A 21\n2022/37 (3): 18-28Egg White Hydrolysate as a new bioactive food ingredient in the prevention of gastrointestinal effects induced by aluminum exposure in rats\nsemi-quantitative scoring system was used to analyze \nand morphologically classify the colon, following the \nprotocol described by34. Briefly, for the morphological \nclassification, it was considered the following features: \n1. epithelium damage (vary from 0, normal to 3, severe \nepithelial lifting), 2. inflammatory cells infiltration (vary \nfrom 0, absence to 3, severe infiltration involving the \nmuscle), 3. extent of muscle thickening (vary from 0, \nnormal to 2, severe), 4. edema (vary from 0, no edema \nto 2, diffuse edema). The results were expressed as a \nsum of scores for each analyzed feature.\n7. Lumogallion staining \nfor the presence of aluminum \nThe presence of Al was verified in formalin-fixed tissues \nusing the specific lumogallion staining method12,35. Briefly, \ntissues were rehydrated and placed for 45 minutes into \neither 1 mM lumogallion (TCI Europe N.V. Belgium) buffered in 50 mM PIPES, pH 7.4 or the PIPES-buffer \nalone for auto-fluorescence analyses. After several \nwashes with PIPES-buffer, slides were rinsed in ultrapure \nwater, mounted using an aqueous mounting medium, \nand stored at 4\u00baC overnight before imaging. Tissues \nwere imaged using a Zeiss Axioskop 2 microscope and, \nthe fluorescence intensity calculated with NIH Image J \nsoftware version 1.46r (http://rsbweb.nih.gov/ij/), using \nthe same imaging parameters.\n8. Statistical analysis\nData are expressed as mean \u00b1 SEM and analyzed \nusing Graphpad Prism6 (GraphPad Software, Inc., \nLaJolla, CA, USA). Results were analyzed using two-way \nANOVA; when ANOVA showed a significant treatment \neffect, Bonferroni\u2019s post hoc test was used to compare \nindividual means. Values were considered statistically \ndifferent when P < 0.05.\nTable I: Effects of EWH on body weight (g), absolute (g or mg) and relative (g/100g or mg/100g) weights of organs and, water and food intake of rats exposure to AlCl3 \nfor 60 days (8.3 mg/kg b.w. per day  \u2013 Group 1), co-treated or not with EWH. \nData are expressed as means \u00b1 SEM. The relative organ weight was calculated by use of the formula: organ weight/body weight x 100. Units: g: gram, mg: milligram, \ncm: centimeters, ml: milliliters; 1 way ANOVA (P>0.05).Parameters   Experimental groups\n  Control AlCl3 Hydrolysate Hydrolysate-Aluminum\n  (n=8) (n=8) (n=8) (n=8)\nInitial body weight (g)  365.6 \u00b1 10.32  409.7 \u00b1 9.57 385.6 \u00b1 14.71  397.7 \u00b1 8.64 \nFinal body weight (g)  434.1 \u00b1 13.11 468 \u00b1 10.58 467.6 \u00b1 21.03 448.4 \u00b1 13.98\nWater intake (ml/day)  36.10 \u00b1 0.80 36.16 \u00b1 0.67 37.73 \u00b1 0.95 35.72 \u00b1 0.38\nFood intake (mg/day)  21.46 \u00b1 0.28 22.55 \u00b1 0.38 22.27 \u00b1 0.59 22.26 \u00b1 0.69\nFaeces (g)  1.57 \u00b1 0.21 2.48 \u00b1 0.50  1.89 \u00b1 0.41   1.82 \u00b1 0.26\nUrine (ml)  24.92 \u00b1 1.41 25.00 \u00b1 3.28  27.25 \u00b1 3.59  19.38 \u00b1 1.98\nLiver (g)  11.93 \u00b1 0.50  12.78 \u00b1 0.59  12.18 \u00b1 0.78 11.06 \u00b1 0.56 \nLiver (g/100g)  2.75 \u00b1 0.13  2.73 \u00b1 0.13  2.59 \u00b1 0.09  2.46 \u00b1 0.06\nKidney (g)  1.15 \u00b1 0.04 1.29 \u00b1 0.08 1.14 \u00b1 0.03  1.19 \u00b1 0.07\nKidney (g/100g)  0.26 \u00b1 0.01 0.58 \u00b1 0.32  0.24 \u00b1 0.01 0.26 \u00b1 0.01\nEpididymal fat (g)  11.13 \u00b1 1.20  13.61 \u00b1 1.37  12.98 \u00b1 1.48  11.69 \u00b1 0.75 \nBrown fat (g) 0.53 \u00b1 0.03  0.51 \u00b1 0.02  0.51 \u00b1 0.05  0.47 \u00b1 0.05 \nSubcutaneous fat (g)  8.82 \u00b1 0.89  10.34 \u00b1 1.01  11.27 \u00b1 2.01  10.27 \u00b1 0.76 \nRetroperitoneal fat (g)  12.72 \u00b1 1.38 13.89 \u00b1 1.40 16.61 \u00b1 2.04 13.30 \u00b1 1.28\nTibia height (cm) 3.81 \u00b1 0.12  3.98 \u00b1 0.02  3.98 \u00b1 0.1 3.97 \u00b1 0.08 \nSoleus (g)  0.13 \u00b1 0.04  0.14 \u00b1 0.01  0.14 \u00b1 0.01 0.12 \u00b1 0.01\nTable II: Effects of EWH on body weight (g), absolute (g or mg) and relative (g/100g or mg/100g) weights of organs and, water and food intake of rats exposure to AlCl3 \nfor 42 days (100 mg/kg b.w. per day  \u2013 Group 2), co-treated or not with EWH.\nData are expressed as means \u00b1 SEM. The relative organ weight was calculated by use of the formula: organ weight/body weight x 100. Units: g: gram, mg: milligram, \ncm: centimeters, ml: milliliters; 1 way ANOVA (P>0.05).Parameters   Experimental groups\n  Control AlCl3 Hydrolysate Hydrolysate-Aluminum\n  (n=8) (n=8) (n=8) (n=8)\nInitial body weight (g) 284.4 \u00b1 12.58  283 \u00b1 9.64 297 \u00b1 9.75  309.5 \u00b1 13.57 \nFinal body weight (g)  386.9 \u00b1 8.59 408.3 \u00b1 12.48 413 \u00b1 7.16 408.5 \u00b1 12.33\nWater intake (ml/day)  31.49 \u00b1 1.30 31.78 \u00b1 1.27 32.45 \u00b1 1.72 30.62 \u00b1 0.76\nFood intake (mg/day)  20.72 \u00b1 0.56 21.48 \u00b1 0.67 21.91 \u00b1 \u00ac0.81 21.58 \u00b1 0.27\nFaeces (g)  2.90 \u00b1 0.20 2.94 \u00b1 0.42  2.21 \u00b1 0.36   2.68 \u00b1 0.32\nUrine (ml)   10.96 \u00b1 3.55 17.37 \u00b1 6.07  16.11 \u00b1 5.33  9.87 \u00b1 3.84\nLiver (g)   10.54 \u00b1 0.39  11.60 \u00b1 0.41  11.38 \u00b1 0.30 11.43 \u00b1 0.41 \nLiver (g/100g)  2.73 \u00b1 0.03  2.80 \u00b1 0.09  2.79 \u00b1 0.04  2.80 \u00b1 0.10\nKidney (g)  1.18 \u00b1 0.08 1.17 \u00b1 0.04 1.19 \u00b1 0.02  1.21 \u00b1 0.04\nKidney (g/100g)  0.30 \u00b1 0.02 0.28 \u00b1 0.01  0.29 \u00b1 0.01 0.29 \u00b1 0.01\nEpididymal fat (g)  8.00 \u00b1 0.89 9.01 \u00b1 0.45 8.51 \u00b1 0.45  10.70 \u00b1 1.23\nBrown fat (g)  0.58 \u00b1 0.03  0.41 \u00b1 0.01  0.53 \u00b1 0.05  0.55 \u00b1 0.03 \nSubcutaneous fat (g)  9.62 \u00b1 0.95  7.38 \u00b1 0.88 9.39 \u00b1 0.83 9.68 \u00b1 1.40\nRetroperitoneal fat (g)  10.03 \u00b1 0.94 10.42 \u00b1 0.66 10.42 \u00b1 1.26 11.61 \u00b1 1.65\nTibia height (cm)  3.75 \u00b1 0.04  3.97 \u00b1 0.04 3.87 \u00b1 0.05 3.90 \u00b1 0.05 \nSoleus (g)   0.12 \u00b1 0.01  0.13 \u00b1 0.01 0.13 \u00b1 0.01  0.15 \u00b1 0.0122\n2022/37 (3): 18-28Caroline Silveira Mart\u00ednez et al.  \nFigure 2: Effects of EWH on oxidative stress assays in Al-exposed rats. Reactive oxygen species (ROS), lipid peroxidation and total antioxidant capacity in liver and \nkidney of rats exposed to AlCl3 at high doses (100 mg/kg b.w. for 42 days) co-treated or not with EWH. Results are expressed as mean \u00b1 SEM, n=8, * P < 0.05 \ncompared with their corresponding controls, # P < 0.05 compared with AlCl3 group (two-way ANOVA and Bonferroni as post-hoc test).\nFigure 1: Effects of EWH on oxidative stress assays in Al-exposed rats. Reactive oxygen species (ROS), lipid peroxidation and total antioxidant capacity in liver and \nkidney of rats exposed to AlCl3 at low doses (8.3 mg/kg b.w. for 60 days) co-treated or not with EWH. Results are expressed as mean \u00b1 SEM, n=8, * P < 0.05 \ncompared with their corresponding controls, # P < 0.05 compared with AlCl3 group (two-way ANOVA and Bonferroni as post-hoc test).23\n2022/37 (3): 18-28Egg White Hydrolysate as a new bioactive food ingredient in the prevention of gastrointestinal effects induced by aluminum exposure in rats\nFigure 3: Effect of EWH on liver histology in Al-treated rats. Representative images showing normal histology in all groups: control (Ct), EWH, Al-exposed rats at 8.3 or \n100 mg/kg b.w., and Al-exposed rats and co-treated with EWH. Scale bar: 100 \u00b5m. \nFigure 4: Effect of EWH on kidney histology in Al-treated rats. Representative images showing normal histology in all groups: control (Ct), EWH, Al-exposed rats at 8.3 \nor 100 mg/kg b.w., and Al-exposed rats and co-treated with EWH. Scale bar: 100 \u00b5m. \nFigure 5: Effect of EWH on colon histology in Al-treated rats. Normal histology in colon of control (Ct) and EWH groups. Colon sections of Al-exposed rats at 100 mg/\nkg b.w. indicating the presence of epithelial damage and mucosal ulcerations (arrows) and Peyer\u2019s patches (*). The co-treatment with EWH prevents the impairment of \ncolon histoarchitecture after Al exposure at 100 mg/kg. Histological damage score after the analysis of the average of 5 fields per rat. Scale bar: 100 \u00b5m.\n24\n2022/37 (3): 18-28Caroline Silveira Mart\u00ednez et al.  \nFigure 6: Effect of EWH on the presence of aluminum (orange) in liver. Representative images indicating the presence of Al: lumogallion fluorescence in control (Ct), \nEWH treated rats and, animals treated with AlCl3 at 8.3 or 100 mg/kg, co-treated or not with EWH. Arrows indicate the presence of aluminum. Fluorescence intensity \nafter the analysis of the average of 6 fields per rat. Scale bar: 50 \u00b5m. \nFigure 7: Effect of EWH on the presence of aluminum (orange) in kidney. Representative images indicating the presence of Al: lumogallion fluorescence in control (Ct), \nEWH treated rats and, animals treated with AlCl3 at 8.3 or 100 mg/kg, co-treated or not with EWH. Arrows indicate the presence of aluminum. Fluorescence intensity \nafter the analysis of the average of 6 fields per rat. Scale bar: 50 \u00b5m.\n25\n2022/37 (3): 18-28Egg White Hydrolysate as a new bioactive food ingredient in the prevention of gastrointestinal effects induced by aluminum exposure in rats\nResults\n1. Body weight, feed, and fluid consumption \nNeither the Al intakes or EWH treatments modified the \nbody and organs weights of rats; the fluid (water or Al) \nand food consumptions were similar between groups \n(Tables I  and II).\n2. Oxidative stress\nAl treatment at low doses of 8.3 mg/kg b.w. raised ROS \nlevels and decreased total antioxidant capacity in the \nliver and raised lipid peroxidation in both liver and kidney \n(Figure 1 ). These effects were almost totally prevented \nby the concomitant oral uptake of EWH ( Figure 1 ). \nRats treated with Al at the highest dose of 100 mg/kg \nb.w. showed increased ROS levels in the kidney and \nlipid peroxidation in the liver, which was prevented by \nthe concomitant intake of EWH ( Figure 2 ). Moreover, \nthe dietary supplementation with EWH decreased ROS \nlevels in liver and lipid peroxidation in the kidney of \nanimals not exposed to Al as well as decreased levels of \nlipid peroxidation in the kidney of animals co-exposed to \nAl and EWH ( Figure 2 ). \n3.Histopathology analysis of liver, \nkidney, and colon\nHistology showed normal histoarchitecture of liver and \nkidney in all experimental groups ( Figures 3  and 4). On \nthe opposite, Al at a high dietary level strongly impaired \nthe histology of the colon ( Figure 5 ). Specifically, Al-\ninduced zonal destruction of epithelium surface and \nmucosal ulcerations involving submucosa, promoted \ninflammatory cell infiltrations and the presence of Peyer\u2019s \npatches ( Figure 5 ). However, rats that were exposed to \nboth Al and EWH showed colon histology similar to the \ncontrol and EWH groups ( Figure 5 ). \n4. Presence of aluminum in liver and kidney\nThe presence of Al in the liver and kidney was verified \nby lumogallion and means of fluorescence microscopy. \nTissues not incubated with lumogallion showed green \nautofluorescence (data not shown) and, tissues \nfrom control (Ct) and EWH rats showed unspecific \nfluorescence ( Figures 6  and 7). Liver and kidney \nsections from Al-treated rats showed specific bright \norange fluorescence when incubated with lumogallion, \nindicating the presence of Al. Rats in the Al + EWH groups \nshowed weakly orange fluorescence, in which the oral \nuptake of EWH significantly prevented the presence of Al \nin the kidney of rats exposed to the highest dose of the \nmetal ( Figures 6  and 7).  \nDiscussion  \nAl is everywhere and, besides the efforts to reduce its \nimpact, humans are continuous highly exposed and, a \nload of Al in the human body, increasing. Oral ingestion is the most important way of human exposure to Al. \nTherefore, the gastrointestinal tract is the first and primary \nAl contact pathway, which, when ingested, seems to \nalter the immune function and microflora permeability36,37. \nAl is a neurotoxin, leading to encephalopathy in renal \ndialysis patients38 and appointed as an environmental \nfactor in Alzheimer\u2019s Disease39,40. Over the past few \ndecades, the involvement of Al in human diseases \nhas considerably increased. Al is now suggested as \nhave a role in human reproductive dysfunction and \ninfertility41, diabetes mellitus42, peripheral neuropathy43, \nhypertension44 bone and hematological diseases9,11. \nThe human toxic effects of Al depend upon the \nachievement of a threshold or burden45. \nOur research group have developed an animal model of \nAl exposure, and we have observed that the equivalent \namount of Al ingested by the dietary source is sufficient \nto induce toxic effects, suggesting the achievement of \nthis \u201ctoxic\u201d threshold17. Herein, we have demonstrated \nthat beyond the increased oxidative stress in target \norgans of Al metabolism, Al strongly impairs colon \nmorphology, inducing inflammation, and mucosal \nulcerations. Interestingly, these alterations already start in \nrats exposed to Al at human equivalent dietary level. \nMoreover, due to numerous applications and sources, \nit seems that most of the population are exceeding the \nmaximum limits imposed by regulatory agencies1,2. In \nthis sense, strategies and therapies that aim to minimize \nor prevent the effects of human exposure to numerous \nenvironmental contaminants are needed. Food-derived \ncompounds could be an important alternative to \nmaximize the benefits of natural ingredients and seem to \nbe a potential remedy46,47.  \nIn the current study, we have addressed the effects of \ndietary supplementation with EWH in rats exposed to \nhuman equivalent dietary Al intakes. Our results appoint \nthe EWH as an effective functional food ingredient in \nthe prevention of long-term effects of Al exposure. \nSpecifically, the co-ingestion of EWH was able to \nprevent colon inflammation and epithelial damages, \nreduce inflammatory cell infiltrations, and the number of \nPeyer\u2019s patches after Al exposure at a high dietary level \nand, the increased oxidative damage in liver and kidney \nof Al-exposed rats. Besides, the ingestion of EWH per \nse seems to reduce the presence of Al in liver and \nkidney of control rats not exposed to Al and prevents the \nincreased presence of Al in the kidney of rats exposed to \nAl at the highest dose, suggesting the putative beneficial \neffect of a functional food ingredient that could be added \nto the human diet. \nIn previous works the potential effects of EWH have been \nattributed to its antioxidant and anti-inflammatory abilities. \nThe pepsin hydrolysis of egg white releases bioactive \npeptides with several biological properties29. Some 26\n2022/37 (3): 18-28Caroline Silveira Mart\u00ednez et al.  \npeptide sequences were identified and some of them \ndemonstrated angiotensin-converting enzyme inhibitory \nactivity29, vascular-relaxing function48 and/or, antioxidant \ncapacity26,49 and in vivo  blood pressure lowering effect50. \nIn the present study, rats exposed to both Al and \nEWH showed reduced oxidative stress in the liver and \nkidney, and the EWH was able to prevent the increased \ngastrointestinal inflammation and histopathological \ndamages observed after Al exposure at a super-dietary \nlevel. The important inflammation and damage in the \ncolon of Al-treated rats and the efficacy of EWH to prevent \nmay suggest a protective action of these bioactive \npeptides in the gastrointestinal tract. The gastrointestinal \ntract is the first site of contact with the oral uptake Al, \ninfluencing its bioavailability and absorption36. It is known \nthat the surrounding gastrointestinal medium and several \ndietary compounds can modulate Al absorption. Citrate \nand other short-chain carboxylic acids such as acetate, \noxalate, lactate, malate, tartrate, gluconate, ascorbate, \nand carbonate seem to increase Al absorption in the \ngastrointestinal tract and, on the contrary, compounds \ncontaining silicone may decrease the absorption of Al \nfacilitating its excretion from the human body51,52,53. \nRecently, by using the intestinal model of Caco-2 cells, \nit was shown that the intestinal cellular uptake of Al \noccurs preferably in the particle form54. Of interest, our \ngroup, by using the same model of differentiated cells, \nhas demonstrated that the EWH released peptides \nFRADHPFL, RADHP and YPI are susceptible to intestinal \ntransepithelial transport through the monolayer28. \nTherefore, we could also postulate a competition between \nthese small peptides and Al transporters influencing the \nAl absorption into the small intestinal epithelial cell. \nNevertheless, there are numerous mechanisms and \npathways by which EWH could be acting to prevent or \nminimize the effects of Al that must be extensively studied. \nIn the cardiometabolic disease, the beneficial effects of \nEWH against metabolic complications in Zucker obese \nrats were related to changes of gut microbiota, specifically \nobese rats receiving EWH in drinking water for 12 weeks \nshow microbiota pattern similar to those of the control \nlean rats55. Recently, it was demonstrated the influence of \ngut microbiota in the Al absorption and systemic effects. \nThe specific probiotic bacteria L. plantarum  CCFM639 \nseems to increase fecal Al excretion, decrease intestinal \nAl absorption and Al accumulation in kidney, liver, and \nbrain, alleviating increased oxidative stress after Al \nexposure in mice56,57. In the current study, EWH was \nable to reduce the tissular presence of Al in the kidney, \nand the increased oxidative stress as well as prevent \ninflammation and colon histopathological damages in \nrats after Al exposure at a human super dietary level. \nTherefore, it is also possible to postulate that EWH could \ninterfere and modulate the gut microbiota, which must be \nfurther investigated and is the focus of our follow studies. Conclusion  \nOur data suggest the use of pepsin EWH as an \nalternative bioactive food ingredient in the prevention \nof Al-related complications as an attempt to reduce \nthe impact of the increased human exposure to Al. The \nEWH supplementation was able to prevent the increased \noxidative stress in the liver and kidney, markedly reduced \ncolon histopathological damages and the presence of Al \nin the kidney of rats exposed to Al at doses that \u201cmimics\u201d \nhigh human exposure to this metal. While there are several \nlines to explain the role of pepsin EWH in the protection \nagainst Al toxicity, its antioxidant and anti-inflammatory \nproperties may play an important role. However, it is likely \nthat the underlying mechanisms of egg-derived peptides \nto reduce the effects of Al are more extensive and must \nbe better understood.\nAcknowledgments \nThe authors would like to acknowledge Antonio M\u00e1rquez \nGallego, Raquel Franco and Julio Paredes from the \nLaboratory of Histology of the Universidad Rey Juan \nCarlos for their technical assistance in tissue preparation. \nThis work was supported by the [National Council for \nScientific and Technological Development \u2013 CNPq] \nunder grant [307399, 2017-6]; [Coordena\u00e7\u00e3o de \nAperfei\u00e7oamento de Pessoal de N\u00edvel Superior; Programa \nNacional de Coopera\u00e7\u00e3o Acad\u00eamica; FAPERGS/PQG] \nunder grant [N\u00ba 19/2551-0001810-0]; [Pr\u00f3-reitoria de \nPesquisa - Universidade Federal do Pampa] under grant \n[N\u00ba 20180615102630]; [FAPES/CNPq/PRONEX] under \ngrant [N\u00ba 80598773]; and [Spanish Goverment MICINN] \nunder grant [AGL 89213, 2017].\nAuthor Contributions\nConceptualization: C.S.M., G.A.W., M.M., F.M.P .; \nFormal analysis: C.S.M., G.A.W., J.A.U.O.; Investigation: \nC.S.M., J.A.U.O; Methodology: C.S.M., G.A.W., M.M., \nF.M.P .; Project administration: C.S.M., G.A.W., and \nM.M.; Writing - original draft: C.S.M., G.A.W., M.M.; \nWriting - review & Editing: C.S.M., G.A.W., M.M., D.V.V., \nF.M.P . and J.A.U.O.\nAll authors have read and approved the final version of \nthe manuscript.\nConflict of Interest\nThe authors declare that they have no conflict of interest.27\n2022/37 (3): 18-28Egg White Hydrolysate as a new bioactive food ingredient in the prevention of gastrointestinal effects induced by aluminum exposure in rats\nReferences\n1 . WHO. Safety Evaluation of Certain Food Additives and Contaminants. \n2007. Food Additive Series.\n2. EFSA J. Safety of Aluminium from Dietary Intake. EFSA. 2008, 754: 1-34.\n3. Exley C. Elucidating Aluminium\u00b4s Exposome. Curr Inorg Chem. 2012, \n2: 3-7. https://doi.org/10.2174/1877944111202010003.\n4. Exley C. Human exposure to aluminium. Environ. Sci. Process Im. \n2013, 1807-16.\n5. Romanski SA, Mccarthy JT, Kluge K, Fitzpatrick L. Detection of subtle \naluminum- related renal osteodystrophy. Mayo Clin Proc. 1993, 68: 419-26.\n6. Spencer AJ, Wood JA, Freeman MS, Saunders HC, Lote CJ. \nDeposition of aluminium in kidney following aluminium chloride or citrate \nadministration in conscious rats. J Physiol London. 1995, 483: 171-2.\n7. Geyikoglu F, T\u00fcrkez H, Bakir TO, Cicek M. The genotoxic, hepatotoxic, \nnephrotoxic, haematotoxic and histopathological effects in rats after \naluminium chronic intoxication. Toxicol Ind Health. 2012, 29(9): 780\u2013791. \nhttps://doi.org/10.1177/0748233712440140.\n8. Noremberg S, Bohrer D, Schetinger MR, Bairros AV, Gutierres J, \nGon\u00e7alves JF, Veiga M, Santos FW. Silicon Reverses Lipid Peroxidation \nbut not Acetylcholinesterase Activity Induced by Long-Term Exposure to \nLow Aluminum Levels in Rat Brain Regions. Biol Trace Elem Res. 2016, \n169: 77-85.\n9. Barata J, D\u2019Haese P , Pires C, Lamberts L, Simoes J, De Broe M. Low-\ndose (5mg/kg) desferrioxamine treatment in acutely aluminium-intoxicated \nhaemodialysis patients using two drug administration schedules. Nephrol \nDial Transplant. 1996, 11: 125-32.\n10. Cheng D, Tang J, Wang X, Zhang X, Wang S. Effect of aluminum \n(Al) speciation on erythrocytic antioxidant defense process: Correlations \nbetween lipid membrane peroxidation and morphological characteristics. \nEcotoxicol Environ Saf. 2018, 15(157): 201\u2013206. https://doi.org/doi: \n10.1016/j.ecoenv.2018.03.039.\n11. Li X, Hu C. Zhu Y, Sun H, Li, Y, Zhang Z. Effects of aluminum exposure \non bone mineral density, mineral, and trace elements in rats. Biol Trace \nElem Res. 2011, 143: 378-85.\n12. Mirza A, King A, Troakes C, Exley C. The Identification of Aluminum in \nHuman Brain Tissue Using Lumogallion and Fluorescence Microscopy. J \nAlzheimers Dis. 2016, 54: 1333-8.\n13. Gherardi RK, Aouizerate J, Cadusseau J, Yara S, Authier FJ. \nAluminum adjuvants of vaccines injected into the muscle: Normal fate, \npathology and associated disease. Morphologie. 2016, 100: 85-94.\n14. Costello S, Brown DM, Noth EM, Cantley L, Slade MD, Tessier-\nSherman B, Hammond SK, Eisen EA, Cullen, M. R. Incident ischemic \nheart disease and recent occupational exposure to particulate matter in \nan aluminum cohort. J Expo Sci Environ Epidemiol. 2014, 24(1): 82-8. \nhttps://doi.org/10.1038/jes.2013.47.\n15. Klein JP , Mold M, Mery L, Cottier M,  Exley C. Aluminum content of \nhuman semen: Implications for semen quality. Reprod Toxicol. 2014,  50: \n43-8. https://doi.org/10.1016/j.reprotox.2014.10.001.\n16. Linhart C, Talasz H, Morandi EM, Exley C. Lindner HH, Taucher S, Egle \nD, Hubalek M, Concin N, Ulmer H. Use of Underarm Cosmetic Products \nin Relation to Risk of Breast Cancer: A Case-Control Study. EBioMedicine. \n2017, 21: 79\u201385. https://doi.org/10.1016/j.ebiom.2017.06.005.\n17. Martinez C, Alterman CDC, Pe\u00e7anha FM, Vassallo DV, Mello-Carpes PB, Miguel M, Wiggers GA. Aluminum Exposure at Human Dietary \nLevels for 60 Days Reaches a Threshold Sufficient to Promote Memory \nImpairment in Rats. Neurotox Res. 2017, 31(1): 20\u201330. https://doi.\norg/10.1007/s12640-016-9656-y.\n18. Novaes RD, Mouro VGS, Gon\u00e7alves RV, Mendon\u00e7a AAS, Santos \nEC, Fialho MCQ, Machado-Neves M. Aluminum: A potentially toxic \nmetal with dose-dependent effects on cardiac bioaccumulation, mineral \ndistribution, DNA oxidation and microstructural remodeling. Environ Pol. \n2018, 242: 814\u2013826. https://doi.org/10.1016/j.envpol.2018.07.034.\n19. Ruip\u00e9rez F, Mujika JI, Ugalde JM, Exley C, X L. Pro-oxidant activity \nof aluminum: promoting the Fenton reaction by reducing Fe(III) to Fe(II). J \nInorg Biochem. 2012, 117: 118-23.\n20. Martinez C, Alterman C, Vera G, M\u00e1rquez A, Uranga J, Pe\u00e7anha \nF, Vassallo D, Exley C, Mello-Carpes P , Miguel M, Wiggers G. Egg \nWhite Hydrolysate as a functional food ingredient to prevent cognitive \ndysfunction in rats following long-term exposure to aluminum. Sci Rep. \n2019, 12(9): 1868. https://doi.org/doi: 10.1038/s41598-018-38226-7.a\n21. Martinez C, Piagette J, Escobar A, Mart\u00edn A, Palacios R, Pe\u00e7anha F, \nVassallo D, Exley C, Alonso M, Salaices M, Miguel M, Wiggers G. Egg \nWhite Hydrolysate: A new putative agent to prevent vascular dysfunction \nin rats following long-term exposure to aluminum. Food Chem Toxicol. \n2019,  133: 110799. https://doi.org/10.1016/j.fct.2019.110799.b\n22. Garc\u00e9s-Rim\u00f3n M, Gonz\u00e1lez C, Vera G., Uranga JA, L\u00f3pez-Fandi\u00f1o \nR, L\u00f3pez-Miranda V,  Miguel M. Pepsin egg white hydrolysate improves \nglucose metabolism complications related to metabolic syndrome \nin zucker fatty rats. Nutrients. 2018, 10(4). https://doi.org/10.3390/\nnu10040441.\n23. Moreno-Fern\u00e1ndez S, Garc\u00e9s-Rim\u00f3n M, Uranga JA, Astier J, Landrier \nJF, Miguel M. Expression enhancement in brown adipose tissue of genes \nrelated to thermogenesis and mitochondrial dynamics after administration \nof pepsin egg white hydrolysate. Food Func. 2018, 9(12): 6599-607. \nhttps://doi.org/10.1039/c8fo01754a.\n24. Rizzetti D A, Altermann CDC, Martinez CS, Pe\u00e7anha FM, Vassallo DV, \nUranga-Ocio JA, Castro MM, Wiggers GA, Mello-Carpes PB. Ameliorative \neffects of egg white hydrolysate on recognition memory impairments \nassociated with chronic exposure to low mercury concentration. \nNeurochem Int. 2016, 101: 30\u201337. https://doi.org/10.1016/j.\nneuint.2016.10.002.\n25. Rizzetti DA, Mart\u00edn \u00c1, Corrales P , Fernandez F, Sim\u00f5es MR, Pe\u00e7anha \nFM, Vassallo DV, Miguel M, Wiggers GA. Egg white-derived peptides \nprevent cardiovascular disorders induced by mercury in rats: Role of \nangiotensin-converting enzyme (ACE) and NADPH oxidase. Toxicol Lett. \n2017, 281: 158\u2013174. https://doi.org/10.1016/j.toxlet.2017.10.001.\n26. Garc\u00e9s-Rim\u00f3n M, Gonz\u00e1lez C, Uranga JA, L\u00f3pez-Miranda V, \nL\u00f3pez-Fandi\u00f1o R, Miguel M. Pepsin egg white hydrolysate ameliorates \nobesity-related oxidative stress, inflammation and steatosis in Zucker fatty \nrats. PLoS ONE. 2016, 11(3): 1\u201315. https://doi.org/10.1371/journal.\npone.0151193.\n27. Miguel M, Lopez-Fandino R, Ramos M, Aleixandre A. Long-term intake \nof egg white hydrolysate attenuates the development of hypertension in \nspontaneously hypertensive rats. Life Sci. 2006, 78: 2960e-66.\n28. Miguel M, D\u00e1valos A, Manso MA, De La Pe\u00f1a G, Lasunci\u00f3n \nMA, L\u00f3pez-Fandi\u00f1o R. Transepithelial transport across Caco-2 cell \nmonolayers of antihypertensive egg-derived peptides. PepT1-mediated \nflux of Tyr-Pro-Ile. Mol Nutr Food Res. 2008, 52(12): 1507\u20131513. https://\ndoi.org/10.1002/mnfr.200700503.28\n2022/37 (3): 18-28Egg White Hydrolysate as a new bioactive food ingredient in the prevention of gastrointestinal effects induced by aluminum exposure in ratsCaroline Silveira Mart\u00ednez et al.  \n29. Miguel M, Recio I, Gomez-Ruiz J, Ramos M, Lopez-Fandino R. \nAngiotensin I-converting enzyme inhibitory activity of peptides derived \nfrom egg white proteins by enzymatic hydrolysis. J Food Prot. 2004, 67: \n1914-20.\n30. Prakash A, Kumar A. Effect of N-Acetyl cysteine against aluminium-\ninduced cognitive dysfunction and oxidative damage in rats. Basic Clin \nPharmacol Toxicol. 2009, 105(2): 98\u2013104. https://doi.org/10.1111/\nj.1742-7843.2009.00404.x.\n31. Loetchutinat C, Kothan S, Dechsupa S, Meesungnoen J, Jay-Gerin \nJP , Mankhetkorn S. Spectrofluorometric determination of intracellular \nlevels of reactive oxygen species in drug-sensitive and drug-resistant \ncancer cells using the 2\u2019,7\u2019-dichlorofluorescein diacetate assay. 2005, \nRadiat Phys Chem. 72(2\u20133): 323-31. \n32. Ohkawa H, Ohishi N, Yagi K. Assay for lipid peroxides in animal \ntissues by thiobarbituric acid reaction. Anal Biochem. 1979, 95(2): 351-\n8. https://doi.org/10.1016/0003-2697(79)90738-3.\n33. Benzie IFF, Strain JJ. The ferric reducing ability of plasma (FRAP) as a \nmeasure of \u201cantioxidant power\u201d: The FRAP assay. Analytical Biochemistry. \n1996, 239(1): 70\u201376. https://doi.org/10.1006/abio.1996.0292.\n34. Saccani F, Anselmi L, Jaramillo I, Bertoni S, Barocelli E, Sternini C. \nProtective role of \u03bc opioid receptor activation in intestinal inflammation \ninduced by mesenteric ischemia/reperfusion in mice. J Neuros Res. \n2012, 90(11): 2146-53. https://doi.org/10.1002/jnr.23108.\n35. Mold M., Eriksso, H, Siesj\u00f6 P , Darabi A, Shardlow E, Exley C. \nUnequivocal identification of intracellular aluminium adjuvant in a \nmonocytic THP-1 cell line. Sci Rep. 2014, 4: 11\u201315. https://doi.\norg/10.1038/srep06287.\n36. Kaminsky LS, Zhang QY. The small intestine as a xenobiotic-\nmetabolizing organ. Drug Metab Dispos. 2003, 31: 1520-5.\n37. Vignal C, Desreumaux P , Body-Malapel M. Gut: An underestimated \ntarget organ for Aluminum. Morphologie. 2016, 100(329): 75\u201384. https://\ndoi.org/10.1016/j.morpho.2016.01.003.\n38. Alfrey AC, LeGendre GR, Kaehny WD. The Dialysis Encephalopathy \nSyndrome \u2014 Possible Aluminum Intoxication. M.D.N Engl J Med. 1976, \n294:184-188 DOI: 10.1056/NEJM197601222940402\n39. Altmann P , Cunningham J, Dhanasha U, Ballard M, Thompson J. \nDisturbance of cerebral function in people exposed to drinking water \ncontaminated with aluminium sulphate: retrospective study of the \nCamelford water incidence. British Medical Journal. 1999, 319: 807-11.\n40. Exley C. Aluminum Should Now Be Considered a Primary Etiological \nFactor in Alzheimer\u2019s Disease. J Alzheimer\u2019s Dis. 2017, 1: 23-5.\n41. Jamalan M, Ghaffari MA, Hoseinzadeh P , Hashemitabar M, Zeinali \nM. Human Sperm Quality and Metal Toxicants: Protective Effects of \nsome Flavonoids on Male Reproductive Function. Int J Fertil Steril. 2016, \n10(2):215-23.\n42. Feng W, Cui X, Liu B, Liu C, Xiao Y, et al. Association of Urinary Metal \nProfiles with Altered Glucose Levels and Diabetes Risk: A Population-\nBased Study in China. PLOS ONE. 2015, 10(4): e0123742. https://doi.\norg/10.1371/journal.pone.0123742\n43. Bakar C, Karaman HI, Baba A, Seng\u00fcnalp F. Effect of high aluminum \nconcentration in water resources on human health, case study: Biga \nPeninsula, northwest part of Turkey. Arch Environ Contam Toxicol. 2010, \n58(4):935-44. doi: 10.1007/s00244-009-9435-3. \n44. Martinez CS, Piagette JT, Escobar AG, Mart\u00edn \u00c1, Palacios R, Pe\u00e7anha \nFM, Vassallo DV, Exley C, Alonso MJ, Miguel M, Salaices M, Wiggers GA. Aluminum exposure at human dietary levels promotes vascular \ndysfunction and increases blood pressure in rats: A concerted action of \nNAD(P)H oxidase and COX-2. Toxicol. 2017, 390: 10\u201321. https://doi.\norg/10.1016/j.tox.2017.08.004.b\n45. Exley C. Why industry propaganda and political interference cannot \ndisguise the inevitable role played by human exposure to aluminum in \nneurodegenerative diseases, including Alzheimer\u2019s disease Front Neurol. \n2014, 27;5:212. doi: 10.3389/fneur.2014.00212. \n46. Deng Y, Xu Z, Liu W, Yang H, Xu B, Wei Y. Effects of lycopene and \nproanthocyanidins on hepatotoxicity induced by mercuric chloride in rats. \nBiol Trace Elem Res. 2012,  146(2): 213\u2013223. https://doi.org/10.1007/\ns12011-011-9242-3.\n47. Garc\u00eda-Ni\u00f1o WR, Pedraza-Chaverr\u00ed J. Protective effect of curcumin \nagainst heavy metals-induced liver damage. Food Chem Toxicol. 2014, \n69: 182\u2013201. https://doi.org/10.1016/j.fct.2014.04.016.\n48. Miguel M, Yolanda A, L\u00f3pez-Fandi\u00f1o R, Alonso MJ, Salaices M. \n\u201cVasodilator Effects of Peptides Derived from Egg White Proteins.\u201d \nRegulatory Peptides. 2007, 140 (3): 131\u201335. https://doi.org/10.1016/j.\nregpep.2006.11.029.\n49. D\u00e1valos A, Miguel M, Bartolom\u00e9 B, Lopez-Fadi\u00f1o R. \u201cAntioxidant \nActivity of Peptides Derived From Egg White Proteins By Enzymatic \nHydrolysis.\u201d Journal of Food Protection. 2004, 67 (9): 1939-44. https://\ndoi.org/10.4315/0362-028X-67.9.1939.\n50. Miguel M, L\u00f3pez-Fandi\u00f1o R, Ramos M, and Aleixandre A. \u201cShort-\nTerm Effect of Egg-White Hydrolysate Products on the Arterial Blood \nPressure of Hypertensive Rats.\u201d British Journal of Nutrition. 2005, 94 (5): \n731-7. https://doi.org/10.1079/bjn20051570.\n51. Domingo JL, Gomez M, Llobet JM, Corbella J. Influence of some \ndietary constituents on aluminum absorption and retention in rats. Kidney \nInt. 1991, 39(4): 598\u2013601. https://doi.org/10.1038/ki.1991.70.\n52. Domingo J, Gomez M, Sanchez D, Llobet J, Corbella J. Effect of \nvarious dietary constituents on gastrointestinal absorption of aluminum \nfrom drinking water and diet. Res Commun Chem Pathol Pharmacol. \n1993, 79(377): 80.\n53. Krewski D, Yokel RA, Nieboer E, Borchelt D, Cohen J, Harry J, \nKacew S, Lindsay J, Mahfouz, AM., Rondeau V. Human health risk \nassessment for aluminium, aluminium oxide, and aluminium hydroxide. \nJ Toxicol Environ Health - Part B: Critical Reviews. 2007, https://doi.\norg/10.1080/10937400701597766.\n54. Sieg H, Braeuning C, Kunz BM, Daher H, K\u00e4stner C, Krause BC, \nMeyer T, Jalili P , Hogeveen K, B\u00f6hmert L, et al. Uptake and molecular \nimpact of aluminum-containing nanomaterials on human intestinal caco-2 \ncells. Nanotoxicol. 2018, 12(9): 992-1013. https://doi.org/10.1080/174\n35390.2018.1504999.\n55. Requena T, Miguel M, Garc\u00e9s-Rim\u00f3n M, Mart\u00ednez-Cuesta MC, \nL\u00f3pez-Fandi\u00f1o R, Pel\u00e1ez C. Pepsin egg white hydrolysate modulates \ngut microbiota in Zucker obese rats. Food Funct. 2017, 8(1): 437\u2013443. \nhttps://doi.org/10.1039/c6fo01571a.\n56. Yu L, Zhai Q, Liu X, Wang G, Zhang Q, Zhao J, Narbad A, Zhang H, \nTian F, Chen W. Lactobacillus plantarum CCFM639 alleviates aluminium \ntoxicity. Appl Microbiol Biotechnol. 2016, 100(4): 1891\u20131900. https://\ndoi.org/10.1007/s00253-015-7135-7.\n57. Yu L, Zhai Q, Yin R, Li P , Tian F, Liu X, Zhao J, Gong J, Zhang \nH, Chen W. Lactobacillus plantarum CCFM639 Alleviate Trace Element \nImbalance-Related Oxidative Stress in Liver and Kidney of Chronic \nAluminum Exposure Mice. Biol Trace Elem Res. 2017, 176(2): 342\u2013349. \nhttps://doi.org/10.1007/s12011-016-0843-8.29\n2022/37 (3): 29-34Received:  10 - II - 2022\nAccepted:  2 - III - 2022\ndoi: 10.3306/AJHS.2022.37.03.29Corresponding author\nMohammad Hassan Hajian  \nE-mail: hajian.hassan@gmail.com   \nAbstract  \nIntroduction and objective:  Hospitals are among the social organizations that play a major role in improving the health status of \nthe country and providing health services. The speed of providing health services and the fact that patients do not wait too long to \nreceive these services are among the factors that are considered as the quality of medical services in each hospital. Especially in \nthe current situation, which is very important in hospitals due to coronary heart disease. Therefore, the purpose of this study is to \ndesign a dynamic model to study the system of hospital services. \nMethods:  In this study, first, important and influential factors in the system of providing health services in the hospital were identified \nthrough literature review, and after drawing the causal relationships between these factors, the flow accumulation diagram of the \nsystem was designed and used using a simulator and a simulator. Was made. \nResults and conclusion:  results of this study show that hospital management by increasing the number of physicians and \nincreasing the number of hospital beds, can create conditions to improve the quality of health services.\nKey words:  Dynamic model, health services, hospital, systems dynamics. \nResumen\nIntroducci\u00f3n y objetivo:  Los hospitales se encuentran entre las organizaciones sociales que desempe\u00f1an un papel importante \nen la mejora del estado de salud del pa\u00eds y en la prestaci\u00f3n de servicios sanitarios. La rapidez en la prestaci\u00f3n de servicios \nsanitarios y el hecho de que los pacientes no esperen demasiado tiempo para recibir estos servicios son algunos de los factores \nque se consideran como la calidad de los servicios m\u00e9dicos en cada hospital. Especialmente en la situaci\u00f3n actual, que es muy \nimportante en los hospitales debido a las enfermedades coronarias. Por lo tanto, el prop\u00f3sito de este estudio es dise\u00f1ar un modelo \ndin\u00e1mico para estudiar el sistema de servicios hospitalarios. \nMetodolog\u00eda:  En este estudio, en primer lugar, se identificaron los factores importantes e influyentes en el sistema de prestaci\u00f3n \nde servicios sanitarios en el hospital a trav\u00e9s de la revisi\u00f3n de la literatura, y despu\u00e9s de dibujar las relaciones causales entre estos \nfactores, se dise\u00f1\u00f3 el diagrama de acumulaci\u00f3n de flujo del sistema y se utiliz\u00f3 utilizando un simulador y un simulador. se realiz\u00f3. \nResultados y conclusi\u00f3n:  Los resultados de este estudio muestran que la gesti\u00f3n del hospital, al aumentar el n\u00famero de \nm\u00e9dicos y el n\u00famero de camas del hospital, puede crear condiciones para mejorar la calidad de los servicios sanitarios.\nPalabras clave: Modelo din\u00e1mico, servicios sanitarios, hospital, din\u00e1mica de sistemas.ORIGINAL\nInvestigation of the dynamic system of providing medical \nservices in the hospital for Covid-19 disease patients \nInvestigaci\u00f3n del sistema din\u00e1mico de prestaci\u00f3n de servicios m\u00e9dicos en el hospital \npara pacientes con la enfermedad de Covid-19  \nMohammad Hassan Hajian1      , Mina Alvandi2      , Ghazal Rezaei2      , \nSeyed Behnam Razavian3      \n1. Department of management, Maastricht University, Nederland   \n2. Arya int global,Istanbul, Turkey   3. Department of computer science, university of Ja\u00e9n. SpaineISSN 2255-0569\nID ID ID\nID30\n2022/37 (3): 29-34Mohammad Hassan Hajian et al.  \nIntroduction\nThe new coronavirus (Covid-19) is caused by acute \nrespiratory syndrome. The disease was first diagnosed in \nDecember 2019 in Hubei Province, Wuhan City, China. \nOn March 11, 2020, the World Health Organization \ndeclared the virus a pandemic. According to the latest \nglobal statistics of the World Database, as of November \n8, 2020, 27 million 327 thousand 404 people in the world \nhave been infected with this virus, of which one million \n211 thousand 428 people have died. The economic \nshock of the Corona outbreak has also led to negative \neconomic effects, including declining sales of many \nrelated businesses1-2. One of the important concerns \nof countries is to prevent this disease and predict ways \nto control and reduce it3-4. The results show that the \ncorrect use of the mask and the observance of social \ndistance as well as air flow in spaces and avoidance of \nclosed spaces have a significant effect on reducing the \nspread of the disease and reducing mortality5-8. \nIn this project, corona prediction is investigated with a \nsystems dynamics approach. First, the relationships of \nimportant effective variables on the development of the \ndisease are obtained in SPSS software and then the data \nis analyzed using Vensim software. In the following, by \nanalyzing the sensitivity and providing recommendations, \nthe effect of vaccines to control the conditions of this \nnew crisis will be examined.\nLiterature review\nHigh quality of services provided in the hospital is related \nto issues such as patient satisfaction, efficiency and \nsuperiority of the organization, but low quality leads to \npoor service, which in turn leads to higher prevalence \nof the disease, higher costs and less trust in the health \nsystem4-5.\nZarei et al in a study aimed at comparing the quality of \nservices from the patient\u2019s perspective in the emergency \ndepartment of public and private hospitals under the \nauspices of Shahid Beheshti University of Medical \nSciences in 2015. In this study, 373 discharged patients \nfrom 8 public and private hospitals were selected by \nconvenience sampling method. Data were analyzed using \ndescriptive statistics, Mann-Whitney and multivariate \nregression tests in SPSS software. The results of this \nstudy show that the quality of emergency services in \nprivate hospitals is better than public hospitals. They \nstated that the management of the hospitals should \npay more attention to the aspects of education before \ndischarge and follow-up treatment, as well as prompt \ntreatment, and by giving educational booklets to the \npatient during discharge, along with telephone follow-up \nand reduction. Waiting times increase patient satisfaction \nby re-engineering care processes.Bozorgi et al conducted a study to determine the speed \nof emergency services and related factors in the 5-level \ntriage system in Imam Khomeini Medical Center in Sari. \nThis cross-sectional study was performed in December \n2012 at Imam Khomeini Medical Center in Sari. They \nreviewed medical records and patient triage sheets by \ncompleting data collection forms and calculating the \nspeed of action taken for each patient. The number of \nsamples was 365, statistical analysis was performed \nusing SPSS16 statistical software and data were \nanalyzed by chi-square and Anova tests. The results of \nthis study showed that there is a significant relationship \nbetween work shift and the time of access to the doctor \nand services and patient assignment. There was a \nsignificant relationship between the patient\u2019s level with \nthe time of access to the doctor and services and \nassignment. In the end, it was found that the time of \nproviding services in the emergency department of \nImam Sari Hospital, which uses a 5-level triage system, \nis short and the speed of providing services is at the \ndesired level.\nIdentify factors and determine \ncausal relationships\nMany variables and factors affect the system that can \naffect the behavior of the model. Like all economic, social, \netc. systems, the health care delivery system is influenced \nby several factors that are related to each other.\nThe first step to build a model in the science of system \ndynamics is to identify important factors and variables \naffecting the system under study so that based on \nthese variables can determine the model boundary and \ndetermine the causal relationships.\nFactors affecting the model of this research and \ninteractions and causal relationships between these \nfactors were identified with the help of experts.\nFigure 1  shows the causal relationships between the \nmodel variables in our study.\nAfter identifying the variables and drawing a causal \ndiagram, the type and nature of the variables should be \ndetermined and then the accumulation-flow diagram of \nthe model should be drawn. The list of variables used in \nthe model and their type and nature are given in table I .\nAfter determining the type of variables, the accumulation-\nflow diagram of the model was plotted as shown in \nfigure 2 .31\n2022/37 (3): 29-34Investigation of the dynamic system of providing medical services in the hospital for Covid-19 disease patients\nFigure 1: Causal diagram of medical services delivery system. Accumulation-flow diagram.\nFigure 2: Accumulation-flow diagram of the health care delivery system.\nTable I: Variables used in the model.\n Name of a variable Type of variable The variable\u2019s nature Name of a variable Type of variable The variable\u2019s nature\n Population Subsidiary External Admission rate Rate Internal\n Rate of hospital admissions Rate Internal Patients waiting for treatment Accumulation Internal\n Time spend on each patient\u2019s  Subsidiary External Reducing hospital admissions Subsidiary External\n examination  \n Availability of doctors Subsidiary External Number of available beds Subsidiary external\n Reducing patient recovery time Subsidiary External Bedridden decrease Subsidiary external\n Recovery rate Rate Internal Rate of patient examinations Rate Internal\n Inpatients Accumulation Internal   32\n2022/37 (3): 29-34Mohammad Hassan Hajian et al.  \nSimulation\nAfter drawing the flow accumulation diagram, in order to \nsimulate the model, it is necessary to write a formula that \nthe formulas used in the research model are:\n(01) FINAL TIME = 168\nUnits: Hour\nThe final time for the simulation.\n(02) INITIAL TIME = 0\nUnits: Hour\nThe initial time for the simulation.\n(03) SAVEPER =\nTIME STEP\nUnits: Hour [0 ,?]\nThe frequency with which output is stored.\n(04) TIME STEP = 1\nUnits: Hour [0 ,?]\nThe time step for the simulation.\n(05) Inpatients = INTEG (hospitalization rate-recovery \nrate, 20)\nUnits: ** undefined **\n(06) Patients waiting in the treatment queue = INTEG \n(Patient examination rate-Patient admission rate, 150)\nUnits: ** undefined **\n(07) Number of beds available = 200\nUnits: ** undefined **\n(08) Number of available physicians = 15Units: ** undefined **\n(09) population = 900000\nUnits: ** undefined **\n(10) Mean examination time per patient = 0.1\nUnits: ** undefined **\n(11) Hospitalization rate = IF THEN ELSE (hospitalized \npatients> = number of available beds, 0, hospitalization \ndeduction * patient examination rate)\nUnits: ** undefined **\n(12) Recovery rate = Patient recovery fraction * Inpatients\nUnits: ** undefined **\n(13) Patient examination rate = number of available \nphysicians * Average examination time per patient\nUnits: ** undefined **\n(14) Patient admission rate = patients waiting in the \ntreatment queue / (population * patient admission \ndeduction)\nUnits: ** undefined **\n(15) Hospitalization fraction = 0.9\nUnits: ** undefined **\n(16) Patient recovery fraction = 0.001\nUnits: ** undefined **\n (17) Patient admission deduction = 0.001\nUnits: ** undefined **\nAfter formulating the model, the structure of the model \nequations should be examined by vensim software. \nFigure 3  shows the accuracy of the structure of the \nequations used in the model.After confirming the model structure, we simulated the \nmodel for a period of 168 hours. The results of model \nsimulation are shown in figures 4  and 5.\nFigure 3: Shows the accuracy of the structure of the equations used in the model.\n33\n2022/37 (3): 29-34Investigation of the dynamic system of providing medical services in the hospital for Covid-19 disease patients\nExcessively waiting for patients to receive medical \nservices has always been an annoying issue for patients, \nwhich will have a negative impact on the quality of service. \nTherefore, it is necessary to review different policies to \nreduce patients waiting in the treatment queue.\nPolicies to increase the number of beds: Patients who go to \nthe hospital and are examined by a doctor, are either treated \non an outpatient basis and are discharged from the hospital, \nor need to be admitted if the hospital does not have enough \nbeds. Can accept a new patient for hospitalization and \ntherefore the patient has to go to another medical center \nor hospital, which can be unpleasant for the patient. Since another factor that affects the quality of medical services is \nthe timely and rapid provision of services to patients and \nthe lack of sufficient beds is a negative factor to determine \nthe quality of the hospital, so increase the number of beds. \nHospitals can be an effective measure to improve the \nspeed of providing medical services to patients. figure 7  \nshows the changes resulting from this policy.Policy to increase the number of hospital physicians and \ntreatment staff: As the number of hospital physicians \nincreases, the speed of service to patients increases and \nas a result, the number of people waiting in the treatment \nqueue decreases. The changes to this policy are shown \nin figure 6 .Figure 4: Patients waiting in the treatment queue during the simulation time.\nFigure 6: Changes resulting from the implementation of the policy of increasing the number of hospital physicians.\nFigure 7: Changes resulting from the implementation of the policy of increasing the number of hospital beds.Figure 5: Patients admitted during the simulation time.\n34\n2022/37 (3): 29-34Investigation of the dynamic system of providing medical services in the hospital for Covid-19 disease patientsMohammad Hassan Hajian et al.  \nConclusion\nHospitals are among the social organizations that play a \nmajor role in improving the health status of the country \nand providing health services. The speed of providing \nhealth services in Mani and not waiting too long for \npatients to receive these services are among the factors \nthat are considered as the quality of the level of medical \nservices in each hospital. The results of model simulation \nand application of different policies show that hospital \nmanagement by increasing the number of physicians can \nreduce the waiting time of patients in the treatment queue \nand lead to patient satisfaction with the quality of medical services. Also, increasing the number of hospital beds \nincreases the capacity of the hospital to accept patients \nwho need to be admitted, and as a result, the probability \nthat the patient needs to be admitted but due to the lack of \nbeds, the hospital will not be able to accept it will be less. \nThis issue also increases patients\u2019 satisfaction with the level \nof quality of medical services.\nConflict of Interest\nThe authors declare that they have no conflict of interest.\nReferences\n1. L\u00f3pez L,  Rodo X. A modified SEIR model to predict the COVID-19 \noutbreak in Spain and Italy: simulating control scenarios and multi-scale \nepidemics. Results in Physics 2021; 21: 103746.\n2. Taner T, Antony J. Comparing public and private hospital  care service \nquality in Turkey. Leadership in Health Services. 2006;19(2):1-10.\n3. Parasuraman A, Zeithaml V, Berry L. SERVQUAL: A multiple-Item scale \nfor measuring consumer perceptions of service quality. In: Findlay A, \nSparks L, editors. Retailing: Critical concepts. London: Taylor & Francis; \n2002.p.140.\n4. Zeithaml VA , Berry LL, Parasuraman A. The Behavioral consequences \nof service quality. Journal Of Marketing. 1996;60(2): 31-46.5. De Man S, Gemmel P , Vlerick P , Va n Rijk P , Dierckx R. Patients\u2019 And \npersonnel\u2019 S perceptions of service quality and patient satisfaction in \nnuclear medicine. European Journal Of nuclear medicine and molecular \nimaging. 2002;29(9): 1109-17. \n6. Abdolhamid MA, Pishvaee MS, Aalikhani R, Parsanejad M. A system \ndynamics approach to COVID-19 pandemic control: a case study of \nIran. Kybernetes 2021. Available at: A system dynamics approach to \nCOVID-19 pandemic control: a case study of Iran | Emerald Insight\n7. Bozorgi M, Amin GH, Shekarchi M, Rahimi R. Medicinal Plants \nof the Genus Drimia: a Review on Traditional Uses, Phytochemistry, \nPharmacology and Toxicology. J Tradit Chin 2022 Med In press\n8. Indrawati, S. Usulan Perbaikan Pelayanan Donor Darah Akibat Pandemi \nVirus Corona dengan Pendekatan Lean Service dan System Dynamics \n(Studi Kasus: Palang Merah Indonesia Kabupaten Sleman). 202035\n2022/37 (3): 35-40Received:  12 - II - 2022\nAccepted:  3 - III - 2022\ndoi: 10.3306/AJHS.2022.37.03.35Corresponding author\nOmar Mili\u00e1n Ram\u00edrez  \nE-mail: marmr@infomed.sld.cu   \nResumen  \nLa COVID-19 es una nueva enfermedad con una alta morbilidad y mortalidad en el mundo y gran variabilidad cl\u00ednica en su \ncomportamiento. Con el objetivo de caracterizar variables cl\u00ednicas y epidemiol\u00f3gicas en los pacientes positivos a la COVID-19 de \nla provincia de Villa Clara, se realiz\u00f3 un estudio descriptivo de casos cl\u00ednicos positivos a la prueba de Reacci\u00f3n en Cadena a la \nPolimerasa de Transcriptasa Reversa en tiempo real de la provincia de Villa Clara (317 pacientes), desde marzo a noviembre de 2020. \nSe utiliz\u00f3 el registro de pruebas de PCR del Laboratorio Provincial de Microbiolog\u00eda y se revisaron las encuestas epidemiol\u00f3gicas. \nPredominaron los pacientes del sexo femenino, el grupo de edad de 40 a 59 a\u00f1os y los residentes en el municipio de Santa Clara. \nLa mayor\u00eda de los enfermos se encontraban asintom\u00e1ticos al diagn\u00f3stico. Los s\u00edntomas de mayor frecuencia resultaron la tos y la \nfiebre. La Hipertensi\u00f3n arterial y la Diabetes Mellitus fueron las comorbilidades que m\u00e1s acompa\u00f1aron a la enfermedad.\nKey words:  SARS-CoV2, COVID-19, caracter\u00edsticas cl\u00ednicas y epidemiol\u00f3gicas de pacientes. \nAbstract\nCOVID-19 is a new disease with high morbidity and mortality in the world and great clinical variability in its behavior. With the \naim of characterizing clinical and epidemiological variables in patients positive for COVID-19 in the province of Villa Clara, a \ndescriptive study of positive clinical cases to the real-time Reverse Transcriptase Polymerase Chain Reaction test was carried \nout. from the province of Villa Clara (317 patients), from March to November 2020. The registry of PCR tests of the Provincial \nLaboratory of Microbiology was used and the epidemiological surveys were reviewed. Female patients, the age group from 40 \nto 59 years and residents in the municipality of Santa Clara prevailed. Most of the patients were asymptomatic at diagnosis. The \nmost frequent symptoms were cough and fever. Arterial hypertension and Diabetes Mellitus were the comorbidities that most \naccompanied the disease.\nPalabras clave: SARS-CoV2, COVID-19, Clinical and epidemiological characteristics of patients.ORIGINAL\nCaracterizaci\u00f3n cl\u00ednico epidemiol\u00f3gica \nde los casos positivos a la COVID-19 en Villa Clara. \nMarzo-noviembre 2020 \nClinical epidemiological characterization of positive cases for COVID-19 in Villa Clara. \nMarch-November 2020  \nOmar Mili\u00e1n Ram\u00edrez1      , Yakel\u00edn Luna Carvajal2      , Angela Moms Carballo2      ,\nYamilet Medina Padr\u00f3n3      , Gretza S\u00e1nchez Padr\u00f3n2      , Jes\u00fas Yasoda Endo Milan1\n1. Universidad de Ciencias M\u00e9dicas de Villa Clara   2. Direcci\u00f3n Provincial de Salud. Universidad de Ciencias M\u00e9dicas de Villa Clara    \n3. Centro Provincial de Higiene, Epidemiolog\u00eda y Microbiolog\u00eda. Universidad de Ciencias M\u00e9dicas de Villa ClaraeISSN 2255-0569\nID\nID ID IDID ID36\n2022/37 (3): 35-40Omar Mili\u00e1n Ram\u00edrez et al.  \nIntroducci\u00f3n\nLa aparici\u00f3n de la enfermedad COVID-19, abreviatura de \n\u201cenfermedad por coronavirus 2 del s\u00edndrome respiratorio \nagudo severo (SARS-CoV-2)\u201d en China en diciembre del \n2019 y su r\u00e1pida propagaci\u00f3n a otros pa\u00edses, motiv\u00f3 \nque la Organizaci\u00f3n Mundial de la Salud (OMS) declarara \nel brote como una Emergencia de Salud P\u00fablica de \nImportancia Internacional (ESPII) el 30 de enero de 2020 \ny como una pandemia el 11 de marzo del mismo a\u00f1o1,2,3.\nLa enfermedad se caracteriza por una alta tasa de \ntransmisi\u00f3n, per\u00edodo de incubaci\u00f3n prolongado, \npresencia de portadores asintom\u00e1ticos o con s\u00edntomas \nleves, posible progresi\u00f3n a s\u00edndrome de dificultad \nrespiratoria del adulto (SDRA) e incluso la muerte, \ndiseminaci\u00f3n viral despu\u00e9s del alivio de los s\u00edntomas y \ntrasmisi\u00f3n ambiental y f\u00f3mites3.\nEs una enfermedad sin tratamiento farmacol\u00f3gico \nespec\u00edfico y con unos mecanismos de transmisibilidad y \nletalidad poco conocidos. Estas caracter\u00edsticas dificultan \nla implementaci\u00f3n de intervenciones sanitarias por parte \nde los sistemas de salud. A este escenario se agregan \nla diversidad de aspectos econ\u00f3micos, sociales y \ndemogr\u00e1ficos, y las capacidades de los sistemas de \nsalud para identificar y ofrecer atenci\u00f3n m\u00e9dica a las \npersonas afectadas.4\nAl 15 de septiembre de 2020, del total de casos \nconfirmados acumulados a nivel global con un total de \n29.155.581 casos, incluidas 926.544 defunciones. La \nproporci\u00f3n m\u00e1s alta de casos, seg\u00fan regiones de la \nOMS es la siguiente: la regi\u00f3n de las Am\u00e9ricas acumula \n14.903.891 casos, incluidas 513.246 defunciones, lo \nque representa 51% del total casos confirmados y 55% \ndel total de las defunciones, seguida por las regiones \nde Asia Sudoriental que representa 19% del total de \ncasos y 10% del total de defunciones (5.565.977 casos, \nincluidas 94.871 defunciones) y Europea con 17% del \ntotal de casos y 25% del total de defunciones (4.873.346 \ncasos, incluidas 226.363 defunciones2.\nEl Ministerio de Salud P\u00fablica, en su sitio digital oficial, \ninforma que Cuba reporta 5 mil 670 casos confirmados \nen el pa\u00eds al 30 de septiembre de 2020 y la provincia de \nVilla Clara, 317 casos que representa un 5,6% del total \ndel pa\u00eds. Con el objetivo de realizar una caracterizaci\u00f3n \ncl\u00ednica y epidemiol\u00f3gica de los casos positivos a la \nCOVID-19 en Villa Clara en el per\u00edodo de marzo-\nseptiembre 2020, se realiz\u00f3 el siguiente trabajo5.\nMateriales y m\u00e9todos\nSe realiz\u00f3 un estudio descriptivo de casos cl\u00ednicos de los \n317 pacientes confirmados positivos a la prueba de RT-\nPCR (reacci\u00f3n en cadena a la polimerasa de transcriptasa reversa en tiempo real) de la provincia Villa Clara desde el \n11 de marzo hasta el 30 de noviembre de 2020, seg\u00fan \nel registro de pruebas de PCR del Laboratorio Provincial \nde Microbiolog\u00eda. Se dise\u00f1\u00f3 y emple\u00f3 una planilla \nrecolectora de datos, los cuales se obtuvieron mediante \nla revisi\u00f3n de las historias epidemiol\u00f3gicas. \nEntre las variables analizadas figuraron la edad, el sexo, \nel municipio de residencia, la forma de presentaci\u00f3n \nde la enfermedad, los s\u00edntomas m\u00e1s frecuentes y las \ncomorbilidades asociadas.\nLos datos obtenidos se registraron en una hoja de \nc\u00e1lculo del programa Microsoft Excel para luego ser \nevaluados en el software estad\u00edstico SPSS versi\u00f3n 23, \nlo cual permiti\u00f3 elaborar tablas estad\u00edsticas y gr\u00e1ficos y \nexponer los hallazgos encontrados durante el proceso \ninvestigativo. Se resumieron las variables utilizadas a \ntrav\u00e9s de la determinaci\u00f3n de las frecuencias absoluta y \nrelativa como medidas de resumen, las cuales sirvieron \npara el an\u00e1lisis y la presentaci\u00f3n de los resultados. \nEsta investigaci\u00f3n se realiz\u00f3 de acuerdo con las normas \n\u00e9ticas para el uso de material y datos humanos, \nestablecidas en la Declaraci\u00f3n de Helsinki de la Asamblea \nM\u00e9dica Mundial, donde se analizan los principios \u00e9ticos \npara las investigaciones m\u00e9dicas en seres humanos.\nResultados\nEl estudio evidenci\u00f3 un predominio del sexo femenino \n(52,4%) sobre el masculino (47,6%). \nEl gr\u00e1fico 1  muestra la distribuci\u00f3n de pacientes \npositivos a la prueba de RT-PCR seg\u00fan grupos de edad. \nObs\u00e9rvese el predominio del grupo de 40 a 59 a\u00f1os \n(31,9%), seguido del de 20 a 39 a\u00f1os (24,0%).\nLa distribuci\u00f3n de pacientes positivos a la prueba de \nRT-PCR seg\u00fan municipios de residencia se muestra \nen el tabla I  apreci\u00e1ndose que el mayor n\u00famero de \npacientes fue aportado por el municipio de Santa \nGr\u00e1fico 1: Distribuci\u00f3n de pacientes positivos a la prueba de RT-PCR seg\u00fan \ngrupos de edad y sexo.\nFuente: Encuesta epidemiol\u00f3gica.2022/37 (3): 35-4037Caracterizaci\u00f3n cl\u00ednico epidemiol\u00f3gica de los casos positivos a la COVID-19 en Villa Clara. Marzo-noviembre 2020\nClara (49,2%), seguido por Camajuan\u00ed (15,8%) y m\u00e1s \nalejado Manicaragua (8,8%) pero todos los municipios \nreportaron casos.\nAl mostrar la distribuci\u00f3n de pacientes positivos a la \nprueba de RT-PCR seg\u00fan forma de presentaci\u00f3n del \ncuadro cl\u00ednico en el gr\u00e1fico 2 , se puede apreciar que el \ndiagn\u00f3stico se realiz\u00f3 con mayor frecuencia en pacientes \nasintom\u00e1ticos (67,2%).\nEl gr\u00e1fico 3  muestra la distribuci\u00f3n de pacientes \nsintom\u00e1ticos positivos a la prueba de RT-PCR seg\u00fan \ns\u00edntomas m\u00e1s frecuentes. Fue la tos (51,0%) el s\u00edntoma \nm\u00e1s frecuente seguido por la fiebre (35,6%) y la \ncongesti\u00f3n nasal (26,9%).\nLa distribuci\u00f3n de pacientes positivos a la prueba de \nRT-PCR seg\u00fan comorbilidades asociadas aparece en el \ngr\u00e1fico 4  y se aprecia el predominio de la Hipertensi\u00f3n \narterial (HTA) como la enfermedad no trasmisible \n(ENT) m\u00e1s asociada a la COVID-19 (56,3%) seguida \npor la Diabetes Mellitus (17,5%) y las enfermedades \ncard\u00edacas (13,8%).Discusi\u00f3n\nExiste gran variedad de casos en el mundo y la prevalencia \npor sexo de los casos notificados de la COVID-19 var\u00eda \nentre los distintos pa\u00edses del mundo. Estudios realizados \nen Espa\u00f1a, B\u00e9lgica, Portugal, Holanda y Georgia afirman \nque no existen diferencias significativas con relaci\u00f3n a \nla distribuci\u00f3n de pacientes por sexo. Otros estudios en \nChina, Reino Unido, Per\u00fa y Cuba plantean un predominio \ndel sexo masculino6-12. \nEl estudio evidenci\u00f3 el predominio del sexo femenino \nentre los diagnosticados que coincide con los resultados Gr\u00e1fico 2: Distribuci\u00f3n de pacientes positivos a la prueba de RT-PCR seg\u00fan \nforma de presentaci\u00f3n del cuadro cl\u00ednico.\nFuente: Encuesta epidemiol\u00f3gica.Gr\u00e1fico 3: Distribuci\u00f3n de pacientes positivos a la prueba de RT-PCR seg\u00fan \ns\u00edntomas m\u00e1s frecuentes.\nFuente: Encuesta epidemiol\u00f3gica.\nGr\u00e1fico 4: Distribuci\u00f3n de pacientes positivos a la prueba de RT-PCR seg\u00fan \ncomorbilidades asociadas.\nFuente: Encuesta epidemiol\u00f3gica.\nTabla I: Distribuci\u00f3n de pacientes positivos a la prueba de RT-PCR seg\u00fan \nmunicipio de residencia y sexo.\nMunicipio Sexo Total %\nde residencia M F  \nCaibari\u00e9n 7 7 14 4,4\nCamajuan\u00ed 20 30 50 15,8\nSagua la Grande 2 1 3 0,9\nCifuentes 2 8 10 3,2\nQuemado de G\u00fcines 1 0 1 0,3\nCorralillo 4 3 7 2,2\nEncrucijada  0 1 1 0,3\nManicaragua 18 10 28 8,8\nPlacetas 7 6 13 4,1\nRanchuelo 4 4 8 2,5\nRemedios 3 2 5 1,6\nSanta Clara 72 84 156 49,2\nSanto Domingo 11 10 21 6,6\nTotal 151 166 317 100\nFuente: Encuesta epidemiol\u00f3gica.38\n2022/37 (3): 35-40Omar Mili\u00e1n Ram\u00edrez et al.  \nde Medina-Fuentes G y colaboradores en Camag\u00fcey \naunque su universo de estudio fue muy reducido. Para \nFerrer Castro JE en Santiago de Cuba, sin embargo, \nexiste una mayor incidencia en el sexo masculino; \nmientras que para Urquiza-Yero Y y colaboradores en \nLas Tunas es igual para ambos sexos12-14.\nEsta disparidad de resultados dentro del pa\u00eds demuestra \nla variabilidad del comportamiento de la enfermedad en \nrelaci\u00f3n al sexo. Se comparte la opini\u00f3n de Smtih J quien \nplantea que la escasez de informaci\u00f3n por g\u00e9nero limita \nteorizar sobre las probabilidades de asociaci\u00f3n entre el \nsexo y la susceptibilidad al virus. No obstante hay expertos \nque proponen explicaciones gen\u00e9ticas y hormonales para \nlas diferencias en la susceptibilidad por sexo15,16.\nExisten varios informes que justifican la menor \nsusceptibilidad femenina al contagio; desde los inicios \nde la pandemia se hablaba de la posible resistencia \nfemenina al virus. Se especula que la poca susceptibilidad \nde las mujeres a las infecciones virales puede deberse a \nla protecci\u00f3n del cromosoma X extra que presentan en \ncomparaci\u00f3n con los hombres7.\nEs oportuno precisar que los resultados se han mostrado \nen n\u00fameros absolutos y no a trav\u00e9s de tendencias, \nsiendo este \u00faltimo tipo de an\u00e1lisis el recomendado en \nlas epidemias, ya que suelen explicar m\u00e1s que las cifras \nabsolutas transversales. Las diferencias antes mostradas \nen la frecuencia por sexo pueden ser reales o fruto de \ncomparaciones transversales preliminares en diversos \nestadios de la epidemia17.\nSe comparte el criterio de Urquiza-Yero Y quien plantea \nque independientemente de las diversas hip\u00f3tesis \nplanteadas referentes a variables biol\u00f3gicas, existen \nvariables sociales como la responsabilidad social, \nejecutada por cada sexo en correspondencia con los \npatrones culturales y el nivel de igualdad de g\u00e9nero \nexistente en una naci\u00f3n, que llevan a que la balanza \nse incline a un sexo u otro, en dependencia de la \nexposici\u00f3n al virus que cada uno tenga en relaci\u00f3n con \nla actividad social que desempe\u00f1a, lo que puede influir \nen el contagio por la enfermedad14.\nCuando se analizan los grupos de edades m\u00e1s \nafectados por la epidemia se evidenci\u00f3 un predominio \ndel grupo de 40 a 59 a\u00f1os seguido del de 20 a 39. \nEstos resultados son similares a los obtenidos por \nCobas Planchez L y colaboradores en La Habana \nquienes obtuvieron un predominio de los pacientes \npositivos a la COVID-19 en los mayores de 40 a\u00f1os \nen un 52,94%. Otras provincias en Cuba muestran un \ncomportamiento diferente, por ejemplo, los resultados \nobtenidos por Medina-Fuentes G, y colaboradores en \nCamag\u00fcey se\u00f1alan un predominio de adolescentes y \nadultos mayores13,17.Los autores consideran que estos grupos de edades \nson los que se han mantenido m\u00e1s activos y con mayor \ninteracci\u00f3n social al permanecer, durante la etapa de \nm\u00e1s alta transmisibilidad de la enfermedad, cubriendo \nla satisfacci\u00f3n de las necesidades de la poblaci\u00f3n m\u00e1s \nvulnerable y, en consecuencia, se mantuvieron m\u00e1s \npropensos al contagio.\nAl hacer referencia al municipio de residencia de los \nafectados, se puede comprobar que el mayor n\u00famero \nperteneci\u00f3 al municipio cabecera que aport\u00f3 el 57,6% \nde los casos. Resultados similares obtiene Urquiza-\nYero Y y colaboradores en Las Tunas que demostraron \nmayor frecuencia en los municipios m\u00e1s densamente \npoblados. Adem\u00e1s los autores coinciden con el criterio \nde estos autores cuando plantean que la densidad \npoblacional del lugar de residencia es una variable \nepidemiol\u00f3gica que influye en la propagaci\u00f3n del virus \nunida a la interacci\u00f3n social14.\nEn el estudio, el 66,5% de los pacientes se encontraban \nasintom\u00e1ticos al momento del diagn\u00f3stico. Estudios \nen Jap\u00f3n, California y en las provincias cubanas de \nSantiago de Cuba y Las Tunas coinciden con estos \nresultados; pero para Medina Fuentes y colaboradores \nen Camag\u00fcey fueron los pacientes sintom\u00e1ticos los m\u00e1s \nrepresentativos.12,14,19,20\nDurante las epidemias, los pacientes asintom\u00e1ticos \ntienen una gran implicaci\u00f3n en el mantenimiento de la \ntransmisi\u00f3n viral en la comunidad, por lo que se debe \ntener en cuenta este grupo en la cadena de trasmisi\u00f3n \nde la misma, sobre todo en los casos donde no se ha \ndemostrado la fuente de infecci\u00f3n14,21.\nLos autores consideran que la eficacia de las medidas \nimplementadas por el Estado en el Plan para la \nPrevenci\u00f3n y Control del nuevo coronavirus (COVID-19) \naprobado, contribuy\u00f3 a estos resultados pues se han \nestado realizando estrictos controles de casos con la \nconsecuente b\u00fasqueda de todos los posibles contactos \nde casos positivos18.\nEn el variado espectro cl\u00ednico hallado, fueron la fiebre \n(41,9%) y la tos (39,5%) los s\u00edntomas m\u00e1s frecuentes \npresentados por los diagnosticados lo cual coincide con \nla opini\u00f3n de expertos que consideran la variabilidad en \nla frecuencia de presentaci\u00f3n del cuadro cl\u00ednico22.\nResultados similares aparecen en un estudio realizado en \nla ciudad de Wuhan, China que evidenci\u00f3 que los signos y \ns\u00edntomas importantes de la COVID-19 eran: fiebre (98%), \ntos seca (76%), disnea (55%), mialgia o fatiga (44%) y \nlinfopenia (63%). Medina Fuentes y colaboradores en \nCuba (Camag\u00fcey), tambi\u00e9n encontraron la fiebre como \ns\u00edntoma m\u00e1s frecuentemente presentado (38,4%) \naunque seguido de los pacientes asintom\u00e1ticos y la tos \n(30,7% respectivamente)14,23.39\n2022/37 (3): 35-40Caracterizaci\u00f3n cl\u00ednico epidemiol\u00f3gica de los casos positivos a la COVID-19 en Villa Clara. Marzo-noviembre 2020\nSin embargo para Pan L y colaboradores, al estudiar \n204 pacientes en la provincia de Hubei (China), el 50,5% \npresent\u00f3 s\u00edntomas digestivos, como p\u00e9rdida del apetito, \ndiarrea, v\u00f3mitos y dolor abdominal24.\nEn el estudio se evidenci\u00f3 que el 31,3% de los enfermos \npresent\u00f3 alguna enfermedad cr\u00f3nica no transmisible \n(ENT) asociada al cuadro cl\u00ednico, siendo la Hipertensi\u00f3n \nArterial (HTA) la m\u00e1s frecuente (56,3%) seguida por la \nDiabetes Mellitus (17,5%) y las cardiopat\u00edas (13,8%).\nEstos resultados coinciden con otros estudios realizados \nen Per\u00fa, China y las provincias cubanas de Camag\u00fcey y \nLas Tunas donde la HTA fue la ENT m\u00e1s frecuentemente \nasociada a la enfermedad en estudio.10,12,14 y 25\nDiversas publicaciones expresan el papel de los \nantecedentes cl\u00ednicos y epidemiol\u00f3gicos en la \nsusceptibilidad, evoluci\u00f3n y pron\u00f3stico de la enfermedad, \ndando a conocer que pacientes mayores de 60 a\u00f1os y con \ncomorbilidades asociadas son m\u00e1s propensos al contagio \ny el desarrollo de formas graves de la enfermedad12.\nHay autores que plantean que por la patogenia de la \nCOVID-19, los pacientes con HTA y Enfermedad Cerebro \nvascular sufren afectaci\u00f3n mioc\u00e1rdica y lesi\u00f3n vascular, \ntrastornos de la coagulaci\u00f3n con formaci\u00f3n de trombos y fen\u00f3menos emb\u00f3licos, todo lo cual empeora el curso de \nestas afecciones, aumenta la tensi\u00f3n arterial, produce \narritmias cardiacas, episodios coronarios agudos e \ninsuficiencia cardiaca con choque cardiog\u00e9nico26.\nSe concluye que en los pacientes diagnosticados \ncon la COVID-19 de la provincia de Villa Clara, han \npredominado los pacientes del sexo femenino y los del \ngrupo de edad de 40 a 59 a\u00f1os; as\u00ed como los residentes \nen el municipio de Santa Clara. La gran mayor\u00eda de los \nenfermos se encontraban asintom\u00e1ticos al momento \ndel diagn\u00f3stico. La tos y la fiebre fueron los s\u00edntomas \nque m\u00e1s frecuencia tuvieron en el cuadro cl\u00ednico y la \nHipertensi\u00f3n arterial y la Diabetes Mellitus fueron las \nenfermedades no trasmisibles que m\u00e1s acompa\u00f1aron \na la enfermedad. \nCompartir las experiencias que se van obteniendo en \nla pr\u00e1ctica, sigue siendo importante para conocer m\u00e1s \nsobre los patrones de transmisi\u00f3n, las caracter\u00edsticas \ncl\u00ednicas y los factores de riesgo de infecci\u00f3n de la \nCOVID-19.\nConflicto de intereses\nLos autores declaran no tener ning\u00fan conflicto de inter\u00e9s.\nReferencias bibliogr\u00e1ficas\n1. Organizaci\u00f3n Panamericana de la Salud / Organizaci\u00f3n Mundial de \nla Salud. Actualizaci\u00f3n epidemiol\u00f3gica: Enfermedad del Coronavirus \n(COVID-19). 26 de agosto de 2020, Washington, D.C.: OPS/OMS; \n2020. Disponible en: https://bit.ly/2Zppxbg\n2. Organizaci\u00f3n Panamericana de la Salud / Organizaci\u00f3n Mundial de \nla Salud. Actualizaci\u00f3n epidemiol\u00f3gica: Enfermedad del Coronavirus \n(COVID-19). 18 de septiembre de 2020, Washington, D.C.: OPS/\nOMS; 2020. Disponible en: https://www.paho.org/es/documentos/\nactualizacion-epidemiologica-enfermedad-por-coronavirus-covid-19-18-\nseptiembre-2020.\n3. L\u00f3pez-Ponce de Le\u00f3n JD, C\u00e1rdenas-Mar\u00edn PA, Giraldo-Gonz\u00e1lez \nGC, Herrera-Escand\u00f3n A. CORONAVIRUS \u2013 COVID 19: M\u00e1s all\u00e1 de \nla enfermedad pulmonar, qu\u00e9 es y qu\u00e9 sabemos del v\u00ednculo con el \nsistema cardiovascular. Rev Colomb Cardiol. [revista en internet]. 2020 \nDisponible en: https://www.sciencedirect.com/science/article/pii/\nS0120563320300784#abs0005.\n4. Medeiros de Figueiredo A, et al. Letalidad del COVID-19: ausencia de \npatr\u00f3n epidemiol\u00f3gico. Gac Sanit. 2020. https://www.easp.es/project/\nletalidad-del-covid-19-ausencia-de-patron-epidemiologico/\n5. Ministerio de Salud P\u00fablica. Parte de cierre del d\u00eda 30 de septiembre \na las 12 de la noche [Internet]. La Habana: Ministerio de Salud P\u00fablica; \n2020. Disponible en:https://salud.msp.gob.cu/parte-de-cierre-del-dia-\n30-de-septiembre-a-las-12-de-la-noche/6. Ruiz-Cantero MT. Las estad\u00edsticas sanitarias y la invisibilidad por sexo y \nde g\u00e9nero durante la epidemia de COVID-19. Gaceta Sanitaria [revista en \ninternet]. 2020.  Disponible en: https://www.sciencedirect.com/science/\narticle/pii/S0213911120300844?dgcid=api_sd_search-api-endpoint\n7. Gold JAW, Wong KK, Szablewski CM, Patel PR, Rossow J, da Silva J, \net al. Characteristics and Clinical Outcomes of Adult Patients Hospitalized \nwith COVID-19 \u2014 Georgia, March 2020. MMWR Morb Mortal WklyRep \n[revista en internet]. 2020 ;69(18): 545-550. Disponible en: https://www.\ncdc.gov/mmwr/volumes/69/wr/mm6918e1.htm.\n8. Chen N, Zhou M, Dong X, Qu J, Gong F, Han Y, et al. Epidemiological \nand clinical characteristics of 99 cases of 2019 novel coronavirus \npneumonia in Wuhan, China: a descriptive study. Lancet [revista en \ninternet]. 2020 [citado 10 de diciembre 2020]; 395(10223): 507\u2013513. \nDisponible en: https://www.thelancet.com/journals/lancet/article/\nPIIS0140-6736(20)30211-7/fulltext.\n9. Docherty AB, Harrison EM, Green CA, Hardwick HE, Pius R, Norman \nL, et al. Features of 20133 UK patients in hospital with covid-19 \nusing the ISARIC WHO Clinical Characterisation Protocol: prospective \nobservational cohort study. BMJ [revista en internet]. 2020; 369: m1985. \nDisponible en: https://www.bmj.com/content/369/bmj.m1985.\n10. Escobar G, Matta J, Taype-Huaman\u00ed W, Ayala R, Amado J. \nCaracter\u00edsticas Cl\u00ednicoepidemiol\u00f3gicas de Pacientes Fallecidos Por \nCOVID-19 En Un Hospital Nacional de Lima, Per\u00fa. Rev. Fac. Med. Hum \n[revista en internet]. 2020; 20(2): 180\u201385. Disponible en: http://www.\nscielo.org.pe/pdf/rfmh/v20n2/2308-0531-rfmh-20-02-180.pdf40\n2022/37 (3): 35-40Caracterizaci\u00f3n cl\u00ednico epidemiol\u00f3gica de los casos positivos a la COVID-19 en Villa Clara. Marzo-noviembre 2020Omar Mili\u00e1n Ram\u00edrez et al.  \n11. Acosta G, Escobar G, Bernaola G, Alfaro J, Taype W, Marcos C, et \nal. Caracterizaci\u00f3n de Pacientes Con COVID-19 Grave Atendidos En Un \nHospital de Referencia Nacional Del Per\u00fa. Rev Peru Med Exp Salud Publica \n[revista en internet]. 2020 ; 37(2). Disponible en: http://www.scielo.org.\npe/scielo.php?pid=S1726-46342020000200253&script=sci_arttext\n12. Ferrer-Castro JE, S\u00e1nchez-Hern\u00e1ndez E, Poulout-Mendoza A, \ndel R\u00edo-Caballero G, Figueredo-S\u00e1nchez D. Caracterizaci\u00f3n cl\u00ednica y \nepidemiol\u00f3gica de pacientes confirmados con la COVID-19 en la provincia \nde Santiago de Cuba. MEDISAN [revista en internet]. 2020; 24(3)\n13. Medina-Fuentes G, Carbajales-Le\u00f3n EB, Figueredo-Gonz\u00e1lez \nY, Carbajales-Le\u00f3n AI, Silva-Corona I. Caracter\u00edsticas cl\u00ednico \nepidemiol\u00f3gicas de pacientes positivos a la COVID-19 pertenecientes al \npolicl\u00ednico \u201cJoaqu\u00edn de Ag\u00fcero y Ag\u00fcero\u201d, Camag\u00fcey. Revista Electr\u00f3nica \nDr. Zoilo E. Marinello Vidaurreta. 2020; [citado 10 de diciembre 2020] \n45(4). Disponible en: http://revzoilomarinello.sld.cu/index.php/zmv/ \narticle/view/2352.\n14. Urquiza-Yero Y, P\u00e9rez-Ojeda MD, Cort\u00e9s-Gonz\u00e1lez AM, Escalona-\nP\u00e9rez I, Cabrales-Le\u00f3n MO. Caracter\u00edsticas cl\u00ednico epidemiol\u00f3gicas de los \npacientes de Las Tunas positivos al RT-PCR para la COVID-19. Revista \nElectr\u00f3nica Dr. Zoilo E. Marinello Vidaurreta. 2020;45(4). Disponible en: \nhttp://revzoilomarinello.sld.cu/index.php/zmv/article/view/2361.\n15. Smith J. Overcoming the \u2018tyranny of the urgent\u2019: integrating \ngender into disease outbreak preparedness and response. Gender & \nDevelopment. 2019 [citado 12/05/2020]; 27 (2). Disponible en: https://\nwww.tandfonline.com/doi/full/10.1080/13552074.2019.1615288.\n16. Almaguer Mederos LE, Cuello Almarales D, Almaguer Gotay D. Rol \nde los genes ACE2 y TMPRSS2 en la susceptibilidad o gravedad de la \nCOVID-19. Anales de la Academia de Ciencias de Cuba. 2020.10 (2). \nDisponible en: http://www.revistaccuba.sld.cu/index.php/revacc/article/\nview/799/860.\n17. Cobas-Planchez L, Mezquia de Pedro N, Armenteros Ter\u00e1n SS. \nCaracter\u00edsticas cl\u00ednicas de pacientes con sospecha de COVID-19 \ningresados en el hospital \u201cFrank Pa\u00eds Garc\u00eda\u201d, La Habana. Revista \nElectr\u00f3nica Dr. Zoilo E. Marinello Vidaurreta [revista en internet]. 2020; \n45(4). Disponible en: http://revzoilomarinello.sld.cu/index.php/zmv/\narticle/view/2339.18. Ministerio de Salud P\u00fablica. Plan para la prevenci\u00f3n y control del \nnuevo coronavirus (COVID-19) [Internet]. La Habana: Ministerio de \nSalud P\u00fablica; 2020 Disponible en: https://www.presidencia.gob.cu/\nes/noticias/pla n-de-prevencion-y-control-del-covid-19- estrategia-para-\nestar-debida-y-oportunamente- preparados/\n19. Nishiura H, Kobayashi T, Miyama T, Suzuki A, Jung SM, Hayashi K, \net al. Estimation of the asymptomatic ratio of novel coronavirus infections \n(COVID-19). International Journal of Infectious Diseases [revista en \ninternet]. 2020; 94: 154-155. Disponible en: https://pubmed.ncbi.nlm.\nnih.gov/32179137/.\n20. Dora AV, Winnett A, Jatt LP , et al. Universal and Serial Laboratory \nTesting for SARS-CoV-2 at a Long-Term Care Skilled Nursing Facility for \nVeterans - Los Angeles, California, 2020. MMWR Morb Mortal Wkly Rep \n2020;69:651- 5. \n21. Espinosa-Brito A. Acompa\u00f1ando la marcha de la pandemia de \nCOVID-19. Una mirada desde Cienfuegos. Medisur [revista en Internet]. \n2020.18(3). Disponible en: http://medisur.sld.cu/index.php/medisur/\narticle/view/4726\n22. Palacios Cruz M, Santos E, Vel\u00e1zquez Cervantes MA, Le\u00f3n Ju\u00e1rez \nM. COVID-19, una emergencia de salud p\u00fablica mundial. Rev Clin \nEsp. 2020. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/\nPMC7102523/\n23. Centers for disease control and prevention. 2019 novel coronavirus, \nWuhan, China. Information for health care professionals [en l\u00ednea]. Atlanta: \nCenters for disease control and prevention; 2020.Disponible en: https://\nwww.cdc.gov/coronavirus/2019-ncov/hcp/index.html.\n24. Pan L, Mu M, Yang P , Sun Y, Wang R, Yan J, et al. Clinical \ncharacteristics of covid-19 patients with digestive symptoms in Hubei, \nChina: A Descriptive, Cross-Sectional, Multicenter Study. Am J \nGastroenterol [revista en internet]. 2020;115(5): 766-773. Disponible en: \nhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC7172492/\n25. Wang D, Hu B, Hu C, Zhu F, Liu X, Zhang J, et al. Clinical \nCharacteristics of 138 hospitalized patients with 2019 novel coronavirus-\ninfected pneumonia in Wuhan, China. JAMA [revista en internet]. \n2020.323(11): 1061-9. \n26. Serra-Vald\u00e9s M. Las enfermedades cr\u00f3nicas no transmisibles y la \npandemia por COVID-19. Revista Finlay [revista en Internet]. 2020.10(2): \nDisponible en: http://www.revfinlay.sld.cu/index.php/finlay/article/view/84641\n2022/37 (3): 41-45Received:  13 - II - 2022\nAccepted:  3 - III - 2022\ndoi: 10.3306/AJHS.2022.37.03.41Corresponding author\nDr. Marzie Bazzi  \nE-mail: marzie.bazzi1370@yahoo.com   \nAbstract  \nBackground:  Various valvular disorders, even severe cases, may be asymptomatic. Studies have found abnormalities in the heart \ntissue, even in cases that are not currently being treated, by cardiac MRI (CMR) examination, and these findings are used to predict \nthe prognosis of patients undergoing aortic or mitral surgery. Mortality or disability after surgery has been found to be beneficial. \nSome of these studies have also suggested that Late gadolinium Enhancement (LGE), which is administered by CMR, can also be \nused as a tool for risk stratification in asymptomatic patients.\nMethods:  This study was performed as a cross-sectional study on 355 Russian patients. The study population included all \npatients who underwent CMR during the study period. And their MRI patterns were examined for edema, hyperhemia, and fibrosis. \nThe information required by patients including demographic and demographic characteristics (age and sex) and the variables \nrequired by patients were recorded in the patient checklist.\nResults:  The prevalence of LGE in midmyocardium and subendocardium in LV posterior wall in patients with less than moderate \nmitral stenosis was significantly higher than others. The pattern of LGE in the septum, which was significantly higher in patients with \nDCM (dilated cardiomyopathy) and moderate and higher mitral regurgitation, was significantly higher in midmyocardial LGE. Among \npatients with primary valve involvement, there was no significant difference between patients with involvement between patients \nwith moderate and higher MR and AI, and patients with moderate MR and AI severity below average.\nConclusion:  The prevalence of LGE in the midmyocardium and subendocardium in the LV posterior wall was significantly higher in \npatients with less than moderate mitral stenosis. In addition, midmyocardial LGE was significantly higher in patients with DCM and \nmoderate and higher mitral regurgitation.\nKey words:  Cardiomyopathy, late gadolinium enhancement (LGE), valvular disorders. \nResumen\nAntecedentes:  Varios trastornos valvulares, incluso los casos graves, pueden ser asintom\u00e1ticos. Los estudios han encontrado \nanomal\u00edas en el tejido card\u00edaco, incluso en los casos que no est\u00e1n siendo tratados actualmente, mediante un examen de resonancia \nmagn\u00e9tica card\u00edaca (RMC), y estos hallazgos se utilizan para predecir el pron\u00f3stico de los pacientes sometidos a cirug\u00eda a\u00f3rtica o \nmitral. Se ha comprobado que la mortalidad o la discapacidad despu\u00e9s de la cirug\u00eda son beneficiosas. Algunos de estos estudios \ntambi\u00e9n han sugerido que el realce tard\u00edo de gadolinio (LGE), que se administra mediante RMC, tambi\u00e9n puede utilizarse como \nherramienta para la estratificaci\u00f3n del riesgo en pacientes asintom\u00e1ticos.\nM\u00e9todos:  Este estudio se realiz\u00f3 como un estudio transversal en 355 pacientes rusos. La poblaci\u00f3n del estudio incluy\u00f3 a \ntodos los pacientes que se sometieron a una RMC durante el per\u00edodo de estudio. Y se examinaron sus patrones de RM para \ndetectar edema, hiperemia y fibrosis. La informaci\u00f3n requerida por los pacientes, incluidas las caracter\u00edsticas demogr\u00e1ficas y de la \npoblaci\u00f3n (edad y sexo), y las variables requeridas por los pacientes se registraron en la lista de comprobaci\u00f3n de los pacientes.\nResultados: La prevalencia del RTG en el miocardio medio y en el subendocardio de la pared posterior del VI en los pacientes \ncon estenosis mitral menos que moderada fue significativamente mayor que en los dem\u00e1s. El patr\u00f3n de RTG en el septo, que \nfue significativamente mayor en los pacientes con MCD (miocardiopat\u00eda dilatada) y regurgitaci\u00f3n mitral moderada y superior, fue \nsignificativamente mayor en el RTG en el miocardio medio. Entre los pacientes con afectaci\u00f3n valvular primaria, no hubo diferencias \nsignificativas entre los pacientes con afectaci\u00f3n entre los pacientes con RM e IA moderada y superior, y los pacientes con RM \nmoderada e IA de gravedad inferior a la media.\nConclusiones:  La prevalencia del RTG en el miocardio medio y el subendocardio en la pared posterior del VI fue significativamente \nmayor en los pacientes con estenosis mitral inferior a la moderada. Adem\u00e1s, el RTG en el miocardio medio fue significativamente \nmayor en los pacientes con MCD y regurgitaci\u00f3n mitral moderada y superior.\nPalabras clave: Miocardiopat\u00eda, realce tard\u00edo de gadolinio (LGE), trastornos valvulares.ORIGINAL\nStudy the late gadolinium enhancement (LGE) \nin patients with heart valvular disorders \nEstudiar el realce tard\u00edo del gadolinio (LGE) en pacientes \ncon trastornos valvulares del coraz\u00f3n \nHamidreza Pouraliakbar1      , Ahmad Amin1      , Marzie Bazzi1\n1. Rajaie Cardiovascular Medical and Research Center, Iran University of Medical Sciences, Tehran, IraneISSN 2255-0569\nID ID ID42\n2022/37 (3): 41-45Hamidreza Pouraliakbar et al.  \nIntroduction\nCardiac valvular disorders are an important category of \ncardiovascular disease. These disorders range from very \nmild and insignificant cases to severe and life-threatening \ncases. These diseases in different societies depending \non the underlying factors and diseases, the general age \nof the population, the prevalence of infectious diseases, \nthe prevalence of addiction Injectable and depending on \ngender can have different prevalence1,2.\nIn developing countries, rheumatic fever is still very \ncommon, valvular diseases have different prevalence in \ndifferent groups, for example, at a young age, the main \ncauses are congenital heart disease, while at an older \nage, it is usually degenerative3. Some valvular disorders \nare also more common in certain groups, such as mitral \nvalve prolapse are more common in women or right heart \nvalve endocarditis and its complications is more common \nin injecting drug users3-5. Valvular disorders, may be \nasymptomatic even in severe form of them. Previous \nstudies, have found abnormalities in the heart tissue in \ncardiac Magnetic resonance imaging (MRI) (CMR) even \nin mild or moderate valvular disease6. This findings can \nbe beneficial for predicting the prognosis of patients \nundergoing aortic or mitral surgery in postoperative \nmortality or morbidity7-9. Some of these studies have \nalso suggested that Late gadolinium Enhancement (LGE) \nsupplied by CMR can also be used as a tool for risk \nstratification of asymptomatic patients10.\nDue to the wide range of valvular disorders and their high \nimportance in quality of life and also the high accuracy of \nCMR in examining heart tissue in this study, we decided \nto investigate late gadolinium enhancement in patients \nwith various valvular disorders.\nMaterials and methods\nEthics\nThis survey was ethically approved by the ethical council \nof research of the Iran University of Medical Sciences, \nTehran, Iran (IR.IUMS.FMD.REC.1399.863). In this study, \nwe adhered to all the ethical laws approved by the Ministry \nof Health at all stages. Also, in this study, no additional \ncost was imposed on the patient. In publishing the results \nof this study, the names of patients and participants in \nthe project were not mentioned. In addition, the proposal \nto carry out this plan was submitted to him for approval \nby the University Medical Ethics Committee.\nStudy procedure\nThis study was a single center, retrospective, cross \nsectional study. This study designed to compare the \ndifferences of LGE pattern in different valvular disease. \nAll patients who underwent cardiac MRI from 2017 \nFebruary to December 2020 and had valvular disease in the MRI report were included in the study. Exclusions \ncriteria were any sort of congenital heart disease. Three \nhundred and fifty five patients finally enrolled in this study \nto be analyzed statistically. 1.5 Tesla MRI technology with \nidentical standards and protocol to all patients. Image \nacquisition was performed using ECG gated Steady-\nState Free Precession (SSFP) to multiple planes of the \nheart (long axis, short axis, 4 chamber, and 3 chamber). \nGadolinium was injected via intravenous line with standard \ndose (0.1 mmol/kg). LGE image using phase-sensitive \ninversion recovery (PSIR) sequence were captured 10 \nminutes after gadolinium injection. All volumes and mass \nmeasurements were indexed to body surface area. \nCMR analysis and interpretation, myocardial fibrosis \nassessment and quantification was performed by a \nteam of cardiovascular imaging cardiologists. Due to the \ndifferent severity of the Valvular disease, for better data \nanalysis, we classified the patients into two groups with \nat least moderate severity and patients with lower than \nmoderate valvular disease.\nStatistical analysis\nData analysis was performed by SPSS software. For \nqualitative variables, frequency and frequency are \ncalculated, and for quantitative variables, mean and \nstandard deviation are calculated. Chi-square test was \nused to test the hypotheses.\nResults\nIn this study, a total of 355 patients were included. \ndemographic data and severity of various valvular \ndisorders and their causes can be seen in tables I, \nII and III.\nThe Late gadolinium Enhancement (LGE) pattern can be \nseen in in table IV .\nTable I: Demographic characters of the studied population.\nDemographic data 1 Mean Std. Deviation Minimum Maximum\nAge 39.91 19.534 1 84\nLVEF 39.3524 16.05875 4.00 78.00\nRVEF 45.0606 13.00391 1.00 74.00\nTable II: Demographic characters of the studied population.\n         Demographic data  Frequency Percent\nRhythm Sinus 317 89.3\n Atrial fibrillation 26 7.3\n Atrial flutter/tachycardia 4 1.1\n Paced rhythm 8 2.3\nHistory of No History 316 89.0\nprior surgery Once 38 10.7\n 2 and more 1 .3\nCAD history No 281 79.2\n History of PCI or  74 20.8\n CABG or MI or \n Angiography confirmed CAD \nGender  Male 230 64.8\n Female 125 35.243\n2022/37 (3): 41-45 Study the late gadolinium enhancement (LGE) In patients with heart valvular disorders\nLGE pattern in different valvular disorders among patients \nwith at least moderate severity of valvular disorders and \npatients with lower than moderate valvular disease, none \nof the patterns were significantly different between the \ntwo groups except one case. The prevalence of LGE \nin midmyocardium and subendocardium in LV posterior \nwall in patients with less than moderate mitral stenosis \nwas significantly higher than others (P-Value <0.001).\nAmong patients, only three patients with concurrent MR \nand AS were evaluated for significant valvular disorders \n(moderate and higher). Also, only 3% of patients (11 \npatients) had MR and AI simultaneously.Among primary myocardial diseases, three of the \nmost common diseases among our patients (DCM, \nHCM and ICMP) were analyze for difference of LGE \npattern in different severity of valvular disease. We only \ncompare different LGE pattern in patents with MR due \nto the very low prevalence of other valvular disorders in \nthese patients. Statistical analysis showed no significant \ndifferences between the two groups of study, except \nfor the LGE pattern in the septum in patient with DCM, \nwhich was significantly higher in patients with moderate \nand higher MR  in midmyocardial LGE. (P-Value: 0.001).\nWhen we compare patients with primary valvular \ninvolvement with these three groups (Primary myocardial \ndisease), the LGE pattern is significantly different (P-Value \n<0.001) in all part of LV and RV. Except in LV Posterior \nwall. (P-Value: 0.5)and in RV free wall. (P-Value: 0.054) \nAnd when we compare the LGE pattern in myocarditis \npatients with these three groups of cardiomyopathies, \nThe LGE pattern is significantly different (P-Value <0.001) \nin all part of LV and RV. except in RV free wall. (P-Value: \n0.44) But when we compare patients with primary valve \ninvolvement with patients with myocarditis in terms of \nLGE pattern, the difference is significant only in the lateral, \ninferior and septal walls.\nAmong patients with primary valve involvement, there \nwas no significant difference between patients with \nmoderate and higher MR and patients with less than Table III: Frequency of valvular disease by etiology.\n               Valvular disease  Frequency Percent\nEtiology of Primary 37 10.4\nValvular disease DCM 83 23.4\noverall (diagnosis) ICMP 72 20.3\n HCM 42 11.8\n Myocarditis 105 29.6\n NCLV 2 .6\n ARVC 7 2.0\n RCM 4 1.1\n CP 2 .6\n Cancer 1 .3\nMR Severity No MR 134 37.7\n Mild or trivial 110 31.0\n Mild to moderate 21 5.9\n At least moderate / moderate 55 15.5\n Moderate to severe 10 2.8\n Severe/very severe 25 7.0\n Total 355 100.0\nMR Etiology No MR 135 38.0\n Prolaptic 18 5.1\n Rheumatic 19 5.4\n Functional (HF/Ischemia) 183 51.5\nMS severity No MS 347 97.7\n Mild  2 .6\n Moderate/at least moderate 2 .6\n Moderate to severe /severe 3 .8\nAI severity No AI 280 78.9\n Mild or trivial 53 14.9\n Mild to moderate 2 .6\n At least moderate / moderate 12 3.4\n Moderate to severe 3 .8\n Severe/very severe 5 1.4\nAI etiology No AI 314 88.5\n Prolaptic 3 .8\n Rheumatic 10 2.8\n Bicuspid  7 2.0\n Degenerative  21 5.9\nAS severity No AS 348 98.0\n Mild  2 .6\n Moderate/at least moderate 1 .3\n Moderate to severe/severe 4 1.1\nTR severity No TR 251 70.7\n Mild or trivial 68 19.2\n Mild to moderate 2 .6\n At least moderate/moderate 16 4.5\n Moderate to severe 3 .8\n Severe/very severe 15 4.2\nTR etiology No TR 251 70.7\n Proleptic  6 1.7\n Rheumatic  4 1.1\n Functional  94 26.5\nPI Severity No PI 351 98.9\n Mild or trivial 2 .6\n At least moderate/moderate 2 .6\nPI Etiology Normal 353 99.4\n Proleptic 1 .3\n functional 1 .3Table IV: Late gadolinium Enhancement (LGE) pattern.\n                 LGE pattern  Frequency Percent\nLV anterior wall No LGE 265 74.6\n Midmyocardial LGE 14 3.9\n Subepicardial LGE 11 3.1\n Subendocardial LGE 15 4.2\n Transmural LGE 44 12.4\n Edema 5 1.4\n Hyperemia 1 .3\nLV Lateral wall Normal 248 69.9\n Midmyocardial LGE 17 4.8\n Subepicardial LGE 50 14.1\n Subendocardial LGE 13 3.7\n Transmural LGE 22 6.2\n Edema 5 1.4\nLV Inferior wall Normal 246 69.3\n Midmyocardial LGE 24 6.8\n Subepicardial LGE 38 10.7\n Subendocardial LGE 13 3.7\n Transmural LGE 29 8.2\n Edema 4 1.1\n Hyperemia 1 .3\nLV Post wall Normal 336 94.6\n Midmyocardial LGE 3 .8\n Subepicardial LGE 11 3.1\n Subendocardial LGE 3 .8\n Transmural LGE 1 .3\n Hyperemia 1 .3\nSeptum Normal 221 62.3\n Midmyocardial LGE 85 23.9\n Subepicardial LGE 19 5.4\n Subendocardial LGE 14 3.9\n Transmural LGE 11 3.1\n Edema 3 .8\n Hyperemia 2 .6\nRV free wall Normal 347 97.7\n LGE 8 2.344\n2022/37 (3): 41-45Hamidreza Pouraliakbar et al.  \nmoderate MR intensity. The same was true of aortic valve \ninsufficiency. Due to the low prevalence of other valvular \ndisorders, comparison between them was omitted. And \nalso due to the low prevalence of valvular disorders in \npatients with myocarditis, the comparison between this \ncases was omitted.\nDiscussion\nLate gadolinium enhancement is a technique used \nin cardiac MRI for cardiac tissue characterization, in \nparticular, the assessment of regional scar formation \nand myocardial fibrosis. Late gadolinium enhancement \nis based on the shortening of T1 and different regional \ndistribution patterns of gadolinium-based contrast agents \nwithin the extracellular space of the myocardium. It also \ndepends on varying uptake and washout patterns within \nthe normal myocardium and those different disease \nprocesses. This is depicted by applying an inversion \npulse to null the inherent signal of the myocardium after a \ncertain amount of time11.\nIn this study, we examined the valvular disorders and the \nprevalence of LGE in different parts of the LV and RV \nwall. This issue has not been done with such details and \nprecision in a study that was completely new in its kind. \nIn different valvular disorders among patients with \nat least moderate valvular disease and patients with \nlower valvular disease, none of the patterns showed a \nsignificant difference between the two groups of study, \nexcept the prevalence of LGE in the midmyocardium \nand subendocardium in LV posterior wall who was \nsignificantly higher in patients with lower mitral stenosis \n(P-Value <0.001).\nDue to the very low prevalence of concurrent valvular \ndisorders, it was not possible to investigate LGE pattern in \npressure overload and volume overload or their combination.\nIn the study of the effect of valvular disorders on the \nLGE pattern in patients with cardiomyopathy, only in \nDCM patients midmyocardial LGE in the septum was \nsignificantly higher in patients with moderate and higher \nMR. In comparison of patients with primary valvular \ninvolvement with these three groups of cardiomyopathy, the LGE pattern was significantly different from these three \ngroups in all cases. Except in LV Posterior wall. Also, in \ncomparing the LGE pattern in patients with myocarditis \nand these three groups of cardiomyopathies, the LGE \npattern is significantly different from these three groups \nin all cases, except in RV free wall. But the difference in \npatints with primary valvular involvement and myocarditis, \nonly was in the lateral, inferior and septal walls LGE.\nHypertrophic cardiomyopathy (HCM) is the most common \ngenetic disease of the heart. HCM is characterized \nby a wide range of clinical expression, ranging from \nasymptomatic mutation carriers to sudden cardiac death \nas the first manifestation of the disease. Over 1000 \nmutations have been identified, classically in genes \nencoding sarcomeric proteins. Noninvasive imaging \nis central to the diagnosis of HCM and cardiovascular \nmagnetic resonance (CMR) is increasingly used \nto characterize morphologic, functional and tissue \nabnormalities associated with HCM. The early and overt \nphenotypic expression of disease that may be identified \nby CMR is reviewed. Diastolic dysfunction may be an \nearly marker of the disease, present in mutation carriers \nprior to the development of left ventricular hypertrophy \n(LVH). Late gadolinium enhancement by CMR is present \nin approximately 60% of HCM patients with LVH and may \nprovide novel information regarding risk stratification in \nHCM. It is likely that integrating genetic advances with \nenhanced phenotypic characterization of HCM with \nnovel CMR techniques will importantly improve our \nunderstanding of this complex disease12-14.\nConclusion\nThe prevalence of LGE in the midmyocardium and \nsubendocardium in the LV posterior wall was significantly \nhigher in patients with less than moderate mitral stenosis \nthan others. In addition, midmyocardial septal LGE was \nsignificantly higher in patients with moderate and higher \nMR in DCM patients.\nConflict of Interest\nThe authors declare that they have no conflict of interest.45\n2022/37 (3): 41-45 Study the late gadolinium enhancement (LGE) In patients with heart valvular disorders\nReferences\n1. Boudoulas KD, Borer JS, Boudoulas H. Etiology of valvular heart \ndisease in the 21st century. Cardiology. 2013;126(3):139-52.\n2. Lincoln J, Garg V. Etiology of Valvular Heart Disease\u2013Genetic and \nDevelopmental Origins\u2013. Circulation Journal. 2014:CJ-14.\n3. Maganti K, Rigolin VH, Sarano ME, Bonow RO. Valvular heart disease: \ndiagnosis and management. InMayo Clinic Proceedings 2010 May 1 \n(Vol. 85, No. 5, pp. 483-500). Elsevier.\n4. Iung B, Vahanian A. Epidemiology of valvular heart disease in the adult. \nNature Reviews Cardiology. 2011 Mar;8(3):162-72.\n5. Mylonakis E, Calderwood SB. Infective endocarditis in adults. New \nEngland Journal of Medicine. 2001 Nov 1;345(18):1318-30.\n6. Myerson SG. CMR in Evaluating Valvular Heart Disease: Diagnosis, \nSeverity, and Outcomes. JACC: Cardiovascular Imaging. 2020 Nov 25.\n7. Garg P , Swift AJ, Zhong L, Carlh\u00e4ll CJ, Ebbers T, Westenberg \nJ, et al. Assessment of mitral valve regurgitation by cardiovascular \nmagnetic resonance imaging. Nature Reviews Cardiology. 2020 \nMay;17(5):298-312.\n8. Swingen C, Kelly RF. Cardiac magnetic resonance imaging for ischemic \nmitral regurgitation: A guide through complex surgical terrain. The Journal \nof thoracic and cardiovascular surgery. 2016 Nov 24;154(1):159-60.9. Blanken CP , Farag ES, Boekholdt SM, Leiner T, Kluin J, Nederveen \nAJ, et al. Advanced cardiac MRI techniques for evaluation of left sided \nvalvular heart disease. Journal of Magnetic Resonance Imaging. 2018 \nAug;48(2):318-29.\n10. Balciunaite G, Skorniakov V, Rimkus A, Zaremba T, Palionis D, \nValeviciene N, et al. Prevalence and prognostic value of late gadolinium \nenhancement on CMR in aortic stenosis: meta-analysis. European \nradiology. 2020 Jan;30(1):640-51.\n11. Kuruvilla S, Adenaw N, Katwal AB, Lipinski MJ, Kramer CM, Salerno M. \nLate gadolinium enhancement on cardiac magnetic resonance predicts \nadverse cardiovascular outcomes in nonischemic cardiomyopathy: \na systematic review and meta-analysis. Circulation: Cardiovascular \nImaging. 2014 Mar;7(2):250-8.\n12. Noureldin RA, Liu S, Nacif MS, Judge DP , Halushka MK, Abraham \nTP ,et al. The diagnosis of hypertrophic cardiomyopathy by cardiovascular \nmagnetic resonance. Journal of Cardiovascular Magnetic Resonance. \n2012 Dec;14(1):1-3.\n13. Eijgenraam TR, Sillj\u00e9 HH, de Boer RA. Current understanding of \nfibrosis in genetic cardiomyopathies. Trends in cardiovascular medicine. \n2020 Aug 1;30(6):353-61.\n14. Unger P , Pibarot P , Tribouilloy C, Lancellotti P , Maisano F, Iung B, \net al. Multiple and mixed valvular heart diseases: pathophysiology, \nimaging, and management. Circulation: Cardiovascular Imaging. 2018 \nAug;11(8):e007862.46\n2022/37 (3): 46-50Received:  15 - II - 2022\nAccepted:  4 - III - 2022\ndoi: 10.3306/AJHS.2022.37.03.46Corresponding author\nZahra Husseinzadeh  \nE-mail: hasanzadehzahra713@gmail.com  \nAbstract  \nSaliva plays a significant role in maintaining oral health, helping to build and maintain the health of soft and hard tissues. When \nsaliva flow is reduced, oral health problems such as dental caries and oral infections can develop. As a biological fluid whose \nmain constituents are proteins and electrolytes, saliva can be a suitable, inexpensive, affordable and non-invasive diagnostic \ntool in the diagnosis of oral infections. By conducting a proteomic study on saliva, one can accurately understand all salivary \nprotein compounds, their role in human health, the function of each of the protein compounds, and the nature of different \nisom\u00e8tres of enzymes in saliva. In this study, after classifying and presenting a summary of the results of research on the \nrole of saliva in the diagnosis and evaluation of oral diseases, especially tooth decay, it has been attempted to discuss the \nimportance of salivary secretion proteins so that the reader can find valuable information on the relationship between saliva and \nthe prevalence of tooth decay.\nKey words:  Saliva, proteomics, biomarkers, salivary leak proteins, tooth decays. \nResumen\nLa saliva desempe\u00f1a un papel importante en el mantenimiento de la salud bucodental, ya que ayuda a construir y mantener la \nsalud de los tejidos blandos y duros. Cuando el flujo de saliva se reduce, pueden surgir problemas de salud bucal como la caries \ndental y las infecciones orales. Como fluido biol\u00f3gico cuyos principales constituyentes son las prote\u00ednas y los electrolitos, la saliva \npuede ser una herramienta de diagn\u00f3stico adecuada, barata, asequible y no invasiva en el diagn\u00f3stico de las infecciones orales. \nAl realizar un estudio prote\u00f3mico de la saliva, se pueden comprender con precisi\u00f3n todos los compuestos proteicos salivales, \nsu papel en la salud humana, la funci\u00f3n de cada uno de los compuestos proteicos y la naturaleza de los diferentes is\u00f3meros de \nenzimas en la saliva. En este estudio, despu\u00e9s de clasificar y presentar un resumen de los resultados de las investigaciones sobre \nel papel de la saliva en el diagn\u00f3stico y la evaluaci\u00f3n de las enfermedades bucodentales, especialmente la caries, se ha intentado \ndiscutir la importancia de las prote\u00ednas de secreci\u00f3n salival para que el lector pueda encontrar informaci\u00f3n valiosa sobre la relaci\u00f3n \nentre la saliva y la prevalencia de la caries.\nPalabras clave: Saliva, prote\u00f3mica, biomarcadores, prote\u00ednas de secreci\u00f3n salival, caries dentales.ORIGINAL\nThe relationship between saliva and the prevalence \nof tooth decay: A mini review \nLa relaci\u00f3n entre la saliva y la prevalencia de la caries dental: Una mini revisi\u00f3n \nZahra Husseinzadeh1\n1. Department of Biology, Rafsanjani Gheire Entefaei University, Tehran, IraneISSN 2255-0569\nID\nIntroduction\nDentists are looking for a suitable diagnostic tool that is \npreferably non-invasive so that they can diagnose caries, \ndetermine the status of periodontal disease, monitor \npatients\u2019 response to treatment, and estimate how \nsensitive individuals are to the progression of possible \nfuture dental disease. Thus, the role of saliva in the \ndiagnosis of diseases was first introduced by the National \nInstitute of Dental and Craniofacial Research (NIDCR)1.This complex oral fluid consists of the secretions of three \npairs of main and secondary salivary glands of mucosa. \nIn the second definition, saliva is an extracellular fluid \nproduced and secreted by the salivary glands of the \nmouth. Salivary secretions are automatically controlled \nby mechanical and neurological factors. Parasympathetic \nnerves lead to watery salivary secretions and sympathetic \nnerves lead to salivary protein secretions2.47\n2022/37 (3): 46-50The relationship between saliva and the prevalence of tooth decay: A mini review\nSaliva is an exocrine solution consisting of 99% water. \nThe remaining 1% consists of a variety of electrolytes and \nproteins. These components combined are responsible \nfor the various functions attributed to saliva3,4.\nSaliva is formed primarily (approximately 90%) from the \nsecretions of the three paired major salivary glands, \nthe submandibular (around 65%), parotid (around \n20%) and sublingual (around 5-7%)5,6. These glands \nare controlled by the autonomic nervous system, \nwhile minor glands (labial, lingual, buccal and palatine), \ndistributed around the oral cavity, produce the \nremaining saliva (<10%)7.\nAt rest, without exogenous or pharmacological \nstimulation, there is a small, continuous salivary flow, an \nunstimulated secretion, present in the form of a film that \ncovers, moisturizes, and lubricates the oral tissues8. This \nflow of saliva at rest is in the region of 0.4\u20130.5mL/minute \nin healthy subjects9.\nStimulated saliva is produced in response to a \nmechanical, gustatory, olfactory, or pharmacological \nstimulus, contributing to around 40-50% of daily salivary \nproduction10. The Salivary Flow (SF) index is a parameter \nallowing stimulated and unstimulated saliva flow to be \nclassified as normal, low or very low (hyposalivation). In \nadults, normal total stimulated SF ranges 1-3 mL/minute, \nlow ranges 0.7-1.0 mL/minute, while hyposalivation is \ncharacterized by a stimulated SF <0.7mL/minute10,11.\nSaliva also contains calcium and phosphate ions, which \nare useful for repairing damaged parts of the tooth and \nreversing the decay process.\nScientists\u2019 research indicates that mother\u2019s saliva boosts \nthe baby\u2019s immune system, so that food pre-chewing \nacquaints the baby\u2019s body with pathogenic pathogens \nin the mother\u2019s saliva, causing the body to produce \nantibiotics and preparing the baby\u2019s immune system12.\nAn introduction to Proteomics\nSaliva consists of gingival cervical fluid, mucosal \ntransudates, nasal and bronchial expectorated \nsecretions, blood and serum derivatives of oral ulcers, \nbacteria, bacterial products, viruses and fungi, fallen \nepithelial cells and other cellular compounds and food \nleftovers13.\nBy studying the proteomics of human saliva, we reach \nfour types of salivary secretion proteins including proline-\nrich proteins, statins, cystatins, histatins14.\nThe purpose of proteomic studies on human saliva are \nas follow: Finding all salivary protein compounds, their role in \nhuman health, learning about the function of each protein \ncompound and identification of different isom\u00e8tres of \nenzymes in saliva15-17.\nSalivary secretion proteins play a significant role \nagainst tooth decay. Now, using Nano-proteomics, the \nconcentration, quantity and quality of substances in \nsaliva can be accurately determined. The term proteome \nwas first coined and used in 1994 by Mark Wilkins. In \nhis definition, a proteome refers to the complete set \nof proteins expressed at a particular moment in a cell. \nToday, however, the level of this definition has extended \nfrom the cell to the organ tissue of the organism. The \nstudy of proteomes is the subject of proteomics18,19.\nBiomarkers\nNumerous researchers have attempted to show the \nrelationship between saliva and the prevalence of caries, \nsince the most important advantages of saliva is its being \ncheap, availability, and easy and non-invasive sampling.\nIn addition, various markers such as hormonal, \nmicrobiological, immunological, pharmacological and \noncological markers can be found in saliva and compared \nwith its serum concentration20. Since the concentration \nof these markers is lower in saliva than that of blood, \nit may distort clinical diagnosis through saliva. However, \nnew methods of diagnosis have been designed to solve \nthis problem21.\nThus, salivary proteins and peptides are easily identified \nby biochemical methods such as liquid chromatography, \ngel electrophoresis, capillary electrophoresis, \nimmunoassay and Lectin probe analysis, and they are \nused as diagnostic biomarkers22.\nBiomarkers play a diagnostic role in detecting oral \ninfections in saliva.\nBiomarkers are actually specific molecules that exist in the \nbody and given their unique properties, they can be used \nby pharmacological or physiological assays as a tool to \npredict a complication and measure the progression of a \ndisease and its treatment effects23.\nTooth decay (caries)\nStudies show that measuring the concentration of specific \noligosaccharides in saliva and specific changes in salivary \nproteome are used to diagnose tooth decay24. As the \namount of proline-rich proteins PRP3, PRPI histatin 1 and \nstatins in saliva increases, tooth decay does not occur \nand a decrease in these proteins causes tooth decay25. \nMoreover, increasing the number of microorganisms 48\n2022/37 (3): 46-50such as Streptococcus mutanus  and lactobacilli in saliva \ncauses tooth decay26.\nStudies show that healthy human saliva contains certain \npeptides, such as histatin, which help heal wounds and \ncaries. In addition to its antibacterial properties, histatin \nprotein increases cell contact and transport, as well as \nthe angiogenesis process. The process of angiogenesis \nis a physiological process in which new blood vessels \ngrow from existing blood vessels. Proline protein has a \nunique structure because it is the only protein-producing \namino acid with a secondary amine. It not only helps \nmake proteins but also acts as a catalyst in many \norganic reactions. The main properties and role of proline \ninclude helping collagen, regenerating cartilage, forming \nconnective tissue, repairing skin damages and wounds, \nimproving intestinal lining, and repairing joints27.\nProline is converted to hydroxycine and hydroxyproline \nto help collagen. One of the reasons why proline is \nimportant in the body is that it, along with the amino acid \nglycine, is involved in collagen synthesis28.\nCollagen is the most abundant protein in the human \nbody and is a major component of connective tissue in \nthe body. Proline is an amino acid that is very similar to \nan amino acid. It is an unnecessary amino acid because \nthe human body can synthesize it spontaneously, unlike \ncertain amino acids that enter the body through the diet. \nHowever, glonamate can be used to produce proline. \nFoods high in proline protein include bone extract, \nsource of proline for animal products such as meat, liver, \nchicken, fish and eggs29.\nDecreased salivary secretion, decreased salivary pH, \ndecreased salivary buffering, increased total protein and \ntotal antioxidants in saliva, decreased total calcium in \nsaliva cause tooth decay in children30.\nTooth decay is one of the most common chronic infectious \ndiseases in childhood, and various studies show that \nits effective factors are: Streptococcus mutans  and \nLactobacilli. Streptococcus mutans  is an acidogenic and to \nsome extent an aciduric bacterium and the main etiological \nfactor in human dental caries, whose high accumulation in \ndental plaque is an important factor in caries31.\nNow, since the decrease in saliva flow, decrease in \nbuffering capacity, and increase in the number of \nStreptococcus mutans  and lactobacilli in saliva are \nusually associated with an increase in the incidence \nof tooth decay32, in health conditions, there is no \nassociation between salivation and tooth decay33. But \nwhen the amount of salivary secretion drops below the \nminimum, the rate of tooth decay increases. The feeling \nof dryness in one\u2019s mouth, called xerostomia (dry mouth), \nis seen in salivary gland disorders, systemic disorders, \npharmacotherapy, radiation therapy, and old age34.In severe cases of xerostomia, saliva is observed \nwith low pH and low buffering capacity, increased \nconcentration of total protein, albumin and sodium, \ndecreased ratio of amylase to protein, increased \nconcentration of lactulose bacilli35.\nCarbonic acid buffer, bicarbonate, acts when saliva flow \nrate increases.\nPhosphate buffer plays an important role when saliva flow \nis very low.\nAt pHs above 6, saliva reaches its highest phosphate \nsaturation due to hydroxyapatite. When the pH drops \nbelow the critical level of 5.5, hydroxyapatite begins to \ndissolve, releasing phosphates in an attempt to restore \nthe pH balance.\nThe mouth is often exposed to foods whose pH is \nlower than that of saliva and can cause tooth enamel to \ndissolve36.\nIn addition, it has been indicated that the formation of \nheterotype complexes between salivary molecules, such \nas high molecular weight mucin glycoprotein, amylase, \nhistatin one, protein one rich in acidic proline and statin \nare associated with plaque formation and dental caries37.\nProteins involved in salivary defense function are38:  \n\u00b7 Immunoglobulins include: IgA, lysozyme, mucins\n\u00b7 Antimicrobial peptides or alarmins\n\u00b7 Catalysidin\n\u00b7 Defensins\n\u00b7 Adrenomedullin \n\u00b7 Histatin: secreted by parotid and submandibular glands.\n\u00b7 Lactoferrin Calprotectin: A protein containing calcium \nand zinc.\nIn addition to moderating microbial factors and \nencouraging preventive dietary behaviors a core goal \nin caries prevention is promoting the natural protective \nmechanisms of saliva39. \nThe pH of dental plaque is a key factor in the balance \nbetween acid demineralization of the teeth and the \nremineralization of the initial caries lesion. Plaque pH \nfalls each time acid accumulates in the plaque due to \nbacterial acid production following the consumption of \nfermentable carbohydrates \u2013mainly sugars\u2013 in foods and \ndrinks. Conversely, plaque pH rises when the acids are \nwashed away or neutralized by saliva, which contains the \nimportant buffer, bicarbonate40. Zahra Husseinzadeh  \nTable I: Methods for identifying proteins in saliva.\nProteins Methods of detection\nCystatins HPLC-ESIMS\nProline RP-HPLC-ESIMS-MALDI-TOFMS\nAStatrine Proteomic method\nHistatin Mass fingerprinting method49\n2022/37 (3): 46-50The relationship between saliva and the prevalence of tooth decay: A mini review\nIn healthy teeth, the loss of minerals is balanced by \nthe reparative mechanisms of saliva. This equilibrium \ncan be depicted chemically by the equation overleaf \nopposite ( Figure 1 )41.\nWhen the saliva pH or the plaque pH is below a \u2018critical \nvalue\u2019 of about 5.5, the saliva or plaque becomes \nunsaturated with respect to tooth mineral42. As a result, \ntooth enamel can begin to dissolve. However, when \nthe pH is above this value, the saliva and plaque are \nsupersaturated with respect to tooth mineral. The \ncalcium and phosphate ions in saliva then start to \nrepair any damaged mineral crystals in the enamel \u2013 \nthe process of remineralization43. Thus, acidic conditions contribute to bringing phosphate \nand hydroxyl ions below saturation levels, allowing \nthe solid hydroxyapatite crystals of the tooth mineral \nto dissolve. If above saturation levels, the chemical \nreaction will move towards remineralization and any \ndamaged crystals will be repaired by the acquisition of \nions from the solution44. \nStimulation of saliva flow results in an increase in the \nwashing out of acids (and sugars), and also an increase \nin the amount and concentration of bicarbonate buffer \nand of remineralising ions45. \nConclusion\nFrom what stated above, one can understand the \nimportance of salivary secretion proteins as methods \nfor identifying and examining oral diseases, especially \ntooth decay. This calls for conductin further studies in \nthis area. Therefore, since the introduction of liposomes \nas carriers of proteins in the 1960s and their proposal \nfor the treatment of diseases, it is recommended to \nuse nanotechnology and biocompatible nanomaterials \nwith optimal mechanical properties as restorers and \npharmacists in dentistry.\nConflict of Interest\nThe authors declare that they have no conflict of interest.\nFigure 1: The process of tooth remineralization41.\nReferences\n1. Zhang CZ, Cheng XQ, Li JY, Zhang P , Yi P , Xu X, et al. Saliva in \nthe diagnosis of diseases. International journal of oral science. 2016 \nSep;8(3):133-7.\n2. Proctor GB. The physiology of salivary secretion. Periodontology \n2000. 2016 Feb;70(1):11-25.\n3. Carpenter GH. The secretion, components, and properties of saliva. \nAnnual review of food science and technology. 2013 Feb 28;4:267-76.\n4. Featherstone JD, Behrman JM, Bell JE. Effect of whole saliva \ncomponents on enamel demineralization in vitro. Critical Reviews in Oral \nBiology & Medicine. 1993 Apr;4(3):357-62.\n5. de Almeida PD, Gregio AM, Machado MA, De Lima AA, Azevedo LR. \nSaliva composition and functions: a comprehensive review. J contemp \ndent pract. 2008 Mar 1;9(3):72-80.\n6. Edgar WM. Saliva: its secretion, composition and functions. British \ndental journal. 1992 Apr;172(8):305-12.7. Humphrey SP , Williamson RT. A review of saliva: normal composition, \nflow, and function. The Journal of prosthetic dentistry. 2001 Feb \n1;85(2):162-9.\n8. Benn AM, Thomson WM. Saliva: an overview. NZ Dent J. 2014 Sep \n1;110(3):92-6.\n9. Edgar WM, O\u2019Mullane DM, Dawes C, editors. Saliva and oral health. \nLondon: British Dental Association; 2004.\n10. Dawes C, Watanabe S. The effect of taste adaptation on salivary \nflow rate and salivary sugar clearance. Journal of dental research. 1987 \nMar;66(3):740-4.\n11. Spielman AI. Interaction of saliva and taste. Journal of dental research. \n1990 Mar;69(3):838-43.\n12. Chen IL, Huang HC, Ou-Yang MC, Chen FS, Chung MY, Chen CC. \nA novel method to detect bacterial infection in premature infants: Using \na combination of inflammatory markers in blood and saliva. Journal of \nMicrobiology, Immunology and Infection. 2020 Dec 1;53(6):892-9.50\n2022/37 (3): 46-50The relationship between saliva and the prevalence of tooth decay: A mini reviewZahra Husseinzadeh  \n13. Roblegg E, Coughran A, Sirjani D. Saliva: An all-rounder of our body. \nEuropean Journal of Pharmaceutics and Biopharmaceutics. 2019 Sep \n1;142:133-41.\n14. Mandel ID. The functions of saliva. Journal of dental research. 1987 \nFeb;66(1_suppl):623-7.\n15. Greabu M, Battino M, Mohora M, Totan A, Spinu T, Totan C, et al. \nCould constitute saliva the first line of defence against oxidative stress?. \nRomanian journal of internal medicine= Revue roumaine de medecine \ninterne. 2007 Jan 1;45(2):209-13.\n16. Hu S, Loo JA, Wong DT. Human saliva proteome analysis. Annals of \nthe New York Academy of Sciences. 2007 Mar;1098(1):323-9.\n17. Castagnola MP , Picciotti PM, Messana I, Fanali C, Fiorita A, Cabras \nT, et al. Potential applications of human saliva as diagnostic fluid. Acta \nOtorhinolaryngologica Italica. 2011 Dec;31(6):347.\n18. Pedersen AM, S\u00f8rensen CE, Proctor GB, Carpenter GH, Ekstr\u00f6m \nJ. Salivary secretion in health and disease. Journal of oral rehabilitation. \n2018 Sep;45(9):730-46.\n19. Gao X, Jiang S, Koh D, Hsu CY. Salivary biomarkers for dental caries. \nPeriodontology 2000. 2016 Feb;70(1):128-41.\n20. Vibhakar AP , Patankar RS, Yadav RM, Vibbhakar AP . Salivary Total \nProtein Levels and their Correlation to Dental Caries. International Journal \nof Oral & Maxillofacial Pathology. 2013 Jul 1;4(3).\n21. Buzalaf MA, Ortiz AD, Carvalho TS, Fideles SO, Ara\u00fajo TT, Moraes \nSM, et al. Saliva as a diagnostic tool for dental caries, periodontal disease \nand cancer: is there a need for more biomarkers?. Expert review of \nmolecular diagnostics. 2020 May 3;20(5):543-55.\n22. Martins C, Buczynski AK, Maia LC, Siqueira WL, de Araujo Castro \nGF. Salivary proteins as a biomarker for dental caries\u2014a systematic \nreview. Journal of dentistry. 2013 Jan 1;41(1):2-8.\n23. Bansode PV, Pathak SD, Wavdhane MB, Birage PP . Salivary \nbiomarkers of dental caries a review article. IOSR J Dent Med Sci. \n2019;18(1):52-8.\n24. Sondej M, Denny PA, Xie Y, Ramachandran P , Si Y, Takashima J, et \nal. Glycoprofiling of the human salivary proteome. Clinical proteomics. \n2009 Mar 1;5(1):52-68.\n25. Iontcheva I, Oppenheim FG, Troxler RF. Human salivary mucin \nMG1 selectively forms heterotypic complexes with amylase, proline-\nrich proteins, statherin, and histatins. Journal of dental research. 1997 \nMar;76(3):734-43.\n26. Karimi N, Jabbari V, Nazemi A, Ganbarov K, Karimi N, Tanomand A, \net al. Thymol, cardamom and Lactobacillus plantarum nanoparticles as a \nfunctional candy with high protection against Streptococcus mutans and \ntooth decay. Microbial pathogenesis. 2020 Nov 1;148:104481.\n27. Bursell E. The role of proline in energy metabolism. InEnergy \nmetabolism in insects 1981 (pp. 135-154). Springer, Boston, MA.\n28. Song L. Basic studies of the cross-linking reaction of collagen with \noxazolidine and plant polyphenols (Doctoral dissertation, University of \nNorthampton).\n29. Mehansho H, Butler LG, Carlson DM. Dietary tannins and salivary \nproline-rich proteins: interactions, induction, and defense mechanisms. \nAnnual review of nutrition. 1987 Jul;7(1):423-40.30. Preethi BP , Pyati A, Dodawad R. Evaluation of flow rate, pH, buffering \ncapacity, calcium, total protein and total antioxidant levels of saliva in \ncaries free and caries active children-An in vivo study. Biomed Res. 2010 \nOct;21(3):289-94.\n31. Zickert I, Emilson CG, Krasse B. Streptococcus mutans, lactobacilli \nand dental health in 13\u201314yearold Swedish children. Community dentistry \nand oral epidemiology. 1982 Apr;10(2):77-81.\n32. Mummolo S, Tieri M, Nota A, Caruso S, Darvizeh A, Albani F, et \nal. Salivary concentrations of Streptococcus mutans and Lactobacilli \nduring an orthodontic treatment. An observational study comparing fixed \nand removable orthodontic appliances. Clinical and experimental dental \nresearch. 2020 Apr;6(2):181-7.\n33. Law V, Seow WK, Townsend G. Factors influencing oral colonization \nof mutans streptococci in young children. Australian dental journal. 2007 \nJun;52(2):93-100.\n34. Lara-Carrillo E, Montiel Bastida NM, S\u00e1nchez P\u00e9rez L, Alan\u00eds Tavira \nJ. Effect of orthodontic treatment on saliva, plaque and the levels of \nStreptococcus mutans and Lactobacillus.\n35. Badet C, Thebaud NB. Ecology of lactobacilli in the oral cavity: a \nreview of literature. The open microbiology journal. 2008;2:38.\n36. Lingstrom P , Van Houte J, Kashket YS. Food starches and dental \ncaries. Critical Reviews in Oral Biology & Medicine. 2000 Jul;11(3):366-80.\n37. Iontcheva I, Oppenheim FG, Troxler RF. Human salivary mucin \nMG1 selectively forms heterotypic complexes with amylase, proline-\nrich proteins, statherin, and histatins. Journal of dental research. 1997 \nMar;76(3):734-43.\n38. Van Nieuw Amerongen A, Bolscher JG, Veerman EC. Salivary \nproteins: protective and diagnostic value in cariology?. Caries research. \n2004;38(3):247-53.\n39. Featherstone JD. Dental caries: a dynamic disease process. \nAustralian dental journal. 2008 Sep;53(3):286-91.\n40. Li X, Wang J, Joiner A, Chang J. The remineralisation of enamel: a \nreview of the literature. Journal of dentistry. 2014 Jun 1;42:S12-20.\n41. Dodds M, Roland S, Edgar M, Thornhill M. Saliva A review of its role \nin maintaining oral health and preventing dental disease. Bdj Team. 2015 \nSep 1;2:15123.\n42. Hicks J, Garcia-Godoy F, Flaitz C. Biological factors in dental caries \nenamel structure and the caries process in the dynamic process of \ndemineralisation and remineralisation (part 2) J Clin Pediatr Dent 2004: \n119-24.\n43. Ship JA. Diagnosing, managing and preventing salivary gland \ndisorders. Oral Diseases 2002; 8, 77-89.\n44. Dawes C, Macpherson LM . Effects of nine different chewing gums \nand lozenges on salivary flow rate and pH. Caries Res. 1992: 176-82\n45. Billings RJ. Studies on the prevalence of xerostomia: preliminary \nresults. Caries Res. 1989: 124 (abstract 124).51\n2022/37 (3): 51-57Received:  18 - II - 2022\nAccepted:  5 - III - 2022\ndoi: 10.3306/AJHS.2022.37.03.51Corresponding author\nBahareh Saeed  \nE-mail: bahareh.saeed@gmail.com\nAbstract  \nBackground/Purpose:  The size and shape of teeth is very important and should be beautiful and in harmony with the face \ncomponents. This study aims to determine the association between the facial features and dimensions of the upper teeth in \nIranian population.\nMaterials and methods:  160 students were selected, (80 male and 80 female), in this cross- sectional survey. Dental \nand facial dimensions were measured and recorded.Infrmation were analyzed utilizing SPSS 21, and independent t-test and \nPearson correlation coefficient.\nResults: A direct and significant relationship was observed between the upper central epicocronal height, face length (r=0.314, \nP<0.001) and mouth width (r=0.166, P=0.036). Also, a direct significant correlation was observed between the upper central \nmesiodistal width and face length (r=0.244, p=0.002). A direct relationship was observed between the upper anterior arch \nenvironment and face length (r=0.415, P<0.001), mouth width (r=0.168, P=0.034), intercanthal distance (r=0.291, P<0.001) \nand bizygomatic width (r=0.165, P=0.037), which was statistically significant.\nConclusion: Although there are different methods for estimating the teeth size, due to the relationship between some \ndimensions of the head, face and teeth, these dimensions of the head and face can be used to estimate the dimensions of \nteeth but most of the available information of facial and dental dimensions and their proportions is related to the other country\u2019s \nstatistics, whose population is definitely different from the Iranian population and that there is no complete related information in \ndental reference books so by use of this study results this method can be used by Iranian dentists.\nKey words:  Anterior tooth dimensions, facial markers, beauty. \nResumen\nAntecedentes/objetivo: El tama\u00f1o y la forma de los dientes son muy importantes y deben ser bellos y estar en armon\u00eda con los \ncomponentes de la cara. Este estudio pretende determinar la asociaci\u00f3n entre los rasgos faciales y las dimensiones de los dientes \nsuperiores en la poblaci\u00f3n iran\u00ed.\nMateriales y m\u00e9todos:  En este estudio transversal se seleccionaron 160 estudiantes (80 hombres y 80 mujeres). Se midieron y \nregistraron las dimensiones dentales y faciales, y se analiz\u00f3 la informaci\u00f3n con el programa SPSS 21, una prueba t independiente \ny el coeficiente de correlaci\u00f3n de Pearson.\nResultados:  Se observ\u00f3 una relaci\u00f3n directa y significativa entre la altura epicocronal central superior, la longitud de la cara \n(r=0,314, P<0,001) y la anchura de la boca (r=0,166, P=0,036). Asimismo, se observ\u00f3 una correlaci\u00f3n directa y significativa entre \nla anchura mesiodistal central superior y la longitud de la cara (r=0,244, p=0,002). Se observ\u00f3 una relaci\u00f3n directa entre el entorno \nde la arcada anterior superior y la longitud de la cara (r=0,415, P<0,001), la anchura de la boca (r=0,168, P=0,034), la distancia \nintercantal (r=0,291, P<0,001) y la anchura bizigom\u00e1tica (r=0,165, P=0,037), que fue estad\u00edsticamente significativa.\nConclusiones: Aunque hay diferentes m\u00e9todos para estimar el tama\u00f1o de los dientes, debido a la relaci\u00f3n entre algunas \ndimensiones de la cabeza, la cara y los dientes, estas dimensiones de la cabeza y la cara se pueden utilizar para estimar las \ndimensiones de los dientes, pero la mayor parte de la informaci\u00f3n disponible de las dimensiones faciales y dentales y sus \nproporciones est\u00e1 relacionada con las estad\u00edsticas de otros pa\u00edses, cuya poblaci\u00f3n es definitivamente diferente de la poblaci\u00f3n \niran\u00ed y que no hay informaci\u00f3n completa relacionada en los libros de referencia dentales por lo que mediante el uso de los \nresultados de este estudio este m\u00e9todo puede ser utilizado por los dentistas iran\u00edes.\nPalabras clave: Dimensiones de los dientes anteriores, marcadores faciales, belleza.ORIGINAL\nRelationship of maxillary anterior teeth and some facial landmarks  \nRelaci\u00f3n de los dientes maxilares anteriores y algunos puntos de referencia faciales \nParviz Amini1      , Bahareh Saeed2      , Rezvan Darabi3      , Reza Amini4      , \nParinaz Pourmoshrefi5\n1. Associate Professor, Faculty of Dentistry, Department of Prosthodontics, Dental College, Kerman University of Medical \nScience, Kerman, Iran.   2. Student of prosthodontic dentistry, Faculty of Dentistry, Department of Prosthodontics, Dental \nCollege, Kerman University of Medical Science, Kerman, Iran.    3. Student of prosthodontic dentistry, Faculty of Dentistry, \nDepartment of Prosthodontics, Dental College, Kerman University of Medical Science, Kerman, Iran.   4. Student of orthodontic \ndentistry, Faculty of Dentistry, Department of orthodontics, Dental College, Kerman University of Medical Science, Kerman, Iran. \n5. Student of prosthodontic dentistry, Faculty of Dentistry, Department of Prosthodontics, Dental College, \nKerman University of Medical Science, Kerman, Iran.eISSN 2255-0569\nID ID ID ID\nID52\n2022/37 (3): 51-57Parviz Amini et al.  \nIntroduction\nWhen anterior teeth are lost for any reason, their replacement \nby prosthetic and orthodontic treatments is essential in \nterms of beauty and function. In this case, creating enough \nspace by orthodontic treatment for prosthetic treatments is \nan important issue. The size and shape of the anterior teeth \nhas played a crucial role the beauty and function of the \nmouth and face. Therefore, several methods have been \nintroduced to choose the measure of the teeth1-5. The \nappearance of the face created by denture reconstruction \nis very important for prosthodontists and their patients. \nFacial beauty is one of the most common reasons why \npatients seek to replace their missing anterior teeth. On the \nother hand, one of the reasons for the failure of prosthetic \nreconstruction is the great importance of beauty in this \ntreatment. One of the most difficult clinical steps in the \nprocess of making a proper denture is the determination \nand substitution of anterior maxillary teeth in lacking of \nrecords before tooth extraction. The absence of these \nrecords can cause patient dissatisfaction with the beauty \nof dentures made6-9. The size of the upper anterior teeth is \nnecessary to optimize the beauty of the teeth and face, and \nalso their location, shape, and color increase the beauty of \nthe smile. The size, position, shape, and color of the upper \nanterior teeth are essential for the beauty of the teeth and \nface, and also these parameters increase the beauty of the \nsmile, so these parameters are of particular importance for \nthe reconstruction of the anterior teeth, although in some \ncases these parameters are not recorded before tooth \nextraction10,11. Anthropological measurements, including \nwidth between two canine tips, bizygomatic width, the \ndistance between two pupils, the distance between \ninteralar, the distance between two canthus, and other \nanatomical structures are also of great importance for the \nreconstruction of the anterior tooth8,9,12.\nThere are limited scientific criteria in dentistry texts that \ncan provide a general and definitive guide to determine \nand define the appropriate tooth size. To choose the size \nof the anterior tooth, in addition to the need for general \nknowledge, the physical and biological factors related to \neach patient must also be considered9,13,14. One of the \ncritical factors for providing beauty and attractiveness \nis the proportion, size, shape, and arrangement of the \nupper anterior teeth, especially the upper central tooth.\nThe average width of the maxillary central incisor is \nestimated to be one-sixteenth of the bizygomatic width. \nThe total width of the 6 upper anterior teeth is less than one-\nthird of the bizygomatic width15-17. The length of the teeth \nis determined by the space between the remaining ridges. \nWhen there is enough space between the ridges, using \nlonger teeth will decrease the visibility of the prosthetic \nbase and increase the beauty. According to studies, there \nis a relationship between the size of the face and the \nheight of the crown of the upper central tooth. The height \nof the upper central tooth is one-sixteenth of the distance between the forehead protrusion and below the chin17,18. \nIn general, the information and standards available in \nthe field of selection of upper anterior teeth have been \nobtained from the Caucasian population and probably \ndo not match the existing population in Iran8. Providing \nthe basis for identifying the average racial dimensions of \neach population, makes it possible to make changes in \nexisting dental generators to provide beauty. Due to the \nlack of such information in Kerman province, this survey \nwas conducted to determine the association between the \ndimensions of upper anterior teeth and facial features. \nMaterials and methods\nIn this cross-sectional study, size of sample was estimated \nat least 160 people based on the previous study6 at the \nlevel of 0.05 alpha and power of 80% test . In this study, \nall 160 students in dental school of Kerman University \nof Medical Sciences were selected. Inclusion criteria \nincluded students in dental school of Kerman University \nof Medical Sciences students with an age range of \n18 to 23 years. The students with any hyperplasia or \ngingivitis, gingival resorption, gingival surgery, previous \nreconstructive interventions, diastema, traumatic injury \nor previous occlusal wear associated with Anterior teeth, \nmalocclusion, or previous orthodontic treatment were \nexcluded. Completed informed consent was gotten \nfrom each student. This survey was supervised and \naffirmed by the Student Research Committee of Kerman \nUniversity of Medical Sciences (1397-203).\nThe measured dental dimensions included the mesiodistial \nwidth of the upper right central tooth, the epicocronal \nheight length of the upper right central tooth, and the arch \ncircumference from the distal of upper right canine to the \ndistal of upper left one. The dimensions were measured with \na digitate caliper with an precision of 0.01 mm. To evaluate \nthe circumference of the arch, a floss was passed through \nthe distal of canines and matched to the arch, and then \nmarked in the contacts area and measured outside the \nmouth. Dimensions of the face include maximum bizygomatic \nwidth (the distance between the outermost points on the \nzygomatic arches on both sides), the distance between the \ninner canthus of the eyes, the distance between the corners \nof the mouth at rest (mouth width), the distance between \nthe two nasal fins (nasal width) and the interval between two \npoints gnathion and nasion (face length). These dimensions \nwere measured directly by a digital caliper while the patient \nwas sitting upright with no head restraints and looking away. \nTo obtain accurate results, each evaluation was performed \nthree times and its average was recorded as the final number. \nAll these measurements were performed by a dentist.\nThe observations was analyzed by independent t-test, \nand the relationship between indicators was investigated \nby Pearson correlation coefficient test. The significance \nlevel in this study was considered 0.05.53\n2022/37 (3): 51-57Relationship of maxillary anterior teeth and some facial landmarks\nResult\nIn this study, 160 participants were studied, (80 male, \nand 80 female). The mean of all upper anterior teeth \ndimensions except central mesiodistal width in men was \nsignificantly higher than female participants. Although \nthe central mesiodistal width index was higher in male \nparticipants, but the results showed no significant \ndifference between groups. Also, men showed \nsignificantly more facial dimensions compared with \nfemale participants ( Table I ).\nA significant and direct relationship was observed \nbetween the upper central epicocronal height, face \nlength (r=0.314, P<0.001) and the mouth width(r=0.166, \nP=0.036), which was statistically significant. also, the \nrelationship between upper central epicocronal height, \nfacial length (r=0.380, P=0.001) and bizygomatic \nwidth (r=0.229, P=0.041) was statistically insignificant. \nin female participants relationship between the upper \ncentral epicocronal height with nasal width (r= -0.221, \np=0.049) was reverse and insignificant. ( Table II ).\nA linear and direct correlation was observed between the \nupper central mesiodistal width and face length(r=0.244, p=0.002). In male participants, the relationship between \nupper central mesiodistal width and face length (r=0.390, \nP<0.001) was direct and significant. ( Table II ).\nA linear and direct significant relationship was observed \nbetween the upper anterior arch environment and face \nlength (r=0.415, P<0.001), mouth width (r=0.168, \nP=0.034), internal canthus distance (r=0.291, P<0.001) \nand bizygomatic width (r=0.165, P=0.037). In male \nparticipants, a linear and significant direct relationship \nbetween the circumference of the upper anterior arch \nand the face length (r=0.547, P<0.001) and intercanthal \ndistance (r=0.341, P=0.002). ( Table II ).\nAmong male and female participants, the mean ratios of \nthe anterior arch to the nose width, the circumference of \nthe anterior arch to the mouth width, the upper central \nmesiodistal width to the nose width, the upper central \nmesiodistal width to the mouth width, the interval from \nthe internal canthus to the nose width, the distance \nfrom the internal canthus to the mouth width showed a \nstatistically significant difference. But other ratios did not \nshow significant differences ( Table III ).\nTable I: The average dimensions difference between the upper anterior teeth and facial  indices based on gender.\nDimension Male Female P\n Mean SD Mean SD \nUpper anterior arch circumference  52.0 3.3 50.8 2.4 0.011\nUpper central epicocronal height  9.8 1.0 9.4 1.2 0.013\nUpper central mesiodistal width  8.1 0.9 7.8 0.9 0.120\nFace length  124.0 6.0 116.9 5.0 <0.001\nNasal width  30.2 3.5 27.2 2.9 <0.001\nMouth width  49.8 3.4 44.5 3.0 <0.001\nIntercanthal distance  30.7 3.1 29.6 2.7 0.026\nBizygomatic distance  117.2 5.2 112.1 5.7 <0.001\nTable II: Relationship between dental dimensions and facial indicators.\n  Face Nose  Mouth  Intercanthal Bizygomatic  \n length width width distance distance\n  r p r p r p r p r p\nUpper central epicocronal height  0.31 <0.001 0.00 0.959 0.17 0.036 0.03 0.694 0.09 0.271\nUpper central epicocronal height (male)  0.38 0.001 0.02 0.853 0.04 0.723 0.13 0.246 0.23 0.041\nUpper central epicocronal height (female)  0.13 0.243 -0.22 0.049 0.07 0.543 -0.13 0.243 -0.17 0.140\nUpper central mesiodistal width  0.24 0.002 0.02 0.761 0.06 0.434 0.05 0.555 0.04 0.594\nUpper central mesiodistal width (Male)  0.39 <0.001 0.07 0.560 -0.04 0.732 0.14 0.214 0.17 0.174\nUpper central mesiodistal width (Female)  0.02 0.865 -0.14 0.219 0.00 0.984 -0.10 0.400 -0.17 0.123\nUpper anterior arch circumference  0.42 <0.001 0.11 0.154 0.17 0.034 0.29 <0.001 0.17 0.140\nUpper anterior arch circumference (male)  0.55 <0.001 -0.07 0.544 -0.02 0.850 0.34 0.002 0.14 0.037\nUpper anterior arch circumference (female)  0.09 0.455 0.20 0.070 0.17 0.130 0.15 0.186 0.03 0.203\nTable III: Differences in the mean ratios under study by gender.\nRatios Male Female Total P\n Mean SD Mean SD Mean SD \nUpper central epicocronal height to face length  0.08 0.01 0.08 0.01 0.07 0.01 0.370\nUpper anterior arch environment to upper central mesiodistal width  6.50 0.61 6.56 0.73 6.52 0.67 0.610\nUpper anterior arch circumference to the nose width  1.75 0.23 1.89 0.20 1.81 0.22 <0.001\nUpper anterior arch circumference to the mouth width  1.05 0.10 1.15 0.09 1.09 0.10 <0.001\nUpper anterior arch circumference to intercanthal distance  1.71 0.18 1.73 0.17 1.71 0.17 0.470\nUpper anterior arch circumference to bizygomatic distance  0.44 0.03 0.45 0.03 0.44 0.03 0.051\nUpper central mesiodistal width to nasal width  0.27 0.04 0.29 0.05 0.28 0.04 0.003\nUpper central mesiodistal width to mouth width  0.16 0.02 0.18 0.02 0.16 0.02 <0.001\nUpper central mesiodistal width to intercanthal distance  0.27 0.04 0.27 0.04 0.26 0.03 0.730\nUpper central mesiodistal width to bizygomatic distance  0.07 0.01 0.07 0.01 0.06 0.01 0.330\nIntercanthal distance to the nose width  1.03 0.14 1.09 0.11 1.06 0.13 0.001\nIntercanthal distance to the mouth width  0.62 0.07 0.67 0.06 0.64 0.06 <0.001\nIntercanthal distance to bizygomatic distance  0.26 0.03 0.26 0.03 0.26 0.02 0.51054\n2022/37 (3): 51-57Parviz Amini et al.  \nDiscussion\n \nBeauty is one of the most important reasons for \nparticipants to seek prosthetic treatments. Also, smile is \naffected personal attractiveness and has a great role in \nthe person\u2019s own mood and his social impact19-21. Having \na beautiful smile directly depends on the condition of \nthe teeth, gums and how they fit with the composition \nof the face9,22,23. The correct choice of the six anterior \nteeth in terms of size, shape and color are major factors \nof successful Prosthetic treatment. The harmony of face \ndimensions, such as the corners of the lips, the filtrum, \nand the distance between the two nasal fins are more \nprominent in complete denture treatment. The correct \nchoice is to access to the best dentolabial harmony \nand the appearance of the face13,24-26. This choice is \nespecially difficult when no information is available from \nthe patient\u2019s natural teeth27. Hayden has been suggested \nto investigate the correct size of the anterior teeth28,29. \nHowever, the ratios expressed in different studies are not \nthe same, and the most similarity in the results is related \nto the ratio between the nose width and the width of \nthe six anterior teeth30. Many efforts have been made to \ninvestigate the approach to suppose the width of these \nteeth and the beauty obtained2,3,9,12,31,32. In this study, \nthe indices of upper anterior Arch circumference, upper \ncentral epicocronal height, upper central mesiodistal \nwidth, face length, nasal width, mouth width, internal \ncanthus distance and bizygomatic width between the \ntwo sexes were measured. The results showed that \nthe mean of all anterior teeth dimension indices except \ncentral mesiodistal width in men was significantly higher \nthan female participants. Although the central mesiodistal \nwidth index was higher in male participants, but this \ndifference was not significant. Facial landmarks were also \nsignificantly higher in men than female participants.\nBased on our results, the relationship between upper \ncentral mesiodistal width and gender was not statistically \nsignificant. Also, the correlation between the upper \ncentral mesiodistal width and the bizygomatic width, the \ndistance between the inner canthus, the mouth and nose \nwidth was not statistically significant, but the correlation \nbetween the upper central mesiodistal width and the face \nlength was statistically significant. It was further found that \nthe ratio of upper central mesiodistal width to nasal width \nwas 0.28, central mesiodistal width to mouth width was \n0.16, upper central mesiodistal width to internal canthus \ndistance was 0.26 and upper central mesiodistal width \nto bizygomatic width was 0.6. All measured ratios except \nupper central mesiodistal width to bizygomatic width \nshowed a significant difference between females and \nmales. This ratio was higher in women than men. In \nIbrahimagic study, the width of the central tooth was 1.5 \nmm smaller than similar samples of Western Europeans \n(average width 7 mm); While in British men, the rate is \n8.65, in Chinese society 8.85 and in Africa 9.9 mm33. \nIn Lavere study, the average length of the upper central tooth was 8.66 in men and 8.19 in women, and It was a \ntotal of 8.46 mm. In some sources, the average length of \nthe right maxillary central tooth is 10.5 mm, and the width \nof the central maxillary tooth is 8.5 mm25. Our results \nshowed that the e width of the right maxillary central \ntooth was 8.55 mm, which agreed with the results of \nprevious researches. In the Keng study, about 42.8% of \nthe subjects had a central width greater than 9.5 mm, \nindicating the larger size of teeth34.\nThe width of the central maxillary tooth in men and women \nin this study is similar to the findings of a number of other \nstudies. For example, Pak nahad  studied the average \nmesiodistal width of the central incisor of 100 students \nof Shahid Beheshti Dental School and 8.58 mm reported \nfor men and 8.23 mm for women35. On the Iranian \npopulation, the mean obtained in this study was 8.7 mm \nin men and 8.4 mm in women35. Further research, Oshaq \net al. Obtained an overall average of 8.4, which is close \nto the results of this study14. These results are different \nfrom Memarian and Rostamkhany et al27, 36. In the first \nstudy, the average width of the upper central tooth in a \npopulation of 100 participants referred to Tehran Dental \nSchool in the age range of 20-30 years was 8.9 in females \nand 9.1 in males. The next study was on a population of \n100 people who were all men. The age range was 17-37 \nyears; the average was 8.9 for this tooth. This difference \ncan be related to the inequality of the number of samples \nin terms of gender in these two studies. Owsen et al., by \nmeasuring the width of the anterior maxillary teeth in various \nethnicities, concluded that despite racial differences, \nmen\u2019s teeth are always wider than females37. Gillen et al. \nfound that men have wider and longer teeth than women \nHe showed that the difference in the measure of the central \nteeth and the canine in the two sexes is significant38. This \ncase is comparable with the result obtained in the study of \nHasanreisoglu et al.13.\nIn the present study, the Pearson correlation coefficient \ntest shows that there is no strong relation between \ninterzygomatic distance and the mesiodistal width of \nthe upper central incisor. These results are similar to the \nfindings of Scandrett et al.39. In Hasanreisoglu et al.\u2019s \nstudy, no relationship was found in men13. This will lead \nto wider teeth selection for the patient. Because the ratio \nobtained is approximately equal to 1:13; however, the \nratio obtained in this study has been confirmed in some \nstudies24. In Rawat et al. study, the width of the central \nmaxillary teeth to the bizygomatic width follows a ratio \nof 1:1640. The result of their study on the relationship \nbetween the bizygomatic width and the central tooth \nin two sexes is similar to the present study. However, \nin our study, the ratio of bizygomatic widthto the width \nof the maxillary central tooth differed from the normal \nvalue, which was also statistically significant. It can be \ndue to the different statistical samples. Their study was \nconducted in India and the present study was conducted \nin a population from southern Iran.55\n2022/37 (3): 51-57Relationship of maxillary anterior teeth and some facial landmarks\nIn this study, the significant relationship observed between \ntooth length and gender. Also, the correlation between the \nupper central length and bizygomatic width, the distance \nbetween the inner canthus, and the nose width was not \nstatistically significant, but the correlation between the \nupper central the face length and the mouth width was \nstatistically significant. There was no significant gender \ndifference in Central epicocronl height. Consistent with \nthe results of the present study in Sadeghi et al.\u2019s 2010 \nstudy, no relationship was found between gender and \ntooth size. In this study, the length of teeth was 9.45 mm \nin men and 9.16 mm in women41. In their study, as in the \npresent study, the length and width of teeth were slightly \nhigher in men than in women. In a 2014 study by Radia et \nal., The relation between upper central and interzygomatic \nwidth was 1:15.56 (1:15.57 in men and 1:15.37 in \nwomen) and the relationship between upper central \nepicocronal height and face height has been achieved \n1:17.93(1:17.97 in men and 1:17.89in women)42.\nThe intercanthal distance in the present study was 30.14 \nmm. In the study of Lotfi et al., The average distance \nbetween the inner canthos was 32.28 mm (7 m), and \nAbdullah et al. findings44 also stated that the average \ndistance of internal canthus was 32 mm, which was very \nclose to the present study. Our finding were lower than \nthe results of Murphy et al.26, who suggested an average \nintercantal distance of 33.9 mm, but higher than the \nresults obtained by Freihofer45. The ratio between the four \nmeasurements of the anterior teeth of the maxilla and the \ndistance of the internal canthus in all samples was very \nclose to the results obtained by Al wazzan et al.43.\nThe results showed that the central mesiodistal width to \nthe medial canthus distance was equal to 0.26 and this \nratio did not show a significant difference in two genders. \nSimilar to the results of the present study, the width of \nthe central tooth to the distance of the internal canthus \nin the study of Lotfi et al46. Was equal to 0.266, which \nwas calculated in the study of Alwazzan et al.43 0.267. In \ngeneral, it should be noted that the differences between \nthe results of the this study with other may be attributable \nto genetic variation as well as existing differences, in \naddition to breeding differences, related to differences \nin measurement methods. In the reconstruction and replacement of anterior teeth, despite the possibility of \nusing different indicators to select teeth with dimensions \nclose to reality, it should be noted that these indicators \nshould not be the sole owner of the selected teeth. \nBecause people\u2019s perceptions of beauty are different \nand individual and social factors affect it47. Therefore, in \naddition to using the basic principles to make the right \nchoices, social, racial and individual differences of each \nperson should be considered to increase participants\u2019 \nsatisfaction with their smiles48.\nOne of our limitations is that it is uni-center due to the \nfact that the dimensions of the teeth are different in \ndifferent ethnicities; it is better to study the information \nabout students in several provinces in future studies. \nIt is suggested that by collecting the results of other \nsimilar studies conducted in Iran and conducting a \ncomprehensive analysis, an effective step be taken in \npresenting the norms of Iranian society and producing \nteeth with appropriate dimensions.\nConclusion\nAlthough there are various techniques for estimating \nthe teeth size, due to the relationship between some \ndimensions of the head, face and teeth, these dimensions \nof the head and face can be used to estimate the \ndimensions of teeth but most of the available information \nof facial and dental dimensions and their proportions is \nrelated to the other country\u2019s statistics, whose population \nis definitely different from the Iranian population and \nthat there is no complete related information in dental \nreference books so by use of this study results this \nmethod can be used by Iranian dentists.\nDeclaration of competing interest\nThe authors have no conflicts of interest to declare.\nAcknowledgments\nThe present study is the result of Bahareh Saeed doctoral \ndissertation, which has been approved by the Vice-\nChancellor Research of Kerman University of Medical \nSciences.56\n2022/37 (3): 51-57Parviz Amini et al.  \nReferences\n1. Arigbede A, Igwedibia P . Size of maxillary anterior teeth in relation to \nselected facial anatomic landmarks among a group of subjects in port \nharcourt. Journal of Advances in Medicine. 2016;14(9):1-6.\n2. Shetty SK, Malli P , D\u2019Souza J, Shenoy K, Chunduri ST, Fernandes K. \nInner Canthal Distance, Inter Pupillary Width, and Golden Proportion, as \nPredictors of Width of the Maxillary Central Incisors - An In Vivo Study. J \nEvol Med Dent Sci. 2021;10(22):1650-5.\n3. Shammas M, Bukhar EO, Rummani AJ, Almasri AA, Bakhsh DE, Hafiz \nLO. Evaluation of Relation between Bizygomatic Width and Mesiodistal \nDimension of Maxillary Central Incisor in Saudi Population: An In-vivo \nStudy. J Clin Diagn Res. 2020;14(10).\n4. Osagbemiro BB, Akadiri OA, Arigbede AO. Patients\u2019 attitude towards \nanterior teeth extraction an prosthetic replacement at the UPTH Dental \nCenter, Port Harcourt. Niger J Med. 2011;20(1):52-6.\n5. Naeem S, Hussain MW, Qamar K. The role of the interalar width in the \nanterior teeth selection. Pakistan Oral & Dental Journal. 2012;32:569.\n6. Deogade SC, Mantri SS, Sumathi K, Rajoriya S. The relationship \nbetween innercanthal dimension and interalar width to the intercanine \nwidth of maxillary anterior teeth in central Indian population. J Indian \nProsthodont Soc. 2015;15(2):91-7.\n7. Kini AY, Angadi GS. Biometric ratio in estimating widths of maxillary \nanterior teeth derived after correlating anthropometric measurements with \ndental measurements. Gerodontology. 2013;30(2):105-11.\n8. Ellakwa A, McNamara K, Sandhu J, James K, Arora A, Klineberg I, et \nal. Quantifying the selection of maxillary anterior teeth using intraoral and \nextraoral anatomical landmarks. J Contemp Dent Pract. 2011;12(6):414-21.\n9. Pierrot KN, Paul SIBJ, Celestin MN, Augustin MM, Joseph LPS, Fidele \nNBJOJoS. Determinants Factors for the Choice of the Width Prosthetic \nUpper Central Incisor: Review of the Literature. Open J Stomatol. \n2020;10(11):333-40.\n10. Hasan AS, Habeeb SH, Qadir AQM, Kazanji M. Relation of Maxillary \nCentral Incisors Width to some Facial Measurements. Journal of Oral and \nDental Research. 2017;4(2).\n11. de Oliveira Farias F, Ennes JP , Zorzatto JR. Aesthetic Value of the \nRelationship between the Shapes of the Face and Permanent Upper \nCentral Incisor. Int J Dent. 2010;2010.\n12. Majeed MI, Haralur SB, Khan MF, Al Ahmari MA, Al Shahrani NF, Shaik \nS. An Anthropometric Study of Cranio-Facial Measurements and Their \nCorrelation with Vertical Dimension of Occlusion among Saudi Arabian \nSubpopulations. Open Access Maced J Med Sci. 2018;6(4):680-6.\n13. Hasanreisoglu U, Berksun S, Aras K, Arslan I. An analysis of \nmaxillary anterior teeth: facial and dental proportions. J Prosthet Dent. \n2005;94(6):530-8.\n14. Oshagh M, Bayani F, Feyzi N. RELATION BETWEEN CRANIOFACIAL \nDIMENSIONS AND ANTERIOR TEETH SIZE. J Dairy Sci. 2009;27(2 \n(80)):84-93.\n15. Shetty K, Kumar M, Palagiri K, Amanna S, Shetty S. Facial \nmeasurements as predictors of the length of the maxillary central incisor \nin a cross section of the Indian population-A clinical study. J Oral Hyg \nHealth. 2013;1(1):1-4.\n16. Rahn AO, Ivanhoe JR, Plummer KD. Textbook of complete dentures: \nPMPH-USA; 2009.17. Jadhav VV, Vasudevan SD, Kamble R, Tiwari MM. ViVan Formula- A \nModified Formula for Estimating the Mesiodistal Width of Maxillary Central \nand Lateral Incisor. J Evolution Med Dent Sci. 2020;9(14):1144-7.\n18. Zarb GA, Bolender CL, Carlsson GE, Boucher CO. Boucher\u2019s \nProsthodontic Treatment for Edentulous Patients: Mosby; 1997.\n19. Jalalian E, Shakeri S, Nasiri A. Evaluation of Relationship between \nSmile Line and Age. Journal of Kerman University of Medical Sciences. \n2004;10(1):43-8.\n20. Horn S, Matuszewska N, Gkantidis N, Verna C, Kanavakis G. \nSmile dimensions affect self-perceived smile attractiveness. Sci Rep. \n2021;11(1):2779.\n21. Golshah A, Serenjianeh AM, Imani MM. Smile attractiveness of \nPersian women after orthodontic treatment. Am J Orthod Dentofacial \nOrthop. 2020;158(1):75-83.\n22. Ricketts RM. The biologic significance of the divine proportion and \nFibonacci series. Am J Orthod. 1982;81(5):351-70.\n23. Marquardt SR. Dr. Stephen R. Marquardt on the Golden Decagon \nand human facial beauty. Interview by Dr. Gottlieb. J Clin Orthod. \n2002;36(6):339-47.\n24. Latta GH, Jr., Weaver JR, Conkin JE. The relationship between the \nwidth of the mouth, interalar width, bizygomatic width, and interpupillary \ndistance in edentulous patients. J Prosthet Dent. 1991;65(2):250-4.\n25. LaVere AM, Marcroft KR, Smith RC, Sarka RJ. Denture tooth selection: \nan analysis of the natural maxillary central incisor compared to the length \nand width of the face: Part II. J Prosthet Dent. 1992;67(6):810-12.\n26. Murphy WK, Laskin DM. Intercanthal and interpupillary distance in the \nblack population. Oral Surg Oral Med Oral Pathol. 1990;69(6):676-80.\n27. Memarian M, Masoomi R. Selection of six anterior teeth for edentulous \npatients. J Dent Med. 2005;17(4):81-7. \n28. Sellen PN, Jagger DC, Harrison A. Methods used to select artificial \nanterior teeth for the edentulous patient: a historical overview. Int J \nProsthodont. 1999;12(1):51-8.\n29. Abdullah MA. Inner canthal distance and geometric progression \nas a predictor of maxillary central incisor width. J Prosthet Dent. \n2002;88(1):16-20.\n30. Ahmadian L, Arbabi R, Arbabi-Kalati F, Soltani B. Correlation between \nsome facial indexes and mesiodistal width of maxillary anterior teeth. \nZahedan J Res Med Sci. 2012;13(8):e93765.\n31. Cesario VA, Jr., Latta GH, Jr. Relationship between the mesiodistal \nwidth of the maxillary central incisor and interpupillary distance. J Prosthet \nDent. 1984;52(5):641-3.\n32. Gomes VL, Gon\u00e7alves LC, do Prado CJ, Junior IL, de Lima Lucas \nB. Correlation between facial measurements and the mesiodistal width of \nthe maxillary anterior teeth. J Esthet Restor Dent. 2006;18(4):196-205.\n33. Ibrahimagi\u0107  L, Jerolimov V, Celebi\u0107  A, Carek V, Bauci\u0107 I, Zlatari\u0107  \nDK. Relationship between the face and the tooth form. Coll Antropol. \n2001;25(2):619-26.\n34. Keng SB, Foong KW. Maxillary arch and central incisor dimensions \nof an ethnic Chinese population in relation to complete denture \nprosthodontics. Int Dent J. 1996;46(2):103-7.57\n2022/37 (3): 51-57Relationship of maxillary anterior teeth and some facial landmarks\n35. Paknahad H. Evaluation of relationship between size of anterior \nteeth and facial indexes. MSD thesis. Tehran University of Medical \nSciences; 1993.\n36. Rostamkhany F, Asadzadeh Aghdaee N, Esmaily H. Evaluation of \nrelationship between length and width of natural maxillary central and \nlateral incisors, and some measurable parameters of the face. Journal of \nMashhad Dental School. 2005;29(Issue):209-14.\n37. Owens EG, Goodacre CJ, Loh PL, Hanke G, Okamura M, Jo KH, \net al. A multicenter interracial study of facial appearance. Part 2: A \ncomparison of intraoral parameters. Int J Prosthodont. 2002;15(3):283-8.\n38. Gillen RJ, Schwartz RS, Hilton TJ, Evans DB. An analysis of selected \nnormative tooth proportions. Int J Prosthodont. 1994;7(5):410-7.\n39. Scandrett FR, Kerber PE, Umrigar ZR. A clinical evaluation of \ntechniques to determine the combined width of the maxillary anterior teeth \nand the maxillary central incisor. J Prosthet Dent. 1982;48(1):15-22.\n40. Rawat A, Godbole S, Sathe S, Patidar N, Ramteke S. Evaluation \nof relation between bizygomatic width and mesiodistal dimension of \nmaxillary central incisor in Indian Population: An in vivo study. Int J Sci \nStud. 2015;3(6):38-42.41. Sadeghi R, Sarlati F, Kalantari S. Relationship between crown forms \nand periodontium biotype. J res dentillofac sci. 2011;8(1):1-8.\n42. Radia S, Sherriff M, McDonald F, Naini FB. Relationship between \nmaxillary central incisor proportions and facial proportions. J Prosthet \nDent. 2016;115(6):741-8.\n43. Al Wazzan KA. The relationship between intercanthal dimension and \nthe widths of maxillary anterior teeth. J Prosthet Dent. 2001;86(6):608-12. \n44. Abdullah MAi, Stipho H, Yf T, Khan N. The significance of inner-\ncanthal distance in prosthodontics. Saudi Dent J. 1997;9:36-9.\n45. Freihofer HP . Inner intercanthal and interorbital distances. J Maxillofac \nSurg. 1980;8(4):324-6.\n46. Lotfi Kamran Mh, Haghparast - Ghomsheh A. The Relationship \nbetween intercanthal dimension and width of maxillary anterior teeth. \nJournal of Indian Dental Association. 2007;19(3):8-13.\n47. Ahmad I. Anterior dental aesthetics: Dental perspective. Br Dent J. \n2005;199(3):135-41;quiz 74.\n48. Gon\u00e7alves LC, Gomes VL, De Lima Lucas B, Monteiro SB. \nCorrelation between the individual and the combined width of the six \nmaxillary anterior teeth. J Esthet Restor Dent. 2009;21(3):182-91.58\n2022/37 (3): 58-63Received:  22 - II - 2022\nAccepted:  8 - III - 2022\ndoi: 10.3306/AJHS.2022.37.03.58Corresponding author\nNastaran Chokhachi Zadeh Moghadam  \nE-mail: nastaran@bu.edu\nAbstract  \nBackground: Zataria multiflora  is a medicinal plant with high antimicrobial effects. It is mainly used as an oral specie in food. The \npresent survey was aimed to assess the antimicrobial effects of Z. multiflora -based mouthwash on the microbial community of \ndental plaques. \nMethods:  Two-hundred dental plaque samples were collected from individuals. Culture technique was used to assess their \nmicrobial contamination. Z. multiflora  was collected and use in a base of mouthwash in 1% concentration. Antimicrobial effects of \nZ. multiflora -based mouthwash was examined against isolated bacteria and compared to antibiotic agents using the disk diffusion. \nMinimum inhibitory concentration of Z. multiflora -based mouthwash was also studied against isolated bacteria. \nResults:  Streptococcus mutans  (19%), Enterobacter cloacea  (17.50%), and Staphylococcus aureus  (15%) were the most \ncommonly identified bacteria amongst the dental plaque samples. H. pylori  (8%) had the lowest prevalence. The mean ranges \nof the diameter of the growth inhibition zones were 5.71\u00b10.92 ( S. aureus  against tetracycline) to 15.68\u00b10.55 ( S. mutans  against \nazithromycin) mm. Z. multiflora  mouthwash (1%) harbored the highest antimicrobial effects against S. mujtans  (15.33\u00b10.81 mm), \nand S. aureus  (12.01\u00b11.10 mm), while showed the lowest against E. coli  (8.38\u00b10.46 mm) and E. cloacea  (10.52\u00b10.84 mm). The \nlowest MIC levels were obtained for S. mutans  (2 mg/ml). The highest MIC level was found for E. cloacea  (8 mg/ml). The MIC levels \nof Z. multiflora  mouthwash against E. coli  and H. pylori  bacteria were higher than examined concentrations. \nConclusion:  Z. multiflora -based mouthwash may be a useful herbal-based mouthwash against bacteria in dental plaque samples. \nKey words:  Zataria multiflora , mouthwash, antimicrobial effects, dental plaques. \nResumen\nAntecedentes:  Zataria multiflora  es una planta medicinal con altos efectos antimicrobianos. Se utiliza principalmente como \nespecie oral en la alimentaci\u00f3n. El presente estudio ten\u00eda como objetivo evaluar los efectos antimicrobianos de un enjuague bucal \na base de Z. multiflora  sobre la comunidad microbiana de las placas dentales. \nM\u00e9todos:  Se recogieron doscientas muestras de placa dental de individuos. Se utiliz\u00f3 una t\u00e9cnica de cultivo para evaluar su \ncontaminaci\u00f3n microbiana. Se recogi\u00f3  Z. multiflora  y se utiliz\u00f3 en una base de enjuague bucal en una concentraci\u00f3n del 1%. Se \nexaminaron los efectos antimicrobianos del enjuague bucal a base de  Z. multiflora  contra las bacterias aisladas y se compararon \ncon los agentes antibi\u00f3ticos mediante la difusi\u00f3n en disco. Tambi\u00e9n se estudi\u00f3 la concentraci\u00f3n m\u00ednima inhibitoria del enjuague \nbucal a base de Z. multiflora  frente a bacterias aisladas. \nResultados:  Streptococcus mutans  (19%), Enterobacter cloacea  (17,50%) y Staphylococcus aureus  (15%) fueron las bacterias \nm\u00e1s com\u00fanmente identificadas entre las muestras de placa dental. H. pylori  (8%) tuvo la menor prevalencia. Los rangos medios \ndel di\u00e1metro de las zonas de inhibici\u00f3n del crecimiento fueron de 5,71\u00b10,92 ( S. aureus  frente a la tetraciclina) a 15,68\u00b10,55 ( S. \nmutans  frente a la azitromicina) mm. El enjuague bucal de Z. multiflora  (1%) alberg\u00f3 los mayores efectos antimicrobianos contra \nS. mujtans  (15,33\u00b10,81 mm), y S. aureus  (12,01\u00b11,10 mm), mientras que mostr\u00f3 los m\u00e1s bajos contra  E. coli  (8,38\u00b10,46 mm) \ny E. cloacea  (10,52\u00b10,84 mm). Los niveles de MIC m\u00e1s bajos se obtuvieron para S. mutans  (2 mg/ml). El nivel de CIM m\u00e1s alto \nse encontr\u00f3 para E. cloacea  (8 mg/ml). Los niveles de CIM de Z. multiflora  contra las bacterias E. coli  y H. pylori  fueron superiores \na las concentraciones examinadas. \nConclusi\u00f3n:  El enjuague bucal a base de Z. multiflora  puede ser un \u00fatil colutorio a base de plantas contra las bacterias presentes \nen las muestras de placa dental.\nPalabras clave: Zataria multiflora , enjuague bucal, efectos antimicrobianos, placas dentales.ORIGINAL\nStudy the antimicrobial effects of Zataria multiflora -based \nmouthwash on the microbial community of dental plaques isolated \nfrom children: A candidate of novel plant-based mouthwash  \nEstudio de los efectos antimicrobianos del enjuague bucal a base de Zataria multiflora \nsobre la comunidad microbiana de placas dentales aisladas de ni\u00f1os: Un candidato a \nenjuague bucal novedoso a base de plantas \nKianosh Mirzaei1      , Amirhossein Fathi2      , Seyedeh Mohadeseh Asadinejad3      ,\nNastaran Chokhachi Zadeh Moghadam4\n1. Postgraduate Student, Department of Operative Dentistry, School of Dentistry, Tehran University of Medical Sciences, Tehran, Iran .\n2. Dental Material Research Center, Department of Prosthodontics, Isfahan University of Medical Sciences, Isfahan, Iran.\n3. Assistant Professor of Periodontology, Department of Periodontics, School of Dentistry, Isfahan University of Medical Sciences, \nIsfahan, Iran.    4. Department of Pediatric Dentistry, Boston University Henry M. Goldman School of Dental Medicine, MA, USA.eISSN 2255-0569\nID ID ID\nID59\n2022/37 (3): 58-63Study the antimicrobial effects of Zataria multiflora-based mouthwash on the microbial community of dental plaques isolated from children \nIntroduction\nDental plaque is the name given to the aggregations of \nbacteria and their products which accumulate on the tooth \nsurface1. When plaque accumulates on the crowns of teeth \nthe natural, smooth, shiny appearance of the enamel is lost \nand a dull, matt effect is produced2. As it builds up, masses \nof plaque become more readily visible to the naked eye3. \nAdditionally, dental plaque bacteria can be a dangerous \nsources of infections for other parts of the body, such as \ngastrointestinal tract, head, neck, and nasopharynx4.\nIn direct smears, the early plaque is dominated by cocci \nand rods, most of which are Gram-positive. In the mature \nplaque (after about 7 days) the percentage of cocci in \nthe plaque decreases rapidly and filaments and rods \nconstitute about 50% of organisms in plaque5. Studies \nrevealed that Streptococcus mutans , Enterobacter \ncloacea, Staphylococcus aureus , Klebsiella pneumonia, \nHelicobacter pylori,  and Escherichia coli , are the most \nimportant and frequent bacterial species isolated from \nthe oral cavity and dental plaque samples, globally6,7.\nSeveral antimicrobial choices are available for the \ninfections of the oral cavity. However, bacterial isolates \nof the dental plaque samples harbored severe resistance \ntoward commonly used antimicrobial agents, particularly \naminogylocides, tetracyclines, penicillins, cephalosporins, \nand quinolones8. Thus, studying the profile and pattern of \nantibiotic resistance amongst bacterial isolates of dental \nplaques as novel reservoirs of bacteria seems essential. \nZataria multiflora  (Z. multiflora ) is a herbal plant belonging \nto the Laminaceae family. It grows in Iran, Pakistan and \nAfghanistan and is known as Avishan Shirazi in Iran. The \nmain components of the essential oil of this plant include \nphenolic compounds such as carvacrol, thymol and \neugenol9. This plant is known as potential antimicrobial \nagents and mainly used as a spice in different foodstuffs10. \nEdible nature of this plant make it possible to use it in several \ntypes of oral drugs, particularly herbal mouthwash11. \nThis study was aimed to assess the antimicrobial effects \nof Z. multiflora -based mouthwash on the microbial \ncommunity of dental plaques as a novel candidate of \nplant-based mouthwash in vitro condition.\nMaterials and methods\nSamples and inclusion criteria \nA total of 200 children referred to the dentistry clinics \nfor routine check-ups were assessed in this survey. All \nchildren with dental plaque samples were included in this \nsurvey. Dental plaque presence is the prominent inclusion \nfactor. All children who had received antimicrobial options \nor antibacterial mouthwashes three months before the \nexperiment were excluded from the research. Dental plaque sample was taken from the gingival crevice at the \nmost profound pocket reading and removed from the \nclinical site using a sterile universal curette. The curette \ntip was inserted into the depths of the crevice/pocket, \nmoved coronally while in contact with the tooth surface \nto remove both sub and supragingival plaque.\nPreparation of plant materials\nZ. multiflora  was purchased from traditional groceries. \nA total of 3500 grams of Z. multiflora  was used to \ncreate an ethanol extract. It was cleaned, dried at room \ntemperature for 24 hours, and processed in a blender \nuntil its texture became smooth. To obtain the extract from \nthe processed Z. multiflora , 2000 ml of a 96% ethanol \nsolution was used, and this process was repeated \nthrice. The initial extract was filtered and evaporated at \ntemperatures ranging from 50 to 60 \u00b0C to obtain a 100% \npure Z. multiflora  extract. The pure extract was weighed, \nstored in a sealed glass container, and subsequently \nplaced in a desiccator before being used as mouthwash.\nMouthwash formulation\nAs much as 100 ml of mouthwash was produced for \neach formulation with Z. multiflora  extract as the active \nsubstance. The formulations of Z. multiflora  mouthwash \naccording to table I . Propylene glycol was included in \nthe Z. multiflora  extract and placed in a glass beaker. It \nwas then raised to 60 \u00b0C, stirred with a magnetic stirrer \nat 300 rpm and Tween 80, and sorbitol and aquadest \nwere added. Benzoic acid and sodium benzoate \nwere dissolved in aquadest and added to the solution \nand stirred with a magnetic stirrer until homogeneous. \nSubsequently, 100 ml of the sorbitol and aquadest ad \nwas stirred until the solution became clear, and Oleum \nmenthae piperitae was added.\nQuality assessment of Z. multiflora mouthwash\nOrganoleptic, acidity, stability, weight mass, viscosity, \nirritation, and contact time of Z. multiflora  mouthwash \nwere assessed using the method described previously12. \nIsolation of bacteria from \nthe dental plaque samples\nThe dental plaque sample from each child was cultured \ninto a sterile tube containing 5% sheep blood agar, \nchocolate agar and a selective medium and transported \nto the microbiology laboratory. All media were incubated \nat 37\u00b0C and 42 \u00b0C for 24 to 48 h. after Gram staining and Table I: Formulation of Z. multiflora mouthwash.\nComponents Frequency (%)\nZ. multiflora  ethanolic extract 1\nPropylene glycol  25\nTween 80  5\nOleum menthe piperitae  0.25\nBenzoate acid 0.1\nSodium benzoate 1\nSorbitol 70% 15\nAquadest 10060\n2022/37 (3): 58-63Kianosh Mirzaei et al.  \nmicroscopy, different biochemical tests were performed \nto identify bacterial strains. The basic biochemical tests \nused to identify bacterial strains includes Starch Test, \nSimon Citrate, Oxidase, Catalase, Voges Proskauer, \nUrease, Indole, Methyl Red and Coagulase Test. \nAnalytical Profile Index (API 20E) (BioMeriouxVitek, Inc., \nMO, USA) system was used to identify bacteria13.\nAntibacterial effects of mouthwash \nagainst isolated bacteria\nThe simple disk diffusion method was used to assess \nthe antimicrobial effects of synthesized mouthwash. For \nthis purpose, isolated bacteria were cultured on Muller \nHinton agar media. A total of 1000 \u00b5l of 1% Z. multiflora  \nmouthwash were poured into the blank disk and located \nat the surface of each media. For comparison,  penicillin \n(10 \u00b5g/disk), tetracycline (30 \u00b5g/disk), azithromycin (15 \n\u00b5g/disk), gentamicin (10 \u00b5g/disk), and ampicillin (10 \u00b5g/\ndisk) (Oxoid, UK) antibiotic disks were accompanies. All \nguidelines were performed according to the Clinical and \nlaboratory standard institute (CLSI)14-16. The Minimum \nInhibitory Concentration (MIC) of synthetic  Z. multiflora  \nmouthwash was also assessed. For this purpose, 1, \n2, 4, and 8 mg/ml concentration of mouthwash were \nprepared and the MIC value was determined using the \npreviously described method17. \nStatistical analysis\nCollected data were transferred to the Microsoft Office \nExcel software and arranged well. Then, they were \nstatistically analyzed using the SPSS software and chi-\nsquare and analysis of variance tests (ANOVA). P<0.05 \nwas consider z significant level18-22. Results\nTable II  shows the distribution of bacteria strains isolated \nfrom dental plaque samples. As shown, S. mutans  \n(19%), E. cloacea  (17.50%), and S. aureus  (15%) were \nthe most commonly identified bacteria amongst the \ndental plaque samples. H. pylori  (8%) had the lowest \nprevalence amongst the examined dental plaque \nsamples. Statistically significant difference was obtained \nbetween the distribution of different bacteria ( P<0.05).\nTable III  shows the dimeter of the growth inhibition zone \nof bacteria against synthetic mouthwash compare to \nantimicrobial agents. The mean ranges of the diameter \nof the growth inhibition zones were 5.71\u00b10.92 ( S. \naureus  against tetracycline) to 15.68\u00b10.55 (S. mutans \nagainst azithromycin) mm. Z. multiflora  mouthwash (1%) \nharbored the highest antimicrobial effects against S. \nmujtans  (15.33\u00b10.81 mm), and S. aureus  (12.01\u00b11.10 \nmm), while showed the lowest against E. coli  (8.38\u00b10.46 \nmm) and E. cloacea  (10.52\u00b10.84 mm). Statistically \nsignificant differences were obtained between the \ndiameter of the growth inhibition zone of bacteria treated \nwith different antimicrobial agents ( P<0.05).\nTable IV  shows the MIC values of Z. multiflora  mouthwash \nagainst different isolated bacteria. Findings showed that \nthe lowest MIC levels were obtained for S. mutans  (2 \nmg/ml). The highest MIC level was found for E. cloacea  \n(8 mg/ml). The MIC levels of Z. multiflora  mouthwash \nagainst E. coli  and H. pylori  bacteria were higher than \nexamined concentrations (non detected).\nTable II: Distribution of bacteria strains isolated from dental plaque samples.\nSamples N. collected Distribution of bacteria (%)\n  S. aureus S. mutans E. cloacea E. coli H. pylori\nDental plaques 200 30 (15) 38 (19) 35 (17.50) 20 (10) 16 (8)\nTable III: Dimeter of the growth inhibition zone of bacteria against synthetic mouthwash compare to antimicrobial agents.\n*Dissimilar small letters in each column show significant statistical differences ( P<0.05).Tested antimicrobial agents Diameter of the growth inhibition zone of bacteria (mm)\n S. aureus S. mutans E. cloacea E. coli H. pylori\nZ. multiflora  mouthwash (1%) 12.01\u00b11.10 a* 15.33\u00b10.81 a 10.52\u00b10.84 a 8.38\u00b10.46 b 10.57\u00b10.61 a\nPenicillin 8.63\u00b10.34 b 9.66\u00b10.23 c 10.14\u00b10.22 a 8.15\u00b10.51 b 10.33\u00b10.35 a\nTetracycline 5.71\u00b10.92 c 6.61\u00b10.28 d 8.17\u00b10.37 b 8.81\u00b10.36 b 8.66\u00b10.25 a\nAzithromycin 13.24\u00b10.95 a 15.68\u00b10.55 a 11.43\u00b10.52 a 10.93\u00b10.44 a 9.90\u00b10.60 a\nGentamicin 6.03\u00b10.32 c 11.82\u00b10.39 b 11.97\u00b10.93 a 8.55\u00b10.81 b 9.93\u00b10.65 a\nAmpicillin 7.15\u00b10.41 c 10.17\u00b10.16 c 10.08\u00b10.09 a 9.72\u00b10.74 ab 9.71\u00b10.69 a\nTable IV: MIC values of Z. multiflora  mouthwash against different isolated bacteria.\n*Non detected.Treatment MIC (mg/ml)\n S. aureus S. mutans E. cloacea E. coli H. pylori\nZ. multiflora  mouthwash  4 2 8 ND* ND61\n2022/37 (3): 58-63Study the antimicrobial effects of Zataria multiflora-based mouthwash on the microbial community of dental plaques isolated from children \nDiscussion\nInfections may cause several life-threating diseases \nglobally23-38. In this regard, medical plants and traditional \nmedicine act as healing sciences39. In this study, Z. \nmultiflora -based mouthwash was used as an antimicrobial \nagent on bacteria isolated from dental plaque samples. \nTotal distribution of S. aureus, S. mutans, E. cloacea, \nE. coli,  and H. pylori  amongst the examined dental \nplaque samples was 15%, 19%, 17.50%, 10%, and 8%, \nrespectively. \nAn Indian survey40 revealed that Streptococcus spp. was \nthe most commonly detected bacteria (51.00%), followed \nby E. coli (19.00%) and Veillonella spp. (19.00%). A \nresearch on United Kingdome41 showed that Tannerella \nforsythensis  (65.00%), Porphyromonas gingivalis  \n(49.00%), and Actinobacillus actinomycetemcomitans  \n(55.00%) were the most commonly detected pathogens \nisolated from dental plaque samples. Similarly in \nKorea42, Streptococcus, Corynebacterium, Neisseria , \nand Fusobacterium  were the most commonly detected \nbacterial strains in dental plaque samples. Brazilian \nsurvey43 showed that the predominant species in all \n600 samples included Corynebacterium diphtheriae, \nEnterococcus faecalis, S. aureus, Acinetobacter \nbaumannii, P. aeruginosa , and E. coli  were predominant \nbacterial pathogens in the dental plaque samples of \nchildren with chronic periodontitis.\nFindings of the current research revealed that Z. multiflora -\nbased mouthwash had the highest antimicrobial effects \non S. mutans  and S. aureus . The main reason for the \nlower antimicrobial effects of the mouthwash against \nother bacteria is that they were Gram-negative and have \nLipopolysaccharide (LPS) in their cell walls which inhibit \nthe penetration of essential oils and herbal extracts. \nAghili et al. (2015)44 reported that the Z. multiflora  extract \nhad the higher antimicrobial effects on experimentally \ncontaminated orthodontic elastomeric ligatures \ncompared to chlorhexidine mouthwash. Milho et al. \n(2021)45 stated that the essential oils of Cymbopogon \ncitratus (DC.) Stapf and Lippia alba (Mill.) seem to be \nthe most promising in fighting microbial biofilm in S. \nmutans , given their high capacity to reduce biofilm at low \nconcentrations. Significant effects of herbal mouthwash \nagainst pathogenic bacteria recovered from the dental \nplaques have similarly been reported by Tusi et al. (2020) \n(Iran)46 and Pedrazzi et al. (2015) (Brazil)47.Conclusion\nAccording to the high antimicrobial effects of the Z. \nmultiflora -based mouthwash compared to antimicrobial \nagents even in low concentrations, its application as a \nnovel and herbal-based mouthwash particularly against \nGram-positive bacteria responsible for dental plaque \nformation has been recommended. However, some \nadditional surveys should perform to assess other effects \nof Z. multiflora -based mouthwash on the oral cavity.\nConflict of Interest\nThe authors declare that they have no conflict of interest.62\n2022/37 (3): 58-63Kianosh Mirzaei et al.  \nReferences\n1. Murakami S, Mealey BL, Mariotti A, Chapple IL. Dental plaque\u2013\ninduced gingival conditions. Journal of clinical periodontology. 2018 \nJun;45:S17-27.\n2. Sreenivasan PK, Prasad KV, Javali SB. Oral health practices and \nprevalence of dental plaque and gingivitis among Indian adults. Clinical \nand experimental dental research. 2016 Jun;2(1):6-17.\n3. Marsh PD. Dental plaque as a biofilm and a microbial community\u2013\nimplications for health and disease. InBMC Oral health 2006 Jun (Vol. 6, \nNo. 1, pp. 1-7). BioMed Central.\n4. Li X, Kolltveit KM, Tronstad L, Olsen I. Systemic diseases caused by \noral infection. Clinical microbiology reviews. 2000 Oct 1;13(4):547-58.\n5. Selwitz RH, Ismail AI, Pitts NB. Dental caries. The Lancet. 2007 Jan \n6;369(9555):51-9.\n6. Marsh PD. Dental plaque as a biofilm and a microbial community\u2013\nimplications for health and disease. InBMC Oral health 2006 Jun (Vol. 6, \nNo. 1, pp. 1-7). BioMed Central.\n7. Marsh PD. Dental plaque as a microbial biofilm. Caries research. \n2004;38(3):204-11.\n8. Meinen A, Reuss A, Willrich N, Feig M, Noll I, Eckmanns T, Al-Nawas B, \nMarkwart R. Antimicrobial Resistance and the Spectrum of Pathogens in \nDental and Oral-Maxillofacial Infections in Hospitals and Dental Practices \nin Germany. Frontiers in microbiology. 2021 Jun 2;12:1418.\n9. Dini S, Dadkhah A, Fatemi F. Biological Properties of Iranian Zataria \nMultiflora Essential Oils: A Comparative Approach. Electronic Journal of \nBiology. 2015;11(3):57-62.\n10. Aghili H, Nadoushan AA, Herandi V. Antimicrobial effect of zataria \nmultiflora extract in comparison with chlorhexidine mouthwash on \nexperimentally contaminated orthodontic elastomeric ligatures. Journal of \ndentistry (Tehran, Iran). 2015 Jan;12(1):1.\n11. Owlia P , Pirveicy H, Saderi H, Rezvani MB, Mansouri S. Evaluation \nof the antimicrobial effects of extract of Zataria multiflora against oral \nStreptococci. Iranian Journal of Pharmaceutical Research. 2010 Nov \n20(Supplement 2):74-5.\n12. Iskandar B, Lukman A, Syaputra S, Al-Abrori UN, Surboyo MD, Lee CK. \nFormulation, characteristics and anti-bacterial effects of Euphorbia hirta L. \nmouthwash. Journal of Taibah University Medical Sciences. 2021 Sep 17.\n13. Shayegani ME, Maupin PS, McGlynn DM. Evaluation of the API 20E \nsystem for identification of nonfermentative Gram-negative bacteria. \nJournal of Clinical Microbiology. 1978;7(6):539-45.\n14. Clinical and Laboratory Standards Institute (CLSI). Performance \nstandards for antimicrobial susceptibility testing; twenty-second \ninformational supplement. M100-S21. Wayne Pa: CLSI; 2012.\n15. Ranjbar R, Seif A, Dehkordi FS. Prevalence of antibiotic resistance \nand distribution of virulence factors in the shiga toxigenic Escherichia \ncoli recovered from hospital food. Jundishapur Journal of Microbiology. \n2019;12(5):8.\n16. Rahi A, Kazemeini H, Jafariaskari S, Seif A, Hosseini S, Dehkordi FS. \nGenotypic and phenotypic-based assessment of antibiotic resistance \nand profile of staphylococcal cassette chromosome mec in the methicillin-\nresistant Staphylococcus aureus recovered from raw milk. Infection and \ndrug resistance. 2020;13:273.\n17. Dadashi M, Hashemi A, Eslami G, Fallah F, Goudarzi H, Erfanimanesh \nS, et al. Evaluation of antibacterial effects of Zataria multiflora Boiss extracts against ESBL-producing Klebsiella pneumoniae strains. Avicenna journal \nof phytomedicine. 2016 May;6(3):336.\n18. Ranjbar R, Yadollahi Farsani F, Safarpoor Dehkordi F. Antimicrobial \nresistance and genotyping of vacA, cagA, and iceA alleles of the \nHelicobacter pylori strains isolated from traditional dairy products. Journal \nof Food Safety. 2019 Apr;39(2):e12594.\n19. Dehkordi FS, Momtaz H, Doosti A. Application of Real-Time PCR for \ndetection of Aspergillus species in aborted ruminant foetuses. Bulg. J. \nVet. Med. 2012 Mar 1;15(1):30-6.\n20. Dehkordi FS. Prevalence study of Coxiella burnetii in aborted ovine \nand caprine fetuses by evaluation of nested and real-time PCR assays. \nAmerican Journal of Animal and Veterinary Sciences. 2011.\n21. Nejat S, Momtaz H, Yadegari M, Nejat S, Safarpour Dehkordi F, \nKhamesipour F. Seasonal, geographical, age and breed distributions \nof equine viral arteritis in Iran. Kafkas Univ Vet Fak Derg. 2015 Jan \n1;21(1):111-6.\n22. Dehkordi FS, Saberian S, Momtaz H. Detection and segregation \nof Brucella abortus and Brucella melitensis in Aborted Bovine, Ovine, \nCaprine, Buffaloes and Camelid Fetuses by application of conventional \nand real-time polymerase chain reaction. The Thai Journal of Veterinary \nMedicine. 2012 Mar 1;42(1):13.\n23. Sheikhshahrokh A, Ranjbar R, Saeidi E, Dehkordi FS, Heiat M, \nGhasemi-Dehkordi P , et al. Frontier therapeutics and vaccine strategies \nfor sars-cov-2 (COVID-19): A review. Iranian Journal of Public Health. \n2020 Jul 11.\n24. Dehkordi FS, Khamesipour F, Momeni M. Brucella abortus and \nBrucella melitensis in Iranian bovine and buffalo semen samples: The \nfirst clinical trial on seasonal, Senile and geographical distribution using \nculture, conventional and real-time polymerase chain reaction assays. \nKafkas Univ Vet Fak Dergisi. 2014;20(6):821-.\n25. Dehkordi FS. Prevalence study of Bovine viral diarrhea virus by \nevaluation of antigen capture ELISA and RT-PCR assay in Bovine, Ovine, \nCaprine, Buffalo and Camel aborted fetuses in Iran. AMB express. 2011 \nDec;1(1):1-6.\n26. Dehkordi FS, Haghighi N, Momtaz H, Rafsanjani MS, Momeni M. \nConventional vs real-time PCR for detection of bovine herpes virus type \n1 in aborted bovine, buffalo and camel foetuses. Bulgarian Journal of \nVeterinary Medicine. 2013 Jun 1;16(2).\n27. Dehkordi FS, Valizadeh Y, Birgani TA, Dehkordi KG. Prevalence study \nof Brucella melitensis and Brucella abortus in cow\u2019s milk using dot enzyme \nlinked immuno sorbent assay and duplex polymerase chain reaction. J \nPure Appl Microbiol. 2014;8(2):1065-9.\n28. Abdolmaleki Z, Mashak Z, Safarpoor Dehkordi F. Molecular and \nvirulence characteristics of methicillin-resistant Staphylococcus aureus \nbacteria recovered from hospital cockroaches. Jundishapur Journal of \nMicrobiology. 2019 Dec 31;12(12).\n29. Mashak Z, Jafariaskari S, Alavi I, Shahreza MS, Dehkordi FS. \nPhenotypic and genotypic assessment of antibiotic resistance and \ngenotyping of vacA, cagA, iceA, oipA, cagE, and babA2 alleles of \nHelicobacter pylori bacteria isolated from raw meat. Infection and drug \nresistance. 2020;13:257.\n30. Dehkordi FS, Haghighi Borujeni MR, Rahimi E, Abdizadeh R. Detection \nof Toxoplasma gondii in raw caprine, ovine, buffalo, bovine, and camel \nmilk using cell cultivation, cat bioassay, capture ELISA, and PCR methods \nin Iran. Foodborne Pathogens and Disease. 2013 Feb 1;10(2):120-5.63\n2022/37 (3): 58-63Study the antimicrobial effects of Zataria multiflora-based mouthwash on the microbial community of dental plaques isolated from children \n31. Dehkordi FS, Gandomi H, Basti AA, Misaghi A, Rahimi E. Phenotypic \nand genotypic characterization of antibiotic resistance of methicillin-\nresistant Staphylococcus aureus isolated from hospital food. Antimicrobial \nResistance & Infection Control. 2017 Dec;6(1):1-1.\n32. Dehkordi FS, Yazdani F, Mozafari J, Valizadeh Y. Virulence factors, \nserogroups and antimicrobial resistance properties of Escherichia \ncoli strains in fermented dairy products. BMC research notes. 2014 \nDec;7(1):1-8.\n33. Dehkordi FS, Parsaei P , Saberian S, Moshkelani S, Hajshafiei P , \nHoseini SR, et al. prevalence study of Theileria annulata by comparison \nof four diagnostic techniques in southwest Iran. Bulgarian Journal of \nVeterinary Medicine. 2012 Jun 1;15(2). \n34. Dehkordi FS, Barati S, Momtaz H, Ahari SN, Dehkordi SN. \nComparison of shedding, and antibiotic resistance properties of Listeria \nmonocytogenes isolated from milk, feces, urine, and vaginal secretion of \nbovine, ovine, caprine, buffalo, and camel species in Iran. Jundishapur \nJournal of Microbiology. 2013 May 1;6(3):284.\n35. Dehkordi FS, Valizadeh Y, Birgani TA, Dehkordi KG. Prevalence study \nof Brucella melitensis and Brucella abortus in cow\u2019s milk using dot enzyme \nlinked immuno sorbent assay and duplex polymerase chain reaction. J \nPure Appl Microbiol. 2014;8(2):1065-9.\n36. Dehkordi FS, Rafsanjani MS. Prevalence study of Coxiella burnetii in \naborted fetuses of small ruminants in various partum and seasons in Iran. \nAfrican Journal of Microbiology Research. 2012 Jul 19;6(27):5594-600.\n37. Dehkordi FS, Tavakoli-Far B, Jafariaskari S, Momtaz H, Esmaeilzadeh \nS, Ranjbar R, et al. Uropathogenic Escherichia coli in the high vaginal swab \nsamples of fertile and infertile women: virulence factors, O-serogroups, \nand phenotyping and genotyping characterization of antibiotic resistance. \nNew Microbes and New Infections. 2020 Nov 1;38:100824.\n38. Safarpordehkordi F, Yahaghi E, Khodaverdi Darian E. Prevalence of \nantibiotic resistance in Escherichia coli isolated from poultry meat supply in \nIsfahan. Iranian Journal of Medical Microbiology. 2014 Aug 10;8(2):41-7.39. Dehkordi FS, Tirgir F, Valizadeh Y. Effects of Guajol\u00ae ointment \nsynthesized from medicinal smoke condensate of jennet feces on burn \nwound healing on Wistar rat. InVeterinary Research Forum 2017 (Vol. 8, \nNo. 3, p. 215). Faculty of Veterinary Medicine, Urmia University, Urmia, Iran .\n40. Srivastava A, Saha S, Sahu C. Early and accurate detection of \nbacterial isolates from dental plaque in subjects with primary, mixed, \nand permanent dentition by matrix-assisted laser desorption/ionization \ntime-of-flight mass spectrometry technique. Journal of Indian Society of \nPeriodontology. 2020 Mar;24(2):104.\n41. Gafan GP , Lucas VS, Roberts GJ, Petrie A, Wilson M, Spratt DA. \nPrevalence of periodontal pathogens in dental plaque of children. Journal \nof Clinical Microbiology. 2004 Sep;42(9):4141-6.\n42. Lee E, Park S, Um S, Kim S, Lee J, Jang J, et al. Microbiome of Saliva \nand Plaque in Children According to Age and Dental Caries Experience. \nDiagnostics. 2021 Aug;11(8):1324.\n43. Souto R, Andrade AF, Uzeda M, Colombo AP . Prevalence of\u201d non-\noral\u201d pathogenic bacteria in subgingival biofilm of subjects with chronic \nperiodontitis. Brazilian Journal of Microbiology. 2006;37:208-15. \n44. Aghili H, Nadoushan AA, Herandi V. Antimicrobial effect of zataria \nmultiflora extract in comparison with chlorhexidine mouthwash on \nexperimentally contaminated orthodontic elastomeric ligatures. Journal of \ndentistry (Tehran, Iran). 2015 Jan;12(1):1.\n45. Milho C, Silva J, Guimar\u00e3es R, Ferreira IC, Barros L, Alves MJ. \nAntimicrobials from Medicinal Plants: An Emergent Strategy to Control \nOral Biofilms. Applied Sciences. 2021 Jan;11(9):4020.\n46. Tusi SK, Jafari A, Marashi SM, Niknam SF, Farid M, Ansari M. The \neffect of antimicrobial activity of Teucrium Polium on Oral Streptococcus \nMutans: a randomized cross-over clinical trial study. BMC Oral Health. \n2020 Dec;20(1):1-8.\n47. Pedrazzi V, Leite MF, Tavares RC, Sato S, do Nascimento GC, Issa \nJP . Herbal mouthwash containing extracts of Baccharis dracunculifolia \nas agent for the control of biofilm: clinical evaluation in humans. The \nScientific World Journal. 2015 Jan 1;2015.64\n2022/37 (3): 64-69Received:  7 - II - 2022\nAccepted:  27 - II - 2022\ndoi: 10.3306/AJHS.2022.37.03.64Corresponding author:\nBasaad Salem Mahmood  \nE-mail: Basaad.salem1102a@conursing.uobaghdad.edu.iq  \nAbstract  \nObjective: Evaluate the nurses\u2019 Practices about the preventive measures of transmission of COVID-19.And determining the \neffectiveness of an Interventional Program on nurses\u2019 Practices about the preventive measures of transmission of COVID-19.\nMethodology:  A quasi-experiment study design (Tow group: pre-test, post-test) was used. This study was conducted in Baghdad \nTeaching Hospital for the period from (28th February 2020 to 1th march,2022) on a non-probability (purposive) sample consisting \nof 60 nurses (30 control group and 30 study group).A questionnaire consisted of two parts: First part: Demographic characteristics \nof the nursing staff and Second part:observational checklist sheet related to the nurses\u2019 practice about the Preventive Measures of \nTransmission of COVID-19. Descriptive and inferential statistics were used to analyze the results of the study using the Statistical \nPackage of Social Sciences (SPSS) version 25 and Microsoft Excel (2010).\nResult: The results show that both groups have low level of Practice(Percentile Grand Mean of Score [PGMS] 19.3 in study \ngroup and 18.84 in control group in pre-test) about the Preventive Measures of Transmission of COVID-19 .After application the \ninterventional program study group responses increase to become PGMS 90.28 in post-test, while the control group responses \nwere PGMS 21.25 in post-test, and that indicate to successful the Interventional program.\nConclusion: The interventional Program has successful effect on study group and improve their Practices about the Preventive \nMeasures of Transmission of COVID-19.\nKey words : COVID-19, interventional program, nurses\u2019 practices.\nResumen\nObjetivo: Evaluar las Pr\u00e1cticas de enfermer\u00eda sobre las medidas preventivas de transmisi\u00f3n de COVID-19. Y determinar la \nefectividad de un Programa de Intervenci\u00f3n sobre las Pr\u00e1cticas de enfermer\u00eda sobre las medidas preventivas de transmisi\u00f3n de \nCOVID-19.\nMetodolog\u00eda: Se utiliz\u00f3 un dise\u00f1o de estudio cuasi-experimental (Grupo remolque: pre-test, post-test). Este estudio se llev\u00f3 \na cabo en el Hospital Universitario de Bagdad durante el per\u00edodo comprendido entre el 28 de febrero de 2020 y el 1 de marzo \nde 2022, en una muestra no probabil\u00edstica (intencional) compuesta por 60 enfermeras (30 del grupo de control y 30 del grupo \nde estudio). Un cuestionario constaba de dos partes : Primera parte: Caracter\u00edsticas demogr\u00e1ficas del personal de enfermer\u00eda \ny Segunda parte: Ficha de cotejo observacional relacionada con la pr\u00e1ctica de los enfermeros sobre las Medidas Preventivas \nde Transmisi\u00f3n del COVID-19. Se utiliz\u00f3 estad\u00edstica descriptiva e inferencial para analizar los resultados del estudio utilizando el \nPaquete Estad\u00edstico de Ciencias Sociales (SPSS) versi\u00f3n 25 y Microsoft Excel (2010).\nResultado: Los resultados muestran que ambos grupos tienen bajo nivel de Pr\u00e1ctica (Percentil Gran Media de Puntaje [PGMS] \n19.3 en grupo estudio y 18.84 en grupo control en pretest) sobre las Medidas Preventivas de Transmisi\u00f3n de COVID-19. Luego \nde la aplicaci\u00f3n el las respuestas del grupo de estudio del programa de intervenci\u00f3n aumentan para convertirse en PGMS 90,28 \nen la prueba posterior, mientras que las respuestas del grupo de control fueron PGMS 21,25 en la prueba posterior, y eso indica \nque el programa de intervenci\u00f3n tuvo \u00e9xito.\nConclusi\u00f3n:  El Programa de intervenci\u00f3n tiene efecto exitoso en el grupo de estudio y mejora sus Pr\u00e1cticas sobre las Medidas \nPreventivas de Transmisi\u00f3n de COVID-19.\nPalabras clave: COVID-19, programa intervencionista, pr\u00e1cticas de enfermer\u00eda.ORIGINAL\nEffectiveness of an Interventional program on nurses\u2019 practices \nabout the preventive measures of transmission of COVID-19 \nin Baghdad Teaching Hospital   \nEficacia de un programa de intervenci\u00f3n sobre pr\u00e1cticas de enfermer\u00eda sobre las \nmedidas preventivas de transmisi\u00f3n de COVID-19 en el Hospital Docente de Bagdad \nBasaad Salem Mahmood, Sabah Abbas Ahmed, PhD\n1. Master\u2019s in Nursing / higher health institute, Diyala Health Department, Ministry of Health eISSN 2255-056965\n2022/37 (3): 64-69Effectiveness of an interventional program on nurses\u2019 practices about the preventive measures of transmission of COVID-19 in Baghdad Teaching Hospital\nIntroduction  \nAccording to the World Health Organization (WHO), \ninfectious diseases are globally the third leading cause \nof death. The situation of emerging epidemics around \nthe world poses a great danger to individuals and \nsocieties. The current and most important pandemic in \nrecent times is the COVID-19 pandemic1.\nOn 2020 April 18, COVID-19 has spread to 198 \ncountries, infecting 2.4 million people and causing \n150,000 deaths across the global, therefore considered \na global pandemic. WHO explains condition of pandemic \nas two criteria were met: Outbreak was affecting more \nthan one area, and cases in each country were beginning \nto develop by community conduction2.\nNursing is an essential component of medical care, and \nnurses\u2019 knowledge and practice about disease directly \naffects patient outcomes. Similarly, during an outbreak,  \ngood nurses\u2019 practice play positive roles in improving the \nrecovery rate, reducing the length of the hospital stay \nand mortality, and preventing in-hospital infection and \noccupational exposure3.\nTo date, most studies focus on the KAP of the general \npublic, and few have investigated the KAP of nurses. \nTo further understand the current status of the KAP of \nnurses towards the prevention and control of COVID-19 \nduring the outbreak, we conducted a cross-sectional \nsurvey of some hospital nurses4.\nHealth care workers (HCWs) are the primary health-care \nproviders in contact with patients and are an important \nsource of exposure to infected cases in health-care \nsettings; thus, HCWs are expected to be at high risk of \ninfection5. \nThe background show the dangerous of COVID19 and \nimportant the of nurses\u2019 Practices about the Preventive \nMeasures of Transmission of COVID-19 so we decided \nstudy the effectiveness of an Interventional Program  \nto determine the importance of program, so positive \neffect of program will encourage health institutions and \nhospitals to establish interventional programs to enhance \nthe practices and thus achieve better goals for patient \nand decrease spread of COVID-19 .\nMethodology\nThe study was designed as a quasi-experiment design \nnon - probability purposive sample using a test-re-\ntest approach. Participants employed were 60 nurses \nworked at Baghdad Teaching Hospital divided into two \ngroups (30 nurses in the control group and another 30 in \nthe study group), and being, tested in two periods pre-\ntest, post-test, the study begin from (28th February 2020 to 1th march,2022) A questionnaire was built as a data \ncollection tool and consisted of two parts: \nPart I: Demographic status includes the general information \nof the nurses (Gender, Age Groups, Educational level, \nCurrent workplace, Years of service in the nursing field, \nand Participation in courses related to corona virus)\nPart II: Observational  checklist sheet related to the nurses\u2019 \npractice about the Preventive Measures of Transmission \nof COVID-19 consist of three domains:\nFirst domain: Identify the patient and preparing the materials, \nsecond domain: practices related to personal protective \nequipment, and third domain: preventive practices to \navoid transmission of the virus. The questionnaire aim \nfor study purposes and involves relevant topics to the \nstudy subject and the interventional program. The validity \nof the questionnaire and the interventional program were \nverified by presenting it to (15) experts. Descriptive and \ninferential statistics were used to analyze the results \nof the study using the Statistical Package of Social \nSciences (SPSS) version 25 and Microsoft Excel (2010) \ntest the participants\u2019 knowledge. The questionnaire aim \nfor study purposes and involves relevant topics to the \nstudy subject and the interventional program. The validity \nof the questionnaire and the interventional program were \nverified by presenting it to (15) experts. Descriptive and \ninferential statistics were used to analyze the results of the \nstudy using the Statistical Package of Social Sciences \n(SPSS) version 25 and Microsoft Excel (2010). \nThe participants were fully acquainted with the current \nstudy and its aims and then voluntary verbal consent \nwas obtained in order to participate in the study. ethical \napproval was obtained from the ethical committee of \nresearch in the Faculty of Nursing/University of Baghdad \nregarding confidentiality and anonymity of participants.\nResults\nTable I  reveals that the high percentage 20 (66.7%) of \nnurses in study group and [22 (73.3%)] in control group \nwere females and the high percentage [16 (53. 3%), \n14 (46.7%)] of nurses in both study and control groups \nrespectively were within the age group (20-less than 30 \nyears). \nConcerning the educational level, most nurses were \nNursing Diploma graduate [15 (50%) in study group and \n12 (40%)] in control group. Related to Current work place, \n6 (20%) of nurses in the study group were working in \nEmergency unit and Hemodialysis units, while 5 (16.8%) \nof nurses in control group were working in Emergency \nunit. As to the number of years in current work place, the \nmajority of both groups are nurses who have (> 5 years) \nof experience in current work place [13 (43, 3 %) and 11 66\n2022/37 (3): 64-69Basaad Salem Mahmood et al.  \n(36.7%)] in the study group. Regarding to participation in \ntraining sessions about corona virus, most [28 (93.3%) \nin study group and 27(90%)] in control groups] of the \nnurses have taken these sessions.\nAs for self-education the majority of nurses [27(90%) in \nstudy group and 28 (93.3%)] in control groups] were \nself-educated. Respect to subjects of studied (SDCv.), \nresults shows that studied groups recorded no significant differences at P>0.05, and that is reflecting validity of the \nselected subjects due to their similarity status in light of \nthat variables, as well as preceding results indicating that \ntwo studied groups are thrown from the same population \nin light of (SDCv.), and that are more reliable for this \nstudy, since any meaningful deviation between the \nstudied meaningful deviation between studied groups \nshould be interpretation by effectiveness of applying the \nsuggested program. \nThe results of table(2-1),(2-2),(2-3)shows that no significant \ndifferences at P>0.05 are accounted in controlled group \nalong pre to post periods, while study group subjects \nhas assigned a highly significant differences at P<0.01 \ncompared along pre to post periods for studied \u201cNurse\u2019s \nPractices about COVID-19\u201d completely with whom were \nparticipated with the proposed program. For summarizes of preceding results it could be conclude \nthat the proposed of an instructional program in charge \nof \u201cNurse\u2019s Practices about COVID-19\u201d has recorded \na positively and a meaningful effects on whom were \nparticipated with the proposed program completely.Part 2: Descriptive Statistics of the studied groups according to (Nurse\u2019s Practices about COVID-19) \nalong Pre to Post periods with comparisons significantTable I : Distribution of the studied groups according to (SDCv.).\nSDCv. Classes Study Control\n  No % No %\nGender  Male 10 33.3 8 26.7\n Female 20 66.7 22 73.3\nAge Groups  20 - less than 30 16 53.3 14 46.7\nYrs. 30 -less than 40 9 30.0 7 23.3\n 40 - 49 5 16.7 9 30.0\nEducational level  Nursing high school graduate 8 26.7 11 36.7\n Nursing Diploma graduate 15 50.0 12 40.0\n Nursing graduate 7 23.3 7 23.3\nCurrent workplace  Emergency  unit 6 20 6 20\n Intensive care units  4 13.3 4 13.3\n Surgical units  3 10 3 10\n Medical units  4 13.3 4 13.3\n Hemodialysis  unit 6 20 5 16.8\n Respiratory units  5 16.8 4 13.3\n Cardiac care unit(CCU) 2 6.6 4 13.3\nYears of service in the nursing field  < 5 13 43,3 11 36,7\n 5 - less than 10 8 26,6 7 23,3\n 10 - less than 20   5 16.8 6 20\n > 20 4 13.3 6 20\nParticipation in courses related to corona virus of:  No 2 6.7 3 10\n Yes 28 93.3 27 90\nDo you educate yourself with specialized knowledge  No 3 10 2 6.70\nin your field of work in a self-reliant manner?  Yes 27 90 28 93.3\nTable II-1 : Domain one: Identify the patient and preparing the materials.\nDomain one: Identify the patient Period No. Study Control\nand preparing the materials   MS SD RS% C.S. P-value MS SD RS% C.S. P-value\n1.Get to know the right patient Pre 30 0.13 0.35 6.5 0.000 0.067 0.25 3.335 1.000\n Post 30 1.53 0.68 76.5 HS 0.067 0.25 3.335 NS\n2. Explain the procedure to the patient Pre 30 0.13 0.35 6.5 0.000 0.17 0.38 8.50 1.000\nand what will be done  Post 30 1.57 0.57 78.5 HS 0.17 0.38 8.50 NS\n3. Prepare tools on a special cart Pre 30 0.33 0.48 16.5 0.000 0.43 0.57 21.5 1.000\nin a sterile way before performing  Post 30 1.70 0.53 85 HS 0.43 0.57 21.5 NS\nany nursing intervention  \n4. Before touching the mask,    Pre 30 0.67 0.71 33.5 0.000 0.73 0.69 36.5 0.317\nclean your hands by rubbing them Post 30 1.93 0.25 96.5  HS 0.77 0.73 38.5 NS\nwith an alcohol-based disinfectant \nand by washing them with soap and water67\n2022/37 (3): 64-69Effectiveness of an interventional program on nurses\u2019 practices about the preventive measures of transmission of COVID-19 in Baghdad Teaching Hospital\nTable II-2 : Domain Two: Practices related to personal protective equipment.\nDomain Two : Practices related  Period No. Study Control\nto personal protective equipment   MS SD RS% C.S. P-value MS SD RS% C.S. P-value\n1. Wear a face shield Pre 30 0.13 0.35 6.5 0.000 0.20 0.41 10 1.000\n Post 30 1.60 0.56 80 HS 0.20 0.41 10 NS\n2. Wear clean gloves Pre 30 0.47 0.63 23.5 0.000 0.40 0.67 20 0.317\n Post 30 1.90 0.31 95 HS 0.43 0.68 21.5 NS\n3. Wear a N95 mask Pre 30 0.20 0.41 10 0.000 0.23 0.5 11.5 0.317\n Post 30 1.93 0.25 96.5 HS 0.27 0.52 13.5 NS\n4. Wear a medical gown-gown Pre 30 0.27 0.45 13.5 0.000 0.33 0.48 16.5 0.317\n Post 30 1.93 0.25 96.5 HS 0.37 0.49 18.5 NS\n5. Wear eye protection-glasses Pre 30 0.37 0.56 18.5 0.000 0.37 0.56 18.5 0.317\n Post 30 1.97 0.18 98.5 HS 0.4 0.56 20 NS\n6. Wear a hair cover Pre 30 0.33 0.55 16.5 0.000 0.43 0.68 21.5 0.317\n Post 30 1.93 0.25 96.5 HS 0.47 0.68 23.5 NS\n7. Always remove protective Pre 30 0.43 0.63 21.5 0.000 0.33 0.48 16.5 1.000\nequipment carefully Post 30 1.93 0.25 96.5 HS 0.33 0.48 16.5 NS\n8. Wash hands with soap and water Pre 30 0.80 0.76 40 0.000H 0.57 0.68 28.5 0.317\nor use an alcohol-based hand rub Post 30 1.97 0.18 98.5 S 0.6 0.67 30 NS\n9. Wash the back and palms of the hands Pre 30 0.63 0.72 31.5 0.000 0.63 0.81 31.5 0.317\n Post 30 1.87 0.43 93.5 HS 0.7 0.84 35 NS\n10. Wash between fingers and nails Pre 30 0.67 0.76 33.5 0.000 0.7 0.75 35 0.157\n Post 30 1.90 0.31 95 HS 0.77 0.73 38.5 NS\n11. Rinse hands together with clean water Pre 30 0.77 0.68 38.5 0.000 0.8 0.81 40 0.317\n Post 30 1.93 0.25 96.5 HS 0.87 0.82 43.5 NS\nTable II-3 : Domain three: preventive practices to avoid transmission of the virus.\nDomain three : preventive practices   Period No. Study Control\nto avoid transmission of the virus    MS SD RS% C.S. P-value MS SD RS% C.S. P-value\n1. Shake hands well and dry them Pre 30 0.63 0.76 31.5 0.000 0.6 0.67 30 0.317\n Post 30 1.93 0.25 96.5 HS 0.63 0.67 31.5 NS\n2. Clean the hands before and after Pre 30 0.57 0.73 28.5 0.000 0.47 0.68 23.5 0.317\ntouching the patient\u2019s surroundings Post 30 1.83 0.46 91.5 HS 0.5 0.68 25 NS\n3. Cleaning the income of the personal Pre 30 0.70 0.79 35 0.000 0.57 0.68 28.5 0.180\nprotective equipment Post 30 1.90 0.40 95 HS 0.67 0.71 33.5 NS\n4. Avoid touching the eyes, nose and Pre 30 0.70 0.79 35 0.000 0.63 0.81 31.5 0.317\nmouth with gloves or potentially  Post 30 1.93 0.25 96.5 HS 0.67 0.8 33.5 NS\ncontaminated hands  \n5. Avoid shaking hands with the patient Pre 30 0.70 0.75 35 0.000 0.57 0.68 28.5 1.000\n Post 30 1.93 0.25 96.5 HS 0.57 0.68 28.5 NS\n6. Routinely cleans and disinfects Pre 30 0.57 0.68 28.5 0.000 0.53 0.73 26.5 1.000\nenvironmental surfaces Post 30 1.83 0.38 91.5 HS 0.53 0.73 26.5 NS\n7. Put the suspect patient in a single room,  Pre 30 0.70 0.75 35 0.000 0.47 0.63 23.5 1.000\nwell ventilated Post 30 2.00 0.00 100 HS 0.47 0.63 23.5 NS\n8. Covering the mouth when Pre 30 0.43 0.63 21.5 0.000 0.63 0.85 31.5 0.317\ncoughing or sneezing Post 30 1.90 0.40 95 HS 0.67 0.84 33.5 NS\n9. Implement the rule of social distancing,  Pre 30 0.50 0.68 25 0.000 0.5 0.68 25 1.000\nmaintaining a distance of at least one meter Post 30 1.87 0.43 93.5 HS 0.5 0.68 25 NS\nfrom patients and other caregivers \n10. Sterilizes and disinfects tools Pre 30 0.50 0.68 25 0.000 0.53 0.73 26.5 0.317\nfor measuring vital signs (stethoscope Post 30 1.97 0.18 98.5 HS 0.6 0.77 30 NS\nand medical thermometer) between \none patient and another \n11. Change gloves from one patient Pre 30 0.47 0.68 23.5 0.000 0.53 0.73 26.5 0.317\nto another Post 30 1.97 0.18 98.5 HS 0.57 0.73 28.5 NS\n12. Performs respiratory hygiene measures Pre 30 0.47 0.63 23.5 0.000 0.5 0.57 25 1.000\nwith persons with respiratory symptoms Post 30 2.00 0.00 100 HS 0.5 0.57 25 NS\n (*)  HS: Highly Sig. at P<0.01; S: Sig. at P<0.05; NS: Non Sig. at P>0.05. C X S: Testing coincidence between Control and Study groups. Testing based \non : Wilcoxon Signed Ranks Test68\n2022/37 (3): 64-69Basaad Salem Mahmood et al.  \nDiscussion\nPart 1: Discussion of Socio-Demographic \nCharacteristics of Nurses (Table I ).\n1. Gender:  The high percentage 20 (66.7%) of nurses \nin study group and [22 (73.3%)] in control group were \nfemales.  This result agrees with is a cross-sectional study \nin northern Ethiopia show that 58.1% of the participants \nwho are female6\n2. Age:  The high percentage [16 (53. 3%), 14 (46.7%)] \nof nurses in both study and control groups respectively \nwere within the age group (20-less than 30 years). This \nresult agree with study done in Egypt7 which shows that \nthe high percentage of nurses ranged (48%) in age from \n(20-29) years7\n3. Educational level:  the most nurses were Nursing \nDiploma graduate [15 (50%) in study group and 12 \n(40%)] in control group. This result agree with study done   \nin Bokhara, Nepal that found that the high percentage \n(43.5%) of nurses were diploma8.  \n4. Current workplace:  in the study group, 6 (20%) of \nnurses in the study group were working in Emergency \nunit and Hemodialysis units, while 6 (20%) of nurses in \ncontrol group were working in Emergency unit. This study \nDisagree with a study conducted in Egypt which shows \nthat the high percentage of nurses (23.5%) were working \nat CUU9.\n5. Years of services in the nursing field:  the majority \nof both groups are nurses who have < 5 of experience \nin current work place [13 (43,3 %) and 11( 36.7%)] in the \nstudy group. This result agrees with the study by (saqlain, \net al.,2020) in Pakistan that found the high percentage \nof nurses who have (>5 years) of experience. And agree \nwith the study done in Ho Chi Minh City that found the \nmajority of (62.9%) of health care workers were less than \n5 years10.\n6. Participation in courses related to corona virus:  \nthe most of the nurses [28 (93.3%) in study group and \n27(90%)] in control groups] have taken these sessions, \nand this result disagree with a study conducted in Egypt \nwhich shows that the high percentage of nurses didn\u2019t \nparticipation in training program10.\n7. Do you educate yourself with specialized \nknowledge in your field of work in a self-reliant \nmanner:  The result show that the most of the nurses in \nboth study and control groups educate themselves with \nspecialized knowledge and identify the resources from  \nInternet and social networking sites. This result agree with \nstudy done in Bokhara, Nepal that found that the high \npercentage of nurses educate themselves and identify \nthe resources from Internet and social networking sites8.Part IV- Discussion of Nurse\u2019s practice about \nCOVID- (Table II-1,2,3 )\nResults shows that no significant differences at P>0.05 \nare accounted in controlled group along pre to post \nperiods, while study group subjects has assigned \nhighly significant differences at P<0.01 compared \nalong pre to post periods for studying \u201cNurse\u2019s practice \nabout COVID-19\u201d for whom had participated with the \nsuggested program.\nThis result consist with study done by in Egypt that show  \nthe total score for nurses\u2019 practices level in pre-test and \npost-test showed statistically significant differences \nbetween nurses\u2019 practices categories indicating \nadequate practice after the educational program \ncompared with practice before the educational program. \nThe researcher suggest that it could be conclude that \nproposed instructional program in charge of \u201cNurse\u2019s \npractice about COVID-19\u201d are recorded a positive and a \nmeaningful effectiveness perfectly11.\nConclusion \n \nAccording to the findings of the present study, the \nresearcher concluded that despite the relatively limited \nnumber of nurses who participated in this study, the \neducational Program was effective on study group and \nimprove their Practices about the Preventive Measures of \nTransmission of COVID-19, this program can be applied \non larger sample of nurses  across Iraq.\nAcknowledgement\nWe are very grateful for the sincere cooperation of \nuniversity of Baghdad college of nursing\nConflict of interest\nAuthors do not have any conflict of interest to declare.69\n2022/37 (3): 64-69Effectiveness of an interventional program on nurses\u2019 practices about the preventive measures of transmission of COVID-19 in Baghdad Teaching Hospital\nReferences\n1. Taghaddom SM, Alrashidi HM, Mohamed HD, Johnson MN. The \nimpact of coronavirus on staff nurses\u2019 feeling while giving direct care to \nCOVID-19 patients in various COVID facilities. Open Journal of Nursing. \n2020 Sep 22;10(09):873.\n2. G\u00f3mez-Salgado J, Dom\u00ednguez-Salas S, Romero-Mart\u00edn M, Ortega-\nMoreno M, Garc\u00eda-Iglesias JJ, Ruiz-Frutos C. Sense of coherence and \npsychological distress among healthcare workers during the COVID-19 \npandemic in Spain. Sustainability. 2020 Jan;12(17):6855.\n3. Bhagavathula AS, Aldhaleei WA, Rahmani J, Mahabadi MA, Bandari \nDK. Knowledge and perceptions of COVID-19 among health care \nworkers: cross-sectional study. JMIR public health and surveillance. 2020 \nApr 30;6(2):e19160.\n4. Chen N, Zhou M, Dong X, Qu J, Gong F, Han Y, Qiu Y, Wang J, Liu \nY, Wei Y, Yu T. Epidemiological and clinical characteristics of 99 cases of \n2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. \nThe lancet. 2020 Feb 15;395(10223):507-13.\n5. Zhong BL, Luo W, Li HM, Zhang QQ, Liu XG, Li WT, Li Y. Knowledge, \nattitudes, and practices towards COVID-19 among Chinese residents \nduring the rapid rise period of the COVID-19 outbreak: a quick online \ncross-sectional survey. International journal of biological sciences. \n2020;16(10):1745.6. Kim K, Lee O. Knowledge, attitudes and perceptions of nurses on \npersonal protective equipment: Response to the Middle East Respiratory \nSyndrome Coronavirus. Journal of Korean Academy of Fundamentals of \nNursing. 2016;23(4):402-10.\n7. Kim E, Kim SS, Kim S. Effects of infection control education for nursing \nstudents using standardized patients vs. peer role-play. International \nJournal of Environmental Research and Public Health. 2021 Jan;18(1):107.\n8. Kafle A, Pahari SP , Khanal S, Baral K, Pathak K, Baral S, Kafle A, Dahal \nM. Knowledge regarding COVID-19 among Registered Nurses of Pokhara, \nNepal. Europasian Journal of Medical Sciences. 2020 Jul 19;2(2):6-12.\n9. Abou Ramadan AH, Eid WM. Effect of Educational Program about \nNurse Managers\u2019 Performance Appraisal during COVID19 on Staff \nNurses, Satisfaction and Motivation.\n10. Huynh G, Nguyen TN, Vo KN, Pham LA. Knowledge and attitude \ntoward COVID-19 among healthcare workers at District 2 Hospital, Ho \nChi Minh City. Asian Pacific Journal of Tropical Medicine. 2020 Jun \n1;13(6):260.\n11. Anwar Abd ElAziz M, Eldien Abd Elhafez NG, Youssef Sayed S. Effect \nof Nursing Educational Program on Nurses\u2019 Knowledge and Practices \nregarding Pandemic Covid-19 in Isolation Unit. Egyptian Journal of Health \nCare. 2021 Dec 1;12(4):248-63.70\n2022/37 (3): 70-75Received:  23 - II - 2022\nAccepted:  9 - III - 2022\ndoi: 10.3306/AJHS.2022.37.03.70Corresponding author\nSadaf Hojjati  \nE-mail: sadaf.hjtx94@gmail.com\nAbstract  \nObjective:  The goal of the research is to Preparation and implement a hospital formulary in the obstetrics and gynecology department. \nTo provide updated information about the use of medicines to physicians, pharmacists, and other health care professionals in the \nhospital for appropriate use of the drugs in Tertiary Care Teaching Hospital of Southwest India.\nMethodology:  Prospective study is conducted for 6 months in the department of obstetrics and gynecology of CSI Holds worth \nMemorial (Mission) Hospital Mysore, Karnataka, India. A survey was conducted using a validated questionnaire for the identification \nof the need and content of obstetrics and gynecology formulary among physicians in the hospital. The obstetrics and gynecology \nformulary was developed and the quality was evaluated using a validated questionnaire form. The content of the formulary was framed \nbased on the opinion of physicians. Finalized drug list was obtained from the P & T committee and monographs were prepared as per \nthe recommendations of the P & T committee. \nResult:  The total number of drugs evaluated was 195. With the help of listed drugs of WHO model formulary and master drug list, some \nmore sources and suggestions from Doctors of OBG department and decision of P and T committee, 61 more drugs were included in \nthe OBG hospital formulary. Out of 61 drugs included in the formulary, 45 (43.26%) were available in the Oral route (Tablets, Capsules, \nSyrups, Suspensions, and other solutions) followed by Parenteral route (IV, IM, SC) 44(42.30%), Topical preparations 10 (9.61%) \nfollowed by rectal, vaginal, nasal and parenteral routes. 11 (18.03%) were Anti-infective medicines (Antibiotics) and 11 (18.03%) were \ndrugs affecting endocrine and hormones followed by Vitamins and Electrolytes 8 (8.19%).22 (36.06%) drugs were under pregnancy and \nlactation category-C, 14 (22.95%) dugs were under category-B, 10 (16.39%) drugs were under category-A. The feedback questionnaire \ncontaining the objective type of questions was distributed to all eight gynecologists and PGs who responded to it thoroughly.\nConclusion:  The formulary was handy, user-friendly, and saves the precious time of busy physicians. It may promote the safe and \neffective use of medicines thereby minimizing drug-related problems in the obstetrics and gynecology department.\nKey words:  Formulary, obstetrics and gynecology, physicians, drug use pattern . \nResumen\nObjetivo:  El objetivo de la investigaci\u00f3n es preparar e implementar un formulario hospitalario en el departamento de obstetricia y ginecolog\u00eda \ny proporcionar informaci\u00f3n actualizada sobre el uso de los medicamentos a los m\u00e9dicos, farmac\u00e9uticos y otros profesionales de la salud del \nhospital para el uso adecuado de ellos en el Hospital Docente de Atenci\u00f3n Terciaria del Suroeste de la India.\nMetodolog\u00eda:  Se realiz\u00f3 un estudio prospectivo durante 6 meses en el departamento de obstetricia y ginecolog\u00eda del CSI Holds \nworth Memorial (Mission) Hospital Mysore, Karnataka, India. Se realiz\u00f3 una encuesta mediante un cuestionario validado para identificar \nla necesidad y el contenido del formulario de obstetricia y ginecolog\u00eda entre los m\u00e9dicos del hospital. Se elabor\u00f3 el formulario de \nobstetricia y ginecolog\u00eda y se evalu\u00f3 su calidad mediante un cuestionario validado. El contenido del formulario se elabor\u00f3 bas\u00e1ndose \nen la opini\u00f3n de los m\u00e9dicos. La lista de medicamentos finalizada se obtuvo del comit\u00e9 de P y T y las monograf\u00edas se prepararon seg\u00fan \nlas recomendaciones del comit\u00e9 de P y T. \nResultado:  El n\u00famero total de medicamentos evaluados fue de 195. Con la ayuda de la lista de medicamentos del modelo de la OMS \ny la lista maestra de medicamentos, algunas fuentes m\u00e1s y sugerencias de los m\u00e9dicos del departamento de obstetrician y la decisi\u00f3n \ndel comit\u00e9 P y T, se incluyeron 61 medicamentos m\u00e1s en el formulario del hospital de obstetricia. De los 61 medicamentos incluidos \nen el vadem\u00e9cum, 45 (43,26%) estaban disponibles por v\u00eda oral (comprimidos, c\u00e1psulas, jarabes, suspensiones y otras soluciones), \nseguidos por la v\u00eda parenteral (IV, IM, SC) 44 (42,30%), preparados t\u00f3picos 10 (9,61%), seguidos por las v\u00edas rectal, vaginal, nasal y \nparenteral. 11 (18,03%) eran medicamentos antiinfecciosos (antibi\u00f3ticos) y 11 (18,03%) eran medicamentos que afectaban al sistema \nendocrino y a las hormonas, seguidos de vitaminas y electrolitos, 8 (8,19%). 22 (36,06%) medicamentos pertenec\u00edan a la categor\u00eda \nC (embarazo y lactancia), 14 (22,95%) a la categor\u00eda B y 10 (16,39%) a la categor\u00eda A. El cuestionario con preguntas objetivas se \ndistribuy\u00f3 a los ocho ginec\u00f3logos y m\u00e9dicos de cabecera, que respondieron de forma exhaustiva.\nConclusi\u00f3n:  El formulario era pr\u00e1ctico, f\u00e1cil de usar y ahorra el valioso tiempo de los ocupados m\u00e9dicos. Puede promover el uso \nseguro y eficaz de los medicamentos, minimizando as\u00ed los problemas relacionados con los mismos en el departamento de obstetricia \ny ginecolog\u00eda.\nPalabras clave: formulario, obstetricia y ginecolog\u00eda, m\u00e9dicos, patr\u00f3n de uso de medicamentos.ORIGINAL\nAllocation and development of hospital formulary for \nobstetrics and gynecology department in a tertiary \ncare teaching hospital of southwest India\nAsignaci\u00f3n y desarrollo del formulario hospitalario para el departamento de obstetricia y \nginecolog\u00eda en un hospital universitario de atenci\u00f3n terciaria del suroeste de la India\nSadaf Hojjati      , Nisar Ahmed      , Pouyan Haghpanah      , Yasaman Jafarniay Jahromi      \nDoctors of Pharmacy, Department of pharmacy practice, Farooqia College of Pharmacy, Mysore, IndiaeISSN 2255-0569\nID ID ID ID71\n2022/37 (3): 70-75Allocation and development of hospital formulary for obstetrics and gynecology department in a tertiary care teaching hospital of southwest India\nIntroduction\nThe hospital formulary is expected to help the physicians \nin choosing appropriate medicines, upgrade the chance of \nrational drug use, and assist the stock control with using the \nspending plan allocated most appropriately. By designing \na formulary, hazardous and inadequate drugs can be \neliminated which can subsequently diminish morbidity \nand mortality. Studies have shown that models help \nhealth care practitioners in executing quality care. Hospital \nmodels originally began life in hospitals as a collection \nof commonly prescribed drug arrangements, delivered \nprimarily for reference purposes. As time continued, the \nhospital formulary was adjusted to the definite data on the \nexpanding number and variety of medicines. It advances \nthe great evidence-based recommending and lessens \nvariety in the degree of treatment given to patients and \ncan be used as an apparatus to rationalize the medicines \nused in standard practice1. \nThe World Health Organization (WHO) release the \nprincipal edition of the WHO model rundown of drugs in \n2002. The core of the Formulary System is the Pharmacy \nand Therapeutics Committee (PTO) Membership will be \nincluded agents of the expert offices/administrations, \npharmacy, house staff, nursing administration, and other \ninvested individuals.PTC reviews the formulary one \nor more times in a year, for the addition and deletion \nof drugs. The study was to prepare a hospital drug \nformulary for the specialty departments in tertiary care \nhospitals. Consequently, the developed formulary will be \nuseful for reducing the brands accessible in the hospital \nwhich helps in rational drug use. Several different issues \nknown to exist in most health care systems are restricted \ndrug financial plans, expanding the number of drug \noptions, irrational prescribing and use of medications, \nrate of perilous and on-useful medications, being shy of \nfair-minded drug information, high costs of medications2.\nThe rationale for formulary advancement is that prescribers \ncome out as comfortable with the pharmacological \nactivities, signs for treatment, secondary effects, \ncooperations and contraindications for a defined range of \ndrugs for normal Formulary systems are used in various \nsettings and associations with strategy articulations on \nthe use of models and formulary systems in hospitals \nand health care systems. Several different issues known \nto exist in most drug systems are restricted drug financial \nplans, expanding the number of therapeutic other options, \nill-advised prescribing and use of medications, presence \nof perilous and non-solid drugs, absence of impartial \ndrug information, high costs of dealing with an enormous \nnumber of drugs, drugs of questionable quality on the \nmarket3. The Formulary system is used in many different \nsettings, and including hospitals, acute care facilities, \nhome care, settings, and long-term\u2013care facilities as well \nas by payers such as Medicaid, insurance companies, \nand managed care organizations4.Consequently, hospital pharmacists evolved to \nimprove physician prescriptions through pharmacy and \ntherapeutics committees, the development of clinical \npharmacy services, and formulary systems5. Pharmacy \nand therapeutics committees are using the medicine \nformulary to facilitate prescribing6. The importance of \nformulary development is that the prescribers have a \ncomplete understanding of the pharmacological actions, \nindication for treatments, adverse effects, possible \ninteractions, and contraindications to be used in the \nspecified group of drugs for common diseases7. Many \norganizations have some policies in case of using the \nformularies. Hospital formulary systems are being \nused in different settings, including, but not limited to, \npayers, such as Medicaid, Medicare, managed care \norganizations, and insurance companies. Furthermore, \nthey are used at in-home care settings, hospital acute \ncare facilities, and hospital long term care facilities8-13.\nTo provide information about the use of medicines. \nConsequently, the focal goals of the formulary are to help \nprescribers in the appropriate drug of the decision to the \nreasonable treatment and to settle on prescribers follow \nthe uniform selection of medicines. The advancement \nof the formulary will significantly affect prescribers and \nhealth care professionals\u2019 for clinical practice to support \nthe quality of life in the patients, by promoting rational \nuse of drugs towards patient care to improve therapeutic \noutcomes ensure efficacy, safety, and quality of the drugs \nto promote rational use, thereby ensuring the availability \nof drugs according to the needs of the population. To \nhelp the transformation of the handbook into electronic \nformat made the drug information available at the fingertip \nof the healthcare professionals.\nMaterials and methods\nThis Prospective study was conducted in Obstetrics \nand Gynaecology the departments of CSI Holdsworth \nMemorial (Mission) Hospital Mysore, Karnataka. \nInpatients\u2019 profile forms/data were collected from the \nOBG department. From the WHO model formulary 2010, \nwe prepared a list of drugs that were being used in the \nOBG department and submitted it to the staff for selecting \nthe drugs to be included in the formulary. Subsequently, a \ndiscussion was held in the P & T committee regarding the \ndesign of the hospital formulary. By soliciting suggestions \nfrom the committee members, contents to be added, \nmonographs, appendices, and the overall design of the \nformulary were specified. Also, the purpose was to design \nthe formulary in a concise, precise, and handy form. \nFurthermore, all the members of the P & T committee \nwere asked to select the drugs and brands to be included \nin the formulary as per the requirements of the health care \nneeds of the local population. Committee members, \nunder the suggestion of OBG doctors, selected the drugs \nand brands coming under the drug classes relevant to the 72\n2022/37 (3): 70-75Sadaf Hojjati et al.  \nOBG department after which a comprehensive finalized \nhospital drug list was prepared. Two questionnaires with \nthe objective type of questions were prepared with the \nhelp of clinical pharmacists and OBG doctors. These \nquestionnaires were designed to gather information like \nindications, precautions, dose, interactions, and adverse \ndrug reactions for them to be included in each drugs \nmonograph. The drugs in the finalized list were classified \nbased upon Pharmacologic-Therapeutic classification \ninto classes or categories. In addition, the monographs for \nthose drugs were prepared as per the recommendation of \nthe P & T committee members with the help of the Master \nDrug List (which contains total brands of drugs available in \nthe hospital with their generic name, quantity, and cost per \nunit) together with some standard drug information from \nsuch sources like, British National Formulary (BNF) 201714, \nWHO Model Formulary 200815, Martindale The Complete \nDrug Reference16, Comprehensive Pharmacy Review17, \nEssentials of Medical Pharmacology18 and CIMS19. As \nsuggested by committee members, information regarding \nindications, mechanisms of action, pharmacological \nclasses, doses, contraindications, precautions, adverse \neffects, pregnancy risk category, and counseling points in \neach monograph of the drugs were all included.\nResult and discussion\nThe total number of drugs evaluated was 195. With the \nhelp of listed drugs of WHO model formulary and master \ndrug list, some more sources and suggestions from \nDoctors of OBG department and decision of the P and \nT committee, 61 more drugs were included in the OBG \nhospital formulary.\nOut of 61 drugs included in the formulary, 45 (43.26%) \nwere available in the Oral route (Tablets, Capsules, Syrups, \nSuspensions, and other solutions) followed by Parenteral \nroute (IV, IM, SC) 44 (42.30%), Topical preparations 10 \n(9.61%) followed by rectal, vaginal, nasal, and parenteral \nroutes as shown in table I .\nOut Of 61 drugs included in the formulary, 11 (18.03%) \nwere Anti-infective medicines (Antibiotics) and 11 \n(18.03%) were drugs affecting endocrine and hormones \nfollowed by Vitamins and Electrolytes 8 (8.19%) as shown \nin table II .\nOut of 61 drugs, 19 (29.23%) drugs were available in \nthree brands, 18 (27.69%) drugs were available in four \nbrands, 13 (20%) drugs were available in five brands, 7 \n(10.76%) drugs were available in single-brand as shown \nin table III .\nOut of 61 drugs, 22 (36.06%) drugs were under \npregnancy and lactation category- C, 14 (22.95%) dugs \nwere under category- B, 10 (16.39%) drugs were under \ncategory- A as shown in table IV .The feedback questionnaire containing the objective type \nof questions was distributed to all eight gynecologists \nand PGs who responded to it thoroughly.Table I: Route of administration of drugs in the prepared Formulary.\nRoutes No. of Drugs (n=61) Percentage (%)\nOral route- (Tablets, Capsules,   45 43.26\nSyrups, Suspensions \nand other solutions)  \nParenteral route (IV, IM, SC)  44 42.3\nInhalations  0 0\nTopical route  10 9.61\nRectal route  3 2.88\nVaginal route  1 0.96\nNasal route  1 0.96\nTable II: Drug use pattern in prepared OBG formulary.\nRoutes No. of Drugs (n=61) Percentage (%)\nAnesthetics   1 1.63\nAnalgesics, antipyretics,  6 9.83\nNSAIDS \nAnticholinergics, 7 11.47\n(Antihistamines,\nAntipruritic, Antispasmodics,\nAntifibrinolytics)\nAntidote, Alkalysing agents 3 4.91\nAnticonvulsants, Antianxiety  2 3.27\nagents (Barbiturates, \nPhenobarbital)\nAnti-infective medicines 11 18.03\n(Antibiotics)\nAnticoagulants 1 1.63\nAlpha/ Beta adrenergic agonist  1 1.63\nAntiarrhythmic 1 1.63\nCalcium channel blockers 1 1.63\nDiuretics 1 1.63\nVasodilators 1 1.63\nDrugs affecting endocrine 11 18.03\nand hormones \nGastrointestinal medicines 5 8.19\nRespiratory system medicines  1 1.63\nVitamins and electrolytes 8 13.11\nTable III: Patterns of brands available for generic drugs in the OBG hospital \npharmacy.\nBrands Number of generic Percentage (%)\n drugs \nSingle brand  7 10.76\nTwo brands  2 3.07\nThree brands  19 29.23\nFour brands  18 27.69\nFive brands  13 20\nSix brands  3 4.61\nSeven brands  1 1.53\nEight brands  1 1.53\nNine brands  0 0\nTen brands  0 0\nEleven brands  1 1.53\nTable IV: Pregnancy categories of drugs in the prepared Formulary.\nPregnancy category No. of drugs(n=61) Percentage (%)\nCategory- A  10 16.39\nCategory- B  14 22.95\nCategory- C 22 36.06\nCategory- D  10 16.39\nCategory- X  5 8.1973\n2022/37 (3): 70-75Allocation and development of hospital formulary for obstetrics and gynecology department in a tertiary care teaching hospital of southwest India\nAs shown in table V , there were 3 Doctors and 5 PGs \nin the OBG department. Comments and answers to the \nfeedback questionnaire distributed to the Head, Doctors, \nand PGs of the OBG the department was as follows. For \nthe first question, 75% of doctors had selected the choice \nAbove average in the form, 12.5% of them had selected \nAverage and 12.5% selected Outstanding, for the second \nquestion 6 (75%) of them had picked Great extend and 2 \n(25%) of them had selected the option Somewhat; for the \nthird question, 5 (62.5%) of them had selected Very useful \nand 3 (37.5%) of them went for the option Useful; for the \nfourth question 4 (50%) of them had selected very Helpful \nand 4 (50%) of them had chosen the option Helpful; \nfor the fifth question 5 (62.5%) of they had selected the \noption Great to extend and 3 (37.5%) had gone for the \noption Somewhat option; for sixth question 1 (12.5%) of \nthem had picked the option always, 5 (62.5%) of them \nhad selected the option Very frequently, 2 (25%) of them \nhad picked the Option Occasionally; for the seventh \nquestion, 2 (25%) of them had gone for Very Useful and 6 \n(75%) of them had picked the option Useful; for the eighth \nquestion, 2 (25%) of them had selected Strongly active, 5 (62.5%) of them had picked Agree and 1 (12.5%) of them \nhad selected neither of the options available; for the ninth \nquestion, 8 (100%) of them had selected the option Yes; \nfor the picked the choice Somewhat satisfied as shown \nin table V .\nA total of 61 drugs were included in the OBG hospital \nformulary based on the opinion of the medical staff of the \nOBG department, clinical pharmacy department, and the \nrequest from the P& T committee as per the requirements \nof health care needs of the local population. Our study \nresult is consistent with the findings of the Tahniyath, F \net al20, and Raj, D et al21. As with both studies, in line \nwith the different standard references, hospital formulary \ndeveloped. To substantiate this further, using a formulary \nsystem leads to rationalization of drug use, hence \nreducing the medication errors in giving unbiased useful \ninformation to medical representatives. On top of it all, it \nis a great inventory control measure that helps to improve \npatient care outcomes.\nAccording to drug use patterns in the OBG department, \nanti-infective medicines (Antibiotics) were the most \ncommonly used drugs in the OBG department. Using \nthese may be due to the susceptibility of pregnant \nwomen to infections. Hence, they are being used to \ntreat common and severe infections before and during \ndelivery, meant to prevent maternal and neonatal \ncomplications. Likewise, they were used as prophylaxis \nbefore any surgical procedure, such as cesarean \nsection or uterine prolapse operations, aimed at treating \ninfections arising from surgical wounds.22 What follows \nis the major group which is drugs affecting endocrine \nand hormones. In addition, it was discovered in the \nOBG hospital formulary that the administration of drugs \nwas mainly through oral route owing to the patient \ncompliance, its non-invasiveness, being easy to handle, \nand the absence of any special sterile settings23. \nMoreover, in the prepared formulary, the distribution of \nbrands available for generic drugs fell mainly under three \nbrands. Also, the availability of more than three brands \nfor a single drug may well be due to marketing strategies, \nPharmaceutical companies, physician preference, \npatient financial condition, Pharmaco-economic factors, \nand pricing which should not be taken for granted when \nit comes to such a variation.\nAccording to the FDA, drugs being used during \npregnancy are categorized into five groups as A, B, C, \nD, and X in which category A drugs are the safest and \ncategory X drugs are contraindicated for the pregnancy \nperiod. Furthermore, it is integral to remember the \nnecessity of the presence of pregnancy categories \nin the OBG department, as some of the patients who \nvisit this department are pregnant. The majority of drugs \nincluded in the formulary were from pregnancy category \nC followed by category B and category A, of which about \n39.34% of drugs were under categories A and B.Table V: Feedback of Doctors on implemented OBG formulary.\nFeedback  No of Doctors No of PGs Total \nquestionnaire/  n= 3 (%) n= 5 (%) n=8 (%)\ncomment    \nThe content in each drug monograph?\nOutstanding 0 1 12.5\nAbove average 2 4 75\nAverage 1 0 12.5\nWhether the order of contents in each monograph is convenient to refer to?\nTo great extend 3 3 75\nSomewhat 0 2 25\nIs it useful to become aware of the brands available \nin the hospital pharmacy?\nVery useful 3 2 62.5\nUseful 0 3 37.5\nWhether this formulary helps reduce the total cost \nof treatment of the patients?\nVery helpful 2 2 50\nHelpful 1 3 50\nWhether this formulary promotes the safe \nand effective use of medicines?\nTo a great extend 2 3 62.5\nSomewhat 1 2 37.5\nThe extent of usage of the formulary\nAlways 1 0 12.5\nVery frequently 2 3 62.5\nOccasionally 0 2 25\nWill it be useful in your clinical practice?\nVery useful 1 1 25\nUseful 2 4 75\nThe presence of a clinical pharmacist is essential in daily practice\nStrongly agree 1 1 25\nAgree 2 3 62.5\nNeither 0 1 12.5\nWhether the formulary is handy?\nYes 3 5 100\nNo 0 0 0\nHow satisfied are you with the developed formulary?\nVery satisfied 3 3 75\nSomewhat satisfied  0 2 2574\n2022/37 (3): 70-75Sadaf Hojjati et al.  \nAlso, a feedback questionnaire, containing 10 questions, \nwas distributed to the medical staff of the obstetrics \nand gynecology wards. The overall response to the \nquestions showed that the presence of a formulary is \nincredibly useful.\nSelected medicines for the preparation of the Hospital \nFormulary satisfied the health care needs of the clinicians. \nThe prepared Hospital formulary is unique in its features, \nas recommended by hospitals\u2019 P&T committee to suit its \nPatient\u2019 health care requirements.\nFollowing a prescription investigation at the hospital \npharmacy, it was seen that several of the medications \nin repeated prescriptions were not available, as the \nresult of which patients had no options left but to rely \non retail pharmacies outside of the hospital to provide \ntheir essentials, while most doctors were unaware of \nhospital pharmacy being devoid of the most sought after \nmedications. As a result, the hospital formulary ensures \nthat the pharmaceuticals needed by patients arriving at \nthe hospital are available. Furthermore, not all hospitals in \nIndia have their formularies. In this world of the advanced \nhealth care system, hospitals in India should establish \ntheir formulary with an efficient system and P&T committee \nto achieve rationality in drug use. Numerous medication \nerrors were reported by healthcare providers due to \ninadequate drug information. Even though our hospital \nis a teaching center, drug information sources were not \nsufficiently available for students active in their different \nwards (nursing, medicine, pharmacies, etc). This is the \ngrounding behind why our department initiated drug \ninformation, ADR reporting center, and medication error \nmonitoring as a primary constructive step. Following this \nfurther, upon the suggestion of the medical staff of the \nOBG department, we initiated the establishment of the \nHospital Formulary, luckily facilitated with the help of PTC. \nEqually significant, drug monographs were organized in \na way that medical, pharmacy, and nursing students \ncould efficiently promote the concept of rational drug \ntherapy. Not to mention, it also served as an educational \ntool for them.\nOwing to the unsatisfactory information provided by the \nmedical representatives to the physicians, unreasonable \nprescriptions are written out. To abolish this all, the \nhospital formulary monographs were created from \nstandard references to provide unbiased information to \nhealthcare professionals. As a result, it provoked the \nfeeling of appreciation of Doctors since it contained a \nplethora of information about medications, making them \naware of all the brands and costs available in the hospital \npharmacy, allowing them to prescribe the most cost-\neffective drug, lowering the total cost of the patients\u2019 \ntreatment accordingly.Conclusion\nHospital formularies are heterogeneous. The prepared \nHospital formulary is unique in its features, as \nrecommended by the hospital\u2019s P & T committee to suit \nits patient\u2019s health care requirements. Not all hospitals in \nIndia have their formularies. In this world of the advanced \nhealth care system, hospitals in India should develop \ntheir formulary with an effective formulary system and \nP & T committee to achieve rationality in drug use. \nP & T committees of the hospitals must implement \npharmacoeconomic analysis to select drugs and their \nproducts for inclusion into formulary. Pharmaceutical \npromotion is a delicate area, where it is the responsibility \nof the hospital\u2019s P & T committee to solve if any conflicts in \ndrug products selection and look after that, drug products \nare selected for the hospital by considering cost, safety, \nand efficacy. The prepared hospital formulary should be \nimplemented in the hospital with an effective formulary \nsystem, which will support and contribute to rationalizing \ndrug use in the hospital., it is informative and will be useful \nfor the health care professionals working in the hospital. By \nreferring to the prepared hospital formulary, prescribers of \nthe hospital can develop of hospital formulary for a rural \ntertiary care teaching hospital in south India knows about \nthe drugs available in the hospital Pharmacy. Where the \nprepared pharmaceutical product list can be referred for \nbrand names and other details of the brands approved \nto use in the hospital. The pharmacy and therapeutics \ncommittee of any hospital must be well balanced \nwith active health care professionals like physicians, \npharmacists, and nurses. Pharmacists play important \nrole in developing formulary and formulary systems \nin a hospital. Pharmacist participation in structuring \nguidelines, policies, and procedures for drug use in the \nhospital is essential. A well-developed hospital formulary, \nwell-structured policies and procedures for additions and \ndeletions of the drugs from the formulary and to address \nother drug-related issues in the hospital are essential \nto run an effective formulary system. Where this in turn \ngives rise to rational drug use.\nConflict of Interest\nThe authors declare that they have no conflict of interest.75\n2022/37 (3): 70-75Allocation and development of hospital formulary for obstetrics and gynecology department in a tertiary care teaching hospital of southwest India\nReferences\n1. Bochner F, Burgess NG, Martin ED. Approaches to rationing \ndrugs in hospitals. An Australian perspective. Pharmacoeconomics . \n1996;10(5):467-74. \n2. Mucklow JC. How can we afford costly medicines?. J R Coll \nPhysicians Lond . 2000;34(2):124-7. \n3. Holloway C, Green T, Carandang E, Hogerzeil H, Laing R. Managing \nthe formulary process. Drugs and Therapeutic Committees: A Practical \nGuide. Geneva: World Health Organization; 2003.\n4. Calicut K. Evaluation of Development and Implementation of Hospital \nFormulary for Paediatric Department in a Rural Tertiary Care Teaching \nHospital of South India. Indian Journal of Pharmacy Practice , 2013;6(3): 21.\n5. Tyler LS, Cole SW, May JR, Millares M, Valentino MA, Vermeulen Jr, et \nal. ASHP guidelines on the pharmacy and therapeutics committee and \nthe formulary system. Am J Health Syst Pharm . 2008;65(13):1272-83. \n6. Penm J, Chaar B, Dechun J, Moles R. Formulary systems and \npharmacy and therapeutics committees in the Western Pacific \nRegion: exploring two Basel Statements. Am J Health Syst Pharm. \n2013;70(11):967-79. \n7. HUGHES GJ, BEIZER JL. Appropriate prescribing. Ham\u2019s Primary \nCare Geriatrics E-Book: A Case-Based Approach, 2021; 59.\n8. Ciccarello C, Leber MB, Leonard MC, Nesbit T, Petrovskis MG, \nPherson E. ASHP Guidelines on the Pharmacy and Therapeutics \nCommittee and the Formulary System. Am J Health Syst Pharm . \n2021;78(10):907-18. \n9. Laing R, Tisocki K. How to develop a national formulary based on the \nWHO model formulary: a practical guide. In How to develop a national \nformulary based on the WHO model formulary: a practical guide (pp. \n45-45). 2004.\n10. American Medical Association. \u201cPolicy H-125.991: drug formularies \nand therapeutic interchange.\u201d\n11. American Medical Association. Policy H-285.965: managed \ncare cost containment involving prescription drugs. www. ama-\nassn. org/apps/pf_new/pf_online? f_ n= resultLink&doc= policyfiles/\nHnE/H-285.965. HTM (accessed 2008 Mar 27).12. Pannier A, Dunn JD. AMCP Format for Formulary Submissions, \nVersion 4.0. J Manag Care Spec Pharm . 2016;22(5):448. \n13. Wharton S, Lau DCW, Vallis M, Sharma AM, Biertho L, Campbell-\nScherer D, et al. Obesity in adults: a clinical practice guideline. CMAJ . \n2020;192(31):E875-E891.\n14. Vincent C, Barber N, Franklin BD, Burnett S. The contribution of \npharmacy to making Britain a safer place to take medicines. London: \nRoyal Pharmaceutical Society of Great Britain; 2009.\n15. World Health Organization. Stuart MC, Kouimtzi M, Hill SR (eds.). \nWHO Model Formulary 2008. World Health Organization, 221; 2009. \n16. Sweetman SC. Martindale: the complete drug reference; 2005.\n17. Shargel L, Mutnick AH, Souney PF, Swanson LN. Comprehensive \npharmacy review. Wilkins& Lippincott Williams; 2009.\n18. Tripathi KD. Essentials of medical pharmacology. JP Medical Ltd; \n2013.\n19. Machowska A, Landstedt K, St\u00e5lsby Lundborg C, Sharma M. \nAntibiotic Prescribing to Patients with Infectious and Non-Infectious \nIndications Admitted to Obstetrics and Gynaecology Departments \nin Two Tertiary Care Hospitals in Central India. Antibiotics (Basel).  \n2020;9(8):464.\n20. Tahniyath F, Hafeez F, Sultana H, Hussain MA, Abdul S, Basha \nA. Development of hospital formulary as a patient safety drug delivery \nsystem in promoting rational use of drugs in tertiary care hospital. Indian \nJournal of Pharmacy Practice, 2015;8(1): 7.\n21. Raj D, Dilip C, Sankar C, Mani LM, Mathew L, Mambra ABM. \nDevelopment of hospital formulary in tertiary care referral hospital. JPR, \n2011;4(8): 2537-40.\n22. Sahoo D, Bandaru R, Samal SK, Naik R, Kumar P , Kesharwani \nP , Dandela R. Oral drug delivery of nanomedicine. In Theory and \nApplications of Nonparenteral Nanomedicines (pp. 181-207). Academic \nPress; 2021.\n23. Sachdeva P , Patel BG, Patel BK. Drug use in pregnancy; a point to \nponder!. Indian J Pharm Sci.  2009;71(1):1-7.76\n2022/37 (3): 76-79Received:  25 - II - 2022\nAccepted:  11 - III - 2022\ndoi: 10.3306/AJHS.2022.37.03.76Corresponding author\nRuhollah Khalil Arjmandi  \nE-mail: ruholla.arjmandi@yahoo.com\nAbstract  \nIntroduction:  The menstrual cycle\u2019s effects on illness susceptibility, development, and severity of acute respiratory syndrome \ncoronavirus 2 (SARSCoV2) infection are poorly understood.  It is estimated that more than a third of regularly menstruating women \ndeveloped irregular cycles during the pandemic, with associated depression, anxiety, and stress. Another study indicates that among \npatients with confirmed COVID-19, a quarter have altered bleeding.\nMethods:  The results of real-time reverse transcriptase polymerase chain reaction (RTPCR) tests and symptoms in two women \ninfected with SARSCoV2 are described in this paper. \nResults:  After being discharged from the hospital, the first patient experienced a fever on the first day of her menstrual period and again \non the first day of her following menstrual period. The findings of the RTPCR test were positive during the first menstrual period before to \nadmission, then went negative during hospitalization, and then were positive again during the second menstrual period following release. \nAfter being released from the hospital, another woman experienced a fever on the first day of her monthly period. Before admission and \nduring hospitalization, the RTPCR test was negative, but it became positive during the first menstrual period after discharge. \nConclusions: According to the cases, SARSCoV2 infection may be aided by sex hormones. The menstrual status of women who \nhave been exposed to SARSCoV2 should be assessed as part of the care procedure.\nKey words:  COVID-19, fever, menstrual cycle, SARS-CoV-2 . \nResumen\nIntroducci\u00f3n: Los efectos del ciclo menstrual sobre la susceptibilidad, el desarrollo y la gravedad de la infecci\u00f3n por coronavirus 2 \ndel s\u00edndrome respiratorio agudo (SARSCoV2) son poco conocidos. Se estima que m\u00e1s de un tercio de las mujeres que menstr\u00faan \nregularmente desarrollaron ciclos irregulares durante la pandemia, con depresi\u00f3n, ansiedad y estr\u00e9s asociados. Otro estudio indica que \nentre los pacientes con COVID-19 confirmado, una cuarta parte tiene sangrado alterado.\nMetodolog\u00eda:  En este art\u00edculo se describen los resultados de las pruebas y los s\u00edntomas de la reacci\u00f3n en cadena de la polimerasa \ncon transcriptasa inversa en tiempo real (RTPCR) en dos mujeres infectadas con SARSCoV2. \nResultados:  Despu\u00e9s de ser dada de alta del hospital, la primera paciente experiment\u00f3 fiebre el primer d\u00eda de su per\u00edodo menstrual \ny nuevamente el primer d\u00eda de su siguiente per\u00edodo menstrual. Los resultados de la prueba RTPCR fueron positivos durante el primer \nper\u00edodo menstrual antes de la admisi\u00f3n, luego fueron negativos durante la hospitalizaci\u00f3n y luego fueron positivos nuevamente durante \nel segundo per\u00edodo menstrual despu\u00e9s del alta. Despu\u00e9s de ser dada de alta del hospital, otra mujer experiment\u00f3 fiebre el primer d\u00eda \nde su per\u00edodo menstrual. Antes del ingreso y durante la hospitalizaci\u00f3n, la prueba RTPCR fue negativa, pero se volvi\u00f3 positiva durante \nel primer per\u00edodo menstrual despu\u00e9s del alta. \nConclusiones: Seg\u00fan los casos, las hormonas sexuales pueden ayudar a la infecci\u00f3n por SARSCoV2. El estado menstrual de las \nmujeres que han estado expuestas al SARSCoV2 debe evaluarse como parte del procedimiento de atenci\u00f3n.\nPalabras clave: COVID-9, fiebre, ciclo menstrual, SARS-CoV-2.ORIGINAL\nEvaluation of the menstrual cycle of female infected with \nSARS-CoV-2 in women aged 36 to 45 years in iranian society\nEvaluaci\u00f3n del ciclo menstrual de mujeres infectadas con SARS-CoV-2 \nen mujeres de 36 a 45 a\u00f1os en la sociedad iran\u00ed\nFaegeh Miryousefiata1, Ruhollah Khalil Arjmandi2   \n1. Medical Student, Osmangazi University, Eskisehir, Turkey\n2. Department of Medicine (M.D), Qom Branch, Islamic Azad University, Qom, IraneISSN 2255-0569\nID77\n2022/37 (3): 76-79Evaluation of the menstrual cycle of female infected with SARS-CoV-2 in women Aged 36 to 45 years in iranian society\nIntroduction\nThe COVID-19 epidemic is already in its seventh month \nover the world. Infections with the novel SARS-CoV-2 \nvirus are on the rise globally, with increasing numbers of \nmortality. International and local public health reactions \ncame almost simultaneously, imposing limits to prevent \nthe virus from spreading, overburdening health systems, \nand a lack of personal protective equipment.\nSince December 2019, the 2019 new coronavirus \ninfection (COVID19), caused by the severe acute \nrespiratory syndrome coronavirus 2 (SARSCoV2), has \nbecome a major worldwide health issue. The pandemic \nhad resulted in 9 473 214 illnesses and 484 249 fatalities \nas of June 27, 2020. 5 A population-level observational \ninvestigation by Sun et al 6 found a substantial increase \nin COVID19 among adults aged 30 to 50 years, with \n40% of the patients being female, indicating that women \nof childbearing age are at high risk of infection. Female \nimmunity appears to alter throughout the menstrual cycle, \naccording to growing research. The menstrual cycle\u2019s \neffects on illness susceptibility, development, and severity \nof COVID19, on the other hand, remain mainly unclear. \nWe provide the epidemiologic and clinical characteristics \nof two female SARSCoV2 infected individuals, as well as \nthe infection\u2019s relationship to the menstrual cycle.1\nOn January 12, 2020, a 37-year-old lady who had \npreviously been healthy (gravida 2, para 2, regular \nmenstrual cycle, and no history of hormonal therapy) had \nsupper with a relative. Her relative developed a fever five \ndays later and was diagnosed with SARSCoV2. Until the \nfirst day of her menstrual period on January 28, 2020, \nthe woman experienced no fever or other gastrointestinal \nor respiratory symptoms. She had a mild and sporadic \nfever at initially. She experienced a high fever, fatigue, \nand a lack of appetite the next day afternoon.\nA community physician prescribed ibuprofen, oseltamivir \n(75 mg every 12 hours orally), arbidol (0.2 g every 8 hours \norally), and moxifloxacin (0.4 g every day orally) due to the \nlikelihood of SARSCoV2 infection. Her antiviral regimen \nwas supplemented two days later with lopinavir and \nritonavir tablets (200 mg/50 mg every 12 hours orally). \nHer symptoms persisted, prompting her to visit the \nemergency department on February 2, 2020. Despite \nthe fact that chest auscultation was normal, chest CT \nscans revealed bilateral lower lobe infiltrates .\nShe was recommended ibuprofen, oseltamivir (75 mg \nevery 12 hours orally), arbidol (0.2 g every 8 hours orally), \nand moxifloxacin (0.4 g every day orally) by a community \nphysician due to the likelihood of infection with \nSARSCoV2. Her antiviral regimen was supplemented 2 \ndays later with lopinavir and ritonavir tablets (200 mg/50 \nmg orally every 12 hours). Her symptoms persisted, \nprompting her to seek medical help on February 2, 2020. Chest computerized tomography (CT) scans revealed \nbilateral lower lobe infiltrates, despite the fact that chest \nauscultation was normal .\nThe patient was admitted to the hospital with COVID19 \non February 4, 2020. On admission, the physical \nexamination revealed a body temperature of 97.5 \ndegrees Fahrenheit (36.4 degrees Celsius), blood \npressure of 98/61 millimeters of mercury, pulse rate of \n78 beats per minute, respiration rate of 20 breaths per \nminute, and oxygen saturation of 95 percent on room \nair. Her laboratory tests revealed a Creative protein \ncount of 12.3 mg/L (low risk of cardiovascular disease: \n1 mg/L; medium risk of cardiovascular disease: 13 \nmg/L; high risk of cardiovascular disease: >3 mg/L; and \ninfection or inflammation: >10 mg/L) and an erythrocyte \nsedimentation rate of 30 mm/H (normal range: 1030 \nmm/H).\nComplete blood count, coagulation tests, liver function \ntests, kidney function tests, metabolic panel testing, and \nhigh-sensitivity cardiac troponin tests did not yield any \nclinically relevant results. On February 8, 2020, a follow-\nup chest CT scan revealed that the shadow on both \nlungs had partially disappeared (Figure 2B). As a result, \nshe was taken off all of her antiviral and antibacterial \ndrugs. Three- and six-days following admission, RTPCR \ntesting for SARSCoV2 nucleic acid on oropharyngeal \nswabs were done, and the findings were positive.2\nThe oropharyngeal swab RTPCR tests were repeated \n10- and 12-days following hospitalization, and both \ntimes the results were negative. A subsequent chest CT \nscan on February 14, 2020, revealed that groundglass \nopacification had improved even more. During her stay \nin the hospital, her temperature stayed normal. This \npatient was discharged on February 18, 2020, based \non Iranian hospital discharge criteria, which included \n(a) a normal temperature for at least three days, (b) \nresolution of respiratory symptoms, (c) significantly \nimproved radiological signs, and (d) negative results in \ntwo consecutive RTPCR tests performed more than or \nequal to 24 hours apart.3\nThe patient was asked to stay in quarantine at home for \nanother 14 days after being released from the hospital. \nShe felt fine till the first day of her monthly cycle on \nFebruary 24, 2020. The patient did not report any other \ninteraction, although he did develop a fever, which peaked \nat 100.2\u00b0F (37.9\u00b0C). She had no additional symptoms at \nthe time save exhaustion. For three days, she took arbidol \n(0.2 g orally every 8 hours) and moxifloxacin (0.4 g orally \nevery day). A RTPCR test on February 25, 2020, and a \nfollow-up test on oropharyngeal swabs four days later \nboth came back positive. Chest CT scans, on the other \nhand, revealed no alterations from the previous results. \nUntil the last day of her menstrual period on February 29, \n2020, the patient experienced a minor and intermittent 78\n2022/37 (3): 76-79Faegeh Miryousefiata et al.  \nfever. Her temperature had stayed normal since then. On \n10 oropharyngeal swabs, the RTPCR test was done.\nA 45-year-old lady working as a nurse in a hospital in Qom, \nIran, was previously healthy (gravida 1, para 1, regular \nmenstrual cycle, and no history of hormonal therapy). She \ndeveloped a mild fever on January 24th, with a high of \n100.4\u00b0F (38\u00b0C) at night . She was prescribed arbidol (0.2 \ng every 8 hours orally) by a physician due to the likelihood \nof infection with SARSCoV2 due to occupational contact \nhistory. She suffered weariness, muscle discomfort, \npalpitation, and a lack of appetite on January 26, 2020, \nthe first day of her menstrual period. During her menstrual \nmonth, she continued to take arbidol, but her symptoms \ndid not improve. The patient was admitted to a hospital\u2019s \noutpatient department on February 2nd.\nMultiple infiltration was seen in the bilateral lung view on \nchest CT images. A blood test revealed a white blood \ncell count of 3.88 109/L and a lymphocyte count of \n0.94 109/L. Despite the fact that an oropharyngeal \nswab RTPCR test came back negative, the woman was \ndiagnosed with COVID19 based on her occupational \nexposure history, symptoms, and chest CT findings. \nThe patient was admitted to the hospital with COVID19 \non February 3, 2020. On admission, the physical \nexamination revealed a body temperature of 99.5 \ndegrees Fahrenheit (37.5 degrees Celsius), blood \npressure of 105/85 millimeters of mercury, pulse rate of \n110 beats per minute, respiration rate of 20 breaths per \nminute, and oxygen saturation of 94 percent on room air. \nHer lab tests revealed a Creactive protein concentration \nof 14.8 mg/L and an erythrocyte sedimentation rate of \n40 mm/H. The serum specific IgM antibodies to eight \nrespiratory pathogens, including respiratory syncytial \nvirus, adenovirus, type A and type B influenza virus, \nparainfluenza virus, Legionella pneumophila, Mycoplasma \npneumoniae, and Chlamydia pneumoniae, were found \nto be negative. After her admission, her temperature \nreturned to normal the next day.\nAll of her antibacterial meds had been revoked. On \nFebruary 8, 2020, a follow-up chest CT scan revealed \ndecreasing infiltration in both the left and right lungs \n. Three, seven, nine-, and eleven-days following \nadmission, RTPCR testing for SARSCoV2 nucleic acid \non oropharyngeal swabs were done, and the results were \nnegative. A repeat chest CT scan on February 14, 2020, \nrevealed considerable improvement in infiltration in all \nlesions . During her stay in the hospital, her temperature \nstayed normal. The patient was ordered to stay at home \nfor 14 days after being discharged from the hospital on \nFebruary 18, 2020. She felt fine till the first day of her \nmonthly cycle on February 21, 2020. Her fever returned, \nthis time with weariness and dizziness, reaching 99.3\u00b0F \n(37.4\u00b0C). For 5 days, she took arbidol (0.2 g orally every \n8 hours) and moxifloxacin (0.4 g orally every day). On \nFebruary 23, 2020, an RTPCR test for SARSCoV2 nucleic acid on oropharyngeal swabs yielded positive results. \nBoth IgG and IgM antibodies against SARSCoV2 were \nfound in her blood. Chest CT scans, on the other hand, \nrevealed no signs of increasing invasion. The patient had \na mild and intermittent fever till February 25, 2020, the \nday before her menstrual period ended. Her temperature \nhad stayed normal since then. On February 28, 2020, \nan oropharyngeal swab was tested for RTPCR, and the \nresults were negative.\nDiscussion and Conclusions\nThere have been reports of sex variations in infectious \nillness susceptibility and outcomes. 9 and 10 SARSCoV2 \nmay have a longer incubation period and less apparent \nsymptoms in women than in men, according to a recent \nepidemiological investigation of the COVID19 outbreak. \n11 The mechanism behind these distinctions, however, \nis unknown. In this paper, we describe two SARSCoV2 \ninfected women whose RTPCR test findings and \nsymptoms altered during their menstrual cycle. After being \ndischarged from the hospital, the first patient experienced \na fever on the first day of her menstrual period and again \non the first day of her following menstrual period. The \nRTPCR test was positive during the first menstrual period \nbefore admission, turned negative during hospitalization, \nand then returned to positive during the second menstrual \nperiod following release.4\nAfter being discharged from the hospital, another woman \ngot a fever on the first day of her menstrual period. Before \nadmission and during hospitalization, the RTPCR test was \nnegative, but it became positive during the first menstrual \nperiod after discharge. These findings suggest that sex \nhormones may play a role in SARSCoV2 infection.\nThe levels of sex hormones, primarily estrogens and \nprogesterone, fluctuate over the menstrual cycle in \nfemale humans and drop rapidly before menstruation. \n12 Changes in immunological function and response \nto respiratory virus infections are linked to substantial \nfluctuations in sex hormone levels. 13 Estrogen has \nbeen shown to be a strong anti-inflammatory hormone \nthat reduces adaptive immune responses and protects \nhosts from influenza A virus-mediated pathogenesis in an \nanimal model of influenza A virus infection.5\nTreatment with an oestrogen receptor antagonist or \novariectomy can increase mortality in females in another \nanimal model of SARSCoV infection, demonstrating that \noestrogen receptor signaling is important in shielding \nfemales against severe SARSCoV infection. 15 in line \nwith earlier research, our findings in this case revealed \na strong link between symptoms, positive RTPCR \ntest results, and menstruation. The observations of \nChadchan et al. may help to explain this phenomenon. \n16 They discovered that in human endometrial stroma, 79\n2022/37 (3): 76-79Evaluation of the menstrual cycle of female infected with SARS-CoV-2 in women Aged 36 to 45 years in iranian society\nthe expression of angiotensin converting enzyme 2 \n(ACE2), which allows SARSCoV2 to enter human cells, \nis high and increases throughout the secretory phase6&7. \nProgesterone also promotes ACE2 expression in the \nhuman endometrial stroma. Future research should \nfocus on the role and mechanism of sex hormones in \nthe pathogenesis of SARSCoV2 infection. In the first \nexample, the fever started on the first day of her period \nand went away on the last day. When menstruation \nbegan in the second case, symptoms intensified. These \nfindings show that the menstrual state should be taken \ninto account during the observation period. Rather than \nsymptoms, the findings of RTPCR testing or CT scans \nshould be used to identify potentially infected patients \nthroughout the observation period.8&9During their first menstrual period after being discharged \nfrom the hospital, the patients in this study experienced \na return of fever and had positive RTPCR test results. \nDespite the possibility that negative RTPCR test findings \nduring hospitalization are false negatives, 17 there are \nan increasing number of reports of positive RTPCR test \nresults among COVID convalescent patients 19. 18, 19, \n20 These findings show that some of the rehabilitated \npatients may still be viral carriers. The hospital discharge \nmanagement strategy may need to be reevaluated, and \nfemale patients\u2019 menstruation status should be assessed \nduring the 14-day home quarantine period.\nConflict of Interest\nThe authors declare that they have no conflict of interest.\nReferences\n1. Abedini A, Mirtajani SB, Karimzadeh M, Jahangirifard A, Kiani A. Can \nHesperidin be the Key to the Treatment of Severe Acute Respiratory \nSyndrome COV-2. Biomedical and Biotechnology Research Journal \n(BBRJ). 2020 Aug 1;4(5):108. \n2. Guo Y-R, Cao Q-D, Hong Z-S, Tan Y-Y, Chen S-D, Jin H-J, et al. \nThe origin, transmission and clinical therapies on coronavirus disease \n2019 (COVID-19) outbreak\u2013an update on the status. Military Medical \nResearch. 2020;7(1):1-10. \n3. Fallahzadeh M, Pourhoseingholi MA, Besharati S, Boroujeni \nMG, Mardani M, Shabani M, et al. Efficacy of Interferon \u03b2-1a in \nTreatment of Hospitalized COVID-19 Patients; SBMU Taskforce on \nthe COVIFERON Study. \n4. Robinson DJ, Christenson RH. Creatine kinase and its CK-MB \nisoenzyme: the conventional marker for the diagnosis of acute myocardial \ninfarction. The Journal of emergency medicine. 1999;17(1):95-104. 5. Feldmann M, Maini RN, Woody JN, Holgate ST, Winter G, Rowland \nM, et al. Trials of anti-tumor necrosis factor therapy for COVID-19 are \nurgently needed. The Lancet. 2020 May 2;395(10234):1407-9. \n6. Zhou L, Xu H. A clinical study for the efficacy and safety of adalimumab \ninjection in the treatment of patients with severe novel coronavirus \npneumonia (COVID-19). Chinese Clin Trial Regist. 2020. \n7. Mair J. Cardiac troponin I and troponin T: are enzymes still relevant as \ncardiac markers? Clinica Chimica Acta. 1997;257(1):99-115. \n8. Vaseghi G, Mansourian M, Karimi R, Heshmat-Ghahdarijani K, \nMahdavi SB, Pezeshki A, et al. Clinical characterization and chest CT \nfindings in laboratory-confirmed COVID-19: a systematic review and \nmeta-analysis. medRxiv. 2020. \n9. Chen M, Fan Y, Wu X, Zhang L, Guo T, Deng K, et al. Clinical \nCharacteristics And Risk Factors For Fatal Outcome in Patients With \n2019-Coronavirus Infected Disease (COVID-19) in Wuhan, China. 2020. 80\n2022/37 (3): 80-84Received:  26 - II - 2022\nAccepted:  12 - III - 2022\ndoi: 10.3306/AJHS.2022.37.03.80Corresponding author\nMitra Ghodratizadeh  \nE-mail: \nAbstract  \nIntroduction and objective:  Thromboembolism after surgery is a significant problem in patients with acetabular fractures. This \nstudy aimed to evaluate the effect of intraoperative administration of subcutaneous heparin on prophylaxy of deep vein thrombosis and \npulmonary thromboemboli  during and after surgery.\nMaterials and methods: This study is a non-blinded trial in which 42 patients over 18 years old with acetabular fractures who required \nsurgery were divided into two groups matched by age and sex. Patients were randomly assigned to one of two treatment groups: with \nand without heparin injection during surgery. \nInclusion criteria included patient with unstable posterior coloumn or wall acetabular fractures that open reduction and internal fixatinon \nwas the choice of treatment, patient more than 18 years old underwent this study. Exclusion criteria included a history of heparin-\ninduced allergy and thrombocytopenia, a history of coagulopathy such as hemophilia.\nResults:  In this study 42 patients with acetabular fractures admitted to the orthopedic ward, 36 patients (85.7%) were male and 6 \npatients (14.3%) were female with a mean age of 49.2 \u00b1 8.1 years. 20 patients (47.6%) received subcutaneous heparin during surgery \nand the other 22 patients (52.4%) did not receive heparin. In the group receiving subcutaneous heparin, proximal deep vein thrombosis \nwas observed in one patient, while 5 patients (22.7%) in the group without heparin showed proximal deep vein thrombosis during \nsurgery. There was no significant difference between the mean age of patients and the volume of intraoperative bleeding in the group \nreceiving heparin (700 \u00b1 50 ccs) and the group without heparin (600 \u00b1 50 ccs).\nConclusion:  Intraoperative subcutaneous injection of heparin can prevent deep vein thrombosis and pulmonary thromboembolism and \nreduce patient mortality.Intraoperative injection of subcutaneous heparin was not associated with a significant increase in intraoperative \nbleeding and had no considerable side effects.\nKey words:  Acetabular fractures, heparin, thromboembolism, Deep Vein Thrombosis, bleeding heparin.\nResumen\nIntroducci\u00f3n y objetivo:  El tromboembolismo despu\u00e9s de la cirug\u00eda es un problema importante en los pacientes con fracturas \nacetabulares. Este estudio tiene como objetivo evaluar el efecto de la administraci\u00f3n intraoperatoria de heparina subcut\u00e1nea en la \nprofilaxis de la trombosis venosa profunda y la tromboembolia pulmonar durante y despu\u00e9s de la cirug\u00eda.\nMaterial y m\u00e9todos:  Este estudio es un ensayo no ciego en el que 42 pacientes mayores de 18 a\u00f1os con fracturas acetabulares que \nrequer\u00edan cirug\u00eda fueron divididos en dos grupos emparejados por edad y sexo. Los pacientes fueron asignados aleatoriamente a uno de \nlos dos grupos de tratamiento: con y sin inyecci\u00f3n de heparina durante la cirug\u00eda. Los criterios de inclusi\u00f3n inclu\u00edan a los pacientes con \nfracturas acetabulares inestables de la columna o la pared posterior cuyo tratamiento elegido era la reducci\u00f3n abierta y la fijaci\u00f3n interna; \nlos pacientes mayores de 18 a\u00f1os se sometieron a este estudio. Los criterios de exclusi\u00f3n inclu\u00edan antecedentes de alergia a la heparina \ny trombocitopenia, y antecedentes de coagulopat\u00eda, como la hemofilia.\nResultados:  En este estudio 42 pacientes con fracturas acetabulares ingresados en la sala de ortopedia, 36 pacientes (85,7%) eran \nhombres y 6 pacientes (14,3%) eran mujeres con una edad media de 49,2 \u00b1 8,1 a\u00f1os. 20 pacientes (47,6%) recibieron heparina \nsubcut\u00e1nea durante la cirug\u00eda y los otros 22 pacientes (52,4%) no recibieron heparina. En el grupo que recibi\u00f3 heparina subcut\u00e1nea, \nse observ\u00f3 trombosis venosa profunda proximal en un paciente, mientras que 5 pacientes (22,7%) del grupo sin heparina mostraron \ntrombosis venosa profunda proximal durante la cirug\u00eda. No hubo diferencias significativas entre la edad media de los pacientes y el \nvolumen de hemorragia intraoperatoria en el grupo que recibi\u00f3 heparina (700 \u00b1 50 cc) y el grupo sin heparina (600 \u00b1 50 cc).\nConclusiones: La inyecci\u00f3n subcut\u00e1nea intraoperatoria de heparina puede prevenir la trombosis venosa profunda y el tromboembolismo \npulmonar y reducir la mortalidad de los pacientes.La inyecci\u00f3n intraoperatoria de heparina subcut\u00e1nea no se asoci\u00f3 a un aumento \nsignificativo de la hemorragia intraoperatoria y no tuvo efectos secundarios considerables.\nPalabras clave: Fracturas acetabulares, heparina, tromboembolismo, trombosis venosa profunda, sangrado Heparina.ORIGINAL\nThe effect of intraoperative subcutaneous heparin on \nprophylaxy of deep vein thrombosis (DVT) in surgical \ntreatment of acetabular fractures\nEl efecto de la heparina subcut\u00e1nea intraoperatoria en la profilaxis de la thrombosis \nvenosa profunda (TVP) en el tratamiento quir\u00fargico de las fracturas acetabulares\nHassan Taleb1      , Mitra Ghodratizadeh2      , Soma Hassanzadeh3   \n1. Department of Orthopedics, Imam Khomeini Hospital, Urmia University of Medical Sciences, Urmia, Iran\n2. Department of Anesthesiology, Imam Khomeini Hospital, Urmia University of Medical Sciences, Urmia, Iran\n3. PhD student at Sulaymaniyah University of Medical Sciences, IraqeISSN 2255-0569\nID ID ID81\n2022/37 (3): 80-84The effect of intraoperative subcutaneous heparin on prophylaxy of deep vein thrombosis (DVT) in surgical treatment of acetabular fractures\nIntroduction\nTreatment of pelvic and acetabular fractures remains \na challenge1-3. Venous thromboembolism (VTE) \nincluding deep vein thrombosis (DVT) and pulmonary \nembolism (PE) is a complication associated with these \nfractures4,5. Studies have shown that in the absence of \nthromboprophylaxis, the incidence of DVT in patients \nwith pelvic fractures is variable up to 61%6. Deep vein \nthrombosis is the most common cause of death of lower \nlimb fractures (hip and pelvis) after the seventh day of \naddmition.\nIn most of these patients, PE was difficult to diagnose \nbefore death, suggesting that PE may be the first \nmanifestation of asymptomatic DVT7. Each year, about 10 \nmillion cases of venous thromboembolism are reported \nworldwide8. According to a Korean study in 1990 on \nthe autopsy of patients undergoing spinal surgery, deep \nvein thrombosis accounted for 1.3% of deaths9. Patients \ncan be classified according to their age, the presence \nor absence of other risk factors for VTE, and the type of \nsurgery to be performed. Patients at lower risk of VTE \nrequire no special treatment but prophylaxy of DVT is \nneeded as soon as possible , while patients at moderate \nor higher risk of DVT10.\nPatients with pelvic trauma are at risk for thromboembolic \ncomplications, but effective guidelines have still to \nbe adopted11. A variety of thromboprophylaxis drugs \nare recommended in high-risk trauma patients. Low-\ndose heparin or intermittent pneumatic compression \ndevices alone are not always effective in preventing \nDVT12,13, whereas low molecular weight heparin (LMWH) \nhas been shown to decrease DVT rates in patients \nwith pelvis or lower limbs fractures11. Anticoagulants, \nsuch as unfractionated heparin (UFH), low molecular \nweight heparin (LMWH), and warfarin, or antiplatelet \nagents, especially acetylsalicylic acid (aspirin), are \npharmacological agents used for thromboprophylaxis. \nProphylaxis of DVT is usually done with low-dose heparin \n(LDH). First, a subcutaneous dose of 5,000 units is \ninjected 2 hours before surgery and repeated every 12 \nhours for up to 6 days. This method produces a good \npreventive effect in most patients14.\nAccording to the literature and the predictable risk, \nanticoagulant therapy should be started as soon as \npossible. In a study by O\u2019Donnell et al., low molecular \nweight heparin (LMWH) or warfarin was suggested as \nthe treatment of choice for patients with spinal cord \nanesthesia and all patients with major trauma15. The \nresults of a study by Wang et al showed that the risk \nof developing DVT is higher in patients older than 60 \nyears, patients with trauma, patients with associated \ninjuries, and surgery after 2 weeks in nonambulate multi \ntrauma patients16. Steele et al.17 reported that LMWH \nif initiated without delay, is a safe and effective method of thromboprophylaxis in high-risk patients with major \npelvic or acetabular fractures. If remains unrecognized, \nDVT can lead to long-term complications from post-\nphlebitic (post-thrombotic) syndrome and predispose \npatients to recurrent VTE10. Because VTE in hospitalized \npatients is often asymptomatic, it is inappropriate to rely \non early detection. In addition, non-invasive tests, such \nas ultrasound, have limited sensitivity for the diagnosis of \nasymptomatic DVT. Therefore, thromboprophylaxis is the \nmost effective strategy to reduce morbidity and mortality \nfrom VTE in surgical patients. Despite this evidence, \nthromboprophylaxis is not used in clinical practice as \nsurgeons believe that the risk of VTE is much lower to \njustify the potential hemorrhagic complications from the \nuse of anticoagulants18. Despite the use of preoperative \nprophylaxis, patients are predisposed to DVT due to \nprolonged prone position, prolonged surgery time, and \nthe use of blood transfusions. this study was the first \nto evaluate the effect of intraoperative administration of \nsubcutaneous heparin on the surgical complications \nof acetabular fractures, including venous thrombosis, \nmortality, intraoperative bleeding, etc.\nMaterials and methods\nThis study aimed to evaluate the effect of intraoperative \nadministration of subcutaneous heparin on the surgical \ncomplications of acetabular fractures. The study \npopulation included patients with acetabular fractures \nadmitted to the orthopedic ward of Imam Khomeini \nHospital affiliated with the Urmia University of Medical \nSciences. The number of people in each group was \ndetermined to be 33 based on the following formula. \nConvenience sampling was used in this study. \nZ1-\u03b2=0.84, Z1-\u03b1/2=1.64\nMethod\nThis study is a non-blinded trial in which 42 patients \nover 18 years old with acetabular fractures who required \nsurgery were divided into two groups matched by age and \nsex. Inclusion criteria included individuals with acetabular \nfractures with posterior involvement who required surgery, \nindividuals over 18 years of age, and consent to participate \nin the study. Exclusion criteria included a history of \nheparin-induced allergy and thrombocytopenia, a history \nof coagulation disorders, and a history of hemophilia and \nthalassemia. Based on the codes provided by Random \nAllocation software, the patients were randomly assigned \nto one of two treatment groups: the group with heparin \ninjection and the group without heparin injection. For n=(Z1-\u03b1/2+Z1-\u03b2)2 [P1(1-P1)+P2 (1-P2)\n(P1-P2)282\n2022/37 (3): 80-84Hassan Taleb et al.  \npatients treated with subcutaneous heparin, 5.000 \nunits of heparin were injected subcutaneously before \nthe surgical incision and after placing the patients \nin the prone position, while no anticoagulants were \ninjected into the other group. Depending on the surgical \nsite and patient\u2019s condition, the patients underwent \na certain form of general anesthesia. Patients with \nprimary embolism thrombosis and preoperative venous \nthrombosis were excluded from the study. According to \ncommon treatment methods, all patients should receive \nanticoagulants, including subcutaneous enoxaparin and \nantithrombotic stockings, from the time of admission and \nafter surgery. Patients undergoing surgery in the prone \nposition (lying on the abdomen) were placed in a group \nundergoing intraoperative prophylaxis with 5.000 units of \nsubcutaneous heparin. The two groups were compared \nfor complications including venous thrombosis, mortality, \nmorbidity, intraoperative cardiovascular findings, \nintraoperative hemorrhage -estimated based on the \namount of blood collected in the suction tank and the \nnumber of blood-soaked gauzes- and postoperative \nhemorrhage - estimated based on the volume of the \nHemovac reservoir. After surgery, patients were visited \ndaily and were evaluated for clinical symptoms including \nswelling, erythema, and pain in the lower extremities. In \nthe case of clinical evidence, the patients were further \nevaluated using color Doppler ultrasound. All patients \nunderwent color Doppler ultrasound on day 14 after \nsurgery for deep vein thrombosis of the lower extremities. \nData collection tools in the present study included \nchecklists and a review of patient records.\nStatistical analysis\nDescriptive statistical methods were used in this \nstudy. Frequency analysis test (chi-square) was used \nto compare qualitative data and statistical analytical \nmethods (independent t-test) were used to compare \nquantitative data between the two groups. Statistical \nanalysis was performed using SPSS17/win software and \na P-value less than 0.05 was considered significant.\nResults\nThis study included 42 patients with acetabular fractures \nadmitted to the orthopedic ward of Imam Khomeini \nHospital affiliated to the Urmia University of Medical \nSciences, of which 20 patients (47.6%) received \nsubcutaneous heparin and other 22 patients (52.4%) did \nnot receive heparin during surgery. The results showed \nthat 85.7% of patients with acetabular fractures were \nmales and 14.3% were females. The mean age of the \npatients was 49.2 \u00b1 8.1 years. The results of the Fisher \ntest showed that there was no significant difference \nbetween the sexes of patients with acetabular fractures \nadmitted to the orthopedic ward in different study groups (the group receiving subcutaneous heparin and \nthe group without heparin during surgery) (P <0.05). \nTherefore, male and female participants were matched \nbetween the two groups. The comparison results for the \nfrequency of mortality, the frequency of proximal deep \nvein thrombosis (iliac and femoral), and drug side effects \nin patients with acetabular fractures between the two \ngroups are presented in table I .\nThe results of the t-test showed that there was a significant \ndifference in patients\u2019 mean age between the two groups \n(subcutaneous heparin receiving group and non-receiving \ngroup during surgery) (P <0.05). Also, there was a \nsignificant difference in the mean intraoperative bleeding \nvolume estimated in the group receiving heparin (700 \u00b1 50 \nccs) and the group without heparin (600 \u00b1 50 ccs) during \nsurgery (P <0.05). However, no significant difference in \nthe mean bleeding volume estimated in Hemovac was \nfound between the two groups (300 ccs vs. 250cc, \nrespectively) (P <0.05). Moreover, no significant difference \nwas also observed in the other variables (hospitalization \ntime/ post-operative bleeding in Hemovac, cc/ heartrate \n/ systolic hypertension / diastolic hypertension) between \nthe two groups of subcutaneous heparin receiver and \nnon-receiver during surgery. ( Table II ).\nDiscussion\nThe present study evaluated the effect of intraoperative \nadministration of subcutaneous heparin on the surgical \ncomplications of acetabular fractures in patients admitted \nto Imam Khomeini Hospital. In the study of Wang et al16 \nto investigate the incidence and risk factors of deep vein \nthrombosis (DVT) in patients with pelvic and acetabular \nfractures, thirty-two (29.09%) patients sustained \nDVT, twenty-one (19.09%) patients showed proximal \nthrombosis, and three patients developed pulmonary \nembolism. Steele et al18 evaluated the outcome of a \nprophylaxis protocol for deep vein thrombosis (DVT) \nin 103 patients who underwent open reduction and \ninternal fixation of pelvic and acetabular fractures. Low \nmolecular weight heparin (LMWH) was administered \nwithin 24 hours of injury or in hemodynamically stable \npatients. The incidence of proximal DVT and pulmonary \nembolism was 10% and 5%, respectively. Proximal DVT \noccurred in 2 of 64 patients (3%) who received LMWH \nwithin 24 hours of injury and also in 8 of 36 patients \n(22%) who received LMWH more than 24 hours after \ninjury. In the present study, lower extremity color Doppler \nultrasound was performed for patients with clinical \nevidence of deep vein thrombosis and for all patients on \na postoperative day 14. According to the results of this \nstudy, there was no significant difference between the \nmean age of patients and the volume of intraoperative \nbleeding in the group receiving subcutaneous heparin \nand the group without heparin (P<0.05). Although \nprevious studies have reported that patients over 30 are 83\n2022/37 (3): 80-84The effect of intraoperative subcutaneous heparin on prophylaxy of deep vein thrombosis (DVT) in surgical treatment of acetabular fractures\nat higher risk of developing DVT19, some studies have \nfound no association between DVT and patient age20. \nHowever, older age is often considered one of the factors \nassociated with the higher risk for DVT21. Similarly, Kim et \nal22 reported a significant increase in DVT rates in patients \nwith pelvic and acetabular fractures over 50 years of age. \nTherefore, elderly patients with pelvic acetabular fractures \nshould be evaluated more precisely for DVT.\nOne of the reasons for the high prevalence of DVT in \npatients is the failure of effective anticoagulant therapy \nin the early periods after the injury due to the risk of \nbleeding19. For patients undergoing acetabular fracture \nsurgery, ACCP guidelines recommended the use of \nLMWH, low-dose UFH, VKA, fondaparinux, aspirin \n(all grade 1B), or IPCD (grade 1C) for at least 10 to 14 \ndays and up to 35 days23. There is a limited number of \nstudies comparing different pharmacologic agents and \nthe results of these studies have not yet clarified which \nthromboprophylaxis agent is preferred24,25. The incidence \nof DVT was 10% in the LMWH group versus 30% in the \ndextran 70 groups. The need for postoperative injection \nwas higher in the Dextran 70 group, but there were no \nother differences in bleeding complications between the \ntwo groups. Gerhart et al26 found lower DVT rates with the \nsame LMWH (Org 10172) versus warfarin (7% and 21%, \nrespectively) but there was no significant difference in PE \nor major bleeding complications. It is difficult to interpret \nthe results of these comparative studies because of \ndifferent medication doses, dosing regimens, population \ndata, rehabilitation protocols, and methods for diagnosing thromboembolic phenomena. Previous studies included \nboth symptomatic and asymptomatic DVT since most of \nor all patients underwent postoperative imaging. These \nstudies also included distal DVT, which has been found \nto have little clinical significance in the progression of PE \ncompared with proximal DVT27.\nConclusion\nIn acetabular fracture surgeries, prone positioning of \nthe patients during surgery and prolonged surgical time \nmake the patient more prone to DVT and eventually \npulmonary thromboembolism. Therefore, intraoperative \nsubcutaneous heparin, can prevent deep vein thrombosis \nand pulmonary thromboembolism and reduce patient \nmortalityas well as not significantly increasing the \npatient\u2019s intraoperative bleeding and having no specific \ndrug side effects.\nConflict of interest\nThe authors declare that they have no conflict of interest.Table I: Comparison of the frequency of mortality, proximal deep vein thrombosis, and drug side effects between the two groups.\n Group Yes No Total\nMortality  Intraoperative heparin 0 (0%) 20 (100%) 20 (100%)\n No intraoperative heparin 2 (9.1%) 20 (90.9%) 22 (100%)\nP-value   0.489\nProximal deep vein thrombosis  Intraoperative heparin 1 (5%) 19 (95%) 20 (100%)\n No intraoperative heparin 5 (22.7%) 17 (77.3%) 22 (100%)\nP-value   0.04\nDrug side effects  Intraoperative heparin 0 (0%) 20 (100%) 20 (100%)\n No intraoperative heparin - - -\nTable II: Research variables between the subcutaneous heparin receiving and non-receiving groups during surgery.\nVariable Group N Mean SD t-value P-value\nAge intraoperative heparin 20 47.4 7.4 2.31 0.026\n No  intraoperative heparin 22 52.4 6.5  \nTime of hospitalization intraoperative heparin 20 5.85 1.49 1.9 0.064\n No  intraoperative heparin 22 6.63 1.17  \nIntraoperative bleeding, cc intraoperative heparin 20 3.2250E2 54.95213 2.31 0.026\n No  intraoperative heparin 22 2.8091E2 61.01593  \nPost-operative bleeding in Hemovac, cc intraoperative heparin 20 91.2500 9.01388 1.18 0.244\n No  intraoperative heparin 22 88.1818 7.7988  \nHeart rate intraoperative heparin 20 91.2 7.24460 0.39 0.698\n No  intraoperative heparin 22 92 6.02376  \nSystolic hypertension intraoperative heparin 20 122.7 12.29 0.231 0.819\n No  intraoperative heparin 22 123.6 12.55  \nDiastolic hypertension intraoperative heparin 20 87.5 6.78 0.281 0.78\n No  intraoperative heparin 22 86.9 6.83  84\n2022/37 (3): 80-84The effect of intraoperative subcutaneous heparin on prophylaxy of deep vein thrombosis (DVT) in surgical treatment of acetabular fracturesHassan Taleb et al.  \nReferences\n1. Briffa N, Pearce R, Hill AM, Bircher M. Outcomes of acetabular \nfracture fixation with ten years\u2019 follow-up. J Bone Joint Surg Br. \n2011;93(2):229-236.\n2. Halawi MJ. Pelvic ring injuries: surgical management and long-term \noutcomes. J Clin Orthop Trauma. 2016;7(1):1-6.\n3. Eckardt H, Egger A, Hasler RM, Zech CJ, Vach W, Suhm N,, et al. Good \nfunctional outcome in patients suffering fragility fractures of the pelvis treated \nwith percutaneous screw stabilisation: assessment of complications and \nfactors influencing failure. Injury. 2017; 48(12):2717-2723.\n4. Stannard JP , Singhania AK, Lopez-Ben RR, Anderson ER, Farris RC, \nVolgas DA, et al. Deep-vein thrombosis in high-energy skeletal trauma \ndespite thromboprophylaxis.  J Bone Joint Surg Br. 2005;87(7): 965-968.\n5. Niikura T, Lee SY, Oe K, Koh A, Koga T, Dogaki Y,  et al. Incidence \nof venous thromboembolism in pelvic and acetabular fractures in the \nJapanese population. J Orthop Sci. 2012;17(3):233-8.\n6. Geerts WH, Code KI, Jay RM, Chen E, Szalai JP . A prospective \nstudy of venous thromboembolism after major trauma. New Engl J Med. \n1994;331(24):1601-6.\n7.Tomotsuka N, Toda N, Shoji E. Acute pulmonary thromboembolism \nafter multiple injuries, despite performing anticoagulant therapy. Masui \n2008; 57(2):174-7.\n8. Heit JA. Poster 68 presented at: American Society of Hematology, \n47th Annual Meeting, Atlanta, GA, December 10-13, 2005.\n9. Dhillon KS, Askander A, Doraismay S. Postoperative deep-vein \nthrombosis in Asian patients is not a rarity: a prospective study of 88 \npatients with no prophylaxis. J Bone Joint Surg Br. 1996; 78:427-30.\n10. Geerts W, Heit JA, Clagett GP , Pineo GF, Colwell CW, Anderson \nFA Jr, et al. Prevention of venous thromboembolism. Chest. 2001; \n119:132S-175S.\n11. Montgomery KD, Geerts WH, Potter HG, Helfet DL. Thromboembolic \ncomplications in patients with pelvic trauma. Clin Orthop. 1996; 329:68-87.\n12. Fisher CG, Blachut PA, Salvian AJ, Meek RN, O\u2019Brien PJ. \nEffectiveness of pneumatic leg compression devices for the prevention \nof thromboembolic disease in orthopaedic trauma patients: a \nprospective, randomized study of compression alone versus no \nprophylaxis. J Orthop Trauma. 1995; 9:1-7.\n13. Knudson MM, Lewis FR, Clinton A, Atkinson K, Megerman J. \nPrevention of venous thromboembolism in trauma patients. J Trauma. \n1994; 37:480-7.\n14. Townsend CM Jr, Beauchamp RD, Evers BM. Mattox KL Sabiston \nTextbook of Surgery, 16th Ed. Philadelphia: PA; 2001. p.1005-6, 1421-28.\n15. O\u2019Donnell M, Weitz JI. Thromboprophylaxis in surgical patients. Can \nJ surg. 2003; 46(2):90-1.16.Wang P , Kandemir U, Zhang B, Wang B, Li J, Zhuang Y, et al. \nIncidence and Risk Factors of Deep Vein Thrombosis in Patients with \npelvic and acetabular fractures. Clin Applied Thrombos/Hemosta. \n2019;25(1-7):1076029619845066.\n17. Steele N, Dodenhoff RM, Ward AJ, Morse MH. Thromboprophylaxis \nin pelvic and acetabular trauma surgery: the role of early treatment \nwith low-molecular-weight heparin. J Bone Joint Surg. British volume. \n2005;87(2):209-12.\n18. Stratton MA, Anderson FA, Bussey HI, Caprini J, Comerota A, \nHaines ST, et al. Prevention of venous thromboembolism: adherence to \nthe 1995 American College of Chest Physicians Consensus Guidelines \nfor Surgical Patients. Arch Intern Med. 2000;160: 334-40.\n19. Geerts WH, Bergqvist D, Pineo GF, Heit JA, Samama CM, Lassen \nMR, et al. Prevention of venous thromboembolism: American College \nof Chest Physicians evidence-based clinical practice guidelines (8th \nEdition). Chest 2008;133(6): 381S-453S.\n20. Montgomery KD, Potter HG, Helfet DL. The detection and \nmanagement of proximal deep venous thrombosis in patients with \nacute acetabular fractures: a follow-up report. J Orthop Trauma. \n1997;11(5):330-6.\n51. Falck-Ytter Y, Francis CW, Johanson NA, Curley C, Dahl OE, \nSchulman S, et al. Prevention of VTE in orthopedic surgery patients: \nAntithrombotic therapy and prevention of thrombosis, 9th ed: American \nCollege of Chest Physicians evidence-based clinical practice guidelines. \nChest 2012;141(2): e278S-e325S.\n22. Sen RK, Kumar A, Tripathy SK, Aggarwal S, Khandelwal N, \nManoharan SR. Risk of postoperative venous thromboembolism \nin Indian patients sustaining pelvi-acetabular injury. Int Orthop. \n2011;35(7):1057-63.\n23. Samama CM, Vray M, Barr\u00e9 J, Fiessinger JN, Rosencher N, \nLecompte T, et al. Extended venous thromboembolism prophylaxis after \ntotal hip replacement: a comparison of low-molecular-weight heparin \nwith oral anticoagulant. Arch Intern Med. 2002;162(19):2191-6.\n24. Lawton JO, Brody EM. Assessment of older people: self-maintaining \nand instrumental activities of daily living. Gerontologist. 1969; 9:179-86.\n25. Davidson TI, Bodey WN. Factors influencing survival following \nfractures of the upper end of the femur. Injury. 1986; 17:12-14.\n26. Zuckerman JD, Skovron ML, Koval KJ, Aharonoff G, Frankel VH. \nPostoperative complications and mortality associated with operative \ndelay in older patients who have a fracture of the hip. J Bone Joint Surg \nAm. 1995; 77:1551-5.\n27. Bergqvist D, Kettunen K, Fredin H, Suomalainen O, Soimakallio S, \nKarjalainen P ,  et al. Thromboprophylaxis in patients with hip fractures: a \nprospective, randomized, comparative study between Org 10172 and \ndextran 70. Surgery. 1991; 109:617-22.85\n2022/37 (3): 85-90Received:  28 - II - 2022\nAccepted:  18 - III - 2022\ndoi: 10.3306/AJHS.2022.37.03.85Corresponding author\nBusuyi Kolade Akinola \nE-mail: bkakinola@futa.edu.ng\nAbstract\nBackground:  Hypertension is estimated to affect over a billion people globally, with that number likely to rise to 1.56 billion by \n2025. Palmer dermatoglyphic is a non-invasive scientific study of epidermal ridges of the volar surfaces of the hands which is \ncurrently finding relevance in the management of gene-linked diseases. \nObjectives:  The goal of this study was to explore the relevance of quantitative palmar dermatoglyphic parameters in predicting the \nlikelihood of developing essential hypertension in the study population. \nMethods:  The study was carried out with a total sample of 200 respondents consisting of 100 essential hypertensive and 100 \nnormotensive individuals between the age group of 20-70 years. Interviewer administered structured questionnaire was used \nto collect relevant information from participants. Finger and palm prints were obtained through the use of CanoScan LiDE 300 \nscanner. Collected data were statistically analyzed using Statistical Package for the Social Science (SPSS) version 26.0 at a \nsignificance level of p<0.05. Results: The results obtained in this study showed that a-b ridge count in both hands was significantly \nlower (p<0.05) in the test group (34.61\u00b13.550) compared to the control (41.83\u00b15.019). Likewise the left atd angle of the test group \n(40.84) was significantly lower (p<0.05) compared to the control (42.54). \nConclusion:  The findings in this study suggested that a significant association exists between palmer dermatoglyphic features \nand essential hypertension predicting the possibility of being a veritable tool in identifying those who are at higher risk of developing \nessential hypertension very early thereby allowing for targeted preventive measures.\nKey words : Hypertension, Palmer dermatoglyphic, epidermal ridges.\nResumen  \nAntecedentes:  Se calcula que la hipertensi\u00f3n afecta a m\u00e1s de mil millones de personas en todo el mundo, y es probable que esa \ncifra aumente a 1.560 millones en 2025. El dermatoglifo de Palmer es un estudio cient\u00edfico no invasivo de las crestas epid\u00e9rmicas de \nlas superficies volares de las manos que actualmente est\u00e1 encontrando relevancia en el tratamiento de enfermedades vinculadas \na los genes. \nObjetivos: El objetivo de este estudio fue explorar la relevancia de los par\u00e1metros dermatogl\u00edficos palmares cuantitativos en \nla predicci\u00f3n de la probabilidad de desarrollar hipertensi\u00f3n esencial en la poblaci\u00f3n de estudio. M\u00e9todos: El estudio se llev\u00f3 a \ncabo con una muestra total de 200 encuestados, compuesta por 100 hipertensos esenciales y 100 normotensos con edades \ncomprendidas entre los 20 y los 70 a\u00f1os. Se utiliz\u00f3 un cuestionario estructurado administrado por un entrevistador para recoger la \ninformaci\u00f3n pertinente de los participantes. Las huellas dactilares y palmares se obtuvieron mediante el uso del esc\u00e1ner CanoScan \nLiDE 300. Los datos recogidos se analizaron estad\u00edsticamente con el Paquete Estad\u00edstico para las Ciencias Sociales (SPSS) \nversi\u00f3n 26.0 a un nivel de significaci\u00f3n de p<0,05. \nResultados:  Los resultados obtenidos en este estudio mostraron que el recuento de crestas a-b en ambas manos fue \nsignificativamente menor (p<0,05) en el grupo de prueba (34,61\u00b13,550) en comparaci\u00f3n con el control (41,83\u00b15,019). Asimismo, \nel \u00e1ngulo atd izquierdo del grupo de prueba (40,84) fue significativamente menor (p<0,05) en comparaci\u00f3n con el control (42,54). \nConclusi\u00f3n: Los hallazgos de este estudio sugieren que existe una asociaci\u00f3n significativa entre las caracter\u00edsticas dermatogl\u00edficas \nde la palma de la mano y la hipertensi\u00f3n esencial, lo que predice la posibilidad de ser una verdadera herramienta para identificar \na aquellos que tienen un mayor riesgo de desarrollar hipertensi\u00f3n esencial de forma muy temprana, permitiendo as\u00ed medidas \npreventivas espec\u00edficas.\nPalabras clave:  Hipertensi\u00f3n, dermatoglifo de Palmer, crestas epid\u00e9rmicas.ORIGINAL\nQuantitative digito-palmar dermatoglyphics analysis in \nessential hypertension in a Nigerian population   \nAn\u00e1lisis cuantitativo de los dermatoglifos digito-palmares \nen la hipertensi\u00f3n esencial en una poblaci\u00f3n nigeriana    \nBusuyi Kolade Akinola      , Toluwase Solomon Olawuyi\nDepartment of Human Anatomy, School of Basic Medical Sciences, Federal University of Technology Akure, NigeriaeISSN 2255-0569\nID ID86\n2022/37 (3): 85-90Introduction\nThe scientific study of epidermal ridges and their \narrangement on the volar surface of the hands, \nfingers, feet, and toes is known as dermatoglyphics1. \nDermatoglyphics is derived from the Greek words \n\u201cDerma\u201d (skin) and \u201cglyphic\u201d (carvings)2. The majority \nof dermatoglyphic features are formed in the womb \nbetween weeks 17 and 24 and do not alter throughout \na person\u2019s life1. Any form of growth disruption during \nthe early stages of fetal life development might result in \nan aberrant dermatoglyphic pattern3. Dermatoglyphics \nhas long been a valuable method for identifying gene-\nrelated abnormalities and disorders. A dermatoglyphic \nrelationship has been found in a number of studies to be \nassociated with a wide range of genetic diseases4.\nEssential hypertension is described as persistently \nhigh blood pressure that is caused by a combination \nof genetic and environmental variables. For example, \nsiblings of hypertensive parents or parents are more \nlikely to acquire hypertension later in life4. Essential \nhypertension can go unnoticed for a long time, but \nit can eventually lead to changes in artery elasticity, \nocular lesions, and occasionally irreversible damage \nincluding myocardial infarction and apoplexy. Essential \nhypertension is defined by a systolic blood pressure of \nmore than 140 mmHg and a diastolic blood pressure \nof more than 90 mmHg for a prolonged period of \ntime. Dermatoglyphics is an advanced branch of \nmedical research in which practitioners analyze skin \nridge patterns to help detect chromosomal and other \nmedical abnormalities5. Several investigations have \nfound a link between dermatoglyphic characteristics \nand hypertension. Given these findings, it\u2019s been \nhypothesized that the likelihood of developing \nhypertension later in life is linked to the development \nof dermatoglyphic features during the first trimester. If \nthis hypothesis is proven, dermatoglyphic indicators \ncould be utilized to screen out people who are at risk of \nbecoming hypertensive6. Given the high mortality and \nmorbidity rates associated with essential hypertension \nworldwide, particularly in Nigeria, the goal of this study \nis to see if the palmar dermatoglyphics pattern may \nbe utilized to predict individuals at risk of developing \nessential hypertension in Ondo State, Nigeria.Materials and Methods\nThis is a cross-sectional observational study. The study \nwas conducted at Federal Medical Centre, Owo, Ondo \nState, Nigeria and Oluwarotimi Specialist and Daignostic \nCentre Akure, Ondo State. This study was carried out \nwith a total sample of 200 adult human subjects. The \nsubjects were divided into two disjoint groups; test group \n(TG) [100 essential hypertensive patients (50 Males and \n50 females) between the age group of 20-70 years] \nand control group (CG) [100 normotensive individuals \n(50 Male and 50 Female) between the age group of \n20-70years].\nInclusion criteria:  1. Known essential hypertensive or \nnewly diagnosed essential hypertensive by a competent \nclinician whether on treatment or not whose age is \nbetween 20 -70 years. 2. Normotensive individuals who \nhas never been diagnosed of any form of hypertension \nand whose blood pressure was within normal limit and \nnot below 20years or above 70 years.\nExclusion criteria: People with deformities and deep \nburns of fingers and palm, people below the age of 20 \nand above 70 years and people who were critically ill.\nThe palm prints were taken with a palm print scanner. The \nparticipants were asked to clean their hands to remove \nany dirt that may be associated with the skin ridges and \nplace it on the electronic palm scanner. The palm prints \nwere captured with the scanner and projected to the \nscreen of the laptop connected to it. The palm prints \nwere studied quantitatively for palmar angle parameters \n[Axial triradius (atd) and Digital triradius (dat) angles) using \nan AutoCAD software ( Figure 1 ).\nTable I: Classification of blood pressure according to the ESC (European Society \nof Cardiology) Guidelines\n(Niebauer, et al., 2018)12.Category Systolic (mmHg) Diastolic (mmHg)\nOptimal  <120 <80\nNormal  120-129 80-84\nHigh normal 130-139 85-89\nGrade 1 hypertension 140 \u2013 159 90 -99\nGrade 2 hypertension  160 \u2013 179 100 \u2013 109\nGrade 3 hypertension  >= 180 >=110\nIsolated systolic hypertension >=140 <90\nFigure 1:  Scheme to show digital patterns, a,b,c,d and triradii, ATD and DAT \nangles (Oladipo et al., 2010)4.Busuyi Kolade et al.  87\n2022/37 (3): 85-90 Quantitative digito-palmar dermatoglyphics analysis in essential hypertension in a Nigerian population\nData collection was done within the period of March \n2021 to May 2021. Using a well-structured interviewer \nadministered questionnaire, in which personal information, \nparameters investigated and blood pressure of participants \nwere recorded. The questionnaire was divided into three \nsections A, B and C. Section A contained the bio-data of \nthe subject, section B contained health related data and \nsection C contained palmar dermatoglyphics data of the \nsubject which were analysed.\nEthical Consideration\nEthical approval for the study was obtained from \nFederal Medical Centre, Owo, Ondo State, Nigeria with \nthe reference number: FMC/OW/380/VOL.CX/162. \nInformed consents was taken from individual persons, \nexplanations about the purpose of the research was \ngiven to them.\nBlood Pressure Measurement\nA digital Sphygmomanometer was used to measure blood \npressure. The subject was asked to sit on a chair with feet \nflat on the floor and arm on the table at heart height. The cuff \nwas wrapped around the upper arm, about 2-3 cm above \nthe elbow, directly against the skin. The start button was \npressed and machine was allowed to record measurement. \nThe individual stayed still and did not move his/her arm \nuntil the measurement was complete. The arm cuff was \ncompletely deflated and removed after measurement. The \nsystolic and diastolic values were recorded in mmHg and \nthe sphygmomanometer was turned off.\nPalmar Dermatoglyphics Parameters\nCanoScan LiDE 300 scanner version 1.5.0 was used to \nobtain the fingerprint of individuals. The right and left hands \nof the respondent were cleaned and placed gently on the \nscreen of the scanner which was connected to a HP Folio \n13-laptop computer and a digital image of the hands were \nobtained. The lid of the scanner was closed when scanning \nto minimize undesirable stray of light. The scanned images \nwere immediately coded with an ID number. Palm angles \nwere measured using AutoCAD software. The a-b ridge \ncounts were determined by counting the number of ridges \nthat cross a straight line drawn from a\u2019 triradius (at the base \nof index finger) to \u2018b\u2019 triradius (at the base of middle finger) \nof the palm in each hand.\nData were analyzed using the Statistical package \nfor social sciences (SPSS) software version 26.0. \nDescriptive variables such as age, gender, anthropometric \nmeasurements and dermatoglyphic values were \npresented as frequencies, percentage and means \n(\u00b1standard deviation). The independent Student\u2019s t-test was used to determine significant differences between \nmeans of quantitative variables. The P value was regarded \nas significant at P<0.05 at a confidence interval of 95%.\nResults\nResults of the study were presented in tables II-XII . \nTable II  shows the biodata of respondents. The means \nage of the test group was 48.67\u00b114.70 while that of the \ncontrol was 39.43\u00b113.87. The mean Body Mass Index \n(BMI) of the test group was 25.18\u00b16.51 and that of the \ncontrol was 22.69\u00b14.28.\nTable III  shows the a-b ridge count of respondent \namong test and control group. The mean of right a-b \nridge count in the control group (41.83\u00b15.019) was \nsignificantly (p<0.001) higher than the test group (34.61 \n\u00b13.550). The mean of left a-b ridge count in the control \ngroup (40.91\u00b14.907) was significantly (p<0.001) higher \nthan the test group (34.39\u00b13.038).\nTable IV  shows the a-b ridge count of male respondent \namong the test and control group. The mean of right a-b \nridge count and left a-b ridge count were significantly \n(p<0.001) higher in the control group than the test group.\nTable V  shows the a-b ridge count of female respondent \namong the test and control group. The right a-b ridge \ncount was statistically (p<0.001) higher in the control group \n(42.56\u00b14.949) than the test group (34.96\u00b13.301). The left \na-b ridge count was significantly (p<0.001) higher in the \ncontrol group (41.46\u00b15.504) than test group (34.64\u00b12.884).\nTable VI  shows the a-b ridge count between male and \nfemale test group. There was no significant difference in \nthe a-b ridge count among the genders.\nTable VII  shows the a-b ridge count between male and \nfemale control group. There was no significant difference \nin the a-b ridge count among the genders.\nTable VIII  shows the palmar angles of respondent. The \nleft atd angle was significantly higher in the control group \nthan the test group. There was no significant difference \nin the right atd angle, right dat angle and left dat angle in \nthe test and control group among the genders.\nTable IX  shows the palmar angles between male and \nfemale test group. The right atd angle was significantly \n(p=0.032) higher in females (42.66\u00b16.573) than in \nmales (40.20\u00b14.562). The left atd angle was significantly \n(p=0.005) higher in females (42.34\u00b15.770) than in males \n(39.34\u00b14.706). However, there was no significant difference \nin the right dat angle and left dat angle among the genders.\nTable X  shows the palmar angle between male and \nfemale control group. There was no statistical significant 88\n2022/37 (3): 85-90Busuyi Kolade et al.  \ndifference in the palmar angle among the male and \nfemale control group.\nTable XI  shows the palmar angle between female \nrespondent among the test and control group. There was no \nstatistical significant difference in the palmar angle (atd and \ndat angles) of females among the test and control group.\nTable XII  shows the palmar angle between male \nrespondent among the test and control group. The left \natd angle was significantly higher in the control group \n(41.8\u00b15.460) than the test group (39.34\u00b14.706). \nHowever, there was no significant difference in the right \natd angle, right dat angle and left dat angle among the \ntest and control group.\nTable II: Showing the Age distribution and Body Mass Index of respondents.\n[* mean (SD)]Parameters Test group Control group Total\n (n=100) (n=100) (n=200)\nAge (Yrs) 48.67(14.70)* 39.43(13.87)* 44.05(14.99)*\n20-30 15 28 43\n31-40 13 29 42\n41-50 21 21 42\n51-60 26 11 37\n61-70 25 11 36\nBMI (Kg/m2) 25.18(6.5)* 22.69(4.28)* 23.93(5.66)*\nTable III: a-b ridge count of respondent.\n Test Group Control Group \nParameters N=100 N=100 P value\n Mean SD Mean SD \nRight a-b 34.61 3.55 41.83 5.019 <0.001\nLeft a-b 34.39 3.038 40.91 4.907 <0.001\n*\nTable IV: a-b ridge count of male respondent.\n Male \n N=100\nParameters Test Group Control Group P value\n N=50 N=50\n Mean SD Mean SD\nRight a-b 34.26 3.784 41.10 5.032 <0.001\nLeft a-b 34.14 3.194 40.36 4.213 <0.001\n*\nTable V: a-b ridge count of female respondent.\n Female \n N=100\nParameters Test Group Control Group P value\n N=50 N=50\n Mean SD Mean SD\nRight a-b 34.96 3.301 42.56 4.949 <0.001\nLeft a-b 34.64 2.884 41.46 5.504 <0.001\n*Table XII: Palmar angle between of male respondent.\n Male \n N=100\nParameters Test Group Control Group P value\n N=50 N=50\n Mean SD Mean SD\nRight atd 40.20 4.562 41.62 6.315 0.200\nLeft atd 39.34 4.706 41.84 5.460 0.016\nRight dat 60.34 4.939 58.86 5.139 0.145\nLeft dat 60.02 6.146 58.50 4.791 0.171Table XI: Palmar angle between of female respondent.\n Female \n N=100\nParameters Test Group Control Group P value\n N=50 N=50\n Mean SD Mean SD\nRight atd 42.66 6.573 43.64 6.555 0.457\nLeft atd 42.34 5.770 43.24 5.909 0.443\nRight dat 57.86 5.845 58.60 5.660 0.522\nLeft dat 58.68 5.575 57.62 5.536 0. 342\n*\nTable VI: a-b ridge count of test group.\n Test Group  \n N=100\nParameters Male Female P value\n N=50 N=50\n Mean SD Mean SD\nRight a-b 34.26 3.784 34.96 3.301 0.327\nLeft a-b 34.14 3.194 34.64 2.884 0.413\n*Table VII: a-b ridge count between male and female control group.\n Control Group  \n N=100\nParameters Male Female P value\n N=50 N=50\n Mean SD Mean SD\nRight a-b 41.10 5.032 42.56 4.949 1.470\nLeft a-b 40.36 4.213 41.46 5.504 0.265\n*\nTable IX: Palmar angles between male and female test group.\n Test Group   \n N=100\nParameters Male Female P value\n N=50 N=50\n Mean SD Mean SD\nRight atd 40.20 4.562 42.66 6.573 0.032\nLeft atd 39.34 4.706 42.34 5.770 0.005\nRight dat 60.34 4.939 57.86 5.845 0.240\nLeft dat 60.02 6.146 58.68 5.575 0.256\n*\nTable X: Palmar angle between male and female control group.\n Control Group \n N=100\nParameters Male Female P value\n N=50 N=50\n Mean SD Mean SD\nRight atd 41.62 6.315 43.64 6.555 0.120\nLeft atd 41.84 5.460 43.24 5.909 0.221\nRight dat 58.86 5.139 58.60 5.660 0.810\nLeft dat 58.50 4.791 57.62 5.536 0.397\n* Test Group Control Group \nParameters N=100 N=100 P value\n Mean SD Mean SD \nRight atd 41.43 5.763 42.63 6.483 0.168\nLeft atd 40.84 5.4517 42.54 5.704 0.032\nRight dat 59.10 5.526 58.73 5.380 0.632\nLeft dat 59.35 5.876 58.06 5.169 0.101\n*Table VIII: Palmar angles of respondent.\n*\n* [Data expressed as mean and SD. P-value < 0.05 was considred \n    as statistically significant]89\n2022/37 (3): 85-90 Quantitative digito-palmar dermatoglyphics analysis in essential hypertension in a Nigerian population\nDiscussion\nA number of studies have found that dermatoglyphic \nfeatures are linked to essential hypertension. The \nimportance of dermatoglyphics is not to diagnose an \nillness that has already occurred, but to avoid sickness \nby identifying people who have a hereditary susceptibility \nto specific diseases7. The present study consist of 200 \n(100 males and 100 females) Nigerian adults who were \nselected randomly irrespective of their ethnic groups.\nIn this study, the mean a-b ridge count in the control group \nwas significantly (p<0.001) higher than the test group. \nThis is similar to a study conducted in India by Devi et al.8 \nwho reported that a significant difference was observed \nbetween hypertensive and control group in their a-b ridge \ncounts where control group found to have significantly \nhigher a-b ridge counts than hypertensive patients.\nIn males, the mean of right and left a-b ridge count was \nsignificantly (p<0.001) higher in the control group than \nthe test group. This was similar to the study by Tafazoli et \nal.9 in Iran where it was observed that in male group, the \nmean a-b ridge count was less in patients than in healthy \npeople. In females, the mean of right and left a-b ridge \ncount was significantly (p<0.001) higher in the control \ngroup than the test group. This was contrary to a similar \nstudy by Tafazoli et al.9 in Iran where it was observed that \nthere was no significant difference in the a-b ridge count \nof both hands of female test and control groups. The \ndifference observed in this study may be due either to the \nvarying sample size or racial and ethnic variation.\nIn the present study, the left atd angle was significantly \nhigher in the control group than the test group, however, \nthere was no significant difference in the right atd angle. \nThis is contrary to a study by Nancy et al.10 in India whereby \nit was reported that the mean atd angle in hypertensive \npatients for both hands was statistically significantly higher \nthan controls. In males, the left atd angle was significantly \nhigher in the control group (41.8\u00b15.460) than the test \ngroup (39.34\u00b14.706). This is similar to the study of Devi \net al.8 whereby it was observed that in males, controls \nhave higher \u2018atd\u2019 value than patients (Means = 47.57 and \n45.22 respectively). \nThere was no statistical significant difference in the atd \nangles of females among the test and control group. \nThis is contrary to the study done in Iran by Tafazoli et \nal.9 whereby it was stated that in females, atd angle was \nsignificantly higher in the test group than the control group. In the test group, the right atd angle was significantly \n(p=0.032) higher in females (42.66\u00b16.573) than in \nmales (40.20\u00b14.562). The left atd angle was significantly \n(p=0.005) higher in female test group (42.34\u00b15.770) than \nmale test group (39.34\u00b14.706). This is contrary to the \nstudy done by Deepa11 in India who observed decreased \natd value for both sexes in hypertensive patients.\nIn the present study, there was no significant difference \nin the right and left dat angle in the test and control group \namong the genders. In males, there was no significant \ndifference in the dat angle among the test and control \ngroup. This is similar to the study of Devi et al.8 whereby it \nwas reported that no significant difference was observed \nbetween groups and hands (left and right) for mean of \n\u2018dat\u2019 angles in males. \nThere was no statistical significant difference in the \npalmar angle among the male and female control group. \nThis is similar to the study of Oladipo et al.4 whereby it \nwas reported that no significant difference was found in \nthe DAT angle between male and female control group.\nThe results obtained in this study shows a definite \nassociation exists between palmar dermatoglyphics \nand essential hypertension. a-b ridge count and atd \nangle are lesser in essential hypertensive population \ncompared to normal people. Thus, measurement of a-b \nridge count can be used as a reliable predictive tool in \nearly identification of individuals who are at higher risk \nof developing essential hypertension and preventive \nmeasures can be undertaken to prevent the occurrence \nof essential hypertension in those at risk.\nAcknowledgements\nNot applicable\nDeclaration of interest statement\nThe authors declared no potential conflicts of interest with \nrespect to the research, authorship, and/or publication of \nthis article.\nFunding\nThis research received no specific grant from any funding \nagency in the public, commercial, or not-for-profit sectors.90\n2022/37 (3): 85-90Quantitative digito-palmar dermatoglyphics analysis in essential hypertension in a Nigerian populationBusuyi Kolade et al.  \nReferences\n1. Akingbade AM, Saalu LC, Akunna GG, Anderson LE, Olusolade F. \nFinger and palmar dermatoglyphic study among the Yorubas in Jos, \nNigeria. Annals of Bioanthropology 2014;2(2):49.\n2. Achalli S, Patla M, Nayak U, Soans, C. Dermatoglyphics and \northodontics. International Journal of Orthodontic Rehabilitation 2016; \n7(4):144.\n3. Abhilasha S, Balreet K, Nidhi P , Ajitpal S. Palmar dermatodlyphics: \nmass screening tool for hypertension. International Journal of Anatomy \nResearch 2017; 5(2.2): 3850-4.\n4. Oladipo G, Bobmanuel I, Ugboma H, Sapira M, Ekeke O. Palmar \ndermatoglyphics in essential hypertension amongst rivers indigenes. \nAustralian Journal of Basic and Applied Sciences 2010; 4:6300-5.\n5. Venkatesh E. Palmar dermatoglyphics in oral leukoplanka and oral \nsquamous cell carcinoma patients (Doctoral dissertation, RGUHS 2006).\n6. Wijerathne BT, Meier RJ, Agampodi TC, Agampodi SB. Dermatoglyphics \nin hypertension: a review. Journal of physiological anthropology 2015; \n34(1):29.7. Bulagouda RS, Patil PJ, Hadimani GA, Bannur BM, Patil B, Mallashetty \nNS, et al. Study of palmar dermatoglyphics in patients with essential \nhypertension between the age group of 20\u201350 years. International \nJournal of Medical Research & Health Sciences 2013; 2(4):773-9.\n8. Sumangala Devi K, Mahalinga M, Savitha M. Palmar Dermatoglyphics \nin Essential Hypertension. Journal of Dental and Medical Sciences (IOSR-\nJDMS) 2016;15(7):27-30\n9. Tafazoli M, Dezfooli SR, Shahri NM. The study of dermatoglyphic \npatterns and distribution of the minutiae in inherited essential \nhypertension disease. Curr Res J Biol Sci. 2013;5:252\u201361.\n10. Anitha N, Harisha P , Vijaykishan B, Chandra Philip X. Palmar & \ndigital dermatoglyphic patterns in essential hypertension \u2013 A study in \nPuducherry population. Indian Journal of Clinical Anatomy and Physiology \n2020; 7(2):164-8.\n11. Deepa G. Study of Palmar Dermatoglyphics in Essential Hypertension. \nNational Journal of Integrated Research in Medicine 2013; 4 (3).\n12. Niebauer J, Boerjesson M, Carre F, Caselli S. Palatini P . Quattrini F \net al. Recommendations for participation in competitive sport of athletes \nwith arterial hypertension: a position statement from sports cardiology \nsection of the European Association of Preventive Cardiology (EAPC). \nEuropean Heart Journal 2018; 39(40):3664-71.91\n2022/37 (3): 91-94Received:  1 - III - 2022\nAccepted:  22 - III - 2022\ndoi: 10.3306/AJHS.2022.37.03.91Corresponding author\nElis Anggeria  \nE-mail: elisanggeria@unprimdn.ac.id\nAbstract  \nIntroduction:  Chronic kidney failure is a failure of kidney function to maintain metabolism and fluid and electrolyte balance. Fatigue \nis one of the most frequent complaints of hemodialysis patients. \nObjective:  The purpose of this study was to determine the relationship between muscle stretching exercises and decreased \nfatigue in chronic renal failure patients undergoing hemodialysis. \nMethods: This type of research is quantitative with cross-sectional. The population in this study was 140 patients who were taken \nusing the purposive sampling technique and 28 patients were obtained as the sample. Analysis of this study using the Pearson test. \nResults:  Pearson test results with a p-value of 0.000 <0.05 so that the conclusion is that there is a training relationship stretching \nof this muscle with decreased fatigue in chronic renal failure patients undergoing hemodialysis. \nConclusion:  There is a relationship between muscle stretching exercises and decreased fatigue in chronic renal failure patients \nundergoing hemodialysis.\nKey words:  Fatigue, stretching, chronic kidney failure.\nResumen\nIntroducci\u00f3n:  La insuficiencia renal cr\u00f3nica es un fallo de la funci\u00f3n renal para mantener el metabolismo y el equilibrio de l\u00edquidos \ny electrolitos. La fatiga es una de las quejas m\u00e1s frecuentes de los pacientes en hemodi\u00e1lisis. \nObjetivo: El prop\u00f3sito de este estudio fue determinar la relaci\u00f3n entre los ejercicios de estiramiento muscular y la disminuci\u00f3n de \nla fatiga en pacientes con insuficiencia renal cr\u00f3nica sometidos a hemodi\u00e1lisis. \nMetodolog\u00eda. Este tipo de investigaci\u00f3n es cuantitativa con corte transversal. La poblaci\u00f3n de este estudio fue de 140 pacientes \nque se tomaron mediante la t\u00e9cnica de muestreo intencional y se obtuvieron 28 pacientes como muestra. El an\u00e1lisis de este \nestudio se realiz\u00f3 mediante el test de Pearson.\nResultados:  Los resultados de la prueba de Pearson con un valor p de 0,000 <0,05 por lo que la conclusi\u00f3n es que existe una \nrelaci\u00f3n entre el entrenamiento de estiramiento de este m\u00fasculo con la disminuci\u00f3n de la fatiga en los pacientes con insuficiencia \nrenal cr\u00f3nica en hemodi\u00e1lisis. \nConclusi\u00f3n:  Existe una relaci\u00f3n entre los ejercicios de estiramiento de este m\u00fasculo con la disminuci\u00f3n de la fatiga en los \npacientes con insuficiencia renal cr\u00f3nica sometidos a hemodi\u00e1lisis.\nPalabras clave: Fatiga, estiramiento, insuficiencia renal cr\u00f3nica.ORIGINAL\nRelationship of muscle stretching exercise \nwith reducing fatigue in renal failure patients chronic \nRelaci\u00f3n del ejercicio de estiramiento muscular con la reducci\u00f3n de la fatiga \nen pacientes con insuficiencia renal cr\u00f3nica\nLuvitha Herli      , Elis Anggeria      , Patimah Sari Siregar      \nFaculty of Nursing and Midwifery, Universitas Prima IndonesiaeISSN 2255-0569\nID ID ID92\n2022/37 (3): 91-94Luvitha Herli et al.  \nIntroduction\nKidney disease is a disorder that affects the kidney organs \nthat arises due to various factors, such as infections, \ntumors, congenital abnormalities, metabolic or degenerative \ndiseases. These abnormalities can affect the structure and \nfunction of the kidneys with varying degrees of severity. \nPatients may feel pain, have urinary problems, etc1. \nAccording to Pernefri2 stated that there were 17,193 new \npatients undergoing hemodialysis, an increase in 2015 \nof 21,050 new patients undergoing hemodialysis. The \naction of acute hemodialysis is not too much, only about \n0.9%. In North Sumatera Province, of the 14 registered \nhemodialysis units, there were 1,075 new patients \nundergoing hemodialysis, and 1,236 patients actively \nundergoing hemodialysis.\nFatigue is one of the most frequent complaints of \nhemodialysis patients and is associated with health \nproblems related to the quality of life. Fatigue is the most \ncommon symptom of hemodialysis and is associated \nwith poor quality of life3. Study El and Bayumi4 stated \na high frequency of fatigue in hemodialysis patients. \nOverall, men had more fatigue than women when treated \nwith hemodialysis.\nHemodialysis nurses are expected to monitor fatigue, \nprovide health education about physical exercise and \nprovide holistic nursing care5. According to Seshadri et \nal6, interventions to increase physical activity should be \nconsidered as a possible approach to managing fatigue \nand insomnia. \nThis research has novelty from other research. This \nstudy suggests a cause-and-effect relationship between \nmuscle stretching exercises with decreased fatigue \nin chronic renal failure patients. Stretches should be \nadapted to muscle structure, flexibility, and varying \ndegrees of tension. The key is to be organized and \nrelaxed. The goal is to reduce muscle tension, allowing \nmovement to be freer than focusing on gaining extreme \nflexibility, which often results in overstrain and injury7.\nMethods\nThis type of research is pre-experimental with a one-group \npre-post test design, which is to reveal a causal relationship \nby involving one group of subjects. This research was \nconducted at the Royal Prima General Hospital, Medan.\nThe population in this study were all patients with kidney \nfailure who underwent hemodialysis at the Royal Prima \nGeneral Hospital Medan as many as 140 patients with \nkidney failure who underwent hemodialysis. The sampling \ntechnique in this research is purposive sampling. Thus \nthe number of samples in this study was 28 people.The data collection technique used a questionnaire \nprepared by researchers according to the needs of \npatients in the field. Guide to doing muscle stretching \nexercises based on Anderson and Anderson7. Ethical \nclearance from the Ethics Committee of Universitas \nPrima Indonesia.\nThe data analysis technique used univariate and bivariate \nanalysis. Univariate analysis with a description of the \nfrequency distribution of muscle stretching exercise activity \nand fatigue in patients. Bivariate analysis to determine \nthe relationship between the independent variable and \nthe dependent variable using the Pearson test. The \nmeasurement results are obtained with a significance degree \n(\u03b1) of 0.05, if x\u00b2 count > x\u00b2 table then Ho is rejected and Ha \nis accepted indicating that there is a relationship between \nthe independent variable and the dependent variable.\nResults  \nUnivariate Analysis\n1. Characteristics of Respondents\nBased on table I  above, it is known that from the 28 \nrespondents the majority were male as many as 15 \npeople (54%), and the female minority as many as 13 \npeople (46%). The majority were aged 36-45 years as \nmany as 12 people (43%) and 26-35 years as many as \n3 people (11%). The majority started hemodialysis for 1 \nyear amounted to 11 people (39%) with the minority for 4 \nyears amounted to 3 people (11%).\nExercise Muscle StretchTable I: Distribution of frequency and percentage of respondents. \nCharacteristics \nNo.  Characteristics \n of Respondents Total (n) Percentage (%)\n1.  Gender  \n Man 15 54\n Woman 13 46\n Total 28 100\n2.  Age  \n 17-25 Years 5 18\n 26-35 Years 3 11\n 36-45 Years 12 43\n 46-55 Years 8 28\n Total 28 100\n3.  Start HD  \n 4 years 3 11\n 3 years 4 14\n 2 years 10 36\n 1 year 11 39\n Total 28 100\nTable II: Distribution of fatigue frequency in chronic kidney failure patients \nundergoing hemodialysis.\nNo.  Muscle Stretching  \n Exercises Amount Percentage(%)\n1.  Active 26 93\n2.  Not active 2 7\n Total 28 10093\n2022/37 (3): 91-94Relationship of muscle stretching exercise with reducing fatigue in renal failure patients chronic \nBased on table II , it is known that after muscle stretching \nexercises, the majority of active exercises were 26 \npeople (93%) while the minority of inactive exercises \nwere 2 people (7%).\nPatient Fatigue\nBased on table III  above, it can be seen that after doing \nstretching exercises the majority of acute fatigue was 26 \npeople (93%) while the minority of chronic fatigue was \n2 people (7%).\nBivariate Analysis\nBased on the results of research on the relationship \nbetween muscle stretching exercises and decreased \nfatigue in renal failure patients undergoing hemodialysis. \nThe relationship of muscle stretching \nwith patient fatigue\nBased on table IV  above, it can be seen that the results \nof the Pearson test when the p-value was obtained \nwas 0.000 < 0.05 so that the conclusion was Ho was \nrejected and Ha was accepted, it was concluded that \nthere was a relationship between muscle stretching \nexercises and decreased fatigue in chronic kidney failure \npatients undergoing hemodialysis at home Royal Prima \nMedan General Hospital.\nDiscussion\nBased on the data after muscle stretching exercise, the \nmajority of active exercises were 26 people (93%) while the \nminority of inactive exercises were 2 people (7%). This is \nindicated by the response of respondents who are willing \nto be given muscle stretching exercises after undergoing \nhemodialysis. Respondents wanted to do the muscle \nstretching exercises independently at home according to \nwhat had been taught by previous researchers.\nBased on data previously obtained from respondents \nwho felt their head felt heavy, yawned frequently, felt tired \nand drowsy. Respondents also often complain that the \nlength of time undergoing hemodialysis makes them feel \ntired. According to research Jhamb et al8, patients with advanced chronic kidney disease experience profound \nfatigue. Symptoms of depression, restless leg syndrome, \nexcessive daytime sleepiness, and low albumin levels may \nprovide targeted interventions to increase fatigue in patients.\nThe results of this study it can be seen that the results \nof the Pearson test when the p-value was obtained was \n0.000 <0.05 so that the conclusion was Ho was rejected \nand Ha was accepted, it was concluded that there was \na relationship between muscle stretching exercises and \ndecreased fatigue in patients with chronic kidney failure \nundergoing hemodialysis.\nExercise can help HD patients to reduce the severity of \nRestless legs syndrome (RLS) or restless legs syndrome, \ndepression, and fatigue9. Stretching exercises are not \nonly done to reduce fatigue but can also be useful for \nreducing the intensity of pain felt by the elderly10. Study \nAgisha Mol et al11 showed that leg ergometric exercises \nwere effective in reducing fatigue levels in Chronic Kidney \nDisease patients undergoing Hemodialysis. There is \na significant relationship between age and duration of \nillness with the level of fatigue.\nMuscle stretching exercises can help patients \nreduce fatigue. Fatigue is a common phenomenon \namong patients with kidney disease, but often goes \nunrecognized12. Fatigue, anxiety, depression, and sleep \nquality are significant problems for patients undergoing \nhemodialysis13. Fatigue is an important symptom for \npatients with advanced chronic kidney disease8.\nMuscle range of motion exercises can be an excellent \nalternative to reduce the patient\u2019s level of fatigue. If the \nmovement is not done at all and the patient\u2019s fatigue is \nnot identified and cannot be described, the patient can \nworsen the treatment process that is being undertaken. \nNurses need to assess fatigue through nursing care, to \nassess and identify the possible impact on patients while \nbeing diagnosed with chronic kidney failure. Decreased \nquality of life and cardiovascular disorders are further \nimpacts that must be prevented so that fatigue does not \nget worse and can be anticipated.\nConclusion\nThe results showed that the majority of muscle stretching \nexercises had active exercises, experienced acute \nfatigue. The results of the Pearson test showed that the \np-value was 0.000 so that Ho failed to be rejected. The \nconclusion is that there is a relationship between muscle \nstretching exercises and decreased fatigue in patients \nwith chronic kidney failure undergoing hemodialysis. \nInterests conflict \nThe authors declare that they have no conflict of interest.Table III: Distribution of Fatigue Frequency in Chronic Kidney Failure Patients \nUndergoing Hemodialysis.\nNo. Fatigue Amount Percentage(%)\n1.  Acute 26 93\n2.  Chronic 2 7\n Total 28 100\n Muscle Fatigue  \nStretching Chronic Acute Total P-value\nExercises \u0192 % \u0192 % N % \nNot active 2 7.1 0 0.0 2 7.1 0.00\nActive 0 0.0 26 92.9 26 92.9 \nTotalTable IV: Frequency Distribution of Muscle Stretching Exercises with Reduction \nof Fatigue in Chronic Kidney Failure Patients Undergoing Hemodialysis.94\n2022/37 (3): 91-94Relationship of muscle stretching exercise with reducing fatigue in renal failure patients chronic Luvitha Herli et al.  \nReferences\n1. Kementerian Kesehatan RI. Riskesdas Tahun 2013. In Jakarta: Badan \nPenelitian dan Pengembangan Kesehatan Departemen Kesehatan \nRepublik Indonesia. 2013 \n2. PERNEFRI. 8th Report Of Indonesian Renal Registry. Program \nIndonesia Renal Registry. 2015.\n3. Georgios T. Assessment of quality of life and fatigue among \nhaemodialysis patients. American Journal of Nursing Science 2015; \n4(2):66-73. \n4. El HA, Bayumi A. Factors affecting fatigue in chronic renal failure \npatients under hemodialysis treatment at Qena University Hospital in \nUpper Egypt. Journal of Biology 2015; 5(14). \n5. Sulistini R, Yetti K, Hariyati RTS. Faktor-faktor yang mempengaruhi \nfatigue pada pasien yang menjalani hemodialisis. Jurnal Keperawatan \nIndonesia 2012; 15(2):75-82. \n6. Sheshadri A, Kittiskulnam P , Johansen KL. Higher physical activity \nis associated with less fatigue and insomnia among patients on \nhemodialysis. Kidney International Reports 2019; 4(2):285-92. \n7. Anderson B, Anderson J. Stretching (Peregangan). 2008 PT. \nSerambi Ilmu Semesta.  Available at:https://books.google.co.id/\nbooks?id=Hdk89FzGDf8C&printsec=frontcover&hl=id&source=gbs_\nge_summary_r&cad=0#v=onepage&q&f=false8. Jhamb M, Liang K, Yabes J, Steel JL, Dew MA, Shah, N, et al. \nPrevalence and correlates of fatigue in CKD and ESRD: Are sleep \ndisorders a key to understanding fatigue? Am J Nephrol 2013; \n38(6):489-95.\n9. Song YY, Hu RJ, Diao YS, Chen L, Jiang XL. Effects of Exercise \nTraining on Restless Legs Syndrome, Depression, Sleep Quality, and \nFatigue Among Hemodialysis Patients: A Systematic Review and \nMeta-analysis. Journal of Pain and Symptom Management 2018; \n55(4):1184-95.\n10. Thejaswi VR, Latha A, Indira A, Radhika M. Effectiveness of leg \nstretch exercises on fatigue among patients undergoing haemodialysis. \nInternational Journal of Applied Research 2016; 2(6):74-6.\n11. Agisha Mol, JM, Nisha CM, Evency AR. Effectiveness of leg \nergometric exercise on level of fatigue among patients with chronic \nkidney disease undergoing haemodialysis. International Journal of \nNursing Education 2020; 12(3):20-3 \n12. Artom M, Moss-Morris R, Caskey F, Chilcot J. Fatigue in advanced \nkidney disease. In Kidney International 2014; 86(3):497-505. \n13. Al Naamani Z, Gormley K, Noble H, Santin O, Al Maqbali M. \nFatigue, anxiety, depression and sleep quality in patients undergoing \nhaemodialysis. BMC Nephrology 2021; 22(1):157. 95\n2022/37 (3): 95-101Received:  8 - III - 2022\nAccepted:  25 - IIII - 2022\ndoi: 10.3306/AJHS.2022.37.03.95Corresponding author\nPedro Antonio L\u00f3pez Guti\u00e9rrez   \nE-mail: unicahinvestigacion20219@gmail.com\nAbstract  \nObjectives:  Helicobacter pylori is a bacterium that infects the gastric mucosa and causes both local and systemic diseases in \nchildren and adults. We aimed to establish Helicobacter pylori prevalence in the population studied and relate its presence with \nknown risk factors for its infection, including parental educational level and nutritional variables. \nMethods:  This was an analytical cross-sectional study conducted in a public school in Tegucigalpa, Honduras, in August 2019, \nwhere 101 students between 6 and 12 years old were randomly selected after the signing of an informed consent form by their \nlegal guardians and the child\u2019s own acceptance. Subsequently, a demographic survey was completed, and a stool sample was \nobtained from the participants to detect Helicobacter pylori antigen. \nResults:  Of the 101 schoolchildren studied, 18 (17.82%) tested positive. The mean age of participation was 8.9 \u00b1 1.88 years, \n58.4% female, 42.6% male. Educational level of the mother and father in relation to the prevalence of Helicobacter pylori had an \nodds ratio: 6.8 (CI 95: 2.17 - 21.63) and odds ratio: 5.7 (1.45 - 23.8), respectively. \nConclusions:  The prevalence of Helicobacter pylori was lower than in similar studies carried out in developing countries, and \nhigher than in research on populations in developed countries. A relationship was identified with the educational level of both \nparents. No association was found with age, gender, body mass index, overcrowding, housing characteristics, access to basic \nservices, pet ownership, family history of Helicobacter pylori infection or gastric cancer. \nKey words:  Helicobacter pylori, prevalence, education, body mass index.\nResumen\nObjetivos: Helicobacter pylori es una bacteria que infecta la mucosa g\u00e1strica y que causa enfermedades tanto locales como \nsist\u00e9micas en ni\u00f1os y adultos. El objetivo fue establecer la prevalencia de su infecci\u00f3n en la poblaci\u00f3n estudiada y relacionar su \npresencia con factores de riesgo conocidos, incluyendo el nivel educativo de los progenitores. \nM\u00e9todos:  Estudio anal\u00edtico, transversal, en una escuela p\u00fablica de Tegucigalpa, Honduras, en agosto de 2019, donde se \nseleccionaron aleatoriamente 101 escolares entre 6 y 12 a\u00f1os, previa firma de un consentimiento informado por parte de sus \ntutores legales, y la aceptaci\u00f3n del propio infante. Se complet\u00f3 una encuesta sociodemogr\u00e1fica y se obtuvo una muestra de heces \nde los participantes para detectar el ant\u00edgeno de Helicobacter pylori. \nResultados: De 101 escolares estudiados, 18 (17.82%) dieron positivo. La edad media de participaci\u00f3n fue de 8.9 \u00b1 1.88 a\u00f1os, \n58,4% mujeres y 42.6% hombres. El nivel educativo de la madre y del padre con respecto a la positividad de Helicobacter pylori \ntuvo un odds ratio: 6.8 (IC 95: 2.17 - 21.63) y odds ratio: 5.7 (1.45 - 23.8), respectivamente. \nConclusiones: La prevalencia de Helicobacter pylori fue inferior a la de estudios similares realizados en pa\u00edses en v\u00edas de \ndesarrollo, y superior a la de investigaciones realizadas en poblaciones de pa\u00edses desarrollados. Se identific\u00f3 una relaci\u00f3n con el \nnivel educativo de ambos padres. No se encontr\u00f3 ninguna asociaci\u00f3n con la edad, sexo, \u00edndice de masa corporal, hacinamiento, \ncaracter\u00edsticas de la vivienda, acceso a los servicios b\u00e1sicos, posesi\u00f3n de animales dom\u00e9sticos, antecedentes familiares de \ninfecci\u00f3n por Helicobacter pylori o de c\u00e1ncer g\u00e1strico.\nPalabras clave: Helicobacter pylori, prevalencia, educaci\u00f3n, \u00edndice de masa corporal.ORIGINAL\nHelicobacter Pylori  infection among asymptomatic \nschoolchildren: Link with parental educational level \nInfecci\u00f3n por Helicobacter Pylori en escolares asintom\u00e1ticos: \nRelaci\u00f3n con el nivel educativo de los padres\nPedro Antonio L\u00f3pez Guti\u00e9rrez1      , Alexandra Marcela Palma Gonz\u00e1les1      ,\nSarah Angelly Membre\u00f1o Soto2      , Gabriel Isa\u00edas Rodriguez Lagos1      ,\nWadia Marie Sim\u00f3n Andonie2      , Blanca Nelys Licona Hern\u00e1ndez2      \n1. Catholic University of Honduras. Faculty of Medicine, General Practitioner\n2. Catholic University of Honduras. Student of General MedicineeISSN 2255-0569\nID ID\nID ID\nID ID96\n2022/37 (3): 95-101Pedro Antonio L\u00f3pez Guti\u00e9rrez et al.  \nIntroduction\nInitially classified and described by a team of Australian \nphysicians through gastroscopic biopsies of the \nantral muscosa1, Helicobacter pylori (H.pylori) is a \nmicroaerophilic, 4- to 6-flagellated, urease-, catalase- \nand oxidase-producing, spiral-shaped, gram-negative \nbacillus-like bacterium2, that has the capacity to invade \nthe gastric mucosa and reduce the natural acidity of this \ntissue, thus enabling it to survive in this environment and \ncontribute to the deterioration of human health3,4.\nEven though its infection can occur asymptomatically5, \nwithin the spectrum of diseases to which H. pylori has \nbeen related to, in the adult population, we encounter a \nspan extending from chronic gastritis, gastroduodenal \nulcer, and vitamin B12 deficiency6-8, all the way to \nesophageal and gastric adenocarcinoma and gastric \nmucosa-associated lymphoid tissue lymphoma (MALT), \nbeing neoplasms its most feared consequence9-11. In \nfact, the International Agency for Research on Cancer \ncategorized it as a type I carcinogenic agent due to \nevidence that demonstrates both a correlative and \netiological relationship with gastric cancer in human \nbeings12,13.  \nThen again, in children, idiopathic thrombocytopenic \npurpura has been described as a disease related to H. \npylori infection14, as well as a decreased growth rate and \nthe development of iron deficiency anemia due to the \npresence of the sabA gene, an encoder of one of the \nadhesin type proteins in H. pylori15,16. In a literary review of \ninternational studies published between 1991 and 2014, \nresearches from the University of Urmia, Iran, not only \ndemonstrated the presence of iron deficiency anemia in \ninfected individuals but also the resolution of refractory \ncases, of the aforementioned type of anemia, once H. \npylori was eradicated17.\nIts role as a carcinogenic agent and its connection \nwith a multiplicity of diseases has motivated a variety \nof studies, including research on the extent of its \nworldwide presence. Regarding this, prevalence rates \ncorresponding to 79.1% in the African region, 63.4% \nin Central America and the Caribbean, 54.7% in Asia, \n47% in Europe, 37.7% in North America and 24.4% in \nOceania have been exposed; figures derived from the \nanalysis of data of studies in the general population \nfrom 1970 to 201618. Then again, pediatric population \ndata suggest prevalences higher than 80% in Oceania, \nhigher than 50% in Africa, about 45% in Central America \nand the Caribbean, about 30% in Asia, less than 20% \nin Europe and close to 15% in North America19.  \nFor both adults and infants the prevalence of H. pylori \nfluctuates widely depending on the characteristics \nof the population studied. Therefore, although the \nregions of Europe, North America, and Oceania present a low prevalence for the general population \ncompared to Latin America, Africa and Asia, even \nwithin these territories there are significant variations \naccording to the subpopulation studied19. Thus, we \nfind in children figures as low as 3.4% in Iceland, \nclose to 24% in Poland and over 40% in indigenous \ncommunities in Canada20-22. In Latin American, Asian, \nand African countries, specific analyses of pediatric \nsubpopulations have also shown results ranging \nfrom 14.2% in Ghana, 44.3% in Uganda, 41.2% in \nEcuador, 77.3% in Colombia, and 31.7% in the United \nArab Emirates23-27.\nRegardless of the differences between subpopulations \nin countries with similar statistical background for \nHelicobacter pylori, it has been shown that the prevalence \nin the general population has decreased significantly \nsince 2000 for the territories of Oceania, North America, \nand Europe; in contrast to Asia and Latin America, where \nit has remained constant as a plateau, and Africa, where \nthe scarce amount of data prior to the year 2000 does \nnot allow for comparison18. \nGenerally, the acquisition of the bacterium, whose onset \nis suggested to occur during infancy28-30, is explained by \nits apparent routes of transmission, being oral-fecal, oral-\noral and gastro-oral, the ones proposed31-33. Although \nnot necessarily mutually exclusive, the three of them \nare more likely to occur in conditions of overcrowding, \npoor hygiene, contact with domestic animals, parental \nlow educational level in pediatric cases, open defecation, \nand ingestion of uncontrolled or poorly treated water, \namong other risk factors34-36, reaching prevalence figures \nclose to 99% in these circumstances37,38. \nIn Honduras, the data obtained estimates prevalences \nranging from 84.7% in adults in the western part of the \ncountry39, and between 61% and 64% in hospital-based \nstudies in adults with gastric symptomatology40,41.\nIn accordance with the information stated above, the \npresent investigation aims to report the prevalence \nof Helicobacter pylori in schoolchildren ages 6 to 12 \nyears from an urban school in the city of Tegucigalpa, \ncapital of Honduras, and its association with known \nrisk factors.\nMethods\nThis is an analytical cross-sectional study carried \nout in August 2019 in asymptomatic children \nenrolled in the Escuela Mixta Los Robles, located \nin neighborhood Los Robles, in the urban area of \nTegucigalpa. The inclusion criteria included age \nbetween 6 and 12 years old, active enrollment in \nEscuela Mixta Los Robles, Honduran nationality, and \nsignature of informed consent by the legal guardians 97\n2022/37 (3): 95-101Helicobacter Pylori infection among asymptomatic schoolchildren: Link with parental educational level\nand assent of the ward. The exclusion criteria included \nhaving gastrointestinal symptoms in the last 15 days \nand ingestion of antibiotics, proton pump inhibitors, \nhistamine 2 receptor antagonists or bismuth in the last \n30 days, due to a decrease in the performance of the \nstool antigen detection test in these situations42,43.\nThe project was approved by both the Institutional Review \nBoard of the Catholic University of Honduras, complying \nwith the Helsinki Declaration, and the local board of \neducation. Meetings were held with the teachers and \nan informed consent form was sent to each parent \nexplaining the details of the study so that they could \nevaluate the possibility of participating in the research. \nA total of 129 signed informed consents were received, \nafter which 101 participants were randomly selected \nafter sample size and sample method were determined \nusing EpiInfo 7.2.4.0 and STATS 2.0, with 5% margin of \nerror and 95% confidence interval.\nMeasurements of weight and height were taken with a \ncalibrated analog body weight scale and a metal strip \ntape measure. Each child was given a survey to be \nanswered at home by their legal guardians to be returned \non the days of the stool sample collection. A total of 101 \nstool samples were obtained over 5 collection days. Two \nnew children were included after two of the originally \nselected failed to provide the stool sample. \nTo obtain the stool sample parents were provided with \na collection jar to deposit it in, instructing them that \nthe sample should be obtained in the morning before \nthe infant attended school or, failing that, to collect \nan overnight stool sample to be kept in an icebox or \nrefrigerator for no more than 24 hours before its delivery \nto the research team.\nUpon delivery, each sample was placed in an icebox at \na temperature of 5 degrees and then transferred to the \nlaboratory 4 hours later where tests were run by means \nof a qualitative enzyme adsorption immunoassay. The \nsensitivity and specificity reported for the Quantitative \nFecal H. pylori Antigen ELISA Kit according to the \nmanufacturer is, under the indicated conditions, 100% of \nboth specificity and sensitivity44. \n101 stool samples were processed. A sample was \nconsidered positive when it was above the cut-off index \nsuggested by the manufacturer, which was greater than \n1.1 for the qualitative cut-off index.\nThe results were computed in Excel 365 and analyzed \nwith EpiInfo 7.2.4.0 statistical software. For the \nassociation of H. pylori with categorical variables, the \nchi-square or Fisher test was used as appropriate, and \nfor numerical variables, the T-student test was used. \nStatistical significance was considered p < 0.05.Results\nAccording to the sociodemographic variables of the \nschoolchildren participating in this study, it was evident \nthat the prevailing sex was female, with 57.42% girls \nand 42.58% boys. The average age was 8.97 years \nold with a standard deviation of 1.88. The prevalence \nof Helicobacter Pylori infection in school children aged 6 \nto 12 years in an urban educational unit in Tegucigalpa, \nHonduras, was of 17.82 % (IC:95 10.92 % - 26.7%) due \nto 18 positive tests out of 101 samples analyzed, as \nshown in table I .\nOpen defecation was nonexistent among the infants \nstudied, with 98.02% having access to a flush toilet and \n1.98% having access to a latrine. All the children ingested \ndrinking water in their homes and 96.04% of their homes \nalso used it for cooking. The type of construction floor \nof each house was reported as 82.28% ceramic and \n17.82% cement; no parent reported that the house they \ncurrently lived in had dirt floors. Exactly 47.52 % stated \nthat their dwelling houses had brick walls, while 44.55 % \nreported they had block walls, 5.94 % wooden walls, and \n1.98% adobe walls. \nRegarding the relationship of risk factors with \nHelicobacter pylori infection, statistical significance was \nfound, with p < 0.05, for the educational level of the \nparents as shown in table II ; 36.1 % of the children of \nmothers with completed or incomplete primary school \nwere positive compared to 8.33 % of the children of \nmothers with more than 9 years of schooling. On the \nother hand, 28.1 % of the children of fathers with \ncomplete or incomplete primary schooling were positive \ncompared to 6.25 % positivity for those whose fathers \nhave more than 9 years of schooling.\nTable I: Frequency distribution of Helicobacter pylori presence among \nschoolchildren 6-12 years old.\nVariable Frequency Percentage\nHelicobacter pylori (+) 18 17.82 %\nHelicobacter pylori (-) 83 82.18 %\nTotal  101 100 %\nTable II: Parent\u00b4s educational level and its relationship to Helicobacter pylori \nprevalence among schoolchildren 6-12 years old.\nEvaluated  Presence OR (IC:95) p - value\nfactors  of H. pylori \n  Yes No\nMother\u00b4s More than 9 years 5 60  \neducational  of schooling   6.8\nlevel 9 years   (2.17-21.63) 0.000351\n of schooling 13 23\n or less\nFather\u00b4s More than 9 years 3 45  \neducational  of schooling   5.7 0.0105\nlevel 9 years of 9 23 (1.45-23.8)\n schooling or less98\n2022/37 (3): 95-101Pedro Antonio L\u00f3pez Guti\u00e9rrez et al.  \nFor the other risk factors evaluated in table III , such \nas age, sex, school grade, BMI, room sharing, bed \nsharing, pets at home, adults at home, children at home, \novercrowding, economic income, family history of H. \npylori, and family history of gastric cancer, no statistically \nsignificant association was found.\nAs height for age and BMI for age are nutritional variables, \nthey were evaluated according to the WHO growth charts for \nchildren and adolescents between 5 and 19 years of age, \nthe results are shown in table IV . No statistically significant \ndifference was shown for BMI and Helicobacter Pylori.\nDiscussion\nThe prevalence of H. pylori obtained in this study was \nobtained by stool antigen detection due to its wide application in microbiology, cost, high sensitivity and \nspecificity, and because it is a non-invasive method45. \nEl-Shabrawi et al. demonstrated in Cairo, Egypt the \napplicability of the stool antigen test in children, detecting \na sensitivity between 89% and 98% and a specificity \nbetween 94 and 100%; only slightly lower than the \nC-13 urea breath test whose operation implies higher \neconomic costs for laboratories and less tolerance by \ninfants46.  Other non-invasive methods include serological \ntests and molecular tests on saliva and stool samples47.\nRegarding the results obtained according to the objectives \nof the study, the prevalence of H. pylori in the population \nstudied, 17.8%, contrasts considerably with other national \nresults in which a higher prevalence of H. pylori than that \nreported in our study has been stated. In 2006, Morgan et \nal. identified that 85% of the asymptomatic adult population \nparticipating in their study in the western part of the country \nhad a positive seroprevalence40 Subsequently, in 2013, \nthrough positive cultures of gastric biopsies, Morgan et \nal. also reported 61.4% of 189 adult patients with gastric \nsymptomatology in Hospital de Occidente, as carriers of \nHelicobacter pylori39.\nIn both cases, the conditions of space, time, and \npopulation in which the study was carried out should \nbe considered, since although the decline in the \nprevalence of H. pylori has been demonstrated mainly Table III: Relationship between other risk factors and Helicobacter pylori prevalence among schoolchildren 6-12 years old.\nOther risk factors studied Presence of H. pylori OR (IC:95) p - value \n  Si No  \nAge 6 to 8 years 5 30 0.68  0. 498\n 9 to 12 years 13 53 (0.22-2.09) \nSex Male 8 35 1.1 0.859\n Female 10 48 (0.39-3.06) \nSchool grade 1 - 3 6 31 0.84 0.748\n 4 - 6 12 52 (0.29-2.46) \nAbnormal BMI  Yes 10 35 1.71  0.3\n No 8 48 (0.61-4.69) \nShares sleeping room Yes 16 66 2.06 0.513\n No 2 17 (0.43-9.84) \nShares bed Yes 11 42 1.53 0.418\n No 7 41 (0.54-4.34) \nHas pets at home Yes 10 41 1.28 0.636\n No 8 42 (0.46-3.57) \nNumber of adults at home More than 3 7 40 0.68 0.473\n 3 or less 11 43 (0.24-1.94) \nNumber of children at home More than 3 6 27 1.04 0.947\n 3 or less 12 56 (0.35-3.06) \nOvercrowding Yes 4 23 0.75 0.774\n No 14 60 (0.22-2.5) \nMonthly economic income More than 10,000 L.*  9 60 2.61 0.065\n Less than 10,000 L. 9 23 (0.92-7.39) \nFamily history of Helicobacter pylori Yes 6 23 1.3 0.633\n No 12 60 (0.44-3.89) \nFamily history of gastric cancer Yes 1 11 0.39 0.688\n No 17 72  (0.05-3.19)\n* L. Stands for Honduran currency: Lempira. As of August 2019: L. 24.4 = 1 USD https://www.bch.hn/estadisticos/GIE/_layouts/15/WopiFrame.\naspx?sourcedoc=%7B90EEBD7C-D458-446A-AB96-FF39D6D7CB00%7D&file=Precio%20Promedio%20del%20D%C3%B3lar%20-%20Serie%20Mensual.\nxlsx&action=default\nTable IV: Frequency distribution of nutritional variables regarding Helicobacter \npylori presence among schoolchildren 6-12 years old.\nStudied variables Helicobacter  Total (%)\n  pylori (+)\nBMI for age  Normal 8 / 56 (14.28) 56 /101 (55.4)\n Risk of overweight 5 / 24 (20.8) 24/101 (23.8)\n Overweight 4 / 18 (22.2) 18/101 (17.8)\n Obesity 1 / 3 (33.3) 3/101 (3)\nHeight for age Normal 18 /101 (17.8) 101 /101 (100)99\n2022/37 (3): 95-101Helicobacter Pylori infection among asymptomatic schoolchildren: Link with parental educational level\nin the inhabitants of socioeconomically developed \nterritories 48-50, similar behavior has also been observed \nin increasingly industrialized countries such as China and \nBrazil, where its decrease has been attributed to better \nliving conditions51,52. Therefore, the high percentage \ncoverage of flush toilets, the absence of open defecation, \nthe construction materials used in dwellings, the high \nconsumption of drinking water, and the pediatric study \npopulation probably explain the low prevalence found.\nSimilarly, in Jordan, a developing country, Eyad Altamimi \net al. found in 2019 that the prevalence of H. pylori for \nasymptomatic pediatric patients, probed by carbon 13 \nbreath test, stood at 14.6 % for infants aged 4 to 17 years, \nand 25% for those aged 6 to 11 years53. In sub-Saharan \nAfrica, in 2017, a study conducted in Ghana by Awuku et \nal. demonstrated a prevalence, by stool antigen, of 14.2 \npercent in pediatric villagers aged 5 to 16 years and 14.5 \npercent in patients aged 5 to 10 years. In those positive \npatients, open defecation, female gender, and source of \ndrinking water represented risk factors23.\nRegarding the educational level of the mother, at least \nsince 2001 information has been obtained identifying it \nas a risk factor for H. pylori infection, as demonstrated by \nMalaty et al. when they studied 356 children between 2 \nand 16 years of age from the Houston area in the United \nStates between 1996 and 1998, obtaining statistically \nsignificant results regarding maternal education as a risk \nfactor with p<0.001 for mothers who had not completed \nat least 12 years of education54. Later Galal et al. examined \n630 Egyptian children with gastric symptomatology and \nfound a prevalence of 64.9 % by stool antigen detection \nand an association between illiterate mothers and stool \nantigen positivity for H. pylori55. \nIn our study, statistically significant differences \nwere found for H. pylori positivity according to the \neducational level of both parents, not only the mother, \ntaking 9 school years as the cut-off educational level, \nsince in Honduras, according to article 22 of the \nFundamental Law of Education published in 2012, \nbasic education consists of 9 years of compulsory \nschooling56. Similarly, in Portugal, Bastos et al. found a \nlower prevalence in adolescents whose parents had a \nhigher level of education57. Wangda et al. also found a \nsimilar association in children from 8 public schools in \nBhutan where H. pylori positivity reflected a statistically \nsignificant difference when comparing children of \ncollege-educated mothers with those of non-college \neducated mothers58. Muhsen et al. obtained, in 2012, \nan association between the fathers\u2019 educational level \nand H. pylori positivity by dividing male parents into 2 \ngroups: those with more than nine grades of schooling \nand those with less than nine grades of schooling. \nWith respect to the mothers\u2019 education, no significant \ndifferences were found in that study59.The statistical results between the association \nof Helicobacter pylori and body mass index has \nsometimes proven to show contradictory data. \nPreviously, Arslan et al. had shown some association \nin their analysis of 103 obese adult patients and 111 \ncontrols, regarding Helicobacter pylori infection and \nBMI, obtaining results with statistical significance p < \n0.01 and odds ratio greater than two60. Chen et al. \nalso obtained results showing an association between \nbody mass index and H. pylori infection, specifically \nin adult patients under 50 years of age61. However, in \npediatric patients, associations inversely proportional to \nBMI have been found, where after H. pylori eradication \nthis parameter increases62, even reaching morbid \nobesity levels63. Moran - Lev et al. showed the same \nphenomenon in symptomatic Israeli children diagnosed \nby means of gastric biopsies; 31% of the non-infected \nchildren presented obesity or overweight, in contrast \nto the infected children, of only whom 11% presented \nobesity, generating a statistically significant difference, \nsuggesting an inverse relationship between the ordinal \nvalue of BMI and H. pylori positivity64. The results \nof our project have yielded data with no significant \nstatistical difference between BMI, both in its ordinal \nand numerical values, and H. pylori infection, as can be \nseen in the publications of Pundak et al. and Choi et al. \nwhere, in the former, they report the lack of relationship \nbetween obesity or overweight and infection by H. \npylori infection65 whereas in the latter they report that \nafter eradication of the bacteria, the treated infants \npresented a significantly greater weight gain than those \nwho were not treated, without specifying whether or \nnot the magnitude of the weight gain caused them to \nmove from one BMI category to another66. The present \ninvestigation did not have the scope to treat infants with \npositive results.\nConclusions\nMore studies covering larger populations will be needed \nto confirm H. pylori\u00b4s prevalence in children. Nonetheless, \nwithin the scope of the present report, a lower prevalence \nwas found when compared to similar studies. Moreover, \na particular association was observed between the lower \neducational level of both parents and Helicobacter pylori \nstool antigen positivity.\nAcknowledgements\nThe authors thank Nissi Laboratories for donating the \ntotal amount of the antigen stool tests used during this \ninvestigation; all other research expenses were self-\nfinanced.\nConflict of Interests\nThe authors have no conflict of interest.100\n2022/37 (3): 95-101Pedro Antonio L\u00f3pez Guti\u00e9rrez et al.  \nReferences\n1. Marshall B, Warren R. Unidentified curved bacilli in the stomach of \npatients with gastritis and peptic ulceration. The Lancet. 1984 Jun; \n323(8390):1311-15.\n2. Burkitt MD, Duckworth C, Williams JM, Pritchard DM. Helicobacter \npylori-induced gastric pathology: insights from in vivo and ex vivo models. \nDisease Models & Mechanisms. 2017 Feb; 10(2):89-104.\n3. Crowe SE. Helicobacter pylori Infection. New England Journal of \nMedicine. 2019 Mar; 380(12):1158-65.\n4. Blanchard TG, Czinn JS. Identification of Helicobacter pylori and the \nevolution of an efficacious childhood vaccine to protect against gastritis \nand peptic ulcer disease. Pediatric Research. 2017 Jan; 81(1):170-76.\n5. Ford AC, Forman D, Hunt RH, Yuhong Y, Moayyedi P . Helicobacter pylori \neradication therapy to prevent gastric cancer in healthy asymptomatic \ninfected individuals: systematic review and meta-analysis of randomised \ncontrolled trials. The BMJ. 2014 May; 348:1-13.\n6. Sugano K, Tack J, Kuipers EJ, Graham DY, El-Omar EM, Miura S, et \nal. Kyoto global consensus report on Helicobacter pylori gastritis. BMJ \njournal. 2015 Sep; 64(9):1353-67.\n7. Ravi K, Joseph J, Thomas D. Helicobacter pylori infection and vitamin \nB-12 deficiency- A cross sectional study. Asian Journal of Medical \nSciences. 2017 Jul; 8(4):16-20.\n8. Ulasoglu C, Temiz H, Sa\u011flam  Z. The Relation of Cytotoxin-Associated \nGene-A Seropositivity with Vitamin B12 Deficiency in Helicobacter pylori-\nPositive Patients. BioMed Research International. 2019 Dec; 2019: 1450536.\n9. Polyzos SA, Zeglinas C, Artemaki F, Doulberis M, Kazakos E, Katsinelos \nP , et al. Helicobacter pylori infection and esophageal adenocarcinoma: a \nreview and a personal view. Annals of Gastroenterology. 2018 Jan - Feb; \n31(1):8-13.\n10. Santambrogio O. Helicobacter pylori and hematological disorders. \nMinerva Gastroenterologica e Dietologica. 2019 Apr; 65(3).\n11. Floch P , M\u00e9graud F, Lehours P . Helicobacter pylori Strains and Gastric \nMALT Lymphoma. Toxins. 2017 Apr; 9(4):132.\n12. World Health Organization. Helicobacter pylori Eradication as a \nStrategy for preventing Gastric Cancer. Scientific report. Lyon: World \nHealth Organization, International Agency for Research on Cancer ; 2014. \nReport No.: ISBN 978-92-832-2454-9.\n13. Diaconu S, Predescu A, Moldoveanu A, Pop C, Fierbin\u021beanu -Braticevici \nC. Helicobacter pylori infection: old and new. Journal of Medicine and Life. \n2017 Apr - Jun; 10(2):112-17.\n14. Hanai H, Pellegrini J, Loggetto S, Strehl R, Hernandes C, Kawakami \nE. Helicobacter pylori infection & immune thrombocytopenic purpura in \nchildren and adolescents: A randomized controlled trial. Platelets. 2015 \nMay; 26(4):336-41.\n15. Dror G, Muhsen K. Helicobacter pylori Infection and Children\u2019s Growth. \nJournal of PEdiatric Gastroenterology and Nutrition. 2016 Jun; 62(6):48 -59.\n16. Kato S, Osaki T, Kamiya S, Zhang XS, Blaser MJ. Helicobacter pylori \nsabA gene is associated with iron deficiency anemia in childhood and \nadolescence. PLOS One. 2017 Aug; 12(8):1-15.\n17. Gheibi S, Farrokh-Eslamlou H, Noroozi M, Pakniyat A. Refractory iron \ndeficiency anemia and HelicobacterPylori Infection in pediatrics: A review. \nIranian Journal of Pediatric Hematology Oncology. 2015 Mar; 15(1):50-64.\n18. Hooi JKY, Lai WY, Khoon Ng W, Suen MMY, Underwood FE, Tanyingoh \nD, et al. Global Prevalence of Helicobacter pylori Infection: Systematic \nReview and Meta-Analysis. Gastroenterology. 2017 Aug; 153(2):420-29.19. Zamani M, Ebrahimtabarm F, Zamani V, Miller VH, Alizadeh-Navaei \nR, Shokri-Shirvani J, et al. Systematic review with meta-analysis: \nthe worldwide prevalence of Helicobacter pylori infection. Alimentary \nPharmacology & Therapeutics. 2018 Jan; 47(7):868-76.\n20. Asgeirsdottir GA, Kjartansdottir I, Olafsdottir AS, Hreinsson JP , \nHrafnkelsson H, Johannsson E, et al. Helicobacter pylori infection in \nIcelandic children. Scandinavian Journal of Gastroenterology. 2017 Mar; \n52(6 -7):686-90.\n21. Anna Szaflarska-Pop\u0142awska AS. Prevalence of Helicobacter pylori \ninfection among junior high school students in Grudziadz, Poland. \nHelicobcater. 2018 Oct; 24(1).\n22. Fagan-Garcia K, Geary J, Chang HJ, McAlpine L, Walker E, Colquhoun \nA, et al. Burden of disease from Helicobacter pylori infection in western \nCanadian Arctic communities. BMC Public Health. 2019 June; 730(19).\n23. Awuku YA, Simpong DL, Alhassan IK, Anamaale D, Afaa TT, Adu P . \nPrevalence of helicobacter pylori infection among children living in a rural \nsetting in Sub Saharian Africa. BMC Public Health. 2017 Apr; 17(1).\n24. Hestvik E, Tylleskar T, H Kaddu-Mulindwa D, Ndeezi G, Grahnquist \nL, Olafsdottir E, et al. Helicobacter pyloriin apparently healthy children \naged 0-12 years in urban Kampala, Uganda: a community-based cross \nsectional survey. BMC Gastroenterology. 2016 Jun; 10(62).\n25. Pico Mawyin TL, Galarza SN, Barzola C, Arcadio G, Saavedra Aguilar \n\u00c1M. Comportamiento de infecci\u00f3n por Helicobacter pylori en pacientes \npedi\u00e1tricos detectados mediante prueba de aliento con urea-c13. Revista \nCientifica Mundo de la Investigacion y el Conocimineto. 2019 Apr; \n3(2):785-800.\n26. Boh\u00f3rquez MS, Li\u00e9vano M, Campuzano G, Bol\u00edvar T, Rozo A. \nPrevalencia de Helicobacter pylori en escolares: factores nutricionales y \nsocio-culturales en Bogot\u00e1. Pediatria. 2012 Jun; 45(2):81-93.\n27. Khoder G, Muhammad JS, Mahmoud I, Soliman SSM, Burucoa \nC. Prevalence of Helicobacter pylori and Its Associated Factors among \nHealthy Asymptomatic Residents in the United Arab Emirates. Pathogens. \n2019 Apr; 8(2):44.\n28. Castro-Mu\u00f1oz LJ, Gonz\u00e1lez-D\u00edaz C, Mu\u00f1oz-Escobara A, Tovar-\nAyonad B, Aguilar L, Anguiano , et al. Prevalence of Helicobacter pylori \nfrom the oral cavity of Mexican asymptomatic children under 5 years of age \nthrough PCR. Archives of Oral Biology. 2017 January; 73(2017):55-59.\n29. Coelho LG, Minho J, Genta R, Ten\u00f3rio L, Friche Pasos MdC, Zaterka \nC. IVth Brazilian Consensus Conference On Helicobater Pylori Infection. \nArchives of Gastroeneterology. 2018 Apr-Jun; 55(2): 97-121.\n30. Kienesberger S, Perez-Perez GI, Olivares AZ, Bardhan P , Sarker SA, \nHasan KH, et al. When is Helicobacter pylori acquired in populations in \ndeveloping countries? A birth-cohort study in Bangladeshi children. Gut \nMicrobes. 2018 March; 9(3):252-63.\n31. Kayali S, Manfredi M, Gaiani FBL, Bizzarri B, Leandro G, di Mario F, et \nal. Helicobacter pylori, transmission routes and recurrence of of infection; \nstate of the art. Acta Biomedica. 2018 Dec; 89(8): 72-6.\n32. Bui D, Brown HE, Harris BR, Oren E. Serologic Evidence for Fecal\u2013\nOral Transmission of Helicobacter pylori. The American Journal of Tropical \nmedicine and Hygiene. 2016 Jan; 94(1):82-8.\n33. Zakrzewska M, Zakrzewski M, Gladka A, Czarniecka-Barglowska K, \nMaciorkowska E. Saliva testing for Helicobacter pylori infection in children \nand adolescents \u2013 a literature review. Polish Journal of Paediatrics. 2019 \nAug; 94(4):255-8.\n34. Krueger WS, Hilborn ED, Converse R, Wade TJ. Environmental risk \nfactors associated with Helicobacter pylori seroprevalence in the United 101\n2022/37 (3): 95-101Helicobacter Pylori infection among asymptomatic schoolchildren: Link with parental educational level\nStates: a cross-sectional analysis of NHANES data. Epidemiology & \nInection. 2015 Jan; 143(12):2520-31.\n35. Ozbeycorresponding G, Hanafiah A. Epidemiology, Diagnosis, and \nRisk Factors of Helicobacter pylori Infection in Children. Eurasian Journal of \nHepato - Gastroenterology. 2017 May; 7(1):34-9.\n36. Eshraghian A. Epidemiology of Helicobacter pylori infection among \nthe healthy population in Iran and countries of the Eastern Mediterranean \nRegion: A systematic review of prevalence and risk factors. World Journal \nof Gastroenterology. 2014 Dec; 20(46).\n37. Goodman KJ, Correa P , Tengan\u00e1 Aux HJ, Ram\u00edrez H, DeLany JP , \nGuerrero O, et al. Helicobacter pylori infection in the Colombian Andes: \na population-based study of transmission pathways. Americna Journal of \nepidemiology. 1996 Aug; 144(3):290-9.\n38. Arboleda RN, Schneider BG, Bravo LE, Romero-Gallo J, Peek RM, \nJr MR, et al. Use of a Non-invasive Test (Entero-test) in the Detection of \nHelicobacter pylori in Children in an Endemic Area in Colombia. Journal of \nPediatric Gastroenterology and Nutrition. 2013 Aug; 57(2):192-6.\n39. Morgan D, Dominguez R, O. Keku T, Heidt P , F. Martin C, Galanko J, et \nal. Gastric Cancer and the High Combination Prevalence of Host Cytokine \nGenotypesand Helicobacter pylori in Honduras. Clinical Gastroenterology \nand Hepatology. 2006 Sep; 4(9):1103-11.\n40. Ortiz V, Estevez-Ordonez D, Montalvan-Sanchez E, Urrutia-Argueta \nS, Israel D, Krishna US, et al. Helicobacter pylori antimicrobial resistance \nand antibiotic consumption in the low-resource Central America setting. \nHelicobacter. 2019 May; 24(4): p. e19525.\n41. Dur\u00f3n RA, Zuniga GA, Zelaya , Jose F, Amador L, de Aviles M, et al. \nIncidencia de Helicobacter. Revista MEdica Hondure\u00f1a. 1990 Aug;58(2).\n42. Calik Z, Karamesea M, Acar O, Karamese S, Dicle Y, Albayrak F, et al. \nInvestigation of Helicobacter pylori antigen in stool samples of patients with \nupper gastrointestinal complaints. Brazilian Journal of Microbiology. 2016 \nJan - Mar; 47(1):167-71.\n43. S\u00e1nchez Delgadoa J, Garc\u00eda-Iglesias P , Tit\u00f3 L, Puig I, Planella M, \nGen\u00e9 E, et al. Update on the management of Helicobacter pylori infection. \nPosition paper from the Catalan Society of Digestology. Gastroenterologia \ny Hepatologia. 2018 Apr; 41(4):272-80.\n44. Epitope Diagnostics, Inc. Epitope Diagnistics. [Online].; 2017 \n[cited 2021 Feb 12. Available from: https://static1.squarespace.com/\nstatic/52545951e4b021818110f9cf/t/592f110d8419c2ffb83d7\nbf6/1496256787481/KT+826+Fecal+H.+Pylori+Antigen+Elisa_v11_IVD.pdf.\n45. Cardinali L, Rocha G, Rocha A, de Moura S, de Figueiredo Soares \nT, Esteves A et al. Evaluation of [ 13 C]Urea Breath Test and Helicobacter \npylori Stool Antigen Test for Diagnosis of H. pylori Infection in Children from \na Developing Country. Journal of Clinical Microbiology. 2003;41(7):3334-5.\n46. El-Shabrawi M, Abd El-Aziz N, Zakaria El-Adly T, Hassanin F, Eskander A, \nAbou-Zekri M, et al. Stool antigen detection versus 13C-urea breath test for \nnon-invasive diagnosis of pediatric Helicobacter pylori infection in a limited \nresource setting. Archives of Medical Science. 2018 Jan; 14(1):69-73.\n47. Kalali B, Formichella L, Gerhand M. Diagnosis of Helicobacter pylori: \nChanges towards the Future. Diseases. 2015 Jun; 3(3):122-35.\n48. Miyamoto R, Okuda M, Lin Y, Murotani K, Okumura A, Kikuchi S. \nRapidly decreasing prevalence of Helicobacter pylori among Japanese \nchildren and adolescents. Journal of Infection and Chemotherapy. 2019 \nJul; 25(7):526-30.\n49. Sonnenberg A, Turner KO, Genta RM. Low Prevalence of Helicobacter \npylori-Positive Peptic Ulcers in Private Outpatient Endoscopy Centers in \nthe United States. The American Journal of Gastroenterology. 2020 Feb; \n115(2):244-50.50. Roberts SE, Morrison-Rees S, Samuel DG, Thorne K, Akbari A, \nWilliams JG. Review article: the prevalence of Helicobacter pylori and the \nincidence of gastric cancer across Europe. Alimentary Pharmacology and \nTherapeutics. 2015 Nov; 43(3):334-45.\n51. Yu X, Yang X, Yang T, Dong Q, Wang L, Feng L. Decreasing prevalence \nof Helicobacter pylori according to birth cohorts in urban China. The Turiskh \nJournal of Gastroenterology. 2017 Mar; 28(2):94-97.\n52. Toscano E, Fernandes F, Dutra-Rulli M, Maia L, Alc\u00e2ntara M, Silva V, et \nal. Epidemiological and Clinical-Pathological Aspects of Helicobacter pylori \nInfection in Brazilian Children and Adults. Gastroenterology Research and \nPractice. 2018 Sep; 2018.\n53. Altamimi E, Alsharkhat NAA, Abu Hamad MR, Abu Assi A, Alawneh \nS, Al-Ahmad M. Declining prevalence of Helicobacter pylori infection in \nJordanian children. Heylon. 2020 Jul; 6(7): p. e04416.\n54. Malaty HM, Logan ND, Graham DY, Ramchatesingh JE. Helicobacter \npylori Infection in Preschool and School-Aged Minority Children: Effect of \nSocioeconomic Indicators and Breast-Feeding Practices. Clinical Infectius \nDiseases. 2001 May; 32(10):1387-92.\n55. Galal YS, Ghobrial CM, Labib JR, Abou-Zekri ME. Helicobacter pylori \namong symptomatic Egyptian children: prevalence, risk factors, and effect \non growth. Journal of Egyptina Public Health Association. 2019 May; 94(17).\n56. Congreso Nacional de Honduras. Ley Fundamental de Educaci\u00f3n. \nDiario Oficial La Gaceta. 2012 Feb: 1-6.\n57. Bastos J, Peleteiro B, Pinto H, Marinho A, T.Guimar\u00e3es J, Ramosa \nE, et al. Prevalence, incidence and risk factors for Helicobacter pylori \ninfection in a cohort of Portuguese adolescents (EpiTeen). Digestive and \nLiver Disease. 2013 Apr; 45(4):290-5.\n58. Wangda S, Richter JM, Kuenzang P , Wangchuk K, Choden T, Tenzin \nK, et al. Epidemiology of Helicobacter pylori infection in asymptomatic \nschoolchildren in Bhutan. Helicobacter. 2017 Dec; 6(22).\n59. Muhsen K, Jurban M, Goren S, Cohen D. Incidence, Age of Acquisition \nand Risk Factors of Helicobacter pylori Infection among Israeli Arab Infants. \nJournal of Tropical Pediatrics. 2012 Jun; 58(3):208-13.\n60. Arslan E, At\u0131lgan H, Yava\u015fo\u011flu  I. The prevalence of Helicobacter pylori \nin obese subjects. European Jornal of Internal Medicine. 2009 Nov; \n20(7):695-7.\n61. Chen LW, Kuo SF, Chen CH, Chien CH, Lin CL, Chien RN. A \ncommunity-based study on the association between Helicobacter pylori \nInfection and obesity. Scientific Reports 8. 2018 Jul; 10746(2018).\n62. Pacifico L, Anania C, Osborn J, Schiavo E, Bonamico M, Chiesa C. \nLong-term effects of Helicobacter pylori eradication on circulating ghrelin \nand leptin concentrations and body composition in prepubertal children. \nEuropean Journal of Endocrinology. 2008 Mar; 158(3):323-32.\n63. Wu MS, Lee WJ, Wang HH. A Case-Control Study of Association of \nHelicobacter pylori Infection With Morbid Obesity in Taiwan. Archives of \nInternal Medicine. 2005 Jul; 165(13):1552-5.\n64. Moran-Lev H, Lubetzky R, Mandel D, Yerushalmy-Feler A, Cohen \nS. Inverse Correlation between Helicobacter pylori Colonization and \nPediatric Overweight: A Preliminary Study. Childhood Obesity. 2017 Aug; \n13(4):267-71.\n65. Pundak OY, Olivestone CT, Hofi L, Kori M. Lack of association \nbetween Helicobacter pylori infection and childhood overweight/obesity. \nHelicobacter. 2020 Jul; 25(5): p. e12728.\n66. Choi JS, Ko KO, Lim JW, Cheon EJ, Min Lee G, Min Yoon J. The \nAssociation between Helicobacter pylori Infection and Body Weight among \nChildren. Pediatric Gastroenterology, Hepatology & Nutrition. 2016 Jun; \n19(2):110-5.102\n2022/37 (3): 102-107Received:  13 - III - 2022\nAccepted:  28 - III - 2022\ndoi: 10.3306/AJHS.2022.37.03.102Corresponding author\nNafiseh Hivechi   \nE-mail: unicahinvestigacion20219@gmail.com\nAbstract  \nEndometrial cancer is one of the most common cancers among women especially in urban areas. The appearance of symptoms \nsuch as abnormal uterine bleeding or infertility on clinical examination increases the risk of endometrial lesion. Vaginal ultrasound and \ndiagnostic hysteroscopy are common gynecological examinations for endometrial lesions. Endometrial cancer is often diagnosed \nin the early stages, in which case surgical removal of the uterus often cures endometrial cancer. However, screening and treatment \nprograms are important in the timely diagnosis and treatment of this disease. Due to the importance of the topic, the present \nstudy was conducted to investigate the prevalence of this disease, the relationship between artificial intelligence as well as various \nimaging methods and the diagnosis of endometrial cancer.\nKey words:  Artificial intelligence, endometrial cancer, imaging modalities.\nResumen\nEl c\u00e1ncer de endometrio es uno de los c\u00e1nceres m\u00e1s comunes entre las mujeres, especialmente en las zonas urbanas. La \naparici\u00f3n de s\u00edntomas como sangrado uterino anormal o infertilidad en el examen cl\u00ednico aumenta el riesgo de lesi\u00f3n endometrial. \nLa ecograf\u00eda vaginal y la histeroscopia diagn\u00f3stica son ex\u00e1menes ginecol\u00f3gicos comunes para detectar lesiones endometriales. \nEl c\u00e1ncer de endometrio a menudo se diagnostica en las primeras etapas, en cuyo caso la extirpaci\u00f3n quir\u00fargica del \u00fatero a \nmenudo cura el c\u00e1ncer de endometrio. Sin embargo, los programas de detecci\u00f3n y tratamiento son importantes en el diagn\u00f3stico \ny tratamiento oportuno de esta enfermedad. Debido a la importancia del tema, el presente estudio se realiz\u00f3 para investigar la \nprevalencia de esta enfermedad, la relaci\u00f3n entre la inteligencia artificial, as\u00ed como diversos m\u00e9todos de imagen y el diagn\u00f3stico \nde c\u00e1ncer de endometrio.\nPalabras clave: Inteligencia artificial, c\u00e1ncer de endometrio, modalidades de imagen.ORIGINAL\nA review on endometrial cancer;\n artificial intelligence, imaging modalities\nUna revisi\u00f3n sobre el c\u00e1ncer de endometrio;\ninteligencia artificial, modalidades de imagen\nLeila Yaminifar1      , Barbara Altisench Jan\u00e92      , Pedro Juan T\u00e1rraga L\u00f3pez3      ,\nPooya Jafari Doudaran4      , Jesus Yasoda Endo Mil\u00e1n5      , Nafiseh Hivechi6\n1. Obstetrician and Gynecologist,Shahid Beheshti university of medical sciences. Tehran,Iran\n2. Atenci\u00f3n Primaria de Mallorca. Spain    3. Universidad de Castilla la Mancha. Spain\n4. Faculty of Medicine, Qom University of Medical Sciences, Qom, Iran\n5. Universidad de Ciencias M\u00e9dicas de Villa Clara. Cuba    \n6. Obstetrics and gynecology department, Imam Khomeini Hospital Complex, Tehran University of Medical Sciences,Tehran, IraneISSN 2255-0569\nID\nID ID IDID ID103\n2022/37 (3): 102-107A review on endometrial cancer; artificial intelligence, imaging modalities\nIntroduction\nEndometrial cancer (EC) is the fourth most common cancer \namong women, and its prevalence has increased steadily, \nespecially in urban areas, due to the increase in obesity \n(BMI > 30) and longevity1,2. EC is the most common genital \ncancer, with about 320,000 newly diagnosed cases \nreported worldwide each year3. A total of 61,880 new \ncases and 12,160 EC-related deaths were estimated in \nthe United States in 20194. In general, the appearance of \nsymptoms such as abnormal uterine bleeding or infertility \non clinical examination increases the risk of endometrial \nlesion5. Vaginal ultrasound and diagnostic hysteroscopy \nare common gynecological examinations for endometrial \nlesions6. Due to abnormal vaginal bleeding, endometrial \ncancer is often diagnosed in the early stages, in which \ncase surgical removal of the uterus often cures endometrial \ncancer7. Although uterine cancer is highly preventable, it \nis still one of the most common causes of cancer death in \nwomen of developing countries, therefore screening and \ntreatment programs are important in the early diagnosis \nand treatment of this disease. Nowadays, the use of \nartificial intelligence technology will be beneficial about \nendometrial cancer. However there have not been many \npublications about artificial intelligence applications in \nendometrial cancers. In the present paper we summarized the characteristics of studies on the use of artificial \nintelligence, imaging methods and clinical factors for the \ndiagnosis of endometrial cancer.\nLiterature search\nWe conducted a comprehensive review of the English-\nlanguage literature involved endometrial cancer. The \nelectronic databases MEDLINE, PUBMED, and EMBASE \nwere searched on July 2021 for reporting the outcomes \nof endometrial cancer. Reference lists of published \npapers were then also hand-searched in an attempt to \nidentify further reports. The following key words were \nused: endometrial cancer; artificial intelligence; deep \nlearning; imaging modalities. The search terms were \nthen entered onto Google Scholar, to ensure that articles \nwere not missed. Papers were excluded if they were \ncase reports or had a patient cohort, were not written \nin English, lacked documentation, non-human studies, \nnarrative reviews, studies without clinical outcomes data, \nsystematic reviews that did not pool data or perform a \nmeta-analysis, and technique articles without outcomes. \nWe then obtained full manuscripts for those studies that \nmet the inclusion criteria. Search algorithm of articles \nincluded in the literature review is presented in figure 1 .\nRecords identified through database searching \nN= 97Removed duplicate citations\nN= 25\nRecords screened \nN= 72\nFull-text articles assessed for eligibility\nN= 50\nIncluded studies\nN= 41\nAll included studies\nN= 46Additional records identified through other sources\nN= 5Full-text articles excluded due \nto Lacking adequate outcome \nN= 9Records excluded based on screening \ntitles and abstracts\nN= 22Figure 1: PRISMA flow diagram.104\n2022/37 (3): 102-107Leila Yaminifar et al.  \nArtificial intelligence (AI) features\nRadiologists use artificial intelligence (AI) to read \nmedical images for different diseases8. Artificial \nintelligence includes a set of algorithms, mathematical \nfunctions, interconnected practical approaches, and \nareas of mathematical and statistical overlap that are \nvery suitable for radiology because the pixel values \nof the MRI image are measurable9. Although literature \non artificial intelligence assistance in the diagnosis \nof endometrial cancer focuses on the function of \n\u201cpostoperative\u201d diagnosis made by convolutional neural \nnetwork-based classification10, however research that \nexamines the \u201cpreoperative\u201d MRI stage, the function \nof interpreting AI in endometrial cancer are limited. \nAlthough current AI technology may not be able to \nreplace the expertise and experience of physicians, it \ncan be used as an auxiliary tool11. Due to the probability \nof human active errors and passive errors, the use \nof AI technology will be beneficial about endometrial \ncancer. There have not been many publications \nabout AI applications in endometrial cancers. The \nresearch of Dong et al.11 was the first attempt to use \nAI technology in order to evaluate the invasion depth \nof myometrium in early stage of endometrial cancers. \nHowever, creating a deep learning model is necessary \nto increase the precision. Generally, artificial intelligence \nas an appropriate option for preoperative assessment \nhas the ability to help radiologists.\nDeep learning is a discipline that has recently played \nan important role in areas such as computer vision and \nspeech recognition. Deep learning as an important branch \nof artificial intelligence made outstanding contributions in \nthe clinical prediction models and radiomics12. Based on \nthe review of literature, artificial intelligence technologies \nhave significant clinical applications. Each technology has a \ndifferent role in predicting and detecting clinical outcomes. \nZhang et al.13 conducted a study, in order to create a \nconvolutional neural network model that can automatically \nclassify endometrial lesions using hysteroscopic images \nas input. After the images were preprocessed, a training \nset of 6478 images was input into a tuned VGGNet-16 \nmodel; and 250 images were used as the test set to \nevaluate the model\u2019s performance. They compared the \nmodel\u2019s results with the diagnosis of gynecologists and \nconcluded that the VGGNet-16 model performs well \nin classifying endometrial lesions from hysteroscopic \nimages and can provide objective diagnostic evidence \nfor hysteroscopists. Chen et al.14 used the deep \nlearning model for detecting myometrial invasion depth \nin endometrial cancer and compare with radiologists for \nevaluating clinical application. In their study two stages \nCNN based deep learning method - trained with YOLOv3 \nfor detection then used Resnet for classification. They \nconcluded that diagnosis and classification of myometrial \ninvasion depth by radiologists improved with deep learning \nmethod for lesions >2cm, radiologists better accuracy for lesions <2cm and false positive error most common for \nboth radiologists and computer.\nImaging modalities\nMagnetic resonance imaging (MRI) is widely used to \ndetermine and classify female malignancies15. Sensitivity \nand specificity related to the evaluation of the myometrial \ninvasion depth in MRI reported varied (sensitivity of 42 -100 \nand specificity of 85-93) in various studies14. The accurate \npre-operative assessment of the depth of myometrial \ninvasion depends on MRI, especially T2-weighted imaging \n(T2WI) and contrast-enhanced T1-weighted imaging16. \nSome findings suggested that diffusion-weighted imaging \n(DWI) may have good diagnostic accuracy for assessing \nmyometrial invasion17. However, in pre-operative MR \nexamination the uterine cavity is often filled with polypoid \ntumors and tumors located in uterine cornu may lead to \nincorrect evaluations on myometrial invasion18. Han et al.19 \nby evaluate whether whole-uterine MRI radiomic features \ncan predict myometrial invasion depth in endometrial cancer \n(EC), reported that whole-uterine MRI radiomic features \nbased on sagittal T2WI and axial DWI show potential in \npredicting myometrial invasion in endometrial cancer.\nUeno et al.20 in a study aimed at building diagnostic radiomic \nmodel and evaluate its accuaracy for assessment of deep \nmyometrial invasion, lymphovascular space invasion, \nhistologic high-grade endometrial cancer, concluded that \ndiagnostic accuracy of the random forest model was 81%, \n76.6% and 78.1% to predict deep myometrial invasion, \nlymphovascular space involvement, and high-grade \ntumors, respectively, as well as random forest model \nperformance analogous to diagnosis by three radiologists. \nLuo et al.21 also reported that the radiomic-based \nmachine-learning model using a nomogram algorithm \nachieved high diagnostic performance for predicting \nlymphovascular space invasion of endometrial carcinoma \npreoperatively, which could enhance risk stratification \nand provide support for therapeutic decision-making. \nPerformance evaluation of MRI based radiomics model \nfor detection of deep myometrial invasion in endometrial \ncancer by Stanzione et al.22 showed that radiologist \ndiagnostic accuracy improved with the aid of machine \nlearning compared to without, however not statistically \nsignificant and model aided radiologists in diagnosing \ndeep myometrial invasion on MR T2w images. Yan et \nal.23 reported that the MRI-based radiomics model could \nbe used to assess the status of pelvic lymph node and \nhelp radiologists improve their performance in predicting \npelvic lymph node metastasis in endometrial carcinoma. \nYan et al.24 also showed that the radiomics nomogram \nachieved the highest diagnostic performance compared \nwith the radiomics signature and the clinical parameters \nmodels. Bereby-Kahane et al.25 reported that there was \nno association between apparent diffusion coefficient and \nhigh grade or lymphovascular space invasion. 105\n2022/37 (3): 102-107A review on endometrial cancer; artificial intelligence, imaging modalities\nClinical features and sample sizes\nThis section of the present paper summarizes information \non clinical factors and sample sizes used in studies. \nThe study of Yan et al.23 was a multi-center study on \n622 endometrial cancer patients (age 56.6 \u00b1 8.8 years; \nrange 27-85 years), which 358 features extracted and \n37 features used to build the model. Stanzione et al.22 \nconducted a single center study by analyzing 54 patients \nthat preprocessed images randomly split to training and \ntest sets. Bereby-Kahane et al.25 also performed a single \ncenter study on 73 patients to evaluate the capabilities \nof two-dimensional MRI-based texture analysis features, \ntumor volume, tumor short axis and apparent diffusion \ncoefficient in predicting histopathological high-grade and lymphovascular space invasion in endometrial \nadenocarcinoma. The sample size of a study by Xu \net al.26 as the first subgroup analysis on different sized \nlymph nodes with preoperative nomogram study in EC \n(benign vs. malignant) was 200 patients. Fasmer et \nal.27 and Chen et al.28 enrolled 138 and 102 patients, \nrespectively, in their studies. A total of 163, 78 and 115 \npatients were analyzed in the studies by Han et al.29, Gillen \net al.30 and De Bernardi et al.31, respectively. Summary of \nstudies and reviews conducted on endometrial cancer is \npresented in table I. \nConflict of Interests\nThe authors have no conflict of interest.\nTable I: Characteristics of studies conducted on endometrial cancer.\nAuthor (s)- Ref.\nYan, et al. (23)\nJacob et al. (32)\nYan et al. (24)\nStanzione  \net al. (22)\nBereby-Kahane \net al. (25)\nXu et al. (26)\nFasmer et al. (27)Deep learning\nPreop MRI\n622 patients\nMulti center\nPositive vs negative lymph nodes\nMachine learning\nMRI\n338 patients\nSingle center\nN/A\nClassical machine learning\nMRI\n717 patients\nMulticenter study\nHigh risk vs low risk EC\nClassical machine learning\nMRI\n54 patients\nSingle center\nDMI + vs -\nClassical ML\n2D MRI\n73 patients\nSingle Center\nHigh grade vs low grade and LVSI +/-\nClassical machine learning?\nMRI\n137 patients\nsingle center study\nNA\nClassical machine learning\nMRI\n138 patients\nPathology confirmed\nSingle center study\nOutcome of interest acc to set cut-\noff.Build RPI model for survival prediction and \nassess association with gene expression \nprofiles.\nRadiomics nomogram developed with MRI-\nbased radiomic feature selection and clinical \nparameters\nPerformance evaluation of MRI based \nradiomics model for detection of Deep \nMyometrial Invasion in EC\nEvaluate MRI based texture features, \ntumor volume and short axis and ADC for \nprediction of high tumor grade and LVSI in \nendo adenocarcinoma\nBuild diagnostic radiomic model and \nevaluate its accuaracy for assessment of \ndeep myometrial invasion, lymphovascular \nspace invasion, histologic high-grade \nendometrial cancer\nTo develop MRI-based whole-volume \ntumor radiomic signatures for prediction of \naggressive EC diseaseBuild MRI radiomic model and assess \nperformance compared to radiologist to \ndiagnose PLNM also, evaluate correlation \nwith immunohistochemical indicesglcm_Correlation feature from T2WI best for \ndifferentiating positive vs negative PLNM\nAUC, CDC, MRI, IDI measures showed higher \ndiagnostic performance and net clinical benefits \nwith radiomics aid than radiologists alone\nHigh RPI associated with advanced FIGO, \ndeep myometrial invasion, LN metastasis and \npoorer 5 year survival\nRPI not associated with age, histological \nsubtype, grade.\nHigh RPI associated with 46 genes \u2013 mainly \nCOMP and DMBT1, with poorer disease survival\nLinking radiomic and transcriptomic tumor \nprofiles potential for more tailored and \ntargeted treatment strategies in EC pts\n11-15 per 100 patients were found to have better \nsurgical planning with radiomics nomogram \nmodel compared to actual surgical procedure\nthe radiomics nomogram achieved the \nhighest diagnostic performance compared \nwith the radiomics signature and the clinical \nparameters models\nRadiologist diagnostic accuracy improved \nwith the aid of ML compared to without, \nhowever not statistically significant\nModel aided radiologists in diagnosing DMI on \nMR T2w images\nTumor vol >14.3 cm3 and SA >20 mm : High \nvs low grade\nTumor vol > 26.3 cm3 and SA > 26 mm : LVSI +/-\nassociation between ADC and high grade or LVSI\nSA >20 mm: best predictor\nDiagnostic accuracy of the RF model to \npredict DMI was 81%, LVSI 76.6% and high-\ngrade tumors 78.1%\nmodel performance analogous to diagnosis \nby three radiologists\nMRI-based whole-tumor radiomic signatures \nyield medium-to-high diagnostic performance \nfor predicting aggressive EC. The signatures \nmay aid in preoperative risk assessment and \nguide personalized treatment strategies in EC.2021\n2021\n2021\n20212020\n2020\n2017Characteristics:\nAI method\nImaging modality\nCohort size\nCenter\nClassification taskObjective Year Conclusions106\n2022/37 (3): 102-107Leila Yaminifar et al.  \nAuthor (s)- Ref.\nChen et al. (28)\nLuo et al. (21)\nGillen et al. (30)\nHan et al. (29)\nChen et al. (14)Classical machine learning\nMRI\n102 patients\nPathology confirmed\nSingle center study\nLow risk vs intermediate to high risk\nClassical machine learning\nPre-operative MRI\n144 PATIENTS\nPathology confirmed\nSingle center study\nPrediction of Lymphovascular \nspace invasion\nDeep learning\nCT\n78 patients\nmulticenter study\nTreatment survival with \nBevacizumab\nClassical ML\nPreop T2WI/DWI MRI\n163 pts\nCenter\nClassification task\nDeep Learning\nMRI\n530 patients\nSingle Center\nDeep vs shallow MIto establish a model based on magnetic \nresonance imaging (MRI) and clinical\nfactors for risk classification of Preoperative \nEC\nTo develop a multiparametric MRI-based \nradiomics nomogram for predicting LVSI in \nEMC and provide\ndecision-making support to clinicians.\nTo examine associations of body mass index \nsubcutaneous fat area and density\nvisceral fat area and density and total psoas \narea to outcomes among patients receiving\nchemotherapy with or without bevacizumab \nfor advanced or recurrent endometrial \ncancer (EC).\nAssess whole uterine MRI based radiomic \nmodel in EC pts for detection predicting \ndepth of myometrial invasion\nDL model for detecting MI depth in EC and \ncompare with radiologists for evaluating \nclinical applicationMRI-based radiomic model has great potential \nin prediction of low-risk ECs.\nthe combined model had a robust predictive \nvalue for patients of low risk or intermediate-\nhigh risk EC\nThe nomogram based on this model a \nnoninvasive and applicable tool for the clinical \ndiagnosis and optimal decision-making of EC\nThe radiomic-based machine-learning model \nusing a nomogram algorithm achieved high \ndiagnostic performance for predicting LVSI \nof EMC preoperatively, which could enhance \nrisk stratification and provide support for \ntherapeutic decision-making.\nObesity has been associated with increased \nlevels of vascular endothelial growth factor \n(VEGF), the main target for bevacizumab \ntherapy. Imaging measurements of VFA may \nprovide prognostic information for patients with \nEC but no adiposity marker was predictive of \nimproved response to bevacizumab\nModels performances \u2013 no significant diff\nCombined model vs subjective diagnosis \u2013 no \nsignificant diff\nSingle-sequence models vs subjective: lower \nspecificity and accuracy but higher sensitivity\nDiagnosis and classification of MI depth by \nradiologists improved with DL method for \nlesions >2cm.\nRadiologists better accuracy for lesions <2cm\nFalse positive error most common for both \nradiologists and computer2021\n2020\n2020\n20202019Characteristics:\nAI method\nImaging modality\nCohort size\nCenter\nClassification taskObjective Year Conclusions\nReferences\n1. Siegel RL, Miller KD, Jemal A. Cancer statistics, 2019. CA: a cancer \njournal for clinicians. 2019;69(1):7-34.\n2. von Gruenigen VE, Waggoner SE, Frasure HE, Kavanagh MB, Janata \nJW, Rose PG, et al. Lifestyle challenges in endometrial cancer survivorship. \nObstetrics & Gynecology. 2011;117(1):93-100.\n3. Nougaret S, Horta M, Sala E, Lakhman Y, Thomassin-Naggara I, Kido A, \net al. Endometrial cancer MRI staging: updated guidelines of the European \nSociety of Urogenital Radiology. European radiology. 2019;29(2):792-805.\n4. Cai S, Zhang H, Chen X, Wang T, Lu J, Liu X, et al. MR volumetry in \npredicting the aggressiveness of endometrioid adenocarcinoma: correlation \nwith final pathological results. Acta Radiologica. 2020;61(5):705-13.\n5. Bacon JL. Abnormal uterine bleeding: current classification and clinical \nmanagement. Obstet Gynecol Clin North Am. 2017 ;44(2):179-93.\n6. Yela DA, Pini PH, Benetti-Pinto CL. Comparison of endometrial \nassessment by transvaginal ultrasonography and hysteroscopy. \nInternational Journal of Gynecology & Obstetrics. 2018;143(1):32-6.\n7. Cooper NA, Barton PM, Breijer M, Caffrey O, Opmeer BC, Timmermans \nA, et al. Cost-effectiveness of diagnostic strategies for the management \nof abnormal uterine bleeding (heavy menstrual bleeding and post-\nmenopausal bleeding): a decision analysis. Health technology assessment \n(Winchester, England). 2014 ;18(24):1-201.8. Bi WL, Hosny A, Schabath MB, Giger ML, Birkbak NJ, Mehrtash A, et al. \nArtificial intelligence in cancer imaging: clinical challenges and applications. \nCA: a cancer journal for clinicians. 2019;69(2):127-57.\n9. Hwang DK, Hsu CC, Chang KJ, Chao D, Sun CH, Jheng YC, et al. \nArtificial intelligence-based decision-making for age-related macular \ndegeneration. Theranostics. 2019;9(1):232.\n10. Sun H, Zeng X, Xu T, Peng G, Ma Y. Computer-aided diagnosis in \nhistopathological images of the endometrium using a convolutional neural \nnetwork and attention mechanisms. IEEE journal of biomedical and health \ninformatics. 2019 ;24(6):1664-76.\n11. Dong HC, Dong HK, Yu MH, Lin YH, Chang CC. Using deep learning \nwith convolutional neural network approach to identify the invasion depth \nof endometrial cancer in myometrium using mr images: a pilot study. \nInternational Journal of Environmental Research and Public Health. \n2020;17(16):5993.\n12. Lee YH, Bang H, Kim DJ. How to establish clinical prediction models. \nEndocrinology and Metabolism. 2016;31(1):38.\n13. Zhang Y, Wang Z, Zhang J, Wang C, Wang Y, Chen H, et al. Deep \nlearning model for classifying endometrial lesions. Journal of Translational \nMedicine. 2021;19(1):1-3.107\n2022/37 (3): 102-107A review on endometrial cancer; artificial intelligence, imaging modalities\n14. Chen X, Wang Y, Shen M, Yang B, Zhou Q, Yi Y, et al. Deep learning \nfor the determination of myometrial invasion depth and automatic lesion \nidentification in endometrial cancer MR imaging: a preliminary study in a \nsingle institution. European radiology. 2020;30(9):4985-94.\n15. Sala E, Rockall AG, Freeman SJ, Mitchell DG, Reinhold C. The added \nrole of MR imaging in treatment stratification of patients with gynecologic \nmalignancies: what the radiologist needs to know. Radiology. 2013 \n;266(3):717-40.\n16. Lee YJ, Moon MH, Sung CK, Chun YK, Lee YH. MR assessment \nof myometrial invasion in women with endometrial cancer: discrepancy \nbetween T2-weighted imaging and contrast-enhanced T1-weighted \nimaging. Abdominal Radiology. 2016 ;41(1):127-35.\n17. Koplay M, Dogan NU, Erdogan H, Sivri M, Erol C, Nayman A,et al. \nDiagnostic efficacy of diffusion-weighted MRI for pre-operative assessment \nof myometrial and cervical invasion and pelvic lymph node metastasis in \nendometrial carcinoma. Journal of medical imaging and radiation oncology. \n2014;58(5):538-46.\n18. Nougaret S, Horta M, Sala E, Lakhman Y, Thomassin-Naggara \nI, Kido A, et al. Endometrial cancer MRI staging: updated guidelines of \nthe European Society of Urogenital Radiology. European radiology. 2019 \n;29(2):792-805.\n19. Han Y, Xu H, Ming Y, Liu Q, Huang C, Xu J, et al. Predicting myometrial \ninvasion in endometrial cancer based on whole-uterine magnetic \nresonance radiomics. Journal of Cancer Research and Therapeutics. \n2020 ;16(7):1648.\n20. Ueno Y, Forghani B, Forghani R, Dohan A, Zeng XZ, Chamming\u2019s F, et al. \nEndometrial carcinoma: MR imaging\u2013based texture model for preoperative \nrisk stratification\u2014a preliminary analysis. Radiology. 2017;284(3):748-57.\n21. Luo Y, Mei D, Gong J, Zuo M, Guo X. Multiparametric MRI-based \nradiomics nomogram for predicting lymphovascular space invasion \nin endometrial carcinoma. Journal of Magnetic Resonance Imaging. \n2020;52(4):1257-62.\n22. Stanzione A, Cuocolo R, Del Grosso R, Nardiello A, Romeo V, \nTravaglino A, et al. Deep myometrial infiltration of endometrial cancer \non MRI: A radiomics-powered machine learning pilot study. Academic \nradiology. 2021;28(5):737-44.23. Yan BC, Li Y, Ma FH, Zhang GF, Feng F, Sun MHet al. Radiologists with \nMRI-based radiomics aids to predict the pelvic lymph node metastasis \nin endometrial cancer: a multicenter study. European Radiology. \n2021;31(1):411-22.\n24. Yan BC, Li Y, Ma FH, Feng F, Sun MH, Lin GW, et al. Preoperative \nAssessment for High-Risk Endometrial Cancer by Developing an MRI-and \nClinical-Based Radiomics Nomogram: A Multicenter Study. Journal of \nMagnetic Resonance Imaging. 2020;52(6):1872-82. \n25. Bereby-Kahane M, Dautry R, Matzner-Lober E, Cornelis F, Sebbag-\nSfez D, Place V, et al. Prediction of tumor grade and lymphovascular space \ninvasion in endometrial adenocarcinoma with MR imaging-based radiomic \nanalysis. Diagnostic and interventional imaging. 2020;101(6):401-11.\n26. Xu X, Li H, Wang S, Fang M, Zhong L, Fan W, et al. Multiplanar MRI-\nbased predictive model for preoperative assessment of lymph node \nmetastasis in endometrial cancer. Frontiers in oncology. 2019;9:1007.\n27. Fasmer KE, Hodneland E, Dybvik JA, Wagner-Larsen K, Trovik J, \nSalvesen \u00d8, et al. Whole-volume tumor MRI radiomics for prognostic \nmodeling in endometrial cancer. Journal of Magnetic Resonance Imaging. \n2021;53(3):928-37.\n28. Chen J, Gu H, Fan W, Wang Y, Chen S, Chen X, et al. MRI-Based \nRadiomic Model for Preoperative Risk stratification in Stage I Endometrial \nCancer. Journal of Cancer. 2021;12(3):726.\n29. Han Y, Xu H, Ming Y, Liu Q, Huang C, Xu J, et al. Predicting myometrial \ninvasion in endometrial cancer based on whole-uterine magnetic \nresonance radiomics. Journal of Cancer Research and Therapeutics. \n2020 ;16(7):1648.\n30. Gillen J, Mills KA, Dvorak J, Zheng B, Thai T, Salani R, et al. Imaging \nbiomarkers of adiposity and sarcopenia as potential predictors for overall \nsurvival among patients with endometrial cancer treated with bevacizumab. \nGynecologic oncology reports. 2019 ;30:100502.\n31. De Bernardi E, Buda A, Guerra L, Vicini D, Elisei F, Landoni C, et \nal. Radiomics of the primary tumour as a tool to improve 18 F-FDG-PET \nsensitivity in detecting nodal metastases in endometrial cancer. EJNMMI \nresearch. 2018;8(1):1-9.\n32. Jacob H, Dybvik JA, Ytre-Hauge S, Fasmer KE, Hoivik EA, Trovik J, \net al. An MRI-Based Radiomic Prognostic Index Predicts Poor Outcome \nand Specific Genetic Alterations in Endometrial Cancer. Journal of Clinical \nMedicine. 2021;10(3):538.108\n2022/37 (3): 108-112Received:  15 - III - 2022\nAccepted:  31 - III - 2022\ndoi: 10.3306/AJHS.2022.37.03.108Corresponding author\nProf. Dr. Pradeep Bastola   \nE-mail: bastola.pradeep@cmc.edu.np\nAbstract  \nBackground:  This study was aimed to find out the demographic characteristics, clinical characteristics and prevalence of \nrhabdomyosarcoma in children presenting to a tertiary level hospital of terrain Nepal, over a period of nine years. The study also \naimed to explore the current understanding of rhabdomyosarcoma management.\nMethods:  This prospective, observational study was carried out in a tertiary hospital of Mid-Western part of Nepal from November \n2011 to April 2019. Histopathologically confirmed cases of rhabdomyosarcomas were included in the study. Demographics, \nclinical characteristics and other relevant findings were entered in a specified proforma for the study and analyzed by Statistical \nPackage for Social Services 24. Point estimate at 95% Confidence Interval was calculated along with frequency and percentage \nfor binary data.\nResults: Among 1180 suspected children, eight (0.68%) (0.29-1.3 at 95% CI) study subjects were diagnosed to have unilateral \norbital rhabdomyosarcoma. Males six (75%) outnumbered the females. The mean age of presentation was seven, 7+-1.8 (Range: \n6-8) years. Embryonal variant of rhabdomyosarcoma (6, 75%) was the commonest type followed by the alveolar type (2, 25%). \nProptosis was the commonest presenting feature and was present in all (8, 100%) study subjects. \nConclusions:  The prevalence of rhabdomyosarcoma was higher in the current study when compared with similar international studies. \nThe embryonal variant of rhabdomyosarcoma was the commonest type encountered. Male predilection for rhabdomyosarcoma \nwas high when compared to the females.\nKey words:  orbital rhabdomyosarcoma, children, chemotherapy, metastasis, oncologist.\nResumen\nAntecedentes:  El objetivo de este estudio era averiguar las caracter\u00edsticas demogr\u00e1ficas, las caracter\u00edsticas cl\u00ednicas y la prevalencia \ndel rabdomiosarcoma en los ni\u00f1os que se presentan en un hospital de nivel terciario de Nepal, durante un per\u00edodo de nueve a\u00f1os. \nEl estudio tambi\u00e9n pretend\u00eda explorar el conocimiento actual del tratamiento del rabdomiosarcoma.\nM\u00e9todos:  Este estudio prospectivo y observacional se llev\u00f3 a cabo en un hospital de nivel terciario del Medio Oeste de Nepal \ndesde noviembre de 2011 hasta abril de 2019. Se incluyeron en el estudio los casos de rabdomiosarcomas confirmados \nhistopatol\u00f3gicamente. Los datos demogr\u00e1ficos, las caracter\u00edsticas cl\u00ednicas y otros hallazgos relevantes se introdujeron en una \nproforma especificada para el estudio y se analizaron mediante Statistical Package for Social Services 24. Se calcul\u00f3 una \nestimaci\u00f3n puntual con un intervalo de confianza del 95% junto con la frecuencia y el porcentaje para los datos binarios.\nResultados:  Entre los 1180 ni\u00f1os sospechosos, ocho (0,68%) (0,29-1,3 con un IC del 95%) sujetos de estudio fueron \ndiagnosticados de rabdomiosarcoma orbitario unilateral. Los varones superaron en seis (75%) a las mujeres. La edad media de \npresentaci\u00f3n fue de siete, 7+-1,8 (rango: 6-8) a\u00f1os. La variante embrionaria del rabdomiosarcoma (6, 75%) fue el tipo m\u00e1s com\u00fan, \nseguido del tipo alveolar (2, 25%). La proptosis fue la caracter\u00edstica de presentaci\u00f3n m\u00e1s com\u00fan y estuvo presente en todos (8, \n100%) los sujetos del estudio. \nConclusiones:  La prevalencia del rabdomiosarcoma fue mayor en el presente estudio en comparaci\u00f3n con estudios internacionales \nsimilares. La variante embrionaria del rabdomiosarcoma fue el tipo m\u00e1s com\u00fan encontrado. La predilecci\u00f3n masculina por el \nrabdomiosarcoma fue elevada en comparaci\u00f3n con la femenina.\nPalabras clave: Rabdomiosarcoma orbital, ni\u00f1os, quimioterapia, met\u00e1stasis, onc\u00f3logo.ORIGINAL\nOrbital rhabdomyosarcoma in the pediatric population:  \nA prospective, observational study from Mid-West Nepal\nRabdomiosarcoma orbital en la poblaci\u00f3n pedi\u00e1trica: Un estudio prospectivo \ny observacional del Medio Oeste de Nepal\nPradeep Bastola1      , Sheeksha Bastola2      , Mandira Khadka1      , Sunil Koirala3  \n1. Department of Ophthalmology, Chitwan Medical College, Bharatpur, - 10, Nepal, \n2. NAME-Institute for Medical Education, Kathmandu - 03, Nepal, \n3. Department of Neurology, National Academy of Medical Sciences, Kathmandu, NepaleISSN 2255-0569\nID ID ID ID109\n2022/37 (3): 108-112Orbital rhabdomyosarcoma in the pediatric population: A prospective, observational study from Mid-West Nepal\nIntroduction\nRhabdomyosarcoma (RMS) is rare yet the most common \nsoft tissue sarcoma in children1. The clear histologic \ndefinition of RMS was recognized by Stout in the year \n1946 however, Weber first described rhabdomyosarcoma \nin 1854. The name is derived from Greek literature, which \nsuggests rod shape for rhabdo and muscle for myo2. With \nan annual incidence of 4.3 cases per million children, RMS \nis one of the rarer malignancies3. First reported by Bayer \norbital Rhabdomyosarcoma (RMS) is the most common \nprimary malignant orbital tumor of childhood. RMS is a \nrare tumor, with an annual incidence of 4.3 cases per \nmillion children3. The primary site of involvement is the \norbit in 9-10% of all childhood RMS3. Metastasis from \norbital RMS is often to the lungs, liver and bone. Lymph \nnode metastasis is seen only in 10% of cases3. \nLike other childhood malignancies, orbital RMS can often \npresent as a masquerading disease. There are reported \nincidences of RMS masquerading acute lymphocytic \nleukemia (ALL)4. The first contact clinicians like the \nOphthalmologist or a pediatrician plays an important role \nin the management of rhabdomyosarcoma due to the \naggressive nature of the disease which can threaten both \nlife and sight in children4.\nThe sudden onset of the disease, aggressive in nature \nwith a possibility of sight loss as well as loss of life warrants \nan excellent core of team dealing with this disease with \nthe Ophthalmologists and Pediatricians playing a vital \nrole. Rhabdomyosarcoma being the commonest primary \nmalignancy in the orbit in children needs more attention \nespecially in developing countries and countries like \nNepal due to the varied and aggressive presentation of \nthe disease. The paucity of knowledge in the developing \ncountries about RMS regarding early diagnosis and \nmanagement protocols further elaborates the importance \nof the disease. When timely diagnosed and treated orbital \nRMS does have high five-year survival rates. This study \nthus was aimed at finding out the demographics, clinical \ncharacteristics, and prevalence of rhabdomyosarcoma \nin a tertiary care hospital of Mid-West Nepal, besides \nexploring the current management protocols.\nMaterials and methods\nThis was a prospective, observational hospital-based \nstudy carried out in a tertiary level hospital of Mid-Western \nNepal from November 2011 \u2013April 2019. The hospital \nserves as a center for patients coming across the Indo-\nNepal border and also millions of people from Western\u2013 \nFar western Nepal. Ethical clearance was obtained from \nthe Institutional Review Board (IRB) before the study was \ncommenced. The study strictly adhered to the tenets \nof declaration of Helsinki. A convenience sampling \ntechnique was used to reach a sample size. After explaining the purpose of the study and confidentiality of \ndata collection, informed consent was obtained from the \nparent /guardian.\nAll patients visiting the department of Ophthalmology \nwilling to get enrolled in the study were included in the \nstudy. The patients who were not willing, who did not \nprovide informed consent were automatically excluded. \nDemographic characteristics of the study participants \nwere entered using a specified proforma for the study. \nThe study participants were evaluated clinically in detail \nin the following sequence: visual acuity measurement of \neach eye separately (unaided and with a pinhole), extra-\nocular movement assessment, cover test, cover-uncover \ntest, refraction using a Heine Beta 200 retinoscope, \nanterior segment examination with a slit lamp, and dilated \nfundus examination using an indirect Ophthalmoscope \nusing +90 D Volk lens, Tropicamide eye drops were used \nfor fundus dilatation. Evaluation of proptosis was carried \nout separately. Local lymph nodes were palpated to rule \nout local spread. Clinical photography was done in a \nfew cases for record purposes. Radiologically, clinically \nand histopathologically confirmed cases needing referral \nwere referred accordingly to higher oncology centres of \nNepal and abroad. \nIn subjects where the initial diagnosis was not confirmed, \ncommunication with the referral hospital and the patient \ninformant was maintained to reach the final diagnosis \nand also the management process. In cases where the \ninformants expressed their willingness to go abroad, the \nsubjects were referred abroad with proper documentation.\nProtocols used in the study: \nAn international guideline was followed for the \nmanagement of study subjects4.\nHistologically RMS was classified into the following \nhistological subsets in the study subjects; \n1. Embryonal RMS (ERMS): Most common accounts \nfor 60-70% of all childhood RMS. Histologically \nERMS is characterized by spindle-shaped \ncells which have a stromal-rich appearance \nmorphologically and are similar to developing \nmuscle cells. ERMS also has two variants and they \nare Botryoid ERMS and Spindle-shaped ERMS5-7. \n2. Alveolar RMS (ARMS): Aggressive variant of RMS \nwith potential to metastasize quickly6,7. \n3. Anaplastic RMS: This subtype has the worst \nprognosis of all RMS5,8-11. \nDue to unclear origin and potential association with ERMS, \nan extremely rare variant of RMS known as sclerosing \nRMS was not included as a histological subtype in the \ncurrent study11.110\n2022/37 (3): 108-112Pradeep Bastola  et al.  \nDifferent parameters were taken into account for the \nprognosis of orbital RMS as per the literature12. The current \nChildren\u2019s Oncology Group protocols for the treatment of \nRMS were used in staging and predicting the outcome of \nthe treatment of orbital RMS. Risk classification was done \nusing the tumor site13,14. \nStatistical analysis\nAn interobserver value of Kappa was used for the \nvalidity of diagnosis and any value more than 0.8 was \nconsidered strong agreement. Data entry and analysis \nwere done using Statistical Package for the Social \nSciences (IBM SPSS Inc, Chicago, Delaware, United \nStates) version 24. Descriptive statistics were applied, \nand results were expressed as frequencies whereas \ncontinuous variables were expressed as mean\u00b1SD \nor median. Prevalence and Point estimate at 95% \nConfidence Interval (CI) was calculated.\nResults\nAmong 1180 suspected children during the study period, \neight (8, 0.68%) (0.29-1.3 at 95% CI) study subjects were \ndiagnosed to have unilateral orbital rhabdomyosarcoma. Male study subject (6, 75%) dominated the females (2, \n25%). Two (2, 25%) of the study subjects were across the \nborder while the remaining six (6, 75%) were from Nepal. \nThe mean age of presentation of the study subjects was \n7+-1.8 years (Range 6-8). All study subjects (8, 100%) \nof RMS were sudden in onset. There was no difference \nin the laterality of the orbit involved (4) 50% right and 4 \n(50%) left orbit. The demographic characteristics, clinical \ncharacteristics, management protocols and outcomes of \nthe participants are summarized in the table ( Table I ).\nDiscussion\nIn the current study, eight participants were diagnosed to \nhave rhabdomyosarcoma, all were unilateral, with male \npredilection, this finding in the study was comparable with \nstudies done elsewhere for RMS12,15,16. However, for orbital \nRMS female predilection is more which differed from the \nfindings of this study. The current study had two non-Nepali \ncitizens as study subjects and six participants from Nepal, \na total of just eight cases over nine years all from the Asian \ncontinent. This finding of the study again was comparable \nwith the current literature about the disease which says \nthere\u2019s slightly a lower prevalence of orbital RMS in Asian \nchildren in comparison to others ( Table I )15,16.\nTable I: Showing epidemiological, and clinical characteristics of the study participants.\nDetail Findings of Rhabdomyosarcoma Study Subjects\n \u2020 (N = 8)\nTotal Number of Rhabdomyosarcoma Diagnosed \u2021 (n = 8)\nSymptoms/Signs/Cases features Present/Yes Absent/No Percentage (%)\nGender: Male (M), Female (F ) 6 (75.0% M),\n 2 (25.0%, F)  100\nAny known predisposing risk factors   8(100%) 100\nSudden onset  8 (100% 0 100\nMean age of presentation (Years)    7 (6-8+-1.8)\nPain 6 (75.0%) 2 (25.0%) 100\nSwelling  6 (75.0%) 2 (25.0%) 100\nWeight loss  2 (25.0%) 6 (75.0%) 100\nFever  4 (50.0%) 4(50.0%) 100\nSevere conjunctival chemosis  8 (100%) 0 100\nLocal spread  2 (25.0%) 6 (75.0%) 100\nBilateral involvement   6 (100%) 100\nLaterality of rhabdomyosarcoma: right (R), Left (L) \u2021  4 (50.0%, R)  100\n 4 (50.0%, L)  \nNon axial proptosis  8 (100%) 0 100\nMetastasis  2 (25.0%) 6 (75.0%) 100\nRapid progression  6 (75.0%) 2 (25.0%) 100\nCervical lymph node involvement  2 (25.0%%) 6 (75.0%%) 100\nDiminished vision  8 (100%) 0 100\nIncisional biopsy done  8 (100%) 0 100\nHomogenous soft tissue mass eroding nearby bony structure in CT scan  8 (100%) 0 100\nHistological type of rhabdomyosarcoma: Embryonal (E), Alveolar (A) \u2021   6 (75.0%, E) 100\n  2 (25.0%, A)  \nIRS treatment protocol followed  8 (100%) 0 100\nExcision of the tumor (Complete: C, Incomplete: IC)  6 (75.0% IC), 2 (25.0% C) 100\nChemotherapy (VAC*, IVA**)  6 (75.0%, VAC), 2 (25.0% IVA) 100\nRadiotherapy  6 (75.0%) 2 (25.0%) 100\nSight saved in last follow up    0 8(100%) 100\nLives saved in last follow up  6 (75.0%) 2 (25.0%) 100\n*Vincristine, actinomycin D, Cyclophosphamide.\n**Ifosfamide, vincristine, actinomycin D\n\u2020 Total number of study subjects diagnosed with rhabdomyosarcoma.\n\u2021 Total number of rhabdomyosarcomas, not applicable for ticking the box for positive or negative findings.111\n2022/37 (3): 108-112Orbital rhabdomyosarcoma in the pediatric population: A prospective, observational study from Mid-West Nepal\nThere have been no established predisposing risk factors \nin the current study ( Table I ), this correlated fine with the \nupdated literature of rhabdomyosarcoma with regards to \npathophysiology and risk factors as it is believed that the \nreason behind rhabdomyosarcoma is unknown16.\nGenetic level studies weren\u2019t carried out in the current \nstudy with any subjects thanks to the study limitations. \nThe alveolar variant of RMS is believed to be related \nto chromosomal translocations and fewer common \ntranslocations involving the PAX genes17,18. Loss of \nheterozygosity is seen within the embryonal subtype19. \nThere was no history of parental use of cocaine and \nmarijuana among the parents of the study subjects in the \ncurrent study. The finding of our study did not compare \nwell with a study done elsewhere20, which reported a \ncorrelation of parental use of cocaine and marijuana in \nRMS children.\nThe mean age of presentation in the current study was 7 \nyears (6-8+-1.8) in the study subjects in our study, this \nfinding from the present study was comparable to the \nprevailing knowledge that in orbital RMS the mean age of \npresentation of the children is 5-9 years21. In the current \nstudy, the demographic characteristics and clinical \ncharacteristics of the study findings as summarized in table \none was highly comparable to studies done elsewhere \n(Table I )3,4. Intergroup Rhabdomyosarcoma Study (IRS) \nmanagement protocol was followed in the current study,4 \nalso keeping in mind the present Children\u2019s Oncology \nGroup (COG) treatment and management protocols for \nRMS13,14. Chemotherapeutic agents utilized in the study \nwere Vincristine, Actinomycin D, and Cyclophosphamide \n(VAC) in most subjects whereas, in two study subjects \nIfosfamide, Vincristine and Cyclophosphamide were \ngiven as that they had local lymph node metastasis and \nextensive tumor mass, but none of the study subjects \nreceived doxorubicin and cisplatin which are believed \nto extend the survival rate when given along with VAC \nregimen22. On a median within the study subjects, 10 \ncycles of chemotherapy were given. Local resection of \nthe tumor with a 2 cm tumor-free margin could not be \ndone in two cases owing to the extensive involvement \nof the orbit and therefore the ocular tissue. Whereas in \nsix cases (75%) resection of the tumor was done with \na good excision up to 2 cm from the tumor margin. \nRadiotherapy was given to all the cases who survived \ninitial chemotherapy and resection of the first tumor. \nSight loss was irreversible because the study subjects \nneeded exenteration surgery. During the study, one study \nsubject of the alveolar variety of RMS with metastasis \npassed away, the other study subject with alveolar type \nrecurred after treatment and subsequently passed away \n(Table I ). The management protocol of the current study \nwas comparable to studies done elsewhere10,16. Overall, \n5-year survival rates have improved to over 80% in RMS \nsubjects with localized disease, consistent with the recent \nliterature on RMS22. However, in metastatic disease, the five-year survival rate is reported to be extremely low at \njust about 30%, the explanation why two of the study \nsubjects with metastatic disease ( Table I ) in the current \nstudy passed away during the treatment phase23. Even \nthough combined use of high-dose myeloablative therapy \nand autologous stem-cell rescue has not improved \noutcomes for these patients with metastatic disease24. In \nan analysis of knowledge collected by the Surveillance, \nEpidemiology, and End Results (SEER) program, mortality \nwas highly associated with age, size, and histology25. \nThe findings from SEER stated that the 5-year survival \nrate was highest in children aged 1-4 years (77%) and \nwas worst in infants and adolescents (47% and 48%, \nrespectively). Orbital and GU sites were the foremost \nfavorable (86% and 80%, respectively). Unfavorable sites \nincluded tumors of the extremities (50%), retroperitoneum \n(52%), and trunk (52%). The prognosis for the Embryonal \nvariant of RMS was best (67%) when compared with \nalveolar histology (49%)25 . Even if the recurrence occurs \nafter initial therapy has been completed most patients \nwith local recurrence are curable with salvage therapy25. \nIn the current study explanation for mortality is probably \nattributed to incomplete resection of the tumor especially \nwithin the alveolar RMS subtype, age of the study subjects \n(adolescents), and presence of metastasis which is \ncomparable with the existing knowledge regarding RMS \nand its prognosis as per SEER25. \nRecent update on chemotherapy \nof rhabdomyosarcoma\nIn a phase II trial of 87 patients with rhabdomyosarcoma who \nhad experienced a primary relapse or disease progression \nand whose prognosis was unfavorable, temsirolimus \n(Torisel) proved superior to bevacizumab (Avastin) as \nadd-on therapy. At 6 months, event-free survival in these \npatients, whose prognosis was unfavorable, was 65% \nwith temsirolimus versus 50% with bevacizumab, when \nthese agents were added to a chemotherapy regimen of \nvinorelbine and cyclophosphamide26,27. At 6 months, the \nresponse rate also favored temsirolimus (47.4% vs 27.5%) \nas did the number of complete responses (5 vs 4) and \nalso the number of partial responses (13 vs 7), the speed \nof progressive disease was also better with temsirolimus \n(28% vs 10%)26,27. In a second study of 461 children with \nintermediate-risk rhabdomyosarcoma, adding irinotecan to \ncombination treatment with vincristine, dactinomycin, and \ncyclophosphamide (VAC) didn\u2019t improve overall or event-\nfree survival. However, the regimen containing irinotecan \nresulted in an exceedingly lower rate of hematologic \ntoxicity and cumulative dose of cyclophosphamide26,28. \nRhabdomyosarcoma is a very rare malignancy and \nis difficult to diagnose, a similar study from Nepal or \nsimilar settings with a large sample size focusing on \norbital rhabdomyosarcoma would be useful. This article \nprovides a baseline for treatment/management of \nrhabdomyosarcoma along with establishing the diagnosis.112\n2022/37 (3): 108-112Pradeep Bastola  et al.  \nOrbital rhabdomyosarcoma in the pediatric population: A prospective, observational study from Mid-West Nepal\nConclusions\nThe prevalence of orbital rhabdomyosarcoma in the current \nstudy was higher when compared with other studies. Male \npredilection is more than the female in rhabdomyosarcoma. \nEmbryonal variant of rhabdomyosarcoma is the \ncommonest subtype. Metastatic disease, alveolar variant \nboth are life and sight threatening. Acknowledgements\nWe would like to acknowledge the study subjects and \ntheir informants for their cooperation and regular follow \nup. We would like to pass our debt to the hospitals where \nthe cases were diagnosed and managed.\nSource of Support:  None\nInterests conflict: The researchers declare that they \nhave no conflict of interest\nReferences\n1. Arndt CA and Crist WM. Common musculoskeletal tumors of childhood \nand adolescence. N Engl J Med 1999; 341(5):342-52. \n2. Stout AP . Rhabdomyosarcoma of the skeletal muscles. Ann Surg \n1946;123:447-72.\n \n3. Bastola P and Adhikari RK. An Unusual Presentation of Alveolar type of \nRhabdomyosarcoma of the Orbit. J Nepal Med Assoc 2009;48(176):324-7. \n4. Bastola P , Koirala S and Adhikari RK. An Experience of Ocular and Orbital \nMalignancies and their Management in Paediatric Population of Nepal: A \nMulticenter Study. J Ped Oncology 2016; 4:1-10 \n5. Newton WA Jr, Gehan EA, Webber BL, Marsden HB, van Unnik AJ, \nHamoudi AB, et al. Classification of rhabdomyosarcoma and related \nsarcomas. Pathological aspects and proposal for a new classification - an \nIntergroup Rhabdomyosarcoma Study. Cancer 1995; 76: 1073-85.\n6. Qualman SJ, Coffin CM, Newton WA, Hojo H, Triche TJ, Parham DM , et \nal. Intergroup Rhabdomyosarcoma Study: Update for pathologists. J of Ped \nPatho and Ped Patho Society 1998;1:550-61. \n7. Meyer WH. Rhabdomyosarcoma. Holland -Frei Cancer Medicine 6th \nEdition. Hamilton: BC Decker.\n8. Cecchetto G, Bisogno G, De Corti F, Dalllgna P , Inserra A. Biopsy or \ndubulking surgery as initial surgery for locally advanced rhabdomyosarcoma \nin children?: the experience of the Italian Cooperative Group studies. Cancer \n2007;110:2561-67.\n9. Hays DM, Lawrence W Jr, Wharam M, Newton W Jr, Ruymann FB, \nBeltangady M, et al. Primary re excision for patients with \u201cmicroscopic \nresidual\u201d tumor following initial excision of sarcomas of trunk and extremity \nsites. J of Ped Surgery 1989;24:5-10. \n10. Meza JL, Anderson J, Pappo AS, Meyer WH. Analysis of prognostic \nfactors in patients with nonmetastatic rhabdomyosarcoma treated on \nintergroup rhabdomyosarcoma studies III and IV: the Children\u2019s Oncology \nGroup. J Clinical Oncology 2006;24:3844-51. \n11. Folpe AL, McKenney JK, Bridge JA, Weiss SW. Sclerosing \nrhabdomyosarcoma in adults: report of four cases of a hyalinizing, matrix-rich \nvariant of rhabdomyosarcoma that may be confused with osteosarcoma, \nchondrosarcoma or angiosarcoma. The American J of Surgical Pathology \n2002;26:1175-83. \n12. Wexler LH and Herman LJ. Principles and practice of pediatric oncology. \n3rd ed. Philadelphia: Lippincott-Raven. pp. 799-829.\n13. Dagher R, Helman L. Rhabdomyosarcoma: an overview. The Oncologist \n1999;4:34-44. \n14. Pedrick TJ, Donaldson SS, Cox RS. Rhabdo- myosarcoma: the \nStandford experience using a TNM staging system. J of Clin Oncology \n1986;4:370-8. \n15. Stiller CA, McKinney PA, Bunch KJ, Bailey CC, Lewis IJ. Childhood \ncancer and ethnic group in Britain: a United Kingdom children\u2019s Cancer \nStudy Group (UKCCSG) study. Br J of Cancer 1919;64:543-48.16. Stiller CA, Parkint DM. International variations in the incidence of \nchildhood soft tissue sarcoma. Pediatr and Perinatal Epidemiology 1994; \n8: 107-19. \n17. Barr FG. Molecular genetics and pathogenesis of rhabdomyosarcoma. J \nPediatr Hematol Oncol 1997;19:483-91. \n18. Sumegi J, Streblow R, Frayer RW, Dal Cin P , Rosenberg A, Meloni-Ehrig \nA,  et al. Recurrent t(2;2) and t(2;8) translocations in rhabdomyosarcoma \nwithout the canonical PAX-FOXO1 fuse PAX3 to members of the nuclear \nreceptor transcriptional coactivator family. Genes Chromosomes Cancer \n2010;49:224-36. PMC2808450\n19. Merlino G, Helman LJ. Rhabdomyosarcoma--working out the pathways. \nOncogene 1999;18:5340-8. \n20. Grufferman S, Schwartz G, Ruymann FB, Maurer HM. Parents use of \ncocaine and marijuana and increased risk of rhabdomyosarcoma in their \nchildren: Cancer causes and control: CCC 1993;4:217-24.\n21. Boggs W. Presenting Characteristics Should Drive Rhabdomyosarcoma \nStaging in Kids. Medscape. Sep 2 2013. Available at http://www.medscape.\ncom/view article/810327. Accessed: November 29, 2017.\n22. Punyko JA, Mertens AC, Baker KS, Ness KK, Robison LL, Gurney JG.  \net al. Long-term survival probabilities for childhood rhabdomyosarcoma. A \npopulation- based evaluation. Cancer 2005;103:1475-83. \n23. Oberlin O, Rey A, Lyden E, Bisogno G, Stevens MC, Meyer WH,  et al. \nPrognostic factors in metastatic rhabdomyosarcomas: results of a pooled \nanalysis from United States and European cooperative groups. J Clin Oncol \n2008;26:2384-9. \n24. Bisogno G, Ferrari A, Prete A, Messina C, Basso E, Cecchetto G, \net al. Sequential high-dose chemotherapy for children with metastatic \nrhabdomyosarcoma. Eur J Cancer 2009;45:3035-41. \n25. Mazzoleni S, Bisogno G, Garaventa A, Cecchetto G, Ferrari A, Sotti \nG,  et al. Outcomes and prognostic factors after recurrence in children and \nadolescents with nonmetastatic rhabdomyosarcoma. Cancer 2005; 104(1): \n183-90. \n26. Nelson R. New Drug Combos Promising in Higher-Risk \nRhabdomyosarcoma. Medscape Medical News. Available at http://www.\nmedscape.com/viewarticle/826251. Accessed: November 29, 2017.\n27. Mascarenhas L, Chi YY, Hingorani P , Anderson JR, Lyden ER, Rodeberg \nDA, et al. Randomized phase II trial of bevacizumab and temsirolimus in \ncombination with vinorelbine (V) and cyclophosphamide (C) for first relapse/\ndisease progression of rhabdomyosarcoma (RMS): A report from the \nChildren\u2019s Oncology Group (COG). ASCO Meeting Abstracts. Available at \nhttp://abstracts.asco.org/144/AbstView_144_126151.html. \n28. Hawkins DS, Anderson JR, Mascarenhas L. Vincristine, dactinomycin, \ncyclophosphamide (VAC) versus VAC/V plus irinotecan (VI) for intermediate-\nrisk rhabdomyosarcoma (IRRMS): A report from the Children\u2019s Oncology \nGroup Soft Tissue Sarcoma Committee. ASCO Meeting Abstracts. Available \nat http://abstracts.asco.org/144/AbstView_144_126983.html. Accessed: \nNovember 29, 2017 113\n2022/37 (3): 113-119Received:  18 - III - 2022\nAccepted:  1 - IV - 2022\ndoi: 10.3306/AJHS.2022.37.03.113Corresponding author\nAalia Akhtar Hayat   \nE-mail: aaliyah.hayat@gmail.com\nAbstract  \nIntroduction:  Intellectual disability (ID) is a prevalent neurodevelopmental issue globally. People having ID suffer invariably from \npsychiatric, behavioral, and emotional disturbances. It is reported that a high rate of comorbidity predisposes the patients to a \npoorer prognosis and quality of life especially if undiagnosed and untreated. We specifically aimed to study the comorbid physical \nand psychiatric disorders in this vulnerable population group and to find any association with various related variables. \nMaterial: The observational cross-sectional study was conducted on male and female patients admitted with disabilities in \nRehabilitation Centre Majmaah. The data was entered and analyzed using IBM SPSS 26.0. \nResults:  The number of participants (n) was 147. The mean age of the patients was 24.32+2.19 years. Out of all patients, 17 \n(11.6%) had mild, 33 (22.4%) had moderate, 56 (38.1 %) had severe and 41 (27.9%) had profound ID. About 72% of the sample \n(n=42) had comorbidity with either a medical or a psychiatric illness whereas 12 participants (8.17%) suffered from both physical \nand psychiatric disorders. In this study, n= 30/147 (20.40%) had psychiatric comorbidity. There was a preponderance of ADHD \n(attention deficit hyperactivity disorder) and Behavioural Disorders. Around 87 patients out of 147 (59.2%) had one or more physical \ncomorbidities. The most common medical comorbidity was Epilepsy (26.53%). Overall, significant association was found between \nseverity of physical and psychiatric diseases (p=0.023). \nConclusion:  Physical and psychiatric comorbidities are common in ID patients. ADHD, Behavioural Disorders and Epilepsy were \npredominant in the research.\nKey words:  Physical comorbidity, psychiatric comorbidity, intellectually disabled, rehabilitation.\nResumen\nIntroducci\u00f3n:  La discapacidad intelectual (DI) es un problema de neurodesarrollo prevalente en todo el mundo. Las personas \ncon DI sufren invariablemente trastornos psiqui\u00e1tricos, conductuales y emocionales. Se ha informado de que una alta tasa de \ncomorbilidad predispone a los pacientes a un peor pron\u00f3stico y calidad de vida, especialmente si no se diagnostican y no se \ntratan. Nuestro objetivo espec\u00edfico es estudiar los trastornos f\u00edsicos y psiqui\u00e1tricos com\u00f3rbidos en este grupo de poblaci\u00f3n \nvulnerable y encontrar cualquier asociaci\u00f3n con diversas variables relacionadas. \nMaterial y m\u00e9todos:  El estudio observacional transversal se realiz\u00f3 en pacientes masculinos y femeninos ingresados con \ndiscapacidad en el Centro de Rehabilitaci\u00f3n Majmaah. Los datos se introdujeron y analizaron con el programa IBM SPSS 26.0. \nResultados:  El n\u00famero de participantes (n) fue de 147. La edad media de los pacientes fue de 24,32+2,19 a\u00f1os. De todos los \npacientes, 17 (11,6%) ten\u00edan una ID leve, 33 (22,4%) moderada, 56 (38,1%) grave y 41 (27,9%) profunda. Alrededor del 72% de \nla muestra (n=42) ten\u00eda comorbilidad con una enfermedad m\u00e9dica o psiqui\u00e1trica, mientras que 12 participantes (8,17%) padec\u00edan \ntanto trastornos f\u00edsicos como psiqui\u00e1tricos. En este estudio, n= 30/147 (20,40%) ten\u00edan comorbilidad psiqui\u00e1trica. Hab\u00eda una \npreponderancia del TDAH (trastorno por d\u00e9ficit de atenci\u00f3n e hiperactividad) y de los trastornos del comportamiento. Alrededor \nde 87 pacientes de 147 (59,2%) ten\u00edan una o m\u00e1s comorbilidades f\u00edsicas. La comorbilidad m\u00e9dica m\u00e1s com\u00fan era la epilepsia \n(26,53%). En general, se encontr\u00f3 una asociaci\u00f3n significativa entre la gravedad y las enfermedades psiqui\u00e1tricas (p=0,023). \nConclusiones:  Las comorbilidades f\u00edsicas y psiqui\u00e1tricas son frecuentes en los pacientes con DI. El TDAH, los trastornos de \nconducta y la epilepsia fueron predominantes en la investigaci\u00f3n.\nPalabras clave: Comorbilidad f\u00edsica, comorbilidad psiqui\u00e1trica, discapacitados intelectuales, rehabilitaci\u00f3n.ORIGINAL\nMedical and psychiatric comorbidity in the patients with intellectual \ndisability in a rehabilitation setting, Kingdom of Saudi Arabia\nComorbilidad m\u00e9dica y psiqui\u00e1trica en los pacientes con discapacidad intelectual \nen un entorno de rehabilitaci\u00f3n, Reino de Arabia Saud\u00ed\nAalia Akhtar Hayat1      , Tabassum Alvi2      , Saira Farhan2      , Waqas Sami3,4      ,\nAreej Habib Meny5  \n1. Department of Neurosciences. Maternity and Children Hospital, Makkah al Mukarramah, Kingdom of Saudi Arabia\n2. Department of Psychiatry, College of Medicine, Majmaah University, 11952, Almajmaah, Kingdom of Saudi Arabia\n3. Department of Community Medicine and Public Health, College of Medicine, Majmaah University, 11952, Almajmaah, \nKingdom of Saudi Arabia   4. Azra Naheed Medical College, Superior University, Lahore, Pakistan\n5. Occupational Therapy Program, College of Applied Medical Sciences, King Saud bin Abdulaziz University for Health Sciences, \nKing Abdullah International Medical Research Center, Kingdom of Saudi ArabiaeISSN 2255-0569\nID ID ID ID\nID114\n2022/37 (3): 113-119Aalia Akhtar Hayat et al.  \nIntroduction\nIntellectual disability (ID) is a prevalent neurodevelopmental \nissue globally. People having ID suffer invariably from \npsychiatric, behavioral, and emotional disturbances.1  \nPeople with an ID appear to be admitted with more severe \nproblems and receive more interventions than those \nwithout ID.2 It is reported that a high rate of comorbidity \nis suggestive of significant problems in the diagnosis of \nmultiple psychiatric illnesses in these patients.3 In Saudi \nArabia between 1990 and 2017, the age-standardized \npercentage of years lived with disability (YLDs) due to \nmental disorders (i.e., depression and anxiety), substance \nuse disorders (i.e. drug and alcohol use disorders), \nand neurological disorders, continued to increase. The \npercentage of YLDs due to mental disorders was found \nto be 15\u00b76%, 6.34% for substance use disorders and \n10.4% for neurological disorders.4\nA systematic review reported that the prevalence rates \nof conditions like Epilepsy (22%), Cerebral Palsy (CP) \n(19.8%), and Anxiety Disorders (10.1%) in children with ID \nwere higher than the prevalence rates in children without \nID.5 Early detection and adequate treatment of comorbid \nhealth conditions are important because these conditions \nmay have a negative impact on the well-being and social \nparticipation of children with ID and their families.6\nThe life expectancy of people with mental sub normality \nand co-morbid psychiatric illness is short as compared \nto the general population.7 The excess mortality which \nis about 60% can be attributed to physical illnesses \nlike Nutritional and Metabolic Diseases, Cardiovascular \nDiseases, Viral Diseases, Respiratory Tract Diseases, \nMusculoskeletal Diseases, pregnancy complications, \nand possibly Cancers. The evidence mentioned in \nstudies may identify etiological causes, necessary \nfor the early identification of these conditions and the \ndevelopment of effective programs8. The reason could \nbe that mentally subnormal individuals cannot voice \ntheir needs as others, as well as mobility limitations \nspecifically in older adults with ID, they are less likely \nto receive standard levels of care, as mobility is rarely \nstudied in the ID literature.9\nConsidering the complexity of the bio-psychosocial \ncause and effect relationship in Intellectually disabled \npatients with mental and physical illnesses, it is important \nto know the comorbidity pattern of diseases by targeted \nresearch. Keeping in mind the scarcity of published data \nin this domain in Saudi Arabia, this study was conducted \nto bridge the knowledge gap about the trends, needs, \nand presentations of people with disabilities living in a \nrehabilitation center in Majmaah City. We specifically \naimed to study the comorbid physical and psychiatric \ndisorders in this vulnerable population group and tried \nto find any association with various related variables. \nTherefore the objectives of the study were to find out the prevalence of comorbid psychiatric disorders among \nID patients, to find out the prevalence of comorbid \nmedical disorders among ID patients and to explore any \nassociation between psychiatric disorders or medical \ndisorders with the severity of the ID.\nMaterials and methods\nThe observational cross-sectional study was conducted \non patients admitted with disabilities in Rehabilitation \nCentre Majmaah. The study participants were both \nmales and females with intellectual disabilities. The data \nwas collected using a systematic random sampling \ntechnique to select the patients from an approximate \nsampling frame. The interval size of 03 was calculated \nby using the following formula. Based on random value \nevery 2nd patient was selected to reach the sample size \nof I04. K=N/n, Where n=sample size; N=population size; \nk=size of interval of selection. The age of participants \nwas between 10-60 years. \nData Collection Procedure:\nThe Rehabilitation Centre was visited by a team of \nresearchers and medical students who were trained \nin advance to understand disability and GAF (global \nassessment of functioning) scoring to fill the observer-\nrated questionnaire. The questionnaire consisted of \ndemographic details, the patient\u2019s diagnosis, and the level \nof severity of intellectual function as well as physical and \nmental diseases. The information was extracted from the \ndocumented records. Collateral information was taken \nfrom attending staff that were allocated to each patient. \nParticipation consent from the family (signed informed \nconsent) in advance through administration was taken. \nAll information was kept purely confidential and was only \nused for research purposes. The research was approved \nby the Ethical Review Board of Majmaah University vide \nreference no MUREC-Jan.28 / COM-2020 / l9-3.\nData analysis: \nThe data was entered and analyzed using IBM SPSS \n26.0. Quantitative variables were expressed as Mean \nSD, whereas qualitative variables were reported as \nfrequencies and percentages. Pearson Chi-square and \nFisher Exact test were applied to observe associations \nbetween qualitative variables. A p-value of<0.05 was \nconsidered statistically significant.\nResults\nThe number of participants (n) was 147. The mean \nage of the patients was 24.32+2.19 years. Most of the \npatients (96.6%-n 142) were in the age range of 11-40 \nyears. Females comprised 53.1 % (78) of the sample, \nthe majority (144) were uneducated and single (98.6). \nOut of all patients, 17 (11.6%) had mild, 33 (22.4%) 115\n2022/37 (3): 113-119Medical and psychiatric comorbidity in the patients with intellectual disability in a rehabilitation setting, Kingdom of Saudi Arabia\nhad moderate, 56 (38.1 %) had severe and 41 (27.9%) \nhad profound ID. About 72% of the sample (n=42) had \ncomorbidity with either a medical or a psychiatric illness \nwhereas 12 participants (8.17%) suffered from both \nphysical and psychiatric disorders. Most of them (75%) \nhad a speech disorder of varying severity. \n1. Psychiatric Disorders and Intellectual Disability\nIn this study, n= 30/147 (20.40%) had psychiatric \ncomorbidity. There was a preponderance of ADHD and \nBehavioural Disorders. The most common comorbidity \nfound was ADHD (11.56%-n=17) followed by Behavioural \nDisorders (11.56 %- n=17) and (10.2%- n=11) Psychotic \nDisorders/ Schizophrenia. Few cases of Psychosis (n=9) \nand a Mood Disorder (n=1) were found in records.\nAssociation of Psychiatric Disorders \nwith the severity of Intellectual disability:\nA significant association was found between the severity \nof ID and psychiatric disorders (P=0.023) as seen \nin table 1 above. This implied that having a severe ID \nwas associated with increased chances of having a \npsychiatric illness generally. \n2. Medical Disorders and Intellectual Disability \nAbout 87 patients (59.2%) had one or more physical \ncomorbidities. In our study, the most common \nmedical comorbidities were Epilepsy n= 39 (26.53%). \nQuadriplegia was found in n=13 (8.84%) and Paraplegia \nin n= 15 (10.20%). Diabetes Mellitus (DM) was found in \nn=8 (5.44%), 8 patients had CP whereas only one patient \neach had (0.68%) illnesses, such as Hypertension, \nCardiac Anomaly, Impaired Vision , Anemia, Urinary Tract \nInfection (UTI), Aphasia and CP . \nAssociation of Medical Disorders \nwith the Severity of Intellectual Disability:\nTwo physical disorders were found to have a statistically \nsignificant association with the severity of ID, including \nEpilepsy (p<0.0001) and Paraplegia (p<0.012). \n3. Medications Used by Patients \nAmong 47 out of 147 patients were on medication \n(50.34%). Forty-six (31.29%) were on antiepileptics \nand mood stabilizers, and 24 (16.32%) were on antipsychotics. One patient each was taking medicines \nlike cortisol, calcium, and vitamin supplements. \nDiscussion\nIn this study, a total of 147 patients with ID have been \nanalyzed, out of which nearly two-thirds suffered from \neither one or more comorbidities. This finding is in line \nwith a recent study by Platt et al which cited a prevalence \nof 65.1% comorbid mental disorders in people with ID. \nThe reason for an even higher prevalence in our sample \ncould be that we included both the physical and the \nmental comorbidities in our study population.10\nIntellectual Disability and Psychiatric Comorbidity \nWe found that a significant proportion of our patients \nwith ID, living in the rehabilitation center had psychiatric \ncomorbidity. There was a preponderance of ADHD and \nBehavioural Disorders in our sample. Whereas only a few \ncases of Psychosis and Mood Disorder were reported.\nIf we compare our findings with other studies done on \npatients with ID, 14.4%7 of individuals had psychiatric \ndiagnoses which are somewhat near our study where we \nfound the percentage to be 20 %. That study reported a \nsignificant proportion of the patients to be having psychosis \n(4.4%) like our study (7.48%), whereas the prevalence of \nMood Disorders (8.8 %) was much more than what we \nfound in our study (1.36%).7 Another study by Deb et al \nin 2001 also reported about 5.6% of Mood Disorders \nwhich is also in contrast with our study had low number.11 \nAlso no cases of ADHD and Behavioural Disorders were \nfound in both the studies.11,12 The possible explanation \nfor the relatively smaller percentage of Psychotic and \nMood Disorders and a higher percentage of ADHD and \nbehavioral disturbances could be the differences in \nsetting and patient population.\nOur study population primarily comprised of children and \nadolescents whereas the other studies were carried out in \nadult outpatient departments. Another reason for low rates \nof psychosis and mood symptoms could be better control \nof symptoms due to the inpatient setting and supervised \ndispensing of the drugs which ensured better compliance.\nTable I: Percentage and association of psychiatric disorders and intellectual disability.\n Mental Retardation    \nPsychiatric Mild Moderate Severe Profound p-value\nDiagnosis  n (%) n (%) n (%) n (%) \nADHD 3 (17.6) 6 (18.2) 8 (14.3) 0 (0.0) \nAutism 0 (0.0) 0 (0.0) 3 (5.4) 3 (7.3)\nBehavioral Disorders 0 (0.0) 3 (9.09) 10 (17.8) 4 (9.8)\nMood Disorder 1 (5.9) 1 (3.03) 0 (0.0) 0 (0.0)\nSleep disorder 0 (0.0) 0 (0.0) 1 (1.8) 0 (0.0) p=0.023*\nPsychotic Disorders 2 (11.8) 3 (9.09) 6 (0.0) 0 (0.0)\nAnxiety Disorder 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0)\nSubstance Abuse 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0)\nOrganic Disorder 0 (0.0) 0 (0.0) 5 (8.9) 5 (12.2)116\n2022/37 (3): 113-119Aalia Akhtar Hayat et al.  \nTable II: Percentages and Association between Intellectual Disability and Medical Diagnosis.\n Intellectual Disability \nMedical Mild Moderate Severe Profound p-value\nDiagnosis n (%) n (%) n (%) n (%)  \nHypertension\nNo 16 (94.1) 33 (100) 56 (100) 41 (100) p=0.053\nYes 1 (5.9) 0 (0.0) 0 (0.0) 0 (0.0)\nDiabetes Mellitus\nNo 16 (94.1) 33 (100) 52 (92.9) 37 (92.5) p=0.469\nYes 1 (5.9) 0 (0.0) 4 (7.1) 3 (7.5)\nUrinary Tract Infection\nNo 17 (94.1) 33 (100) 55 (98.2) 41 (100) p=0.651\nYes 0 (0.0) 0 (0.0)  1 (1.8) 0 (0.0) \nSpastic Paraplegia  \nNo 17 (100) 33 (100) 54 (96.4) 41 (100) p=0.348\nYes 0 (0.0) 0 (0.0) 0 (3.6)  0 (0.0)\nQuadriplegia  \nNo  17 (100) 33 (100) 53 (94.6) 31 (75.6) p<0.001*\nYes 0 (0.0) 0 (0.0) 3 (5.4) 10 (24.4)\nEpilepsy\nNo 16 (94.1) 25 (75.8) 44 (78.6) 23 (56.1) p=0.012*\nYes 1 (5.9) 8 (24.2) 12 (21.4) 18 (43.9)\nParaplegia\nNo 17 (100) 31 (93.9) 48 (85.7) 36 (87.8) p=0.290\nYes 0 (0.0) 2 (6.1) 8 (14.3) 5 (12.2)\nMSKD\nNo 17 (100)  33 (100) 56 (100) 41 (100) ---\nYes 0 (0.0)  0 (0.0) 0 (0.0) 0 (0.0)\nHypothyroidism\nNo 16 (94.1) 33 (100) 56 (100) 41 (100)  p=0.053\nYes 1 (5.9) 0 (0.0) 0 (0.0) 0 (0.0)\nHemiplegia\nNo 17 (100) 32 (97.0) 55 (98.2) 40 (97.6) p=0.904\nYes 0 (0.0) 1 (3.0) 1 (1.8) 1 (2.4)\nHemiparesis\nNo 17 (100)  33 (100) 55 (98.2)  41 (100) p=0.651\nYes 0 (0.0) 0 (0.0) 1 (1.8) 0 (0.0)\nDown Syndrome\nNo 17 (100) 31 (93.9) 55 (98.2) 38 (92.7) p=0.407\nYes 0 (0.0) 2 (6.1)  1 (1.8) 3 (4.1)\nCardiac Anomaly\nNo 17 (100) 32 (97.0) 56 (100)  41 (100) p=0.324\nYes 0 (0.0)  1 (3.0) 0 (0.0) 0 (0.0)\nTotal 17 33 56 41 \nTable III: Percentages and association between Intellectual Disability and Medical Diagnosis continued.\n Intellectual Disability    \nMedical  Mild Moderate Severe Profound p-value\nDiagnosis  n (%) n (%) n (%) n (%) \nDiabetes Millets\nNo 17 (100) 33 (100) 56 (100) 41 (100) ---\nYes 0 (0.0) 0 (0.0) 0 (0.0)  0 (0.0) \nPoor Vision\nNo 7 (100) 33 (100) 55 (98.2) 41 (100) p=0.585\nYes 0 (0.0) 0 (0.0)  1 (1.8) 0 (0.0)\nAnemia\nNo 17 (94.1) 33 (100) 55 (98.2) 41 (100) p=0.651\nYes 0 (0.0)  0 (0.0)  1 (1.8) 0 (0.0)\nAphasia\nNo 17 (100) 33 (100) 55 (98.2) 41 (100) p=0.651\nYes 0 (0.0) 0 (0.0)  1 (1.8) 0 (0.0)\nCerebral Palsy\nNo 17 (100) 31 (93.9) 54 (96.4) 37 (90.2) p=0.413\nYes 0 (0.0)  2 (6.1)  2 (3.6) 4 (9.8)117\n2022/37 (3): 113-119Medical and psychiatric comorbidity in the patients with intellectual disability in a rehabilitation setting, Kingdom of Saudi Arabia\nAttention Deficit Hyperactivity Disorder: \nADHD was found comorbid in about 18 (12.24%) of \nthe patients. Three patients with mild ID (17.64%), six \nwith moderate ID and eight with severe ID (14.28%) \nhad a diagnosis of ADHD. None of those with profound \ndisabilities suffered from ADHD. This finding is \nsupported by various other studies as well.8,10,14 ADHD \nincludes the symptoms of over activity, inattention, and \nimpulsivity, which occur significantly higher in children \nwith Learning Disabilities. Dekker and Koot (2003) found \na 14.8% prevalence of ADHD in children attending \nspecial schools.13 Emerson (2003) reported an 8.7% \nprevalence of Hyperkinetic Disorder in children with \nglobal Learning Disabilities and 0.9% prevalence in the \ngeneral population.13\nAnother retrospective study was done on patients under \n19 years of age. ADHD was diagnosed in 25.5% of the \npatients. Of these, 28.3% had coexistent Expressive \nLanguage Disorder and 38.7% had to coexist mild Mental \nRetardation.14 This ascertains the fact that in children \nand adolescents with ID, symptoms and diagnosis of \nADHD is rather a common finding. Another reason for \nincreased percentage of ADHD might seen in light of \nresponsiveness to treatment shown in the study that \nADHD symptoms in patients with Mental Retardation \nmay be less responsive to medical treatment and more \nsusceptible to side effects than in patients without Mental \nRetardation13.\nBehavioural Disorder: \nIn our study 11.56% of patients had Behavioural \nDisorders. The results are consistent with a study \nconducted by Dekker et al in 2001 in Holland among \n968 children of age 6 to 18 years with ID that revealed \nattention problems in 24.0%, delinquent behavior \nin 13.7%, and aggressive behavior in 19.2%.12 In \nanother study like ours, 15% of the adults with severe \nLearning Disabilities were found to have severe \nBehavioural Disorders, like Self-Injury, Restlessness, \nAggressiveness, Destructiveness, and Impulsivity.16\nIntellectual Disability and Physical Comorbidity \nAbout 87 patients out of 147 had one or more physical \ncomorbidities (59.2%) in our study sample. This \nfinding is supported by literature that the prevalence \nrates of chronic health conditions in children with ID \nare higher than the prevalence rates in studies of \nchildren without ID.2\nPeople with ID experience more chronic illness than \nthe general.8 In our study, the most common medical \ncomorbidities were Epilepsy (26.53%), Quadriplegia \nn=13 (8.84%) and Paraplegia n=15 (10.20%) and few \nhad DM, n=8 (5.44%), and only one patient each had \n(0.68%) illnesses, including Hypertension, Cardiac \nAnomaly, Hypothyroidism, Impaired Vision and UTI \nwhereas in another study different results were found including; most common physical comorbidities along \nwith mental sub normality are DM, Cardiovascular \nDisease, Asthma, and conditions affecting the bones \nand joints-Osteoporosis, Arthritis which were least \npresent in our study.22\nEpilepsy:\nIn our study, 26.53% of the participants had comorbid \nEpilepsy. Out of half of the total patients, 67 (46.2%) 46 \nwere on antiepileptic or mood-stabilizing medications.\nPrevalence rates of Epilepsy were reported in 14 \nstudies and ranged from 5.5% to 35.0%7. Though a few \nstudies showed a prevalence rate of Epilepsy to be as \nlow as about 5.44% in the people with disabilities16, a \nsystematic review showed not only higher rates (22%,) \nbut also that the most prevalent chronic health condition \nin children with ID was Epilepsy.5 \nThere have been different postulations for this increased \nprevalence and frequent comorbidity. Corbet, 1981 \nfound that Epilepsy and Mental Retardation have the \nsame root cause, i.e. Cerebral Imperfection. Corbett \n(1974) found that Epilepsy in mentally subnormal with an \nintelligent quotient less than 50 is a particular problem \nof early childhood and the occurrences of seizures \nincreases with the severity of retardation12.\nDiabetes Mellitus: \nVarious studies have postulated that people with ID are \nat greater risk of developing both Type 1 and Type 2 \ndiabetes.20 In our study 8 patients (5.44%) had DM. Unlike \nour study, McVilly found that the prevalence of diabetes \nin people with ID was 8.7% whereas it was 5.4% for the \ngeneral population21. Peterson found that the prevalence \nof diabetes among people with ID was 19.4%.22\nOne reason for not having so high a prevalence of DM \nin our sample could be that only a few patients were \non antipsychotics which are known to increase the \npropensity of DM and Metabolic Syndrome if used in high \ndoses and for the long term. Also, a major proportion of \nour population was in the younger age group so their \nexposure to antipsychotic medication was relatively not \na very long term yet. Lack of continuous screening for \nDM could have been another reason for missing a few \npotential cases in this population as well.\nCerebral Palsy: \nIn our study, we found that only 8 patients (5.44%) had a \ndocumented diagnosis of CP . A study from Saudi Arabia \nrevealed that CP was the most common neurologic \ndisorder among Saudi children with a prevalence rate \nof 23.4%.23 Another study reported overall, CP was \nthe largest proportion of children (N = 163 (45.2%) with \ndisability7. A systematic review has shown that the most \nprevalent chronic health condition in children with an ID is \nEpilepsy (22%) followed by CP (19.8%).5118\n2022/37 (3): 113-119Aalia Akhtar Hayat et al.  \nThis was the most unexpected finding of our study \nbecause most of our patients had issues of mobility and \nvarious motor disorders which are the main hallmarks of \nCP . One reason could be that the diagnoses were mainly \ntaken from the medical records and the treating doctors \nsynonymized the diagnosis of ID with CP or categorized \nthem under diagnoses, such as Hemiparesis, Hemiplegia \netc. Instead of CP .\n \nHypothyroidism \nA systematic review suggested that the most \nprevalent chronic health conditions in children with ID \nwere Endocrine and Thyroid Gland Disorders (e.g., \nPhenylketonuria, Hypothyroidism) which ranged from \napproximately 0.8% to 13.1%.7 Another study from \nFinland reported a prevalence of 0.6% of Congenital \nHypothyroidism in children with ID.19\nPeople with ID were also almost twice as likely as the \ngeneral population to have Hearing Loss, Eczema, \nDyspepsia, Thyroid Disorders, and Parkinson\u2019s Disease \naccording to various studies.19,22\nThese findings are in line with our study as we found n=1 \n(0.68%) prevalence of Hypothyroidism in our patients.\nDown Syndrome: \nWhen we look at various relevant studies, we find that the \nprevalence of Down\u2019s Syndrome was variable in different \npopulations and settings. For example, one inpatient \nstudy found the prevalence to be between 2.1-20.3%7 in \npeople with ID whereas another in Finland reported 14.3% \nindividuals with down syndrome in a rehabilitation center \nfor mentally subnormal individuals23. In our population, \nthe prevalence of Down\u2019s Syndrome was 4.76% (n=6). \nThis is broadly in line with other available literature.\nOther Disorders: \nIn our study, only one patient each had (0.68%) illnesses \nlike Hypertension, Cardiac Anomaly, Impaired Vision \nand UTI which is somewhat the same as found in some \nother studies that reported the rates of disorders of \nMusculoskeletal, genital/urinary, digestive, or Circulatory \nSystems to be from 0.8% to 13.1%7. \nLimitations\nThe main limitation of the study was that the design was \nobservational and cross sectional, and the data was \ncollected mainly using the records. Conclusion\nPhysical and psychiatric comorbidities are common in \nID patients. ADHD, Behavioural Disorders, and Epilepsy \nwere predominant in the research. One third of the \npatients had both medical and psychiatric comorbidity. \nIn such cases screening can play a major role in proper \nmanagement of ID patients. Secondly, comorbidity and \ncomplexity of diseases makes it difficult to differentiate \nbetween both ADHD and Behavioural Disorders which \nmight result in improper medication management. \nRecommendations\nConsidering these findings and a high prevalence of \nmedical and psychiatric disorders in this patient population, \nwe highly recommend a regular physical and medical \nscreening schedule by the experts in relative domains.\nAlso, improving the methods of record-keeping and \nreviewing the diagnosis by psychiatrists and medical \nspecialists instead of general physicians will improve \nthe accuracy of information and data. This can help in \npolicymaking and service delivery by analyzing the needs \nand demands of these patients.\nAlso, the drug and medication practices would improve, for \nexample, using stimulants in cases of ADHD, which was the \nmost prevalent comorbidity, can bring about a significant \nimprovement in the overall well-being of the individuals. \nAcknowledgements\nThe medical students who helped us in data collection \nare highly appreciated. The Rehabilitation Centre allowed \nus wholeheartedly to visit and collect data.\nFunding Statement\nThe authors extend their appreciation to the Deanship of \nScientific Research at Majmaah University for funding this \nwork under project number (R-2022-62).\nConflict of interests\nThe authors have no conflict of interest.119\n2022/37 (3): 113-119Medical and psychiatric comorbidity in the patients with intellectual disability in a rehabilitation setting, Kingdom of Saudi Arabia\nReferences\n1. World Health Organization. World report on disability: World Health \nOrganization. Geneva, Switzerland. 2011.\n2.Tyrovolas S, El Bcheraoui C, Alghnam SA, Alhabib KF, Almadi MA, Al-\nRaddadi RM, Bedi N, El Tantawi M, Krish VS, Memish ZA, Mohammad \nY. The burden of disease in Saudi Arabia 1990\u20132017: results from the \nGlobal Burden of Disease Study 2017. The Lancet Planetary Health. \n2020 May 1; 4(5): e195-208.\n3. Gautam P , Bhatia MS, Rathi A. Intellectual disability and multiple co \nmorbid psychiatric disorders in a child: a case report. Journal of clinical \nand diagnostic research: JCDR. 2014 Nov; 8(11): WD01.\n4. Bindawas SM, Vennu V. The national and regional prevalence rates \nof disability, type, of disability and severity in Saudi Arabia\u2014analysis of \n2016 demographic survey data. International journal of environmental \nresearch and public health. 2018 Mar; 15(3):419.\n5. Oeseburg B, Dijkstra GJ, Groothoff JW, Reijneveld SA, Jansen DE. \nPrevalence of chronic health conditions in children with intellectual \ndisability: a systematic literature review. Intellectual and developmental \ndisabilities. 2011 Apr; 49(2):59-85.\n6. Jones N, Abu Hamad B, Odeh K, Pereznieto P , Abu Al Ghaib O, Plank \nG, Presler-Marshall E, Shaheen M. Every child count: Understanding the \nneeds and perspectives of children with disabilities in the State of Palestine. \nUNICEF-State of Palestine. Overseas Development Institute (https://www. \nunicef. org/oPt/ODI_Report_01-06-2017_FINAL. pdf). 2016.\n7. Lunsky Y, White SE, Palucka AM, Weiss J, Bockus S, Gofine T. \nClinical outcomes of a specialized inpatient unit for adults with mild to \nsevere intellectual disability and mental illness. Journal of Intellectual \nDisability Research. 2010 Jan; 54(1):60-9.\n8. Uzun C\u0131cek A, Sar\u0131 SA, Mercan Is\u0131k C. Sociodemographic \nCharacteristics, Risk Factors, and Prevalence of Comorbidity among \nChildren and Adolescents with Intellectual Disability: A Cross-sectional \nStudy. Journal of Mental Health Research in Intellectual Disabilities. \n2020 Apr 2; 13(2):66-85.\n9. Cleaver S, Hunter D, Ouellette-Kuntz H. Physical mobility limitations \nin adults with intellectual disabilities: a systematic review. Journal of \nIntellectual Disability Research. 2009 Feb; 53(2):93-105.\n10. Platt JM, Keyes KM, McLaughlin KA, Kaufman AS. Intellectual \ndisability and mental disorders in a US population representative sample \nof adolescents. Psychological medicine. 2019 Apr;49(6):952-61.\n11. Deb S, Thomas M, Bright C. Mental disorder in adults with \nintellectual disability. 1: Prevalence of functional psychiatric illness \namong a community-based population aged between 16 and 64 years. \nJournal of Intellectual Disability Research. 2001 Dec;45(6):495-505.12. Nath K, Naskar S. A clinical study on seizure disorder in intellectually \ndisabled patients in Barak Valley, North-Eastern India. Open Journal of \nPsychiatry & Allied Sciences. 2016;7(1):46-53.\n13. Haessler F, Thome J. Mental retardation and ADHD. Zeitschrift \nfur Kinder-und Jugendpsychiatrie und Psychotherapie. 2012 Mar \n1;40(2):83-93.\n14. Al Haidar FA. Co-morbidity and treatment of attention deficit \nhyperactivity disorder in Saudi Arabia. EMHJ-Eastern Mediterranean \nHealth Journal, 9 (5-6), 988-995, 2003.\n15. McDermott S, Moran R, Platt T, Wood H, Isaac T, Dasari S. \nPrevalence of Epilepsy in adults with mental retardation and related \ndisabilities in primary care. American Journal on Mental Retardation. \n2005 Jan;110(1):48-56.\n16. Pearson DA, Lachar D, Loveland KA, Santos CW, Faria LP , Azzam \nPN, Hentges BA, Cleveland LA. Patterns of behavioral adjustment \nand maladjustment in mental retardation: comparison of children with \nand without ADHD. American Journal on Mental Retardation. 2000 \nJul;105(4):236-51.\n17. Dekker MC, Koot HM. DSM-IV disorders in children with borderline \nto moderate intellectual disability. I: Prevalence and impact. Journal of \nthe American Academy of Child & Adolescent Psychiatry. 2003 Aug \n1;42(8):915-22.\n18. Bittles AH, Glasson EJ. Clinical, social, and ethical implications of \nchanging life expectancy in Down Syndrome. Developmental medicine \nand child neurology. 2004 Apr;46(4):282-6.\n19. Arvio MA, Sillanp\u00e4\u00e4 M. Prevalence, etiology and comorbidity \nof severe and profound intellectual disability in Finland. Journal of \nIntellectual Disability Research. 2003 Feb;47(2):108-12.\n20. Bittles AH, Petterson BA, Sullivan SG, Hussain R, Glasson EJ, \nMontgomery PD. The influence of intellectual disability on life expectancy. \nThe Journals of Gerontology Series A: Biological Sciences and Medical \nSciences. 2002 Jul 1;57(7):M470-2.\n21. McVilly K, McGillivray J, Curtis A, Lehmann J, Morrish L, Speight \nJ. Diabetes in people with an intellectual disability: a systematic \nreview of prevalence, incidence and impact. Diabetic medicine. 2014 \nAug;31(8):897-904.\n22. Peterson, M. D., Gordon, P . M., & Hurvitz, E. A. (2013). Chronic \ndisease risk among adults with cerebral palsy: The role of premature \nsarcopenia, obesity and sedentary behaviour. Obesity Reviews, 14(2), \n171-182. doi:10.1111/j.1467-789X.2012. 01052.x\n23. Al Salloum AA, El Mouzan MI, Al Omar AA, Al Herbish AS, Qurashi MM. \nThe prevalence of neurological disorders in Saudi children: a community-\nbased study. Journal of child neurology. 2011 Jan;26(1):21-4.120\n2022/37 (3): 120-126Received:  20 - III - 2022\nAccepted:  2 - IV - 2022\ndoi: 10.3306/AJHS.2022.37.03.120Corresponding author\nSubasini Uthirapathy\nE-mail: subasini.uthirapathy@tiu.edu.iq\nAbstract  \nIntroduction:  Ayurveda is well known system of medicine and practiced in Indian subcontinent since about 5000 years. Ayurveda \noffers holistic life style caring for the individual\u2019s mind and spirit as well as their body. Psoralea corylifolia  Linn. (Fabaceae) is well \nknown traditional plant used in Ayurveda and Chinese system of medicines and known for its beneficial actions in skin diseases \nsuch as psoriasis, alopecia, leprosy, leucoderma, and vitiligo etc. \nObjective:  The aim of present study to determine toxicity of hydroalcoholic extract of P. corylifolia  in acute and sub-chronic toxicity \nassay models. \nMethods: The albino mice were used in cute toxicity study for dose ranging from 10 to 1000 mg/kg, b.w.; and in sub-chronic \ntoxicity assay, albino wistar rat used for dose ranging from 100 to 500 mg/kg, b.w. Daily body weight, food intake and different \nbiochemical and haematological parameters were measured. Macroscopic observation of the vital organ of the test groups when \ncompared to the control group. \nResults:  The results of toxicity study showed that there are no toxic symptoms produced in acute as well as in sub-chronic toxicity \nstudies upto 1000 mg/kg, b.w. when tested in albino mice and rats orally. The overall behaviour of the animals was more active \nand healthy during the treatment period. It was found that there was no remarkable difference indicating the non-toxic property of \nthe seed extract on acute toxicity and sub-acute repeated administration causes mild adverse effects.  \nConclusion:  The current study provides scientific data on safety of P. corylifolia .\nKey words:  Psoralea corylifolia, babchi, fabaceae, acute toxicity assay, sub-chronic toxicity assay.\nResumen\nIntroducci\u00f3n:  El Ayurveda es un sistema de medicina muy conocido y practicado en el subcontinente indio desde hace unos \n5000 a\u00f1os. El Ayurveda ofrece un estilo de vida hol\u00edstico que cuida la mente y el esp\u00edritu del individuo, as\u00ed como su cuerpo. La \nPsoralea corylifolia  Linn. (Fabaceae) es una planta tradicional muy conocida que se utiliza en el sistema de medicina ayurv\u00e9dica \ny china y es conocida por sus acciones beneficiosas en enfermedades de la piel como la psoriasis, la alopecia, la lepra, la \nleucodermia y el vit\u00edligo, etc. \nObjetivo: El objetivo del presente estudio es determinar la toxicidad del extracto hidroalcoh\u00f3lico de P. corylifolia  en modelos de \nensayo de toxicidad aguda y subcr\u00f3nica. \nMetodolog\u00eda:  En el estudio de toxicidad aguda se utilizaron ratones albinos con dosis de 10 a 1000 mg/kg, p.c.; y en el ensayo \nde toxicidad subcr\u00f3nica, ratas albinas wistar con dosis de 100 a 500 mg/kg, p.c. Se midieron el peso corporal diario, la ingesta \nde alimentos y diferentes par\u00e1metros bioqu\u00edmicos y hematol\u00f3gicos. La observaci\u00f3n macrosc\u00f3pica de los \u00f3rganos vitales de los \ngrupos de prueba se compar\u00f3 con el grupo de control. \nResultados: Los resultados del estudio de toxicidad mostraron que no se produjeron s\u00edntomas t\u00f3xicos en los estudios de \ntoxicidad aguda y subcr\u00f3nica hasta 1000 mg/kg, b.w. cuando se prob\u00f3 en ratones y ratas albinos por v\u00eda oral. El comportamiento \ngeneral de los animales fue m\u00e1s activo y saludable durante el per\u00edodo de tratamiento. Se comprob\u00f3 que no hab\u00eda diferencias \nnotables que indicaran la propiedad no t\u00f3xica del extracto de semillas en la toxicidad aguda y que la administraci\u00f3n repetida \nsubaguda causa efectos adversos leves.  \nConclusi\u00f3n:  El presente estudio aporta datos cient\u00edficos sobre la seguridad de P. corylifolia .\nPalabras clave: Psoralea corylifolia, babchi, fabaceae, ensayo de toxicidad aguda, ensayo de toxicidad subcr\u00f3nica.ORIGINAL\nToxicity profiles of the hydroalocholic seed extract \nof Psoralea Corylifolia  L Fabaceae in Wistar rats\nPerfiles de toxicidad del extracto hidroalcoh\u00f3lico \nde semillas de Psoralea corylifolia L Fabaceae en ratas Wistar\nSubasini Uthirapathy1      , Javed Ahamad2  \n1. Department of Pharmacology, Tishk International University, Erbil, Kurdistan Region, Iraq\n2. Department of Pharmacognosy, Tishk International University, Erbil, Kurdistan Region, IraqeISSN 2255-0569\nID ID121\n2022/37 (3): 120-126Toxicity profiles of the hydroalocholic seed extract of Psoralea corylifolia L Fabaceae in Wistar rats\nIntroduction\nTraditional medicine has a high impact on the prevention, \ncontrol and treatment of diseases. In this regard, \nseveral medicinal plants and essential oils have been \ndeveloped for treatment and control of diseases1. \nPsoralea corylifolia  Linn. (Babchi) is an erect annual \nherb belonging to Fabaceae family. Medicinal values \nof P. corylifolia  have been described in Ayurveda and \nChinese Traditional system of medicine2. P. corylifolia  \nhas been reported to possess several bioactivities like \nlaxative, stimulant, aphrodisiac, leprosy, leucoderma, \nvitiligo, and psoriasis etc2,3. P. corylifo  seeds mainly rich in \nfurocoumarins (e.g. psoralens and 8-methoxypsoralen)4. \nP. corylifolia  has been reported by several authors as \npotent antibacterial5, anti-inflammatory6,7, anticancer8-10, \nantipsoriatic11, hepatoprotective agent, antifungal, \nantioxidant, estrogenic, immunomodulatory activity12,13, \nand also causes vasodilation. This seed mainly used \nin the treatment of leucoderma (vitiligo), menopausal \nsymptoms, depression, impotence and leprosy14. \nDue to wide application and utilization of P. corylifolia  \nplant as medicinal agent, it becomes necessity of the day \nto examine its toxicity in in-vivo model. Toxicity assays \nare performed in short term and long term basis; short \nterm assays are known as acute toxicity assay while long \nterm study refers as sub-chronic toxicity assay15. Acute \ntoxicity refers to those adverse effects occurring within \na short time but in the case of sub-acute toxicity tests \nare intended to evaluate the toxicity of the plant samples \nafter repeated administration16,17. These methods should \nbe based on the OECD guidelines and examination \nshould include the behavioural responses, mortality, \nfood intake and determination of ALP , ACP , SGPT, \nSGOT and creatinine level along with histopathological \nparameters18,19. Hence the objective of present study \nto perform acute, sub-chronic toxicity assays including \nhaematological examination to determine its safety and \nefficacy as medicinal agent20. The seed extract is safe on \nshort term acute study and long term chronic toxicity by \nrepeated oral administration causes mild adverse effects.\nMaterials and methods\nSeed collection and Identification\nDried seeds of Psoralea corylifolia  (500 g) were collected \nfrom Tampcol herbal at Chennai, and it was authenticated \nby the Pharmacognosist at Captain Srinivasamurthy \nDrug Research Institute (CSMDRI), Anna Hospital \nArumbakkam, Chennai, Tamil Nadu India and confirmed \nby RAPINAT herbarium, St. Joseph College Trichy.\nChemicals and Equipment\nWeighing balance, desiccators, empty bottles, EDTA \nbottles, capillary tubes, water bath, evaporating dish, \nhaematocrit centrifuge, and Haematology meter. Other materials include methanol, chloroform, distilled water \nand 10 % formalin.\nPreparation of the Hydroalcoholic seed extract\nDried seeds of P. corylifolia  were shade dried for a week. \nAfter drying the seeds (100 g) were coarsely powdered \nusing a pulverizer. Size reduced seeds were extracted by \ncold percolation method using water and ethanol (1:4) \nas solvent (200 ml). The extract was concentrated by \nseparating the solvent from the extract and drying it in a \nwater bath. The extracts were weighed and kept in the \nrefrigerator at 4\u00b0C until needed.\nExperimental Animals\nThe toxicity study utilized healthy Wistar albino rats of either \nsex and of about the same age, weighing about 170-250 \ng, and healthy albino mice of either six and of about the \nsame age, weighing around 20 to 35 g. The Institutional \nAnimal Ethical Committee reviewed the experimental \nprotocol and gave it their approval before it could begin. \n817 / 04 / ac / CPCSEA is the CPCSEA registration \nnumber. The animals were kept in polypropylene cages \nwith standard pellet feed (Tamil Nadu Veterinary University \nAnimal House, Chennai) and water ad libitum, and were \nkept in regular conditions (12 hr light / 12 hr dark cycles, \n20 \u00baC to 27\u00ba C, 36-60 % humidity).\nAcute Toxicity studies\nThe extract\u2019s oral median lethal dose (LD50) was measured \nin rats using the (20) Dixon and Mood method (1948).  \nHealthy adult albino mice of either sex were separated \ninto six groups (n= 6) and orally fed escalating doses of \nhydroalcoholic extract (10, 50, 100, 250, 500, and 1000 \nmg/kg b.w.). When given orally in doses up to 1000 mg/\nkg body weight, the whole hydroalcoholic extract did not \ncause any toxicity or mortality in mice when observed \nup to 24 hours after delivery. Clinical Observations (from \nthe time of injection to 14 days later, clinical signs and \nsymptoms). There were no unusual symptoms in any \nof the three groups. Below is a summary of the general \nclinical examination report.\nSub-chronic toxicity studies\nHealthy adult albino rats of either sex were separated \ninto five groups (n=5) and orally fed escalating dosages \n(100, 250, 3500, and 500 mg/kg b. w.) of hydroalcoholic \nextract, while the control group received 1 percent \nDMSO vehicle for 90 days, according to OECD-425 \n(21) recommendations. The treatment was done once \ndaily by orally for 90 days. The rats were fasted for \n18 hrs at the end of the 90th day, they were sacrificed \nafter giving due anaesthesia. The blood was collected \nfrom the jugular vein and used for the determination of \nbody weight changes, (at 9 am once weekly using a \nsensitive balance before the commencement of dosing), \nhaematological parameters, biochemical parameters \nlike ALP , ACP , SGPT and SGOT, serum urea and \nserum creatinine. The haematological parameters 122\n2022/37 (3): 120-126Subasini Uthirapathy et al.  \nwere measured by retro-orbital method. Finally, the \nhistopathological studies also carried out.  \nAt the end of the 90-day observation period, all of the \nanimals were necropsied for pathological abnormalities. \nThe brain, heart, liver, kidney, lungs, spleen, GIT tract, \nand uterus were removed, weighed, and kept in 10% \nformalin until utilized for histological research. Each \ngroup had a portion of organ tissue preserved in 10% \nformalin and processed for histopathology. Serial slices \nof 5 \u00b5 thicknesses were made after paraffin embedding \nand block construction. They were inspected under a \nmicroscope after being stained with Haematoxylin and \nEosin. Photomicrographs of a few sample specimens \nwere also obtained.\nStatistical Analysis\nThe \u2018t\u2019 test was used to examine the results reported as \nmean \u00b1SD, P<0.05 values were deemed statistically \nsignificant21,22.\nResults\nAcute toxicity test\nToxicity experiments are carried out to find out the \npharmacological level (Lethal dose) but they do not \nproduce any toxic symptoms in the animals. Till the dose \nof 2000 mg/kg, it is found that all the groups have no \nmortality at all ( Table I ). However, all the animals are \nunusually behaved immediately after drug administration, \nbut recovered after 24 hrs. Unusual symptoms of mild \nwrithing and stretching of hind limbs are observed half \nan hour after drug administration but all the animals are \nrecovered completely after 3 hrs.\nAt higher doses i.e., at the dose of 3000 mg/kg and 4000 \nmg/kg, it is seen that 80 % of the animals are dead. The \nsurvived ones have exhibited severe toxic symptoms, \nbut recovered after 24 hrs ( Table II  and Figure 1 ).\nFrom the above data, it may be concluded that the doses \nof 500 mg/kg and 1000 mg/kg (LD50) might be the \nappropriate safe doses to be administered to the mice in \norder to assess the pharmacological effects.\nThe body weight recorded has given a gradual increase \neven at higher dosages. The haematological observations for the parameters such as haemoglobin content and \nRBCs, have recorded decrease in their values in both of \nthe sexes after the treatment with seed extract. But there \nis no significant reduction in the values. The values of \nMCV, MCH and MCHC are as comparable to the normal \nlimits. The level of WBC has given increased value for \nmale and PCV has put up similar values in both the sexes \nbefore and after the treatment.\nSub-chronic toxicity\nThe results of P. corylifolia  sub-chronic toxicity show that \nthere were significant increases in body weight of female \nrats given extract at doses of 400mg/kg when compared \nto the control group. There was no statistically significant \ndifference in the relative organ weights of any of the \nseed extracts tested. Every animal was monitored on a \ndaily basis for signs of toxicity, body weight, neurological \nexamination, and mortality ( Table III  and Figure 2 ).\nOn examination, the seed extract did not produce \nany significant differences in haematological markers \n(Figure 3 ). At the doses studied, the photomicrograph \ndemonstrated normal architecture in the kidney and \nliver. On examination, the heart, lungs, spleen, uterus, \nand ovaries showed no morphological abnormalities \nin architecture. At the end of the 90-day observation \nperiod, all of the animals were necropsied for pathological \nabnormalities. A thorough post-mortem assessment \nof all of the animals indicated no major pathological \nalterations linked to the extract. Table IV  shows the \nrelative organ weights in detail as well as a summary \nof necropsy lesions. Table V  shows the tabulation of \nlesions at necropsy.Table I: Symptoms observed on treatment.\n Dose Recovery/ No. of Toxicity\n (mg/kg) Death animals died/ Observed\n  After 24 hrs animals treated  \n 10 Recovery 0/6 Nil\n 50 ,, 0/6 F\n 100 ,, 0/6 F\n 250 ,, 0/6 F\n 500 ,, 0/6 F\n 1000 ,, 0/6 F\nF = abnormal gaitTable II: Assessment of LD50 dose of P. corylifolia .\n Dose Log Dead/ % %\n (mg/kg) Dose Total Dead Corrected Probit\n 10 1.0000 0/6 0 4.17 3.26\n 50 1.6989 0/6 0 4.17 3.26\n 100 2.0000 0/6 0 4.17 3.26\n 250 2.3979 0/6 0 4.17 3.26\n 500 2.6989 0/6 0 4.17 3.26\n 1000 3.0000 0/6 0 4.17 3.26\n 1500 3.1761 0/6 0 4.17 3.26\n 2000 3.3010 0/6 0 4.17 3.26\n 3000 3.4771 2/6 33.3 33.3 4.58\n 4000 3.6021 4/6 66.6 66.6 5.42\nCorrection for 0% dead   = 100(0.25/6); 100 % dead =100X (n-0.25/6)\nFigure 1: Rats given with 2000 mg /kg of the extract showing no significant \npathological changes at necropsy.123\n2022/37 (3): 120-126Toxicity profiles of the hydroalocholic seed extract of Psoralea corylifolia L Fabaceae in Wistar rats\nHistopathology\nHistopathological examination of the Heart, Lungs, Liver, \nSpleen, Pancreas, Kidney, Genital organ, GIT and Leg part \nof treated and control groups were done. Histopathological \nobservations were carried out for both control and treated \ngroup of animals. At the highest dose of 500 mg/kg the \nresults are given for those groups of animals of 90 days\u2019 \nobservation after administration of P. corylifolia  extract can \nbe seen in figures 3-5 . At 500 mg/kg, the liver architecture \nshowed very minor quiescent inflammatory alterations (Plate \n1-E1). At 500 mg/kg, the photomicrograph demonstrated \nmild acute tubular necrosis with hyperplasia in kidney (Plate \n2-E2). However, histology of the GIT tract, heart, spleen, \nlungs, uterus, and ovaries in the treated groups revealed no \naberrant architecture (Plate 1 (A, B, C, D) and 2 (E, G, F, H).\nDiscussion\nAccording to a recent estimate, nearly 75% of people \naround the world, mainly in poor nations, rely on traditional \nmedicine and its practice for their health care needs23. \nIn rats, the extract\u2019s oral median lethal dose (LD50) was \ndetermined to be greater than 5000 mg/kg body weight. \nThis indicates that the extract is basically non-toxic when \nadministered acute (orally)24. Increased body weight and \nrelative organ weight are usually considered non-toxic \neffects of extract on animals, resulting in increased food \nand water consumption25. When compared to the control \ngroup, the extract generated a rise in body weight, \nindicating that the extract was rather safe for the rats.\nToxicity experiments were carried out to find out the \npharmacological level (lethal dose) but they did not \nproduce any toxic symptoms in the animals till the dose \n2000 mg/kg but at higher doses i.e. 3000 mg/kg and \n4000 mg/kg exhibit that 80% of the animals died. So \nthat from the result it may be concluded that the doses \nof 500 mg/kg and 1000 mg/kg (LD50) might be the \nappropriate safe doses to be administered to the mice in \norder to assess the pharmacological effects26. Whereas \nthe sub-acute toxicity studies exhibit mild abnormal \nchanges were observed in treated animal\u2019s liver and \nkidney organ in comparison with control. Biochemical \nand haematological parameters were not significantly \ndifferent between the control and experimental groups \nof rats27. In histopathological studies the pictures do not \nshow any significant shift in the architecture of the heart, \nlungs, spleen, uterus and ovary of respective organ. \nThe kidney is a vital organ in the body that helps to \nmaintain homeostasis by performing osmoregulatory \nfunctions (electrolyte and blood pressure management, \nacid-base balance maintenance)28. Urea is a by-product \nof protein metabolism that is eliminated entirely through \nthe kidneys29, whereas creatinine is a by-product of \nmuscle metabolism that is similarly expelled solely \nthrough glomerular filtration29. As a result, creatinine, urea, Table III: Sub-chronic toxicity examination through neurological parameters.\n S.No Identification Locomotor Tail Ataxic gait Head\n   activity elevation  position\n 1 Head Casual Normal None Without tilt\n 2 Neck Casual Normal None Without tilt\n 3 Body Casual Normal None Without tilt\n 4 Tail Casual Normal None Without tilt\n 5 Colourless Casual Normal None Without tilt\nTable IV: Relative organ weights.\n S.No Identification Brain Lungs Liver Kidney Spleen Ovary Heart\n 1 Head 0.72 0.96 4.8 0.72 0.72 1.2 0.48\n 2 Neck 1.08 0.81 5.15 1.8 0.54 0.8 0.54\n 3 Body 91 0.91 4.56 0.68 0.45 1.36 0.45\n 4 Tail 0.5 0.74 4.7 1 0.5 0.75 0.5\n 5 Colourless 1.12 0.84 5.36 0.84 0.56 0.84 0.56\n Mean \u00b1 S.D 0.866 0.854 4.914 0.864 0.554 0.99 0.506\n   \u00b10.26 \u00b10.08 \u00b10.33 \u00b10.17 \u00b10.10 \u00b10.26 \u00b10.04\nTable V: Tabulation of lesions at necropsy.\nOrgan H N B T C\nLiver NAD NAD NAD NAD NAD\nLungs NAD NAD NAD NAD NAD\nHeart6 NAD NAD NAD NAD NAD\nBrain NAD NAD NAD NAD NAD\nKidney NAD NAD NAD NAD NAD\nStomach NAD NAD NAD NAD NAD\nAdrenal NAD NAD NAD NAD NAD\nGIT tract NAD NAD NAD NAD NAD\nLymph nodes NAD NAD NAD NAD NAD\nTestis/ovary NAD NAD NAD NAD NAD\nUterus NAD NAD NAD NAD NADFigure 2: Body weight of sub-chronic oral Toxicity of P . corylifolia by using albino \nwistar rat.\nWhere, NAD: No abnormal changes detected; H: head; N: neck; B: back; T: tail; \nand C: colourless.124\n2022/37 (3): 120-126Subasini Uthirapathy et al.  \nFigure 3: Pre and Post Haematological reports of sub-chronic oral toxicity of P. corylifolia  by using albino wistar rats.\nFigure 4: Photomicrographs of a section of tissues (H & E\u00d7250) of Wistar rat\u2019s oral administration of hydroalcoholic extract P. corylifolia : Heart (A), Lungs (B), Spleen \n(C), and Liver (D) and Liver (D1).\n125\n2022/37 (3): 120-126Toxicity profiles of the hydroalocholic seed extract of Psoralea corylifolia L Fabaceae in Wistar rats\nFigure 5: Photomicrographs of a section of tissues (H & E\u00d7250) of Wistar rat\u2019s oral administration of hydroalcoholic extract  P. Corylifolia . Kidney (E), Kidney (E1), Uterus \nand Ovaries (F), GIT tract (G), and Uterus with histology of ovaries and fallopian tubes (H).\nsodium, potassium, and chloride levels are utilized to \nassess kidney function29. There is no significant increase \nin the serum levels of renal biochemical parameters \ntested indicates that the medications tested have no \neffect on kidney function.\nThe liver is the most important organ in the living system \nfor drug and xenobiotic metabolism. Biomarkers for \nassessing liver function include alanine transaminase, \naspartate transaminase, and alkaline phosphatase27,29. \nThe substantial increases in the level of AST might \nbe an indicator of liver damage, which is suggestive \nof hepatotoxic impact. Although ALT and AST are \ncommonly employed in the assessment of liver damage \ncaused by extract or any hepatotoxic chemical (since \nthey produce hepatocyte inflammation, cellular leakage, \nand cell membrane destruction)30,31, an elevated level of \nALT is more specific for liver-related injuries or disorders32. \nA high AST level, on the other hand, can indicate liver \ndamage, myocardial infarction, and muscular injury33. \nALT is only found in minute amounts in the liver, but it \nis secreted in the bile, and modest intra-hepatic biliary \nobstruction causes a significant increase in serum ALP34.\nWhen testing involves rats, the study of haematological parameters is significant in determining the harmful effect \nof a chemical since it has a better predictive value of \ntoxicity in humans. When the extract-treated groups were \ncompared to the control group, there was no significant \ndifference in hematological parameters. After 90 days of \noral treatment of the seed extract to rats, histopathological \nanalysis revealed that the normal morphology of the heart, \nlungs, spleen, uterus and ovaries, and the GIT tract were \nnot changed by the examined seed extracts, but liver \nand kidney had a mild unfavorable effect, suggesting that \nthe extract could be harmful to the liver and kidney.\nConclusion\nThe hydroalcoholic seed extract of P. Corylifolia  is a safe \ndrug when taken in small doses; however, repeated use \nof extracts, may cause toxic effects on certain organs \nsuch as the liver and kidney.\nConflict of interests\nThe authors have no conflict of interest.\nReferences\n1. Dehkordi FS, Tirgir F, Valizadeh Y. Effects of Guajol\u00ae ointment \nsynthesized from medicinal smoke condensate of jennet feces on \nburn wound healing on Wistar rat. Veterinary Research Forum. 2017; \n8(3):215.\n2. Chopra B, Dhingra AK, Dhar KL. Psoralea corylifolia L.(Buguchi)\u2014\nfolklore to modern evidence. Fitoterapia. 2013 Oct 1;90:44-56. 3. Shrestha S, Jadav HR, Bedarkar P , Patgiri BJ, Harisha CR, Chaudhari \nSY, Prajapati PK. Pharmacognostical evaluation of Psoralea corylifolia \nLinn. seed. Journal of Ayurveda and integrative medicine. 2018 Jul \n1;9(3):209-12. \n4. Zhang X, Zhao W, Wang Y, Lu J, Chen X. The chemical constituents \nand bioactivities of Psoralea corylifolia Linn.: a review. The American \njournal of Chinese medicine. 2016 Feb 2;44(01):35-60. 126\n2022/37 (3): 120-126Toxicity profiles of the hydroalocholic seed extract of Psoralea corylifolia L Fabaceae in Wistar ratsSubasini Uthirapathy et al.  \n5. Borate A, Khambhapati A, Udgire M, Paul D, Mathur S. Preliminary \nphytochemical studies and evaluation of antibacterial activity of Psoralea \ncorylifolia seed extract. American Journal of Phytomedicine and Clinical \nTherapeutics www. ajpct. org. 2014. \n6. Chen CH, Hwang TL, Chen LC, Chang TH, Wei CS, Chen JJ. \nIsoflavones and anti-inflammatory constituents from the fruits of Psoralea \ncorylifolia. Phytochemistry. 2017 Nov 1;143:186-93. \n7. Kong L, Ma R, Yang X, Zhu Z, Guo H, He B, et al. Psoralidin \nsuppresses osteoclastogenesis in BMMs and attenuates LPS-\nmediated osteolysis by inhibiting inflammatory cytokines. International \nImmunopharmacology. 2017 Oct 1;51:31-9. \n8. Bronikowska J, Szliszka E, Jaworska D, Czuba ZP , Krol W. The \ncoumarin psoralidin enhances anticancer effect of tumor necrosis \nfactor-related apoptosis-inducing ligand (TRAIL). Molecules. 2012 \nJun;17(6):6449-64.\n9. Hao W, Zhang X, Zhao W, Chen X. Psoralidin induces autophagy \nthrough ROS generation which inhibits the proliferation of human lung \ncancer A549 cells. PeerJ. 2014 Sep 9;2:e555. \n10. Xu QX, Zhang YB, Liu XY, Xu W, Yang XW. Cytotoxic heterodimers \nof meroterpene phenol from the fruits of Psoralea corylifolia. \nPhytochemistry. 2020 Aug 1;176:112394. \n11. Dwarampudi LP , Dhanabal SP , Shanmugam R, Muruganantham \nN. Antipsoriatic activity and Cytotoxicity of ethanolic extract of Psoralia \ncorylifolia seeds. Hygeia JD Med. 2012 Oct;4(2):41-8. \n12. Hong Y, Choi SI, Hong E, Kim GH. Psoralea corylifolia L. extract \nameliorates nonalcoholic fatty liver disease in free-fatty-acid-incubated \nHEPG2 cells and in high-fat diet-fed mice. Journal of Food Science. \n2020 Jul;85(7):2216-26.\n13. Wang J, Luo M, Shen J, Liu Z, Chen Y, Luo J, et al. Bakuchiol \nfrom Psoralea corylifolia L. Ameliorates acute kidney injury and \nimproves survival in experimental polymicrobial sepsis. International \nImmunopharmacology. 2020 Dec 1;89:107000. \n14. Kassahun Gebremeskel A, Wijerathne TD, Kim JH, Kim MJ, Seo \nCS, Shin HK, et al. Psoralea corylifolia extract induces vasodilation in \nrat arteries through both endothelium-dependent and-independent \nmechanisms involving inhibition of TRPC3 channel activity and \nelaboration of prostaglandin. Pharmaceutical biology. 2017 Jan \n1;55(1):2136-44.\n15. Botham PA. Acute systemic toxicity-prospects for tiered testing \nstrategies. Toxicology in vitro. 2004 Apr 1;18(2):227-30. \n16. Chinedu E, Arome D, Ameh FS. A new method for determining acute \ntoxicity in animal models. Toxicology international. 2013 Sep;20(3):224. \n17. Chen Y, Chen S, Song C, Yin Z, Chen Z, Jia R, et al. Acute and \nsubchronic toxicity as well as evaluation of safety pharmacology of \ntraditional Chinese medicine \u201cHuhezi\u201d. International journal of clinical and \nexperimental medicine. 2015;8(8):14553. \n18. Ahamad J, Mir SR, Naquvi KJ. Hypoglycemic activity of aqueous \nextract of Berberis aristata stems bark in STZ-induced rats. J. Res. \nIndian Med. 1969;4:83-96. \n19. Naquvi KJ, Ali MO, Ahmad J. Antidiabetic activity of aqueous extract \nof Coriandrum sativum L. fruits in streptozotocin induced rats. Indian J \nExp Biol. 2004;42(9):909-12. 20. Dixon WJ, Mood AM. A method for obtaining and analyzing \nsensitivity data. Journal of the American Statistical Association. 1948 \nMar 1;43(241):109-26. \n21. Dehkordi FS, Saberian S, Momtaz H. Detection and segregation \nof Brucella abortus and Brucella melitensis in aborted bovine, ovine, \ncaprine, buffaloes and camelid fetuses by application of conventional \nand real-time polymerase chain reaction. The Thai Journal of Veterinary \nMedicine. 2012;42(1):13.\n22. Dehkordi FS, Momtaz H, Doosti A. Application of Real-Time PCR for \ndetection of Aspergillus species in aborted ruminant foetuses. Bulgarian \nJournal of Veterinary Medicine. 2012;15(1):30-6.\n23. Kifayatullah M, Mustafa MS, Sengupta P , Sarker MM, Das A, Das \nSK. Evaluation of the acute and sub-acute toxicity of the ethanolic \nextract of Pericampylus glaucus (Lam.) Merr. in BALB/c mice. Journal of \nAcute Disease. 2015 Oct 1;4(4):309-15.\n24. Loomis H, Hayes AW. Loomis\u2019s Essentials of Toxicology, 4th, \nAcademic Press,California, U.S.A, 1996, p. 282.\n25. Teo S, Stirling D, Thomas S, Hoberman A, Kiorpes A, Khetani \nV. A 90-day oral gavage toxicity study of d-methylphenidate and d, \nl-methylphenidate in Sprague-Dawley rats. Toxicology. 2002 Oct \n15;179(3):183-96. \n26. Uthirapathy S. Cardioprotection effects of diosgenin from Dioscorea \nbulbifera against isoproterenol-induced myocardial infarction. Drugs \nand Cell Therapies in Hematology. 2021;10(1). \n27. Uthirapathy S. Analgesic and Anti-inflammatory Activity of \nWithania somnifera Root Extract. Journal of Pharmaceutical Research \nInternational. 2021;33(41A):75-84 \n28. Chindo BA, Anuka JA, Gamaniel KS. Toxicity screenings of Ficus \nplatyphylla stem bark in rats. Pharmacologia. 2012;3(10):499-505. \n29. Uthirapathy S. Chronic Toxicity Study of Poly Herbal Formulation \n(PHF) in Albino Wistar Rats. Drugs and Cell Therapies in Hematology. \n2021. 10(3), 343-59.\n30. Schwartz CR, Garrison MW. Interpretation of clinical laboratory tests. \nIn; Applied Therapeutics. The clinical use of drugs edited by Mary Anne \nkoda-Kimble, et al. Ninth edition Lippicott Williams & Wilkins, Maryland \nUSA. Ch.2. 2008 pp. 1-22.\n31. Stephens FB, Constantin-Teodosiu D, Laithwaite D, Simpson EJ, \nGreenhaff PL. An acute increase in skeletal muscle carnitine content \nalters fuel metabolism in resting human skeletal muscle. The Journal \nof Clinical Endocrinology & Metabolism. 2006 Dec 1;91(12):5013-8. \n32. Refaie AA, Mohafrash SM, Ibrahim AW, Mossa AT. Sub-acute 28-\ndays Oral toxicity study of deltamethrin on female rats and the protective \nrole of moringa tea. Trends Appl Sci Res. 2017;12(2):10-7. \n33. Dobbs NA, Twelves CJ, Gregory W, Cruickshanka C, Richards MA, \nRubens RD. Epirubicin in patients with liver dysfunction: development \nand evaluation of a novel dose modification scheme. European journal \nof cancer. 2003 Mar 1;39(5):580-6. \n34. Ganesan M, Loganathan GB, Dhanasekar J, Ishwarya KR, \nBalambica V. Implementing industrial robotics arms for material holding \nprocess in industries. journal of harbin institute of technology. 2021 Sep \n30;53(9):2021.127\n2022/37 (3): 127-130Received:  23 - III - 2022\nAccepted:  2 - IV - 2022\ndoi: 10.3306/AJHS.2022.37.03.127Corresponding author\nNithin Kumar\nE-mail: nithin.kumar@tiu.edu.iq\nAbstract  \nBackground:  A vital part of forensic anthropology is to differentiate between sexes by morphologic analysis of osseous tissue. \nOne of these osseous structures that displays a significant degree of sexual dimorphism is mandibular bone. Gender variances in \nthe mandibular anatomy, from its height, position of mental orifice, gonial angle, bigonial width and bicondylar breadth have been \nobserved in various studies.This study was aimed at evaluating the sexual dimorphism based on the average length between the \nupper and the lower edge of the mental orifice to the mandibular lower border and the mandibular height on right and left side of \nthe jaw on digital panoramic radiographs in a sample of Kurdish population of Iraq. \nMethods:  Panoramic radiographs of 460 patients (230 males and 230 females) were included in the study. The length from both \ninferior and superior margins of mental orifice to the mandibular lower border and the mandibular height in the mental orifice region \nwas measured on both left and right sides. The data was statistically analysed to estimate the differences among the sexes using \nIndependent sample t-test. \nResults:  The mandibular height in the mental orifice region from alveolar crest to mandibular lower border was more in males as \ncompared to the females, this being statistically significant. The length from superior margin and inferior margin of mental orifice to the \nmandibular lower border and the mandibular height was more in males as compared to females but was not statistically significant. \nConclusion:  The height of the mandible in the mental orifice region showed significant sexual dimorphism in the sample of Erbil \npopulation.\nKey words:  Mandibular height, mental orifice, panoramic radiograph, sexual dimorphism.\nResumen\nAntecedentes: Una parte vital de la antropolog\u00eda forense consiste en diferenciar los sexos mediante el an\u00e1lisis morfol\u00f3gico del \ntejido \u00f3seo. Una de estas estructuras \u00f3seas que muestra un grado significativo de dimorfismo sexual es el hueso mandibular. \nEste estudio ten\u00eda como objetivo evaluar el dimorfismo sexual basado en la longitud media entre el borde superior e inferior del \norificio mental y el borde inferior de la mand\u00edbula, as\u00ed como la altura de la mand\u00edbula en el lado derecho e izquierdo en radiograf\u00edas \npanor\u00e1micas digitales en una muestra de poblaci\u00f3n kurda de Iraq. \nM\u00e9todos:  Se incluyeron en el estudio las radiograf\u00edas panor\u00e1micas de 460 pacientes (230 hombres y 230 mujeres). Se midi\u00f3 \nla longitud desde los m\u00e1rgenes inferior y superior del orificio mentoniano hasta el borde inferior de la mand\u00edbula y la altura \nde la mand\u00edbula en la regi\u00f3n del orificio mentoniano, tanto en el lado izquierdo como en el derecho. Los datos se analizaron \nestad\u00edsticamente para estimar las diferencias entre los sexos mediante la prueba t de muestras independientes. \nResultados:  La altura mandibular en la regi\u00f3n del orificio mental, desde la cresta alveolar hasta el borde inferior de la mand\u00edbula, \nfue mayor en los hombres que en las mujeres, siendo esto estad\u00edsticamente significativo. La longitud desde el margen superior \ny el margen inferior del orificio mental hasta el borde inferior de la mand\u00edbula y la altura mandibular fue mayor en los hombres en \ncomparaci\u00f3n con las mujeres, pero no fue estad\u00edsticamente significativa. \nConclusi\u00f3n:  La altura de la mand\u00edbula en la regi\u00f3n del orificio mental mostr\u00f3 un dimorfismo sexual significativo en la muestra de \nla poblaci\u00f3n de Erbil.\nPalabras clave: Altura de la mand\u00edbula, orificio mental, radiograf\u00eda panor\u00e1mica, dimorfismo sexual.ORIGINAL\nEvaluation of sexual dimorphism by radiographic analysis \nof mental orifice and mandibular height \nin a sample of Kurdish population of Iraq\nEvaluaci\u00f3n del dimorfismo sexual mediante el an\u00e1lisis radiogr\u00e1fico del orificio mental \ny la altura mandibular en una muestra de poblaci\u00f3n kurda de Iraq  \nNithin Kumar  \n1. Assistant Lecturer, Faculty of Dentistry, Tishk International University. Erbil, Kurdistan, IraqeISSN 2255-0569\nID128\n2022/37 (3): 127-130Nithin Kumar  \nIntroduction\nA significant part of forensic sciences has been \ndistinguishing morphometric differences between sexes \nand among different racial groups. Forensic scientists and \nanthropologists have been commonly using morphologic \nfeatures of the lower jaw for sex determination in human \nskeleton. Significant differences between sexes in the \nheight of mandible (MH), mental orifice location (MF), \ngonial angle, bigonial width and bicondylar breadth have \nbeen shown in numerous studies1-5. \nIn forensic field, the radiographs can be an indispensable \ntool for identification, provided sufficient antemortem \nrecords are available. Panoramic radiographs (OPG) \nshow bilateral position of the body, ramus, angle of the \nmandible, mandibular orifice, and MF. OPG allows MF \nto be localized more accurately in horizontal and vertical \ndimensions. On an OPG, MF appears as either rounded, \noblong, slit-like or irregular radiolucency, which may be \npartially or completely corticated, located in between the \nalveolar margins and inferior border in the mandible6.\nData regarding gender differentiation in Kurdish population \nusing panoramic radiography based on location of MF and \nmandibular height (MH) are sparse. With this background, \ncurrent study was intended to evaluate the gender \ndifferences in measurements between the superior border \nof MF (SMF) and inferior border of MF (IMF) to the MLB \nand the height of mandible (MH) in the mental orifice region \nusing OPG in a sample of Kurdish population. \nMaterials and methods\nA retrospective study comprising of 460 patients (230 \nmales and 230 females) aged between 20 and 78 \nyears, who underwent conventional OPG for diagnostic, \nsurgical, or periodontal reasons in the radiology \ndepartment between March 2019 to March 2020. The \nOPG images were acquired using a Orthopantomograph \nmachine (NewTom Giano, CEFLA s.c., Imola, Italy) with \nthe following technical parameters: Exposure Parameters \n\u00b7 Kvp - 72; mA - 8; Exposure time 18 sec Dose to the \npatient. The inclusion criteria were all patients aged 20 \nyears and over and high quality OPG\u2019s with minimum \nradiographic errors. Exclusion criteria were all patient who \nhad undergone any surgical intervention on mandible and \nany radiolucent or radiopaque lesions in the mental orifice \nregion. After identifying and marking of the MF on OPG, \ntangents were marked from IMF, SMF, alveolar crest (AC), \nand MLB. Perpendicular lines were also marked from \nthese tangents IMF, SMF and AC to the LBM bilaterally. \nThe distance was recorded bilaterally from MLB-SMF, \nMLB-IMF and MLB-AC (MH) ( Figure 1 ).\nStandard deviations as well as mean were obtained \nfor MLB-SMF, MLB-IMF and MLB-AC in both genders. Statistical Package for the Social Sciences (SPSS) \nsoftware version 25 (Armonk, New York: IBM. Corporation) \nwas used to perform the statistical calculations. Mean \nvalues calculated and independent sample t-test applied \nto see the significant differences; P value less than 0.05 \nwas taken to be statistically significant7,8.\nResults\nOverall mean measurements between sexes for both \nsides are shown ( Table I ). \nThe mean MLB-SMF, MLB-IMF and MH measurements \nof the whole study sample was 13.9mm,11.4mm and \n28.1mm respectively. The average MLB-SMF in males \nwas 14.1mm and in females was 13.6mm. The average \nMLB-IMF in males was 11.5mm and in females was \n11.4mm. The mean MH in males and females were \n29.8mm and 26.4 mm respectively. Overall MLB-SMF, \nMLB-IMF and MH measurement showed significant \ndifference among the genders(p<0.05). ( Table II ).\nFigure 1: Orthopantomogram showing the measurements \u2013 IMF-LMB (yellow \nline), SMF-LMB (orange line) and MH (red line).\nTable I: Total mean measurements between genders on both sides combined.\nTotal mean measurements\nGender  SMF-LBM IMF-LBM MH\nMale Mean 15.4 12.6 32.7\n N 460 460 460\n Std. Deviation 1.98 1.89 2.67\nFemale Mean 13.5 11.1 29.1\n N 460 460 460\n Std. Deviation 1.24 1.19 2.27\nTotal Mean 14.4 11.8 30.9\n N 920 920 920\n Std. Deviation 1.88 1.76 3.07\nTable II: Comparison of mean measurements between genders on both sides \ncombined.\nGroup Statistics - Combined side\n Gender N Mean Std.  Std. Error Sig.\n    Deviation Mean  (2-tailed)\nSMF-LBM Male 460 15.4087 1.98022 .29197 0.000\n Female 460 13.5791 1.24180 .18309\nIMF-LBM Male 460 12.6770 1.89415 .27928 0.000\n Female 460 11.1183 1.19806 .17664\nMH Male 460 32.7887 2.67564 .39450 0.000\n Female 460 29.1378 2.27624 .33561129\n2022/37 (3): 127-130Evaluation of sexual dimorphism by radiographic analysis of mental orifice and mandibular height in a sample of Kurdish population of Iraq\nOn the left side ( Table III ), the average MLB-SMF in \nmales was 14.3mm and in females was 13.7mm. The \naverage MLB-IMF in males was 11.5mm and in females \nwas 11.4mm. The mean MH in males and females were \n29.9mm and 26.2mm respectively. Again, there was \nstatistically significant difference in MLB-SMF, MLB-IMF \nand MH on the left side between the genders (p<0.05).\nComparing the right side ( Table IV ), the average MLB-SMF \nin males was 13.9mm and in females was 13.5mm. The \naverage MLB-IMF in males was 11.4mm and in females \nwas 11.4mm. The mean MH in males and females were \n29.7mm and 26.6mm respectively. Mean MLB-SMF, \nMLB-IMF and MH measurements did show a statistically \nsignificant difference between the genders. (p<0.05).\nDiscussion\nDental studies have been considered a big portion \nin medical sciences9-11. In forensic sciences, sex \nidentification is an imperative aspect involved and many \ntechniques have been utilized including study of skeletal \nremains, figure prints, polymerase chain reaction and DNA \nanalysis12-14. A part from these, gender dimorphism has \nalso been studied using orofacial structures including use \nof dental records, lip prints, palatoscopy, canine teeth \ndimorphism, and measurements of orofacial skeleton \nfrom radiological studies15,16. Radiographs are crucial \ntools as well as the simplest and cheapest method for \nage estimation and gender determination when related to \nthe histological and biochemical methods17. \nExtensive studies have been done on gender dimorphism \nusing radiological assessment of skull, maxilla and \nmandible. Mandible has been sought as a reliable source \nto study sexual dimorphism as it is a hard and durable \nbone18.  If adequate ante mortem records are lacking, \nradiographs can perform a valued role in the identification of human remains. Numerous studies have investigated \nmental orifice in terms of its position concerning sexual \ndimorphism19. Wical et al determined that the distance \nof mental orifice from the inferior border of the mandible \nremains relatively constant throughout life despite the age-\nrelated resorption of alveolar bone above mental orifice6. \nApart from this, mandibular height in this region has also \nbeen studied extensively for sexual dimorphism19-21. For \nthis reason, mental orifice (SMF and IMF), alveolar crest \n(AC) and lower mandibular border (LMB) in this region was \nchosen for measurement.\nIn the present study, the mean of MLB to SMF values and \nMLB to IMF value were higher in males when comparing to \nfemales which was statistically significant(p<0.05). This is in \nagreement with studies done in other population of the world \nsuch as Catovie et al, Mahima et al, and Thomas et al.2,22,23 \nThis was similar comparing both right and left side between \nthe sexes, which showed higher measurement in males than \nfemales. In contrast, Vodanovic et al detected that the mean \nvalue of MLB to IMF does not exhibit sexual dimorphism.24 \nThe differences observed in our study may be due to racial \nvariance and small sample size of our study sample. Overall \nmean mandibular height in males (32.7\u00b1 2.6) was definitely \nmore than the females (29.1 \u00b1 2.2). This difference in the \nmandibular height was statistically significant (p<0.05). \nWhen comparing either sides (right side or left side) mean \nmandibular height in the premolar region was more in males \nas related to females and the difference was statistically \nsignificant (p<0.05). This result of current study is consistent \nwith studies conducted in other populace of the world24. \nBased on the outcomes in this study, we can deduce that \nthe mandibular height and the position of the mental orifice \nin relation to mandibular lower border does show sexual \ndimorphism in this small sample of Kurdish population in \nErbil. The drawback of the current study was the small \nsample number because of which this study results may \nnot be applicable to the whole Kurdish population of Iraq. \nAdditional studies are required on a larger sample size to \nconfirm the gender dimorphism in the mandible among \nthis population group. The present survey showed that \ndespite all advances in dental studies25-30, several issues \nneed to be assess in more accurate manner\nConclusion\nDifferentiating between sexes on an OPG based on the \nheight of the mandible and position of mental orifice in \nrelation to the mandibular lower border may be possible. \nSexual dimorphism does exist in the mandible among \nthe Kurdish populace. Further studies on a larger sample \nsize can enhance the understanding of this sexual \ndimorphism in mandible.\nConflict of interests\nThe authors have no conflict of interest.Table III: Comparison of mean measurements between genders on left side.\nGroup Statistics - Left side\n Gender N Mean Std.  Std. Error Sig.\n    Deviation Mean  (2-tailed)\nSMF-LBM Male 230 15.2861 2.06031 .42961 0.001\n Female 230 13.4809 1.23559 .25764 \nIMF-LBM Male 230 12.5543 1.95255 .40713 0.002\n Female 230 10.9774 1.31345 .27387 \nMH Male 230 32.6178 2.64212 .55092 0.000\n Female 230 29.0691 2.48332 .51781\nTable IV: Comparison of mean measurements between genders on right side.\nGroup Statistics - Right side\n Gender N Mean Std.  Std. Error Sig.\n    Deviation Mean  (2-tailed)\nSMF-LBM Male 230 15.5313 1.93505 .40349 0.000\n Female 230 13.6774 1.26781 .26436 \nIMF-LBM Male 230 12.7996 1.86943 .38980 0.001\n Female 230 11.2591 1.08135 .22548 \nMH Male 230 32.9596 2.75711 .57490 0.000\n Female 230 29.2065 2.10267 .43844130\n2022/37 (3): 127-130Evaluation of sexual dimorphism by radiographic analysis of mental orifice and mandibular height in a sample of Kurdish population of IraqNithin Kumar  \nReferences\n1. Arnay-de-la-Rosa M, Gonzalez-Reimers E, Fregel R, VelascoVazquez \nJ, Delgado-Darias T, Ana Gonzalez M, Larruga JM. Canara islands \naborigine sex determination based on mandible parameters contrasted \nby amelogenin analysis. J Archaeol Sci 2006; 11:1-8.\n2. Mahima VG. Mental Orifice for gender determination: A panoramic \nradiographic study. Medico-Legal Update 2009; 9:33-35.\n3. Xie Q, Wolf J, Ainamo A. Quantitative assessment of vertical heights \nof maxillary and mandibular bones in panoramic radiographs of elderly \ndentate and edentulous subjects, Acta Odontol Scand 1997;55:155-61.\n4. Phillips JL, Weller RN, Kulild JC. The mental orifice; Part 3, Size and \nposition on panoramic radiographs. J Endol 1992; 18:383-6.\n5. Ural C, Bereket C, Sner I, Aktan AM, Akpinar YZ. Bone height \nmeasurement of maxillary and mandibular bones in panoramic \nradiographs of edentulous patients. J Clinc. Exp Dent 2011; 3(1):5-9.\n6. Wical KE, Swoope CC. Studies of residual ridge resorption. Part \n1. Use of panoramic radiographs for evaluation and classification of \nmandibular resorption Prosthetic Dent 1974; 32:7-12.\n7. Fathi A, Giti R, Farzin M. How different influential factors affect the \ncolor and translucency of y-ztp: a review of the literature. Annals of \nDental Specialty. 2018;6(3):338-41.\n8. Fathi A, Farzin M, Giti R, Kalantari MH. Effects of number of firings \nand veneer thickness on the color and translucency of 2 different \nzirconia-based ceramic systems. The Journal of prosthetic dentistry. \n2019;122(6):565-e1.\n9. Ghasemi E, Fathi AH, Parvizinia S. Effect of three disinfectants on \ndimensional changes of different impression materials. Journal of Iranian \nDental Association. 2019;31(3):169-76.\n10. Monirifard R, Abolhasani M, Tahani B, Fathi A, Choobdaran A. \nRelationship of Personality Traits and Patient Satisfaction with Fixed \nImplant Prosthodontic Treatments. Journal of Iranian Dental Association. \n2019;31(4):182-8.\n11. Abolhasani M, Givehchian P , Fathi A, Goudarzi S. Relationship of Life \nSatisfaction and Satisfaction with Fixed Implant-Supported Prostheses \nin the Elderly. Journal of Iranian Dental Association. 2021;33(1):17-21.\n12. Sr A, Suragimath G, Sande AR, Kulkarni P , Nimbal A, Shankar T, \net al. Comparison of lip print patterns in two Indian subpopulations and \nits correlation in ABO blood groups. J Clin Diagn Res 2014;8:ZC40 3 \n \n13. Tsuchimochi T, Iwasa M, Maeno Y, Koyama H, Inoue H, Isobe I, et \nal. Chelating resin based extraction of DNA from dental pulp and sex \ndetermination from incinerated teeth with Y chromosomal alphoid repeat \nand short tandem repeats. Am J Forensic Med Pathol 2002;23:268 71. \n14. Sivagami AV, Rao AR, Varshney U. A simple and cost effective \nmethod for preparing DNA from the hard tooth tissue, and its use in \npolymerase chain reaction amplification of amelogenin gene segment \nfor sex determination in an Indian population. Forensic Sci Int \n2000;110:107 15. \n15. Iscan MY, Kedici PS. Sexual variation in bucco lingual dimensions in \nTurkish dentition. Forensic Sci Int 2003;137:160 4.16. Chandra A, Singh A, Badni M, Jaiswal R, AgnihotriA. Determination \nof sex by radiographic analysis of mental orifice in North Indian \npopulation. J Forensic Dent Sci 2013;5:52 5. \n17. Malik M, Laller S, Saini RS, Mishra RK, Hora I, Dahiya N. Mental \norifice: An Indicator for Gender Determination-A Radiographic Study. \nSantosh Univ J Health Sci. 2016;2:12-4. \n18. Giles E. Sex determination by discriminant function analysis of the \nmandible. Am J Phys Anthropol 1964;22:129 35.\n19. Ghodousi A, Sheikhi M, Zamani E, Gale Bakhtiari S, \nJahangirmoghaddam M. The value of panoramic radiography in gender \nspecification of edentulous Iranian population. J Dent Mater Tech \n2013;2:45 9. \n20. Thakur M, Reddy VK, Sivaranjani Y, Khaja S. Gender determination \nby mental orifice and height of the body of the mandible in dentulous \npatients a radiographic study. J Indian Acad Forensic Med 2014;36:13 8. \n21. Catovie A, Bergman V, Seifert D, Poljak Guberina R. Influence of sex, \nage and presence of functional units on optical density and bone height \nof the mandible in the elderly. Acta Stomatol Croat 2002;36:327 8. \n22. Thomas CJ, Madsen D, Whittle C. A radiologic survey of the \nedentulous mandible relevant to forensic dentistry. Leb J Dent Med \n2004;3:15 20.\n23. Vodanovic M, Dumancic J, Demo Z, Mihelic D. Determination of \nsex by discriminant functional analysis of mandibles from two Croatian \narcheological sites. Acta Stomatol Croat 2006;40:263 77\n24. Suragimath G, Ashwinirani SR, Christopher V, Bijjargi S, Pawar R, \nNayak A. Gender determination by radiographic analysis of mental orifice \nin the Maharashtra population of India. J Forensic Dent Sci 2016;8:176.\n25. Ebadian B, Fathi A, Khodadad S. Comparison of the effect of four \ndifferent abutment screw torques on screw loosening in single implant-\nsupported prosthesis after the application of mechanical loading. \nInternational Journal of Dentistry. 2021;2021:1-6.\n26. Barakati B, Khodadadi R, Asadi P , Fathi A. Evaluate The Effect \nOf Various Titanium Abutment Modifications On The Behavior Of \nPeri-Implant Soft Tissue Healing, Inflammation, And Maintenance: \nA Systematic Review And Meta-Analysis. Turkish Onilne Journal of \nQualitative Inquiry. 2021; 12:11401-10.\n27. Ebadian B, Fathi A, Savoj M. In Vitro Evaluation of the Effect \nof Different Luting Cements and Tooth Preparation Angle on the \nMicroleakage of Zirconia Crowns. International Journal of Dentistry. \n2021;2021:1-7.\n28. Monajem Zade SM, Elyaskhil M, Fathi A, Asadinejad SM. Evaluate \nRisk Markers For Periodontal Disease In Children With Type 1 Diabetes: \nA Systematic Review And Meta-Analysis. 2021;12:5715-22.\n29. Ashtiani AH, Mardasi N, Fathi A. Effect of multiple firings on the \nshear bond strength of presintered cobalt-chromium alloy and veneering \nceramic. The Journal of Prosthetic Dentistry. 2021;126(6):803-e1.\n30. Mosharraf R, Molaei P , Fathi A, Isler S. Investigating the Effect of \nNonrigid Connectors on the Success of Tooth-and-Implant-Supported \nFixed Partial Prostheses in Maxillary Anterior Region: A Finite Element \nAnalysis (FEA). International Journal of Dentistry. 2021;2021:1-12.131\n2022/37 (3): 131-133Received:  25 - III - 2022\nAccepted:  5 - IV - 2022\ndoi: 10.3306/AJHS.2022.37.03.131Corresponding author\nJavier Cort\u00e9s \nE-mail: cortes@ocea.es\nAbstract  \nWe present the results of an investigative trial that very significantly validate the use of Papilocare\u00ae, a vaginal application gel, \nfor the clearance of the presence in the lower female genital tract of the human papilloma virus and the regression of low-grade \nintraepithelial lesions that its infection initially causes in the cervix. Based on these results, two new lines of research are proposed \nand detailed.\nKey words:  Papilloma virus, clearance, low grade intraepithelial lesion, conization.\nResumen\nSe presentan los resultados de un ensayo de investigaci\u00f3n que validan de forma muy significativa el uso de Papilocare\u00ae, un gel \nde aplicaci\u00f3n vaginal, para la eliminaci\u00f3n de la presencia en el tracto genital inferior femenino del virus del papiloma humano y la \nregresi\u00f3n de las lesiones intraepiteliales de bajo grado que su infecci\u00f3n provoca inicialmente en el cuello uterino. A partir de estos \nresultados, se proponen y detallan dos nuevas l\u00edneas de investigaci\u00f3n.\nPalabras clave: virus del papiloma, aclaramiento, lesi\u00f3n intraepitelial de bajo grado, conizaci\u00f3n.ORIGINAL\nThe management of human papilloma virus infection: \nresults of the paloma clinical trial and derived research projects\nEl manejo de la infecci\u00f3n por el virus del papiloma humano: \nresultados del ensayo cl\u00ednico paloma y proyectos de investigaci\u00f3n derivados  \nJavier Cort\u00e9s1      , Dami\u00e1n Dexeus2      , Andr\u00e9s Carlos L\u00f3pez3      , Luis Serrano4      ,\nFernando Losa5      , Josep Combalia6      , Carine Emsellem6      , Yann Gaslain6      ,\nSantiago Palacios7   \n1. Royal Academy of Medicine, Palma    2. Cl\u00ednica Ginecol\u00f3gica Women\u2019s CD , Barcelona    3. Hospital Quir\u00f3nsalud, M\u00e1laga\n4. HM Gabinete Vel\u00e1zquez, Madrid    5. Cl\u00ednica Sagrada Familia, Barcelona    6. Procare Health Iberia, Barcelona\n7. Instituto Palacios, Salud y Medicina de la Mujer, MadrideISSN 2255-0569\nIDID ID ID IDID ID ID\nIntroduction\nIn 1974 Harald zur Hausen identified and described the \nstructure of the human papillomavirus (HPV)1, a sexually \ntransmitted virus2 that has subsequently been identified \nas a necessary causative agent of cervical cancer (CC)3 \nand of a proportion discharge from other cancers, as \nshown in tables I  and II.\nThese data confirm the great relevance of the causal \nHPV oncological pathologyand, consequently, of the \nenormous importance of its prevention.\nThe CLEOPATRE6 study revealed the prevalence of HPV \ninfection in women in Spain, data that have not been \nsubsequently corrected. The study evaluated 1,918,805 \nwomen between 18-65 years of age, distributed \nproportionally by population rate in all the Spanish \nAutonomous Communities. Figure 1  reflects what was The latest data available for Spain are expressed in table II :Table I: Annual number of causal HPV cancers in Europe.\nSource: Ref. 4.Cancer of Men Women\nPenis 1.090 \nAnus 1.700 2.930\nHead and neck 12.700 2.530\nVulva and vagina  3.850\nCervix  23.250Table II: Date of Spain.\nCancer of Number of cases % HPV +\nAnus 360 324\nCervix 1.948 1.948\nPenis 330 132\nVulva 570 228\nVagina 105 74\nOro-pharynx 800 216\nPre-neoplastic 54.600 54.600\ncervix ID132\n2022/37 (3): 131-133Javier Cort\u00e9s et al.  \ndetected in the study: around 30% of women under 30 \nyears of age are HPV + and around 10% from this age, \nfor a global of 14%.\nThe natural history of CC, perhaps the best known \ncancer in its development of all of us who suffer, has \nbeen precisely identified, encompassing the entire \noncogenic process, from the initial viral presence to \ninvasive cancer, passing through intraepithelial lesions, \nlow and high grade7.\nWe have solid evidence that vaccination against HPV has \nhigh rates of efficacy, effectiveness, efficiency and safety \nand that the current recommendation of secondary \npreventive methodology \u2013early diagnosis, screening\u2013 of \nthe CC is well established8, taking its joint action \u2013vaccine, \nscreening\u2013 to what we have called \u201cIntegral Cervical \nCancer Prevention\u201d, aimed at responding positively to the \ncall made by the World Health Organization to eradicate \nCC9 from our world, the first cancer in which this health \naction of so much draft is possible.\nBut we did not have any strategy that, applied to women \nwho are carriers of HPV, a significant fraction of the \nfemale population, as previously noted, would facilitate \nthe clearance of the virus and the regression of the initial \nlesion caused in the epithelium by its presence, the \nlow-grade squamous intraepitelial lesi\u00f3n (LG.SIL). We \ndid not have it, but the recent publication of the results \nof the PALOMA study has filled this gap10, a study \npreceded by the demonstration that the application of \nPapilocare\u00ae, a vaginal administration gel that basically \ncontains Coriolus versicolor, a fungus containing \npolysaccharidopeptides, Polysaccharide-K / Krestin \n(PSK) and Polysaccharidopeptide (PSP), caused a very \nintense normalization of the vaginal ecosystem and, \nin addition, very clearly improved the epithelialization \nof the cervix11. The PALOMA trial was designed as a \nphase IIb - III, prospective, randomized to a Papilocare\u00ae \ntreatment group versus routine clinical practice, that is, \nfollow-up without further ado, clinical practice for which \nthe expected results are known, HPV clearance at 6 \nmonths of 29%12, and a regression of the LG.SIL at 2 \nyears of 59%13. Papilocare\u00ae significantly demonstrated \nto cause a 63% clearance of high-risk HPV 16 after \n6 months of treatment and to re-epithelialize the neck \nof uterus of women carrying high-risk strains of HPV \nin 87.8% of cases, percentages markedly higher than \nthose obtained, as indicated above, with current clinical \npractice. The PALOMA results, which were confirmed \nby two independent studies carried out in parallel14,15, \nopen a door until now closed, that of being able to \nintervene in the day-to-day care in the treatment of the \npresence of HPV in the lower genital tract and in that \nof LG.SIL.\nPapilocare\u00ae also showed a very high tolerability, \nexpressed in that there were no serious adverse effects related to the treatment and only two dropouts due to \nmild intolerance were noted.\nThe research group was also interested in sub-analyzing \nwhether these high efficacy data from Papilocare\u00ae were \nreproduced in women over 40 years of age, a group that, \nbeing a carrier of HPV, is at a clear high-risk of developing \nCC, given its immunosenescence17, a concept coined a \nfew years ago, related to the gradual deterioration of the \nimmune system caused by the natural advancement of \nage and that involves both the host\u2019s ability to respond \nto infections and the development of long-term immune \nmemory. The analysis of this group of women over 40 \nyears of age has concluded18 that the data obtained in \nthe PALOMA study are improved: 90.5% regression of \nthe LG.SIL in the treated group versus 33% in the control \ngroup; 66.7% clearance of high-risk HPV in the treated \ngroup versus 44.4% in the control group.\nWe believe that all these results are of great importance, \nsince they provide a solid basis for a therapeutic indication \nlacking evidence so far.\nAs a consequence of these excellent results, the research \ngroup has considered two new projects:\n\u00b7 Apply Papilocare\u00ae post-conization to explore \nif a normalization of the vaginal microbiota is \nobtained, usually altered by the presence of HPV: \nmodifications of the microbiota play a decisive role \nin the development of CC19.\n\u00b7 To test whether the anal application of Papilocare\u00ae \nobtains the same results as its vaginal application \nin women with rectal HPV: there is evidence that \na high fraction of women with HPV in the lower \ngenital tract also present it in anus20, a relevant \nfact and that together with the lack of agreements \nand application of early diagnosis techniques \nand programs21,22 could explain the tendency to \nincrease the incidence of anal cancer, 90% causal \nHPV23, which the registries note24\nFigure 1: Prevalence of VPH according age (%).\n133\n2022/37 (3): 131-133The management of human papilloma virus infection: results of the paloma clinical trial and derived research projects\nBibliography\n1. zur Hausen H, Meinhof W, Scheiber W, Bornkamm GW.: Attempts to \ndetect virus-specific DNA in human tumors. I. Nucleic acid hybridizations with \ncomplementary RNA of human wart virus. Int J Cancer 1974; 13: 650-6.\n2. Kjaer S, Chackerian B, van den Brule AJ, Svare EI, Paull G, Walbomers \nJM et al.: High-risk human papillomavirus is sexually transmitted: \nevidence from a follow-up study of virgins starting sexual activity \n(intercourse). Cancer Epidemiol Biomarkers Prev 2001; 10: 101-6.\n3. Walboomers JM, Jacobs MV, Manos MM, Bosch FX, Kummer JA, \nShah KV et al.: Human papillomavirus is a necessary cause of invasive \ncervical cancer cervical worldwide. J Pathol 1999; 189: 12-19.\n4. Stanley M.: Program Research Epidemiology of Cancer. Cambridge \nUniversity.\n5. Institut Catal\u00e0 d\u2019Oncologia. Presentado en EUROGIN 2018.\n6. Castellsagu\u00e9 X, Iftner T, Roura E, Vidart JA, Kjaer SK, Bosch FX et al.: \nPrevalence and genotype distribution of human papillomavirus infection of \nthe cervix in Spain: the CLEOPATRE study. J Med Virol 2012; 84: 947-56.\n7. Darragh TM, Colgan TJ, Cox JT, Heller DS, Henry MR, Luff RD et \nal.: The Lower Anogenital Squamous Terminology Standardization \nProject for HPV-Associated Lesions: Background and Consensus \nRecommendation from the College of American Pathologist and the \nAmerican Society for Colposcopy and Cervical Pathology. Journal of \nLower Genital Tract Disease. 2012; 3: 205-42.\n8. Vidart-Arag\u00f3n JA, Cort\u00e9s J.: Prevenci\u00f3n integral del c\u00e1ncer de cuello \nuterino. An RANM 2019;  136(03): 262-265. \n9. Ghebreyesus TA, Director General: Reuni\u00f3n Ejecutiva OMS\nIntercontinental Hotel, Geneva, 19 May 2018.\n10. Serrano L, L\u00f3pez  AC, Gonz\u00e1lez SP , Palacios S, Dexeus D, \nCenteno-Mediavilla C et al.: Efficacy of a Coriolus versicolor\u2013Based \nVaginal Gel in Women With Human Papillomavirus\u2013Dependent Cervical \nLesions: The PALOMA Study. Journal of Lower Genital Tract Disease \n2021; 25: 130-6.\n11. Gonz\u00e1lez SP , Serrano L, Vezza T, Garrido Mesa J, Algieri F, Mor\u00f3n \nR et al. Effect of a Coriolus versicolor-based vaginal gel on cervical \nepithelization and vaginal microbiota in HPV-positive women: EPICERVIX \npilot study. Acam J Health Science. 2022;37(2): 139-45.12. Bulkmans NW, Berkhof J,  Bulk S, Bleeker MCG, van Kemenade \nFJ, Rozendaal L et al.: High-risk HPV type-specific clearance rates in \ncervical screening Br J Cancer 2007; 96(9): 1419-24.\n13. Matsumoto K, Oki A, Furuta R, Maeda H, Yasugi T, Takatsuka N et \nal.: Predicting the progression of cervical precursor lesions by human \npapillomavirus genotyping: a prospective cohort study. Int J Cancer. \n2011; 128(12): 2898-910.\n14. Criscuolo AA, Sesti F, Piccione E, Mancino P , Belloni E, Gullo C \net al. Therapeutic efficacy of a Coriolus Versicolor-based vaginal gel \nin women with cervical uterine high-risk HPV infection. A retrospective \nobservational study. Adv Ther 2021;38:1202-11.\n15. Riera M, Rup\u00e9rez B, L\u00e1zaro I, Felgueroso A, Fontanet E, Tena Y et \nal.: Effect of a multi-ingredient vaginal gel on clearance and/or cytology \nnormalization in high-risk HPV positive patients. [Abstract]. J Low Genit \nTract Dis. 2020; 24(1S): S16.\n16. Cuzick J.: Proposed new classification of HPV types based on their \noncogenic potential. Ponencia a EUROGIN 2017. Amsterdam. \n17. Ginaldi L, Loreto MF, Corsi MP , Modesti M, de Martinis M: \nImmunosenescence and infectious diseases. Microbes Infect. 2001; \n3(10): 851-7.\n18. Cort\u00e9s J, Palacios S, Serrano L, Gaslain Y, Seydoux G. Efficacy of \na Coriolus versicolor-Based Vaginal Gel in HPV+Women Older Than 40 \nYears: Sub-Analysis of Paloma Study. [Abstract-Poster #000917].  J \nLow Genit Tract Dis. 2021 April; 25(2,1S):S9-S10.\n19. Kyrgiou M, Mitra  A, Moscicki AB .: Does the vaginal microbiota play a \nrole in the development of cervical cancer?. Transl  Res. 2017; 179: 168-82.\n20. Cort\u00e9s J.: XX Congreso Anual de la Asociaci\u00f3n Espa\u00f1ola de \nPatolog\u00eda Cervical y Colposcopia. Madrid, Noviembre 2008.\n21. Wieland U, Kreuter A.: Anal cancer risk: HPV-based cervical \nscreening programs. Lancet Infect Dis. 2019; 19(8): 799-800\n22. Albuquerque A.: Cytology in Anal Cancer Screening: Practical \nReview for Clinicians. Acta Cytol. 2020; 64(4): 281-7.\n23. Valvo F, Ciurlia E, Avuzzi B, Doci R, Ducreux M, Roelofsen F, Roth A et \nal.: Cancer of the anal region. Crit Rev Oncol Hematol. 2019; 135: 115-27.\n24. Nelson VM, Benson AB.: Epidemiology of Anal Canal Cancer. Surg \nOncol Clin N Am. 2017; 26(1): 9-15.Conflict of interests\nJaC has received travel and / or research grants and / or conference and / or consulting fees from Genomics, GSK, \nMerck, Procare Health, Qiagen, Roche, and SPMSD.\nDD has received conference and / or consulting fees from Sanofi Pasteur, MSD, and Procare Health.\nACL has received consulting fees from Procare Health.LS ha recibido honorarios por conferencias y/o asesor\u00edas de \nShionogi, Iprad y Procare Health.\nFL has received travel and / or research grants and / or conference and / or consulting fees from Bayer, Boiron, No -\nvonordisk, Iprad, and Procare Health.\nJoC has a professional relationship with Procare Health for medical advice.\nCE has an employment relationship with Procare Health.\nYG has an employment relationship with Procare Health.\nSP has received research grants and / or fees for conferences and / or consultancies and / or for being a member of \nthe advisory committee from Pfizer, Amgen, MSD, Sandoz, Procare Health, Bayer, MSD, Serelys, Shionogi, Servier, \nAbbott, Novo Nordisk, Theramex and Gedeon Richter.134\n2022/37 (3): 134-141Received:  28 - III - 2022\nAccepted:  6 - IV - 2022\ndoi: 10.3306/AJHS.2022.37.03.134Corresponding author\nM\u00aa Te\u00f3fila Vicente-Herrero \nE-mail: vicenteherreromt@gmail.com\nResumen\nIntroducci\u00f3n:  La obesidad se ha convertido en una pandemia mundial de origen multifactorial y puede ser m\u00e1s com\u00fan de lo que \nse diagnostica considerando \u00fanicamente el \u00cdndice de Masa Corporal (IMC).\nMetodolog\u00eda:  Estudio descriptivo transversal en 815 trabajadores de edades entre 18-66 a\u00f1os, datos recogidos en los \nreconocimientos peri\u00f3dicos de vigilancia de la salud de las empresas participantes desde marzo de 2020 hasta junio de 2021.\nSe estima el Nivel de Riesgo Cardiometab\u00f3lico (NR) desde 0 a 3 en funci\u00f3n de la presencia de: s\u00edndrome metab\u00f3lico, riesgo \ncardiovascular elevado y valores fuera de rango de, al menos, dos par\u00e1metros de adiposidad. Se establecen relaciones con \nvariables sociolaborales y con h\u00e1bitos de vida (dieta y actividad f\u00edsica).\nResultados:  M\u00e1s del 70% de la poblaci\u00f3n estudiada presenta alg\u00fan grado de riesgo y se relaciona significativamente con el IMC \n(<0.0001), es mayor en varones y aumenta con la edad. Los indicadores de adiposidad son el factor que m\u00e1s se asocia con el NR \nen hombres y en mujeres, en el NR2 destaca la mayor presencia de S\u00edndrome metab\u00f3lico en mujeres y de Riesgo cardiovascular \nen hombres (<0.0001). El nivel de actividad f\u00edsica se relacionan con el NR en ambos sexos, pero en la adherencia a la dieta \nmediterr\u00e1nea se observan diferencias estad\u00edsticamente significativas entre hombres y mujeres.\nConclusi\u00f3n:  El NR estimado guarda relaci\u00f3n con el IMC, se relaciona con la edad, g\u00e9nero, nivel cultural y actividad f\u00edsica realizada. \nSu estratificaci\u00f3n facilita actuaciones preventivas, de control y seguimiento coordinado en trabajadores espa\u00f1oles.\nPalabras clave: obesidad; riesgo cardiometab\u00f3lico; cuestionario PREDIMED; cuestionario IPAQ.\nAbstract  \nIntroduction: Obesity has become a worldwide pandemic of multifactorial origin and may be more common than is diagnosed \nconsidering Body Mass Index (BMI) alone.\nMethodology:  Cross-sectional descriptive study in 815 workers aged 18-66 years, with data collected in the periodic health \nsurveillance examinations of the participating companies from March 2020 to June 2021.\nThe Cardiometabolic Risk Level (CRL) of each participant is estimated from 0 to 3 according to the presence of: metabolic \nsyndrome, elevated cardiovascular risk and values outside the range of at least two adiposity parameters. Relationships were \nestablished with sociolaboral variables and lifestyle habits (diet and physical activity).\nResults:  More than 70% of the population studied presented some degree of risk and this was significantly related to BMI \n(<0.0001), which was higher in men and increased with age. Adiposity indicators are the factor most associated with NR in men \nand women; in NR2 there is a greater presence of Metabolic Syndrome in women and Cardiovascular risk in men (<0.0001). The \nlevel of physical activity was related to NR in both sexes, but statistically significant differences were observed between men and \nwomen in adherence to the Mediterranean diet.\nConclusion:  The estimated NR is related to BMI, age, gender, cultural level and physical activity. Its stratification facilitates preventive \nactions, control and coordinated follow-up in Spanish workers.\nKey words:  Obesity; cardiometabolic risk; PREDIMED questionnaire; IPAQ questionnaire.ORIGINAL\nEstimaci\u00f3n del nivel de riesgo cardiometab\u00f3lico en \ntrabajadores con sobrepeso/obesidad durante la pandemia \nCovid-19. Estilo de vida y variables sociodemogr\u00e1ficas\nCardiometabolic risk level estimated in workers with overweight/obesity. \nLifestyle and sociodemographic variables  \nM\u00aa Te\u00f3fila Vicente-Herrero1      , M\u00aa Victoria Ram\u00edrez-I\u00f1iguez de la Torre1      , \n\u00c1ngel Arturo L\u00f3pez Gonz\u00e1lez2\n1. Especialista en Medicina del Trabajo. Grupo Obesidad y Trabajo\nAsociaci\u00f3n espa\u00f1ola de especialistas en Medicina del Trabajo-AEEMT  \n2. Especialista en Medicina del Trabajo Servei de Salut de les Illes Balears. Escuela Universitaria ADEMAeISSN 2255-0569\nIDID ID135\n2022/37 (3): 134-141Estimaci\u00f3n del nivel de riesgo cardiometab\u00f3lico en trabajadores con sobrepeso/obesidad durante la pandemia Covid-19. \nIntroducci\u00f3n\nLa prevalencia de la obesidad, como enfermedad \nde origen multifactorial y pandemia mundial, se ha \nduplicado desde 1980. Actualmente, casi un tercio de \nla poblaci\u00f3n mundial presenta sobrepeso u obesidad, \nindependientemente de la residencia, origen \u00e9tnico o \nnivel socioecon\u00f3mico.\nAlgunos estudios epidemiol\u00f3gicos recientes sugieren \nque diagnosticar la obesidad solo en base al \u00cdndice de \nMasa Corporal (IMC) puede suponer infradiagn\u00f3stico, \ndificultando su prevenci\u00f3n y control poblacional1.\nLa enfermedad cardiovascular (ECV), directamente \nrelacionada con la obesidad, es la causa m\u00e1s com\u00fan \nde morbilidad y mortalidad mundial, particularmente en \npresencia de s\u00edndrome metab\u00f3lico (SMet). Su prevenci\u00f3n \nincluye actuar sobre los factores de riesgo cardiovascular \n(RCV), e invenciones dirigidas a diagnosticar, tratar y \nprevenir el SMet  y la obesidad grave2.\nLa presencia de SMet con prevalencia en torno al 31%, \nduplica el riesgo de desarrollar enfermedad coronaria \no cerebrovascular y aumenta1,5 veces el riesgo de \nmortalidad por todas las causas3. Tras contraer la \nenfermedad por COVID-19 se observa peor evoluci\u00f3n \nen pacientes obesos lo que, junto a las complicaciones \ncardiometab\u00f3licas relacionadas con la obesidad, \nincrementa el riesgo de muerte en estos pacientes4.\nEs objetivo de este trabajo establecer unos niveles \nde riesgo cardiometab\u00f3lico que faciliten actuaciones \npreventivas, control y seguimiento coordinado en \ntrabajadores espa\u00f1oles, valorando la presencia de \nRCV, SMet e indicadores de adiposidad, de forma \nindependiente al grado de sobrepeso u obesidad que \npresenten.  \nMetodolog\u00eda\nEstudio descriptivo transversal en poblaci\u00f3n laboral \nespa\u00f1ola, con muestra de 815 trabajadores (481 \nhombres y 334 mujeres), de edades entre 18-66 a\u00f1os, \ndurante los reconocimientos peri\u00f3dicos de vigilancia de \nla salud de las empresas participantes desde marzo de \n2020 hasta junio de 2021, con participaci\u00f3n voluntaria y \nconsentimiento informado para el uso epidemiol\u00f3gico de \nlos resultados.\nEl estudio fue aprobado por el Comit\u00e9 \u00c9tico de \nInvestigaci\u00f3n Cl\u00ednica del \u00c1rea de Salud de Baleares (IB \n4383/20). \nEl peso y la altura se midieron con b\u00e1scula SECA 700 \ny tall\u00edmetro SECA 220. El IMC se calcul\u00f3 como el peso \nen kg dividido por el cuadrado de la altura en metros. Se utilizaron los rangos para IMC considerados por la OMS: \nnormopeso <25; sobrepeso >25-<30; obesidad grado \n1 >30-<40; obesidad grado 2 >405.\nEl per\u00edmetro de cadera y el per\u00edmetro de cintura fueron \ndeterminados con cinta m\u00e9trica modelo SECA 20. \nLa composici\u00f3n corporal se determin\u00f3 con el analizador \nTANITABC-420MA, estimando el porcentaje de grasa \ncorporal y grasa visceral.\nComo indicadores de adiposidad  (IA) se han calculado \nlos siguientes:\n\u00b7 Per\u00edmetro de cintura (PCI): normal en el hombre un valor \n<94 cm y en la mujer <80 cm. \n\u00b7 El \u00edndice cintura/cadera (ICC): normal en hombres si es \n<0,94 y en mujeres si es <0,84.\n\u00b7 El \u00edndice cintura/altura (ICA): normal si es <0,5 tanto \npara hombres como para mujeres.\n\u00b7 El porcentaje de grasa corporal (GC): normal en hombre \nsi es <10 y en la mujer si es <20.\n\u00b7 La grasa visceral (GV): normal si es <10 para ambos, \nhombres y mujeres.\nSe considera riesgo la presencia de al menos 2 de los IA \nvalorados alterados.\nLas variables sociales y laborales  incluidas en el \nestudio han sido:\n\u00b7 Edad- rangos: 18-39 a\u00f1os; 40-50 a\u00f1os; 51-66 a\u00f1os.\n\u00b7 G\u00e9nero: mujer u hombre.\n\u00b7 Clase social y tipo de trabajo: a partir de la Clasificaci\u00f3n \nNacional de Ocupaciones del a\u00f1o 2011 (CNO-11), \nseg\u00fan propuesta del grupo de determinantes sociales \nde la Sociedad Espa\u00f1ola de Epidemiologia6. Para \nel tratamiento estad\u00edstico de nuestros datos se ha \nutilizado la clasificaci\u00f3n reducida a tres categor\u00edas: \n\u2013 Clase I. Directores/gerentes, profesionales \nuniversitarios, deportistas y artistas. \n\u2013 Clase II. Ocupaciones intermedias y trabajadores \npor cuenta propia sin asalariados. \n\u2013 Clase III. Trabajadores/as no cualificados/as. \n\u00b7 El tipo de trabajo, seg\u00fan la simplificaci\u00f3n de estos \nmismos autores, se distingue como manual (blue \ncollar) y no-manual (white collar).\n\u00b7 Nivel de estudios: se categorizaron en tres niveles, de \nacuerdo con el sistema educativo vigente en Espa\u00f1a:\n\u2013 Elementales: Si el participante realiz\u00f3 los seis niveles \nb\u00e1sicos, desde primero a sexto de primaria.\n\u2013 Medios: haber cursado la educaci\u00f3n secundaria \nobligatoria (E.S.O)\n\u2013 Superiores: se incluyen todos aquellos que \nhubieran realizado alguna ense\u00f1anza universitaria o \nde formaci\u00f3n profesional en grado superior. \n\u00b7 Caracter\u00edsticas del puesto de trabajo: se incluy\u00f3 \nmanipulaci\u00f3n manual de cargas y conducci\u00f3n de \nveh\u00edculos (al menos 1/3 de la jornada laboral) y trabajos \nsedentarios (al menos el 50% de la jornada sentados).136\n2022/37 (3): 134-141M\u00aa Te\u00f3fila Vicente-Herrero et al.  \nSe valor\u00f3 la adherencia a dieta mediterr\u00e1nea (MedDiet) \nmediante el cuestionario PREDIMED, con puntuaci\u00f3n:< \n9 baja adherencia > 9 buena adherencia7 y la actividad \nf\u00edsica (AF) semanal mediante el cuestionario IPAQ \nreducido: actividad f\u00edsica moderada como m\u00ednimo 600 \nMET y alta, al menos 3000 MET8.\nSe consideraron pacientes con RCV elevado a los que \nobtuvieron un riesgo de muerte cardiovascular \u2265 5% en \nlas tablas del SCORE y/o un riesgo \u2265 10% en las tablas \nde Framingham-REGICOR9. \nEl s\u00edndrome metab\u00f3lico se calcul\u00f3 con la aplicaci\u00f3n \ndisponible on line y validada en pacientes espa\u00f1oles que \nincluye: sexo, per\u00edmetro abdominal, triglic\u00e9ridos, tensi\u00f3n \narterial m\u00e1xima y m\u00ednima y glucemia basal, considerando \npresencia de SMet con tres o m\u00e1s par\u00e1metros alterados10.\nSe propone en este estudio calcular el Nivel de Riesgo \nCardiometab\u00f3lico (NR), valorando la presencia o no \nde: SMet, RCV elevado (medido con Score o Regicor) \ny valores an\u00f3malos en 2 o m\u00e1s de los indicadores de \nadiposidad (IA). Estos valores se relacionaron de forma \nindependiente con el valor del IMC clasificado por la \nOMS con los par\u00e1metros anteriormente referidos.\nSe establecen as\u00ed 4 niveles de Riesgo Cardiometab\u00f3lico \nen funci\u00f3n de la presencia de ninguno, 1, 2 \u00f3 3 aspectos \nalterados: NR 0= ninguno de los aspectos valorados \nalterados; NR1= 1 de los 3 aspectos valorados en l\u00edmites \nde no-normalidad; NR 2= 2 de los 3 aspectos valorados \nen l\u00edmites de no-normalidad y NR 3= los 3 aspectos \nvalorados alterados ( Tabla I ). \nSe establecen actuaciones preventivo/asistenciales en \nfunci\u00f3n del NR estimado:\nAn\u00e1lisis estad\u00edstico\nSe realiz\u00f3 un an\u00e1lisis descriptivo de las variables \ncateg\u00f3ricas, calculando la frecuencia y la distribuci\u00f3n \nde las respuestas para cada una de ellas. Para \nlas variables cuantitativas se calcul\u00f3 la media y \nla desviaci\u00f3n est\u00e1ndar y para las cualitativas el \nporcentaje. Se realiz\u00f3 un an\u00e1lisis de asociaci\u00f3n \nbivariante mediante el test de 2 (con una correcci\u00f3n \ncon el test estad\u00edstico exacto de Fisher, cuando las \ncondiciones lo requer\u00edan) y una prueba t de Student \npara muestras independientes. El an\u00e1lisis estad\u00edstico \nse realiz\u00f3 con el programa SPSS 27.0, considerando \nvalor p de <0,05 estad\u00edsticamente significativo.Resultados\nLas caracter\u00edsticas de la muestra poblacional se recogen \nen la tabla II . \nPoblaci\u00f3n de 48 a\u00f1os de edad media global, con IMC \nen valores de sobrepeso, m\u00e1s en hombres (27,49) que \nen mujeres (26,33), y diferencias significativas entre \nambos en todos los IA, teniendo en cuenta los distintos \nvalores de referencia en algunos de ellos seg\u00fan g\u00e9nero: \nel per\u00edmetro de cintura est\u00e1 elevado en la mujer (84.5 \ncm) pero es casi normal en el hombre (94.6 cm). El \nICA y el ICC est\u00e1n en los l\u00edmites de la normalidad tanto \nen hombres como en mujeres. La grasa corporal est\u00e1 \nelevada en ambos g\u00e9neros, (24,7 en hombres y 36,08 \nen mujeres). La grasa visceral est\u00e1 elevada en hombres \n(11,35) pero es normal en mujeres (7,5).\nNo se observan diferencias significativas en el nivel \neducacional entre g\u00e9neros. En ambos g\u00e9neros \npredomina la clase social tipo III y realizar un tipo de \ntrabajo manual, encontrando valores m\u00e1s elevados en \nhombres en ambos casos, con diferencias tambi\u00e9n \nestad\u00edsticamente significativas. Se observan, asimismo, \ndiferencias significativas en las caracter\u00edsticas del puesto \nde trabajo: en los varones predomina la conducci\u00f3n de \nveh\u00edculos (al menos 1/3 de la jornada) con manipulaci\u00f3n \nmanual de cargas (MMC) y en las mujeres los trabajos \ncon sedentarismo (al menos el 50% de la jornada).\nRefieren mayor adherencia a la dieta mediterr\u00e1nea las \nmujeres, con resultados significativos, pero es mayor \nel porcentaje de hombres que realiza un nivel alto de \nactividad f\u00edsica.\nLa distribuci\u00f3n porcentual del Nivel de Riesgo \nCardiometab\u00f3lico (NR) estimado se muestra en la \nfigura 1  y refleja que m\u00e1s del 70% de la poblaci\u00f3n \nestudiada presenta alg\u00fan grado de riesgo, si bien el m\u00e1s \nprevalente es el NR1 con un 43,5% (al menos 1 de los \n3 factores estudiados alterados) frente al 23.3 % y 8.7%, \nrespectivamente, de los trabajadores que presentan un \nNR2 o NR3 (2 \u00f3 3 de los factores estudiados alterados).\n \nSe muestra en la tabla III-A  la distribuci\u00f3n individualizada \nen hombres y mujeres de los 3 aspectos cuantificados \npara estimar el NR (presencia de s\u00edndrome metab\u00f3lico, \nRCV elevado y al menos 2 indicadores de adiposidad \nalterados): se observan mayores porcentajes de valores \nalterados en hombres en todos los aspectos, con \nsignificaci\u00f3n estad\u00edstica, siendo especialmente amplia \nesta diferencia en RCV elevado (41,85 % en hombres \nfrente a 11.34% en mujeres).\nLas relaciones entre el NR estimado y el IMC calculado \nse muestran en la tabla III-B . Encontramos relaci\u00f3n \nestad\u00edsticamente significativa entre IMC elevado y NR \naltos (p>0.001). Los trabajadores con normopeso NR-0. No repercusi\u00f3n en ning\u00fan apartado: Control regular\nNR-1. Repercusi\u00f3n en 1 par\u00e1metro: Vigilancia y control con medidas iniciales\nNR-2. Repercusi\u00f3n en 2 par\u00e1metros \u2013Intervenci\u00f3n desde medicina del \ntrabajo y/o derivaci\u00f3n especializada y coordinada.\nNR-3. Repercusi\u00f3n en 3 par\u00e1metros - derivaci\u00f3n especializada y \ncoordinada y control y seguimiento por medicina del trabajo137\n2022/37 (3): 134-141Estimaci\u00f3n del nivel de riesgo cardiometab\u00f3lico en trabajadores con sobrepeso/obesidad durante la pandemia Covid-19. \nTabla II: Caracter\u00edsticas de la muestra. Comparativa hombres-mujeres.\nVariables analizadas  Hombres n=481 Mujeres n=334 P\n  Media (dt) Media (dt) \nVariables antropom\u00e9tricas Edad 48,25 (8,35) 48,89 (8,16) 0.277\ny de adiposidad (medias) Peso 82,79 (13,93) 67,97 (11,98) <0.0001\n Altura 173,42 (6,81) 160,72 (5,98) <0.0001\n IMC 27.49 (4,01) 26,33 (4,47) <0.0001\n Cintura 94,61 (10,96) 84,35 (11,43) <0.0001\n Cintura/altura 0,55 (0,06) 0,53 (0,07) <0.0001\n Cadera 106,22 (58,83) 99,00 (10,13) 0.027\n Cintura/cadera 0,92 (0,07) 0,85 (0,06) <0.0001\n Grasa corporal 24,70 (6,58) 36,08 (7,78) <0.0001\n Grasa visceral 11,35 (4,53) 7,53 (2,65) <0.0001\n  Hombres % Mujeres % \nClasificaci\u00f3n IMC (porcentajes) Normopeso 29.11 41.62 0.001\n Sobrepeso 48.86 39.52 \n Obesidad 22.04 18.86 \nVariables sociales y culturales (porcentajes) Nivel estudios B\u00e1sicos 49,06 41,92 0.116\n  Intermedios 32,43 35,63 \n  Superiores 18,50 22,46 \n Clase social Clase I 3,33 2,40 <0.0001\n  Clase II 20,58 36,83 \n  Clase III 76,09 60,78 \n Tipo de trabajo Trabajo no manual 23,91 39,22 <0.0001\n  Trabajo manual 76,09 60,78 \nCaracter\u00edsticas de su puesto de trabajo Trabajo sedentario 25,16 41,92 <0.0001\n(porcentajes)  (Sentado > 50%) \n Conducci\u00f3n de veh\u00edculos 71,93 53,29 <0.0001\n  (al menos 1/3 de la jornada) + MMC \nH\u00e1bitos de vida: Dieta mediterr\u00e1nea-PREDIMED Adherencia dieta mediterr\u00e1nea alta 43,87 56,89 <0.0001\nH\u00e1bitos de vida: Actividad F\u00edsica-IPAQ Ejercicio bajo 1,87 3,29 0.041\n Ejercicio moderado 40,33 47,31 \n Ejercicio alto 57,80 49,40 \ndt= desviaci\u00f3n t\u00edpica, magnitud en que se desv\u00edan las diversas puntuaciones obtenidas de su valor medio. Se considera significativo un valor de p<0.005; IMC: \nnormopeso <25; sobrepeso >25-<30; obesidad grado 1 >30-<40; obesidad grado 2 >40; PREDIMED: < 9 baja adherencia a MedDiet, >= 9 alta adherencia; IPAC: \nactividad f\u00edsica moderada al menos 600 SMet , alta actividad f\u00edsica al menos 3000 SMet .Tabla I: Estimaci\u00f3n del nivel de riesgo cardiometab\u00f3lico y relaci\u00f3n con el IMC.\n Presencia  RCV alterado      \n de SMet Score/Regicor      \n S\u00cd/NO S\u00cd /NO  \n   1.  2.  3.  4.  5.  Resultado:\n   GV GC PCi ICA ICC >2 IA alterados\n        S\u00ed/No \nnormopeso         NR0 NR1 NR2 NR3\n(<25)         \nsobrepeso         NR0 NR1 NR2 NR3\n(>25-<30)         \nobesidad tipo 1          NR0 NR1 NR2 NR3\n(>30-<40)         \nobesidad tipo 2          NR0 NR1 NR2 NR3\n(>40)IA\n(Se\u00f1alar los que est\u00e9n alterados) Nivel \nde Riesgo\nCardiometab\u00f3licoIMC\nIMC= \u00cdndice de masa corporal; SMet = s\u00edndrome metab\u00f3lico; RCV= riesgo cardiovascular\nIA=indicadores de adiposidad: GV=grasa visceral ;GC=grasa corporal ;PCi=per\u00edmetro de cintura\nICA= \u00edndice cintura/altura;ICC= \u00edndice cintura/caderapresentan de forma predominante NR0 (62%); el NR1 es \nel m\u00e1s frecuente en los que tienen sobrepeso, pero es de \ndestacar que un porcentaje moderado de ellos presenta \nNR 2 (27.5%); y en los trabajadores con obesidad (tipo 1 \n\u00f3 2) m\u00e1s del 43% se encuentra en NR 2 y m\u00e1s del 23% \nen NR 3, aunque llama la atenci\u00f3n que el 33.5 % de los \nque presentan obesidad tienen NR1 (bajo). En la tabla III-C  se recogen las relaciones del NR \nestimado con los tres factores de riesgo valorados. En \nNR1 (un par\u00e1metro alterado) lo m\u00e1s frecuente, en ambos \ng\u00e9neros, es tener al menos 2 \u00edndices de adiposidad \nalterados (88.83% y 96.36% respectivamente). En NR2 \n(2 par\u00e1metros alterados), el 100% de los trabajadores \nvalorados presentan al menos 2 IA alterados, pero en el 138\n2022/37 (3): 134-141M\u00aa Te\u00f3fila Vicente-Herrero et al.  \nTabla III: Distribuci\u00f3n porcentual de los factores incluidos en la valoraci\u00f3n del nr estimado. Relaci\u00f3n con IMC y factores de riesgo valorados. Diferencias por g\u00e9nero.\n A. Distribuci\u00f3n porcentual de los factores incluidos en la valoraci\u00f3n del NR. Diferencias por g\u00e9nero\n  Hombres % Mujeres % P\nPresencia de SMet  20.88 16,82 <0.0001\nPresencia de RCV elevado 41,85 11,34 <0.0001\nPresencia de \u2265 2 IA alterados 75,05 68.26 0.001\n B. Relaci\u00f3n del NR estimado con el IMC y los factores de riesgo valorados\nRelaci\u00f3n del nivel de riesgo estimado y relaci\u00f3n con el IMC\n NR estimado Normopeso Sobrepeso Obesidad  P\n  n % n % n % \n NR 0 173 62.0 26 7.1 0 0 <0.0001\n NR 1 89 31.9 207 56.9 57 33.9 <0.0001\n NR 2 16 5.7 100 27.5 72 42.9 <0.0001\n NR 3 1 0,4 31 8,5 39 23.2 <0.0001\nC. Relaci\u00f3n del NR estimado y relaci\u00f3n con los 3 factores valorados. Diferencias por g\u00e9nero\nNR estimado* Presencia de SMet  Presencia de RCV elevado (Score/Regicor ) Presencia de \u2265 2 IA elevados \n hombres mujeres p hombres mujeres p hombres mujeres P\nNivel de Riesgo 1 1.06 0  11.73 4.03  88.83 96.36 \nNivel de Riesgo 2 30.37 77.78 <0.0001 73.28 25 <0.0001 100 100 0.006\nNivel de Riesgo 3 100 100  100 100  100 100 \n*Se excluye el NR 0 por no presentar ninguno de los factores valorados alterados.  Se considera significativo un valor de p<0.005. IMC: normopeso <25; sobrepeso \n>25-<30; obesidad grado 1 >30-<40; obesidad grado 2 >40; Se considera alto riesgo Score \u2265 5% y Framingham-REGICOR \u226510%. Se considera la presencia de \nS\u00edndrome metabolic (SMet ) con tres o m\u00e1s par\u00e1metros alterados\nTabla IV: Relaci\u00f3n entre el nivel de riesgo estimado con variables sociales y laborales.\nMMC= manipulaci\u00f3n manual de cargas; Se considera significativo un valor de p<0.005.  Relaci\u00f3n entre el Nivel de Riesgo Estimado con: edad, g\u00e9nero, clase social, tipo de trabajo y nivel cultural\n  Edad G\u00e9nero Clase social Tipo de trabajo Nivel cultural\n 18-39 40-50 51-66 p hombre mujer p I II III p manual No manual  p Bajo medio alto p\nNR-0 54.26 25.19 14.66 <0.0001 20.58 29.94 <0.0001 20.83 22.52 25.31 0.483 25.31 22.36 0.582 19.41 27.27 31.10 0.015 \nNR-1 38.76 55.18 37.03  39.09 49.40  58.33 40.55 43.76  43.76 42.28  43.35 43.27 43.29 \nNR-2 6.98 15.93 33.65  28.48 16.47  12.50 26.58 22.85  22.85 25.20  25.80 22.91 19.51 \nNR-3 0.00 3.70 14.66  11.85 4.19  8.33 10.36 8.08  8.08 10.16  11.44 6.55 6.10 \n Relaci\u00f3n del NR estimado con las caracter\u00edsticas del puesto de trabajo desempe\u00f1ado\nNivel de riesgo estimado Tareas sedentarias Conducci\u00f3n de veh\u00edculos+MMC\n hombres mujeres Hombres mujeres\n s\u00ed no p S\u00ed no p s\u00ed no p s\u00ed no p\nNR-0 11.57 23.61 0.221 30.00 29.90 0.448 23.99 11.85 0.112 30.34 29.49 0.339\nNR-1 40.50 38.61  46.42 51.55  38.14 41.48  50.00 48.72 \nNR-2 30.57 27.78  19.29 14.43  27.75 30.37  14.60 18.58 \nNR-3 17.36 10.00  4.29 4.12  10.12 16.30  5.06 3.21 \nSe considera significativo un valor de p<0.005; PREDIMED: < 9 baja adherencia a MedDiet, >= 9 alta adherencia; IPAC:  actividad f\u00edsica moderada al menos 600 SMet, \nalta actividad f\u00edsica al menos 3000 SMet .Tabla V: Relaci\u00f3n entre el nivel de riesgo estimado y los h\u00e1bitos de vida: alimentaci\u00f3n mediterr\u00e1nea y actividad f\u00edsica.\n Relaci\u00f3n de los resultados del cuestionario PREDIMED con el NR estimado\nNivel de riesgo estimado Adherencia alta Adherencia baja\n hombres mujeres p hombres mujeres P\nNR-0 25.12 31.58 <0.0001 17.04 27.78 <0.0001\nNR-1 31.75 47.36  44.81 52.08 \nNR-2 31.75 16.32  25.93 16.67 \nNR-3 11.38 4.74  12.22 3.47 \nRelaci\u00f3n de los resultados del cuestionario IPAC con el NR estimado\n Actividad f\u00edsica / Ejercicio bajo/moderado Actividad f\u00edsica / Ejercicio alto\n hombres mujeres p hombres mujeres P\nNR-0 10.34 24.26 <0.0001 28.06 35.75 <0.0001\nNR-1 41.38 49.11  37.41 49.70 \nNR-2 32.02 21.30  25.90 11.52 \nNR-3 16.26 5.33  8.63 3.03 139\n2022/37 (3): 134-141Estimaci\u00f3n del nivel de riesgo cardiometab\u00f3lico en trabajadores con sobrepeso/obesidad durante la pandemia Covid-19. \nsegundo factor, en hombres predomina, el RCV elevado \n(73.28%), mientras que en las mujeres destaca la \npresencia de SMet (77.78%). En el NR3, por definici\u00f3n, \nlos tres par\u00e1metros valorados se encuentran alterados. \nEn la relaci\u00f3n entre el NR estimado y las variables socio-\ndemogr\u00e1ficas: edad, g\u00e9nero, clase social, tipo de trabajo \ny nivel cultural ( Tabla IV ), se ha encontrado significaci\u00f3n \nestad\u00edstica con la edad (la prevalencia de NR 2 y 3 aumenta \ncon la edad), el g\u00e9nero (mayor presencia de NR elevados, \n2-3, en varones) y nivel cultural (prevalencia m\u00e1s alta de \nNR 2-3 en estudios bajos). No se observan diferencias \nsignificativas en el NR en relaci\u00f3n con clase social, tipo de \ntrabajo o caracter\u00edsticas del puesto desempe\u00f1ado.\nAl relacionar el NR estimado con el grado de actividad f\u00edsica \n(AF), tanto en hombres como en mujeres encontramos \nmayor prevalencia de NR elevados (2-3) en aquellos \nque realizan ejercicio bajo/moderado. Se observan, sin \nembargo, resultados parad\u00f3jicos en relaci\u00f3n con el grado \nde adherencia a la dieta mediterr\u00e1nea: los hombres que \nrefieren adherencia baja presentan menor porcentaje de \nNR 2 y las mujeres menor prevalencia de NR3. Existen \ndiferencias estad\u00edsticamente significativas entre g\u00e9neros: \nen los hombres encontramos NR m\u00e1s elevados (NR 2 y 3) \nque en las mujeres en relaci\u00f3n con bajo nivel de ejercicio y \nbaja adherencia a dieta mediterr\u00e1nea ( Tabla V ).\nDiscusi\u00f3n\nLos resultados de nuestro trabajo muestran que m\u00e1s del \n70% de la poblaci\u00f3n estudiada presenta alg\u00fan nivel de \nriesgo cardiometab\u00f3lico y que el NR se asocia a distintos \nfactores relacionados con obesidad. Cerca de una cuarta \nparte presenta NR 2, esto es, dos factores alterados, \nsiendo los m\u00e1s coincidentes en hombres el SMet y el \nRCV. El NR aumenta a medida que lo hace el IMC. \nEn este trabajo se ha simplificado la clasificaci\u00f3n de la \nOMS del IMC con el objetivo de no subdividir la muestra \nen exceso, si bien esto puede suponer un sesgo ya \nque, en la actualidad, la categorizaci\u00f3n se basa en una \nclasificaci\u00f3n en seis grupos, tanto en la clasificaci\u00f3n \nampliada de la OMS como por trabajos m\u00e1s recientes11 que han servido  para documentos de consenso de \nmanejo de la obesidad, como el recientemente publicado \npor la SEEN12.\nRespecto al RCV, el informe de 2019 del Atlas de la \nSociedad Europea de Cardiolog\u00eda, muestra un aumento \nprogresivo en los \u00faltimos 30 a\u00f1os de la prevalencia de \nobesidad y diabetes, que supone un desaf\u00edo para lograr \nmayores reducciones en la carga de ECV intensificando \niniciativas que permitan reducir el riesgo y priorizar la \nprestaci\u00f3n de atenci\u00f3n de salud cardiovascular13.\nEl SMet definido por la OMS como una condici\u00f3n \npatol\u00f3gica caracterizada por obesidad abdominal, \nresistencia a la insulina, hipertensi\u00f3n e hiperlipidemia, \nse asocia con un aumento del riesgo de enfermedad \ncoronaria, enfermedad cerebrovascular y de mortalidad \npor todas las causas con un elevado costo por atenci\u00f3n \nm\u00e9dica y p\u00e9rdida de actividad econ\u00f3mica potencial14.\nEn nuestro trabajo, tanto hombres como mujeres \npresentan con frecuencia al menos dos IA fuera de los \nrangos de normalidad. En todos los casos, el NR es \nmayor en los hombres y aumenta con la edad, por lo que \nlas estrategias han de tener en consideraci\u00f3n esta visi\u00f3n \nde g\u00e9nero, tanto m\u00e1s cuando el 65% de la poblaci\u00f3n \nestudiada est\u00e1 en niveles de sobrepeso/obesidad tipo \n1 y que el NR aumenta seg\u00fan lo hace la obesidad \ncuantificada en funci\u00f3n del IMC.\nEl NR se relaciona con los h\u00e1bitos de vida: dieta \nmediterranea recogidos con el cuestionario PREDIMED \ny Actividad F\u00edsica recogido con el cuestionario IPAQ \nreducido. Si bien en algunos estudios se apunta que \nla evidencia que respalda el uso del IPAQ-SF como \nindicador de actividad f\u00edsica relativa o absoluta es d\u00e9bil15, \nel debate en torno a este cuestionario sigue abierto16 \ny en otros estudios se afirma que los instrumentos \nIPAQ tienen propiedades de medici\u00f3n aceptables, y \npropiedades de medici\u00f3n razonables para monitorizar \nlos niveles de actividad f\u00edsica de adultos de 18 a 65 \na\u00f1os en diversos entornos. El formulario corto de se \nrecomienda para el seguimiento y el formulario largo \npara investigaciones que requieren una evaluaci\u00f3n m\u00e1s \ndetallada17. En nuestro caso, su uso ha sido sencillo y \nbien aceptado, haci\u00e9ndolo recomendable para estudios \nepidemiol\u00f3gicos en entorno laboral.\nEn las mujeres encontramos mayor adherencia a dieta \nmediterr\u00e1nea, mientras que los hombres refieren m\u00e1s \nactividades f\u00edsicas intensas y en ambos el NR es menor al \naumentar la Actividad F\u00edsica. Estudios realizados en este \ntema en pa\u00edses como EE. UU. afirman que la obesidad \nse asocia con mayor prevalencia de FRCV y la actividad \nf\u00edsica y el entrenamiento se relacionan con factores de \nriesgo cardiometab\u00f3lico mejorados y p\u00e9rdida de peso \npor creaci\u00f3n de un balance energ\u00e9tico negativo18. Por \nel contrario, el sedentarismo se encuentra entre los Figura 1: Distribuci\u00f3n porcentual de nivel de riesgo cardiometab\u00f3lico estimado (NR).\n140\n2022/37 (3): 134-141M\u00aa Te\u00f3fila Vicente-Herrero et al.  \nprincipales factores de riesgo modificables relacionados \ncon las enfermedades cardiovasculares y la mortalidad \npor todas las causas. Los autores recomiendan la \npr\u00e1ctica de ejercicio habitual para la prevenci\u00f3n de \nenfermedades cr\u00f3nicas no transmisibles, incluida la \nobesidad y la enfermedad cardiovascular19. Estudios \nrealizados en poblaci\u00f3n coreana muestran que la \nactividad f\u00edsica regular se asocia con baja prevalencia de \nenfermedades cardiovasculares, independientemente \nde la composici\u00f3n corporal y de los factores de riesgo \nconvencionales, con una dosis-respuesta positiva20. \nEn estudios realizados sobre adherencia a dieta \nmediterr\u00e1nea, los autores destacan que el consumo \nde fruta reduce el riesgo cardiovascular y s\u00edndrome \nmetab\u00f3lico, especialmente en personas de mayor \nedad21. Tambi\u00e9n diversos estudios epidemiol\u00f3gicos y \nensayos cl\u00ednicos proporcionan evidencias que respaldan \nel efecto beneficioso de la dieta mediterr\u00e1nea tradicional \n(MedDiet) sobre el riesgo de diabetes mellitus tipo 2 y \ns\u00edndrome metab\u00f3lico22. Los resultados obtenidos en \nnuestro trabajo no son totalmente coincidentes con \nesta evidencia, ya que encontramos trabajadores con \nbaja adherencia a MedDiet que tienen NR bajos (0-1). \nEsta divergencia podr\u00eda explicarse porque, para calcular \nel nivel de riesgo cardiometab\u00f3lico (NR) se tienen en \ncuenta otros factores de riesgo, adem\u00e1s de la presencia \nde s\u00edndrome metab\u00f3lico.\nNuestro estudio se ha desarrollado en periodo de \npandemia COVID-19, lo que puede suponer un sesgo \nen los resultados ya que ha supuesto una modificaci\u00f3n \nde los h\u00e1bitos de vida en nuestro pa\u00eds, hecho este que \nse refleja tambi\u00e9n en otros estudios en Europa (Italia \ny Espa\u00f1a) y Am\u00e9rica Latina (Brasil, Chile y Colombia) \ndurante este per\u00edodo pand\u00e9mico del SARS-CoV-2 y \nque han observado mayor prevalencia de inactividad \nen la poblaci\u00f3n y modificaciones en la dieta, con \nmayor consumo de ultraprocesados, especialmente \nen Am\u00e9rica Latina23. Nuestros hallazgos refuerzan la \nimportancia de promover un estilo de vida saludable, \ncon ejercicio y dieta mediterr\u00e1nea, a\u00fan m\u00e1s durante los \nper\u00edodos de aislamiento social.Destacamos como fortalezas de este trabajo su tama\u00f1o \nmuestral, el hecho de que recoja datos del periodo \nde pandemia COVID en Espa\u00f1a y la aportaci\u00f3n de un \nc\u00e1lculo global en obesidad que se extiende al riesgo \ntanto metab\u00f3lico como cardiovascular (SMet + RCV) y a \nlos IA, que dan una idea global que permite anticiparse al \nriesgo en algunos casos y actuar precozmente en otros.\nComo sesgos considerar que el estudio se ha llevado \na cabo en poblaci\u00f3n en edad laboral, excluyendo \nmenores de 18 y mayores de 66 lo que impide extrapolar \nresultados a poblaci\u00f3n general, no poder calcular el RCV \nen menores de 40 a\u00f1os y la desigual distribuci\u00f3n en los \ngrupos de riesgo (pocos incluidos en los NR3 lo que \npuede desvirtuar el resultado).\nConclusiones\nEl nivel de riesgo cardiometab\u00f3lico guarda relaci\u00f3n \nsignificativa con el IMC, aumenta con la edad, niveles \neducativos bajos y es m\u00e1s alto en hombres. En el NR \n2, el factor m\u00e1s prevalente es la alteraci\u00f3n de \u00cdndices \nde Adiposidad, el RCV es m\u00e1s prevalente en hombres \ny la presencia de SMet en mujeres. El NR se relaciona \ndirectamente con bajos niveles de actividad f\u00edsica y muestra \nresultados contradictorios con la adherencia a la dieta \nmediterr\u00e1nea, con diferencias entre hombres y mujeres.\nLa estratificaci\u00f3n del NR puede ser un apoyo en \nactuaciones preventivas, de control y seguimiento \ncoordinado en trabajadores valorando, junto con el IMC, \nla presencia de RCV, s\u00edndrome metab\u00f3lico, indicadores \nde adiposidad y la influencia de la dieta mediterr\u00e1nea y el \nejercicio f\u00edsico realizado.\nConflicto de intereses\nLos autores declaran no tener conflicto de intereses.141\n2022/37 (3): 134-141Estimaci\u00f3n del nivel de riesgo cardiometab\u00f3lico en trabajadores con sobrepeso/obesidad durante la pandemia Covid-19. \nBibliograf\u00eda\n1. Chooi YC, Ding C, Magkos F. The epidemiology of obesity. \nMetabolism. 2019 Mar;92:6-10. doi: 10.1016/j.metabol.2018.09.005. \nEpub 2018 Sep 22. PMID: 30253139\n2. Said S, Mukherjee D, Whayne TF. Interrelationships with Metabolic \nSyndrome, Obesity and Cardiovascular Risk. Curr Vasc Pharmacol. \n2016;14(5):415-425. doi: 10.2174/157016111466616072212161. \nPMID: 27456105.\n3. Engin A. The Definition and Prevalence of Obesity and Metabolic \nSyndrome. Adv Exp Med Biol. 2017;960:1-17. doi: 10.1007/978-3-\n319-48382-5_1. PMID: 28585193.\n4. Sanchis-Gomar F, Lavie CJ, Mehra MR, Henry BM, Lippi G. Obesity \nand Outcomes in COVID-19: When an Epidemic and Pandemic \nCollide. Mayo Clin Proc. 2020 Jul;95(7):1445-1453. doi: 10.1016/j.\nmayocp.2020.05.006. Epub 2020 May 19. PMID: 32622449; PMCID: \nPMC7236707.\n5. World Health Asociation. Body mass index - BMI. 2020. Disponible \nen: https://www.euro.who.int/en/health-topics/disease-prevention/\nnutrition/a-healthy-lifestyle/body-mass-index-bmi.\n6. Domingo-Salvany A, Bacigalupe A, Carrasco JM, Espelt A, Ferrando \nJ, Borrell C. Propuestas de clase social neoweberiana y neomarxista \na partir de la Clasificaci\u00f3n Nacional de Ocupaciones 2011. Gac Sanit \n[Internet]. 2013 Jun [citado 2021 Sep 07]; 27(3):263-272. Disponible en: \nhttp://scielo.isciii.es/scielo.php?script=sci_arttext&amp;pid=S0213-\n91112013000300013&amp;lng=es.  https://dx.doi.org/10.1016/j.\ngaceta.2012.12.009\n7. Emilio Ros. The PREDIMED study. Endocrinol Diabetes Nutr. 2017 \nFeb;64(2):63-66. doi: 10.1016/j.endinu.2016.11.003. Epub 2017 Feb 1\n8. Lee PH, Macfarlane DJ, Lam TH, Stewart SM. Validity of the \nInternational Physical Activity Questionnaire Short Form (IPAQ-SF): a \nsystematic review. Int J Behav Nutr Phys Act. 2011 Oct 21;8:115. doi: \n10.1186/1479-5868-8-115. PMID: 22018588; PMCID: PMC3214824.\n9. Gil-Guill\u00e9n V, Orozco-Beltr\u00e1n D, Maiques-Gal\u00e1n A, Aznar-Vicente J, \nNavarro J, Cea-Calvo L, Quirce-Andr\u00e9s F, Red\u00f3n J, Merino-S\u00e1nchez J. \nConcordancia de las escalas REGICOR y SCORE para la identificaci\u00f3n \ndel riesgo cardiovascular alto en la poblaci\u00f3n espa\u00f1ola Rev Esp Cardiol. \n2007 Oct;60(10):1042-50.\n10. Taberner R. Calculadora multiplataforma para s\u00edndrome metab\u00f3lico \ny riesgo cardiovascular en pacientes con psoriasis [Multiplatform \napplication to determine presence of metabolic syndrome and \ncardiovascular risk in patients with psoriasis]. Actas Dermosifiliogr. 2012 \nMar;103(2):111-9. Spanish. doi: 10.1016/j.ad.2011.11.003. Epub \n2012 Jan 28. PMID: 22284865.\n11. Hebebrand Jet al. A Proposal of the European Association for the \nStudy of Obesity to Improve the ICD-11 Diagnostic Criteria for Obesity \nBased on the Three Dimensions Etiology, Degree of Adiposity and \nHealth Risk. Obes Facts. 2017;10(4):284-307.\n12. Ballesteros Pomar MD, Vilarrasa Garc\u00eda N, Rubio Herrera M\u00c1, \nBarahona MJ, Bueno M, Caix\u00e0s A, et al. The SEEN comprehensive \nclinical survey of adult obesity: Executive summary. Endocrinol Diabetes \nNutr (Engl Ed). 2021 Feb;68(2):130-6. 13. Timmis A, Townsend N, Gale CP , Torbica A, Lettino M, Petersen SE, \net al. European Society of Cardiology. European Society of Cardiology: \nCardiovascular Disease Statistics 2019. Eur Heart J. 2020 Jan \n1;41(1):12-85. doi: 10.1093/eurheartj/ehz859. Erratum in: Eur Heart J. \n2020 Dec 14;41(47):4507. PMID: 31820000.\n14. Saklayen MG. The Global Epidemic of the Metabolic Syndrome. \nCurr Hypertens Rep. 2018 Feb 26;20(2):12. doi: 10.1007/s11906-\n018-0812-z. PMID: 29480368; PMCID: PMC5866840.\n15. Hallal PC, Victora CG. Reliability and validity of the International \nPhysical Activity Questionnaire (IPAQ). Med Sci Sports Exerc. 2004 \nMar;36(3):556. doi: 10.1249/01.mss.0000117161.66394.07. PMID: \n15076800\n16. Bauman A, Ainsworth BE, Sallis JF, Hagstr\u00f6mer M, Craig CL, \nBull FC, et al; IPS Group. The descriptive epidemiology of sitting. \nA 20-country comparison using the International Physical Activity \nQuestionnaire (IPAQ). Am J Prev Med. 2011 Aug;41(2):228-35. doi: \n10.1016/j.amepre.2011.05.003. PMID: 21767731.\n17. Craig CL, Marshall AL, Sj\u00f6str\u00f6m M, Bauman AE, Booth ML, Ainsworth \nBE, et al. International physical activity questionnaire: 12-country \nreliability and validity. Med Sci Sports Exerc. 2003 Aug;35(8):1381-95. \ndoi: 10.1249/01.MSS.0000078924.61453.FB. PMID: 12900694.\n18. Swift DL, McGee JE, Earnest CP , Carlisle E, Nygard M, Johannsen \nNM. The Effects of Exercise and Physical Activity on Weight Loss and \nMaintenance. Prog Cardiovasc Dis. 2018 Jul-Aug;61(2):206-213. doi: \n10.1016/j.pcad.2018.07.014. Epub 2018 Jul 9. PMID: 30003901.\n19. Lavie CJ, Ozemek C, Carbone S, Katzmarzyk PT, Blair SN. \nSedentary Behavior, Exercise, and Cardiovascular Health. Circ Res. \n2019 Mar;124(5):799-815. doi: 10.1161/CIRCRESAHA.118.312669. \nPMID: 30817262.\n20. Kim GS, Im E, Rhee JH. Association of physical activity on \nbody composition, cardiometabolic risk factors, and prevalence of \ncardiovascular disease in the Korean population (from the fifth Korea \nnational health and nutrition examination survey,2008-2011). BMC \nPublic Health. 2017 Mar 21;17(1):275. doi: 10.1186/s12889-017-\n4126-x.\n21. Becerra Tom\u00e1s N, Paz Graniel I, Tresserra Rimbau A, Mart\u00ednez \nGonz\u00e1lez M\u00c1, Barrub\u00e9s L, Corella D,et al; PREDIMED-Plus Investigators. \nFruit consumption and cardiometabolic risk in the PREDIMED-plus \nstudy: A cross-sectional analysis. Nutr Metab Cardiovasc Dis. 2021 \nJun 7;31(6):1702-1713. doi: 10.1016/j.numecd.2021.02.007. Epub \n2021 Feb 17. PMID: 33838995.\n22. Salas Salvad\u00f3 J, Guasch Ferr\u00e9 M, Lee CH, Estruch R, Clish CB, \nRos E. Protective Effects of the Mediterranean Diet on Type 2 Diabetes \nand Metabolic Syndrome. J Nutr. 2015 Apr 1;146(4):920S-927S. doi: \n10.3945/jn.115.218487. PMID: 26962178; PMCID: PMC4807638.\n23. Ru\u00edz Roso MB, de Carvalho Padilha P , Matilla Escalante DC, Brun P , \nUlloa N, Acevedo-Correa D, et al. Changes of Physical Activity and Ultra-\nProcessed Food Consumption in Adolescents from Different Countries \nduring Covid-19 Pandemic: An Observational Study. Nutrients. 2020 \nJul 30;12(8):2289. doi: 10.3390/nu12082289. PMID: 32751721; \nPMCID: PMC7468997.142\n2022/37 (3): 142-146Received:  31 - III - 2022\nAccepted:  8 - IV - 2022\ndoi: 10.3306/AJHS.2022.37.03.142Corresponding author\nDiego Gonz\u00e1lez Carrasco \nE-mail: president@eua.edu.es\nAbstract\nIntroduction:  3D haptic technology stands out in the field of dentistry as a tool that allows preclinical practice, which is very close \nto reality. The objective of this study is to collect the assessments of teachers, students, and other groups related to dentistry, on \nthe use of this technology in the teaching-learning process. \nMethodology:  Exploratory, non-probabilistic study. A survey and interviews are given to 865 subjects from different fields of \ndentistry to collect assessments on the use of 3D haptic technology in teaching.\nResults: The evaluation of different interest groups related to the teaching of the Dentistry degree, both in the interviews and \nin the surveys carried out, show a high degree of user satisfaction and the conviction that this tool can help in the learning of \ndentistry professionals.\nKey words : virtual reality, dental health, education.\nResumen  \nIntroducci\u00f3n:  La tecnolog\u00eda h\u00e1ptica 3D se destaca en el campo de la odontolog\u00eda como una herramienta que permite una \npr\u00e1ctica precl\u00ednica, muy cercana a la realidad. El objetivo de este estudio es recoger las valoraciones de docentes, estudiantes y \notros colectivos relacionados con la odontolog\u00eda, sobre el uso de esta tecnolog\u00eda en el proceso de ense\u00f1anza-aprendizaje.\nMetodolog\u00eda:  Estudio exploratorio, no probabil\u00edstico. Se realiza una encuesta y entrevistas a 865 sujetos de diferentes campos \nde la odontolog\u00eda para recopilar valoraciones sobre el uso de la tecnolog\u00eda h\u00e1ptica 3D en la ense\u00f1anza.\nResultados:  La evaluaci\u00f3n de diferentes grupos de inter\u00e9s relacionados con la docencia de la carrera de Odontolog\u00eda, tanto en \nlas entrevistas como en las encuestas realizadas, muestran un alto grado de satisfacci\u00f3n de los usuarios y el convencimiento de \nque esta herramienta puede ayudar en el aprendizaje de los profesionales de la odontolog\u00eda.\nPalabras clave:  realidad virtual, salud dental, educaci\u00f3n.ORIGINAL\nDigitization with 3D haptic technology in dental training\nDigitalizaci\u00f3n con tecnolog\u00eda h\u00e1ptica 3D en la formaci\u00f3n dental  \nDiego Gonz\u00e1lez-Carrasco (DLT)      , Pere Riutord-Sbert (PhD, MD, DDS)      , \nDaniela Paz Vallejos Rojas (DDS)      , Daniel Alexander Norton      , \nTeresa Szupiany-Janeczek (PhD, MD, DDS)      , Jorge Dom\u00ednguez P\u00e9rez (DDS)      , \nThais Cristina Pereira (PhD, DDS)      , P\u00e5l Barkvoll (PhD, DDS)      , Pilar Tom\u00e1s Gil\nADEMA School of Dentistry, IUNICS ADEMA HEALTH GROUP, University of the Balearic Islands, Palma, Balearic Islands, SpaineISSN 2255-0569\nID\nID ID\nID ID\nID ID IDID143\n2022/37 (3): 142-146 Digitization with 3D haptic technology in dental training\nIntroduction\nA fundamental part of the teaching-learning process in the \nfield of dentistry involves acquiring procedural knowledge, \nthat is, it involves \u201cknowing how\u201d to do something, or \nknowledge in action1 . The automation of certain motor \nand executive skills is necessary to be able to carry out \ninterventions in any of the treatments that current dentistry \nstudents will have to enact in their professional work.\nTo move from declarative knowledge, that is, having ideas \nand knowledge of how things should be done (theoretical \nknowledge) to procedural knowledge or knowing how to \ndo them (practical application), the most important thing \nis to carry out practical activities continuously, habitually, \nand consciously to be able to acquire the necessary skills \nwith a high level of automation. This is how, by doing \nthings many times with the aim of acquiring the skills \ninvolved, the student will be able to reduce the cognitive \nload required to develop the activity.\nIn the field of health sciences in general and in dentistry \nin particular, where carrying out internships implies \ncarrying out treatments with real patients, being able \nto exercise the necessary skills for learning is, in most \ncases, truly complex, and the same time, it entails a \ngreat responsibility, which is why it is necessary to use \nmethods that allow the acquisition of preclinical skills with \nthe maximum guarantees to face clinical application2.\nAt the Adema University School, a center attached to the \nUniversity of the Balearic Islands, we have state-of-the-\nart 3D haptic technology, which allows training through \nvirtual practices in different oral and dental treatments. \nThis technology is capable of transferring realistic \nsensations, allowing one to see and to feel at a tactile \nand auditory level, a high degree of similarity to reality, \nwhile performing multiple dental treatments3.\nDuring the process of incorporating 3D haptic technology \ninto dentistry degree studies, the opinion of the different \nusers of the aforementioned technology has been \ncollected in order to know their assessment. After using \nthe simulators, they were administered a questionnaire \nand an interview was conducted through which their \nassessments were collected.\nMaterial and method\nStudy is exploratory, qualitative, not probabilistic\n1. Poll\nThe survey was conducted in autofill format through the \nGoogle Forms application , voluntarily and anonymously. A \nquestion was included in which the participants expressed \nconsent for the use of the data collected for research purpos -\nes. No identification data was collected except for differences \nin interest groups: teachers, students, dentists and others.The questionnaire was administered after using the 3D \nhaptic simulators and included questions directed, first \nof all, to assess the degree of use that participants had \nin handling the computer devices. That is, if they used \nthem on a daily basis and if they had had any previous \nexperience with 3D haptic technology. The next questions \nassessed the use of 3D haptic tools in preclinical practice \nand their possible usefulness for practicing treatments of \ncomplex cases before treating real patients.  Finally, they \nwere asked about the degree to which it helped in their \ntraining, to use 3D haptic technology as a tool to acquire \nskills during the learning process.\n2. Interviews\nAn undirected interview with open questions focused on \nassessing the experience of using the simulators, and \nthe degree of application to the teaching of dentistry.\n3. Selection of participants\nThe sample for both the questionnaire and the interview \nis a deliberate selection or intentional sample, since it \ntakes into account the relationship of dentistry studies \nwith the use of 3D haptic technology at the Adema \nUniversity School during the academic years 2018-19 \nand 2019-20 (ceasing to collect information during a \nperiod in which access to the center was not possible \ndue to a state of alarm due to covid-19).\nIncluded in the sample are dental degree and undergraduate \nstudents, professors from the Adema University School, \nprofessors who visited the school and who teach the \nDegree in Dentistry at other Universities, Dentists in \nprofessional practice and representatives of dental brands. \nLikewise, taking advantage of other visiting professionals; \npoliticians, directors and teachers from other centers were \nasked to assess the 3D haptic technology.\nA total of 865 subjects distributed as follows: 90 Dentistry \nStudents, 550 Undergraduate Students (includes Oral \nHygiene Superior Technician, Dental Prosthesis Superior \nTechnician and Baccalaureate students), 50 Dentists, 40 \nDentistry professors of the School Adema University and \n25 from other Universities, 30 dentistry visitors and 40 \nrepresentatives of dental brands, 15 politicians, 5 school \ndirectors and 20 school teachers.\n4. Target\nThe objective pursued was to assess, after the experience \nof using 3D haptic technology, its use-value as a tool \nto improve learning during undergraduate studies,  and \nif it was considered that virtual simulation could be an \nelement to improve the training of our students.\nResults\nThe assessment and opinion collected by applying inter -\nviews and surveys to different interest groups related to 144\n2022/37 (3): 142-146Diego Gonz\u00e1lez Carrasco et al.  \nthe field of oral health and the teaching of the Dentistry \ndegree have provided the following results.\n1. Poll\nIn relation to the level of knowledge regarding the use \nof computing devices, most of the respondents valued \ntheir level as medium or medium-high ( Figure 1 ). Of \nthe sample, only 3.5% indicated that they used digital \ntechnology little, or not on a daily basis, while 65.5% \nindicated that they had medium use.\n56.7% indicated that they did not know 3D haptic \ntechnology before using it in Adema, while 40% indicated \nthat they had known it before. When asked how long they \nhad known it, 40% indicated that it was less than two years \nago, 36.7% less than a year and 20% for six months.\nThey were asked about the degree to which the \nsimulation was close to reality ( Figure 2 ), to which the \nmajority responded medium high and high.\nThe foregoing implies the level of validity that this technology \ncan have for the preclinical practice that all students must \ncarry out during their training. Most respondents consider \nthe validity to be medium-high or very high ( Figure 3 ). \nThey also consider that it can be a useful tool for training \nin complex cases, for testing treatments before carrying \nthem out with patients ( Figure 4 ).When asked if our respondents would have liked to have \nhad 3D haptic technology earlier in their learning process, \nand whether it would have helped them advance their \nobtaining skills, the answer was positive ( Figure 5 ), \nin fact 86.7% indicated that they would have liked this \ntechnology earlier.\nFinally, we wanted to know if they considered it appropriate \nto use this technological innovation in our university \nschool, to which the respondents answered affirmatively \n(Figure 6 ).\nFigure 1: Level of knowledge in the use of computing devices.\nFigure 2: Degree to which simulators approximate to reality.Figure 4: Usefulness of the technology for training before dealing with real cases.\nFigure 5: Degree to which 3D Haptic Technology would have allowed them to \nadvance in obtaining skills.Figure 3: The level of validity that 3D haptic technology has for learning in \npreclinical practice.\n145\n2022/37 (3): 142-146 Digitization with 3D haptic technology in dental training\n2. Interview\nAfter analyzing the content of the answers obtained \nafter the interviews, the results are specified by interest \ngroups, differentiating between students, teachers, other \ninterested parties, and dentists.\nDentistry and undergraduate students:\n\u00b7 They enjoy playing and learning\n\u00b7 They feel new sensations\n\u00b7 They are having fun\nTeachers from the Adema University School and from \nother universities where the Degree in Dentistry is taught:\n\u00b7 They find it a great tool for teaching-learning\n\u00b7 Students will be better able to acquire skills\n\u00b7 Students can improve learning outcomes.\n\u00b7 Teachers will have to update\n\u00b7 Teachers need training to prepare their classes using \nsimulators\nOther stakeholders including medical visitors, teachers, \ncenter directors and politicians:\n\u00b7 It is an advance in the methodology of teaching \nstudents.\n\u00b7 They see many possibilities\nDentists in professional practice:\n\u00b7 The benefit that they would have had at the \nbeginning of their learning if they had had this \ntechnology at their fingertips.\nConclusions\nHaptic technology is occupying an increasingly prominent \nplace in the teaching and learning process of dentistry. It is a \nnew technology that for a few years has been incorporated \ninto undergraduate dentistry studies worldwide4,5.\nThe Adema University School has been implementing the \nuse of the aforementioned technology in Dentistry Degree \nstudies for two years. It is a fundamental tool for learning and work, since it allows the future dentist to enter the \noperative field from different perspectives, without time \nlimitations, and being able to change the types and \ncomplexity of treatment. It is therefore positioned as a tool \nthat simulates the real treatment process in a reliable way.\nThroughout this process of incorporating technology into \nteaching, contributions have been collected from different \ninterest groups on its use as a method for acquiring skills \nand generating procedural knowledge in the teaching-\nlearning process.\nFrom the results collected through the interviews and \nsurveys, a high degree of user satisfaction and the \nconviction that 3D haptic technology can help dental \nprofessionals learn, is inferred.\nIn all cases, the great similarity of the simulation with \nreal practice and its validity in preclinical practice stands \nout, alongwith the positive assessment of the tools as a \nmethod for training in interventions and case studies prior \nto carrying them out in clinical practice.\nEqually, it seems a good way to solve some of the \nshortcomings that teaching within the degree of dentistry \nhas had until now,  thanks to the great similarity that the \ntechnology has with real exercises, and the possibility of \nunlimited practice that is allowed.\nThroughout the interviews, the students have highlighted \nthe most playful, dynamic, attractive and entertaining \ncomponent of the technology, while the teachers \nemphasize the potential they represent for better \nacquiring skills and improving learning results.\nWe can conclude that haptic technology can be a \nfundamental tool for learning and work in the University \nFaculties and that the data obtained show that it is well \nreceived by students, teachers and other professionals \nrelated to the world of dentistry.\nDiscussion\nIn the review of studies we have verified that 3D haptic \ntechnology presents itself as an option in the teaching of \ndentistry at an international level and that it allows preclinical \npractices to be carried out in degree level training6.\nThe assessment in our study has been very positive \nand all the participants have seen the potential of this \ntechnology in the teaching process. We have not \nreceived negative evaluations regarding the use of the \nsimulators. Presumably there are critical voices in relation \nto their application for student training, but perhaps \nthe site in which the survey and interviews took place, \nthe Adema university school, which has opted for the \nincorporation of technology, has inhibited this kind of Figure 6: Assessment of the uses of technological innovations at the Adema \nUniversity School.146\n2022/37 (3): 142-146Digitization with 3D haptic technology in dental trainingDiego Gonz\u00e1lez Carrasco et al.  \nnegative assessment. However, given the diversity of \nstudents, teachers and other professionals who have \nparticipated, we believe we are in a position to support a \npositive view of the incorporation of 3D haptic technology \nas a learning tool.\nWe have collected contributions from the teachers on \nthe implications that incorporating this technology means \nfor them when the need arises to train and master the \ntechnology to be able to use it in teaching. Certainly, the \nincorporation of technology supposes the modification of \nthe teaching-learning model and requires a change in the \nconception of practices in the field of dentistry, providing a new scenario to which centers, teachers and students \nwill have to adapt.\nIt should be noted that this work is a first approach to \nlearn about simulators and their use in the dentistry \ndegree. It will be their practice and use in teaching in \nthe different subjects, and the learning results that are \ngenerated, which will finally confirm the value of their use \nas indicated by the data described in this study.\nConflict of interests\nThe authors have no conflict of interest.\nBibliography\n1. Woolfolk  A. Educational Psychology, Educational Psychology. 11th \nedition. Pearson Education, Mexico, 2010.\n2. Serrano CM, Wesselink PR, Vervoorn JM. First experiences \nwith patient-centered training in virtual reality. J Dent Educ . 2020 \nMay;84(5):607-14.\n3. Gonz\u00e1lez D. ICTs and new 3D haptic technologies applied in the \nteaching of health sciences in a state of alarm by Covid19. Medicina \nBalear 2020; 35(2):9-114. Ria S, Cox MJ, Quinn BF, San Diego JP , Bakir A, Woolford MJ. A \nScoring System for Assessing Learning Progression of Dental Students\u2019 \nClinical Skills Using Haptic Virtual Workstations. J Dent Educ. 2018 Mar \n;82 (3):277-85.\n5. Mirghani I, Mushtaq F, Allsop MJ, Al-Saud LM, Tickhill N, Potter C, et \nal. Capturing differences in dental training using a virtual reality simulator. \nEur J Dent Educ. 2018 Feb ;22 (1):67-71.\n6. Liebermann A, Erdelt K. Virtual education: Dental morphologies in a \nvirtual teaching environment. J Dent Educ . 2020 Oct;84(10):1143-50.147\n2022/37 (3): 147-151Received:  2 - IV - 2022\nAccepted:  9 - IV - 2022\ndoi: 10.3306/AJHS.2022.37.03.147Corresponding author\nShaima S. Ali Miraj \nE-mail: s.miraj@seu.edu.sa\nAbstract\nIntroduction and aim: The Covid- 2019 pandemic has caused serious threats to the life of people all over the world, including \nSaudi Arabia, leading to a more alarming concern of public health. This maiden pandemic to most of the century\u2019s inhabitants has \nalso raised a wide range of psychological problems, such as distress, panic disorder, anxiety and depression, which could be \nlong lasting and more devastating. The main purpose of the present questionnaire based study was to measure the prevalence \nand severity of distress in the population of six major regions of Saudi Arabia to have an idea of the impact of the second wave \nof Covid-19. \nMethods: This initial analysis, is an important large-scale study of psychological distress among the Saudi population during the \nsecond wave of COVID-19 epidemic, as few reports exist in literature in the area. An online cross sectional study was conducted \nfrom 24th March 2021 to 15 April 2021 in important regions of KSA where bilingual questionnaires with both Arabic and English \nversions were circulated to volunteers. Sample size calculation was based on WHO recommended criteria, minimum sample \nsize being 385 based on 95% confidence interval with 5% significance level. \nResults:  Among the total participants, 33.5% showed mild level of anxiety, followed by moderate (25.5%) and severe (14.3%) \nanxiety levels. A total of 230 out of 525 (43.8%) showed depression symptoms and among the total participants, females \nexpressed more depressive symptoms compared to the male participants. \nConclusion:  The findings of the study can be used for developing better and improved care and provision for people with \npsychological burden and mental illness, as it is necessary to offer targeted treatment, such as online psychotherapy in particular \nfor the distressed.\nKey words : distress, anxiety, Covid-19 second-wave.\nResumen  \nIntroducci\u00f3n y objetivo:  La pandemia de Covid- 2019 ha provocado graves amenazas para la vida de las personas en todo el \nmundo, incluida Arabia Saud\u00ed, lo que ha llevado a una preocupaci\u00f3n m\u00e1s alarmante de la salud p\u00fablica. Esta pandemia inaugural \npara la mayor\u00eda de los habitantes del siglo tambi\u00e9n ha planteado una amplia gama de problemas psicol\u00f3gicos, como la angustia, el \ntrastorno de p\u00e1nico, la ansiedad y la depresi\u00f3n, que podr\u00edan ser duraderos y m\u00e1s devastadores. El objetivo principal del presente \nestudio basado en un cuestionario era medir la prevalencia y la gravedad de la angustia en la poblaci\u00f3n de seis grandes regiones \nde Arabia Saud\u00ed para tener una idea del impacto de la segunda oleada de Covid-19. \nMetodolog\u00eda: Este an\u00e1lisis inicial, es un importante estudio a gran escala de la angustia psicol\u00f3gica entre la poblaci\u00f3n saud\u00ed \ndurante la segunda ola de la epidemia de COVID-19, ya que existen pocos informes en la literatura en el \u00e1rea. Se llev\u00f3 a cabo un \nestudio transversal en l\u00ednea desde el 24 de marzo de 2021 hasta el 15 de abril de 2021 en importantes regiones de KSA donde se \ndistribuyeron cuestionarios biling\u00fces con versiones en \u00e1rabe e ingl\u00e9s a los voluntarios. El c\u00e1lculo del tama\u00f1o de la muestra se bas\u00f3 \nen los criterios recomendados por la OMS, siendo el tama\u00f1o m\u00ednimo de la muestra de 385 basado en un intervalo de confianza \ndel 95% con un nivel de significaci\u00f3n del 5%. \nResultados:  Del total de participantes, el 33,5% mostraba un nivel de ansiedad leve, seguido de niveles de ansiedad moderados \n(25,5%) y graves (14,3%). Un total de 230 de 525 (43,8%) mostraron s\u00edntomas de depresi\u00f3n y, entre el total de participantes, las \nmujeres expresaron m\u00e1s s\u00edntomas depresivos en comparaci\u00f3n con los hombres. \nConclusi\u00f3n:  Los resultados del estudio pueden servir para desarrollar una mejor atenci\u00f3n y provisi\u00f3n para las personas con carga \npsicol\u00f3gica y enfermedades mentales, ya que es necesario ofrecer un tratamiento espec\u00edfico, como la psicoterapia en l\u00ednea, en \nparticular para los angustiados.\nPalabras clave:  angustia, ansiedad, Covid-19 segunda ola.ORIGINAL\nOn the psychological levels of general population \nof Saudi Arabia amidst the second wave of COVID 19: \na cross sectional study  \nSobre los niveles psicol\u00f3gicos de la poblaci\u00f3n general de Arabia Saud\u00ed \nen medio de la segunda ola de COVID 19: un estudio transversal    \nTintu Thomas Uthup      , Shaima S. Ali Miraj      , Mohammed AL-Mohaithef\nDepartment of Public Health, College of Health Sciences, Saudi Electronic University, Riyadh, KSAeISSN 2255-0569148\n2022/37 (3): 147-151Tintu Thomas Uthup et al.  \nIntroduction \nThe COVID-19 epidemic has caused serious threats to \nthe physical health and life of people as a whole including \nSaudi Arabia. Originating in China, the disease has a \nrapid progression to other countries. Research suggests \nremarkable genomic resemblance of 2019-nCoV with \nSevere Acute Respiratory Syndrome (SARS) which has \na history of a pandemic in 2002, resulting in a return of \nmore serious global public health emergency, (WHO \n2020, Gralinski and Menachery, 2020).\nAs the Corona Virus -19 has been reported to spread \nfaster than its two ancestors the SARS-CoV and Middle \nEast respiratory syndrome coronavirus (MERS-CoV), but \nhas lower fatality. Since the WHO, declared the New \nSARS-CoV-2 in China, in late 2019, a public health \nemergency of international followed in every continent, \nwith several data based and review articles flooding \nthe scientific literature. The global impact of this new \nepidemic is yet uncertain, (WHO, 2020, Singhal 2020), \nthough with concentrated international efforts and better \npreparedness for such pandemics at the global levels,  \nthe caused scars on human race will fade and humanity \nwill carry on with each other\u2019s healing touches, (Shaima \nMiraj 2020 and Miraj & Miraj 2021). \nThis has led to a more alarming concern of public health \nwith war footing attempts to curtail its impact on global \nhealth and economy, including human health and \nwellness of mind and body. This pandemic has also \nraised a wide range of psychological problems, such \nas fear, panic disorder, anxiety and depression, which \nare long lasting and more devastating. Several studies \nconducted recently after the pandemic and during \nits onset as well have reported serious psychological \ndistress due to the pandemic in human subjects \nanalyzed in several countries, (Feng et al (2020), \nCostantini & Mazzotti, (2020), Horesh and Brown 2020, \nJahanshahi et al (2020) and Jim\u00e9nez et al., (2021).\nThe main purpose of the present questionnaire based \nstudy was to measure the prevalence and severity of \ndistress for the population of the important regions of \nKingdom of Saudi Arabia to have an idea of the impact \nof the second wave of CORONA viral disease 2019, \nconsequent to the more serious first wave in the kingdom. \nThe initial analysis, is an important large-scale study \nof psychological distress among the Saudi population \nduring the second wave of COVID-19 epidemic, as few \nreports exist in literature in the area. The findings of the \nstudy can be used for developing better and improved \ncare and provision for people with psychological burden \nand mental illness, as it is necessary to offer targeted \ntreatment, such as online psychotherapy in particular for \nthe distressed. Methodology\nAn online cross sectional study was conducted in \nMarch and April 2021 in six major regions of Saudi \nArabia during the 2nd wave of Covid-19 pandemic, \nwhere about 1251 daily confirmed cases with 7347 \ndeaths, been reported by May end 2021. The bilingual \nquestionnaires with both Arabic and English versions \nwere circulated to the volunteers with the help of social \nplatforms like emails and WhatsApp  to reach all different \ncategories and major regions of general population \nin KSA. The eligibility criteria was defined as the \nparticipants should be residents of  KSA, aged 18 years \nand above to participate in the study  by answering the \nquestionnaires. Participation in the study was completely \nvoluntary, and the participants were requested to give \ntheir informed consent and endorse their eligibility for \nparticipation. Sample size calculation was based on \nWHO recommendation\u2019s criteria. The minimum sample \nsize required for this study is 385 based on 95% \nconfidence interval with 5% significance level. The study \nwas approved by the Institutional Review Board (IRB \napproval number: SEUREC-CHS21102).\nThe reliability and validity pretested questionnaire from \nthe pilot study (Cronbach\u2019s alpha > 8) was used for \nthe data collection. The study questionnaire composed \nof four major parts which included socio demographic \ninformation, information of health related factors, anxiety \nmeasurement scales a (DAD-7, 7 item generalized \nanxiety severity scale) and depression measurement \nscales (CESD-10).\nThe questionnaire was provided to 1105 individuals and \nout of which 728 (65.8 %) initiated to fill the questionnaire  \nand among those 624 full filled the eligibility criteria. A \ntotal 84% (525 out of 624) completed all domains of the \nquestionnaire including the baseline and demographic \ndetails, GED-7 and CESD 10 items. \nResults and discussion \nThe results of the present study point out towards \nincreasing levels of distress anxiety and fear among \nthe participants indicating that the second wave of \nthe pandemic is more distressful and is a significant  \ncausative factor of sustained stress among all sections \nof the studied volunteers, both males and females, \nbeing higher in females than the males. Recent studies \nalso show that there are increasingly comprehensive \ndata on recognition of the psychological impact of the \ncoronavirus disease 2019 (COVID 19) pandemic on \nglobal populations. In most regions of the world, the \neconomic and psychological burden on the general \npopulation and persons with mental disorders has risen \nsharply over the course of the pandemic, (Liu et al 2021).149\n2022/37 (3): 147-151 On the psychological levels of general population of Saudi Arabia amidst the second wave of COVID 19: a cross sectional study\nThe demographic features of the participants studied \nin the present investigation are summarized in table I , \nshowing that majority of participants being female (67.8%) \nand nearly half of the participants (41.9%) were under 25 \n-34 years of age group, followed by less than 25 years \n(28.2%), 35- 44 years (26.7%), 45 years older (3.2% ) \nrespectively. About, 87.8% were from Saudi nationalities \nand half of the participants were married (50.5%). Most of \nthe participants were from central region (40.8%), followed \nby eastern (23.2%) and western regions (21.0%). Most of \nthe participants had completed undergraduate level of \neducation (44.4 %) and one third of the participants were \nworking in government sector (33.7%).\nThe anxiety and depression levels of the studied samples \nare illustrated in figure 1.1 . Among the total participants, \n33.5% showed mild level of anxiety, followed by moderate \n(25.5%) and severe (14.3%) anxiety levels. A total of 230 \nout of 525 (43.8%) showed depression symptoms and  Table I: Socio demographic information.\nVariable   Frequency  %\nAge   \n< 25 years  148 28.2\n25- 34 years  220 41.9\n35 - 44 years  140 26.7\n45 years and older  17 3.2\nNationality   \nSaudi 461 87.8\nNon Saudi 64 12.2\nGender    \nFemale  356 67.8\nMale  169 32.2\nMarital status   \nSingle  221 42.1\nMarried  265 50.5\nDivorced/ widowed  39 7.4\nEducation   \nDiploma  64 12.2\nHigh school or less  175 33.3\nPost graduate and above  53 10.1\nUndergraduate  233 44.4\nOccupation  \nStudent  160 30.5\nGovernment  177 33.7\nPrivate  94 17.9\nSelf employed  4 0.8\nRetired  3 0.6\nNot working  87 16.6\nRegions   \nCentral  214 40.8\nEastern  122 23.2\nNorthern  1 0.2\nSouthern  53 10.1\nWestern  110 21.0\nOthers  25 4.8Table II: Showing the levels of Anxiety and Depression.\nAnxiety  Frequency     %\nNone /Minimal  140  26.7\nMild  176 33.5\nModerate  134 25.5\nSevere  75 14.3\nDepression    \nPresent  230 43.8\nAbsent  295 56.2\nTable III: Association between anxiety and demographic variables .\nVariables  Levels of anxiety   \n No/ Minimal  Mild  Moderate  Severe  P value\nGender      \nMale  52(30.8%) 81(47.9%) 15(8.9%) 21(12.4%) 0.000*\nFemale  88(24.7%) 95(26.7%) 119(33.4%) 54(15.2%) \nAge  group     \n18- 24 30(20.3%) 36(24.3%) 39(26.4%) 43(29.1%)  \n25-34 years  65(29.5%) 56(25.5%) 81(36.8%) 18(8.2%) 0.000*\n35-44 years  37(26.4%) 77(55.0%) 12(8.6%) 14(10.0%) \n45 years and above  8(47.1%) 7(41.2%) 2(11.8%) 0(0.00) \nMarital status      \nMarried  60(22.6%) 103(38.9%) 79(29.8%) 23(8.7%) \nSingle  48(21.7%) 71(32.1%) 52(23.5%) 50(22.6%) 0.000*\nDivorced/ widowed  32(82.0%) 2(5.12%) 3(7.69%) 2(5.12%) \nEducation      \nHigh school or less  25(14.3%) 59(33.7%) 74(42.3%) 17(9.7%) \nDiploma  43(67.2%) 18(28.1%) 1(1.6%) 2(3.1%) \nUndergraduate  54(23.2%) 75(32.2%) 53(22.7%) 51(21.9%) 0.000*\nPost graduate and above  18(34.0%) 24(45.3%) 6(11.3%) 5(9.4%) \nOccupation      \nGovernment  78(44.1%) 73(41.2/% 13(7.3%) 13(7.3%) \nPrivate / self employed 14(14.28%) 56(57.1%) 11(11.2%) 17(17..3%) 0.000*\nStudent  37(23.12%) 39(24.37%) 47(29.37%) 37(23.12%) \nNot working /retired  11(12.2%) 8(8.88%) 63(70%) 8(8.88%) \nRegion      \nCentral  56(26.2%) 85(39.4%) 28(13.1%) 45(21.0%) \nEastern  18(14.8%) 55(45.1%) 29(23.8%) 20(16.4%) 0.000*\nSouthern  40(75.5%) 7(13.2%) 4(7.5%) 2(3.8%) \nWestern  15(13.6%) 24(21.8%) 66(60.0%) 5(4.5%) \nNorthern / Others  11(42.30%) 5(19.2%) 7(26.9%) 3(11.5%) \n*P<0.005, statistically significant at 5% significance level.150\n2022/37 (3): 147-151Tintu Thomas Uthup et al.  \n17.9% of the married population showed moderate to \nsevere anxiety with respect to 21.9% who were single, \nfound to be statistically significant (p=0.00*) ( Table III ).\nEvaluating Occupation status with anxiety levels it \nwas observed that 24.5% of the population showing \nmild anxiety symptoms were employed either in \ngovernment, private or self. It is in comparison to 8.9 % \nof population who were unemployed (either students/\nretired professionals). This was in contrast to 10.2% of \nthe employed professionals who showed moderate to \nsevere anxiety in comparison to unemployed  population \n(29.5%), found to be statistically significant (p=0.008)\n(Table III ).\nEvaluating the association between various demographic \nfactors with reference to depression, it was observed \nthat females were depressed more(50.2%) as compared \nto males, found to be statistically significant (p=0.00*)\n(Table IV ). Likewise, 68.2% of the population was found \nto be depressed between the age group of 18-24 years. \nRecent studies conducted in Italy and Spain, have also \ndemonstrated that women showed a higher level of \ndistress, as well as in the Spanish sample (Magomed-\nEminov et al., 2020; Jim\u00e9nez et al., 2021), similar to the \npresent investigation. It has been also observed in these \nprevious studies that the survivors of the COVID-19 \ncontraction are characterized by higher indicators of the \nindex of distress than for those who are not ill and have \nnot encountered the disease in their family environment, \n(Costantini & Mazzotti, 2020). Table III: Association between depression and demographic variables .\n*P< 0.05   statistically significant   at 5% significance level  Variables  Depression   \n Yes  No P value\nGender \nMale  51(30.2.%)  118(69.8%)  0.000*\nFemale  179(50.2%)  177(49.7)%  \nAge group\n18- 24 101(68.2%) 47(31.8%)  \n25-34 years  77(35.0%) 143(65.0%) 0.000*\n35-44 years  46(32.9%) 94(67.1%) \n45 years and above  6(35.3%) 11(64.7%) \nMarital status \nMarried  77(29.1%) 188(70.9%) \nSingle  147(66.5%) 74(33.5%) 0.000*\nDivorced/ widowed  6(15.38%) 33(84.61%) \nEducation \nHigh school or less  47(26.9%) 128(73.1%) \nDiploma  18(28.1%) 46(71.9%) 0.000*\nUndergraduate    137(58.8%) 96(41.2%) \nPost graduate and above  28(52.8%) 25(47.2%) \nOccupation \nGovernment  70(39.5%) 107(60.5%) \nPrivate / self employed 39(39.7%) 59(60.2%) 0.000*\nStudent  106(66.2%) 54(33.8%) \nNot working /retired  15(16.6%) 75(83.33%) \nRegion\nCentral  119(55.6%) 95(44.4%) \nEastern  59(48.4%) 63(51.6%) \nSouthern  9(17.0%) 44(83.0%) 0.000*\nWestern  27(24.5%) 83(75.5%) \nNorthern / Others  16(61.53%) 10(38.46%) \namong the total participants, female expressed more \ndepressive symptoms compared to male participants. \nWith reference to the demographic distribution related \nto age, it was observed that 33.5% of the sample \npopulation had mild anxiety as compared to 39.8% of \nthe population which had moderate to severe anxiety. \nOn further gender wise evaluation it was observed that \nfemales had more moderate to severe anxiety (44.9%) \nas compared to males(9.35%), found to be statistically \nsignificant ( Table III ). 17% of the sample population \nhad symptoms of mild anxiety between 18-34 years as \ncompared to 16% observed between age group of 35 \nyears and above. However, with respect to moderate \nto severe anxiety, it was observed that 34.47% of the \npopulation in the age group of 18-34 years complained \nof the symptoms in comparison to 5.3% in the age group \nof 35 years or above found to be statistically significant \n(p=0.00*) ( Table III ). \nWith relation to the effect of marital status to anxiety, it was \nobserved that 38.9% of the married population had mild \nsymptoms in comparison to single (32.1%). Likewise, \n19.4% of the married showed moderate to severe \nsymptoms as compared to 20.3% who were single/\nwidowed ( Table III ). Comparing in terms of education \nwith relation to anxiety levels it was found that 14.6% \nof the sample having education high school/diploma or \nless had mild symptoms in comparison to 18.8% who \nhad qualification undergraduate or above. In comparison 151\n2022/37 (3): 147-151On the psychological levels of general population of Saudi Arabia amidst the second wave of COVID 19: a cross sectional study\nUnivariate analysis showed the association of different \ndemographic factors namely age group, gender, marital \nstatus, education level, occupational status with anxiety \nand depressive symptoms (p<0.05) at 5% significance \nlevel. Detailed analysis is depicted in tables III  and IV. \nThe mean and SD of anxiety score was 8.08 \u00b15.62   \non GED 7 scale and depression score was 10.41\u00b1 \n6.21on CESD-on a 10 scale. There is significant positive \ncorrelation showed (r=0.680, p= 0.000) between anxiety \nand depression score at 5% significance level and p \nvalue <0.05.\nConclusion\nAmong the total participants, 33.5% showed mild level of \nanxiety, followed by moderate (25.5%) and severe (14.3%) \nanxiety levels. A total of 230 out of 525 (43.8%) showed \ndepression symptoms and among the total participants, \nfemales expressed more depressive symptoms \ncompared to the male participants. The findings of the \nstudy can be used for developing better and improved \ncare and provision for people with psychological burden \nand mental illness, especially in a current scenario like \npresent when the world is gearing for a new omicron third \nwave as it is necessary to offer targeted treatment, such \nas online psychotherapy in particular for the distressed.Data Availability Statement  \nThe datasets generated and/or analysed during the \ncurrent study are not publicly available due to privacy and \nconfidentiality agreements as well as other restrictions \nbut are available from the corresponding author on \nreasonable request. \nAuthor Contributions  \nAll authors made substantial contributions to conception, \ndesign, acquisition of data, analysis and interpretation of \ndata, drafting the article or revising it critically for intellectual \ncontent and reasoning, provided final approval of the \nversion to be published, and agreed to be accountable \nfor all aspects of the work. \nAcknowledgements\nThis project was funded by the Deanship of Scientific \nResearch (DSR) at Saudi Electronic University, Riyadh \nunder grant no. ELI/CHS20115. The authors therefore \nacknowledge the DSR for technical and financial support \nfor this work.\nConflict of interests\nThe authors have no conflict of interest.\nReferences\nCostantini, A. & Mazzotti E... (2020). Italian validation of CoViD-19 \nPeritraumatic Distress Index and preliminary data in a sample of general \npopulation. Rivista di psichiatria. 55. 145-151. 10.1708/3382.33570.\nFeng L. S, Dong Z. J, Yan R. Y, Wu X. Q, Zhang L, Ma J., Zeng Y. \n(2020). Psychological distress in the shadow of the COVID-19 pandemic: \nPreliminary development of an assessment scale. Psychiatry Res. \n291:113202. doi: 10.1016/j.psychres.2020.113202. \nGralinski LE, Menachery VD. (2020) Return of the Coronavirus: 2019-\nnCoV.Viruses ; 12(2):135. https://doi.org/10.3390/v12020135\nHoresh D., Brown A. D. (2020). Traumatic Stress in the Age of COVID-19: \nA Call to Close Critical Gaps and Adapt to New Realities. Psychological \nTrauma: Theory, Research, Practice, and Policy Vol. 12, No. 4, 331-\n335/2020. http://dx.doi.org/10.1037/tra0000592\nJahanshahi A. A, Dinani M. M, Madavani A. N, Li J, Zhang S. X. (2020). \nThe distress of Iranian adults during the Covid-19 pandemic - More \ndistressed than the Chinese and with different predictors. Brain Behav \nImmun. 87: P . 124-125. doi: 10.1016/j.bbi.2020.04.081. \nJim\u00e9nez M. P , Rieker J. A, Reales J. M., Ballesteros S. (2021). COVID-19 \nPeritraumatic Distress as a Function of Age and Gender in a Spanish \nSample. Int J Environ Res Public Health. 14;18(10):5253. doi: 10.3390/\nijerph18105253. PMID: 34069224; PMCID: PMC8155941.\nJim\u00e9nez M. P , Rieker J. A, Reales J. M., Ballesteros S. (2021). COVID-19 \nPeritraumatic Distress as a Function of Age and Gender in a Spanish \nSample. Int J Environ Res Public Health. 14;18(10):5253. doi: 10.3390/\nijerph18105253. PMID: 34069224; PMCID: PMC8155941.Liu S, Heinz A, Haucke MN and Heinzel S (2021)The global impact \nof the COVID-19 pandemic on the care provision for people \nwith mental health problems, Der Nervenarzt, 11 Feb 2021, \n92(6):556-561Language:gerDOI: 10.1007/s00115-021-01068-2 PMID: \n33575836 PMCID: PMC7877534\nMagomed-Eminov M.S., Karacheva E., Kvasova O., Savina O. et al. \n(2021). Psychological Applications and Trends (Edited Clara Pracana & \nMichael Wang). InScience Press Lisboa, Portugal, P . 447\u2013449.\nMiraj M and Miraj SA (2020) Corona Virus Disease-19: The New \nChallenge for Saving the Human Race Biosc.Biotech.Res.Comm Vol. 13 \nNo 1 (Jan-Mar 2020) 1-5 DOI: 10.21786/bbrc/13.1/1 \nMiraj SA (2021)  Abiding by the World Health Organization Guidelines: \nA Hobson\u2019s Choice Coronaviruses Vol 2 Iss No 3 The World\u2019s First \nInternational Journal Dedicated to Coronaviruses Volume 2 , Issue 3 , \n2021 DOI : 10.2174/2666796701999201113113014\nSinghal T. (2020) A Review of Coronavirus Disease-2019 (COVID-19) \nIndian J Pediatr. 2020; 87(4): 281\u2013286.\nQun Li (2020) The 2019-nCoV Outbreak Joint Field Epidemiology \nInvestigation Team, An outbreak of NCIP (2019-nCoV) infection in China \u2014 \nWuhan, Hubei Province, 2019\u22122020. China CDC Wkly. 2020;2(5):790.\nViruses Jan 24;12(2):135. doi: 10.3390/v12020135.PMID: 31991541 \nWorld Health Organization (2020) Coronavirus Disease 2019 (COVID-19) \nSituation Report 28 Who.int.2020.  https://www.who.int/docs/\ndefaultsource/coronaviruse/situation-reports/20152\n2022/37 (3): 152-156Received:  5 - IV - 2022\nAccepted:  11 - IV - 2022\ndoi: 10.3306/AJHS.2022.37.03.152Corresponding author\nJosu Hernando-P\u00e9rez \nE-mail: josu.hernando@ehu.eus\nResumen  \nLa llamada gripe rusa que afect\u00f3 a distintos pa\u00edses de Europa a partir de noviembre de 1889, lleg\u00f3 a Baleares los \u00faltimos d\u00edas del \na\u00f1o, vincul\u00e1ndose los primeros casos con la aduana de Palma. Los m\u00e9dicos de la \u00e9poca se\u00f1alaron que la mitad de la poblaci\u00f3n \nenferm\u00f3 presentando, por lo general, cuadros cl\u00ednicos leves. La epidemia no produjo un incremento significativo de las tasas \nbrutas de mortalidad en el conjunto de las Islas Baleares ni en ninguna de las tres principales capitales que hemos estudiado. \nSe\u00f1alamos que la ausencia de fallecimientos podr\u00eda ser debida a la avanzada transici\u00f3n demogr\u00e1fica de Mallorca.\nPalabras clave:  Pandemia, 1889, gripe rusa, higiene, aislamiento, transici\u00f3n demogr\u00e1fica.\nAbstract\nThe so-called Russian flu pandemic, which affected different European countries from November 1889, reached the Balearic \nIslands in the last days of the year. The first cases were linked to the Palma customs office. The doctors of the time pointed out \nthat half of the population fell ill, generally presenting mild clinical symptoms. However, the epidemic did not produce a significant \nincrease in the crude mortality rates in the Balearic Islands or in any of the three main capitals we have studied. We note that the \nabsence of deaths could be due to the advanced demographic transition in Mallorca.\nKey words : Pandemic, 1889, russian flu, hygiene, Isolation, demographic transition.ORIGINAL\nLa pandemia de gripe rusa en las Islas Baleares (1889-1892)\nThe Russian flu pandemic in the Balearic Islands (1889-1892)\nJosu Hernando-P\u00e9rez1      , Joan March2      , Anton Erkoreka1      ,\nJoana Maria Pujadas-Mora3\n1. Basque Museum of History of Medicine (UPV/EHU). Grupo de Investigaci\u00f3n de Historia Urbana. Poblaci\u00f3n y Patrimonio\n2. Grup d\u2019Investigaci\u00f3 d\u2019Hist\u00f2ria de la Salut IUNICS.(UIB)   3. Open University of Catalonia / Center for Demographic StudieseISSN 2255-0569\nID ID ID\nID\nIntroducci\u00f3n\nLa llamada pandemia de \u201cgripe rusa\u201d constituye un hito \nimportante en la historia de las enfermedades porque, \ntras un siglo XIX marcado por epidemias de c\u00f3lera y fiebre \namarilla, y en el caso concreto de la isla de Mallorca por \nuna epidemia de peste en 1820, la pandemia de 1889 \ninici\u00f3 un nuevo ciclo. Es la primera de las pandemias \nv\u00edricas de los \u00faltimos 130 a\u00f1os que han afectado de una \nmanera grave y generalizada a Europa y a todo el mundo, \nculminando el 2020 con la llegada de la Covid-19.\nEl origen de la pandemia de 1889 seguramente estuvo \nen China, tras las inundaciones de 1888. La tenemos \ndocumentada en Asia Central, concretamente en Tomsk \n(Siberia) y Bukhara (Uzbekistan) en octubre de 1889. \nA finales de ese mes aparece en San Petersburgo, \nextendi\u00e9ndose r\u00e1pidamente por toda Europa gracias al \nferrocarril. El 17 de noviembre de 1889 ya hay casos \ndocumentados en Par\u00eds; el 30 de noviembre en Berl\u00edn y \nViena; a mediados de diciembre en Londres y, a finales de ese mes en los pa\u00edses del sur de Europa, desde \nItalia hasta Portugal. Por v\u00eda mar\u00edtima a mediados de \ndiciembre de 1889 lleg\u00f3 a Am\u00e9rica; en enero de 1890 \na Suez y \u00c1frica del Sur; en febrero a la India y en abril \nhasta Australia. Es decir, la expansi\u00f3n del nuevo virus \npor todo el mundo ocurri\u00f3 a una velocidad incre\u00edble y \ndesconocida hasta ese momento.\nLa aparici\u00f3n y el desarrollo de la epidemia en Par\u00eds \nest\u00e1 bien estudiada por Bertillon2 (1), apareciendo los \nprimeros casos benignos, a mediados de noviembre, \nen empleados de grandes almacenes, de Correos y \nTel\u00e9grafos, ministerios, etc. A partir del 15 de diciembre, \nel virus se volvi\u00f3 extremadamente virulento empezando \na provocar un gran n\u00famero de defunciones. Entre el \n16 de diciembre de 1889 y el 31 de enero de 1890 \nfallecieron en Paris 5.042 personas por esta causa. La \nmayor\u00eda fueron mayores de 50 a\u00f1os y m\u00e1s hombres que \nmujeres. La tasa de mortalidad de esta primera ola fue, 153\n2022/37 (3): 152-156La pandemia de gripe rusa en las Islas Baleares (1889-1892)\nseg\u00fan Bertillon, de 2,1 por 1000 habitantes (hombres \n2,5 por 1000 y mujeres 1,7 por 1000 habitantes).  \nLa presentaci\u00f3n cl\u00ednica de esta enfermedad en Par\u00eds fue \nmuy bien estudiada por el Dr. Proust3, distinguiendo en \nsu informe, publicado por la Acad\u00e9mie de M\u00e9decine  de \nParis, tres formas definidas de la enfermedad (2): lo que \nllam\u00f3 \u201cgripe nerviosa\u201d de comienzo brusco, con cefalea \ny fuertes dolores articulares y musculares; una \u201cforma \npulmonar\u201d  con los mismos s\u00edntomas adem\u00e1s de una \ngrav\u00edsima neumon\u00eda; y una tercera \u201cforma g\u00e1strica\u201d en la \nque prevalec\u00edan los trastornos digestivos con v\u00f3mitos, \ndiarrea, etc.\nLa pandemia lleg\u00f3 a Espa\u00f1a por diferentes v\u00edas en el \nmes de diciembre de 1889. A trav\u00e9s del Mediterr\u00e1neo se \nencontraron los primeros casos en ciudades portuarias \ncomo Valencia o M\u00e1laga desde comienzos de mes, \nen ambos casos la prensa se hizo eco de la llegada \nde una \u201cepidemia de dengue\u201d (3). Paralelamente, por \nv\u00eda ferroviaria y a trav\u00e9s de los Pirineos la pandemia \nlleg\u00f3 a Barcelona y a Ir\u00fan (4). A lo largo de este mes la \ndifusi\u00f3n por el resto de territorios peninsulares fue muy \nr\u00e1pida y los efectos comenzaron a ser visibles en las \ntasas de mortalidad desde finales de diciembre pero, \nespecialmente, en enero de 1890.\nMaterial y m\u00e9todo\nNuestra investigaci\u00f3n se fundamenta en el estudio de \ndistintas fuentes relativas a la mortalidad en las islas \nBaleares a finales del siglo XIX. En un primer nivel, hemos \ntrabajado los datos generales relativos a Espa\u00f1a y a las \nIslas Baleares en base a la informaci\u00f3n del Movimiento \nNatural de Poblaci\u00f3n (MNP). Esta fuente ha permitido \nel c\u00e1lculo de las tasas brutas de mortalidad generales \nde las tres principales ciudades del archipi\u00e9lago: Palma, \nMah\u00f3n (Ma\u00f3) y la ciudad de Ibiza (Eivissa). Estas tasas se \nhan calculado para los a\u00f1os m\u00e1s pr\u00f3ximos a la pandemia \nestudiada, 1886-1892. A partir de la informaci\u00f3n \nagregada del MNP tambi\u00e9n hemos estimado las tasas \nde mortalidad a nivel nacional y las observadas en el \nconjunto del Archipi\u00e9lago Balear. Desgraciadamente \nla informaci\u00f3n del MNP no permite la realizaci\u00f3n de \nestudios desagregados de la mortalidad por edades.\nEn un segundo nivel, hemos consultado informaci\u00f3n \nepidemiol\u00f3gica m\u00e1s concreta para estos a\u00f1os a trav\u00e9s de los res\u00famenes estad\u00edsticos de mortalidad \npublicados en la Revista Balear de Ciencias M\u00e9dicas4. \nEn esta fuente se recogen datos demogr\u00e1ficos como la \nnatalidad y, especialmente, los res\u00famenes de mortalidad \npor edades, meses del a\u00f1o y causas de defunci\u00f3n. \nParalelamente tambi\u00e9n hemos estudiado los discursos \ny noticias sobre la gripe rusa aparecidas en esa Revista. \nEn dichas fuentes, m\u00e9dicos y especialistas de la \u00e9poca \nrelatan de primera mano la llegada de la pandemia a las \nislas y como va discurriendo a lo largo del tiempo. Se \ntrata de textos de elevado valor hist\u00f3rico que ponen de \nmanifiesto el desconcierto y desconocimiento de los \nprofesionales de la \u00e9poca a la hora de hacer frente a \nla propagaci\u00f3n de un nuevo agente pat\u00f3geno. En este \ntipo de trabajos los especialistas del momento relatan, \nprincipalmente, la sintomatolog\u00eda observada en diferentes \npacientes, la expansi\u00f3n de la pandemia y debaten en \ntorno a los tratamientos m\u00e1s eficaces.\nResultados\nEl archipi\u00e9lago balear a lo largo del siglo XIX y \nespecialmente en los a\u00f1os previos a la llegada de la \npandemia de 1889-1892 destaca por sus reducidas \ntasas de mortalidad en comparaci\u00f3n con las cifras \npeninsulares. Somos conscientes de que la comparaci\u00f3n \nde las tasas brutas de mortalidad entre diferentes \npoblaciones puede estar afectada por la estructura por \nedades de estas. En la d\u00e9cada de 1880 las tasas brutas \nde Baleares se mantuvieron siempre muy por debajo \ndel promedio nacional (ver tabla I ). Algunos autores \nya se han hecho eco de esta realidad y han tratado de \nofrecer diferentes explicaciones en torno a la menor \nmortalidad general e infantil del archipi\u00e9lago (5). Incluso, \nhemos recogido opiniones de especialistas de la \u00e9poca, \nhigienistas como el Dr. Fajarn\u00e9s Tur5 (6) que hablan de \nla \u201cbondad\u201d del clima balear para justificar las reducidas \ntasas de mortalidad observadas.\nLo cierto es que, m\u00e1s all\u00e1 de esta mejor situaci\u00f3n \nepidemiol\u00f3gica balear en comparaci\u00f3n con las cifras \npeninsulares, en los dos a\u00f1os inmediatamente anteriores \na la llegada de la pandemia estudiada, 1887 y 1888, se \naprecia un notable incremento de las tasas de mortalidad. \nEn el conjunto del archipi\u00e9lago se pasa de cifras inferiores \na los 20 fallecidos por 1000 habitantes en los a\u00f1os \nprevios a un 25,94 y un 27,24 por 1000 en 1887 y 1888 \nrespectivamente. El incremento es especialmente elevado \nTabla I: Tasa bruta de mortalidad (TBM) en Palma, Ibiza, Mah\u00f3n, Baleares y Espa\u00f1a, 1886-1892.\nElaboraci\u00f3n propia a partir de datos del Movimiento Natural de Poblaci\u00f3n, MNP .Localidad 1886 1887 1888 1889 1890 1891 1892\nPalma  21,54 30,27 26,53 24,38 22,61 22,31 23,39\nIbiza  25,65 27,62 32,34 21,28 19,97 25,28 19,58\nMah\u00f3n  19,23 19,52 20,02 17,04 19,07 22,93 20,42\nBaleares  19,06 25,94 27,24 21,86 21,34 21,24 22,88\nEspa\u00f1a  29,12 32,68 30,09 30,88 32,62 31,87 31,02154\n2022/37 (3): 152-156Josu Hernando-P\u00e9rez et al.  \nen las capitales de Palma e Ibiza, en las que se llegaron \na sobrepasar las 30 defunciones por 1000 habitantes. \nLa causa de este mayor incremento en las principales \nciudades la podemos localizar en una cierta penalizaci\u00f3n \nurbana o \u201cUrban penalty\u201d, a la vez que un posible mejor \nregistro en las ciudades como consecuencia de una \nmayor institucionalizaci\u00f3n como se ha demostrado en \notras zonas de Espa\u00f1a (7), ya que la mortalidad en zonas \nrurales baleares era a\u00fan m\u00e1s reducida (8). Con respecto \nal agente pat\u00f3geno que provoc\u00f3 esta epidemia en los \na\u00f1os 1887 y 1888, los datos observados nos llevan \na hablar de la coexistencia de dos enfermedades que \nincrementaron especialmente la mortalidad infantil: viruela \n(9) y, especialmente, sarampi\u00f3n. Fajarn\u00e9s Tur describi\u00f3 \ntambi\u00e9n los efectos de esta \u00faltima afecci\u00f3n que, a modo \nde ejemplo, entre los meses de marzo y septiembre de \n1887 supuso m\u00e1s del 20% de las defunciones totales de \nPalma, con 237 decesos (6). \nPara el a\u00f1o 1889 la situaci\u00f3n epidemiol\u00f3gica balear \nretorn\u00f3 a la realidad previa, aunque, tal y como se aprecia \nen las cifras estad\u00edsticas ofrecidas por la Revista Balear \nde Ciencias M\u00e9dicas  siguieron apareciendo nuevos \ncasos de viruela. En diciembre de 1889 la pandemia \nconocida hist\u00f3ricamente como \u201cgripe rusa\u201d comenz\u00f3 a \ndisparar las cifras de mortalidad en diversas ciudades \neuropeas (10). Sin embargo, esta pandemia no lleg\u00f3 a \nafectar de verdad a las Islas Baleares hasta mediados \nde enero de 1890, cuando ya todo el territorio peninsular \nestaba afectado por la misma.\nA la hora de valorar el impacto de esta pandemia en \nlos datos demogr\u00e1ficos de Baleares observamos una \nrealidad inesperada y totalmente opuesta a lo observado \nen otras zonas de la geograf\u00eda espa\u00f1ola. La pandemia \nde 1889-1892 no produjo un incremento significativo de \nlas tasas brutas de mortalidad de Baleares. De hecho, \nse prosigui\u00f3 con un descenso de las cifras de mortalidad \nobservadas en los a\u00f1os anteriores. No se aprecia, por lo \ntanto, una mortalidad en exceso durante estos a\u00f1os, ni \nen el conjunto de las Islas Baleares ni en ninguna de las \ntres principales capitales, tal y como puede apreciarse \nen el gr\u00e1fico 1  y en la tabla I .Estos datos confirman el escaso impacto que tuvo \nla pandemia en las tasas de mortalidad de las Islas \nBaleares. Es cierto que el pico de mortalidad observado \nen el conjunto de Espa\u00f1a tampoco es muy elevado, ya \nque la pandemia no afect\u00f3 por igual a todas las zonas \ny las principales tasas de mortalidad las podemos \nencontrar en los grandes n\u00facleos urbanos e industriales, \nm\u00e1s afectados por la penalizaci\u00f3n urbana. Madrid es un \nejemplo de esto, con una mortalidad en exceso del 5,8 \npor 1000 (11) o el caso de Bilbao, en el que en los varios \na\u00f1os de afecci\u00f3n de la pandemia, se sobrepasaron las \n10,6 defunciones en exceso por 1000 habitantes (4). \nSin embargo, en Baleares el impacto de la pandemia \nes m\u00ednimo, lo que nos podr\u00eda llevar a plantear que no \nse propag\u00f3 el virus o que tuvo una menor afecci\u00f3n. Las \nfuentes primarias consultadas confirman que el virus s\u00ed \nlleg\u00f3 a las islas y que se extendi\u00f3 por ellas afectando \na una buena parte de la poblaci\u00f3n con cuadros que, \naparentemente, no fueron muy graves. As\u00ed lo atestiguan \nlos siguientes testimonios de facultativos que vivieron la \npandemia de primera mano y publicaron sus impresiones \nen la Revista Balear de Ciencias M\u00e9dicas :\nUno de los mejores testimonios disponibles al respecto \ncorresponde al Dr. Pere Mas Oliver, que describi\u00f3 a la \nperfecci\u00f3n la llegada y propagaci\u00f3n del virus por la ciudad \nde Palma. En sus \u201cNotas para el estudio de la epidemia \ngripal en Palma\u201d publicadas en la citada Revista Balear \nde Ciencias M\u00e9dicas , Mas constata que tuvo noticias de \nla epidemia a trav\u00e9s de las informaciones de la prensa \nrelativas a Madrid. La pandemia no lleg\u00f3 a la isla hasta el \n25 de diciembre de 1889, y empez\u00f3 en una mujer de 35 \na\u00f1os que presentaba la siguiente sintomatolog\u00eda: \n\u201cEl d\u00eda anterior hab\u00eda sentido un violento \nescalofr\u00edo seguido de una cefalea frontal intensa, \nlumbago, dolores articulares m\u00e1s acentuados \nen las extremidades inferiores y fiebre alta. Por \nla noche le fue imposible conciliar el sue\u00f1o y, a \nla ma\u00f1ana, en mi primera visita pude apreciar el \nextra\u00f1o cuadro sindr\u00f3mico, para mi cl\u00ednicamente \ndesconocido con el que describen los pat\u00f3logos \nla Influenza.\u201d \nEl doctor dud\u00f3 en realizar un diagn\u00f3stico al no existir \nprecedentes en la isla. Lo cierto es que el virus \nposiblemente infect\u00f3 primero a su marido, trabajador de \nla aduana de Palma, aunque los primeros s\u00edntomas los \nexperiment\u00f3 el hijo de ambos que present\u00f3 la misma \nsintomatolog\u00eda de la madre.  Poco a poco enfermaron \n8 de los 10 miembros de la familia y, con posterioridad, \nvecinos de la casa contigua. Posteriormente, ya en \nenero, se generaron otros focos con casos importados \ndesde Madrid. Para esta fecha la pandemia se hab\u00eda \nextendido y los nuevos casos surg\u00edan por toda la isla con \nsintomatolog\u00edas similares. El 15 de febrero los m\u00e9dicos \ndieron por finalizada la pandemia. \nTabla I: Tasa bruta de mortaldad (TBM) en Espa\u00f1a y Baleares, 1886-1892.155\n2022/37 (3): 152-156La pandemia de gripe rusa en las Islas Baleares (1889-1892)\nPese a que el Dr. Mas estim\u00f3 que pr\u00e1cticamente la mitad \nde la poblaci\u00f3n se contagi\u00f3, el n\u00famero de defunciones \ntanto por gripe como por patolog\u00edas respiratorias \nvinculadas con la epidemia fue muy limitado. Al contrario \nque en otras poblaciones, la enfermedad no caus\u00f3 \ncuadros muy graves: \u201cLos cuadros graves fueron \nexcepcionales, no solo en personas j\u00f3venes y robustas \nsino en viejos y enfermos\u201d  no generando una gran \npreocupaci\u00f3n entre la poblaci\u00f3n y las autoridades. \nEstos apuntes recogidos por el Dr. Mas se ven \nconfirmados y complementados por los escritos del \nDr. Guillem Serra y Benn\u00e0ssar6 desde Barcelona \nnuevamente en la Revista Balear de Ciencias M\u00e9dicas  en \n1890. En estos textos, el doctor se refiri\u00f3 a la pandemia \ncomo \u201cEl dengue\u201d , contando as\u00ed c\u00f3mo tuvo noticia de la \nenfermedad:\n\u201cA \u00faltimos de noviembre el tel\u00e9grafo nos sorprendi\u00f3 \ncon la noticia de haberse desarrollado esta \nenfermedad en San Petesburgo, cont\u00e1ndose unas \n150.000 invasiones en pocos d\u00edas y continuando \nde manera que pocos habitantes de la capital se \nhan librado del contagio, sin exceptuar a la familia \nimperial, cuyos miembros, en su mayor parte lo \nhan pasado\u201d.\nOtros lo definieron como una fiebre catarral \u201cno \ncontagiosa\u201d . El Dr. Serra y Benn\u00e0ssar consider\u00f3 \ninaceptables estas definiciones, poniendo de manifiesto \nque es una enfermedad infecciosa aunque no se conozca \n\u201cel microbio\u201d  que la produce. Espa\u00f1a, en palabras del \ndoctor, bautiz\u00f3 a la pandemia como \u201ctrancazo\u201d , Francia y \nAlemania hablaron de \u201cgrippe\u201d , Italia como \u201cpantomima\u201d  \ny \u201cfiebre polka\u201d . En el Reino Unido fue conocida como \n\u201cdandy fever\u201d  o \u201cbreak bones\u201d  (quebranta huesos) y en \nRusia \u201cinfluenza\u201d .\nRespecto a los tratamientos, se hace eco de los \ndict\u00e1menes de la Junta de Sanidad de Madrid. En todo \nmomento se busc\u00f3 favorecer la sudoraci\u00f3n del paciente \npermaneciendo abrigados, mantener en la habitaci\u00f3n un \nm\u00ednimo de 16 grados y recomendaci\u00f3n de permanecer \nen la cama, con botellas de agua caliente a los pies. \nTambi\u00e9n el tratamiento con sustancias como antipirina, \npolvos de Dover7, tintura de ac\u00f3nito o salicilato de Sosa.\nPor \u00faltimo, el Dr. Federico Farinos Delhom8 tambi\u00e9n \npublic\u00f3 sus apuntes sobre la \u00faltima epidemia relativos \na la isla de Menorca en la Revista Balear de Ciencias \nM\u00e9dicas . Seg\u00fan este doctor, la gripe apareci\u00f3 en \nMenorca a finales de enero, cuando ya hab\u00eda alcanzado \nsu mayor incremento en el litoral mediterr\u00e1neo y en \nMallorca. En la segunda decena de enero se extendi\u00f3 \npor Ma\u00f3. El doctor calcula que la tercera parte de sus \nhabitantes padecieron la epidemia con mayor o menor \nintensidad. Comenz\u00f3 a disminuir la afecci\u00f3n a finales de \nmes y comienzos de febrero. A mediados de este mes dieron por finalizada la pandemia. Hacen referencia a que \nm\u00e1s de la mitad de la poblaci\u00f3n sufri\u00f3 la enfermedad, \naunque de forma benigna en la mayor parte de los casos \ny sin incrementos significativos de mortalidad. En los \nindividuos sanos el pron\u00f3stico fue, por lo general, leve. \nLa mortalidad, en palabras del doctor, se increment\u00f3 en \nlos casos con patolog\u00edas preexistentes, siendo mayor \nen ni\u00f1os y ancianos. Se recomend\u00f3 el aislamiento de \nlos afectados, pero las \u201cnecesidades de la vida moderna \nlo hacen impracticable; los perjuicios y los males que \nacarrear\u00eda ser\u00edan, quiz\u00e1s, m\u00e1s temibles que la misma \nenfermedad (\u2026)\u201d . \nPor \u00faltimo, el doctor expone el caso del Hospital Militar \nde Ma\u00f3, en el que ejerc\u00eda como m\u00e9dico y donde, entre \nel d\u00eda 16 de enero y el 10 de febrero, ingresaron un total \nde 62 militares. Su presentaci\u00f3n cl\u00ednica fue muy leve \nen casi todos los enfermos y de mediana intensidad \nen unos pocos. Tan solo hubo 4 casos graves. En \ntotal enfermaron 197 soldados y un enfermero que, a \nla postre, fue el \u00fanico fallecido. El Dr. Farin\u00f3s Delhom \nexpone finalmente su opini\u00f3n de que la enfermedad se \npropag\u00f3 menos dentro de esta unidad militar que en el \nresto de la isla.\nEn conclusi\u00f3n, podemos observar que, aunque las cifras \nde mortalidad no revelen un impacto de la pandemia \nen el territorio balear, los testimonios de la \u00e9poca \nconfirman que la epidemia lleg\u00f3 a las Islas Baleres y se \npropag\u00f3 afectando a la mayor parte de sus habitantes. \nEn cualquier caso, los cuadros fueron muy leves y no \nincrementaron las cifras de fallecidos. \nDiscusi\u00f3n\nLa pandemia de gripe rusa no present\u00f3 un modelo \nde afecci\u00f3n y mortalidad homog\u00e9neo a lo largo de la \ngeograf\u00eda espa\u00f1ola. Tal y como hemos comentado, \nlas mayores tasas de mortalidad en exceso parecen \nconcentrarse en regiones industriales, que se \ncaracterizaban, en esta \u00e9poca, por presentar d\u00e9ficits \nen materias de higiene, servicios asistenciales, por \nhacinamiento, etc. Las Islas Baleares no experimentaron \nun incremento de la mortalidad a causa de la pandemia, \naunque su nivel de industrializaci\u00f3n era importante sobre \ntodo centrado en su capital la ciudad de Palma, aspecto \nque podr\u00eda ser explicado desde una doble hip\u00f3tesis: la \nno propagaci\u00f3n de la pandemia o una menor afecci\u00f3n \nde esta a las tasas de mortalidad. La primera hip\u00f3tesis \nno se sostiene ya que los testimonios m\u00e9dicos de la \n\u00e9poca estudiados en este art\u00edculo atestiguan que la \ngripe rusa lleg\u00f3 a las Islas Baleares y que la mayor parte \nde la poblaci\u00f3n se vio afectada. \nPor tanto, dado que la pandemia s\u00ed se propag\u00f3 por el \narchipi\u00e9lago y que la cronolog\u00eda de los contagios (enero \nde 1890) es similar a la observada en los territorios 156\n2022/37 (3): 152-156La pandemia de gripe rusa en las Islas Baleares (1889-1892)Josu Hernando-P\u00e9rez et al.  \npeninsulares, descartamos la posible existencia de una \ncepa del virus menos letal, debiendo buscar la causa de \nla baja mortalidad en otros factores. Los m\u00e9dicos de la \n\u00e9poca destacaron que los cuadros cl\u00ednicos observados \nrara vez revistieron gravedad y que los fallecimientos \nfueron algo extraordinario en este territorio. Las causas \nde esta diferente afecci\u00f3n pueden ser m\u00faltiples, pero \ndestaca el avanzado proceso de transici\u00f3n demogr\u00e1fica \nobservado en Baleares, tal y como se refleja en \nlas conclusiones del proyecto de investigaci\u00f3n de \nFrancesc Bujosa, Bernat Sureda, e Isabel Moll (12). \nEste territorio se encontraba en un estadio demogr\u00e1fico \nm\u00e1s avanzado, con tasas de mortalidad inferiores a las \npeninsulares sobre todo en cuanto a la mortalidad infantil \ny juvenil (Pujadas-Mora, 2009). Los habitantes baleares \ndispondr\u00edan ya de una mejor salud, que se reflejaba en \nla mayor esperanza de vida y una afecci\u00f3n m\u00e1s leve por \nlas pandemias como la gripe rusa.\nA esta m\u00e1s avanzada transici\u00f3n demogr\u00e1fica hay que \na\u00f1adirle otros factores muy relacionados con el control \nde la mortalidad: mejores condiciones higi\u00e9nicas, alimentaci\u00f3n de los habitantes, una clase m\u00e9dica \nmuy preparada para la \u00e9poca y unas infraestructuras \nsanitarias avanzadas, como la Casa de Socorro o una \nred de conventos religiosos que se preocup\u00f3 por el \ndesarrollo de normas b\u00e1sicas de higiene (Pujadas-Mora \n& Salas-Vives, 2021).\nEn cualquier caso, el resultado es claro: la pandemia \nde gripe rusa lleg\u00f3 a Baleares a finales de diciembre de \n1889, se extendi\u00f3 r\u00e1pidamente en enero del 1890 hasta \nafectar a la mayor parte de la poblaci\u00f3n y posiblemente \nalcanzar cifras cercanas a la inmunidad de reba\u00f1o \npara, posteriormente, remitir en febrero. La pandemia, \nsin embargo, no revisti\u00f3 gravedad, aspecto que los \nestudiosos de la \u00e9poca achacaban a la \u201cbenignidad \ndel clima\u201d, pero que debe estar m\u00e1s relacionado con \nla propia estructura demogr\u00e1fica balear y su avanzada \ntransici\u00f3n de la mortalidad.\nConflicto de intereses\nNinguno\nReferencias \n1. Bertillon J. La grippe a Paris et dans quelques autres villes de France \net de l\u2019\u00e9tranger en 1889-1890. Paris: Imprimerie municipale, 1892.\n2. Proust A. Sur l\u2019enqu\u00e9te concernant l\u2019\u00e9pid\u00e9mie de grippe de 1889-\n1890 en France. Bulletin de l\u2019Acad\u00e9mie de m\u00e9decine 15, 1892: 510-31 \ny 16,1892: 552-96.\n3. Garc\u00eda Ferrero S. La gripe de 1889-1890 en Madrid. Madrid: \nUniversidad Complutense, Tesis doctoral, 2017.\n4. Erkoreka A, Hernando-P\u00e9rez J, March J. La pand\u00e9mie de grippe russe au \nPays basque (1889-1892). Bulletin du Mus\u00e9e Basque 2021; 196: 99-110.\n5. Pujades Mora JM. L\u2019evoluci\u00f3 de la mortalidad infantil i juvenil a la Ciutat \nde Palma (Mallorca 1838-1960). Tesis Doctoral. Universitat de les Illes \nBalears, 2009.\n6. Fajarn\u00e9 y Tur E.  Epidemia de sarampi\u00f3n en Palma durante el a\u00f1o \n1887. Palma, Imprenta de Juan Colomar, 1888.\n7. Reher Sullivan DS. \u201cEn busca de la \u201cpena urbana\u201d explorando los \npatrones de mortalidad urbana y rural en Espa\u00f1a durante la transici\u00f3n \n1 Este autor forma parte del proyecto: El mapa de la desigualdad: las ciudades en la primera mitad del siglo XX . PID2020-116797GB-I00. Financiado por el Ministerio de \nCiencia e Innovaci\u00f3n.\n2 Jaques Bertillon (1851-1922). M\u00e9dico dem\u00f3grafo franc\u00e9s responsable de la oficina de estad\u00edstica del Ayuntamiento de Par\u00eds.\n3 Adrien Proust (1834-1903). M\u00e9dico epidemi\u00f3logo franc\u00e9s y padre del escritor Marcel Proust.\n4 Revista Balear de Ciencias M\u00e9dicas  (1\u00aa \u00e9poca, 1888-1918). Revista del Colegio M\u00e9dico-Farmac\u00e9utico de Palma (1882-1895). En la \u00e9poca que se recogen los datos \nde este trabajo era una revista quincenal.\nPara este trabajo hemos utilizado la informaci\u00f3n publicada entre los n\u00fameros aparecidos el 16 de noviembre del 1889 y el 12 junio del 1890. Los datos estad\u00edsticos de las \nenfermedades son los recogidos 30 d\u00edas antes de la aparici\u00f3n de cada n\u00famero de la revista. M\u00e1s detalles sobre el desarrollo estad\u00edstico en esta revista puede verse en: \nPujadas-Mora, J. M. (2012). La cuantificaci\u00f3n demogr\u00e1fica y epidemiol\u00f3gica en el higienismo balear, 1850-1930. Dynamis , 32(1), 165-184.\n5 Enrique Fajarnes y Tur (1858-1934). M\u00e9dico, dem\u00f3grafo y higienista. Public\u00f3 quincenalmente en la Revista Balear de Ciencias M\u00e9dicas  los datos estad\u00edsticos de las \nenfermedades reinantes. Miembro de la Real Academia de Medicina de Palma. Fue el principal difusor de la revista por todo el mundo utilizando su situaci\u00f3n de alto cargo \ndel Servicio de Correos de  Espa\u00f1a y as\u00ed se puede encontrar una colecci\u00f3n completa de la revista en la United States Library of Medecine situada en Marylan, Bethesda \nLibrary (USA). Sobre esta figura puede consultarse: Pujadas-Mora, Joana-Maria. La producci\u00f3 cient\u00edfica d\u2019Enric Fajarn\u00e9s i Tur (1858- 1934). In: Prats Garcia, Ernest; \nPujadas-Mora, Joana-Maria, eds. Enric Fajarn\u00e9s i Tur (1858-1934), entre la hist\u00f2ria i la demografia. Palma: Conselleria d\u2019Economia, Hisenda i Innovaci\u00f3. Govern de les Illes \nBalears; 2008, p. 35-78.\n6 Guillem Serra Bennssar (1844-1910). M\u00e9dico mallorqu\u00edn miembro de la Real Academia de Medicina de Palma y redactor habitual de la Revista Balear de Ciencias M\u00e9dicas .\n7 P\u00edldoras fundamentalmente de opio e ipecacuana muy usadas en los siglos XVII al XIX, adormec\u00edan a los pacientes y les produc\u00edan una gran sudoraci\u00f3n.\n8 Federico Farin\u00f3s Delhom (1851-1899). M\u00e9dico del Cuerpo de Sanidad Militar. Entre 1893 y 1896 fue director del hospital militar de Ma\u00f3. demogr\u00e1fica\u201d. Revista Internacional de Geograf\u00eda de la Poblaci\u00f3n, 2001, \np.105-12 \n8. Moll Blanes I, Salas Vives P , Pujadas-Mora JM, Canaleta Safont E. \nLa lluita per la vida: administraci\u00f3, medicina i reforma sanit\u00e0ria, Mallorca \n1820-1923. El Gall 2014.\n9. Grau Sancho P . \u201cLa historiografia de les epid\u00e8mies a Mallorca\u201d  (segles \nXIII a XIX). Gimbernat 2002; 37.\n10. Valleron AJ, Cori A, Valtat S, Meurisse S, Carrat F, Bo\u00eblle PY. \nTransmissibility and geographic spread of the 1889 influenza pandemic. \nProc Natl Acad Sci U S A. 2010;107(19):8778-81. \n11. Ramiro D, Garc\u00eda S, Casado Y, Cilek L, Chowell G. Age-specific \nexcess mortality patterns and transmissibility during the 1889\u20131890 \ninfluenza pandemic in Madrid, Spain. Annals of epidemiology 2018; 28 \n(5): 267-72.\n12. Bujosa F, Moll I, Sureda B. La avanzada transici\u00f3n demogr\u00e1fica \nen Mallorca, el caso de la mortalidad infantil. Revista de Demograf\u00eda \nHist\u00f3rica 2000; 18 (2): 125-46.157\n2022/37 (3): 157-161ORIGINAL\nDistribution of the antibiotic resistance genes amongst \nmethicillin-resistant Staphylococcus aureus  bacteria isolated \nfrom human clinical infections  \nDistribuci\u00f3n de los genes de resistencia a los antibi\u00f3ticos en las bacterias Staphylococcus \naureus resistentes a la meticilina aisladas de infecciones cl\u00ednicas humanas  \nAtiyeh Ziyaei Chamgordami1      , Hassan Momtaz1      , Noosha Zia-Jahromi2\n1. Department of Microbiology   2. Department of Biology \nShahrekord Branch, Islamic Azad University, Shahrekord, IraneISSN 2255-0569\nReceived:  8 - IV - 2022\nAccepted:  13 - IV - 2022\ndoi: 10.3306/AJHS.2022.37.03.157Corresponding author\nProf. Hassan Momtaz (Ph.D)\nFull Professor of the Department of Microbiology, Shahrekord Branch, \nIslamic Azad University, Shahrekord, Iran\nE-mail: hamomtaz@yahoo.comID ID ID\nAbstract  \nBackground:  Methicillin-resistant Staphylococcus aureus  (MRSA) strains are important causes of human clinical infections in the \nhospital environment. The present survey was performed to assess the distribution of antibiotic resistance genes amongst the \nMRSA strains isolated from human clinical infections. \nMethods:  Thirty-five MRSA strains were isolated from human clinical infection samples. All isolates were confirmed using culture, \nbiochemical tests and cefoxitin (30 \u00b5g) and oxacillin (1 \u00b5g) susceptibility testing. DNA was extracted from isolates and subjected to \nPCR for detection of antibiotic resistance genes. \nResults: Prevalence of MRSA in isolates collected from sputum, urine, pus, and blood samples was 23.68%, 26.31%, 31.57%, \nand 10.52%, respectively. MRSA bacteria harbored the highest distribution of blaZ (100%), msrA  (68.42%), and tetK (57.89%). \nDistribution of ermB  (31.57%) and aacA-D  (42.10%) antibiotic resistance genes were lower than others. Statistically significant \ndifferences were obtained between the distribution of emrA  and ermB  (P value <0.05), and msrA  and msrB  (P value <0.05). \nDistribution of ermA and msrB antibiotic resistance genes were 55.26% and 39.47%, respectively. \nConclusion:  Regarding the high prevalence of MRSA and antibiotic resistance encoding genes among isolates in the hospitals, \nspecial health-based measures should be taken to reduce the use of antibiotics and control infections in the hospital.\nKeywords:  Methicillin-resistant Staphylococcus aureus  (MRSA), antibiotic resistance genes, hospital infections, distribution.\nResumen\nAntecedentes:  Las cepas de Staphylococcus aureus  resistentes a la meticilina (SARM) son causa importante de infecciones \ncl\u00ednicas humanas en el entorno hospitalario. El presente estudio se realiz\u00f3 para evaluar la distribuci\u00f3n de los genes de resistencia \na los antibi\u00f3ticos entre las cepas de SARM aisladas de infecciones cl\u00ednicas humanas. \nM\u00e9todos:  Se aislaron 35 cepas de SARM de muestras de infecciones cl\u00ednicas humanas. Todos los aislados se confirmaron \nmediante cultivo, pruebas bioqu\u00edmicas y pruebas de susceptibilidad a la cefoxitina (30 \u00b5g) y la oxacilina (1 \u00b5g). Se extrajo el ADN \nde los aislados y se someti\u00f3 a la PCR para detectar los genes de resistencia a los antibi\u00f3ticos. \nResultados:  La prevalencia de SARM en los aislados recogidos de muestras de esputo, orina, pus y sangre fue del 23,68%, \n26,31%, 31,57% y 10,52%, respectivamente. Las bacterias MRSA albergaban la mayor distribuci\u00f3n de blaZ (100%), msrA \n(68,42%) y tetK (57,89%). La distribuci\u00f3n de los genes de resistencia a los antibi\u00f3ticos ermB  (31,57%) y aacA-D  (42,10%) fue \nmenor que la de los dem\u00e1s. Se obtuvieron diferencias estad\u00edsticamente significativas entre la distribuci\u00f3n de emrA  y ermB  (valor P \n<0,05), y msrA  y msrB  (valor P <0,05). La distribuci\u00f3n de los genes de resistencia a los antibi\u00f3ticos ermA  y msrB  fue del 55,26% \ny del 39,47%, respectivamente. \nConclusiones:  En relaci\u00f3n con la alta prevalencia de SARM y de genes codificadores de resistencia a los antibi\u00f3ticos entre los \naislados en los hospitales, deben tomarse medidas especiales de car\u00e1cter sanitario para reducir el uso de antibi\u00f3ticos y controlar \nlas infecciones en el hospital.\nPalabras clave:  Staphylococcus aureus  resistente a la meticilina (SARM), Genes de resistencia a los antibi\u00f3ticos, Infecciones \nhospitalarias.158\n2022/37 (3): 157-161Introduction \nDespite all advances created in the medical sciences, \ninfectious diseases become an important life-threating \nissue among people of developed and developing \ncountries1-8. Among them, the methicillin-resistant \nStaphylococcus aureus (MRSA) accounted for severe \ncases of infections in the hospitals and healthcare units9. \nMRSA strains are Gram-positive, catalase positive, and \ncocci-shaped bacteria originate from both hospital \nand the community10. They are mostly responsible for \nplain nosocomial and community-acquired infections, \nparticularly Respiratory Tract Infections (RTIs), soft tissue \ninfections, Urinary Tract Infection (UTIs), wound and burn \ninfections, endocarditis, blood infections, and etc11.\nMRSA strains are mainly resist toward all types of \npenicillins and cephalosporins, simultaneously12. \nTreatment of infections caused by these strains are \nmostly difficult, because they are resist toward some \nother types of antimicrobial agents13. MRSA bacteria are \nthe chief causes of around 100,000 morbidity with 20% \nmortality yearly in the United States14. MRSA bacteria \nharbored significant resistance toward penicillins, \ncephalosporins, tetracyclines, aminoglycosides, \nphenicols, fluoroquinolones, lincosamides, macrolides, \nand glycopeptides15. \nAccording to the high important of antibiotic resistant-\nMRSA strains, it is essential to signify the main source \nfor the occurrence of resistance among MRSA strains. \nSome researches showed the role of antibiotic resistance \ngenes for the occurrence of antibiotic resistance among \nbacterial strains16. In this regard, tet ( K and M), aacA-D , \nblaZ, erm  (A, B, and C), and msr (A and B) are the genes \nthat responsible for the occurrence of resistance against \ntetracyclines, aminoglycosides, penicillins, macrolides, \nand macrolides antimicrobial agents, respectively17. \nMRSA strains have been tested in hospital infections \nto assess their role as a definitive cause of nosocomial \ninfections. High pathogenicity of MRSA strains and \ngeneral weakness of hospitalized patients make it \nnecessary to assess their antimicrobial resistance in \nhuman clinical infections. Thus, the present survey was \ndone to assess the prevalence rate and distribution of \nantibiotic resistance genes amongst the MRSA strains \nisolated from human clinical infections.\nMaterials and methods \nBacterial strains and confirmation\nThirty-five MRSA strains were isolated from different \nhuman clinical specimens. Strains were isolated from \nAl-Zahra and Shariati Hospitals, Isfahan, Iran. For \nconfirmation, all isolates were cultured in blood agar (BA, \nMerck, Darmstadt, Germany) and incubated aerobically at 37\u00b0C for 48 h. Additionally, colonies were subjected \nto morphological analysis including Gram-staining, \nmicroscopical morphology, catalase and coagulase \nproduction tests. Furthermore, pigment production, \nglucose O/F test, resistance to bacitracin (0.04 U) and \nnovobiocin, oxidase test, mannitol fermentation on \nMannitol Salt Agar (MSA, Merck, Darmstadt, Germany), \nnitrate reduction, phosphatase, urease activity, \ndeoxyribonuclease (DNase) test and carbohydrate \n(sucrose, xylose, maltose, trehalose, mannose, lactose, \nand fructose) fermentation tests were applied to confirm \nisolates (18). For MRSA identification, cefoxitin (30 \u00b5g) \nand oxacillin (1 \u00b5g) susceptibility testing was performed18.\nDNA extraction and quality assessment\nMRSA isolates were sub-cultured on TSB media and \nfurther incubated for 48 h at 37\u00baC. Genomic DNA \nwas extracted from bacterial colonies using the DNA \nextraction kit (Thermo Fisher Scientific, St. Leon-Rot, \nGermany) according to manufacturer\u2019s instruction. Purity \n(A260/A280) and concentration of extracted DNA were \nthen checked (NanoDrop, Thermo Scientific, Waltham, \nMA, USA). The quality of the DNA was assessed on a 2% \nagarose gel stained with ethidium bromide (0.5 \u03bcg/mL) \n(Thermo Fisher Scientific, St. Leon-Rot, Germany)19-25.\nDetection of antibiotic resistance genes\nTable I  represents the list of primers and PCR conditions \nused for amplification of antibiotic resistance genes in \nthe MRSA strains. A programmable DNA thermo-cycler \n(Eppendorf Mastercycler 5330, Eppendorf-Nethel-\nHinz GmbH, Hamburg, Germany) was used in all PCR \nreactions. Ten microliters of PCR product were exposed \nto electrophoresis in a 2% agarose gel in 1X TBE buffer at \n80 V for 30 min, stained with SYBR Green. The UVI doc \ngel documentation systems (Grade GB004, Jencons \nPLC, London, UK) was applied for analysis of images26.\nData analysis\nStatistical analysis was done using the SPSS 21.0 \nstatistical software (SPSS Inc., Chicago, IL, USA). Chi-\nsquare test and Fisher\u2019s exact two-tailed test were used \nto assess any significant relationship between data \nobtained from the present study. P value <0.05 was \nconsidered as statistical significant level27,28. \nResults \nAmong all 38 isolates, sputum, urine, pus, and blood \nsamples were harbored 9 (23.68%), 10 (26.31%), 12 \n(31.57%), and 4 (10.52%) MRSA isolates, respectively. \nTable II  shows the distribution of antibiotic resistance \ngenes amongst the MRSA strains isolated from human \nclinical infections. According to obtained data, MRSA \nbacteria harbored the highest distribution of blaZ (100%), \nmsrA  (68.42%), and tetK (57.89%). Distribution of ermB  Atiyeh Ziyaei Chamgordami et al.  159\n2022/37 (3): 157-161Distribution of the antibiotic resistance genes amongst methicillin-resistant Staphylococcus aureus bacteria isolated from human clinical infections\n(31.57%) and aacA-D  (42.10%) antibiotic resistance \ngenes were lower than others. Statistically significant \ndifferences were obtained between the distribution of \nemrA  and ermB  (P value <0.05), and msrA  and msrB  \n(P value <0.05). Distribution of ermA  and msrB  antibiotic \nresistance genes were 55.26% and 39.47%, respectively.\nDiscussion \nS. aureus  is considered as an important bacterium \nresponsible for hospital infections and food poisoning29-32. \nThe most important issue regarding infections caused by \nMRSA strains is the occurrence of antibiotic resistance \nin bacterial strains. High resistance rate of the MRSA \nstrains harden the procedure of treatment and faced \npatients with high economic burden. Thus, it is essential to found all epidemiological aspects of MRSA infections \nin the hospital environment.\nOne of the most important epidemiological aspects of \nthe MRSA strains is presence of antibiotic resistance \ngenes amongst the bacteria. The present survey \nshowed that human clinical infections harbored the \nhigh distribution of MRSA strains harbored antibiotic \nresistance genes. Widespread and unauthorized \nadministration of antimicrobials and excessive using of \ndisinfectant solutions in hospital environment have been \nconsidered to be a major factor in the emergence of \nantibiotic resistance amongst MRSA strains. \nHigh prevalence of resistance of MRSA bacteria \nisolated from diverse kinds of clinical infectious \nTable II: Distribution of antibiotic resistance genes amongst the MRSA strains isolated from human clinical infections.\nClinical specimens)   N. isolates harbored each gene (%)\n(N. MRSA aacA-D tetK balZ ermA ermB msrA msrB\nSputum (9) 4 (44.44) 5 (55.55) 9 (100) 5 (55.55) 2 (22.22) 6 (66.66) 3 (33.33)\nUrine (10)  5 (50) 6 (60) 10 (100) 6 (60) 4 (40) 7 (70) 4 (40)\nPus (12)  6 (50) 9 (75) 12 (100) 8 (66.66) 5 (41.66) 10 (83.33) 6 (50)\nBlood (4)  1 (25) 2 (50) 4 (100) 2 (50) 1 (25) 3 (75) 2 (50)\nTotal (38)  16 (42.10) 22 (57.89) 38 (100) 21 (55.26) 12 (31.57) 26 (68.42) 15 (39.47)Table I: Target genes, oligonucleotide primers and PCR conditions used for detection of antibiotic resistance genes amongst MRSA strains.\nTarget gene Primer sequence (5\u2019-3\u2019) PCR product (bp) PCR programs PCR volume (50\u00b5L)\nAacA-D F: TAATCCAAGAGCAATAAGGGC  1 cycle:\n R: GCCACACTATCATAACCACTA 227 94 0C ------------ 5 min. 5 \u00b5L PCR buffer 10X\nermA F: AAGCGGTAAACCCCTCTGA 190 25 cycles: 1.5 mM Mgcl2\n R: TTCGCAAATCCCTTCTCAAC  94 0C ------------ 60 s\n   55 0C ------------ 70 s 200 \u00b5M dNTP\ntetK F: GTAGCGACAATAGGTAATAGT 360 72 0C ------------ 60 s\n R: GTAGTGACAATAAACCTCCTA  1 cycle: 0.5 \u00b5M of each primers F & R\n   72 0C ------------ 10 min \nermB  F: CCGTTTACGAAATTGGAACAGGTAAAGGGC 359  1.25 U Taq DNA polymerase\n R: GAATCGAGACTTGAGTGTGC\n    2.5 \u00b5L DNA template\nmsrA F: GGCACAATAAGAGTGTTTAAAGG 940 1 cycle:\n R: AAGTTATATCATGAATAGATTGTCCTGTT  94 0C ------------ 6 min. 5 \u00b5L PCR buffer 10X\n   34 cycles: 2 mM Mgcl2\n   95 0C ------------ 60 s \n   50 0C ------------ 70 s 150 \u00b5M dNTP\n   72 0C ------------ 70 s\nmsrB  F: TATGATATCCATAATAATTATCCAATC 595  0.75 \u00b5M of each primers F & R\n R: AAGTTATATCATGAATAGATTGTCCTGTT  1 cycle:\n   72 0C ------------ 8 min 1.5 U Taq DNA polymerase\n \n    3 \u00b5L DNA template\n \n blaZ F: TGAACCGTATGTTAGTGC 681 1 cycle: 5 \u00b5L PCR buffer 10X\n R: GTCGTGTTAGCGTTGATA  94 0C ------------ 6 min. \n    2 mM Mgcl2\n   30 cycles: \n    150 \u00b5M dNTP\n   95 0C ------------ 60 s\n   59 0C ------------ 60 s 0.75 \u00b5M of each primers F & R\n   72 0C ------------ 60 s\n    1.5 U Taq DNA polymerase\n   1 cycle:\n   72 0C ------------ 10 min 3 \u00b5L DNA template160\n2022/37 (3): 157-161specimens have been described toward penicillins \n(33-38), cephalosporins33-35,39, tetracyclines33-35,40, \nmacrolides33-35,41, and aminoglycosides33-35,42. \nAbdolmaleki et al. (2019)43 reported that BlaZ, aacA-D, \ntetK, msrA, dfrA, ermA, gyrA, grlA  and rpoB were the \nmost commonly detected antibiotic resistance genes \namongst the MRSA strains with a distribution rate \nbetween 11 to 100%. Rahi et al. (2020)44 reported that \nthe most frequently distinguished antibiotic resistance \nmarkers were blaZ (100%), tetK (85.71%), dfrA1  \n(71.42%), aacA-D  (67.85%), ermA  (50%) and gyrA \n(42.85%). Akanbi et al. (2017)45 reported that blaZ, \nmecA, rpoB, ermB  and tetM were the most generally \nidentified antibiotic resistance genes amongst the S. \naureus  bacteria recovered from food samples in South \nAfrica which was relatively similar to our findings. In this \nregard, Momtaz and Hafezi (2014)46 reported that the \ndistribution of mecA, tetK, ermA, ermC, tetM, aacA-D, \nlinA, msrA, vatA, vatC  and vatB antibiotic resistance genes in the  S. aureus  strains isolated from human \nclinical infections were 80.30%, 34.84%, 30.30%, \n25.75%, 24.24%, 19.69%, 7.57%, 7.57%, 6.06%, \n3.03% and 1.51%, respectively.\nConclusion \nSum it up, we recognized boost incidence of MRSA \nbacteria in human clinical infections on top of boost \nincidence of the genes encode resistance toward \nantibiotic agents. High prevalence of MRSA bacteria and \nhigh distribution of blaZ, tetK, aacA-D ermA  and msrA  \nantibiotic resistant genes may pose a possible menace \nregarding the MRSA human infections in hospitals.\nInterests conflict \nThe authors declare no conflict of interest.\nReferences\n1. Ranjbar R, Mahmoodzadeh Hosseini H, Safarpoor Dehkordi F. A \nreview on biochemical and immunological biomarkers used for laboratory \ndiagnosis of SARS-CoV-2 (COVID-19). The Open Microbiology Journal. \n2020 Dec 15;14(1).\n2. Sheikhshahrokh A, Ranjbar R, Saeidi E, Dehkordi FS, Heiat M, \nGhasemi-Dehkordi P , Goodarzi H. Frontier therapeutics and vaccine \nstrategies for sars-cov-2 (COVID-19): A review. Iranian Journal of Public \nHealth. 2020 Oct;49(Suppl 1):18.\n3. Mirzaie A, Halaji M, Dehkordi FS, Ranjbar R, Noorbazargan H. A \nnarrative literature review on traditional medicine options for treatment \nof corona virus disease 2019 (COVID-19). Complementary therapies in \nclinical practice. 2020 Aug 1;40:101214.\n4. Halaji M, Farahani A, Ranjbar R, Heiat M, Dehkordi FS. Emerging \ncoronaviruses: first SARS, second MERS and third SARS-CoV-2: \nepidemiological updates of COVID-19. Infez Med. 2020;28(suppl):6-17.\n5. Mashak Z, Jafariaskari S, Alavi I, Shahreza MS, Dehkordi FS. Phenotypic \nand genotypic assessment of antibiotic resistance and genotyping of vacA, \ncagA, iceA, oipA, cagE, and babA2 alleles of Helicobacter pylori bacteria \nisolated from raw meat. Infection and drug resistance. 2020;13:257.\n6. Dehkordi FS. Prevalence study of Bovine viral diarrhea virus by evaluation \nof antigen capture ELISA and RT-PCR assay in Bovine, Ovine, Caprine, \nBuffalo and Camel aborted fetuses in Iran. AMB express. 2011 Dec;1(1):1-6.\n7. Rahimi E, Yazdanpour S, Dehkordi FS. Detection of Toxoplasma gondii \nantibodies in various poultry meat samples using enzyme linked immuno \nsorbent assay and its confirmation by polymerase chain reaction. J Pure \nAppl Microbiol. 2014;8(1):421-7.\n8. Dehkordi FS, Saberian S, Momtaz H. Detection and segregation of \nBrucella abortus and Brucella melitensis in Aborted Bovine, Ovine, \nCaprine, Buffaloes and Camelid Fetuses by application of conventional \nand real-time polymerase chain reaction. The Thai Journal of Veterinary \nMedicine. 2012 Mar 1;42(1):13.\n9. Mart\u00ed M, Tu\u00f1\u00f3n-Molina A, Aachmann FL, Muramoto Y, Noda T, \nTakayama K, Serrano-Aroca \u00c1. Protective face mask filter capable of \ninactivating SARS-CoV-2, and methicillin-resistant Staphylococcus aureus and Staphylococcus epidermidis. Polymers. 2021 Jan;13(2):207.\n10. Mitevska E, Wong B, Surewaard BG, Jenne CN. The Prevalence, \nRisk, and Management of Methicillin-Resistant Staphylococcus aureus \nInfection in Diverse Populations across Canada: A Systematic Review. \nPathogens. 2021 Apr;10(4):393.\n11. Jaradat ZW, Ababneh QO, Sha\u2019aban ST, Alkofahi AA, Assaleh D, Al \nShara A. Methicillin Resistant Staphylococcus aureus and public fomites: \na review. Pathogens and Global Health. 2020 Nov 16;114(8):426-50.\n12. Grema HA, Geidam YA, Gadzama GB, Ameh JA, Suleiman A. \nMethicillin resistant Staphylococcus aureus (MRSA): a review. Adv Anim \nVet Sci. 2015;3(2):79-98.\n13. Purrello SM, Garau J, Giamarellos E, Mazzei T, Pea F, Soriano A, \nStefani S. Methicillin-resistant Staphylococcus aureus infections: a review \nof the currently available treatment options. Journal of Global Antimicrobial \nResistance. 2016 Dec 1;7:178-86.\n14. Klevens RM, Morrison MA, Nadle J, Petit S, Gershman K, Ray S, et \nal. Invasive methicillin-resistant Staphylococcus aureus infections in the \nUnited States. JAMA. 2007;298:1763-71.\n15. Hasanpour Dehkordi A, Khaji L, Sakhaei Shahreza MH, Mashak Z, \nSafarpoor Dehkordi F, Safaee Y, Hosseinzadeh A, Alavi I, Ghasemi E, \nRabiei-Faradonbeh M. One-year prevalence of antimicrobial susceptibility \npattern of methicillin-resistant Staphylococcus aureus recovered from raw \nmeat. Trop Biomed. 2017;34(2):396-404.\n16. Otarigho B, Falade MO. Analysis of antibiotics resistant genes in different \nstrains of Staphylococcus aureus. Bioinformation. 2018;14(3):113.\n17. Li SM, Zhou YF, Li L, Fang LX, Duan JH, Liu FR, et al. Characterization \nof the multi-drug resistance gene cfr in methicillin-resistant Staphylococcus \naureus (MRSA) strains isolated from animals and humans in China. \nFrontiers in microbiology. 2018 Nov 27;9:2925.\n18. Dehkordi FS, Gandomi H, Basti AA, Misaghi A, Rahimi E. Phenotypic \nand genotypic characterization of antibiotic resistance of methicillin-\nresistant Staphylococcus aureus isolated from hospital food. Antimicrobial \nResistance & Infection Control. 2017 Dec;6(1):1-1.Atiyeh Ziyaei Chamgordami et al.  161\n2022/37 (3): 157-161Distribution of the antibiotic resistance genes amongst methicillin-resistant Staphylococcus aureus bacteria isolated from human clinical infections\n19. Dehkordi FS, Khamesipour F, Momeni M. Brucella abortus and \nBrucella melitensis in Iranian bovine and buffalo semen samples: The first \nclinical trial on seasonal, Senile and geographical distribution using culture, \nconventional and real-time polymerase chain reaction assays. Kafkas Univ \nVet Fak Dergisi. 2014;20(6):821-.\n20. Dehkordi FS, Valizadeh Y, Birgani TA, Dehkordi KG. Prevalence study \nof Brucella melitensis and Brucella abortus in cow\u2019s milk using dot enzyme \nlinked immuno sorbent assay and duplex polymerase chain reaction. J \nPure Appl Microbiol. 2014;8(2):1065-9.\n21. Ghorbani F, Gheisari E, Dehkordi FS. Genotyping of vacA alleles \nof Helicobacter pylori strains recovered from some Iranian food items. \nTropical Journal of Pharmaceutical Research. 2016 Sep 5;15(8):1631-6.\n22. Ranjbar R, Seif A, Dehkordi FS. Prevalence of antibiotic resistance \nand distribution of virulence factors in the shiga toxigenic Escherichia \ncoli recovered from hospital food. Jundishapur Journal of Microbiology. \n2019;12(5):8.\n23. Ranjbar R, Yadollahi Farsani F, Safarpoor Dehkordi F. Antimicrobial \nresistance and genotyping of vacA, cagA, and iceA alleles of the \nHelicobacter pylori strains isolated from traditional dairy products. Journal \nof Food Safety. 2019 Apr;39(2):e12594.\n24. Dehkordi FS. Prevalence study of Coxiella burnetii in aborted ovine \nand caprine fetuses by evaluation of nested and real-time PCR assays. \nAmerican Journal of Animal and Veterinary Sciences. 2011.\n25. Dehkordi FS, Momtaz H, Doosti A. Application of Real-Time PCR for \ndetection of Aspergillus species in aborted ruminant foetuses. Bulg. J. Vet. \nMed. 2012 Mar 1;15(1):30-6.\n26. Abdolmaleki Z, Mashak Z, Safarpoor Dehkordi F. Molecular and \nvirulence characteristics of methicillin-resistant Staphylococcus aureus \nbacteria recovered from hospital cockroaches. Jundishapur Journal of \nMicrobiology. 2019 Dec 31;12(12).\n27. Dehkordi FS, Tirgir F, Valizadeh Y. Effects of Guajol\u00ae ointment \nsynthesized from medicinal smoke condensate of jennet feces on burn \nwound healing on Wistar rat. InVeterinary Research Forum 2017 (Vol. 8, \nNo. 3, p. 215). Faculty of Veterinary Medicine, Urmia University, Urmia, \nIran.\n28. Ranjbar R, Dehkordi FS, Heiat M. The frequency of resistance genes in \nSalmonella enteritidis strains isolated from cattle. Iranian Journal of Public \nHealth. 2020 May;49(5):968.\n29. Momtaz H, Dehkordi FS, Rahimi E, Asgarifar A, Momeni M. Virulence \ngenes and antimicrobial resistance profiles of Staphylococcus aureus \nisolated from chicken meat in Isfahan province, Iran. Journal of Applied \nPoultry Research. 2013 Dec 1;22(4):913-21.\n30. Madahi H, Rostami F, Rahimi E, Dehkordi FS. Prevalence of \nenterotoxigenic Staphylococcus aureus isolated from chicken nugget in \nIran. Jundishapur journal of microbiology. 2014 Aug;7(8).\n31. Momeni Shahraki M, Shakerian A, Rahimi E, Safarpoor Dehkordi \nF. Study the frequency of enterotoxin encoding genes and antibiotic \nresistance pattern of methicillin-resistant Staphylococcus aureus isolated \nfrom vegetable and salad samples in Chaharmahal Va Bakhtiari province. \nJournal of Food Microbiology. 2020 Jun 21;7(2):55-69.\n32. Madahi H, Rostami F, Rahimi E, Safarpoor Dehkordi F, Jalali M. \nDetection of classical enterotoxins of Staphylococcus aureus isolates \nfrom chicken nugget and ready to eat foods in Esfahan province by ELISA \ntechnique. Food Hygiene. 2013;3(11):1-10.\n33. Dormanesh B, Siroosbakhat S, Darian EK, Afsharkhas L. Methicillin-\nresistant Staphylococcus aureus isolated from various types of hospital infections in pediatrics: Panton-Valentine leukocidin, staphylococcal \nchromosomal cassette mec SCCmec phenotypes and antibiotic resistance \nproperties. Jundishapur journal of microbiology. 2015 Nov;8(11).\n34. Abubakar U, Sulaiman SA. Prevalence, trend and antimicrobial \nsusceptibility of Methicillin Resistant Staphylococcus aureus in Nigeria: \na systematic review. Journal of infection and public health. 2018 Nov \n1;11(6):763-70.\n35. Vicetti Miguel CP , Mejias A, Leber A, Sanchez PJ. A decade of \nantimicrobial resistance in Staphylococcus aureus: A single center \nexperience. PLoS One. 2019 Feb 12;14(2):e0212029.\n36. Liang Y, Tu C, Tan C, El-Sayed MA. Antimicrobial resistance, \nvirulence genes profiling and molecular relatedness of methicillin-resistant \nStaphylococcus aureus strains isolated from hospitalized patients in \nGuangdong Province, China. Infection and drug resistance. 2019;12:447.\n37. Gitau W, Masika M, Musyoki M, Museve B, Mutwiri T. Antimicrobial \nsusceptibility pattern of Staphylococcus aureus isolates from clinical \nspecimens at Kenyatta National Hospital. BMC research notes. 2018 \nDec;11(1):1-5.\n38. Jafari-Sales A, Farhadi F, Ezdiyadi M, Tarbiat-Nazloo D. Study of \nantibiotic resistance pattern in methicillin-resistant Staphylococcus aureus \nisolated from clinical samples of hospitals in Tabriz\u2013Iran. International \nJournal of Biomedicine and Public Health. 2018 Apr 27;1(2):71-5.\n39. Nicolau DP , Silberg BN. Cefazolin potency against methicillin-resistant \nStaphylococcus aureus: a microbiologic assessment in support of a novel \ndrug delivery system for skin and skin structure infections. Infection and \ndrug resistance. 2017;10:227.\n40. Hau SJ, Haan JS, Davies PR, Frana T, Nicholson TL. Antimicrobial \nresistance distribution differs among methicillin resistant Staphylococcus \naureus sequence type (ST) 5 isolates from health care and agricultural \nsources. Frontiers in microbiology. 2018 Sep 11;9:2102.\n41. Saba CK, Amenyona JK, Kpordze SW. Prevalence and pattern of \nantibiotic resistance of Staphylococcus aureus isolated from door handles \nand other points of contact in public hospitals in Ghana. Antimicrobial \nResistance & Infection Control. 2017 Dec;6(1):1-6.\n42. Hauschild T, Sacha P , Wieczorek P , Zalewska M, Kaczy\u0144ska  K, \nTryniszewska E. Aminoglycosides resistance in clinical isolates of \nStaphylococcus aureus from a University Hospital in Bialystok, Poland. \nFolia Histochemica et Cytobiologica. 2008;46(2):225-8.\n43. Abdolmaleki Z, Mashak Z, Dehkordi FS. Phenotypic and genotypic \ncharacterization of antibiotic resistance in the methicillin-resistant \nStaphylococcus aureus strains isolated from hospital cockroaches. \nAntimicrobial Resistance & Infection Control. 2019 Dec;8(1):1-4.\n44. Rahi A, Kazemeini H, Jafariaskari S, Seif A, Hosseini S, Dehkordi FS. \nGenotypic and phenotypic-based assessment of antibiotic resistance and \nprofile of staphylococcal cassette chromosome mec in the methicillin-\nresistant Staphylococcus aureus recovered from raw milk. Infection and \ndrug resistance. 2020;13:273. \n45. Akanbi OE, Njom HA, Fri J, Otigbu AC, Clarke AM. Antimicrobial \nsusceptibility of Staphylococcus aureus isolated from Recreational waters \nand beach sand in Eastern Cape province of south Africa. Int J Environ \nRes Publ Health. 2017;14(9):1001.\n46. Momtaz H, Hafezi L. Meticillin-resistant Staphylococcus aureus isolated \nfrom Iranian hospitals: virulence factors and antibiotic resistance properties. \nBosnian journal of basic medical sciences. 2014 Nov;14(4):219.162\n2022/37 (3): 162-165ORIGINAL\nGeneralized anxiety disorder among \nsaudi university medical students\nTrastorno de ansiedad generalizada en estudiantes de universitarios saud\u00edes\nElsadig Y. Mohamed\nAssociate professor, Department of Community Medicine, College of Medicine, Majmaah University, Saudi ArabiaeISSN 2255-0569\nReceived:  10 - IV - 2022\nAccepted:  15 - IV - 2022\ndoi: 10.3306/AJHS.2022.37.03.162Corresponding author\nElsadig Y. Mohamed\nE-mail: elsadigoo@outlook.com / ey.mohamed@mu.edu.sa\nAbstract  \nBackground:  Generalized Anxiety Disorder is a common mental health problem associated with high morbidity and mortality. \nThe disorder is highly prevalent among undergraduate medical students. The objectives of the current study were to determine \nthe prevalence of Generalized Anxiety Disorder and its relation to socio-demographic characteristics among medical students at \nMajmaah University, Saudi Arabia. \nMethods:  This is a cross-sectional study conducted on medical students at the Medical Colleges of Majmaah University, Saudi \nArabia. The colleges were Colleges of Medicine, Dentistry, and Applied Medical Sciences. The medical students of both sexes who \nwere registered for the current academic year performed the sample frame of the study. The sample was calculated as 369. The \ndata collection was performed by a pre-tested questionnaire. The data analysis was performed using SPSS version 24.  \nResults: Students with mild, moderate, and severe Generalized Anxiety Disorder were 49.6%, 21.7%, and 13.8% respectively. \nMale students who had mild, moderate, and severe GAD were 55.4%, 17.4%, and 7.1 % respectively. Female students who \nhad mild, moderate, and severe GAD were 47.0%, 24.9%, and 15.1% respectively. Students of the College of Medicine who \nhad severe Generalized Anxiety Disorder were 14.7%. Students of the College of Dentistry and the College of Applied Medicine \nSciences who had severe GAD were 6.3% and 5.6% respectively. \nConclusion:  Generalized Anxiety Disorder among medical students at Majmaah University, Saudi Arabia is high and the severe \nform of the disease is higher compared with other studies. The rate of the disorder is higher in females than male students.\nKeywords:  Generalized anxiety disorder, medical students.\nResumen\nAntecedentes:  El Trastorno de Ansiedad Generalizada es un problema de salud mental com\u00fan asociado a una alta morbilidad y \nmortalidad. Este trastorno tiene una alta prevalencia entre los estudiantes de medicina. Los objetivos del presente estudio fueron \ndeterminar la prevalencia del Trastorno de Ansiedad Generalizada y su relaci\u00f3n con las caracter\u00edsticas sociodemogr\u00e1ficas entre los \nestudiantes de medicina de la Universidad de Majmaah, Arabia Saud\u00ed. \nM\u00e9todos:  Se trata de un estudio transversal realizado en estudiantes de medicina de las facultades de medicina de la Universidad \nde Majmaah (Arabia Saud\u00ed). Las facultades eran las de Medicina, Odontolog\u00eda y Ciencias M\u00e9dicas Aplicadas. Los estudiantes \nde medicina de ambos sexos inscritos en el curso acad\u00e9mico actual constituyeron el marco muestral del estudio. La muestra se \ncalcul\u00f3 en 369. La recogida de datos se realiz\u00f3 mediante un cuestionario previamente probado. El an\u00e1lisis de los datos se realiz\u00f3 \ncon el programa SPSS versi\u00f3n 24.\nResultados:  Los estudiantes con Trastorno de Ansiedad Generalizada leve, moderado y grave fueron el 49,6%, el 21,7% y el \n13,8% respectivamente. Los estudiantes varones que presentaban un TAG leve, moderado y grave eran el 55,4%, el 17,4% y \nel 7,1% respectivamente. Las alumnas que presentaban un TAG leve, moderado y grave eran el 47,0%, el 24,9% y el 15,1%, \nrespectivamente. Los estudiantes de la Facultad de Medicina que presentaban un trastorno de ansiedad generalizada grave eran \nel 14,7%. Los estudiantes de la Facultad de Odontolog\u00eda y de la Facultad de Ciencias M\u00e9dicas Aplicadas que padec\u00edan TAG grave \neran el 6,3% y el 5,6% respectivamente. \nConclusiones:  El Trastorno de Ansiedad Generalizada entre los estudiantes de medicina de la Universidad de Majmaah (Arabia \nSaud\u00ed) es elevado y la forma grave de la enfermedad es mayor en comparaci\u00f3n con otros estudios. La tasa del trastorno es mayor \nen las mujeres que en los estudiantes varones.\nPalabras clave:  Trastorno de ansiedad generalizada, estudiantes de medicina.ID163\n2022/37 (3): 162-165Generalized anxiety disorder among saudi university nedical students\nIntroduction\nGeneralized Anxiety Disorder is a mental condition \ncharacterized by excessive or unrealistic anxiety \nabout two or more aspects of life such as work, social \nrelationships, and financial matters. The condition is \noften accompanied by symptoms such as palpitations, \nshortness of breath, or dizziness. Extreme worrying \nalmost every day for six months or more may suggest \ngeneralized anxiety disorder1.\nGeneralized Anxiety is associated with high morbidity \nand mortality. According to a report by the World Health \nOrganization, about 264 million people live with anxiety \ndisorder2. Mental disorders are increasing in the East \nMediterranean Region (EMR), Generalized disorders rank \nnumber two after Depression as a cause of mental illness \nin the region.3 It was estimated that the prevalence of the \ncondition is 10.4% and females have a higher prevalence \ncompared to males4. The average age of GAD onset \nis the typical college age ranging from 18 to 24 years, \n75 percent of all individuals with an anxiety disorder will \nexperience symptoms before the age of 22 years5.\nThe estimated prevalence of generalized anxiety disorder \nfor undergraduate students is 15.6%. Studies showed \nthat students with financial constraints were at higher \nrisk for anxiety disorders6. The medical field is one of the \nmost demanding undergraduate degrees, and mental \nhealth problems are more frequently encountered among \nmedical students than is generally recognized. Anxiety \ndisorder is one of the issues frequently addressed in the \nmedical education field7.\nIn Medical college life students experience different types \nof stress such as new lifestyle, exposure to new cultures, \ndifficult lessons, language barriers, quizzes, and exams. \nIf students are not adequately prepared to cope with the \nnew challenges of a college environment, they could easily \nbecome susceptible to many psychological disorders \nincluding anxiety. In college life, competition is more \nsignificant and there is continuous pressure on students \nto do better and the demands usually come from family \nand the student8. It is more likely for medical students to \ndevelop generalized anxiety disorder due to the fact that \nthey tend to link symptoms and signs of serious medical \nconditions they are studying with body sensations9. \nThe objectives of the current study were to determine \nthe prevalence of Generalized Anxiety Disorder among \nmedical students at the Medical Colleges of Majmaah \nUniversity, Saudi Arabia and to determine its relationship \nto socio-demographic characteristics.\nMaterials and methods\nThis is a cross-sectional study conducted among \nmedical students at the Medical Colleges, Majmaah University, Saudi Arabia. The colleges were the College \nof Medicine, the College of Dentistry, and the College of \nApplied Medical Sciences (AMS). The medical students \nof both sexes registered for the current academic year \nperformed the sample frame of this study. The size of the \nsample, which was calculated as 369, was collected by \nstratified sampling. \n \nThe data collection was performed by a pre-tested \nquestionnaire after acquiring the ethics approval from \nMajmaah University IRB. Informed consent was obtained \nfrom the students. Cronbach\u2019s alpha was employed to \nconfirm the reliability of the questionnaire. The reliability \nof the questionnaire was Cronbach\u2019s alpha = 0.835. \nThe questionnaire included questions related to socio-\ndemographic characteristics of the sample and questions \nto determine the presence or absence of Generalized \nAnxiety Disorder. The pretest of the questionnaire \nwas conducted on medical students at the College of \nApplied Medical Sciences at Qassim University. The \nrevision took place for ambiguous and difficult questions. \nGeneralized Anxiety Disorder Assessment (GAD-7) was \nused to assess GAD. The GAD-7 score is calculated \nby assigning scores of 0, 1, 2, and 3, to the response \ncategories of \u2018not at all, \u2018several days\u2019, \u2018more than half the \ndays\u2019, and \u2018nearly every day, respectively. A summation \nof the scores for the seven questions took place. Scores \nof 5, 10, and 15 are taken as the cut-off points for mild, \nmoderate, and severe anxiety, respectively. Data analysis \nwas conducted using SPSS version 24. The Chi-square \ntest was used to compare qualitative data. The p-value of \nless than 0.05 was considered significant. \nResults\nTable I  shows the social characteristics of the sample. \nFemale and male students were 50.1% and 49.1% \nrespectively. Students from colleges of Medicine, \nDentistry and Applied Medical\nTable II  shows the response to some questions related to \nGeneralized Anxiety Disorder. One hundred and sixty-eight \n(45.5%) of the students were not aware of their dryness \nof mouth while 26.5% and 10.3% had some degree and \nvery much degree of awareness. Two hundred and ten \n(56.9%) students experienced breathing difficulty while \n20.7% and 11.4% showed some degree and very much \nTable I: Gender and college distribution of the students.\nSciences were 59.1%, 21.7% and 19.2% respectivelyItem Frequency %\nGender\nFemale 185 50.1\nMale 184 49.9\nTotal 369 100.0\nCollege\nMedicine 218 59.1\nDentistry 80 21.7\nApplied Medical Sciences 71 19.2\nTotal 369 100164\n2022/37 (3): 162-165Elsadig Y . Mohamed et al.  \ndegree of breathing difficulty. One hundred and eighty \n(49.0%) students were aware of the action of their hearts \nin the absence of physical exertion while 22.6%,13.9%, \nand 14.4% had some degree, considerable degree, and \nvery much consideration of awareness respectively. Two \nhundred and five students (55.7%) feel scared without \nany good reason while 20.1%, 10.3%, and 13.9% show \nsome degree, considerable degree, and very much \ndegree of scaring without reason.\nTable III  shows the relation between Generalized Anxiety \nDisorder and social characteristics. Male students who \nhad mild, moderate, and severe GAD were 55.4%, \n17.4%, and 7.1 % respectively. Female students who \nhad mild, moderate, and severe GAD were 47.0%, \n24.9%, and 15.1 % respectively.\nDiscussion\nThis study was conducted to determine the level of \nGeneralized Anxiety Disorder among 369 students of \nMajmaah University, Saudi Arabia. Three hundred and \nfourteen students (85.1%) had simple, moderate and, \nsevere GAD. This rate is higher compared with the rate \nof the disorder among medical students in different parts \nof the world: 45.3% in Nepal10, 66% in Turkey11, 25% in \nSpain12, and 62.4% in Egypt13. This rate of Generalized \nanxiety disorder is also higher than the findings of \nstudies conducted among medical students in Saudi \nArabia which found that 17% and 31.7% of students \nwere suffering from the disease2,14. Our study revealed \nthat 13.8% of students had a severe level of GAD. This \nfinding is lower than the finding of a study conducted \nin Saudi Arabia which found that 14.3% of the students \nhad a severe form of the disorder14. Our finding is higher than that reported among medical students in Taibah \nUniversity, Saudi Arabia in which only 4% of the students \nwere suffering from the severe form of the disease15. \nOur study found that the rate of GAD is higher among \nfemales compared to male students (87.0% and 79.9%, \np= 0.008). This is finding is consistent with studies \nconducted among Turkish, Spanish, and Egyptian \nmedical students11-13. This finding is also consistent with \nstudies conducted among medical students in different \nparts of Saudi Arabia14,16,17.\nThe prevalence of Generalized Anxiety Disorder is higher \namong the students of the College of Dentistry followed \nby the students of the College of Medicine. The students \nof the Applied Medical Sciences had the least level of \nGAD (86.2%, 83.0%, 81.7%; p=0.063), but the relation \nbetween the prevalence of GAD and type of college is \nnot significant.\nThis finding is consistent with a study conducted in \nKSA, which showed that the students of the College \nof Medicine reported lower levels of anxiety compared \nto students from the College of Dentistry: However, \nduring their clinical rotations, the students of the College \nof Medicine used to have higher levels of Generalized \nAnxiety Disorder18.\nConclusion\nThis study concluded that Generalized Anxiety Disorder \namong medical students at Majmaah University, Saudi \nArabia is high and the severe form of the disease Table II: Generalized Anxiety Disorder among university students.\n No Some degree Considerable degree V. much   \nItem n (%) n (%) n (%) n (%)\nI was aware of dryness of my mouth  168(45.5) 98(26.6) 65(17.6) 38(10.3)\nI experienced breathing difficulty  210(56.9) 77(20.7) 40(10.8) 42(11.4)\nI experienced trembling (e.g. in the hands)  180(49) 97(26.4) 46(12.5) 44(11.9)\nI was worried about situations in which  167(45.3) 95 (25.7) 59(16.0) 48 (13.0)\nI might panic and make a fool of myself\nI felt I was close to panic  209(59.6) 75(20.3) 42(11.4) 41(11.1)\nI was aware of the action of my heart\nin the absence of physical exertion  180(49.0) 83(22.6) 51(13.9) 53(14.4)\nI felt scared without any good reason  205(55.7) 74(20.1) 38(10.3) 51(13.9)\nTable III: Relation between Generalized Anxiety Disorder and social characteristics.\nRate of disease in males= 79.9%. Rate of disease in females=87%Social characteristics Anxiety\n  No Mild Moderate Severe Total p \n n (%) n (%) n (%) n (%) n (%)\nGender:\nMale 37(20.1) 102(55.4) 32(17.4) 13(7.1) 184(100) 0.008\nFemale 24(13.0) 87(47.0) 46(24.9) 28(15.1) 185(100)\nCollege:\nMedicine 37(17.0 99(45.4) 50(22.9%) 32(14.7) 218(100)\nDentistry 11(13.8) 51(63.7) 13(16.3%) 5(6.3%) 80(100) 0.063\nAMS 13(18.3) 39(54.9) 15(21.1%) 4(5.6%) 71(100)165\n2022/37 (3): 162-165Generalized anxiety disorder among saudi university nedical students\nis higher compared with other studies. The rate of \nGeneralized Anxiety Disorder is higher in females than in \nmale students. The disorder is higher among students of \nthe college of Dentistry while the severe form is higher \namong the students of the College of Medicine. \nStudent counseling programs emphasizing coping \ntechniques are advised to be implemented, especially \nin the College of Medicine and the College of Dentistry. \nThis urges periodic mental health screenings, providing \nindividual guidance and psychological counseling \nservices for medical students could be beneficial.Acknowledgment\nThe author would like to acknowledge the Deanship of \nScientific Research, Majmaah University for supporting \nthis research.\nConflict of interest\nThe researcher declares that he has no conflict of interest \nin this study.\nBibliography\n1. Leonard K, Abramovitch A. Cognitive functions in young adults with \ngeneralized anxiety disorder. Eur Psychiatry. 2019; 56:1-7.\n2. Ezmeirlly HA, Farahat FM. Illness anxiety disorder and perception of \ndisease and distress among medical students in western Saudi Arabia. \nSaudi Med J. 2019 Nov;40(11):1144-9. \n3. Charara R, Forouzanfar M, Naghavi M, Moradi-Lakeh M, Afshin A, Vos \nT, et al. The Burden of Mental Disorders in the Eastern Mediterranean \nRegion, 1990-2013. PloS one, 2017; 12(1), e0169575. \n4. Lina Z, Ahmed W, Sadiq N, Mahbub H Md, Atif R, Khalid S, Daniela \nF. Prevalence of Mental Disorders in the WHO Eastern Mediterranean \nRegion: A Systematic Review and Meta-Analysis. Frontiers in Psychiatry \n2021;12: 1035    \n5. Beesdo K, Knappe S, Pine DS. Anxiety and anxiety disorders in children \nand adolescents: Developmental issues and implications for DSM-V. \nPsychiatr Clin North Am. 2009;32(3):483-524. \n6. Eisenberg D, Gollust SE, Jennifer L. Hefner J. Prevalence and Correlates \nof Depression, Anxiety, and Suicidality Among University Students, \nUniversity of Michigan, American Journal of Orthopsychiatry 2007. Vol. \n77 (4) :534\u201342\n7. Rotenstein LS, Ramos MA, Torre M, et al. Prevalence of Depression, \nDepressive Symptoms, and Suicidal Ideation Among Medical Students: A \nSystematic Review and Meta-Analysis. JAMA. 2016; 316 (21):2214-36.      \n8. Leonard NR, Gwadz MV, Ritchie A, Linick JL, Cleland CM, Elliott L, \nGrethel M. A multi-method exploratory study of stress, coping, and \nsubstance use among high school youth in private schools. Front Psychol. \n2015 Jul 23;6:1028.\n9. Zahid MF, Haque A, Aslam M, Aleem NA, Hussain S, Fahad H, et al. \nHealth-related anxiety and hypochondriacal concerns in medical students: \nA cross-sectional study from Pakistan. Teach Learn Med 2016; 28: 252-9.10. Nishan P , Ramesh K, Pratikchya T. Depression, anxiety, and burnout \namong medical students and residents of a medical school in Nepal: a \ncross-sectional study. BMC Psychiatry 2020; 20:298:     \n11. \u0130lkay D,  Nurhan D. The Prevalence of Depression, Anxiety, Stress \nand Its Association with Sleep Quality among Medical Students. Ankara \nMedical Journal 2019; 3: 550-8\n12. Capdevila-Gaudens P , Garc\u00eda-Abajo JM, Flores-Funes D, Garc\u00eda-\nBarbero M, Garc\u00eda-Esta\u00f1 J. Depression, anxiety, burnout and empathy \namong Spanish medical students. PLoS One. 2021 Dec 2;16(12): \ne0260359. \n13. Wafaa A, Safaa H. Prevalence and associated factors of stress, anxiety \nand depression among medical Fayoum University students. Alexandria \nJournal of Medicine 2016. 53. 10.1016/j.ajme.2016.01.005.\n14. AlShamlan NA, AlOmar RS, Al Shammari MA, AlShamlan RA, \nAlShamlan AA, Sebiany AM. Anxiety and Its Association with Preparation \nfor Future Specialty: A Cross-Sectional Study Among Medical Students, \nSaudi Arabia. journal of Multidisciplinary Healthcare 2020:13 581-91\n15. Al Raddadi W, Aljabri JN, Kareem MA, Alattas AM, Alkhalawi MJ. \nThe Prevalence of Depression and Anxiety among Medical Students in \nComparison with Non-Medical Students: A Cross-Sectional Study in \nTaibah University, Al Madinah Al Munawwarah, Saudi Arabia. International \nJournal of Academic Scientific Research 2017; 5 (1): 72-80\n16. Inam SB. Anxiety and Depression among Students of a Medical \nCollege in Saudi Arabia. Int J Health Sci (Qassim). 2007;1(2):295-300.\n17. Mirza AA, Milaat WA, Ramadan IK, Baig M, Elmorsy SA, Beyari GM, \net al. Depression, anxiety and stress among medical and non-medical \nstudents in Saudi Arabia: An epidemiological comparative cross-sectional \nstudy. Neurosciences Journal 2021; 26 (2): 141-51\n18. Saddik B, Hussein A, Sharif-Askari FS, Kheder W, Temsah MH , Koutaich \nRA ,et al. Increased Levels of Anxiety Among Medical and Non-Medical \nUniversity Students During the COVID-19 Pandemic in the United Arab \nEmirates. Risk Management and Healthcare Policy 2020;13: 2395-406 .166\n2022/37 (3): 166-170SPECIAL ARTICLE\nVaccination against human papilloma virus in men: \nsituation and proposals\nVacunaci\u00f3n contra el virus del papiloma humano en hombres: situaci\u00f3n y propuestas\nJavier Cort\u00e9s1      , \u00c1ngel Gil2      , Federico Martin\u00f3n3      , Francisco Xavier Bosch4      ,\nJos\u00e9 Manuel Ram\u00f3n y Cajal5\n1. Royal Academy of Medicine of the Balearic Islands.\n2. Professor of Preventive Medicine and Public Health at the Rey Juan Carlos University.\n3. Coordinator and Head of the Pediatric Service. University Clinical Hospital of Santiago de Compostela. Coordinator Group of \nGenetics, Vaccines, Infections and Pediatrics. Sanitary Research Institute of Santiago de Compostela.\n4. Consultant Catalan Institute of Oncology. Associate Professor Open University of Catalonia.\n5. Gynecology Service. Hospital of San Jorge, HuescaeISSN 2255-0569\nReceived:  14 - IV - 2022\nAccepted:  17 - IV - 2022\ndoi: 10.3306/AJHS.2022.37.03.166Corresponding author\nJavier Cort\u00e9s \nE-mail: ortes@ocea.es\nAbstract  \nThe causal epidemiology of papillomavirus pathology in man and its incidence and the status of its preventive activity in Spain are \ndescribed, which does not conform to the recommendation that scientific evidence has formulated and that many countries in our \nenvironment are following. Lines of action are detailed in this regard that are considered preferred from the point of view of health \npolitical action.\nKeywords:  Vaccination, human papilloma virus, prevention.\nResumen\nSe describe la epidemiolog\u00eda causal de la patolog\u00eda papiloma virus causal en el hombre y su incidencia y la situaci\u00f3n de su \nactividad preventiva en Espa\u00f1a, no conforme con la recomendaci\u00f3n que la evidencia cient\u00edfica ha formulado y que numerosos \npa\u00edses de nuestro entorno s\u00ed est\u00e1n siguiendo. Se detallan l\u00edneas de acci\u00f3n al respecto que se consideran preferentes desde el \npunto de vista de acci\u00f3n pol\u00edtico \u2013 sanitaria.\nPalabras clave:  Vacunaci\u00f3n, virus papiloma humano, prevenci\u00f3n.\nIntroduction\nThe human papillomavirus (HPV) is a transmission virus \nassociated with sexual activity, not necessarily coital: \ntransmission by skin-to-mucosal contact is an essential \ncondition for contagion to occur1. The World Health \nOrganization2 reports that In the world more than 290 \nmillion women are infected with HPV. Actually, it is a \nuniversal pathogenic microorganism, since it affects \nboth men and women: around 80-85% of sexually active \nindividuals will be in contact with HPV at some point in \ntheir lives. Most of these infections will be controlled by \nthe infected person\u2019s immune system, but in general, \nin 1 or 2 cases out of 10, the infection will persist and \nput the carrier at risk of developing HPV-dependent \ndisease. At the time, the CLEOPATRE3 study reported that in Spain 14% of women over 30 years of age were \npositive for HPV. Right now, the prevalence of HPV DNA \nin Spanish women is estimated to range between 1.3 \nand 5%,4 which represents a number of female carriers \nbetween 350,000 and 900,000.\nKnowledge of the structure of HPV and the mechanisms \nof its oncogenic action5 have allowed the development \nof very effective, safe, effective and efficient strategies \nfor primary and secondary prevention of the pathology \nit causes, cervical cancer in women \u2013also of the vulva \nand vagina\u2013, of the penis in men and of the oro-pharynx \nand anus in both, in addition to skin warts and recurrent \nrespiratory papillomatosis.ID ID ID ID167\n Vaccination against human papilloma virus in men: situation and proposals\n2022/37 (3): 166-170This volume of disease constitutes a significant \noncological burden6. For the National Health System, \nits treatment represents an annual cost of slightly more \nthan \u20ac150 million7. Consequently, establishing guidelines \nand recommendations for population application for \nits prevention must be a priority. The World Health \nOrganization (WHO) has declared cervical cancer \u2013\ncaused in 100% of cases by HPV8\u2013 as the first eradicable \ncancer in our world9. To achieve this, implement \npreventive action in women \u2013very consolidated and in \nmajority application in clinical practice10\u2013 with actions \nalso in men seems absolutely essential.\nThis work updates and summarizes the evidence \nin this regard and, in its conclusions, establishes \nrecommendations for preventive action.\nEpidemiology of HPV in men\nThe evidence indicates that the prevalence of genital HPV \ninfection in healthy men is relatively higher than in women, \nwith very important differences published that reach 73% \nin reference works11, differences attributable to the different \npopulations studied, to the anatomical sites used for the \ndetermination and the different HPV detection methods \nused. Everything shows that the study of HPV infection \nin men is far from having obtained the solidity of the data \nobtained in women: we cannot at this time offer a man a solid \nrecommendation on how and in what way to detect HPV. \nIn prospective multinational studies, it has been observed \nthat up to 50.5% of the men studied were positive for at \nleast 1 type of HPV, oncogenic or not. HPV type 16 was \nthe most commonly detected, up to 6.5%12, a relevant \nfact since it is the type most involved in oncological \ndamage13. In asymptomatic heterosexual men, the penis \nand scrotum were the sites in which almost 95% of \ngenital HPV11 infections were detected.\nAn important aspect is that in men the risk of acquiring \nan HPV infection does not change with age. This lack of \nassociation with age suggests that the prevalence of male \nHPV infection is relatively constant and may be due to the \ncontinual acquisition of new infections throughout life. The \ngood news is that infections in men are less likely to persist \nthan in women: the median time to clearance of an infection \nin men is 5.9 months, with 75% of infections cleared \nwithin12 months post infection14, a risk of persistence that \ndecreases more among circumcised men15.\nIn relation to the most important locations of causal HPV \ncancer mentioned above in men, anus and oropharynx, it \nshould be noted that in the \u201cHPV Infection in Men\u201d study, \nthe prevalence of anal HPV in heterosexual men was \n12% and the rate of the incidence of anal cancer was \n8.1%, a prevalence that was markedly higher \u201347.2%\u2013 \namong men who had sex with men11.The incidence of oral HPV infection is higher in adults \naged between 31-50 years, and, as in other locations, the \npersistence of HPV infection in the oral cavity increases \nwith age16, with a prevalence of HPV infection in the \noropharynx in men between 18 and 65 years of 11.5%. It \nis noted that oral infection is more prevalent in men than \nin women, with a bimodal distribution throughout life in \nmen, higher in adulthood.\nAnother characteristic of HPV infection in men is that \nonly 7.7% have antibodies against HPV 6-11-16-18 at \n36 months post-infection, with titers 4 to 10 times lower \nthan those of women. This weak seroconversion does \nnot protect against subsequent infections, a protection \nthat is manifested in women17.\nHPV disease in men\nA recent publication15 reports that HPV causes 118 \npenile cancers in Spain each year and, in men, 522 \nhigh-grade intraepithelial lesions of the anus or anal \ncancers, 603 oropharyngeal cancers, and 28,047 \ngenital warts.\nThe estimate for Europe is that 325,700 cases of genital \nwarts and 12,700 of oropharyngeal, 1,700 anal, and \n1,090 penile cancers are diagnosed annually in men18. \nThere are no secondary prevention programs against \nany of these cancers, so primary prevention, vaccination \nagainst HPV, is the only possible alternative.\nVaccines against HPV\nOnce the infectious cause of a disease is known, the \nprimary preventive measure to apply preferentially if \navailable is vaccination against the causal agent. The \ntwo HPV vaccines currently available, Cervarix\u00ae and \nGardasil9\u00ae, do not include a gender difference in the \nindication for their administration in their technical data \nsheet approved and disseminated by the European \nMedicines Agency: both are said to be vaccines \nindicated for immunization of people from the age of \n9 years19,20. Consequently, male vaccination against \nHPV is approved by all European national regulatory \nagencies.\nThe degrees of efficacy of both vaccines against pre-\ncancerous lesions of the cervix, vulva, vagina and anus \nare very high, always greater than 90-95%19, 20. In addition, \non June 15, 2020, the Food and Drug Administration of \nthe United States specifically approved the indication of \nGardasil9\u00ae for the primary prevention of oropharyngeal \ncancers caused by HPV21.\nWe therefore have highly effective vaccines against \ncancers caused by HPV, but are they safe? Is their \napplication to men efficient?168\n2022/37 (3): 166-170Javier Cort\u00e9s et al.  \nAlthough it is true that at some point adverse reactions \noccurred that initially seemed associated and only \ninitially raised some doubts, the safety of HPV vaccines \nis unquestionable after more than 15 years of use and \nhundreds of millions of doses administered. The latest \nreview by the WHO is forceful in its report22: its vaccine \nsafety review committee reaffirms that no doubt should \nbe raised about the safety of HPV vaccines and that \npolitical decisions based on unverified data that induce \ndoubt about its safety and that consequently lower the \nquality of the recommendation for its use can cause \nconsiderable damage to the health of the affected \ncommunity.\nThe most recent reports on the cost/benefit of the \napplication of HPV vaccines in population-based \nPublic Health programs for boys, from France23 and \nthe Netherlands24 and from other countries and \nscenarios25, demonstrate their high efficiency: to the \nbenefit of Prevention of HPV lesions in them adds to \nthe impact on transmission to girls. Collecting this \nevidence, already 53 countries from the five continents \n\u2013 28 Europeans \u2013 include financed vaccination against \nHPV in children in the vaccination schedules of their \nPublic Health programs25. An associated benefit that \nhas been highlighted of male vaccination is that HPV \ncould be eradicated even in conditions of low coverage \nin female vaccination26.\nIn Spain, the vaccination calendar published by the \nMinistry of Health 27 includes HPV vaccination for \nadolescent women according to the following guideline:\n\u00b7 Vaccination at 12 years of age: 2 doses will be \nadministered at least 5-6 months apart (depending \non the vaccine used).\n\u00b7 Vaccination between 13 and 18 years: Only \nadolescents who have not been vaccinated, or who \nhave not received the complete schedule, will be \nvaccinated. Two doses will be administered at least \n5-6 months apart (depending on the vaccine used).\n\u00b7 If vaccination is started after 14 or 15 years of age, \n3 doses will be administered with a schedule of 0, \n1-2, 6\nThe Advisory Committee on Vaccines of the Spanish \nAssociation of Pediatrics states that vaccinating boys \nwithin the current Spanish vaccination calendar should be \nan immediate recommendation, in line with the proposal \nof the European Center for Diseases Prevention and \nControl27. This recommendation has not been collected, \nhowever, in the latest edition of the \u201cCancer Strategy of \nthe National Health System\u201d28, unlike the European plan \nagainst Cancer, published in the same year, which not \nonly includes the indication of male vaccination, but also \nestablishes vaccination against HPV in girls and boys as \none of the emblematic initiatives of plan29.HPV vaccination coverage in Spain\nA crucial aspect of all vaccination procedures in Public \nHealth is to achieve sufficient coverage to, in addition \nto protecting the vaccinated, achieve herd immunity \nand block and perhaps prevent the circulation of the \nvirus. Coverage greater than 70% would be required to \nachieve these objectives30. In Spain, the latest report \navailable from the Ministry of Health31 details that in 2019 \na satisfactory coverage of 79% was achieved in the \nadministration of the second dose of the HPV vaccine to \ngirls born in 2006, with a range that goes from 75.4% in \nAndalusia to 91% in La Rioja, although it should be noted \nthat the table does not include the data on the coverage \nachieved in Aragon, Asturias, the Balearic Islands and \nthe Canary Islands. Working to maintain or improve this \ncoverage when \u2013as soon as possible\u2013 the boys are \nincluded in the program, constitutes a priority and a \nvictory for equality32, as Kevin Pollock titled in his very \nrecent article communicating the inclusion of the males \nin the UK vaccination programme. Along these lines is \nthe publication of the Evaluation Service of the Canary \nIslands Health Service, supported by the Spain Ministry \nof Health33, in which it is stated verbatim that \u201cit would be \nadvisable to introduce the universal vaccination strategy \nagainst HPV with a vaccination schedule of two dose at \n12 years of age for both sexes in Spain, with the condition \nof reviewing its cost-effectiveness with new evidence on \nthe effectiveness, costs or alternative guidelines\u201d.\nA review of the vaccination calendar in execution in all \nthe Spanish Autonomous Communities and the two \nAutonomous Cities carried out in September 2021, was able \nto document that only in Euskadi34, Cantabria35, Catalonia36 \nand Castilla y Le\u00f3n37 is it implemented, with different age \nindications and circumstances, vaccination of males.\nConclusions\n1. The human papillomavirus is the most common \nsexually transmitted infection, and is considered a \nuniversal pathogen, since it affects both women and \nmen.\n2. In recent years, progress has been made in \nunderstanding the burden of disease associated with \nHPV: it is currently estimated that HPV is responsible for \n5% of cancer that occurs in humans.\n3. Men can develop cancers of the anus, penis, head, \nand neck that are related to HPV.\n4. The prevalence of genital warts is high and similar in \nboth sexes. \n5. Unlike what happens with cervical cancer, cancers \nthat affect men lack secondary prevention methods \n(screening).\n6. The available vaccines against HPV have proven to be \neffective, safe, effective and efficient in their application \nto women and men.169\n2022/37 (3): 166-170Vaccination against human papilloma virus in men: situation and proposals\n7. A gender-independent HPV vaccination program \nwould be more equitable than the situation that currently \nexists in access to this vaccine in our country, it could \nprovide direct health benefits not only for women, \nbut also for men and women, it would maximize the \nprevention of cervical cancer, accelerating the global \ncontrol of HPV infection, in addition to helping to mitigate \nthe negative impact on the prevention of possible low \nfemale vaccination coverage.\nDefinitely, the WHO has formally requested38 that HPV \nvaccination be extended immediately to all eligible \npopulations, saying that \u201c\u2026there is also a clear risk in \nterms of missed opportunities for the expansion of other \nimmunization services, for example, the safe and effective \nimplementation of HPV vaccines. Low-income countries \nneed timely access to vaccines at sustainable prices and \ntimely financial support\u201d, a position also defended by the \nEuropean Center for Disease Control and Prevention in \na recent publication39. On the other hand, international \nreference sources40 call for a global solidarity policy \naimed at the elimination of HPV-dependent pathology.\nThe authors of this work formally align themselves with \nthese requests and make them their own, hoping that \nthe Spanish Health Institutions will take the appropriate \nmeasures to comply with them.Conflict of interests\nJC has received travel and/or research grants and/or \nspeaking and/or consulting fees from Genomics, GSK, \nMerck, Procare Health, Qiagen, Roche, and SPMSD.\nAG has received grants for travel and/or fees for \nconferences and/or sponsorship of projects and/or \nconsultancies from Sanofi Pasteur, MSD, GSK, Seqirus \nand Pfizer.\nFM has received fees from Biofabri, GSK, Pfizer, Sanofi  \nPasteur, MSD, Segirus, Novavax and Janssen as \nadvisor, consultant or speaker outside the scope of this \nwork and has worked as principal investigator in clinical \ntrials promoted by the aforementioned pharmaceutical \ncompanies and , in addition, Ablynx, Regeneron, Roche, \nAbbott and Medlmmune, with fees paid to the Institution.\nFXB is International Consultant of MSD.\nJMRyC has received professional fees for work carried \nout, conferences and scholarships for assistance in \ntraining activities from Roche Diagnostics, Qiagen, GSK \nand MSD\nBibliography\n1. Kjaer SK, Chackerian B, van den Brule AJ, Svare EI, Paull G, \nWalbomers JM et al.: High-risk human papillomavirus is sexually \ntransmitted: evidence from a follow-up study of virgins starting sexual \nactivity (intercourse). Cancer Epidemiol Biomarkers Prev 2001; 10: 101-6\n2. Available in https://www.who.int/es/news-room/fact-sheets/detail/\nsexually-transmitted-infections-(stis)     Access 01.08.2021.\n3. Castellsagu\u00e9 X, Iftner T, Roura E, Vidart JA, Kjaer SK, Bosch FX et al.: \nPrevalence and genotype distribution of human papillomavirus infection of \nthe cervix in Spain: the CLEOPATRE study. J Med Virol. 2012; 84: 947-56.\n4. Spanish Society of Epidemiology. Papilloma Virus and Cancer. \nAvailable in:\nhttps://www.seepidemiologia.es/documents/\ndummy/4monografiaVirusPapilomaYCancer.pdf. Access 02.08.2021\n5. Szymonowicz KA, Chen J.: Biological and clinical aspects of HPV-\nrelated cancers Cancer Biol Med. 2020; 17: 864-78.\n6. Available in:\nhttps://www.aecc.es/es/todo-sobre-cancer/que-es-cancer/factores-\nriesgo        Access 02.08.2021.\n7. L\u00f3pez, N, Torn\u00e9 A, Franco A, San-Mart\u00edn, M, Viayna E, Barrull C \net al.: Epidemiologic and economic burden of HPV diseases in Spain: \nimplication of additional 5 types from the 9-valent vaccine. Infect Agent \nCancer. 2018; 13: 15.8. Walboomers JM, Jacobs MV, Manos MM, Bosch FX, Kummer JA, \nShah KV et al.: Human papillomavirus is a necessary cause of invasive \ncervical cancer worldwide. J Pathol. 1999; 189: 12-9. \n9. Ghebreyesus TA, Director General.: Reuni\u00f3n Ejecutiva OMS \nIntercontinental Hotel, Gen\u00e8ve, Conf\u00e9d\u00e9ration Suisse. 19 May 2018.\n10. Cort\u00e9s J, Bosch X, Concha A, Gonz\u00e1lez A, Martin\u00f3n F, Ortiz de \nLejarazu R et al.: Asociaci\u00f3n Espa\u00f1ola contra el C\u00e1ncer: Documento de \nposici\u00f3n sobre prevenci\u00f3n del C\u00e1ncer de Cuello de \u00datero. Prog Obstet \nGinecol 2019; 61: 510-44.\n11. Giuliano AR, Lazcano-Ponce E, Villa LL, Flores R, Salmeron J, Lee \nJ-H et al.: The human papillomavirus infection in men study: human \npapillomavirus prevalence and type distribution among men residing in \nBrazil, Mexico, and the United States. Cancer Epidemiol Biomarkers \nPrev. 2008; 17: 2036-43 \n12. Ingles DJ, Lin HY, Fulp WJ, Sudenga SL, Lu B, Schabath MB et al.: \nAn analysis of HPV infection incidence and clearance by genotype and \nage in men: The HPV Infection in Men (HIM) Study. Papillomavirus Res \n2015; 1: 126-35 \n13. Bruni L, Diaz M, Castellsagu\u00e9 X, Ferrer E, Bosch FX, de Sanjos\u00e9 \nS.: Cervical human papillomavirus prevalence in 5 continents: meta-\nanalysis of 1 million women with normal cytological findings. J Infect Dis. \n2010; 202: 1789-99.170\n2022/37 (3): 166-170Vaccination against human papilloma virus in men: situation and proposalsJavier Cort\u00e9s et al.  \n14. Giuliano AR, Lee J-H, Fulp W, Villa LL, Lazcano-Ponce E, Papenfuss \nMR, Abrahamsen M et al.: Incidence and clearance of genital human \npapillomavirus infection in men (HIM): a cohort study. Lancet 2011; 377: \n932-40. \n15. Albero G, Villa LL, Lazcano-Ponce E, Fulp W, Papenfuss MR, \nNyitray AG et al.: Male circumcision and prevalence of genital human \npapillomavirus infection in men: a multinational study. BMC Infect Dis. \n2013; 13: 18.\n16. Chatuverdi AK, Engels EA, Pfeiffer RM, Hern\u00e1ndez BY, Weihong \nX, Kim E et al.: Human papillomavirus and rising oropharyngeal cancer \nincidence in the United States. J Clin Oncol. 2011; 29: 4294-301.\n17. Giuliano AR, Viscidi R, Torres N, Ingles DJ, Sudenga SL, Villa LL et \nal.: Seroconversion Following Anal and Genital HPV Infection in Men: \nThe HIM Study. Papillomavirus Res. 2015; 1: 109-15.\n18. Stanley M.: Program Research Epidemiology of Cancer. Cambridge \nUniv. Presented at EUROGIN 2018. 2-5 December. Lisbon. Portugal.\n19. Cervarix\u00ae summary product characteristics. Available in https://\ncima.aemps.es/cima/dochtml/ft/07419004/FT_07419004.html      \nAccess 03.08.2021.\n20. Gardasil9\u00ae summary product characteristics. Available in https://\ncima.aemps.es/cima/dochtml/ft/1151007002/FT_1151007002.html     \nAccess 03.08.2021.\n21. Available in: https://search.usa.gov \nsearch?query=gardasil9+expanded&affiliate=fda1 Access 03.07.2021\n22. Global Advisory Committee on Vaccine Safety (GACVS). Weekly \nEpidemiological Record: 92; 28. 14 de julio de 2017.\n23. Majed L, Bresse X, El Mouaddin N, Schmidt A, Daniels VJ, Pavelyev \net al.: Public health impact and cost-effectiveness of a nine-valent gender-\nneutral HPV vaccination program in France. Vaccine. 2021; 39: 438-46.\n24. Simons JJM, Vida N, Westra TA, Postma MJ.: Cost-effectiveness \nanalysis of a gender-neutral human papillomavirus vaccination program \nin the Netherlands. Vaccine. 2020; 38: 4687-94. \n25. Qendri V, Bogaards JA, Baussano I, Lazzarato F, V\u00e4nsk\u00e4 S, Berkhof \nJ.: The cost-effectiveness profile of sex-neutral HPV immunisation in \nEuropean tender-based settings: a model-based assessment. Lancet \nPublic Health. 2020; 5: e592 \u2013 e603.\n26. V\u00e4nsk\u00e4 S, Luostarinen T, Baussano I, Apter D, Eriksson T, Natunen \nK et al.: Vaccination With Moderate Coverage Eradicates Oncogenic \nHuman Papillomaviruses If a Gender-Neutral Strategy Is Applied. J Infect \nDis. 2020; 222: 948-56.\n27. Available in https://www.mscbs.gob.es/profesionales/saludPublica/\nprevPromocion/vacunaciones/vacunas/profesionales/vph.htm     \nAccess 27.08.2021.28. Available in:\nhttps://vacunasaep.org/profesionales/noticias/VPH-informe-ECDC-\nvacunacion-varones-y-otros-temas     Access 03.08.2021.\n29. European Commission. Europe\u2019s Beating Cancer Plan. \nCommunication from the Commission to the European Parliament \nand the Council 2021. Available in: https://ec.europa.eu/health/sites/\ndefault/files/non_communicable_diseases/docs/eu_cancer-plan_\nen.pdf     Access 27.08.2021\n30. Marra F, Cloutier K, Oteng B, Marra C, Ogilvie G.: Effectiveness \nand cost effectiveness of human papillomavirus vaccine: a systematic \nreview. Pharmacoeconomics 2009; 27: 127-47.\n31. Available in: \nhttps://www.mscbs.gob.es/profesionales/saludPublica/\nprevPromocion/vacunaciones/calendario-y-coberturas/coberturas/\ndocs/Tabla11.pdf)     Access 03.08.2021.\n32. K Pollock (2019). Adolescent male vaccination in the United \nKingdom - a victory for equality. www.HPVWorld.com, 94.\n33. Linertov\u00e1 R, Guirado Fuentes C, Toledo Ch\u00e1varri A, Vallejo Torres \nL, Garc\u00eda P\u00e9rez L, Delgado Rodr\u00edguez J et al.: Vacuna frente a VPH \nen varones adolescentes: coste-efectividad e impacto presupuestario. \nMinistry of Health, Consumption and Social Welfare. Evaluation Service \nof the Canary Islands Health Service; 2020. Health Technology \nAssessment Reports.\n34. Available in https://www.euskadi.eus/informacion/vacuna-contra-\nel-virus-del-papiloma/web01-a2adik/es/  Access 10.09.2021\n35. Available in:\nhttps://saludcantabria.es/index.php?page=vacunaciones Access \n10.09.2021\n36. Available in:\nhttps://salutpublica.gencat.cat/web/.content/minisite/aspcat/\npromocio_salut/vacunacions/00manual_de_vacunacions/\ncapitols_i_annexos_manual/apartat_4_vacunes_disponibles/Manual-\nVacunacions-apartat-4_12.pdf      Access 11.09.2021\n37. Available in:\nhttps://www.saludcastillayleon.es/es/vacunaciones/vacunacion-frente-\nvirus-papiloma-humano-vph-2019     Access 11.09.2021\n38. Available in https://www.who.int/news/item/22-07-2021-vaccine-\ninequity-undermining-global-economic-recovery     Access 02.09.2021.\n39 Colzani E, Johansen K, Johnson H, Celentano LP .: Human \npapillomavirus vaccination in the European Union/European Economic \nArea and globally: a moral dilemma. Euro Surveill. 2021; 26(50).\n40. Lehtinen M, Baussano I, Paavonen J, V\u00e4nska S, Dillner J.: \nEradication of human papillomavirus and elimination of HPV-related \ndiseases - scientific basis for global public health policies. Expert Rev \nVaccines. 2019; 18: 153 \u2013 160.171\n2022/37 (3): 171-172Received:  17 - IV - 2022\nAccepted:  29 - IV - 2022\ndoi: 10.3306/AJHS.2022.37.03.171Corresponding author\nLaura Aizpiri Anto\u00f1ana \nE-mail: lauraaizpiri@gmail.com\nAbstract\nUremia is a condition that eases bleeding in patients with chronic kidney disease. We present the case of a 68-year-old male \nin current predyalisis situation, who was admitted for transurethral resection of a bladder tumor, suffering from hematuria in the \npostoperative period, which stopped after treatment with desmopressin.\nKey words : Desmopressin, anemizing hematuria, platelet dysfunction, uremia.\nResumen  \nLa uremia es una condici\u00f3n que facilita el sangrado en pacientes con enfermedad renal cr\u00f3nica. Presentamos el caso de un var\u00f3n \nde 68 a\u00f1os en situaci\u00f3n actual de predilecci\u00f3n, que ingres\u00f3 para resecci\u00f3n transuretral de un tumor vesical, sufriendo hematuria \nen el postoperatorio, que ces\u00f3 tras el tratamiento con desmopresina.\nPalabras clave:  Desmopresina, hematuria anemizante, disfunci\u00f3n plaquetaria, uremia .CASE REPORT\nDesmopressin as treatment of anemizing hematuria \nsecondary to platelet dysfunction in the setting of uremia   \nDesmopresina como tratamiento de la hematuria anemizante secundaria \na la disfunci\u00f3n plaquetaria en el contexto de la uremia    \nLaura Aizpiri Anto\u00f1ana      , Daniel Mu\u00f1oz V\u00e9lez      , Enrique Carmelo Pieras Ayala\nDepartment of Urology, Son Espases University HospitaleISSN 2255-0569\nID ID ID\nIntroduction\nHematuria is a common complication in the postoperative \nperiod of endoscopic surgery. Anemia is considered an \nindependent predictor of high postoperative morbidity \nand mortality1. The possible risk of transmission of \ninfections as well as the reactions associated with the \ntransfusion of blood products has aroused interest in \nagents that reduce blood loss, such as tranexamic acid \nor desmopressin (DDAVP)2. \nCase presentation\n68-year-old male, former smoker, with a history of \nhypertension, type 2 diabetes mellitus and diabetic \nnephropathy for which he received a kidney transplant 7 \nyears ago, in current pre-dialysis situation with residual \ndiuresis of 1.5 liters, baseline creatinine of 3.5 mg/dl and \nestimated glomerular filtration rate of 17 mL/min /1.73m2 \naccording to the Modification of Diet in Renal Disease \n(MDRD). On antiplatelet therapy with acetylsalicylic acid \n100 mg because of a coronary stent implantation 24 \nyears ago due to ischemic heart disease. He has received \na follow-up from 2008 onwards because of a recurrent \nlow-grade pTa urothelial transitional cell carcinoma. \nHe was admitted for a scheduled surgical intervention of a \nnew bladder tumor recurrence, endoscopically observed as extensive papillary areas at the bladder fundus, dome \nand left lateral side. According to the physical examination, \nthe abdomen was soft and depressible, with no masses \nor megalies, and digital rectal examination was normal. \nTransurethral resection of the described bladder lesions \nwas carried out without intraoperative complications, after \na previous interruption of antiplatelet treatment for 7 days.\nIn the first postoperative hours the patient came up with \ngross hematuria without hemodynamic repercussion and \nassociating few clots which were manually evacuated. \nDespite achieving clearing up of the urine by continuous \nbladder irrigation, hematuria reappeared once and again \nafter its withdrawal. \nBlood test showed progressive anemization, up to a \nminimum hemoglobin of 6.8 g/dl and hematocrit of \n20% in a few days, requiring red blood cell transfusion \nduring admission. Likewise, an exacerbation of his basal \nthrombopenia was observed, presenting 93,600/\u00b5L \nplatelets on the first postoperative day. His renal function \nalso got worse presenting a creatinine of 5.3 mg/dl and \nuremia increased up to 218 mg/dl. Renal ultrasound \ndescribed absence of hydronephrosis in the kidney graft. \nRegarding coagulation parameters, a slight initial alteration \nwas observed - prothrombin time (PT) being 62% and \nan international normalized ratio (INR) of 1.37 - returning 172\n2022/37 (3): 171-172Desmopressin as treatment of anemizing hematuria secondary to platelet dysfunction in the setting of uremia\nto normal values after administration of a dose of 10 mg \nphytomenadione. \nGiven the persistence of hematuria refractory to bladder \nirrigation withdrawal, and due to platelet dysfunction in the \nsetting of a patient with chronic renal failure, a single dose \nof desmopressin 0.3 mcg/kg solution was administered \nin 30 minutes, being this effective, after which hematuria \ndefinitely stopped. The first postoperative cystoscopy \nensured the absence of tumor recurrence. The patient \nhas not suffered from new episodes of hematuria so far.\nDiscussion\nBleeding and hemostasis defects are two common \ncomplications of uremia. This bleeding may be associated \nwith ineffective binding of the von Willebrand Factor (a \ncomponent of factor VIII) to platelet membranes, acquired \nstorage-pool deficiency, and anemia. In relation to this, \nalterations in the synthesis of prostaglandins, defects \nin platelet aggregation or platelet retention have been \nreported. These defects can contribute to prolonged \nbleeding times in patients with uremia. Uremic patients \nmay develop epistaxis, purpura, and bleeding from the \ngastrointestinal tract or urinary tract. The standard treatment \nfor bleeding derived from uremia is dialysis, however, it \ndoes not completely correct platelet dysfunction and so, it \nis sometimes ineffective. Therefore, both cryoprecipitates \nand desmopressin (DDAVP) have been studied as \nalternatives when an immediate effect is desired3,4. \nDesmopressin is a synthetic analog of the antidiuretic \nhormone vasopressin, the first clinical use of which was \nestablished in 1977 as a treatment for diabetes insipidus. \nIts mechanism of action is based on the increase in \nplasma levels of von Willebrand factor (vWF), coagulation \nfactor VIII and activation of tissue plasminogen (t-PA), \nshortening the activated partial thromboplastin time (aPTT) \nand bleeding time. In addition, it exerts a vasodilator effect \nwhich is explained by a direct action on the endothelium, \nfrom the activation of endothelial vasopressin receptors \n(V2R) and and cAMP-mediated signaling5.\nDesmopressin can be administered intravenously (0.3 \nmicrograms / kg diluted in 50-100 ml of isotonic saline by infusing over 30 minutes), subcutaneously, or intranasally. \nIt takes approximately 30 minutes to reach its peak \nconcentration and this effect lasts for about 8 hours6. \nTachyphylaxis is to be considered after the second dose \ndue to the depletion of multimers from endothelial storage.\nDespite not being an agent commonly used in the treatment \nof hematuria, it has the advantages of being an inexpensive \ndrug with a good safety profile, and also avoids the risk \nof transmission of viral infections related to transfusion. \nBecause of that, it has already proved useful in the prevention \nof bleeding from minor procedures such as kidney or liver \nbiopsy, where the risk of bleeding is below 1%2.\nVon Willebrand Factor is essential for forming normal \nclots through platelet adhesion and the aggregation \nthat follows endothelial damage. Increasing vWF \nlevels in patients undergoing interventional or surgical \nprocedures may reduce or even prevent bleeding loss, \ntherefore reducing the need for red blood cell transfusion. \nPrevention of bleeding in patients with platelet dysfunction \nis of particular interest. Uremia, which associated with \nplatelet dysfunction, can result in a major bleeding event \nafter an invasive procedure or surgery that may be \naggravated by antiplatelet agents. In this setting, a single \ninfusion of desmopressin before invasive procedures in \nuremic patients on antiplatelet drugs appeared to be well \ntolerated and improved platelet dysfunction measured \nby collagen/epinephrine-closure time7. Moreover, as a \nresult of its quick response in these patients and its high \navailability, desmopressin is a cheap drug that should be \nbeared in mind when managing bleeding complications \nsuch as gross hematuria in a postoperative setting.\nConclusions\nPlatelet disfunction caused by uremia can ease the \nonset of hematuria after a minor procedure or surgical \nintervention. Desmopressin proved an effective agent \nin the treatment of persistent and anemizing gross \nhematuria in this setting.\nConflict of interests\nThe authors have no conflict of interest.\nReferences\n1 Carson JL, Noveck H, Berlin JA, Gould SA. (2002), Mortality and morbidity in \npatients with very low postoperative Hb levels who decline blood transfusion. \nTransfusion 2002; 42: 812-8 \n2 Desborough MJ, Oakland K, Brierley C, Bennett S, Doree C, Trivella, M, \net al. Desmopressin use for minimising perioperative blood transfusion. The \nCochrane database of systematic reviews 2017; 7(7), CD001884. \n3 Couch P , Stumpf JL. Management of uremic bleeding. Clin Pharm. 1990 \nSep;9(9):673-81. PMID: 2171866.\n4 Triulzi DJ, Blumberg N. Variability in response to cryoprecipitate treatment for hemostatic defects in uremia. The Yale journal of biology and medicine \n1990; 63(1):1-7.\n5 Kaufmann JE, Vischer UM. Cellular mechanisms of the hemostatic effects \nof desmopressin (DDAVP). J Thromb Haemost. 2003;1(4):682-9.\n \n6 Franchini M, Lippi G. The use of desmopressin in acquired haemophilia A: \na systematic review. Blood Transfus 2011; 9(4):377-82. \n7 Kim JH, Baek CH, Min JY, Kim JS, Kim SB, Kim H. Desmopressin improves \nplatelet function in uremic patients taking antiplatelet agents who require \nemergent invasive procedures. Ann Hematol. 2015;94(9):1457-61. Laura Aizpiri et al.  173\n2022/37 (3): 173-174Received:  19 - IV - 2022\nAccepted:  30 - IV - 2022\ndoi: 10.3306/AJHS.2022.37.03.173Corresponding author\nCarolina Quintero  \nE-mail: carolina.quintero@quironsalud.es\nResumen  \nLa Neisseria meningitidis  (N. m.) es un g\u00e9rmen que se halla en la nasofar\u00ednge de los portadores, generalmente asintom\u00e1ticos, y se \ntransmite por la saliva y las gotitas de Fl\u00fcgge. Su diseminaci\u00f3n hemat\u00f3gena origina meningitis y eventualmente meningococemia. \nLa diseminaci\u00f3n al aparato respiratorio puede causar neumon\u00eda, que es muy infrecuente.\nPresentamos un caso que re\u00fane las caracter\u00edsticas t\u00edpicas de la neumon\u00eda por N.m., una entidad posiblemente infradiagnosticada. \nPalabras clave : Neumon\u00eda, Neisseria meningitidis.\nAbstract\nNeisseria meningitidis (N. m.) is a germ found in the nasopharynx of carriers, who are generally asymptomatic, and is transmitted \nvia saliva and Fl\u00fcgge droplets. Its hematogenous dissemination causes meningitis and eventually meningococcemia. In case of \ndissemination to the respiratory tract it can cause pneumonia, but very rarely.\nWe present a case that meets the typical characteristics of N.m. pneumonia, possibly an underdiagnosed entity.\nKey words : Pneumonia, Neisseria meningitidis.CASE REPORT\nNeumonia meningoc\u00f3cica: un nuevo caso   \nMeningococcal pneumonia: a new case    \nCarolina Quintero1      , Francisco L\u00f3pez1      , Jaime Llabr\u00e9s1      , Francisco Aliaga2\n1. Servicio de Medicina Interna   2. Servicio de An\u00e1lisis Cl\u00ednicos\nHospital Quironsalud PalmaplanaseISSN 2255-0569\nID ID ID ID\nCaso cl\u00ednico\nMujer de 70 a\u00f1os de edad con antecedentes de cifoplastia, hipertensi\u00f3n \narterial y enfermedad pulmonar obstructiva cr\u00f3nica, por la que precisa \noxigenoterapia domiciliaria.\nAcudi\u00f3 al hospital por empeorar su disnea con febr\u00edcula de 37.7\u00baC, sin tos \nni expectoraci\u00f3n.\nEn la exploraci\u00f3n cl\u00ednica se apreciaba evidente disnea con acrocianosis (Sat. \nO2 82%) y ausencia de edemas. La auscultaci\u00f3n respiratoria mostraba roncos \ny sibilancias bilaterales con crepitantes y discreta matidez en la base pulmonar \nderecha. La radiograf\u00eda de t\u00f3rax evidenci\u00f3 una silueta card\u00edaca normal y una \ncondensaci\u00f3n con patr\u00f3n alveolar en el l\u00f3bulo inferior derecho. ( Figuras 1  y 2)\nLas determinaciones anal\u00edticas sangu\u00edneas practicadas fueron normales, \nresaltando un recuento leucocitario normal sin desviaci\u00f3n a la izquierda. \n\u00danicamente la prote\u00edna C reactiva (CRP) estaba elevada: 105.9 mg/L (Inf. 5.0).\nSe practicaron dos hemocultivos con crecimiento de N. m. y PCR (Protein \nChain Reaction) positivo para meningococo. As\u00ed mismo se realizaron tomas \npara PCR de SARS \u2013CoV-2 y pat\u00f3genos respiratorios que resultaron \nnegativas.\nSe instaur\u00f3 tratamiento con oxigenoterapia con Ventimask  y Ceftriaxona a \ndosis de 2gr/24h. La evoluci\u00f3n cl\u00ednica fue satisfactoria y fue dada de alta a \nlos 11 d\u00edas de la hospitalizaci\u00f3n. \nFigura 1: Radiograf\u00eda postero anterior: \nCondensaci\u00f3n basal derecha.\nFigura 2: Radiograf\u00eda lateral: Adem\u00e1s de la \ncondensaci\u00f3n de l\u00f3bulo inferior derecho, se \naprecia vertebroplastia dorsal.174\n2022/37 (3): 173-174Neumonia meningoc\u00f3cica: un nuevo caso\nDiscusi\u00f3n\nLa Neisseria meningitidis  o meningococo posee una \nc\u00e1psula de polisac\u00e1ridos que permiten clasificarlo en 13 \nserogrupos, de los que el A, B, C, W, e Y son los de \nm\u00e1s importancia patol\u00f3gica. El g\u00e9rmen se mantiene en la \nnasofaringe de los portadores con una prevalencia media \ndel 10% que se eleva mucho durante las epidemias. \nLa infecci\u00f3n orofar\u00edngea suele ser asintom\u00e1tica y la \nenfermedad se transmite por la saliva o las gotitas de \nFl\u00fcgge al toser o estornudar; la diseminaci\u00f3n hemat\u00f3gena \npredomina en los j\u00f3venes y puede originar meningitis y en \nocasiones meningococemia. En los casos de neumon\u00eda \npor N.m, propia de adultos, el serogrupo m\u00e1s frecuente \nes el Y, seguido del W.\nLa neumon\u00eda por meningococo tiene una prevalencia tan \nescasa que los tratados de Medicina Interna le dedican \nsolo unas l\u00edneas1. El primer caso se describi\u00f3 en 1907 \ny posteriormente continuaron public\u00e1ndose otros casos \nespor\u00e1dicos, con un evidente incremento durante la \npandemia gripal de los a\u00f1os 1918-19192. En la actual \npandemia de la COVID-19 no parece que se haya \nproducido nada semejante, ya que solamente hemos \nlocalizado un caso de meningitis meningococica en un \npaciente infectado por el SARS-CoV-23. De la neumon\u00eda \npor N.m. se han comunicado casos aislados en todos \nlos continentes4,5,6.\nEn el a\u00f1o 2000 se public\u00f3 una revisi\u00f3n de 78 casos7 \nque ha permitido perfilar mejor las caracter\u00edsticas de \neste cuadro neum\u00f3nico. Afecta por igual a pacientes \nde ambos sexos, con edad superior a los 50 a\u00f1os, \nque presentan los cl\u00e1sicos factores de riesgo de estos procesos respiratorios: Tabaquismo, diabetes, \ninmunodepresi\u00f3n, etc. El comienzo suele ser con tos y \nfiebre, ocasionalmente dolor pleur\u00edtico, y habitualmente \ndisnea. La exploraci\u00f3n f\u00edsica y radiol\u00f3g\u00edca es indistinguible \nde otras neumon\u00edas bacterianas y por esto puede \ntratarse de un proceso infra diagnosticado, ya que el \nmeningococo solo se a\u00edsla en el esputo en el 30%  de \nlos casos. Es llamativo que los hemocultivos pueden ser \npositivos hasta en el 79% de los pacientes. La mortalidad \nes del 8.2% y solo 2 pacientes sufrieron shock s\u00e9ptico. \nNo hay un tratamiento establecido para este proceso \nneum\u00f3nico, pero la creciente resistencia del meningococo \na la Penicilina, determina que el tratamiento de elecci\u00f3n \nsean las cefalosporinas de 3\u00aa generaci\u00f3n. Se acepta que \nla mejor elecci\u00f3n es la Ceftriaxona a dosis de 50mg/kg \ndurante 7 d\u00edas. En caso de alergia a los betalact\u00e1micos \npuede usarse el Aztreonam 30mg/kg/6h.1. No hay \nevidencia de que el uso de corticosteroides en los casos \ngraves sea beneficioso2.\nEthical approval\nPatient\u00b4s consent has been obtained before writing this \nmanuscript.\nDeclaration of interest\nThe authors of this manuscript has not conflict of interest\nAcknowlegment\nWe thank Alfonso Ballesteros MD, PhD for assistance in \nmanuscript preparation\nBibliograf\u00eda\n1. Cabellos C. Infecciones meningoc\u00f3cicas. In: Rozman, C; Cardellach, F. \nMedicina Interna. 19th ed. Elsevier; 2020. p. 2105-7.\n2. Feldman C, Anderson R. Meningococcal pneumonia: a review. \nPneumonia (Nathan Qld). 2019;11:3.\n3. Gallacher SD, Seaton A. Meningococcal meningitis and COVID-19 co-\ninfection. BMJ Case Rep. 2020 Aug;13(8).\n4. Yubini MC, Contreras C, D\u00edaz G, Cerda MA, Gu\u00ed\u00f1ez D, Rogers N, et al. \nNeumon\u00eda bacter\u00e9mica por Neisseria meningitidis: Primer caso reportado \nen Chile y revisi\u00f3n bibliogr\u00e1fica. Rev Med Chil. 2018;146(2):249-53.5. Amir A, Umur N. Meningococcal pneumonia: a case report. Int J Infect \nDis [Internet].  2020;101:148\u20139. Available from: https://doi.org/10.1016/j.\nijid.2020.09.404\n6. Mahmoud FM, Harhara T. Neisseria meningitidis pneumonia with \nbacteremia without meningitis: An atypical presentation. Vol. 21, IDCases. \n2020. p. e00897.\n7. Winstead JM, McKinsey DS, Tasker S, De Groote MA, Baddour LM. \nMeningococcal Pneumonia: Characterization and Review of Cases Seen \nOver the Past 25 Years. Clin Infect Dis [Internet]. 2000 Jan 1;30(1):87-94. \nAvailable from: https://doi.org/10.1086/313617Laura Aizpiri et al.  www.ramib.org \nJunta Directiva de la Reial Acad\u00e8mia de Medicina de les Illes Balears\n President   Maci\u00e0 Tom\u00e0s Salv\u00e0 \n Vicepresident   \u00c1ngel Arturo L\u00f3pez Gonz\u00e1lez\n Secretari General   Antonio Ca\u00f1ellas Trobat\n Vicesecretari   Sebastian Cresp\u00ed Rotger \n Tresorer   Joan Besalduch Vidal \n Bibliotec\u00e0ria   Antonia Barcel\u00f3 Bennasar\nAcad\u00e8mics d\u2019honor\n 2003 - Excm. Sr. Santiago Grisolia Garc\u00eda, Premi Pr\u00edncep d\u2019Ast\u00faries \n 2007 - Excm. Sr. Ciril Rozman, Premi Jaime I\nAcad\u00e8mics numeraris\nM. I. Sra. Juana M. Rom\u00e1n Pi\u00f1ana\nM. I. Sr. Josep Tom\u00e0s Monserrat\nM. I. Sr. Bartomeu Anguera Sans\u00f3\nM. I. Sr. Bartomeu Nadal Moncadas\nM. I. Sr. Alfonso Ballesteros Fern\u00e1ndez\nM. I. Sr. Ferran Tolosa i Caban\u00ed\nM. I.  Sr. Maci\u00e0 Tom\u00e0s Salv\u00e0\nM. I. Sra. Joana M. Sureda Trujillo\nM. I. Sr. Joan Buades Rein\u00e9s\nM. I. Sr. Jos\u00e9 L. Olea Vallejo\nM. I. Sr. Pere Riutord Sbert\nExcm.  Sr. Joan Besalduch Vidal \nM. I. Sr. F\u00e8lix Grases Freixedas\nM. I. Sr. Antoni Ca\u00f1ellas Trobat\nM. I. Sr. Josep Francesc Forteza Albert\u00ed\nM. I. Sr. Jordi Ib\u00e1\u00f1ez Juv\u00e9\nM. I. Sr. Joan March Noguera\nM. I. Sr. \u00c1ngel Arturo L\u00f3pez Gonz\u00e1lez\nM. I. Sra. Pilar Roca Salom\nM. I. Sr. Javier Cort\u00e9s Bordoy\nM. I. Sr. Llu\u00eds Masmiquel Comas\nM. I. Sr. Sebasti\u00e0 Cresp\u00ed Rotger\nM. I. Sra. Ant\u00f2nia Barcel\u00f3 Bennassar\nM. I. Sr. Javier Garau Alemany\nM. I. Sr. Jordi Reina Prieto\nM. I. Sr. Joan M. Benejam Gual\nM. I. Sr. Claudio Rub\u00e9n Mirasso Santos\nM. I. Sr. Josep M\u00aa Vicens G\u00f3mez\nM. I. Sr. Rafael Morales Soriano\nAcad\u00e8mics supernumeraris\nM.I. Sr. \u00c0lvar Agust\u00ed Garc\u00eda-Navarro \nM.I. Sra. Marta Emma Couce Matovelle\nAcad\u00e8mics em\u00e8rits\nM.I. Sr. Arnau Casellas BernatProtectors de la Reial Acad\u00e8mia\nBanca March\nConselleria de Presid\u00e8ncia\nASISA\nConselleria de Salut\nCol\u00b7legi Oficial de Metges de les Illes Balears\nFundaci\u00f3 Patronat Cient\u00edfic del Col\u00b7legi de Metges de les Illes Balears\nBenefactors de la Reial Acad\u00e8mia  \nSalut i For\u00e7a\nPatrocinadors de la Reial Acad\u00e8mia\nCl\u00ednica Rotger\nMetges Rossell\u00f3\nGrup Hospitalari Quir\u00f3nsalud\nCol\u00b7legi Oficial d\u2019Infermeria de les Illes Balears\nAssociaci\u00f3 Espanyola contra el C\u00e0ncer a les Illes Balears\nCol\u00b7legi Oficial de Farmac\u00e8utics de Balears\nEscola Universit\u00e0ria ADEMAwww.ramib.org www.medicinabalear.orgMEDICINA BALEARACADEMIC  JOURNAL  \nOF HEALTH  SCIENCES", "language": "PDF", "image": "PDF", "pagetype": "PDF", "links": "PDF"}